https://rjrindex.com/articles/primary-care-pcp-and-oncology-onc-provider-perspectives-on-primary-care-involvement-in-cancer-cl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-pediatric-and-adolescent-thyroid-carcinoma-incidence-and-survival-in-the-united-states-20 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intermittent-fruquintinib-plus-trifluridinetipiracil-in-refractory-metastatic-colorectal-cancer-mc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-appendiceal-cancer-mortality-in-the-united-states-from-1999-to-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-clinical-outcomes-with-lenvatinib-versus-cabozantinib-post-progression-on-first-line-imm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cv-care-cardiovascular-care-of-androgen-related-effects-in-prostate-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridge-barriers-to-real-world-implementation-of-diagnostic-genomics-quantifying-the-genomic-awarene 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expert-perspectives-in-the-management-of-myelofibrosis-mf-a-survey-of-20-us-based-specialists 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-clinical-factors-impacting-survival-in-malignant-pheochromocytoma-a-population-base 2026-08-24 monthly 0.7 https://rjrindex.com/articles/indocyanine-green-guided-lymphadenectomy-in-gastrectomy-for-gastric-cancer-a-systematic-review-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iparomlimab-and-tuvonralimab-combined-with-paclitaxel-and-cisplatin-as-neoadjuvant-therapy-for-cervi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/scintmatch-a-probabilistic-soft-matching-framework-for-integrating-single-cell-genomes-and-transcri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-randomized-open-label-study-of-pasritamig-jnj-78278343-a-t-cell-engager-targeting-huma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-center-phase-ii-study-of-chemotherapy-sox-plus-tislelizumab-as-first-line-therapy-for-gast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/polypharmacy-discussions-in-older-adults-with-newly-diagnosed-acute-myeloid-leukemia-aml 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-for-identification-of-distinct-tolerance-phenotypes-with-differential-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-and-safety-of-transarterial-chemoembolization-combined-with-apatinib-in-hepatocellular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neo-era-01cleap2507-a-multi-center-single-arm-phase-ii-study-with-neoadjuvant-therapy-of-haic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-high-claudin-18-expression-in-gallbladder-cancer-and-association-with-survival-implic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-disparities-in-hepatocellular-carcinoma-incidence-in-the-united-states-2001-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-gastric-cancer-incidence-by-age-and-sex-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-fertility-preservation-and-pregnancy-after-treatment-in-young-patients-with-brca-associat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-implantable-central-venous-access-devices-chemoports-in-patients-with-malign 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chronotherapy-in-metastatic-melanoma-retrospective-outcomes-of-immunotherapy-administration-timing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-and-demographic-patterns-of-mucosal-lentiginous-melanoma-a-retrospective-ncdb-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastatic-prostate-cancer-and-heart-failure-hospitalizations-an-intersection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adenocarcinoma-with-cartilaginous-and-osseous-metaplasia-a-study-of-demographic-and-socioeconomic-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/when-disaster-strikes-a-scoping-review-of-climate-resilience-toolkits-relevant-to-cancer-care-deliv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-breast-cancer-incidence-mortality-and-disability-adjusted-life-years-in-europe-1990-202 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acute-care-events-after-outpatient-systemic-therapy-among-patients-at-elevated-risk-for-acute-care-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iccnd1i-amplification-and-breast-cancer-specific-survival-in-estrogen-recep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-as-a-surrogate-mortality-and-vascular-risk-in-gastrointestinal-stromal-tumor-after-frailty-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/limitations-in-us-cancer-screening-rate-data-and-opportunities-for-improvement 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-melanoma-of-unknown-versus-known-primary-receiving-immunotherapy-a-systemic-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-malignant-melanoma-in-the-african-union-from-1980-2023-insights-from-the-gbd-2023-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-chemotherapy-induced-neuropathy-and-gabapentin-exposure-among-adults-receiving-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-causes-and-predictors-of-inpatient-mortality-among-cancer-patients-in-a-tertiary-center-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-translational-approach-for-in-vitro-monitoring-of-patient-derived-tumor-organoid-responses-to-anti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-specific-risk-of-mood-and-anxiety-disorders-following-cancer-diagnosis-in-adolescents-and-young 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antibody-drug-conjugate-plus-immunotherapy-versus-chemotherapy-immunotherapy-in-pd-l1-positive-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disrupting-the-microbiome-disrupting-immunity-antibiotic-exposure-and-survival-outcomes-with-immun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pucotenlimab-plus-dose-intensified-radiotherapy-and-chemotherapy-for-locally-advanced-rectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breaking-the-silence-sexual-quality-of-life-in-moroccan-women-after-gestational-trophoblastic-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparison-of-atezolizumabbevacizumab-vs-durvalumabtremelimumab-in-decompensated-hepato 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-body-mass-index-bmi-impact-in-advanced-cholangiocarcinoma-cca-treated-with-chemo-immuno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-remodeling-of-the-tumor-immune-microenvironment-time-on-neoadjuvant-chemo-immunotherapy-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-lung-cancer-mortality-among-adults-younger-than-55-years-a-cdc-wonder-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psma-petct-guided-intensification-of-salvage-radiotherapy-versus-conventional-planning-for-biochemi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-differences-in-adverse-events-associated-with-epidermal-growth-factor-receptor-inhibitor-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/omission-of-postoperative-antibiotic-prophylaxis-after-radical-cystectomy-interim-results-of-the-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-heart-failure-in-breast-cancer-patients-receiving-her2-directed-therapy-a-retr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-risk-the-epidemiology-and-long-term-outcomes-of-early-onset-luminal-b-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-population-specific-ikrasi-alterations-on-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-from-pulmonary-embolism-among-patients-with-lung-and-bronchus-malignancies-national-trend 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-mortality-burden-of-primary-brain-malignancies-versus-brain-metastases-in-the-united-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leptomeningeal-disease-in-alk-positive-nsclc-survival-impact-of-third-generation-alk-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/galeterone-and-gemcitabine-in-advanced-pancreatic-ductal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accelerating-national-burden-of-pancreatic-cancer-in-the-united-states-contemporary-real-world-tren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-and-efficacy-of-neuroendoscopic-resection-of-intraventricular-tumors-a-systematic-review-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adult-medulloblastoma-long-term-follow-up-analysis-of-a-single-center-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultra-lightweight-deep-learning-for-glioma-detection-mobilenet-based-mri-classification-to-enable-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transforming-renal-cell-carcinoma-outcomes-the-paradigm-shift-influenced-by-immune-checkpoint-inhib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-first-in-human-study-of-skb500-in-patients-with-locally-advanced-or-metastatic-solid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-hypofractionation-stereotactic-body-radiotherapy-metastatic-radiotherapy-utilization-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-resident-education-in-ambulatory-oncology-a-novel-flipped-classroom-curriculum-for-intern 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantifying-the-macroeconomic-burden-of-tobacco-attributable-cancers-in-2023-global-disparities-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/embark-testosterone-recovery-to-gt250-ngdl-following-treatment-suspension 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mosunetuzumab-plus-polatuzumab-vedotin-mosun-pola-versus-rituximab-gemcitabine-and-oxaliplatin-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/application-of-unsupervised-genetic-clustering-to-identify-biologically-distinct-cholangiocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-controlled-pilot-study-of-aromatherapy-to-reduce-anxiety-and-pain-during-bone-marrow-as 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-dimensional-multiplex-immunofluorescence-to-reveal-immune-microenvironment-remodeling-in-matche 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-phase-operational-readiness-gaps-in-oncology-cell-and-gene-therapy-trials-and-implications-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-the-nccn-distress-thermometer-to-evaluate-clinically-elevated-levels-of-distress-among-caregiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antibody-drug-conjugate-adc-biomarker-targets-in-endometrial-cancer-ec-molecular-characterizati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-denosumab-treatment-strategies-to-balance-skeletal-related-events-for-prevention-and-oste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-analysis-of-daratumumab-carfilzomib-pomalidomide-and-dexamethasone-in-relapsedrefractory-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-head-to-head-comparison-of-sextant-systematic-biopsy-versus-extended-systematic-biopsy-for-prostat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-mixed-formulation-aprepitant-and-palonosetron-qlm2010-for-prevention-of-cis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-smoking-tumor-genetics-and-outcomes-in-men-with-metastatic-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-nectin4-in-shaping-the-tumor-microenvironment-and-potentiating-the-efficacy-of-immunothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-penpulimab-combined-with-taxanes-and-carboplatin-in-triple-negative-breast-cancer-updat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-immune-related-adverse-events-from-checkpoint-inhibitors-in-cancer-patients-with-autoimmune 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-a-feasibility-and-safety-trial-of-tile-based-radiation-therapy-with-cesium-131-followed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-drug-industry-payments-to-oncologists-and-use-of-guideline-preferred-cancer-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/when-autoimmunity-meets-immunotherapy-immune-checkpoint-inhibitors-in-cancer-patients-with-rheumato 2026-08-24 monthly 0.7 https://rjrindex.com/articles/signatures-of-biological-heterogeneity-associated-with-treatment-outcome-in-diffuse-large-b-cell-lym 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-durvalumab-plus-neoadjuvant-chemoradiotherapy-cross-with-and-without-tremelimumab-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dual-brafmek-inhibition-in-ibrafi-supv600esup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-biliary-drainage-in-malignant-biliary-obstruction-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immunotherapy-in-combination-with-chemotherapy-in-resectable-locally-advanced-head-and-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/body-mass-index-bmi-and-overall-survival-os-among-hispanic-patients-treated-with-immune-checkpoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-generation-h1-antihistamine-use-with-survival-and-immune-related-outcomes-in-lung-cancer-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-chemotherapy-with-nab-paclitaxel-and-cisplatin-versus-docetaxel-cisplatin-and-fluorourac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-oncogenic-protein-sequestration-by-platelets-on-early-and-stage-specific-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-ikrasi-co-mutations-on-the-efficacy-of-durval 2026-08-24 monthly 0.7 https://rjrindex.com/articles/suicide-gene-therapy-for-recurrent-glioblastoma-using-allogeneic-bone-marrow-derived-mesenchymal-ste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disease-kinetics-and-practice-patterns-in-4-year-long-term-beneficiaries-of-immune-checkpoint-inhi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-venous-thromboembolism-in-lung-cancer-patients-treated-with-chemotherapy-versus-immunotherap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncologic-safety-of-autologous-fat-grafting-as-part-of-local-regional-management-of-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-safety-and-antitumor-activity-from-a-first-in-human-phase-1-study-of-awt020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/individualizing-first-line-treatment-choices-in-metastatic-urothelial-carcinoma-muc-results-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-epigenomic-profiling-for-identification-of-mechanisms-of-sensitivity-primary-and-acquired-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-ii-clinical-trial-of-a-fasting-mimic-diet-prior-to-chemotherapy-to-evaluate-the-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/c-met-expression-by-ihc-and-response-to-cabozantinib-in-patients-with-relapsed-refractory-germ-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-rhamnose-derived-from-gut-microbiome-in-modulating-the-efficacy-of-non-small-cell-lung-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/costs-per-avoided-event-cpae-in-adjuvant-cdk46-inhibitor-therapy-a-comparative-analysis-of-subgr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-biological-and-immune-microenvironment-features-of-msi-h-braf-supv600 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-delta-like-ligand-3-dll3-expression-levels-and-characteristics-of-patients-pts-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-tumor-mutation-profiles-preoperative-circulating-tumor-dna-ctdna-and-clinical-featur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/soluble-cd137-in-health-and-disease-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptional-correlates-of-iarnti-expression-and-its 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cadonilimab-combined-with-anlotinib-in-patients-with-advanced-nsclc-refractory-to-prior-systemic-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disentangling-ikeap1i-and-istk11 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitor-therapy-in-patients-with-advanced-cancer-and-chronic-viral-infections-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-of-ki-67-index-and-histologic-grade-between-biopsy-and-surgical-specimens-in-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-landscape-of-gynecological-malignancies-in-india-as-associated-with-distinct-msi-and-histo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-clinical-and-genomic-landscape-of-bilateral-parenchymal-non-small-cell-lung-cancer-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-and-clinical-characteristics-of-women-lt-50-years-and-impact-on-adjuvant-chemothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-ct-use-by-oncotype-dx-o-dx-recurrence-score-rs-in-hormone-receptor-positive-her2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-pkpd-and-efficacy-results-from-expand-1-a-phase-1-dose-escalation-study-of-the-novel-pd-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-induced-gut-microbiota-taxonomic-deviation-and-its-association-with-outcomes-and-toxici 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-mortality-due-to-brain-metastases-secondary-to-lung-cancer-in-the-united-states-a-populat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vepdegestrant-a-proteolysis-targeting-chimera-protac-estrogen-receptor-er-degrader-plus-atirmo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncological-safety-of-oncoplastic-breast-conservation-surgery-experience-of-over-a-decade-in-early 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-autologous-tumor-infiltrating-lymphocytes-gt201-plus-toripalimab-in-recurrent-or-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-high-dose-chemotherapy-in-adult-patients-with-relapsed-or-refractory-medulloblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-of-brain-tumors-complicated-by-respiratory-failure-national-patterns-and-forecaste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/projected-trends-in-ischemic-heart-disease-mortality-among-patients-with-multiple-myeloma-in-the-uni 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-characteristics-and-inpatient-outcomes-of-early-onset-pancreatic-cancer-in-the-united-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-outcomes-and-early-survival-after-curative-intent-non-small-cell-lung-cancer-nsclc-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/group-based-versus-individualized-exercise-programs-in-lung-cancer-results-from-the-randomized-cros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rapid-multi-task-intraoperative-diagnosis-of-lung-cancer-via-deep-neural-network-driven-label-free-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-international-phase-iii-randomized-double-blind-double-dummy-trial-comparing-duloxetine-and-pre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-sequential-androgen-receptor-pathway-inhibitors-arpis-versus-novel-therapies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-immunogenicity-and-efficacy-of-ad5f35-gucy2c-padre-vaccine-in-patients-with-gi-cancers-at 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precemtabart-tocentecan-precem-tct-m9140-an-anti-ceacam5-antibody-drug-conjugate-adc-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/are-socio-economic-status-indicators-barriers-for-enrollment-in-phase-1-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-toxicity-across-epidermal-growth-factor-receptor-egfr-tyrosine-kinase-inhibitors-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-late-recurrence-patterns-and-immune-landscape-of-her2-positive-invasive-lobular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-egfr-alk-and-pd-l1-testing-performance-and-end-to-end-intervals-in-colombian-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-arpi-sequencing-in-mcrpc-a-propensity-matched-real-world-comparison-of-su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intraoperative-precision-margin-assessment-in-breast-conserving-surgery-using-handheld-fluorescence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-performance-status-as-a-predictive-tool-for-mortality-and-supportive-care-needs-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-urcc-ncorp-research-base-nationwide-phase-ii-randomized-controlled-trial-rct-investigating-the-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-homologous-recombination-deficiency-hrd-in-gastric-cancer-real-world-prevalence-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-enabled-clinical-trial-framework-for-end-to-end-site-recommendation-and-enrollment-projection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prophylactic-vs-reactive-peg-tube-placement-in-early-stage-head-and-neck-hampn-cancer-treated-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-circulating-tumor-dna-ctdna-burden-detected-mutations-and-clinical-outcomes-in-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/asc4first-wk-144-analysis-efficacy-and-safety-and-tolerability-with-asciminib-asc-vs-investigator 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-translational-analysis-of-a-phase-ibii-combination-of-atezolizumab-cobimetinib-and-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stage-specific-circulating-tumor-dna-ctdna-positivity-and-minimal-residual-disease-mrd-decision 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fruquintinib-plus-folfiri-or-mfolfox6-as-second-line-therapy-for-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pharmacokinetics-and-pharmacodynamics-of-the-gcn2-activator-hc-7366-in-a-phase-1a-study-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spino-rt-a-multicenter-randomized-controlled-phase-iii-study-of-adjuvant-radiotherapy-versus-surve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-of-liposomal-curcumin-in-combination-with-standard-radiation-and-temozolomide-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aspirin-use-and-outcomes-with-immune-checkpoint-inhibitors-in-metastatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-atypical-iegfri-mutations-in-early-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-and-racial-disparities-in-receipt-of-treatment-among-early-stage-erpr-her2-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/action-phase-1-study-of-sup225sup-acac-psma-617 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-quality-of-life-hrqol-in-the-phase-3-trial-of-standard-chemotherapy-alone-or-combin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-combined-with-induction-chemotherapy-and-concurrent-chemoradiotherapy-in-locally-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-evaluation-and-mitigation-strategies-for-approved-oncology-drug-and-non-cellular-biologic-produ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-safety-and-efficacy-of-puxitatug-samrotecan-puxi-sam-azd8205-in-patients-pts-with-endom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/promise-or-predicament-real-world-analysis-of-molecular-targets-and-therapy-approaches-in-uro-oncol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/next-generation-adcs-and-emerging-conjugate-platforms-in-breast-cancer-a-clinicaltrialsgov-landsca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptomic-profiling-to-identify-cancer-immune-meta-programs-in-penile-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sentinel-lymph-node-positivity-in-microinvasive-breast-cancer-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antiviral-prophylaxis-to-prevent-hepatitis-b-reactivation-in-patients-receiving-anti-cd20-based-chem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-versus-delayed-initiation-of-first-line-immune-checkpoint-inhibitors-in-metastatic-non-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surrogate-end-points-for-overall-survival-a-meta-analysis-exploring-adequacy-of-progression-free-su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-efficacy-of-cognitive-behavioral-therapy-on-anxiety-depression-and-distress-in-peopl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expressive-writing-for-body-image-distress-and-anxiety-in-adolescent-and-young-adult-cancer-survivor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-transarterial-chemoembolization-combined-with-donafenib-for-hepatocellular-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pcsk9-inhibitors-and-association-with-lower-risk-of-metastasis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-a-multi-cancer-early-detection-test-mced-for-detecting-small-hepatocellular-carcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deb-tace-combined-with-apatinib-and-camrelizumab-as-second-line-therapy-for-unresectable-intrahepati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-ivonescimab-combined-with-liposomal-irinotecan-in-patients-with-small-cell-lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-the-rs72725854agtt-allele-and-prostate-cancer-in-males-of-african-ancestry-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-electronic-patient-reported-outcome-measure-eprom-triggered-collaborative-care-cc-bas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tbcrc-050-a-phase-1b2-trial-of-niraparib-and-trastuzumab-in-her2-positive-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-efficacy-between-2-and-3-cycles-of-neoadjuvant-immunotherapy-combined-with-chemotherap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-tumor-regression-after-neoadjuvant-immunochemotherapy-in-oral-squamous-cell-carcinoma-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-and-enablers-to-pediatric-palliative-care-integration-in-low-and-middle-income-countries 2026-08-24 monthly 0.7 https://rjrindex.com/articles/indirect-comparison-of-nivolumab-ipilimumab-versus-chemotherapy-chemo-andor-immunotherapy-in-dmmr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/osteoporosis-and-osteoporosis-related-fractures-among-older-male-cancer-patients-a-nationwide-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clonal-hematopoiesis-as-a-predictor-of-immune-toxicity-and-efficacy-after-chimeric-antigen-receptor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/classification-tree-phenotypes-for-early-treatment-limiting-toxicity-after-androgen-receptor-pathway 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hrs-1167-m9466-a-parp1-inhibitor-combined-with-abiraterone-acetate-and-prednisone-in-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-after-unrelated-donor-allogeneic-hematopoietic-cell-transplantation-in-age-65-using-post-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-overall-survival-os-in-patients-pts-with-her2-positive-her2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/symptom-based-individual-risk-prediction-for-late-mortality-a-report-from-the-childhood-cancer-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-validation-of-artificial-intelligence-ai-based-stratipath-breast-risk-stratification-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/parent-willingness-to-enroll-children-with-acute-lymphoblastic-leukemia-in-escalation-and-de-escalat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peritumoral-stiffness-as-a-novel-noninvasive-biomarker-predicting-tace-response-in-intermediate-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-socioeconomic-and-clinical-factors-with-overall-survival-in-immunotherapy-eligible-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detecting-imtapi-loss-in-liquid-biopsies-from-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantitative-baseline-ctdna-as-a-prognostic-biomarker-in-metastatic-urothelial-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-feasibility-of-accelerated-consolidative-gamma-knife-radiotherapy-following-brain-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-associations-between-ambient-pm25-and-pm10-and-lung-cancer-hospital-admissions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-as-a-shaper-of-immune-communication-in-the-triple-negative-breast-cancer-microenvironme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-bg-c9074-b7-h4-targeting-adc-in-advanced-solid-tumors-dose-escalation-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-thoracic-radiotherapy-in-metastatic-non-small-cell-lung-cancer-during-the-imm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantum-mechanics-based-multi-tensor-aiml-as-predictor-of-patients-overall-survival-gene-targets 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-prior-immune-checkpoint-inhibition-on-the-clinical-efficacy-of-belzutifan-in-advanced-rena 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-a-hybrid-tumor-informed-and-tumor-agnostic-ctdna-assay-for-optimal-ctdna-mrd-detection-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/seer-based-projections-of-us-meningioma-and-glioblastoma-incidence-and-survival-through-2050 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-access-to-onc201-dordaviprone-trials-for-pediatric-diffuse-midline-glioma-in-the-united 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-structural-factors-associated-with-access-to-stereotactic-body-radiation-therapy-sbrt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-chemotherapy-delivery-following-neuropathy-in-patients-with-stage-i-iiia-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-applicability-of-the-21-gene-assay-to-inform-chemotherapy-benefit-in-lymph-node-positive-hormone 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-sys6043-a-novel-b7-h3-targeting-antibody-drug-conjugate-in-patients-with-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-exchange-in-myeloma-associated-acute-kidney-injury-a-multicenter-propensity-matched-cohort-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-multicenter-validation-of-a-machine-learning-framework-for-predicting-severe-myelosu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sacituzumab-tirumotecan-sac-tmt-plus-pembrolizumab-p-versus-pembrolizumab-p-as-first-line-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-geography-the-intersecting-impact-of-rurality-race-and-depression-on-breast-cancer-surviva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/penpulimab-plus-oral-anlotinib-and-capecitabine-as-first-line-treatment-for-recurrent-or-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalized-n-of-1-combinations-based-on-molecular-profiles-in-advanced-malignancies-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inferring-optimal-detection-of-homozygous-loss-homozygous-deletion-in-head-and-neck-cancer-associ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/soho-01-updated-safety-and-efficacy-of-sevabertinib-in-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-electronic-frailty-index-used-to-identify-high-risk-older-adults-receiving-chimeric-antigen-rece 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-genomic-co-mutation-profiles-including-tp53-in-resected-early-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thymoma-type-a-nos-a-national-cancer-database-study-of-demographic-and-socioeconomic-factors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-of-baseline-fatigue-and-severe-cancer-treatment-toxicity-by-comorbid-conditions-a-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-and-hiv-status-as-survival-predictors-in-hhv8-positive-diffuse-large-b-cell-lymphoma-the-larges 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-machine-learning-ml-based-six-gene-signature-for-risk-stratification-and-therapeutic-target-iden 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-toxicity-in-early-phase-cancer-clinical-trials-a-review-of-sponsor-supplied-information-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-remote-therapeutic-monitoring-with-patient-reported-outcomes-on-hospitalization-in-real-wo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-of-its-kind-multi-omic-assay-using-lipids-and-proteins-to-identify-early-stage-ovarian-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-ai-derived-lung-cancer-risk-and-social-determinants-of-health-to-improve-risk-stratifica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/budget-impact-analysis-of-heated-intraperitoneal-chemotherapy-at-interval-cytoreductive-surgery-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-apatinib-plus-camrelizumab-in-renal-cell-carcinoma-with-inferior-vena-cava-tumor-thrombu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fragmentia-ai-lymphoma-a-cfdna-language-model-for-lymphoma-detection-using-ultra-low-pass-wgs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-shocks-and-advance-care-planning-among-us-older-adults-evidence-from-hrs-2012-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-adoption-and-sequencing-of-cldn182-pd-l1-and-her2-testing-in-advanced-gastric-and-gast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surufatinib-plus-kn046-and-chemotherapy-as-first-line-treatment-for-advanced-pancreatic-ductal-adeno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-adoption-of-comprehensive-genomic-profiling-in-a-national-cohort-of-patients-with-resecte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-use-of-generative-ai-tools-by-cancer-patients-and-caregivers-a-cross-sectional-survey-of-awaren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-steroid-exposure-with-overall-survival-and-hypersensitivity-reaction-risk-in-paclitax 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-plinabulin-plindocetaxel-doc-plus-pembrolizumab-pemb-in-metastatic-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-significance-of-the-preoperative-cachexia-index-as-a-prognostic-predictor-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-high-risk-genomic-alterations-on-survival-outcomes-in-patients-with-stage-iii-non-small-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-prior-chemotherapy-ct-on-dabrafenib-plus-trametinib-d-t-outcomes-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-nodal-burden-in-tailor-rt-eligible-breast-cancer-an-ncdb-analysis-informing-regional-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-integrated-routine-biomarkers-for-breast-cancer-risk-stratification-a-scalable-str 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-intensive-care-unit-outcomes-for-lung-cancer-patients-a-15-year-analysis-of-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-folfox-with-or-without-bevacizumab-in-small-bowel-and-ampullary-adenocarcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anti-cd38-treatment-patterns-in-multiple-myeloma-patients-with-medicaremedicaid-versus-private-insu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-malnutrition-on-in-hospital-outcomes-among-young-adults-hospitalized-with-gastrointestina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-outcomes-and-disparities-in-lung-cancer-related-hospitalizations-in-the-united-states-2012 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-antihypertensive-drug-classes-in-patients-with-gastrointestinal-maligna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/placing-oncology-and-conflicts-of-interest-in-a-global-context-evidence-from-the-large-internationa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-interactions-between-immune-cells-as-a-predictor-of-pcr-to-neoadjuvant-chemotherapy-nact-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liquid-biopsy-with-peripheral-blood-mononuclear-cells-deciphering-systemic-immunity-to-predict-parp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mtor-activation-and-racial-disparity-in-early-breast-cancer-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reporting-of-sex-related-data-in-landmark-phase-iii-solid-tumor-trials-presented-at-asco-2025 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bispecific-antibodies-in-the-treatment-of-relapsed-refractory-multiple-myeloma-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-value-based-breast-cancer-screening-in-a-safety-net-health-system-a-multimodal-approach-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characteristics-and-outcomes-of-a-real-world-cohort-of-carcinoma-of-unknown-primary-determ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodal-immune-profile-score-ips-signature-as-a-predictive-response-biomarker-to-immune-checkpo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/defining-second-line-sequencing-in-advanced-renal-cell-carcinoma-a-systematic-review-and-meta-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/1l-olomorasib-plus-pembrolizumab-chemotherapy-in-ikrasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-learning-identification-of-high-risk-lung-adenocarcinoma-histologic-subtypes-a-decision-suppor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-frontline-gemcitabine-5-fluorouracilleucovorin-and-cisplatin-gemflp-in-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/scaling-prior-authorization-for-philanthropic-funding-with-artificial-intelligence-ai-five-year-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-of-a-phase-2-trial-of-cabozantinib-plus-nivolumab-cabonivo-in-patients-with-non-clea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-deulorlatinib-tgrx-326-in-patients-with-locally-advanced-or-metastatic-alk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-pancreatic-cancer-incidence-and-shifting-survival-trends-in-the-united-states-1999-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-detection-of-second-primary-solid-tumors-in-patients-with-an-index-solid-malignancy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-selection-for-first-and-second-line-therapy-and-survival-outcomes-in-advanced-biliary-tra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-racial-and-ethnic-reporting-in-clinical-trials-cited-by-the-nccn-bladder-cancer-treatm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-trial-resq201a-of-nogapendekin-alfa-inbakicept-nai-plus-tislelizumab-and-docetaxel-vs-doc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-tislelizumab-and-apatinib-combined-with-hepatic-arterial-infusion-chemotherap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-polatuzumab-rituximab-and-lenalidomide-in-frail-pts-with-diffuse-large-b-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nrg-gy037-a-phase-iii-randomized-trial-of-induction-chemotherapy-and-pembrolizumab-followed-by-chem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-23-study-of-eik1001-in-combination-with-pembrolizumab-and-chemotherapy-in-participants-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-yttrium-90-radioembolization-on-epigenomic-immune-remodeling-in-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antitumor-efficacy-of-2-11-dimethyl-1h-benzoeindol-2-yl-567-trichloro-13-tropolone-on-variou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ibiii-randomized-double-blinded-placebo-controlled-study-of-suvemcitug-combined-with-triflu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inca033890-303-a-randomized-double-blind-phase-3-study-of-folfox-and-bevacizumab-with-or-without 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sonrotoclax-bgb-11417-zanubrutinib-sz-vs-venetoclax-acalabrutinib-av-in-treatment-naive-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-chimeric-antigen-receptor-t-cell-therapy-in-diffuse-large-b-cell-lymphoma-dlbcl-a-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-inpatient-outcomes-with-cannabis-use-disorder-in-head-and-neck-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/symptom-profiles-and-cancer-stage-at-diagnosis-in-gastroesophageal-junction-adenocarcinoma-an-ordin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-versus-delayed-biologic-therapy-for-immune-checkpoint-inhibitor-associated-colitis-a-propensi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-trends-in-car-t-cell-therapy-and-bispecific-antibodies-among-medicare-beneficiaries-a-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-performance-of-child-pugh-and-meld-scores-in-critically-ill-patients-with-hepatocellular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-following-surgery-versus-non-surgical-management-for-gallbladder-cancer-patients-presenting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-immune-checkpoint-inhibitors-combined-with-chemotherapy-and-lenvatinib-for-biliary-tract-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-infiltrative-hepatocellular-carcinoma-and-efficacy-of-combination-treatment-for-conversio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lymphoma-histology-as-independent-predictor-of-icu-mortality-after-adjustment-for-illness-severity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-care-connected-access-and-remote-expertise-beyond-walls-pilot-phase-2-clinical-trial-to-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-of-response-to-sup177sup-lu-dotatat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/op-neu-101-a-phase-12-open-label-dose-finding-and-expansion-study-to-investigate-the-safety-and-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-inpatient-outcomes-in-hispanic-patients-with-primary-hccbiliary-tract-cancer-a-retrospe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-study-evaluating-microbiome-modulation-therapy-in-patients-undergoing-first-line-therapy-for-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-communication-about-cancer-management-and-cancer-care-delivery-for-older-adults-with-demen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-stratification-in-systemic-al-amyloidosis-with-cardiac-involvement-using-a-multiparametric-echo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-distinct-immune-microbiome-axis-in-early-onset-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-extent-of-consensus-among-oncologists-in-treatment-selection-for-nsclc-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-solid-tumor-patients-characteristics-and-cure-expectations-with-their-portal-reporte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-cost-of-inequity-estimating-the-impact-of-delayed-access-to-neoadjuvant-pertuzumab-in-canada 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-cardiotoxicity-the-hidden-burden-of-functional-disability-in-cardio-oncology-survivorship 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-disparities-in-sepsis-associated-mortality-among-patients-with-gastrointestinal-mal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/t-cell-prolymphocytic-leukemia-a-review-of-induction-therapies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-1-trial-of-cisplatin-based-chemotherapy-with-or-without-sodium-thiosulfate-for-men 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-features-and-prognosis-of-anaplastic-and-poorly-differentiated-thyroid-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-survival-after-induction-immunochemotherapy-followed-by-concurrent-chemoradiotherapy-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analyzing-variants-and-methylation-in-complex-genomic-regions-using-targeted-long-read-nanopore-sequ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reporting-of-propranolol-use-in-studies-of-beta-blockers-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/attenuation-of-long-term-survival-benefit-of-biological-therapy-in-metastatic-colorectal-cancer-mcr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-melanoma-mortality-among-us-adults-aged-55-before-and-after-the-introduction-of-immunot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genome-wide-association-study-of-tyrosine-kinase-inhibitor-induced-hepatotoxicity-in-all-of-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frailty-phenotypes-and-acute-care-escalation-in-hospitalized-patients-with-solid-tumors-a-national 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pilot-rct-to-study-the-effect-of-chronotherapy-on-gefitinib-plasma-concentrations-and-adherence-in-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/uniting-providers-across-institutions-to-support-osteosarcoma-care-insights-from-64-cases-reviewed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/faith-in-the-balance-examining-religious-and-spiritual-influences-on-cancer-treatment-decisions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-yield-of-percutaneous-versus-open-surgical-biopsy-for-tibial-bone-lesions-a-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-time-breath-volatile-organic-compound-analysis-for-detection-of-newly-diagnosed-treatment-naiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progression-patterns-and-management-after-frontline-platinum-in-advanced-epithelial-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/morphological-features-of-melanoma-destruction-under-the-influence-of-egfr-inhibitors-gefitinib-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-performance-of-chatgpt-in-addressing-ethical-dilemmas-in-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-real-world-effectiveness-of-all-approved-brafmek-inhibitor-combinations-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/contemporary-outcomes-and-treatment-patterns-in-neuroendocrine-carcinoma-of-the-breast-a-population 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-anlotinib-plus-docetaxel-versus-docetaxel-monotherapy-in-advanced-non-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-iruplinalkib-in-ialki 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-cancer-stem-cell-markers-on-survival-outcomes-in-solid-tumors-a-systematic-rev 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-neoadjuvant-concomitant-polychemotherapy-tec-versus-dose-dense-regimen-in-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-in-triple-negative-breast-cancer-tnbc-in-patients-with-residual-disease-after 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proof-of-concept-for-machine-learning-based-models-to-predict-response-to-anticancer-treatments 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-adjuvant-immunotherapy-on-stage-iii-acral-malignant-melanoma-alm-in-a-peruvian-cancer-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-ai-guided-multi-analyte-precision-oncology-based-platform-on-clinical-outcomes-in-treatmen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-anthracycline-containing-and-anthracycline-free-neoadjuvant-regimens-in-her2-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-system-inequities-as-a-mediator-of-age-related-survival-differences-in-high-grade-serous-ovar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-intratumoral-ifusobacterium-nucleatumi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evolution-of-treatment-and-survival-in-primary-tracheal-cancer-insights-from-a-global-real-world-da 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiotoxicity-diagnoses-and-inpatient-outcomes-in-principal-breast-cancer-hospitalizations-nationa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-genomic-landscapes-at-single-cell-resolution-of-pulmonary-and-salivary-adenoid-cystic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-external-validation-of-a-recursive-attention-based-multimodal-deep-learning-model-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recurrence-modeling-with-electronic-health-records-through-natural-language-processing-and-machine-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-concurrent-chemoradiotherapy-withwithout-nimotuzumab-in-high-risk-patients-with-loc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-experience-of-cancer-patients-with-clonal-hematopoiesis-in-an-urban-county-hospital-syste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subtype-specific-representation-of-thyroid-cancers-in-contemporary-basket-clinical-trials-2018-2024 2026-08-24 monthly 0.7 https://rjrindex.com/articles/short-course-radiotherapy-followed-by-ivonescimab-and-capox-as-neoadjuvant-therapy-for-locally-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determinants-of-pathologic-complete-response-in-early-stage-triple-negative-breast-cancer-at-a-singl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/automated-abstraction-of-colorectal-cancer-registry-data-using-ai-accuracy-and-implementation-insig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-ovarian-cancer-detection-with-a-multiomic-liquid-biopsy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-quality-of-life-and-breast-specific-symptoms-among-long-term-survivors-of-breast-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tp53-loss-in-relation-to-mtorc1-activation-and-autophagy-suppression-shaping-an-immune-cold-phenotyp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-complications-and-perioperative-outcomes-following-total-mesorectal-excision-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-mortality-trends-in-colorectal-cancer-patients-with-psychiatric-and-respiratory-comorbiditi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-baseline-neurological-disorders-on-composite-gastrointestinal-toxicity-risk-in-cancers-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-molecular-landscape-of-mtap-deleted-thoracic-tumors-across-western-and-asian-cohorts-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-and-healthcare-resource-utilization-of-emergency-department-visit-etiology-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-amivantamab-monotherapy-in-advanced-egfr-mutant-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-cervical-cancer-and-heart-failure-mortality-a-21-year-retrospective-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/language-use-and-its-relationship-to-patient-experience-and-treatment-compliance-in-genitourinary-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/failure-to-rescue-following-major-surgical-complications-in-gynecologic-oncology-a-national-inpatie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-mrd-and-post-remission-strategies-on-outcomes-following-dose-dense-mini-hyper-cvd-inot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1ab-study-of-ab248-a-cd8-selective-il-2-mutein-fusion-protein-alone-or-in-combination-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-clinical-trial-investigating-the-safety-pharmacokinetics-pharmacodynamics-and-antitumor-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hepatic-arterial-infusion-chemotherapy-combined-with-immunotherapy-for-unresectable-intrahepatic-cho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-gata6-expression-as-a-biomarker-in-advanced-pancreatic-cancer-real-world-evidence-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-bl-m14d1-a-novel-dll3-directed-antibody-drug-conjugate-adc-in-patients-with-loc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dysregulation-of-the-insulin-like-growth-factor-system-in-non-small-cell-lung-cancer-tissue-and-hist 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concurrent-chemoradiotherapy-plus-cytokine-induced-killer-cells-therapy-or-observation-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/redtail-a-next-generation-systemic-platform-for-tumor-localized-expression-of-bites-and-immune-acti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/training-fellows-in-genomic-oncology-a-pilot-team-based-workshop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iia-study-of-tosposertib-a-dual-tgfvri-and-vegfr2-inhibitor-in-combination-with-pembrolizuma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psychological-burden-and-burnout-among-regional-healthcare-providers-communicating-hereditary-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cellular-consequences-of-a-germline-ismc5i-variant-enri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evolving-management-of-advanced-stage-resectable-cutaneous-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-efficacy-and-safety-of-tiragolumab-plus-atezolizumab-across-solid-tumors-a-meta-analysis-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-retifanlimab-across-solid-tumors-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-level-clinical-response-dynamics-in-advanced-melanoma-with-anzutresgene-autoleucel-anzu-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transposable-elements-and-homotypic-niches-as-drivers-of-immune-dynamics-and-resistance-in-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whole-genome-profiling-to-identify-chromosomal-instability-as-a-distinct-feature-of-lung-cancer-brai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-expression-of-ciita-the-master-mhc-ii-regulator-as-a-predictor-of-survival-benefit-from-immun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b2-study-of-jk06-a-5t4-targeted-antibody-drug-conjugate-adc-in-patients-with-unresecta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-evaluation-of-the-prame-targeted-immtac-brenetafusp-in-advanced-melanoma-mel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/blinded-comparison-of-natural-killer-cell-detection-with-ai-driven-nanophotonic-imaging-versus-tradi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-genetic-polymorphism-underlying-immune-checkpoint-inhibitor-induced-endocrine-toxicity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-integrated-transcriptomic-clustering-for-prognostic-stratification-in-epithelioid-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surufatinib-combined-with-toripalimab-for-the-treatment-of-recurrent-ovarian-clear-cell-carcinoma-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-a-clinical-research-coordinator-led-care-delivery-model-crc-model-in-an-early-phase-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-ivermectin-medication-records-with-cancer-as-the-primary-diagnosis-following-public-attent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-a-novel-pd-l14-1bb-bispecific-antibody-qlf31907-in-previously-treated-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-ntx1088-a-first-in-class-anti-pvr-monoclonal-antibody-as-monotherapy-and-combined 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-early-onset-paradox-of-gastric-cancer-assessment-of-geographic-clustering-biology-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/developing-harmonized-tumor-microenvironment-subtypes-for-patient-stratification-in-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-phase-iii-study-evaluating-cts3497-an-mta-cooperative-prmt5-inhibitor-in-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rural-urban-disparities-in-demographics-clinical-characteristics-and-hospitalization-burden-among 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-learning-derived-mri-features-for-risk-stratification-in-post-surgical-ii 2026-08-24 monthly 0.7 https://rjrindex.com/articles/consolidation-pd-l1-inhibitor-after-definitive-chemoradiotherapy-for-unresectable-stage-iii-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-payer-based-disparities-in-inpatient-resource-utilization-and-mortality-among-patients-ho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-impact-of-treatment-timing-with-recombinant-human-thrombopoietin-for-cancer-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/population-based-analysis-of-cancer-disparities-and-social-determinants-of-health-in-hereditary-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-tumor-naive-methylation-based-preoperative-ctdna-testing-with-pathologic-upstaging-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-evaluating-ssgj-707-pf-08634404-a-pd-1vegf-bispecific-antibody-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-burden-and-outcomes-across-gastrointestinal-cancer-subtypes-among-younger-adults-in-the-un 2026-08-24 monthly 0.7 https://rjrindex.com/articles/histopathology-verified-comparison-of-fet-pet-and-contrast-enhanced-mri-for-tumor-visualization-in-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-randomized-phase-2-trial-of-ramucirumab-and-pembrolizumab-versus-pembrolizumab-as-fir 2026-08-24 monthly 0.7 https://rjrindex.com/articles/renal-function-eligibility-in-multiple-myeloma-car-t-and-bispecific-antibody-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comorbidities-as-independent-predictors-of-mortality-in-lung-cancer-a-real-world-multivariate-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acute-respiratory-distress-syndrome-and-non-metastatic-solid-tumor-a-propensity-score-matched-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/self-reported-ethnicity-and-outcomes-of-newly-diagnosed-multiple-myeloma-ndmm-in-the-anti-cd38-mon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-first-in-human-study-of-avzo-021-a-selective-cyclin-dependent-kinase-2-inhibitor-cdk2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multiomic-machine-learning-integration-of-dna-and-rna-features-to-predict-immunotherapy-benefit-in-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-dedicated-care-coordination-on-access-to-multidimensional-support-services-in-young-onset 2026-08-24 monthly 0.7 https://rjrindex.com/articles/copernicus-a-pragmatic-phase-2b-study-of-first-line-1l-subcutaneous-sc-amivantamab-ami-laze 2026-08-24 monthly 0.7 https://rjrindex.com/articles/scalable-knowledge-distillation-for-thyroid-cancer-diagnosis-resnet-based-ultrasound-classification 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-mechanical-ventilation-in-metastatic-cancer-hospitalizations-a-national-inpatient-sam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-clonality-analysis-of-patients-with-metastatic-lung-limited-non-small-cell-lung-carcinoma-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-class-pd-1il-2-supa-biassup-bispecific-antibo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-pathology-driven-graph-neural-network-modeling-for-predicting-response-to-neoadjuvant-immuno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/body-composition-and-quality-of-life-qol-with-lenvatinib-everolimus-len-eve-versus-cabozanti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antibody-mediated-targeting-of-secretory-protein-scube3-for-cancer-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/to-re-test-or-not-evaluating-candidacy-for-precision-therapy-in-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-testing-patterns-and-patient-outcomes-for-metastatic-nsclc-crc-and-metastaticrecurrent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detection-of-mutational-signatures-in-advanced-cancer-patients-using-clinical-grade-specimens 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-cabazitaxel-plus-carboplatin-versus-cabazitaxel-alone-in-metastatic-castratio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iiia-first-in-human-multicenter-monotherapy-and-combination-therapy-with-nivolumab-dose 2026-08-24 monthly 0.7 https://rjrindex.com/articles/behavioral-predictors-of-pain-control-among-adult-cancer-survivors-examining-the-impact-of-smoking 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toripalimab-plus-chemotherapy-and-radiotherapy-for-treatment-naive-advanced-esophageal-squamous-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-analysis-of-cabomain-a-prospective-single-arm-phase-2-clinical-trial-of-cabozantinib-as-ma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-machine-learning-algorithm-for-optimizing-treatment-selection-for-patients-with-up-to-three-hepato 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incorporating-ca19-9-testing-in-a-prospective-study-of-pancreatic-cancer-surveillance-pcs-among-hi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/benchmarking-the-keynote-811-standard-of-care-using-ai-reconstructed-external-control-arms-in-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-azer-cel-an-allogeneic-cd19-car-t-for-the-treatment-of-patients-with-relapse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-selective-serotonin-reuptake-inhibitor-use-and-outcomes-in-metastatic-melanoma-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-a-whole-food-plant-based-diet-wfpbd-on-weight-and-metabo-inflammation-in-men-with-prosta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-safety-and-genetic-analysis-of-orelabrutinib-combined-with-rituximab-as-first-line-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-prior-sars-cov-2-infection-with-advanced-cancer-presentation-in-newly-diagnosed-solid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-concomitant-medications-on-immune-checkpoint-inhibitor-outcomes-in-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/three-monthly-gonadotropin-releasing-hormone-agonist-for-ovarian-function-suppression-in-premenopaus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-bevacizumab-on-the-efficacy-of-antibody-drug-conjugates-as-later-line-treatment-of-basal-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-actionable-machine-learning-driven-clinicogenomic-model-as-a-predictor-of-brain-metastasis-risk-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/car-t-cell-detection-and-clonality-assessment-in-immune-effector-cell-associated-enterocolitis-follo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-tgf-v-inhibition-galunisertib-enhance-response-to-enzalutamide-in-metastatic-castration-resist 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicenter-phase-2-study-of-hydroxychloroquine-hcq-and-chlorphenesin-carbamate-cpc-in-combinati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-combined-with-donafenib-and-gemox-as-first-line-treatment-for-advanced-biliary-tract-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-disparities-in-current-clinical-trials-in-cervical-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lusato-1-phase-i-study-of-sup177sup-lu-sso110-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-cabozantinib-cabo-in-advanced-neuroendocrine-tumors-net-according-to-horm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-a-novel-blood-based-lung-cancer-screening-test-in-elevated-risk-subjects 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-influence-of-advanced-age-on-outcomes-in-patients-with-diffuse-large-b-cell-lymphoma-treated-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pirtobrutinib-in-treatment-naive-patients-with-cllsll-pooled-results-from-bruin-cll-313-and-bruin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-of-a-phase-ii-study-of-fluorouracil-fu-leucovorin-lv-and-nanoliposomal-irinoteca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hearingvestibular-dysfunction-and-longitudinal-changes-in-psychosocial-well-being-among-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subgroup-analysis-of-participants-pts-with-her2-ihc0-in-the-ascent-07-study-of-sacituzumab-govitec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nimotuzumab-combined-with-paclitaxel-and-cisplatin-as-first-line-treatment-for-metastatic-esophageal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-implications-and-diagnostic-utility-of-sup68sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-and-determinants-of-radiotherapy-treatment-default-in-a-rural-cancer-centre-a-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neurosensory-deficits-and-functional-outcomes-in-childhood-cancer-survivors-a-report-from-the-child 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-low-coverage-whole-genome-sequencing-based-urinary-tumor-fraction-and-chromosomal-insta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rethinking-the-role-of-tumor-size-in-bladder-preservation-comparing-survival-outcomes-of-radical-cy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-high-postoperative-physical-activity-with-ctdna-mrd-positivity-and-recurrence-free-su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-tumor-infiltrating-iymphocytes-tils-in-the-biomarker-landscape-of-gastroesophageal-ade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expansion-of-a-highly-activated-hla-drcd38-car-t-cell-population-after-mezigdomide-exposure-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-to-hidacmitoxantronevenetoclax-hmv-in-patients-with-relapsedrefractory-rr-acute-mye 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-study-of-mpmri-guided-salvage-radiotherapy-with-lesion-directed-dose-escalation-after 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-markers-of-resistance-to-first-line-1l-therapy-with-a-cdk46-inhibitor-cdki-and-endocrin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-burden-of-childhood-cancers-in-the-south-asian-association-for-regional-cooperation-saarc-regi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-and-recurrence-risk-factors-of-liver-transplantation-for-permanently-unresectabl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-genomics-imaging-and-clinical-data-for-late-onset-cardiomyopathy-prediction-in-pediatr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characterization-of-residual-disease-post-neoadjuvant-sacituzumab-govitecan-sg-pembroli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-ctdna-tumor-fraction-and-confidence-in-driver-negative-liquid-biopsy-findings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sepsis-related-30-and-90-day-readmissions-among-patients-with-pancreatic-cancer-a-nationwide-readm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-related-to-anal-carcinoma-in-the-united-states-1999-2023-a-population-based-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/urinary-creatine-riboside-for-risk-stratification-of-clinically-significant-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-copd-related-mortality-among-adults-with-lung-cancer-in-the-united-states-1999-2025-a-cd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-mortality-trends-of-malignant-melanoma-associated-with-cerebrovascular-diseases-in-the-unit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-and-demographic-landscape-of-advanced-cutaneous-melanoma-a-10-year-experience-of-a-nation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circrna-signatures-to-identify-candidate-biomarkers-of-treatment-resistance-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-psychological-distress-during-chemotherapy-assessment-of-anxiety-and-depression-in-mi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-23-clinical-trial-investigating-rp2-plus-nivolumab-vs-ipilimumab-plus-nivolumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-body-composition-on-prognosis-treatment-toxicity-and-surgical-complications-in-locally-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stars-nct-07265661-surgical-timing-after-preoperative-hypofractionated-radiotherapy-for-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-supervised-physical-activity-into-breast-cancer-survivorship-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lung-cancer-screening-for-early-detection-of-suspicious-lung-nodules-in-latin-america-lucas-latam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epcore-nhl-6-phase-2-study-of-subcutaneous-sc-epcoritamab-as-outpatient-treatment-for-2l-relapse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accelerated-failure-time-as-an-alternative-to-cox-proportional-hazards-for-parathyroid-carcinoma-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-st316-a-first-in-class-ss-catenin-antagonist-in-metastatic-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-complete-response-to-neoadjuvant-immunochemotherapy-in-locally-advanced-head-and-neck-squ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalized-tumor-informed-ctdna-monitoring-for-recurrence-in-high-risk-locally-advanced-gastrointe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/atrial-fibrillation-mortality-among-patients-with-neoplasms-national-trends-and-deep-learning-forec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-glp-1-receptor-agonist-use-with-overall-survival-in-patients-with-colorectal-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-socioeconomic-patterns-of-malignant-melanoma-in-junctional-nevus-an-ncdb-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/morphologic-and-genomic-changes-in-clinical-relapse-of-young-onset-tongue-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-trends-in-esophageal-cancer-burden-across-africa-1990-2023-a-global-burden-of-disease-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immunotherapy-combined-with-immunonutrition-therapy-for-gastric-cancer-a-single-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stage-at-diagnosis-and-survival-outcomes-in-esophageal-carcinoma-a-multicenter-real-world-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-analysis-of-colorectal-cancer-mutations-and-their-associated-risk-of-oxaliplatin-induc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-adverse-childhood-experiences-aces-and-common-cancers-in-the-all-of-us-databas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fear-of-cancer-recurrence-in-oncology-follow-up-prevalence-and-the-role-of-patient-oncologist-commu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-melatonin-on-the-fatigue-sleep-and-depression-symptom-cluster-in-breast-cancer-according 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oral-mucin-expression-in-the-early-diagnosis-of-esophagogastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-the-impact-of-an-established-oncology-program-for-adolescents-and-young-adults-the-ro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fruquintinib-in-combination-with-sintilimab-and-capeox-as-first-line-treatment-for-advanced-gastric 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-tumor-mutation-status-pretreatment-weight-change-and-overall-survival-in-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-performance-of-methylene-blue-vital-staining-for-early-detection-of-oral-epithelial-dyspl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-genome-wide-modifiers-of-response-to-next-generation-fgfr-inhibitors-in-solid-tumors-an-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/supportive-care-prescribing-a-real-world-comparison-of-community-vs-academic-oncology-practices 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-laparoscopic-versus-open-gastrectomy-for-far-advanced-gastric-cancer-after-pre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-assessment-of-circulating-tumor-dna-as-a-disease-monitoring-biomarker-in-soft-tissue-sa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-gaps-in-relapsedrefractory-follicular-lymphoma-care-perceived-barriers-to-treatment-and-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-stratified-cancer-screening-in-idiopathic-inflammatory-myopathies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-chemotherapy-and-immunotherapy-encounters-in-the-united-states-recent-trends-acute-compl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/self-expandable-metallic-versus-plastic-biliary-stents-in-malignant-biliary-obstruction-a-systemati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ibii-study-of-mirdametinib-in-combination-with-palbociclib-in-patients-with-advanced-dediff 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-butyrate-and-chenodeoxycholic-acid-cdca-for-anti-inflammatory-and-hepatoprotective-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/somatic-and-actionable-genomic-alterations-in-early-onset-colorectal-cancer-versus-late-onset-diseas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-comparison-of-data-processing-methods-to-support-patient-matching-to-oncology-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-asxl1-somatic-mutation-on-patients-with-chronic-myeloid-leukemia-a-systemic-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-prior-exposure-to-erythropoiesis-stimulating-agents-esa-on-thromboembolic-events-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-equity-in-breast-cancer-biomarker-testing-an-updated-study-on-hospital-settings-and-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conversion-therapy-with-pd-1pd-l1-inhibitors-plus-gemcitabine-based-chemotherapy-for-initially-unre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-trial-of-the-oncolytic-virus-svv-001-with-nivolumab-and-ipilimumab-in-patients-with-high-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-macrophage-migration-inhibitory-factor-a-phase-2-and-pharmacodynamic-study-of-sitagliptin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enrollment-outcomes-after-screening-in-phase-1-oncology-clinical-trials-real-world-evidence-from-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-klotho-protein-with-the-risk-of-late-complications-in-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-cns-exile-an-ai-driven-audit-of-active-brain-metastasis-exclusions-in-modern-nsclc-immunotherap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-analysis-of-hepatic-arterial-infusion-chemotherapy-plus-pd-1pd-l1-antibodies-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-chronic-kidney-disease-on-adverse-event-topography-and-economic-burden-in-car-t-cell-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-design-of-invoke-a-phase-1-study-of-okn4395-a-first-in-class-ep2ep4dp1-triple-prostanoid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-adjuvant-donafenib-based-therapy-for-patients-with-hepatocellular-carcinoma-at-high-ri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lung-cancer-and-stroke-mortality-trends-in-middle-aged-and-older-us-adults-1999-2023-a-cdc-wonder 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serum-mir-181-5p-mir-214-3p-and-mir-223-3p-expression-in-epithelial-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conditional-survival-following-first-line-treatment-of-mss-metastatic-colorectal-cancer-a-pooled-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/standardizing-communication-during-icu-transfers-of-oncology-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-precision-treatment-with-artificial-intelligence-assisted-subtyping-on-first-line-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-local-mucosal-patterns-vision-transformer-based-modeling-for-diagnosis-of-gastric-tumors-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarkers-to-predict-anthracycline-induced-cardiotoxicity-in-adult-hematologic-malignancies-a-syst 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-robot-assisted-interval-debulking-surgery-in-older-women-with-advanced-ovarian-cancer-un 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-study-of-triple-negative-breast-cancer-patients-with-brain-metastases-a-multicenter-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-antibody-drug-conjugates-in-advanced-colorectal-cancer-a-systematic-review-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aspiration-pneumonitis-and-inpatient-outcomes-in-adult-cancer-hospitalizations-a-2018-2022-national 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-stratified-outcomes-hormone-receptor-expression-and-treatment-utilization-in-neuroendocrine-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-characteristics-and-targeted-therapy-response-in-ialki 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reversible-epigenetic-control-of-cd146-phenotypic-states-in-mda-mb-231-breast-cancer-cells 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequential-use-of-antibody-drug-conjugates-in-advanced-breast-cancer-a-real-world-study-based-on-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrative-spatial-omics-to-identify-determinants-of-response-to-neoadjuvant-chemo-immunotherapy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-of-patients-with-metastatic-uveal-melanoma-and-assessment-of-long-term-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-for-cervical-cancer-related-mortality-rates-from-1999-2020-a-national-inpatient-sam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ea3231-a-randomized-phase-iii-study-of-braf-targeted-therapy-vs-cabozantinib-in-rai-refractory-diff 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aspria-a-single-arm-phase-2-trial-of-atezolizumab-with-sacituzumab-govitecan-to-prevent-recurrence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-ii-study-of-capmatinib-plus-osimertinib-with-or-without-ramucirumab-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ib-study-of-momelotinib-during-and-following-hematopoietic-stem-cell-transplantation-for-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/four-year-landmark-survival-analysis-of-low-dose-nivolumab-added-to-metronomic-chemotherapy-in-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cognitive-effects-of-darolutamide-vs-enzalutamide-results-of-aracog-aft-47-a-randomized-clinical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relationship-between-glp-1-receptor-agonists-on-cancer-recurrence-and-survival-of-patients-with-stag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-sglt2-inhibitors-and-glp-1-receptor-agonists-or-dpp-4-inhibitors-with-incident-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-of-glp-1-receptor-agonist-use-with-survival-and-immune-related-adverse-events-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sotorasib-vs-adagrasib-in-the-2l-setting-outcomes-in-a-large-multi-institutional-real-world-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-results-with-prame-directed-t-cell-receptor-tcr-t-cell-therapies-in-synovial-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-destiny-breast09-analysis-of-treatment-duration-and-clinical-outcomes-by-best-response-to-trastuzu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dareon-8-updated-efficacy-and-safety-from-a-phase-i-dose-escalationexpansion-trial-of-first-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-doxorubicin-and-paclitaxel-in-advanced-kaposi-sarcoma-a-trinetx-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-analysis-of-anlotinib-combined-with-etoposide-plus-ifosfamide-in-the-treatment-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-and-transcriptomic-correlates-of-deep-psa-response-in-patients-with-metastatic-hormone-sensi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultra-sensitive-whole-genome-sequencing-based-molecular-residual-disease-detection-in-resectable-sar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-dual-epitope-nanobody-anti-cd5-car-t-for-relapsedrefractory-t-allptcl-phase-i-dose 2026-08-24 monthly 0.7 https://rjrindex.com/articles/discrepancy-between-plasma-cell-free-dna-and-tissue-based-analysis-for-detection-of-gene-amplificati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reirradiation-with-nbtxr3sbrt-in-combination-with-nivolumab-or-pembrolizumab-for-the-treatment-of-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-tumor-suppressor-and-dna-damage-repair-gene-mutations-in-oral-cavity-squamous-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-anticancer-therapy-in-patients-with-de-novo-metastatic-pancreatic-adenocarcinoma-a-real-wo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-robotic-surgery-better-preserve-sensory-function-the-significance-and-strategy-of-nerve-preser 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relationships-between-clinical-stage-pathological-stage-and-disease-free-dfs-survival-in-renal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-correlates-of-leptomeningeal-disease-after-brain-metastasis-resection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-pralsetinib-in-advanced-or-metastatic-ireti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-genomic-hla-class-i-allelic-imbalance-on-enduring-immunotherapy-response-in-advanced-non-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-science-insights-from-a-community-embedded-cervical-cancer-screening-program-integrat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-multi-scale-histopathologic-classification-of-epithelial-ovarian-cancer-to-support-precisi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-continuous-intra-arterial-cisplatin-and-recombinant-human-endostatin-combined 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-chemotherapy-ct-benefit-in-invasive-lobular-carcinoma-ilc-by-oncotype-dx-recurrence-sco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-dan-222-plus-niraparib-in-high-risk-her2-negative-breast-cancer-results-from-the-i-spy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effectiveness-of-a-multidisciplinary-pain-program-in-improving-adherence-to-the-use-of-aromatase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-gabapentinoids-for-oncologic-pruritus-a-retrospective-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-capacity-assessment-of-pediatric-oncology-research-biorepositories-across-a-regional-collaborative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-to-add-prognostic-stratification-beyond-ca-125-in-epithelial-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-ibrcai-pathogenic-variants-and-novel-targeted 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-safety-results-and-adverse-event-ae-management-recommendations-in-patients-with-erher2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/autologous-natural-killer-cell-infusion-as-consolidation-therapy-after-first-line-chemoradiotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-trial-of-tersolisib-ly4064809stx-478-a-pan-mutant-selective-pi3ka-inhibitor-pi3kai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-of-a-phase-ii-study-of-utidelone-capsule-the-first-solid-oral-microtubule-stabilizer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/androgen-receptor-ar-gene-dynamics-in-ctdna-post-abirateroneenzalutamide-longitudinal-study-in-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-the-70-gene-assay-and-homologous-recombination-deficiency-in-patients-with-high-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-second-or-further-line-kc1036-in-patients-with-thymoma-and-thymic-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-bal0891-as-monotherapy-and-in-combination-with-paclitaxel-results-from-a-pha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hospital-acquired-sepsis-as-a-driver-of-failure-to-rescue-in-aml-and-mds-a-national-inpatient-sampl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oral-mucositis-as-a-predictor-of-differential-long-term-adverse-events-and-mortality-in-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hrd-as-a-predictor-of-response-to-platinum-based-chemotherapy-and-parp-inhibitors-in-a-chinese-ovari 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evidence-linked-complementary-care-ai-supporting-standard-oncology-real-world-outcomes-in-pancreati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptomic-validation-of-ialki-fusions-by-rna-step 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cervical-cancer-in-armenia-current-situation-and-challenges 2026-08-24 monthly 0.7 https://rjrindex.com/articles/environmental-co-benefits-of-wisdom-risk-based-breast-cancer-screening-a-multi-institutional-pathwa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-onset-cancer-signature-eocs-pan-cancer-molecular-alterations-with-prognostic-significance-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/physician-preferences-in-large-language-models-for-breast-cancer-management 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-and-persistent-disparities-among-us-adults-with-lung-cancer-and-hypertensive-dise 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oral-darolutamide-therapy-in-patients-with-metastatic-hormone-sensitive-prostate-cancer-mhspc-a-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-darolutamide-based-triplet-therapy-in-chinese-patients-with-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-and-neoadjuvant-evaluation-of-a-structural-variant-based-mrd-assay-in-early-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/wearable-derived-physical-activity-monitoring-with-ai-based-detection-of-treatment-related-adverse-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-post-operative-circulating-tumor-dna-ctdna-in-real-world-treatment-and-outcome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sars-cov-2-infection-vaccination-and-mgus-progression-with-covid-19-outcomes-in-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-enfortumab-vedotin-ev-rechallenge-after-disease-progression-in-metastatic-urothelial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/functional-domain-disruption-to-define-the-molecular-and-clinical-spectrum-of-germline 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-spop-mutation-with-survival-outcomes-following-sup177sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liquid-biopsy-to-stratify-metastatic-breast-cancer-progression-risk-using-multi-analyte-cell-subtypi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-peripheral-blood-activated-to-total-cd8-central-memory-t-cell-ratio-to-identify-melanoma-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/endothelin-1-levels-in-lung-tissue-of-patients-with-non-small-cell-lung-cancer-with-previous-covid-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-associations-of-the-g8-geriatric-screening-tool-in-the-eortc-brain-tumor-group-trials-160 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-landscape-and-trends-of-antibody-drug-conjugates-in-oncology-a-machine-learning-driven-decad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-study-on-safety-and-efficacy-of-hypofractionated-versus-conventional-fractionated-sequ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-translation-of-pepticrad-1-interim-clinical-evaluation-of-a-modular-oncolytic-adenovirus-v 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-non-invasive-methylation-based-ngs-assay-for-sensitive-detection-of-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gender-representation-in-first-and-senior-authorship-of-phase-iii-solid-tumor-trials-presented-at-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-translational-study-of-ybx1-as-a-biomarker-and-therapeutic-target-in-bone-metastasis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/automated-discovery-and-curation-of-public-spatial-transcriptomic-datasets-across-multiple-cancer-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/study-on-the-mechanisms-of-alpha-linolenic-acid-in-influencing-the-efficacy-of-immunotherapy-for-lun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-immune-and-gut-microbial-metabolic-profiles-associated-with-hepatic-immune-related-adverse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-diagnostic-utility-of-cerebrospinal-fluid-ctdna-in-central-nervous-system-lymphoma-a-syste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-survival-rates-in-pediatric-and-adolescent-melanoma-in-the-united-states-2001-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-g-csf-after-venetoclax-based-induction-for-acute-myeloid-leukemia-multicenter-associations-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-randomized-controlled-trial-of-fapi-petct-guided-radiotherapy-combined-with-second-li 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multivariable-analyses-mvas-of-overall-survival-os-in-the-phase-3-sunmo-starglo-and-polargo-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whole-genome-sequencing-to-identify-novel-clinically-relevant-findings-missed-by-standard-of-care-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-longitudinal-circulating-tumor-dna-ctdna-and-carcinoembryonic-antigen-cea-for-post 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhanced-local-and-systemic-efficacy-in-refractory-solid-tumors-via-integrated-intra-tumoral-injecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-t-cell-subsets-as-drivers-of-response-to-different-neoadjuvant-treatments-in-esophageal-squ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-trends-in-pancreatic-cancer-incidence-mortality-and-disability-adjusted-life-years-in-pak 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-survivorship-care-plans-patients-needs-benefits-retrospective-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-liquid-ikrasi-mutation-screening-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-discordances-between-histomorphology-and-molecular-biomarkers-in-precision-oncol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pan-cancer-long-mononucleotide-repeat-microsatellite-instability-testing-for-detection-and-immunothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-neighborhood-socioeconomic-deprivation-and-diet-quality-on-immune-checkpoint-blockade-outc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zip-code-level-distress-as-a-predictor-for-advanced-stage-and-mortality-in-female-breast-cancer-acro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-re-profiling-for-identification-of-missed-drivers-and-a-high-risk-fusion-subgroup-in-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cell-free-dna-methylation-profile-based-fusion-epigenotyping-to-enhance-ialk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-of-tissue-and-plasma-ngs-in-early-stage-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/palliative-care-utilization-and-disparities-among-adults-with-advanced-cancer-hospitalized-for-sepsi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-following-salvage-surgery-for-recurrent-and-residual-head-and-neck-squamous-cell-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-crs-and-icans-following-tarlatamab-and-its-association-with-survival-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pre-existing-mental-health-diagnosis-and-colorectal-cancer-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-colorectal-cancer-in-renal-transplant-recipients-compared-with-the-general-population-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intersectional-analysis-of-raceethnicity-geography-and-socioeconomic-status-on-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-expression-of-m6a-modified-acly-immunotherapy-resistance-and-poor-survival-in-head-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-trust-in-health-information-sources-among-persons-with-a-cancer-diagnosis-an-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adenoid-basal-carcinoma-an-ncdb-study-of-demographic-and-socioeconomic-factors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progression-free-survival-outcomes-of-first-line-maintenance-therapy-in-ovarian-cancer-stratified-by 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-differences-in-thyroid-cancer-in-hanoi-incidence-trends-and-projections-to-2045-from-the-hanoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/malignant-ameloblastoma-real-world-outcomes-of-a-rare-odontogenic-malignancy-using-the-seer-databas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reactive-versus-prophylactic-percutaneous-endoscopic-gastrostomy-in-patients-with-head-and-neck-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mapping-the-association-between-federal-ai-investment-and-clinical-validation-in-oncology-a-multi-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/uveal-melanoma-a-retrospective-cohort-study-of-long-term-outcomes-and-impact-of-surveillance-imagin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-melanoma-immune-profile-mip-to-predict-rfs-in-stage-ii-iii-melanoma-on-adjuvant-inte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-versus-delayed-oral-feeding-after-esophagectomy-for-esophageal-cancer-a-systematic-review-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-national-mortality-analysis-in-hospitalized-patients-with-cancer-diagnoses-using-machine-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-to-radiotherapy-access-and-workflow-efficiency-in-a-resource-limited-tertiary-center-a-rea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/education-income-treatment-and-survival-a-retrospective-cohort-study-of-patients-with-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastatic-male-breast-cancer-what-do-we-know-about-treatment-efficacy-and-survival-a-multicenter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-venetoclax-dosing-on-outcomes-in-aml-a-single-center-real-world-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/female-cancer-patterns-and-treatment-disparities-in-southeastern-para-brazilian-amazon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatiotemporal-evolution-of-immune-evasion-divergent-resistance-mechanisms-in-primary-refractory-ve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-skin-cancer-with-bruton-tyrosine-kinase-inhibitors-a-faers-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-genomic-dna-stability-and-white-blood-cell-integrity-in-tflb-and-streck-blood-collecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-clinical-impact-of-totally-implantable-venous-access-ports-during-trabectedin-therapy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-ketogenic-diet-and-psychological-factors-on-tumor-shrinkage-in-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/publication-pathways-and-impact-metrics-of-african-cancer-research-presented-at-major-international 2026-08-24 monthly 0.7 https://rjrindex.com/articles/education-and-decision-making-autonomy-as-drivers-of-hpv-screening-outcomes-in-nepal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-commercial-cd19-car-t-inaticabtagene-autoleucel-in-relapsedrefractory-extr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-toxicity-of-cdk46-inhibitors-in-early-and-metastatic-hrher2-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-liposomal-irinotecan-plus-fruquintinib-as-third-or-later-line-therapy-for-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-mortality-and-contemporary-survival-in-intravascular-large-b-cell-lymphoma-a-population-based 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-first-line-lenvatinib-versus-sorafenib-in-advanced-hcc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-treatment-delay-on-outcomes-with-adjuvant-chemotherapy-vs-chemoradiotherapy-in-r1-resected 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-houses-index-a-novel-patient-level-measure-of-socioeconomic-status-linking-real-world-housing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-open-label-clinical-trial-to-treat-stage-iv-cancer-patients-harboring-multiple-patient-spec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/asp2998-a-trophoblast-cell-surface-antigen-2-trop2-targeted-immunostimulatory-antibody-drug-conju 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-to-fertility-preservation-counseling-in-young-cancer-patients-a-retrospective-chart-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-multiple-primary-malignancies-in-mantle-cell-lymphoma-insights-from-a-seer-based-study-200 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-evaluating-ivonescimab-in-combination-with-chemotherapy-as-first-and-second-line-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-trends-and-burden-of-liver-cancer-mortality-due-to-hepatitis-b-in-sub-saharan-africa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-ros1-tyrosine-kinase-inhibitors-for-advanced-ros1-positive-non-sm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-of-artificial-intelligence-ai-scribes-ais-by-the-hematology-and-oncology-hemonc-wo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-for-monitoring-disease-status-in-hpv-negative-head-and-neck-cancer-in-an-underserved-populatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-an-electronic-best-practice-advisory-on-fertility-preservation-referral-and-consultation-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-great-mismatch-assessing-cancer-clinical-trial-accrual-rates 2026-08-24 monthly 0.7 https://rjrindex.com/articles/right-sided-circulatory-failure-without-pulmonary-embolism-in-hospitalized-cancer-patients-national 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-risk-in-msh2-and-msh6-lynch-syndrome-female-patients-a-single-institution-retrospecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sacituzumab-govitecan-in-combination-with-capecitabine-for-the-treatment-of-advanced-gastrointestina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aquarius-a-longitudinal-multi-center-molecular-biomarker-discovery-registry-for-patients-with-hemat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/population-level-forecasting-of-car-t-related-toxicities-using-meta-analytic-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/severe-immune-related-adverse-events-in-the-neoadjuvant-and-adjuvant-setting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemoimmunotherapy-with-or-without-locoregional-therapy-for-biliary-tract-cancer-a-propensity-score 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-novel-blood-based-translational-pcr-screen-for-monoclonal-b-cell-lymphocytosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-risk-factors-and-outcomes-of-tumor-lysis-syndrome-in-hospitalized-patients-with-malignancy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-almonertinib-followed-by-chemo-immunotherapy-in-ii-iiib-egfr-mutant-nsclc-a-single-arm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-glp-1-agonists-with-breast-cancer-incidence-in-women 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fuzuloparib-combined-with-abiraterone-acetate-and-prednisone-aa-p-as-first-line-1l-treatment-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camizestrant-plus-ribociclib-in-hormone-receptor-positiveher2-negative-advanced-breast-cancer-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/electra-an-open-label-multicenter-phase-1b2-study-of-elacestrant-in-combination-with-abemaciclib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-add-on-ruxolitinib-for-patients-with-severe-checkpoint-inhibitor-pneumoni 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antibody-encapsulated-actinomycin-d-for-targeted-cancer-treatments 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-giredestrant-gire-in-patients-pts-with-estrogen-receptor-positive-her2-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-phase-1-study-results-of-nt-175-engineered-t-cell-therapy-in-itp53i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-racial-socioeconomic-and-tumor-characteristics-on-potential-years-of-life-lost-pyll 2026-08-24 monthly 0.7 https://rjrindex.com/articles/car-mix-cell-therapies-to-treat-solid-tumors-by-providing-synergistic-interaction-between-engineered 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-mitochondrial-apoptosis-profile-in-meningiomas-and-gliomas-comparing-the-effects-of-patient-sex 2026-08-24 monthly 0.7 https://rjrindex.com/articles/has-early-detection-improved-trends-in-localized-pdac-diagnoses-in-the-us-2004-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-of-a-first-in-human-study-of-the-mc1r-targeting-radiopharmaceutical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cell-free-dna-cfdna-methylation-based-multi-cancer-early-detection-mced-assay-to-enable-subtypin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-management-strategies-and-outcomes-of-brain-metastases-in-patients-with-mrcc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/older-adults-with-extensive-stage-small-cell-lung-cancer-treated-with-first-line-chemoimmunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-targeting-replication-stress-in-neuroblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-the-safety-pharmacokinetics-and-pharmacodynamics-of-intermittent-oral-prtx007 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zidesamtinib-efficacy-and-safety-in-patients-with-advanced-iros1i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-automated-prostate-cancer-risk-assessment-an-ensemble-llm-framework-for-clinical-t-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastatic-renal-cell-carcinoma-treated-with-pembrolizumab-lenvatinib-versus-nivolumab-cabozantinib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-xnw27011-a-claudin-182-targeted-cldn182-adc-in-advanced-pancreatic-duct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zirconium-engineered-nanoplatform-to-enhance-radiotherapy-through-nod-like-receptor-mediated-pyropto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imneskibart-low-dose-subcutaneous-il-2-nivolumab-in-patients-with-cpi-refractory-cutaneous-melan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-hypofractionated-versus-conventional-radiotherapy-following-mastectomy-for-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pro-results-from-the-beamion-lung-1-trial-in-treatment-naive-patients-with-ihe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-coronary-heart-disease-and-hepatocellular-carcinoma-mortality-among-us-adults-a-25-year 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-analysis-of-cancer-care-for-refugees-in-moldova-during-the-war-in-ukraine-2022-2025 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-with-nivolumab-ipilimumab-in-metastatic-renal-cell-carcinoma-by-nephrectomy-stat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimal-timing-of-circulating-tumor-dna-ctdna-dynamics-to-prognosticate-immune-checkpoint-inhibito 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultrasensitive-tumor-informed-ctdna-mrd-detection-to-identify-metastatic-relapse-and-as-predictor-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-powered-characterization-of-the-tumor-microenvironment-landscape-in-her2-overexpressing-non-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eik1003-a-parp1-selective-inhibitor-in-combination-with-paclitaxel-ptx-initial-combination-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-of-met-inhibitors-versus-immunotherapy-chemotherapy-in-1l-for-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-immunotherapy-infusion-timing-with-outcomes-in-early-stage-triple-negative-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-genomic-discordance-and-chemotherapy-ct-outcomes-in-early-stage-hrher2-invasive-lobula 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantitative-pre-cystectomy-ctdna-levels-for-identification-of-ctdna-positive-patients-with-surgical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-patients-with-rtk-ras-pathway-alterations-by-treatment-type-the-md-anderson-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interrupting-heg1cx43-interaction-to-promote-cuproptosis-via-inhibiting-gap-junction-to-overcome-gl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evidence-implicating-human-papillomavirus-in-bladder-carcinogenesis-a-case-control-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kras-mutational-landscape-and-immune-microenvironment-features-in-pancreatic-cancer-implications-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lutetium-177-psma-617-sup177sup-lu-psma-617-in-neuro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/next-generation-sequencing-based-mutation-profiling-in-solid-tumors-a-study-from-a-north-indian-ter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-of-ceacam7-as-a-novel-diagnostic-biomarker-of-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pilot-study-of-ctc-enumeration-and-ar-v7-detection-using-a-microporous-chip-filtration-system-in-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-photoimmunotherapy-for-recurrent-nasopharyngeal-carcinoma-a-natio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-analysis-of-furmonertinib-in-the-treatment-of-iegfri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-of-multiple-myeloma-patients-achieving-mrd-negativity-at-10 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-therapeutic-intervention-versus-observation-in-high-risk-smoldering-multiple-myeloma-a-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evolution-of-the-pulmonary-immune-microenvironment-from-premalignant-lesions-to-invasive-lung-adenoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rab11-family-interacting-proteins-as-regulators-of-t-cell-recognition-and-infiltration-in-triple-neg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-safety-of-adoptive-cellular-therapy-with-lifileucel-in-patients-with-advanced-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-type-stratified-causal-machine-learning-to-identify-heterogeneous-benefit-of-pd-l1ctla-4-ve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-predictors-of-early-mortality-in-patients-with-pd-l1-high-advanced-nsclc-treated-with-first 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-analysis-of-pembrolizumab-combined-with-chemotherapy-in-platinum-sensitive-recurrent-low-gra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-we-omit-surgical-axillary-staging-in-early-stage-invasive-lobular-carcinoma-results-from-a-lar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-efficacy-of-a-novel-oral-serd-tfx06-in-prior-fulvestrant-treated-erher2-advanced-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-cisplatingemcitabine-or-carboplatingemcitabine-on-efficacy-toxicity-and-quality-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dentist-led-systematic-oral-education-programs-in-the-prevention-of-radiation-induced-oral-toxicitie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-immunotherapy-based-regimens-in-russian-patients-with-iegfri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-squamous-and-non-squamous-penile-cancers-insights-from-seer-database 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-serum-tumor-markers-in-phase-i-immunotherapy-trials-a-single-institution-retros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-following-resistance-to-immune-checkpoint-inhibition-in-advanced-cutaneous-squamou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bladder-preservation-in-patients-with-urothelial-muscle-invasive-bladder-cancer-who-refused-radical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-specific-supportive-care-utilization-after-first-line-pd-1-inhibitor-therapy-real-world-trans 2026-08-24 monthly 0.7 https://rjrindex.com/articles/landscape-of-therapeutically-actionable-hrr-gene-variants-in-moroccan-breast-and-ovarian-cancer-a-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-dose-apatinib-combination-with-first-line-chemotherapy-rechallenge-in-advanced-osteosarcoma-a-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-of-itp53i-y220c-mutated-clinically-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-hspa6-on-lenvatinib-resistance-in-hcc-via-phase-separation-mediated-txnrd1-stabilization-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-survival-after-chemo-immunotherapy-in-veterans-with-extensive-stage-small-cell-lung-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthcare-resource-use-hcru-intensity-prior-to-cancer-diagnosis-and-real-world-outcomes-in-early 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-deruxtecan-t-dxd-bevacizumab-bev-as-first-line-1l-maintenance-therapy-in-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-hematologic-malignancies-clonal-hematopoiesis-of-indeterminate-potential-and-the-risk-of-sol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sup68sup-ga-ga-nym096-petct-in-patients-with-primar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/organotropic-and-genomic-characterization-of-pancreatic-neuroendocrine-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-serplulimab-for-locally-advanced-or-metastatic-squamous-non-small-cell-lung-cancer-updat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-randomized-double-arm-open-label-controlled-study-of-asp-1929-photoimmunotherapy-pit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-of-nutritional-factors-on-disease-control-and-survival-in-patients-with-recurrentme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ablation-plus-immunotherapy-in-advanced-nsclc-patients-who-develop-oligo-residual-disease-after-anti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-specific-trends-in-liver-cancer-mortality-in-the-united-states-1999-2023-a-joinpoint-regressio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-single-arm-exploratory-study-on-the-efficacy-and-safety-of-romiplostim-n01-for-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-fndc1-and-gv2-in-suppression-of-the-v-catenin-destruction-complex-and-promotion-of-gastric-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-clinicopathological-features-and-prognosis-of-patients-with-small-cell-carcinoma-of-ga 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-burden-of-cholangiocarcinoma-in-the-united-states-a-20-year-analysis-of-temporal-trends-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-barriers-to-treatment-access-and-home-delivery-in-rare-cancers-across-five-european 2026-08-24 monthly 0.7 https://rjrindex.com/articles/venous-sinus-involvement-in-meningiomas-and-its-association-with-intracranial-hypertension-features 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-decade-national-trends-and-forecasting-of-brain-tumor-mortality-among-older-adults-in-the-unite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tgf-v-signaling-alterations-in-bevacizumab-treated-early-onset-colorectal-cancer-an-artificial-inte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-targeted-phosphoproteomic-assay-to-enable-the-prediction-of-response-to-intensive-chemotherapy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/olanzapine-for-weight-gain-in-children-undergoing-chemotherapy-for-solid-organ-malignancies-an-inve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shifting-dietary-drivers-of-colorectal-cancer-mortality-in-the-united-states-a-33-year-global-burde 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-functional-survivorship-in-oral-cavity-cancer-quality-of-life-qol-outcomes-by-return-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-implications-of-primary-and-metastatic-tumor-informed-clonal-tracking-for-mrd-assessment-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/maternal-and-neonatal-complications-associated-with-breast-cancer-systemic-treatments-a-vigibase-di 2026-08-24 monthly 0.7 https://rjrindex.com/articles/universal-adipogenic-and-immunologic-remodeling-in-the-recurrent-myeloid-leukemia-microenvironment-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-genomic-and-clinical-high-risk-features-on-outcomes-after-bcma-directed-bispecific-anti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/measurable-residual-disease-mrd-by-circulating-tumor-ct-dna-in-patients-pt-with-rr-follicular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-fluoropyrimidine-cardiotoxicity-using-a-focus-beyond-routine-cardiovascular-risk-assessme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiac-safety-of-l-annamycin-at-high-cumulative-anthracycline-exposure-pooled-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dexamethasone-free-antiemetic-prophylaxis-with-olanzapine-in-children-and-adolescents-receiving-high 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dermatologic-adverse-events-daes-and-emotional-quality-of-life-qol-in-patients-pts-with-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-immunologic-vs-progenitor-landscapes-in-myeloid-leukemia-recurrence-adaptive-immune-persis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-related-adverse-events-cvd-aes-and-echocardiographic-echo-changes-with-immunother 2026-08-24 monthly 0.7 https://rjrindex.com/articles/palliative-neck-radiation-therapy-rt-in-combination-with-lenvatinibpembrolizumab-lp-in-braf-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-placebo-controlled-randomized-controlled-trial-using-combination-therapy-for-treatment-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-ml-based-prediction-of-fatal-immune-checkpoint-inhibitor-ici-associated-myocard 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-perioperative-anlotinib-combined-with-cisplatin-and-doxorubicin-in-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/protract-a-randomized-phase-ii-trial-comparing-ctdna-guided-biomarker-directed-therapy-vs-patientc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ccl3-supsup-neutrophil-signature-as-a-predictor-of-res 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-baseline-testosterone-t-level-with-survival-outcomes-in-patients-pts-with-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-in-palliative-care-use-among-hospitalized-cancer-patients-a-seven-year-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantifying-equol-producing-and-beta-glucuronidating-gut-bacteria-in-breast-cancer-using-16s-rdna-se 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-tumor-lysis-syndrome-in-non-hodgkin-lymphoma-hospitalizations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-myeloma-therapy-utilization-in-digital-health-advocacy-users-a-large-us-cohort-analysis-of-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/avatrombopag-for-chemotherapy-induced-thrombocytopenia-in-gastrointestinal-malignancies-act-gi-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/population-pharmacokinetic-analysis-of-raludotatug-deruxtecan-r-dxd-a-cadherin-6-cdh6-directed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-nimotuzumab-combined-with-concurrent-chemoradiotherapy-for-patients-with-postoperative-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lorlatinib-as-first-line-therapy-for-alk-positive-advanced-non-small-cell-lung-cancer-a-retrospecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/automated-eligibility-screening-for-adjuvant-cdk46-inhibitors-in-high-risk-hrher2-early-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-barriers-to-cancer-clinical-trial-participation-at-an-urban-inner-city-safety-net-hospital 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-gut-microbiome-and-metabolomic-profiles-associated-with-durable-response-to-first-line-thir 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-trials-to-the-clinic-real-world-experience-with-mirvetuximab-soravtansine-in-platinum-resistan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-ikrasi-sub-mutations-in-metastatic-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elevated-genomic-risk-and-treatment-gaps-in-black-patients-with-hr-early-breast-cancer-a-mammaprin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/driving-efficiency-in-oncology-care-tactical-solutions-for-inpatient-flow-challenges 2026-08-24 monthly 0.7 https://rjrindex.com/articles/occult-neoplasia-in-risk-reducing-bilateral-salpingo-oophorectomy-pathological-findings-and-clinica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-yield-of-three-models-to-evaluate-germline-genetic-risk-in-patients-pts-with-pancreati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-spectrum-of-bevacizumab-induced-renal-injury-a-systematic-review-of-published-case-reports 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-arrhythmia-related-mortality-among-older-adults-with-cancer-in-the-united 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fluoropyrimidine-related-cardiotoxicity-in-patients-with-idpydi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-adjuvant-anlotinib-for-esophageal-squamous-cell-carcinoma-with-residual-disease-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-weekend-effect-in-spontaneous-tumor-lysis-syndrome-in-patients-with-hematological-malignancy-na 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bnt326-01-a-phase-1b2-trial-of-bnt326yl202-her3-adc-as-monotherapy-and-in-combination-with-pumi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-of-germline-genetic-testing-in-prostate-pancreatic-and-ovarian-cancer-in-a-rural-setti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-study-of-xaluritamig-a-steap1-x-cd3-t-cell-engager-in-pediatric-adolescent-and-adult 2026-08-24 monthly 0.7 https://rjrindex.com/articles/escalating-site-burden-and-cost-whats-driving-the-surge-in-oncology-investigator-grants-over-the-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-tmab-plus-chemotherapy-ct-vs-ct-alone-in-the-perioperative-treatment-of-her2-positiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-over-18-months-in-the-utilization-of-ctdna-monitoring-assays-for-solid-tumor-patients-in-us-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-clinicopathological-factors-impacting-survival-in-malignant-carcinoid-tumors-a-seer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-second-round-prrt-in-patients-with-progressive-refractory-stage-iv-neuroendocrine-neopla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bnt324-03-phase-3-randomized-open-label-trial-of-bnt324db-1311-a-b7h3-adc-versus-docetaxel-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-utilization-sequencing-patterns-and-healthcare-resource-utilization-in-walden 2026-08-24 monthly 0.7 https://rjrindex.com/articles/signal-er-101-signatera-guided-cdk46-inhibitor-therapy-in-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/severe-cognitive-effects-of-avapritinib-towards-a-mechanistic-understanding 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mechanistic-evaluation-of-thymol-in-a-rat-model-of-methotrexate-induced-intestinal-injury-nf-kb-nr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trofuse-036gog-3123engot-cx22-a-2-part-phase-3-randomized-study-of-sacituzumab-tirumotecan-sac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-neoadjuvant-zanzalintinib-zanza-plus-nivolumab-nivo-in-patients-with-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-corticosteroid-and-tocilizumab-use-on-infection-incidence-and-outcomes-following-car-t-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-risk-factors-for-polyneuropathy-in-patients-receiving-immune-checkpoint-inhibitor-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-substance-use-disorder-on-pneumonia-hospital-outcomes-in-chronic-lymphocytic-leukemia-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/network-meta-analysis-of-first-line-therapies-for-unresectable-her2-negative-gastricgastroesophagea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-a-multidisciplinary-committee-within-a-national-oncology-society-an-educational-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-vs-nivolumab-plus-chemotherapy-in-metastatic-gastric-cancer-trinetx-propensity-score 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-economic-and-clinical-impact-of-lung-cancer-patient-support-programs-lc-psp-using-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alignment-of-vietnams-national-essential-medicines-list-with-cancer-incidence-and-the-who-eml 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-trial-of-brain-mri-surveillance-in-stage-iv-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iiia-study-to-evaluate-the-safety-and-tolerability-activity-and-pk-of-a-potential-novel-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cohort-expansion-of-a-phase-i-study-of-pln-101095-a-first-in-class-dual-a-sub 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stromal-remodeling-and-neoantigen-clonality-as-used-to-evaluate-benefit-from-sirt-nivolumab-in-hcc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-open-label-dose-escalation-and-expansion-study-of-gamitrinib-a-first-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-acceptance-of-trained-scent-detection-dogs-for-postoperative-surveillance-among-cancer-survivor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/benefit-of-chemotherapy-on-survival-in-women-aged-70-with-hr-positive-her2-negative-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/profiling-i-inrg1i-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iiia-image-guided-alpha-particle-therapy-study-of-sup203sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-physician-perspectives-on-neoadjuvant-immunotherapy-and-chemotherapy-in-early-stage-tripl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-genotoxic-and-tumorigenic-potential-of-artificial-food-dyes-and-implications-for-color 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-saving-analysis-of-neoadjuvant-versus-adjuvant-immunotherapy-in-clinical-stage-iii-melanoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/opioid-prescribing-in-cancer-patients-compared-with-non-cancer-patients-over-two-decades-2000-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-efbemalenograstim-alfa-versus-peg-rhg-csf-in-preventing-neutropenia-in-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-different-induction-chemotherapy-regimens-in-pediatric-and-adolescent-patients-with-lo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-primary-malignancies-spm-risk-after-car-t-cell-therapy-a-real-world-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-omentectomy-with-reduced-therapeutic-efficacy-of-lenvatinib-plus-pembrolizumab-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-characteristics-and-outcomes-in-platinum-resistant-ovarian-cancer-proc-patients-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-bevacizumab-plus-trifluridinetipiracil-and-irinotecan-as-second-line-therapy-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-pet-ct-in-the-management-of-colorectal-liver-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-and-immunogenomic-characteristics-of-ikrasi-al 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-sociodemographic-factors-and-healthcare-utilization-of-immune-related-adverse-even 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-to-assess-the-safety-and-efficacy-of-bomedemstat-img-7289-in-combination-with-mome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-study-of-the-treatment-journey-following-antibody-drug-conjugate-adc-initiation-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-analysis-on-the-management-of-post-mastectomy-lymphedema-in-breast-cancer-patients-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-outcomes-after-metastatic-recurrence-following-perioperative-chemoimmunothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hypercalcemia-as-a-marker-of-in-hospital-mortality-and-resource-utilization-in-breast-cancer-a-nati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/delays-in-receipt-of-neoadjuvant-chemotherapy-in-patients-with-localized-muscle-invasive-bladder-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-d842v-platelet-derived-growth-factor-alpha-pdgfra-mutant-gastrointestinal-stromal-tumours-gis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-neoadjuvant-chemo-immunotherapy-in-triple-negative-breast-cancer-at-a-safety 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-adjuvant-pembrolizumab-in-resected-stage-iii-melanoma-real-world-evidence-from-a-peruvian-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ovarian-cancer-and-hypertension-changes-in-comorbidity-related-mortality-among-us-women-aged-45 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-analysis-of-patients-with-metastatic-melanoma-treated-with-sequential-metronomic-tem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-presentation-management-strategies-and-recurrence-rates-in-vulvar-intraepithelial-neoplas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/awareness-of-breast-cancer-symptoms-and-risk-factors-among-urban-delhi-women 2026-08-24 monthly 0.7 https://rjrindex.com/articles/orbital-cancer-historical-trends-in-histological-composition-and-cause-specific-mortality-based-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-subtypes-and-lymph-node-metastasis-in-endometrial-cancer-an-updated-systematic-review-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/telehealth-and-the-patient-experience-in-rural-america 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-patients-knowledge-and-willingness-for-biospecimen-donation-at-prisma-health 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recurrence-patterns-and-survival-in-hormone-receptor-positiveher2-negative-early-breast-cancer-a-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-survival-outcomes-of-radiotherapy-based-treatment-strategies-for-esophageal-cancer-a-pop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-glucocorticoid-toxicity-index-assessing-corticosteroid-toxicity-in-patients-with-immune-related 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-characteristics-of-kaposi-sarcoma-related-hospitalizations-and-in-hospital-outcomes-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-self-administered-e-health-dietary-quality-dq-assessment-in-patients-pts-at-increased-heredita 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tyrosine-kinase-inhibitors-in-philadelphia-chromosome-positive-acute-lymphoblastic-leukemia-all-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-factors-associated-with-early-combination-therapy-initiation-in-metastatic-hormone-sensit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-pkpd-profiling-in-human-ex-vivo-tumor-slices-to-identify-exposure-limited-niches-driving-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glp-1-receptor-expression-in-a-molecularly-characterized-cohort-of-endometrial-carcinoma-results-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-on-post-neoadjuvant-trastuzumab-emtansine-to-benchmark-destiny-breast-05-and-11-eme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-to-cancer-immunotherapy-for-p53-antibody-positive-non-small-cell-lung-cancer-according-to-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emiltatug-ledadotin-emi-le-a-b7-h4-directed-antibody-drug-conjugate-adc-in-patients-with-aggre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-ii-dose-optimization-study-for-alveltamig-zg006-a-trispecific-t-cell-engager-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/checkmate-9dw-4-year-follow-up-overall-survival-by-depth-of-response-and-outcomes-in-long-term-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/farnesyl-transferase-inhibitor-fti-darlifarnib-ko-2806-in-combination-with-adagrasib-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-response-and-outcomes-in-patients-with-myeloproliferative-neoplasms-treated-with-interfero 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-colorectal-cancer-among-adults-with-diabetes-mellitus-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cell-proliferation-immune-cell-infiltration-and-survival-outcomes-in-sarcomas-with-high-cancer-ass 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-cadonilimab-ak104-in-locally-advanced-msi-hdmmr-gastric-or-gastroesophageal-junctio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bacillus-calmette-guerin-bcg-and-beyond-is-systemic-immunotherapy-for-bcg-naive-non-muscle-invasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intratumoral-dendritic-cell-dc1-therapy-prior-to-neoadjuvant-chemotherapy-in-her2-positive-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/majestec-9-a-phase-3-randomized-study-of-teclistamab-monotherapy-vs-investigators-choice-of-pomali 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-trial-of-trastuzumab-rezetecan-vs-standard-of-care-soc-for-chemotherapy-refractory-her2-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-age-on-immune-related-toxicities-and-survival-in-non-small-cell-lung-cancer-treated-with-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-folfirinox-versus-gemcitabine-based-regimens-in-locally-advanced-pancreatic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dietary-supplement-use-among-adult-cancer-survivors-results-from-a-large-cross-sectional-study-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-metastatic-site-and-survival-in-non-small-cell-lung-cancer-a-seer-based-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psa-nadir-stratified-outcomes-of-arpi-doublet-and-docetaxel-triplet-therapy-in-metastatic-prostate-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-tmb-characterizing-tumor-intrinsic-genomic-architectures-of-immune-resistance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/structural-mimicry-of-the-top1-cleavage-complex-by-intratumoural-bacterial-proteins-as-a-possible-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-monitoring-of-high-risk-breast-cancer-patients-a-retrospective-descri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-the-next-generation-nectin-4-targeting-antibody-drug-conjugate-crb-701-sys6002 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intra-arterial-chemotherapy-for-retinoblastoma-treatment-outcomes-and-globe-preservation-a-tertiary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-reduction-in-intraoperative-frozen-sections-on-positive-margin-findings-in-the-final-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-of-concurrent-intrathecal-toripalimab-and-pemetrexed-pm-for-leptomeningeal-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-a-multimodal-tcrbcr-repertoire-foundation-model-on-blood-rna-seq-based-prediction-of-sev 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-and-the-sequence-relative-to-survival-outcomes-in-sclc-analysis-of-the-national-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eif4b-expression-in-lung-squamous-cell-carcinoma-using-bulk-and-single-cell-transcriptomic-profiling 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burnout-bo-among-oncology-professionals-in-the-middle-east-and-north-africa-mena-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-to-evaluate-the-safety-and-efficacy-of-bb-1701-in-combination-with-sintilimab-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lambert-eaton-myasthenic-syndrome-in-united-states-veterans-with-small-cell-lung-carcinoma-sclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantitative-assessment-of-tumor-shedding-using-ai-derived-radiographic-tumor-burden-and-quantified 2026-08-24 monthly 0.7 https://rjrindex.com/articles/organ-specific-progression-and-ai-based-prognostic-modeling-in-metastatic-nsclc-treated-with-chemo-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cerebrospinal-fluid-proteomics-to-identify-biomarkers-for-the-diagnosis-and-prediction-of-leptomenin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-with-brentuximab-vedotin-in-vitro-and-car-t-cell-function-and-viability-implications-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-metformin-on-outcomes-with-immune-checkpoint-inhibitors-in-renal-cell-carcinoma-a-large-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-genomic-profiling-of-matched-ctdna-and-tissue-from-patients-with-four-common-cancers-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-analysis-of-car-t-cell-toxicities-target-antigens-and-dosing-in-solid-and-hematologi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-immunotherapy-in-older-adults-with-advanced-nsclc-a-retrospective-cohort-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-l1-score-tool-effectiveness-in-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-pet-ct-and-tumor-biology-for-pathological-complete-response-in-triple-negative-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-molecular-features-of-patients-with-ipik3cai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-detection-of-pancreatic-ductal-adenocarcinoma-pdac-with-a-multiomic-liquid-biopsy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-impact-of-itp53i-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-fractionated-stereotactic-radiotherapy-followed-by-surgical-resection-for-brain-metastas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-digital-health-intervention-to-enhance-well-being-among-adolescent-and-young-adult-survivors-of-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/contemporary-trends-in-early-stage-non-small-cell-lung-cancer-diagnosis-and-disparities-2018-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-characteristics-treatment-patterns-social-determinants-of-health-and-safety-in-patients-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-durvalumab-and-safety-by-treatment-period-in-matterhorn-a-randomized-phase-3-study-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fovinaciclib-versus-placebo-combined-with-fulvestrant-for-advanced-breast-cancer-after-endocrine-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-analysis-of-adoptive-neoantigen-specific-t-cell-immunotherapy-for-mgmt-unmethylated-glioblas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-docetaxel-d-ramucirumab-r-and-pembrolizumab-p-for-patients-with-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-dose-furmonertinib-in-iegfri-mutated-advanced-nsc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intrapatient-comparative-analysis-of-tumor-informed-ctdna-and-cthpv-dna-in-patients-with-hpv-driven 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-outcomes-by-treatment-free-interval-among-patients-receiving-palbociclib-plus-endocrin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clonal-hematopoiesis-related-outcomes-associated-with-radioligand-therapy-in-prostate-cancer-a-rea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-proton-pump-inhibitor-use-with-cancer-specific-mortality-in-a-nationally-representati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevention-of-paclitaxel-induced-neurotoxicity-with-lithium-results-from-a-multicenter-randomized 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-of-patients-with-resectable-early-stage-non-small-cell-lung-cancer-treated-with-neoa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-large-language-models-for-multimodal-prediction-of-homologous-recombination-deficiency-usi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-broadening-trial-eligibility-criteria-on-the-inclusion-of-patients-infected-with-hiv-in-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-prognostic-scores-in-hispanic-patients-with-advanced-solid-tumors-enrolled-in-a-single 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-t-bren-bl-m07d1-monotherapy-or-in-combination-with-pertuzumab-in-patients-with-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-lenvatinib-beyond-immunotherapy-progression-in-endometrial-cancer-a-real-world-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-organ-adjacent-extracellular-vesicle-proteomics-from-uterine-lavage-on-accurate-detection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultrasensitive-circulating-tumor-dna-detection-and-molecular-clearance-as-a-prognostic-and-predictiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pilot-study-of-a-digital-patient-directed-consent-process-for-msk-impact-tumor-normal-genetic-tes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-tumor-growth-models-to-improve-late-stage-lung-cancer-outcome-prediction-using-early-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-endocrine-therapy-omission-in-er-positive-breast-cancer-treated-with-neoadjuvant-chemothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-results-from-the-phase-12-linker-al2-trial-of-linvoseltamab-linvo-in-patients-pts-with-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diabetes-risk-reduction-diet-and-mortality-outcomes-following-breast-cancer-diagnosis-in-black-women 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-immunotherapy-use-and-survival-outcomes-by-metastatic-pattern-in-metastatic-triple-negativ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-results-of-a-phase-1-dose-exploration-and-expansion-study-of-xaluritamig-plus-abiraterone-ac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pfs2-outcomes-by-prior-therapy-from-dreamm-8-a-phase-3-study-assessing-belantamab-mafodotin-belama 2026-08-24 monthly 0.7 https://rjrindex.com/articles/complex-segmentectomy-versus-lobectomy-in-small-sized-peripheral-non-small-cell-lung-cancer-a-post 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-post-discharge-home-care-for-reducing-potentially-avoidable-readmissions-in-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-resource-use-and-cost-in-patients-treated-with-originator-or-biosimilar-rituximab-in-a-la 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ql1706-pd-1ctla-4-bispecific-antibody-plus-bevacizumab-specific-for-patients-with-hepatocellular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extrachromosomal-dna-as-a-shaper-of-aggressive-transcriptional-states-in-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-stratification-of-early-stage-nsclc-patients-using-preoperative-circulating-tumor-dna-ct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pharmacokinetic-pk-assessment-of-revumenib-in-patients-with-relapsedrefractory-rr-acute-leukem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-biomarkers-in-retroperitoneal-dedifferentiated-liposarcoma-and-their-clinical-impact-on-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evaluation-of-germline-pathogenic-variants-pvs-in-cancer-predisposition-genes-among-uns 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-and-etiologic-heterogeneity-of-liver-cancer-in-the-united-states-a-comprehensive-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cadonilimab-in-combination-with-chemotherapy-versus-chemotherapy-alone-in-patients-with-immunotherap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-ikrasi-mutant-circulating-tumor-dna-as-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethnicity-based-comparative-analysis-of-treatment-endpoints-of-30000-hrher2-metastatic-breast-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pemivibart-for-prevention-of-covid-19-subset-analysis-of-canopy-participants-with-solid-tumor-or-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-in-first-in-human-chemotherapy-free-combination-immunotherapy-targeting-lymphopenia-in-recu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insurance-hospital-and-racial-disparities-in-surgical-treatment-and-mortality-among-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ocular-toxicity-and-safety-profile-of-mirvetuximab-soravtansine-in-ovarian-cancer-a-systematic-revi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-prospective-real-world-study-of-irinotecan-liposome-ii-based-combination-regimens-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/two-decades-of-landscape-change-in-the-treatment-of-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-nal-iri5-fulv-benmelstobart-anlotinib-with-or-without-immunoradiotherapy-for-second-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-bermuda-model-achieving-world-class-equitable-and-efficient-cancer-care-in-a-small-island-nat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fair-inclusion-in-clinical-trials-updated-good-pharma-scorecard-evaluations-of-fda-oncology-drugs-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-secn-15-a-neuropilin-1-targeting-antisense-oligonucleotide-on-resistance-to-immune-chec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/il7-il15-fusion-cytokine-fusokine-secreting-ipsc-derived-mesenchymal-stromal-cells-to-convert-immu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/benchmarking-survival-outcomes-of-quemliclustat-in-first-line-metastatic-pancreatic-ductal-adenocarc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-nivolumab-in-high-risk-muscle-invasive-urothelial-carcinoma-real-world-evidence-from-the-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cladribine-clad-low-dose-arac-ldac-venetoclax-ven-in-patients-with-acute-myeloid-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-dose-escalation-results-of-sup177sup-lu-nym032 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-and-biomarker-analysis-of-neoadjuvant-chemoradiotherapy-with-or-without-pd-1-anti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-results-of-a-prospective-phase-ii-study-iputrial-of-inetetamab-and-pyrotinib-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-four-marker-protein-signature-to-predict-ramucirumab-efficacy-in-combination-with-tas-102-in-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-transanal-vs-laparoscopic-total-mesorectal-excision-on-5-year-overall-survival-in-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-trial-of-cetuximab-for-patients-with-locally-advancedmetastatic-chordoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-fih-study-of-cabotamig-a-tce-cdh17-x-cd3-in-cdh17-expressing-gi-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-fedratinib-in-patients-with-mdsmpn-and-chronic-neutrophilic-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sintilimab-combined-with-short-course-intensified-chemotherapy-regimen-nab-pof-in-the-treatment-of-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcome-of-sandwich-therapy-with-induction-chemoimmunotherapy-followed-by-concurrent-chemor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/myelodysplasia-related-mutation-dynamics-and-outcomes-in-newly-diagnosed-nd-acute-myeloid-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insurance-and-racial-disparities-in-car-t-cell-therapy-outcomes-a-national-inpatient-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bxq-350-in-combination-with-folfox7-and-bevacizumab-evaluation-of-effect-on-oxaliplatin-induced-cip 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-detection-five-year-screening-behaviors-and-patient-reported-perceptions-in-detect-a-partici 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-circulating-tumor-dna-ctdna-following-liver-resection-in-a-high-risk-population-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-car-t-and-bispecific-antibodies-in-relapsedrefractory-large-b-cell-lym 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cadonilimab-or-ivonescimab-plus-axitinib-in-metastatic-mucosal-melanoma-results-from-a-phase-ib-tri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-activity-of-homoharringtonine-against-melanoma-leptomeningeal-disease-using-patient-deri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-a-single-arm-muti-center-prospective-clinical-study-of-disitamab-vedotin-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anti-tumor-activity-and-safety-of-syn429-a-synthetic-type-i-ifn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-tp53-pathologic-variants-for-cancer-immunotherapy-using-a-self-replicating-mrna-vaccine-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-stage-matched-genomic-analysis-to-support-molecular-similarity-of-unknown-primary-merkel-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-performance-safety-and-biodistribution-of-sup68sup-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-tremelimumab-plus-durvalumab-stride-versus-durvalumab-monotherapy-in-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-receipt-of-guideline-concordant-adjuvant-chemotherapy-and-survival-outcomes-among-imm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-prrt-sequencing-after-progression-on-somatostatin-analogue-in-neuroendocrine-tumors-a-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-a-fak-inhibitor-combined-with-albumin-bound-paclitaxel-and-an-anti-pd-1ctla-4-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interrogating-acquired-pd-1-resistance-through-bet-bromodomain-inhibition-in-hepatocellular-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/social-determinants-of-health-and-survival-outcomes-in-metastatic-breast-cancer-mbc-retrospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/protact-a-first-in-human-phase-1-dose-escalation-and-expansion-study-evaluating-the-safety-tolera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rationale-and-study-design-of-the-kov-hipec-04-a-phase-iii-randomized-controlled-trial-in-primary-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/noga-neoadjuvant-treatment-optimization-via-mri-guided-de-escalation-in-stage-ii-iii-tnbc-a-phase-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/uncovering-genetic-susceptibility-to-second-malignant-neoplasms-in-children-and-young-adults-findin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conditioning-intensity-and-post-transplant-outcomes-in-acute-myeloid-leukemia-a-real-world-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immunotherapy-combined-with-concurrent-chemoradiotherapy-for-locally-advanced-esophageal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-medicaid-expansion-on-survival-across-five-cancer-types 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-artificial-intelligence-ai-as-a-decision-support-tool-in-clinic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-prevalence-of-lung-cancer-screening-and-covariates-among-women-undergoing-breast-cancer-scr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/operative-and-non-operative-management-of-small-bowel-obstruction-in-colorectal-cancer-hospitalizati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunohistochemical-profile-and-age-distribution-of-breast-cancer-at-a-tertiary-referral-center-in-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/total-neoadjuvant-chemotherapy-with-flot-for-resectable-gastric-and-gastroesophageal-junction-adenoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-remission-after-tyrosine-kinase-inhibitor-cessation-in-chronic-myeloid-leukemia-cml-a-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-of-measurable-residual-disease-mrd-rates-in-the-peripheral-blood-and-bone-marrow-after 2026-08-24 monthly 0.7 https://rjrindex.com/articles/associations-between-neighborhood-disadvantage-cannabis-use-and-patient-reported-outcomes-among-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-radiation-interruption-and-associated-factors-on-overall-survival-in-head-and-neck-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-organ-immune-related-adverse-events-following-immune-checkpoint-inhibitor-therapy-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-risk-factors-and-survival-of-secondary-primary-cns-tumors-following-hematologic-malignan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neutropenic-diet-nd-versus-liberalized-diet-ld-in-patients-with-cancer-a-systematic-review-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-travel-distance-on-oncologic-outcomes-after-curative-intent-surgery-for-retroperitoneal-sa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-complementary-anti-cancer-and-analgesic-properties-of-the-natural-product-barettin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-clinicogenomic-profiling-of-mucinous-carcinomas-of-the-gastrointestinal-tract 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-in-iegfri-subtypes-and-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-national-cancer-database-analysis-of-hepatoid-adenocarcinoma-epidemiology-socioeconomic-and-cli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-patient-reported-gynecomastia-following-neoadjuvant-androgen-deprivation-therapy-and-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conditional-survival-in-advanced-stage-epithelial-ovarian-cancer-implications-for-survivorship-plan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-and-survival-of-melanoma-in-jordan-2013-2022-a-registry-based-study-of-trends-and-his 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ascertain-real-world-asciminib-asc-effectiveness-in-patients-pts-with-philadelphia-chromosome-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-clinical-outcomes-among-us-patients-with-non-muscle-invasive-bladd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mental-health-and-malignancy-real-world-associations-between-early-onset-gastrointestinal-cancers-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-adjuvant-chemotherapy-in-high-risk-stage-ii-colon-cancer-with-microsatellite-instability 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comments-on-the-lunar-trial-in-oligorecurrent-hormone-sensitive-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-molecular-and-clinical-characterization-of-early-onset-gastrointestinal-cancers-integ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-immune-architecture-as-a-predictor-of-response-to-neoadjuvant-chemoradiotherapy-in-rectal-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/abvd-versus-beacopp-for-front-line-treatment-of-hodgkin-lymphoma-a-systematic-review-and-meta-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ivonescimab-plus-gemcitabinecisplatin-and-stereotactic-body-radiotherapy-as-first-line-treatment-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-by-insurance-coverage-in-non-hodgkin-lymphoma-nhl-experience-from-two-academic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/donafenib-combined-with-anti-pd-1-antibody-as-adjuvant-therapy-for-patients-with-hepatocellular-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-long-term-survival-in-esophageal-carcinoma-is-it-the-same-for-all-stages 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-in-hospital-mortality-among-critically-ill-patients-in-icu-with-cancer-a-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-and-machine-learning-in-relapsedrefractory-multiple-myeloma-a-systematic-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/structured-interventional-strategies-to-prevent-and-reduce-burnout-in-medical-oncologists-the-resil 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-model-prognostic-evaluation-of-immunotherapy-in-advanced-biliary-tract-cancer-and-development 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-and-preliminary-efficacy-of-a-peer-community-navigator-pcn-led-intervention-for-minori 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-of-first-line-niraparib-maintenance-therapy-in-korean-patients-with-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-mortality-from-malignant-neoplasms-and-cardiac-arrest-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-camrelizumab-with-chemotherapy-naci-in-pd-l1-negative-locally-advanced-cervical-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/allostatic-load-neutrophil-to-lymphocyte-ratio-and-body-composition-in-patients-with-metastatic-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/online-biographies-of-gynecologic-oncologists-analysis-of-linguistic-differences-based-on-gender-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-eligibility-to-enrollment-evaluating-barriers-to-clinical-trial-participation-for-leiomyosarco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/double-lung-transplantation-in-patients-with-metastatic-lung-limited-non-small-cell-lung-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preferences-and-motivations-for-self-collection-hpv-testing-among-cervical-cancer-screening-eligible 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-integrated-profiling-of-jak-stat-mapk-and-rtk-ras-signaling-alterations-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detecting-resistant-subpopulations-by-profiling-drug-response-heterogeneity-in-patient-derived-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/albumin-bilirubin-index-as-a-determinant-of-short-and-long-term-outcomes-after-locoregional-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctnow-pilot-study-a-multilevel-clinical-trial-education-and-clinical-trial-referral-coordination-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/associations-between-circulating-immunologic-markers-and-hcc-in-individuals-with-chronic-hcv-infecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/palliative-care-utilization-and-acute-care-outcomes-in-metastatic-prostate-cancer-in-a-safety-net-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-and-machine-learning-for-predicting-immune-checkpoint-inhibitor-associated-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-venetoclax-based-regimens-in-chronic-myelomonocytic-leukemia-a-systematic-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-molecular-landscape-of-biliary-tract-cancers-in-and-near-bronx-ny 2026-08-24 monthly 0.7 https://rjrindex.com/articles/respiratory-failure-in-patients-treated-with-immune-checkpoint-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pre-existing-autoimmune-disease-on-clinical-outcomes-in-patients-treated-with-bispecific-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-center-real-world-validation-of-the-hfa-icos-cardio-oncology-risk-tool-in-her2-positive-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/information-needs-of-breast-cancer-patients-in-a-brazilian-capital-city 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b2-study-of-qls1304-a-novel-highly-potent-and-selective-dual-inhibitor-of-kat6a6b-plu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-adjuvant-therapy-of-donafenib-in-hepatocellular-carcinoma-with-high-risk-recurrence-fa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/saturn-sts-phase-ii-study-of-neoadjuvant-atezolizumab-with-doxorubicin-concurrent-atezolizumab-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-study-of-donafenib-with-or-without-tace-as-postoperative-adjuvant-therapy-for-hepato 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erbiotax-ttcc-2022-02-a-phase-ii-multicenter-randomized-study-of-cetuximab-with-or-without-week 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radical-treatment-of-extraskeletal-myxoid-chondrosarcoma-a-retrospective-analysis-of-long-term-outc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequential-therapy-in-braf-mutant-melanoma-comparison-of-combination-immunotherapy-anti-ctla4-and-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stomatitis-as-a-harbinger-of-harm-long-term-mortality-and-multiorgan-adverse-events-associated-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-response-in-relation-to-total-neoadjuvant-therapy-sequence-completion-and-extra-consoli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-associated-with-overall-survival-in-patients-with-merkel-cell-carcinoma-a-retros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-trends-in-incidence-and-mortality-of-liver-cancer-by-etiology-and-sociodemographic-index-amon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/graft-and-infectious-outcomes-following-immune-checkpoint-inhibitor-exposure-in-kidney-transplant-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-california-end-of-life-option-act-a-case-series-of-77-consecutive-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/divergent-age-specific-trends-in-colorectal-cancer-mortality-a-22-year-analysis-of-the-emerging-ear 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-trends-in-colorectal-cancer-mortality-in-south-asia-1990-2023-a-retrospective-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-rna-based-homologous-recombination-deficiency-algorithm-to-predict-first-line-platinum-res 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quizartinib-in-combination-with-decitabine-and-venetoclax-for-newly-diagnosed-and-relapsedrefractor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/event-free-survival-from-the-randomized-phase-2-neohip-trial-evaluating-neoadjuvant-taxane-her2-tar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-nivolumab-plus-ipilimumab-and-adjuvant-nivolumab-in-patients-with-localized-microsatelli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-corticosteroid-timing-paradox-in-immune-checkpoint-inhibitor-treated-solid-tumors-and-its-associ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-global-randomized-double-blinded-phase-3-trial-of-vorasidenib-vs-placebo-in-patients-with-grade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-impact-of-glp-1-receptor-agonists-ras-on-stage-of-pdac-diagnosis-a-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-iii-study-of-a-highly-selective-fgfr2-inhibitor-3hp-2827-in-patients-with-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-factors-associated-with-durable-response-to-atezolizumab-in-extensive-stage-small-cell-lung 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transforming-evidence-into-answers-an-agentic-framework-to-support-living-clinical-practice-guideli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iegfri-mutational-landscape-in-non-small-cell-lung-cancer-a-10-year-experi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-deep-learning-derived-psma-pet-biomarkers-for-metastatic-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-treating-fields-in-newly-diagnosed-glioblastoma-an-updated-systematic-review-and-meta-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-chemotherapy-in-lung-cancer-survival-outcomes-in-small-cell-and-non-small-cell-lung-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-neoadjuvant-cemiplimab-in-hedgehog-inhibitor-hhi-naive-basal-cell-carcinoma-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-external-beam-radiation-therapy-and-androgen-deprivation-therapy-on-physical-activity-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-risk-of-interstitial-lung-disease-with-dxd-based-versus-non-dxd-trop2-antibody-drug-con 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-and-transcriptomic-correlates-of-her3-expression-in-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-trastuzumab-with-or-without-pertuzumab-after-pathologic-complete-response-to-neoadjuvant-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-different-formulations-and-dosing-intervals-of-goserelin-on-testosterone-suppression-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-related-changes-in-body-composition-during-maximal-androgen-blockade-mab-for-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/next-generation-sequencing-in-non-small-cell-lung-cancer-management-in-lebanon-clinical-practices-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-burden-of-stomach-cancer-attributable-to-alcohol-use-1990-2023-a-comprehensive-epidemiolog 2026-08-24 monthly 0.7 https://rjrindex.com/articles/laminectomy-versus-laminoplasty-in-the-surgical-management-of-long-segment-intradural-spinal-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-population-tumor-kinetics-analysis-for-early-cycle-ctdna-guided-therapy-decisions-in-dlbcl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iesr1i-mutation-longitudinal-dynamics-in-rwd-cohort-of-hrher2-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilizing-large-language-models-for-lung-cancer-patient-education-compared-to-publicly-available-inf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncomovies-cancer-in-cinema-from-early-sound-film-to-2025 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-review-and-meta-analysis-treatment-related-adverse-events-of-neoadjuvant-immune-checkpoint 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-twin-survival-calibration-to-enable-cross-disease-interpretation-of-early-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precision-or-perplexity-assessment-of-discordance-among-different-pd-l1-assays-in-the-same-specimen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expansion-of-circulating-nkg7-cytotoxic-cd4-t-cells-as-a-predictor-of-response-to-pd-1-blockade-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/de-escalated-chemotherapy-and-endocrine-therapy-outcomes-in-young-women-with-stage-i-hrher2-breas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pan-cancer-analysis-of-stat6-expression-and-its-relationship-with-tumor-microenvironment-characteris 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-quality-of-life-with-low-dose-pembrolizumab-plus-chemotherapy-in-early-triple-negativ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intracranial-pharmacokinetics-and-resistance-mechanisms-of-tucatinib-in-patients-with-her2mutant-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-and-preliminary-efficacy-of-a-12-week-remotely-delivered-exercise-program-in-patients-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-stratification-and-age-related-disparities-with-abemaciclib-responses-in-early-er-positiveher2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-squamous-cell-carcinoma-of-the-pancreas-a-seer-based-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-circrna-in-modulating-tumor-microenvironment-from-mycobacterial-infection-to-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-pi3k-v-to-develop-novel-combinational-therapies-for-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-line-cetuximab-plus-immune-checkpoint-inhibitor-ici-versus-cetuximab-plus-carboplatin-and-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-data-platform-for-comparative-analysis-of-treatment-patterns-costs-and-cost-effective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-role-of-atm-in-gastric-cancer-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-neoadjuvant-therapy-in-resectable-pancreatic-cancer-updated-systematic-revie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-neurologic-death-in-nsclc-patients-with-brain-metastases-treated-with-radiosurgery-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-to-evaluate-the-safety-tolerability-and-pk-of-eik1005-a-novel-wrn-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparison-of-remission-status-in-newly-diagnosed-multiple-myeloma-treated-with-daratumum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-management-of-locally-advanced-pancreatic-cancer-with-arterial-resections-and-reconstructio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-changes-in-coping-among-early-phase-cancer-clinical-trial-epct-participants 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-sarcopenia-and-adiposity-in-prognosis-of-pleural-mesothelioma-a-ct-based-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/escape-to-learn-a-team-based-gamified-educational-experience-for-hematologyoncology-fellows 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hematology-oncology-bootcamp-educational-impact-of-an-interactive-guideline-based-101-curriculum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-amivantamab-plus-lazertinib-versus-osimertinib-plus-chemotherapy-for-first-lin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-population-based-modular-multi-objective-optimization-framework-with-decoupled-exploration-and-exp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tarlatamab-in-small-cell-lung-cancer-with-brain-metastases-a-real-world-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sinonasal-adverse-events-of-immune-checkpoint-inhibitors-pharmacovigilance-using-faers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/local-delivery-of-sn-38-using-a-biodegradable-implantable-membrane-for-treatment-of-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/volrustomig-monotherapy-for-recurrentmetastatic-hnscc-substudy-2-of-the-evolve-02-phase-2-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/caregiver-professional-employment-and-its-impact-on-glioblastoma-patient-survival-results-from-two 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-ivonescimab-ak112-a-pd-1vegf-bispecific-antibody-combined-with-nab-paclitaxel-and-ci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-tissue-transcriptome-deconvolution-of-grade-associated-tumor-microenvironment-patterns-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-evolving-landscape-of-chimeric-antigen-receptor-car-t-cell-therapy-for-plasma-cell-leukemia-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidentally-discovered-lung-cancer-in-explanted-lungs-at-the-time-of-lung-transplantation-manageme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-venetoclax-based-therapy-in-t1114-positive-relapsedrefractory-multiple-myeloma-a-sy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/discovery-of-gene-set-based-biomarkers-and-therapeutic-targets-for-papillary-thyroid-cancer-based-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lanreotide-for-advanced-gastroenteropancreatic-neuroendocrine-tumors-gep-nets-in-a-korean-populati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-chronic-atrial-fibrillation-on-outcomes-of-acute-pulmonary-embolism-in-pancreatic-cancer-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-liposomal-irinotecan-in-combination-with-cisplatin-and-bevacizumab-for-high-grade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-neoadjuvant-ipilimumab-nivolumab-relatlimab-inr-combination-immunotherapy-in-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/class-specific-clinical-and-molecular-features-of-ismarca4i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiac-substructure-dose-signatures-as-predictors-of-late-cardiovascular-events-in-childhood-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-electronic-phenotyping-algorithms-for-prostate-cancer-in-all-of-us-and-their-impact-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reporting-of-patient-reported-outcomes-in-randomized-phase-3-clinical-trials-of-fda-approved-medicat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-clinical-utility-of-mri-for-preoperative-staging-of-early-stage-cervical-cancer-in-a-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-bispecific-rdcadc-theranostic-approach-to-overcome-trastuzumab-deruxtecan-resistance-and-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/indirect-comparison-of-the-effectiveness-of-tepotinib-and-immunotherapy-in-nsclc-with-metex14-skippi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-her2-targeted-tyrosine-kinase-inhibitors-in-iher2i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-factors-of-biochemical-recurrence-after-robot-assisted-radical-prostatectomy-results-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-chemotherapy-response-guided-selection-for-hypoxia-directed-major-radiation-de-escalation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-patients-at-risk-for-non-receipt-of-guideline-concordant-treatment-in-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-validation-study-of-a-novel-biomarker-based-scoring-system-east-score-for-limited-stage-small-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-fovinaciclib-versus-placebo-combined-with-aromatase-inhibitor-for-advanced-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dose-dense-weekly-versus-standard-three-weekly-paclitaxel-in-combination-with-carboplatin-for-resect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-social-determinants-of-health-on-women-with-early-onset-colorectal-cancer-a-retrospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tme-informed-bioprinted-3d-tissue-model-as-used-to-characterize-architecture-associated-drug-uptake 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-based-differences-in-outcomes-among-small-cell-lung-cancer-patients-treated-with-tarlatamab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-disclosure-of-frontline-treatment-1l-tx-with-the-selective-cdk4-inhibitor-bgb-43395-in-combi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-life-and-treatment-tolerability-of-bria-imt-cpi-in-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-na-chemoradiotherapy-ctrt-plus-avelumab-ave-in-locally-advanced-rectal-cancer-lar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-benmelstobart-plus-anlotinib-combined-with-sox-in-the-first-line-treatment-of-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genome-wide-association-and-mendelian-randomization-analyses-of-body-mass-index-and-breast-cancer-ri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evaluation-of-cxcl910-with-pd-l1-and-tmb-as-predictors-of-pembrolizumab-benefit-in-tripl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/synovial-sarcoma-misdiagnosis-and-potential-utility-of-ngs-testing-patient-identification-for-autolo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-subset-analysis-of-clinical-activity-and-pharmacodynamic-biomarkers-in-patients-with-sarcomas-in-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-ifebemtinib-combined-with-garsorasib-in-kras-g12c-mutant-colorectal-cancer-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lymphopenia-in-breast-cancer-and-association-with-clinical-outcomes-an-analysis-from-over-30000-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epcoritamab-epcor-chemoimmunotherapy-cit-in-patients-pts-with-relapsedrefractory-large-b-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-bmi-dependent-overall-survival-differences-in-postmenopausal-breast-cancer-patients-treate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-pathogeniclikely-pathogenic-plp-variants-in-epithelial-neuroendocrine-neoplasms-the-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimal-prostate-specific-antigen-cutoff-for-prostate-cancer-detection-a-prospective-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/new-onset-inflammatory-bowel-disease-associated-with-immune-checkpoint-inhibitor-therapy-a-real-wor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-egfr-mutant-primary-lung-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-an-mri-derived-recurrence-assay-in-women-with-hormone-receptor-positive-her2-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-cognitive-impairment-after-car-t-therapy-compared-with-autologous-stem-cell-transplantatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-of-ismad4i-alterations-in-an-immune-col 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-toxicity-of-bispecific-antibodies-versus-car-t-cell-therapy-in-diffuse-large-b-cell-lymph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/invasive-field-radiotherapy-plus-rituximab-versus-rituximab-alone-after-response-to-immunochemothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-open-label-single-arm-study-to-evaluate-the-efficacy-of-pembrolizumab-for-leukoplakia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/microbial-dysbiosis-as-predictor-of-benefit-from-cbm588-as-an-adjunct-to-immune-checkpoint-blockade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aspirin-use-and-survival-outcomes-in-endometrial-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fraction-genome-altered-to-predict-survival-in-early-stage-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-and-disparities-in-early-onset-non-colorectal-cancer-mortality-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/noninvasive-detection-of-early-gastric-cancer-via-red-blood-cell-dna-features-associated-with-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-pd-l1-testing-among-persistent-recurrent-or-metastatic-cervical-cancer-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-pancreatic-fistula-after-resection-of-pancreatic-neuroendocrine-tumors-incidence-pre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-group-community-health-worker-led-advance-care-planning-education-on-advance-care-planning 2026-08-24 monthly 0.7 https://rjrindex.com/articles/homologous-recombination-deficiency-signature-hrdsig-in-older-women-with-advanced-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantifying-the-impact-of-protocol-design-on-enrollment-and-dropout-rates-in-breast-cancer-clinical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-analysis-and-functional-profiling-of-galectin-3-in-the-tumor-immune-microenvironment-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-outpatient-car-t-cell-therapy-administration-on-healthcare-utilization-in-patients-with-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultra-early-onset-metastatic-colorectal-cancer-lt35-years-ras-driven-apctp53-depleted-tmb-lo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-dynamics-and-prognostic-value-during-first-line-treatment-of-metastatic-colorectal-cancer-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-determinants-of-cisplatin-resistance-in-germ-cell-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-of-a-randomized-phase-ii-trial-of-second-line-treatment-for-advanced-soft-tissue-sarco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dual-microbial-signature-as-a-predictor-of-postoperative-colorectal-cancer-recurrence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-transcriptomic-signature-to-predict-immune-checkpoint-inhibition-efficacy-in-proficient-mismatch-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/family-cancer-history-and-perceived-value-of-multi-cancer-early-detection-tests-in-a-national-us-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/triplet-combination-of-anlotinib-plus-nab-paclitaxel-and-gemcitabine-ag-as-a-first-line-strategy-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-tecotabart-vedotin-plus-toripalimab-with-or-without-chemotherapy-as-first-lin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/large-language-model-protein-set-generation-for-interpretable-serum-proteomics-in-localized-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lumbar-puncture-in-thrombocytopenic-adults-with-leukemia-and-lymphoma-revisited-a-scoping-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-epigenome-wide-associations-and-pre-chemotherapy-prediction-of-post-chemotherapy-inflam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-metabolic-syndrome-associated-mortality-among-patients-with-upper-gastrointestina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-neutrophil-released-myeloperoxidase-in-cancer-associated-cachexia-in-patients-with-pancr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-optical-genome-mapping-ogm-to-identify-atypical-or-cryptic-ikmt2ai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-expression-analysis-of-microrna-and-its-associated-gene-network-in-thyroid-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/choosing-wisely-pakistan-a-call-for-value-based-oncology-practice-in-resource-limited-settings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intensity-modulated-proton-therapy-versus-intensity-modulated-photon-radiotherapy-for-locally-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographics-and-clinical-characteristics-of-epithelioid-leiomyosarcoma-a-national-cancer-database 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-transarterial-chemoembolization-tace-plus-sorafenib-vs-tace-alone-in-the-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-characteristics-of-combined-hepatocellular-cholangiocarcinoma-tumors-in-a-tertiary-care-cent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-assessment-of-skin-toxicity-in-prone-vs-supine-positions-during-preoperative-breast-radi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-features-and-prognosis-analysis-of-11-patients-with-tfe3-rearranged-perivascular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/promoting-acral-melanoma-awareness-among-nail-salon-technicians-and-cosmetology-educators-in-califor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-onset-colorectal-cancer-in-a-developing-region-a-five-year-real-world-analysis-from-brazil 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-influencing-the-decision-for-contralateral-risk-reducing-mastectomy-in-japanese-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trend-analysis-of-survival-socioeconomic-and-racial-disparities-in-esophageal-squamous-cell-carcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-switching-from-ribociclib-to-palbociclib-due-to-toxicity-in-hormone-receptor-positive-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-signal-dilution-in-cancer-trials-estimation-of-toxicities-through-term-fragmentation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-burden-of-disease-analysis-of-acute-lymphoblastic-leukemia-in-children-in-africa-incidence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-performance-of-large-language-model-derived-and-clinician-documented-ecog-ps-in-predicti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-trends-and-burden-of-retinoblastoma-mortality-in-south-asia-a-retrospective-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-aligned-evaluation-of-large-language-models-for-oncology-clinical-decision-support-across-dis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-clinical-trial-of-ivonescimab-vegfxpd-1-bispecific-antibody-in-patients-with-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proteolysis-targeting-chimera-protac-targeting-btk-degradation-for-cancer-therapy-in-mantle-cell-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/waveline-011-zilovertamab-vedotin-plus-r-chp-versus-polatuzumab-vedotin-plus-r-chp-as-first-line-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-following-car-t-therapy-in-adults-with-relapsedrefractory-b-all-according-to-prior-inotuzu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-trends-and-disparities-in-indolent-and-aggressive-non-hodgkin-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-calmangafodipir-in-preventing-chemotherapy-induced-peripheral-neuropathy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-arm-phase-ii-study-of-sequential-therapy-with-curative-intent-in-de-novo-her2-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-in-association-with-adrenal-insufficiency-in-hospitalized-solid-tumor-patients-on-immun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-personalized-digital-approach-to-cancer-risk-assessment-in-a-diverse-gynecology-clinic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-implementation-of-a-pilot-prescreening-tool-for-potential-clinical-trial-participant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exosomal-micrornas-and-key-pathways-associated-with-cognitive-impairment-in-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-trends-and-burden-of-burkitt-lymphoma-mortality-in-south-asia-a-retrospective-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-and-perioperative-management-of-inflammatory-myofibroblastic-tumors-at-a-single 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-disparities-and-inpatient-outcomes-in-appendiceal-adenocarcinoma-a-us-nationwid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-outcomes-of-durvalumab-versus-pembrolizumab-in-gastric-cancer-a-propensity-matched-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rna-expression-signatures-as-predictors-of-prognosis-in-thin-and-thick-primary-cutaneous-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-oral-medicine-oncology-nexus-periodontal-disease-as-a-predictor-of-survival-and-complications-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/levels-of-vegf-a-vegf-c-svegfr-1-and-svegfr-2-in-tumor-tissue-and-serum-of-patients-with-rare-end 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-chemotherapy-to-checkpoints-survival-trends-in-rectal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-economic-impact-of-modifiable-risk-factors-in-colorectal-cancer-a-comprehensive-analysis-usi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-a-real-time-targeted-expert-outreach-model-on-conversion-of-biomarker-results-to-precision 2026-08-24 monthly 0.7 https://rjrindex.com/articles/meaning-centered-psychotherapy-versus-dignity-therapy-for-spiritual-well-being-in-patients-with-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamic-disease-trajectories-not-treatment-timing-as-a-driver-of-outcomes-in-intrahepatic-cholangi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-combined-with-capecitabine-as-maintenance-therapy-for-metastatic-nasopharyngeal-carcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-of-the-association-between-primary-insomnia-and-early-onset-gastrointestinal-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nationwide-trends-in-mortality-with-concurrent-colorectal-cancer-and-chronic-ischemic-heart-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expression-of-fgfr2b-and-her2-in-gastric-cancer-implications-for-targeted-therapy-selection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-analysis-of-tad-a-phase-2-single-arm-open-label-study-of-combination-therapy-of-transarteri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characterization-and-association-with-autoimmunity-in-immune-checkpoint-inhibitor-ici-med 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tolerance-of-gemcitabine-oxaliplatin-gemox-in-advanced-and-metastatic-gallbladder-cancer-a-real-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-treatment-of-low-grade-upper-tract-urothelial-carcinoma-lg-utuc-with-padeliporfin-vascul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antigen-switch-and-bcr-axis-enriched-multi-target-car-t-re-infusion-after-prior-car-t-failure-in-rr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-immunotherapy-response-with-direct-acting-antiviral-therapy-in-patients-with-advanced-hepa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-benchmarking-of-us-oncology-populations-and-survival-using-a-multi-health-system-ehr-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-of-sarcoma-in-syria-a-retrospective-study-from-the-national-referral-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/variability-in-higher-education-support-for-adolescents-and-young-adults-with-active-cancer-a-cross 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-hematologyoncology-education-for-physician-trainees-through-an-interactive-online-platfor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-modal-quality-improvements-impact-on-colorectal-cancer-screening-among-people-experiencing-ho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targetable-genomic-alterations-in-early-onset-colorectal-cancer-and-their-therapeutic-implications 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-during-and-after-treatment-with-cdk46-inhibitors-for-hr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/malnutrition-and-deaths-associated-with-cancer-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-a-multidisciplinary-biomarker-care-pathway-to-reduce-somatic-sequencing-failure-ra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alcohol-and-cancer-risk-a-review-of-messaging-content-on-websites-of-medical-cancer-government-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multivariate-survival-analysis-and-prevalence-disparities-in-spindle-cell-carcinoma-a-seerstat-base 2026-08-24 monthly 0.7 https://rjrindex.com/articles/malignant-pericardial-effusion-a-high-risk-marker-for-in-hospital-mortality-and-cardiovascular-coll 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-a-vertically-integrated-care-system-on-mortality-risks-in-insured-patients-by-socio-eco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/equal-hopes-medicaid-breast-cancer-coordination-of-care-improvement-initiative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cytokine-profiles-in-hpv-associated-cervical-intraepithelial-neoplasia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-nuclear-lamina-associated-alterations-as-predictors-of-prostate-cancer-recurrence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nutritional-and-inflammatory-factors-associated-with-chemotherapy-response-and-survival-in-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-rna-based-ngs-on-false-positive-fusion-calls-in-colorectal-cancer-compared-with-dna-ngs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sun-protective-behaviours-amongst-indigenous-communities-a-scoping-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-utility-of-comprehensive-genomic-and-transcriptomic-profiling-in-metastatic-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zongertinib-in-previously-treated-advanced-her2-mutant-non-small-cell-lung-cancer-a-single-center-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/supportive-care-gaps-during-breast-cancer-treatment-in-vietnam-determinants-and-quality-of-life-cor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-cardiovascular-outcomes-among-solid-tumor-adcs-a-tumor-agnostic-observational-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-comparison-of-google-medgemma-and-chatgpt-5-in-expert-reviewed-gastrointesti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/text-based-electronic-patient-reported-outcome-monitoring-in-oncology-a-180-day-longitudinal-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intracranial-efficacy-of-tarlatamab-versus-chemotherapy-ctx-as-second-line-2l-treatment-for-smal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-characterization-of-conventional-dedifferentiated-and-mesenchymal-chondrosarcoma-a-550-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-enabled-multimodal-adjudication-of-revised-imwg-progression-after-bcma-car-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-first-line-treatments-in-patients-with-metastatic-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-dietary-fiber-and-fructose-with-progression-free-survival-pfs-in-metastaticadvance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-ctdna-dynamics-assessed-by-a-personalized-whole-genome-sequencing-based-assay-as-a-predictor-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-informed-ctdna-as-a-biomarker-of-outcomes-following-stereotactic-body-radiotherapy-in-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-covid-19-pandemic-on-breast-cancer-incidence-and-immunohistochemical-subtype-distribution 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recurrence-of-ductal-carcinoma-in-situ-a-large-south-american-multicenter-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/middle-high-altitude-residence-as-a-predictor-of-improved-immune-checkpoint-inhibitor-outcomes-in-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinically-actionable-turbt-derived-bladder-cancer-organoid-pharmacotyping-as-a-predictor-of-postope 2026-08-24 monthly 0.7 https://rjrindex.com/articles/histochrome-virtual-multiplex-immunohistochemistry-from-routine-hampe-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/large-language-models-as-decision-support-in-the-absence-of-genomic-profiling-a-simulated-prospecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-ultra-low-psa-after-3-and-6-months-of-intensified-androgen-deprivation-therapy-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/observation-versus-maintenance-pd-1-inhibitor-therapy-after-clinical-complete-response-in-dmmrmsi-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obese-patients-with-non-small-cell-lung-carcinoma-and-the-intratumor-microbiome-and-immune-microenvi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-circulating-tumor-dna-in-pancreatic-ductal-adenocarcinoma-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decision-support-for-treatment-of-patients-with-glioblastoma-a-systems-biology-approach-enabled-by 2026-08-24 monthly 0.7 https://rjrindex.com/articles/application-of-pet-rano-10-criteria-and-associations-with-outcome-in-iidh-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-hb0025-a-pd-l1vegf-bispecific-antibody-in-combination-with-chemotherapy-as-fi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-related-adverse-event-severity-and-clinical-outcomes-with-immune-checkpoint-inhibitor-immunot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalized-neoantigen-vaccine-as-adjuvant-therapy-in-high-risk-postoperative-esophageal-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-level-association-between-age-enriched-populations-and-treatment-effect-in-frontline-randomize 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-and-role-in-guiding-individualized-treatment-of-imaging-extranodal-extension-iene 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combining-immune-checkpoint-inhibition-and-dendritic-cell-vaccination-in-advanced-pleural-and-perito 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-powered-spatial-tumor-microenvironment-analysis-in-metastatic-microsatellite-stable-colorectal-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-outcomes-of-biweekly-compared-with-standard-triweekly-gemcitabinenab-paclitaxel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characteristics-and-outcomes-of-early-onset-pancreatic-cancer-10-year-retrospective-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-a-centralized-app-led-peer-to-peer-program-on-patient-access-provider-burden-and-institu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-clearance-of-adjuvant-chemotherapy-in-localized-colorectal-cancer-using-an-ult 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-yield-after-pre-biopsy-steroid-administration-in-primary-cns-high-grade-b-cell-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-integrating-early-palliative-care-in-advanced-sarcoma-patients-for-enhanced-quality-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-inpm1i-co-mutation-on-post-transplant-outcome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-central-review-process-on-response-rates-in-neuroblastoma-clinical-trials-a-report-from-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/data-from-a-real-world-study-association-of-cdcp1-expression-level-with-survival-outcomes-in-mcrc-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-migration-patterns-of-practicing-medical-oncologists-in-the-united-states-2020-2025 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-prophylactic-cyclophosphamide-on-alc-and-delayed-neurotoxicity-after-cilta-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intracranial-efficacy-and-safety-of-trastuzumab-deruxtecan-in-her2-positive-and-her2-low-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-covid-19-mrna-vaccination-on-bispecific-antibody-outcomes-in-hematologic-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-zn-a-1041-a-highly-blood-brain-barrier-bbb-permeable-her2-tyrosine-kinase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-prediction-models-for-familial-breast-cancer-a-cochrane-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/management-of-pulmonary-nodules-across-latin-america-a-real-world-observational-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-cell-type-specific-circadian-disruption-in-pediatric-b-all-on-clock-based-biomarkers-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-oncologic-outcomes-in-patients-with-triple-negative-tn-lobular-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/standardized-mean-differences-of-primary-outcomes-found-in-randomized-controlled-trials-of-wellness 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-transcriptomic-profiling-to-identify-stroma-based-prognostic-groups-in-oncogene-addicted-lun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-efficacy-of-gfh375-in-patients-with-advanced-cholangiocarcinoma-or-colorectal-cancer-har 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-to-treatment-initiation-for-triple-negative-breast-cancer-in-brazil-a-call-for-public-health-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-and-safety-of-axicabtagene-ciloleucel-versus-lisocabtagene-maraleucel-in-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-lung-cancer-mortality-among-us-adults-aged-55-before-and-after-the-introduction-of-immu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prag-50-personalized-thymosin-alpha-1-and-radioimmunotherapy-for-advanced-refractory-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-ai-foundation-model-as-a-predictor-of-efficacy-of-next-generation-checkpoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-sintilimab-combined-with-nab-paclitaxel-and-s-1-as-first-line-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-molecular-and-clinical-features-of-systemic-cancers-that-spread-to-the-intradural-spi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-quiet-crisis-pancreatic-cancer-incidence-mortality-and-dalys-in-latin-america-and-the-caribbean 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-cohort-validation-of-a-semaphorin-prognostic-signature-to-identify-an-immune-excluded-subtype 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cognition-of-apalutamide-adt-treatment-responders-versus-non-responders 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-of-first-line-etcdk46i-continuation-beyond-disease-progression-in-a-large-cohort-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-prostate-specific-antigen-psa-decline-among-the-latin-american-subgroup-of-libertas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-cetuximab-irinotecan-rechallenge-versus-regorafenib-in-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-small-cell-lung-cancer-and-the-obesity-paradox-a-retrospective-cohort-study-using-the-trinetx-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sigvotatug-vedotin-sv-an-investigational-integrin-beta-6-ib6directed-antibody-drug-conjugate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-exploratory-single-center-single-arm-trial-of-r-isv-folactis-in-situ-vaccination-for-advanced-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-derived-cd8-cytotoxic-t-cell-immune-signatures-from-baseline-hampe-images-to-predict-immunothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pooled-analysis-of-phase-i-and-expanded-access-study-cohorts-of-doc1021-dubodencel-in-combination 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-prophylactic-anticoagulation-in-patients-with-multiple-myeloma-receiving-imm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/turning-clinically-approved-parp-inhibitors-into-immunotherapy-sensitizers-by-reprogramming-the-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shifting-etiologic-burden-of-hepatocellular-carcinoma-hospitalizations-in-the-united-states-2016-20 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-serum-folate-receptor-alpha-levels-in-colon-cancer-association-with-diagnosis-clinic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-tsn1611-a-highly-selective-oral-kras-g12d-inhibitor-in-solid-tumors-efficacy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-aps03118-a-next-generation-ret-inhibitor-in-patients-with-non-small-cell-lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cfdna-based-signatures-of-nucleosome-organization-to-enable-prostate-cancer-subtyping 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-androgen-receptor-pathway-inhibition-for-patients-with-high-risk-localized-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elevated-red-blood-cell-distribution-width-to-albumin-ratio-and-incident-cancer-risk-a-prospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/satmm-a-systems-genetic-network-analysis-based-risk-stratification-tool-validated-across-the-diseas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prophylactic-vedolizumab-to-facilitate-use-of-immune-checkpoint-inhibitors-in-cancer-patients-at-hig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-of-black-patients-with-newly-diagnosed-multiple-myeloma-in-the-era-of-triplet-and-q 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lap-net1-results-of-a-phase-1b-evaluating-np137-an-inhibitor-of-the-epithelial-to-mesenchymal-tran 2026-08-24 monthly 0.7 https://rjrindex.com/articles/consensus-molecular-subtypes-mutational-features-and-circulating-tumor-dna-dynamics-in-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-income-related-lung-cancer-disparities-since-the-introduction-of-uspstf-screening-guidelin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-safety-and-patient-reported-quality-of-life-with-first-line-chemotherapy-in-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-data-from-rosetta-lung-02-a-global-randomized-phase-23-trial-of-pumitamig-pd-l1-vegf-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-life-among-caregivers-of-patients-with-breast-cancer-in-mexico-a-multicenter-cross-secti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expanded-germline-genetic-testing-of-patients-with-hematologic-malignancies-to-identify-high-proport 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-the-covid-19-pandemic-on-breast-cancer-stage-at-time-of-diagnosis-at-a-major-health-sy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-to-identify-racial-and-socioeconomic-disparities-in-the-onset-and-tumor-distributio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-analysis-in-the-era-of-systemic-immunotherapy-for-bcg-naive-high-risk-non-muscle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-controlled-trial-of-a-psychosocial-digital-application-thrive-mm-for-patients-living-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-and-ipilimumab-nivo-ipi-as-first-line-1l-treatment-for-patients-with-metastatic-renal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-with-fruquintinib-plus-sintilimab-versus-axitinib-or-everolimus-in-advanced-renal-cell-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/application-of-a-neoadjuvant-21-gene-breast-recurrence-score-assay-to-redirect-surgical-and-systemic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/direct-oral-anticoagulants-versus-low-molecular-weight-heparin-for-venous-thromboembolism-in-primary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ripretinib-as-preoperative-therapy-in-patients-with-potentially-resectable-advanced-gastrointestinal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-versus-adjuvant-chemotherapy-in-cardiac-tumor-resection-a-propensity-matched-analysis-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-pro-during-and-after-multimodal-treatment-for-resectable-esophageal-aden 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-phase-ibii-study-of-trastuzumab-deruxtecan-combined-with-nivolumab-and-capox-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-atlas-of-peripheral-blood-immune-landscape-in-pmmrmss-rectal-cancer-treated-with-neoadj 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-anti-epcam-x-anti-cd3-bispecific-antibody-m701-for-the-treatment-of-malignant-pleural-effusion 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-btae-haic-combined-with-lenvatinib-and-camrelizumab-for-patients-with-high-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigation-of-the-role-of-ifitm3-and-the-pi3kakt-axis-in-the-acute-myeloid-leukemia-tumor-microe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-a-phase-ii-trial-of-nivolumab-and-ipilimumab-in-children-and-young-adults-with-relapsed-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efbemalenograstim-alfa-for-prophylaxis-in-non-small-cell-lung-cancer-patients-patients-with-chemothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcome-of-adjuvant-braf-and-mek-inhibition-with-dabrafenib-and-trametinib-in-braf-v600k-compared-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-lung-cancer-among-patients-with-idiopathic-interstitial-lung-disease-a-cohort-study-using-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-lb1410-a-bivalent-tim-3pd-1-bispecific-antibody-in-patients-with-advanced-solid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intrathecal-it-pd-1ctla-4-antibody-combined-with-pemetrexed-pm-for-leptomeningeal-metastases-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sglt-2-inhibitors-more-than-glycemic-control-in-diabetic-patients-with-renal-cell-carcinoma-a-real 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incremental-clinical-yield-of-serial-large-ngs-panel-liquid-biopsies-in-routine-care-analysis-of-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imtapi-deletions-and-co-mutational-landscape-from-whole-genome-sequencing-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anti-pd-l1-plus-chemotherapy-in-advanced-pd-l1-negative-nonsquamous-non-small-cell-lung-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploiting-ribosomal-biogenesis-dependence-through-rna-polymerase-i-inhibition-in-medulloblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-agnostic-and-cross-indication-actionable-alterations-in-iidhi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/different-roles-of-sall4-and-oct34-in-the-development-and-evolving-processes-of-benign-and-malignan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-nationwide-population-based-study-on-the-incidence-and-prognosis-of-patients-with-her2-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-adjuvant-anti-pd-1anti-pd-l1-immunotherapy-in-resected-renal-cell-carcinoma-rcc-an-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interpretable-ai-driven-pan-cancer-pre-screening-of-actionable-gene-fusions-from-hampe-slides-a-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-regional-disparities-in-prostate-cancer-associated-dementia-mortality-in-the-united-state 2026-08-24 monthly 0.7 https://rjrindex.com/articles/denosumab-as-an-immune-modulator-results-of-a-window-of-opportunity-study-in-early-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-ipilimumab-nivo-ipi-vs-nivo-in-microsatellite-instability-highmismatch-repair-defic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-human-epidermal-growth-factor-receptor-2-her2-amplified-and-her2-mutated-left 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cladribinecyclophosphamide-lymphodepletion-efficacy-and-toxicity-in-cd19-car-t-therapy-for-b-all 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-genomic-landscape-of-osteosarcoma-systematic-review-and-analysis-of-1058-patients-ac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-progression-free-survival-pfs-with-microsatellite-instability-high-msi-h-or-misma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-the-warburg-effect-mitochondrial-metabolic-modulation-with-intermittent-fasting-during-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/protective-factors-supporting-caregiver-well-being-in-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sparto-a-phase-i-study-of-pd-1-inhibitor-spartalizumab-pdr001-in-combination-with-low-dose-of-paz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antitumor-activity-of-amivantamab-by-consensus-molecular-subtypes-in-irasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-study-of-olverembatinib-hqp1351-in-patients-with-chronic-phase-chronic-myeloid-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mc240701-decentralized-pilot-study-of-triple-oral-metronomic-chemotherapy-in-recurrentmetastatic-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precision-dc-personalized-neoantigen-dendritic-cell-vaccine-pilot-trial-for-high-risk-triple-negati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fierce-hn-a-multicenter-randomized-double-blind-placebo-controlled-phase-3-study-of-ficlatuzuma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-controlled-clinical-study-of-neoadjuvant-combination-of-axitinib-plus-torip 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-sup111sup-in-xyimsr-01-spect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-variation-in-outcomes-and-resource-utilization-among-us-hospitalizations-for-tumor-lysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/microbiota-prognostic-signature-in-colon-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-or-targeted-therapy-real-world-comparative-outcomes-in-advanced-and-recurrent-head-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rural-and-urban-disparities-in-cancer-mortality-in-texas-during-the-covid-19-pandemic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortalities-due-to-pneumonitis-in-esophageal-cancer-in-the-united-states-1999-2020-a-pop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-disability-adjusted-life-years-from-hepatitis-c-related-liver-cancer-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-covid-changes-to-healthcare-utilization-expenditures-and-care-prioritization-among-us-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-flexible-and-adapted-follow-up-strategies-in-a-patient-centric-phase-ii-trial-of-first 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-safety-profiles-of-frontline-btk-inhibitor-containing-regimens-in-mantle-cell-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-inpatient-burden-of-nausea-vomiting-and-dehydration-during-radiotherapy-a-hcup-nis-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/xerostomia-following-lutetium-177-psma-radioligand-therapy-in-metastatic-prostate-cancer-associatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncology-clinicians-empathy-association-with-mean-number-of-visits-and-referrals-to-psychosocial-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chronic-condition-cost-burden-among-older-medicare-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-outcomes-by-socioeconomic-characteristics-among-younger-adults-hospitalized-with-gastroint 2026-08-24 monthly 0.7 https://rjrindex.com/articles/associations-between-chronic-pain-depression-and-social-vulnerability-in-us-adults-with-colon-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/establishing-a-rapid-diagnostic-clinic-at-a-tertiary-care-cancer-center-the-indiana-university-simo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intratumoral-spatial-distribution-of-high-risk-prostate-cancer-patterns-evaluation-on-digital-patho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anthracycline-free-vs-anthracycline-containing-dual-anti-her2-neoadjuvant-therapy-real-world-outcom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-evaluation-of-a-multidisciplinary-lung-cancer-early-detection-program 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-differences-between-primary-and-metastatic-melanoma-insights-from-aacr-genie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-endometrial-cancer-surgery-on-the-development-of-cardiovascular-risk-factors-in-women-unde 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-idpydi-genotyping-in-response-to-fda 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-as-high-acuity-phenotypes-in-us-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-stratification-and-actionable-genomic-alterations-in-endometrial-carcinoma-real-world-dat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-neoadjuvant-endocrine-therapy-versus-chemotherapy-in-hormone-receptor-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinically-significant-immune-related-adverse-events-with-perioperative-pembrolizumab-in-early-tripl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-targeted-tumor-genomic-profiles-in-prostate-cancer-among-black-and-white-men 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-bladder-cancer-journey-using-a-social-media-campaign-to-uncover-educational-needs-of-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lymph-node-ratio-in-relation-to-the-survival-benefit-of-immediate-breast-reconstruction-in-node-posi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-analysis-of-high-dose-rate-brachytherapy-combined-with-total-neoadjuvant-therapy-versus-tot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-dna-and-rna-next-generation-sequencing-ngs-for-accurate-diagnosis-dx-and-sub 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-maternal-outcomes-among-pregnant-patients-with-cancer-a-national-inpatient-sa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-analysis-of-recurrentmetastatic-platinum-resistant-nasopharyngeal-cancer-patients-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-approach-to-identify-hdl-as-a-prognostic-factor-for-melanoma-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reducing-avoidable-observation-stays-in-cancer-patients-requiring-procedural-interventions-through-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-of-endometrial-cancer-subsets-ipolei 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pathologic-necrosis-on-clinical-outcomes-following-neoadjuvant-radiation-for-soft-tissue-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neuropathy-following-chimeric-antigen-receptor-t-cell-therapy-incidence-and-associated-risk-factors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genotype-anatomic-correlates-and-survival-outcomes-in-a-molecularly-validated-90-patient-cohort-of-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/failure-to-rescue-after-acute-complications-in-gastrointestinal-cancer-hospitalizations-in-the-unite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-agent-ai-platform-for-clinical-trial-operations-specialized-agents-to-accelerate-feasibilit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reproductive-outcomes-after-chemotherapy-in-young-women-with-non-hodgkin-lymphoma-a-systematic-revi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/smoking-prevalence-as-a-predictor-of-preventable-cancer-burden-a-mediation-analysis-with-health-sys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/carfilzomib-based-combinations-for-waldenstrom-macroglobulinemia-real-world-experience-from-a-singl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mechanical-ventilation-timing-categories-and-inpatient-outcomes-in-adult-cancer-hospitalizations-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-istreptococcus-anginosusi-with-gastric-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/on-the-borderline-gej-coding-as-a-driver-for-stage-migration-and-survival-difference-a-seer-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-related-disparities-in-catastrophic-health-expenditures-among-cancer-survivors-in-the-united-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-circulating-tumor-cells-with-pd-l1-expression-and-clusters-in-confirmative-tumor-thro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-of-azd6750-a-cd8-guided-interleukin-2-agent-alone-and-in-combination-with-other-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-ferroptosis-score-activity-as-a-predictor-of-survival-and-rituximab-response-in-diffuse-large-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-landscape-of-oncology-clinical-trials-in-africa-over-the-last-three-decades-1995-2025 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-integrated-rehabilitation-and-risk-of-distant-metastases-in-breast-cancer-patients-a-prospect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-carboplatin-paclitaxel-cp-for-metastatic-anal-squamous-cell-carcinoma-ascc-an-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-flag-based-versus-standard-37-induction-therapy-in-adults-with-newly-diagno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intelligence-driven-data-extraction-for-the-breast-cancer-multidisciplinary-team-meeting-case-prepar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-frailty-among-hospitalized-patients-with-acute-myeloid-leukemia-a-national-inpatient-sa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-incidence-and-stage-at-presentation-of-hepatocellular-carcinoma-a-seer-based-study-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analgesia-profile-and-racial-disparity-in-opioid-use-among-cancer-patients-hospitalized-in-a-public 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sepsis-related-mortality-in-adults-with-liver-and-intrahepatic-bile-duct-malignancies-a-25-year-nat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-patient-outcomes-and-tumor-genetics-in-perinatal-early-onset-colorectal-cancer-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-of-cancer-drug-indication-pairs-recommended-for-funding-on-the-australian-pharmaceut 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-recurrence-after-perioperative-flot-for-resectable-gastric-cancer-a-systematic-review-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/g8-geriatric-score-as-a-determinant-of-survival-and-treatment-in-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-international-multicenter-randomized-controlled-trial-of-selective-index-lymph-node-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-palliative-care-delivery-in-oncology-in-a-resource-constrained-setting-experience-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-analysis-of-prognostic-value-of-ctdna-monitoring-among-advanced-breast-cancer-with-oligo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-dental-prophylaxis-on-long-term-systemic-risks-in-therapy-induced-oral-mucositis-a-real-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/womens-perceptions-and-preferences-regarding-liquid-biopsy-for-breast-cancer-screening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-tolerability-and-outcomes-of-generic-palbociclib-in-metastatic-hr-positive-her2-negative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-survival-outcomes-in-colon-cancer-patients-with-autism-spectrum-disorder-a-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determinants-of-lung-metastasis-in-pediatric-and-young-adult-differentiated-thyroid-cancer-a-meta-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-early-onset-cancers-in-hungary-nationwide-trends-in-incidence-and-mortality 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-antifungal-prophylaxis-in-acute-myeloid-leukemia-a-systematic-review-and-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reducing-manual-chart-review-in-oncology-validation-of-an-ai-based-monitoring-tool-for-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-progression-free-and-overall-survival-from-response-endpoints-in-oncology-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/convergent-pi3k-pathway-activation-and-swisnf-dysfunction-as-characteristics-of-bone-metastatic-end 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-mediated-toxicities-iraes-in-immune-checkpoint-inhibitor-ici-therapy-in-various-combinati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-the-awareness-to-enrollment-gap-an-assessment-of-oncologist-barriers-in-clinical-tria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/flt3-inhibitors-across-the-allogeneic-transplant-continuum-in-iflt3i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mrna-profiles-to-identify-metaphase-histone-and-cancer-testis-antigen-gene-overexpression-in-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-arm-phase-ii-study-of-ivonescimab-in-combination-with-folfox-in-advanced-her2-negative-gas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/telisotuzumab-adizutecan-temab-a-plus-osimertinib-osi-as-1l-treatment-for-unresectablemetastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-of-urine-liquid-biopsy-in-detecting-of-clinically-relevant-genomic-alterations-in-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reporting-of-occupational-mesothelioma-in-brazil-2007-2024-a-comparative-analysis-between-clinica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-delivery-of-tobacco-treatment-in-oncology-care-moving-the-needle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-adjuvant-sequential-chemoradiotherapy-on-long-term-overall-survival-in-early-stage-cervica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-glp-1-receptor-agonist-therapy-with-bcg-response-in-high-risk-non-muscle-invasive-bla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intismeran-autogene-plus-pembrolizumab-versus-pembrolizumab-alone-in-high-risk-resected-melanoma-5 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-patient-characteristics-treatment-patterns-and-clinical-outcomes-in-patients-diagnosed-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bulumtatug-fuvedotin-bfv-9mw2821-plus-toripalimab-in-patients-with-locally-advanced-or-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-results-from-exceed-a-phase-1-study-of-ly4101174-an-antibody-drug-conjugate-targeting-nect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inferring-molecular-signatures-in-colorectal-cancer-directly-from-routine-whole-slide-images 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-glp-1-receptor-agonists-in-hormone-receptor-positive-breast-cancer-patients-receiving-cdk4 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-baseline-serotonergic-antidepressant-use-on-survival-and-immune-related-adverse-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicogenomic-characteristics-associated-with-non-durable-response-to-first-line-immunotherapy-amon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-quality-of-life-following-tumor-infiltrating-lymphocyte-til-therapy-with-commercial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adaptive-targeting-of-lung-cancer-using-the-anti-p329g-adapter-car-t-cell-platform 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ipredict-phase-ii-study-of-cd8-pet-in-patients-with-immunoresponsive-solid-tumors-imaging-character 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-consensus-based-feature-selection-on-machine-learning-performance-for-metastatic-lung-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-data-disclosure-from-the-first-in-human-phase-12-trial-of-smp-3124lp-the-first-investigation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-mortality-across-gastrointestinal-malignancies-by-hospital-structural-characteristics-in-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comorbidity-related-medical-expenditures-and-health-outcomes-in-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-pd1pdl1-inhibitor-based-regimens-in-unresectable-stage-iiib-iiic-and-iv-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/synthetic-data-generation-from-breast-cancer-patients-to-enable-psm-on-wide-and-multidimensional-rea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-immune-checkpoint-inhibitor-anti-vegf-inhibitor-combinations-in-non-small-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preparedness-of-internal-medicine-residents-for-oncologic-emergencies-and-end-of-life-discussions-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-us-pneumonia-related-admissions-among-patients-with-multiple-myeloma-2006-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-identification-of-patients-at-risk-for-early-infectious-complications-after-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-from-the-trinetx-database-comparing-abiraterone-versus-darolutamide-in-hormone-sensi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-line-cetuximab-monotherapy-following-pd-1-inhibitor-treatments-in-patients-with-recurrentmet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-dynamics-following-molecularly-targeted-therapy-for-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-results-from-a-first-in-human-phase-12-study-of-askg915-an-anti-pd-1pro-il-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chronotherapy-in-metastatic-non-small-cell-lung-cancer-clinical-outcomes-according-to-immune-checkp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-hepatocellular-carcinoma-vs-intrahepatic-cholangiocarcinoma-related-mortal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/durable-efficacy-of-first-line-necitumumab-plus-pembrolizumab-in-pd-l1-high-advanced-nsclc-final-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-gastrointestinal-malignancies-in-hiv-the-impact-of-opportunistic-and-non-opportunistic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-thymic-epithelial-tumors-tets-with-lynch-syndrome-ls-per-germline-genetic-testing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-safety-of-adjuvant-capecitabine-in-triple-negative-breast-cancer-tnbc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-pretreatment-vitamin-d-insufficiency-in-racial-disparity-in-taxane-induced-peripheral-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/scaling-deep-learning-for-neuro-oncology-knowledge-distilled-efficientnetb0-powered-mri-classificat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-cardiotoxicity-with-chimeric-antigen-receptor-t-cell-car-t-therapy-a-systematic-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-clinical-study-of-act001-combined-with-radiotherapy-in-newly-diagnosed-pediatric-diffuse-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-characterization-of-ismarca4i-mutant-versus-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regorafenib-in-recurrent-glioblastoma-real-world-outcomes-from-a-colombian-cohort-regoma-col 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-istk11i-ikeap1i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gene-treatment-interaction-modeling-to-identify-temozolomide-sensitive-iidhi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-dose-intestinal-irradiation-to-enhance-the-efficacy-and-prognosis-of-pd-1-blockade-in-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-investigator-initiated-phase-i-study-evaluating-the-safety-tolerability-and-preliminary-efficac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-toxicities-associated-with-sulfamethoxazoletrimethoprim-tmp-smx-for-pneumocys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glp-1-receptor-agonist-therapy-and-risk-of-small-intestinal-neoplasms-real-world-evidence-from-a-gl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-associated-with-tarlatamab-for-extensive-stage-small-cell-lung-cancer-es-sclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunologic-determinants-in-procured-melanoma-tissue-as-drivers-of-durable-response-to-tumor-infiltr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-muscle-invasive-and-metastatic-bladder-and-urethral-pure-adenocarcinoma-buad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicogenomic-profile-and-progression-patterns-in-lung-squamous-cell-carcinoma-treated-with-immune 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serum-albumin-as-an-early-predictor-of-survival-in-patients-receiving-antibody-drug-conjugates 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-microenvironment-msi-status-and-tumor-mutational-burden-as-prognostic-factors-in-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radical-cystectomy-vs-bladder-sparing-therapy-in-very-high-risk-non-muscle-invasive-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-powered-volumetric-and-radiomic-mri-brain-analysis-for-prognostication-and-treatment-response-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/defining-safe-pre-chemotherapy-absolute-neutrophil-count-thresholds-in-early-stage-breast-and-colon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-tumor-stroma-crosstalk-with-icam1-antibody-drug-conjugates-to-enable-dual-compartment-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/b-cell-responses-in-recurrent-respiratory-papillomatosis-patients-treated-with-dna-immunotherapy-ino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-3-year-landmark-overall-survival-analysis-of-rp1-plus-nivolumab-in-patients-with-anti-pd-1-failed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-in-patients-with-extensive-stage-small-cell-lung-cancer-treated-with-durvalumab-ins 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-lego-as-a-constructivist-teaching-tool-in-undergraduate-and-patient-education-of-cancer-su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-anti-pd-1-prolgolimab-monotherapy-in-resectable-high-risk-melanoma-pathologic-response 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-bone-marrow-biopsy-bmbx-performance-relative-to-a-mastery-level-standard-a-sim-bmbx-inte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pathology-based-model-for-postoperative-recurrence-or-metastasis-prediction-and-adjuvant-immunothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bc3195-a-novel-adc-targeting-cadherin-3-cdh3-preliminary-results-of-a-phase-i-study-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stratos-p-clinical-model-for-prognosis-and-selection-of-patients-with-metastatic-hormone-sensitive-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-safety-and-efficacy-of-dkrd-versus-dvrd-regimens-in-multiple-myeloma-a-systematic-revie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-on-treatment-dose-adjustments-on-the-efficacy-of-enfortumab-vedotin-and-pembrolizumab-evp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-after-recurrence-on-neoadjuvant-chemo-immunotherapy-ncit-in-patients-pts-with-high-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interpretable-machine-learning-to-identify-health-system-levers-for-survival-outcomes-of-patients-wi-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-mortality-due-to-coexisting-respiratory-infections-and-multiple-myeloma-am 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multiple-myeloma-in-the-united-states-and-india-an-international-collaborative-study-comparing-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dose-response-relationship-of-serum-iron-ferritin-and-transferrin-saturation-with-cancer-related-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mc1923-phase-ii-durvalumab-plus-lurbinectedin-in-platinum-resistant-relapsed-extensive-stage-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-effect-of-neoadjuvant-chemotherapy-in-gbrca-mutated-compared-to-gbrca-wild-type-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-circulating-small-extracellular-vesicle-associated-mirna-in-head-and-neck-squamous-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-burden-and-distribution-of-febrile-neutropenia-among-hospitalizations-with-pancreatic-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bispecific-antibodies-in-breast-cancer-a-systematic-landscape-analysis-of-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glucagon-like-peptide-1-receptor-agonist-use-in-lung-cancer-patients-receiving-immune-checkpoint-inh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gk01-stemness-enriched-tumor-reactive-t-cell-therapy-plus-il-2-in-advanced-solid-tumors-orr-and-clo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/knowledge-distillation-for-pancreatic-cancer-diagnosis-efficientnet-based-deep-learning-for-stage-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-small-extracellular-vesicle-protein-based-model-for-ovarian-cancer-relapse-detection-and-monitorin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/malnutrition-and-cachexia-as-drivers-of-failure-to-rescue-in-gynecologic-cancer-hospitalizations-20 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-for-patients-pts-with-synchronous-versus-metachronous-metastatic-urothelial-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-treatment-patterns-and-outcomes-among-patients-pts-with-metastatic-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primal-precision-randomized-clinical-trial-comparing-mtb-assisted-care-to-usual-care-quality-of-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multiomic-spatial-analysis-of-tumor-microenvironment-during-neuroendocrine-ne-transformation-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-ai-powered-human-in-the-loop-real-time-registry-platform-to-enable-clinical-trials-pragmatic-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicenter-phase-ii-trial-of-atezolizumab-plus-carboplatin-and-etoposide-for-extensive-stage-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-sintilimab-combined-with-nab-paclitaxel-in-the-treatment-of-platinum-resistant-rec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/everolimus-and-aromatase-inhibitors-for-advanced-and-recurrent-low-grade-serous-ovarian-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/has-racial-and-ethnic-representation-in-oncology-clinical-trials-changed-a-30-year-systematic-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rethinking-mri-surveillance-after-breast-cancer-in-the-context-of-persistent-racial-disparities-in-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emergency-department-visits-and-hospitalizations-in-cancer-survivors-with-disabilities-a-national-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-in-vivo-car-t-cell-generation-using-a-cd8-targeted-lipid-nanoparticle-platform-in-rel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/navigating-the-post-covalent-bruton-tyrosine-kinase-inhibitor-cbtki-landscape-in-mantle-cell-lymph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zamboni-a-phase-ii-study-of-zanzalintinib-for-metastatic-clear-cell-renal-cell-carcinoma-with-bone 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-omaha-u01-substudy-01a-oral-steroidogenesis-inhibitor-opevesostat-alone-or-in-combination 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12a-multicenter-first-in-human-open-label-clinical-trial-evaluating-mdx2004-monotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-induction-chemoimmunotherapy-ici-with-cemiplimab-in-combination-with-cisplatin-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/four-decades-of-population-based-cancer-incidence-trends-in-costa-rica-implications-for-cancer-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-a-treatment-based-algorithm-to-infer-biomarker-status-in-real-world-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interventions-to-improve-hope-and-psychosocial-outcomes-in-patients-with-advanced-solid-tumor-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/endometrial-cancer-response-to-pro-emt-effects-of-type-2-diabetic-exosomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-comparison-of-patient-derived-organoid-drug-screening-with-standard-guideline-recommenda 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-outcomes-of-cytoreductive-surgery-with-hyperthermic-intraperitoneal-chemotherapy-in-the-un 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-xenograft-alignment-with-patient-tumors-to-inform-treatment-studies-in-uterine-carcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthcare-provider-perceptions-and-barriers-to-palliative-care-in-pakistan-a-narrative-synthesis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-landscape-and-survival-outcomes-in-gastric-adenocarcinoma-a-hispaniclatino-cohort-from-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/faith-fatigue-associated-with-immunotherapeutics-analyzing-patterns-and-associated-factors-during-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tacehaic-combined-with-bevacizumab-and-tislelizumab-as-third-line-therapy-for-colorectal-cancer-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-survival-outcomes-with-pembrolizumab-plus-chemotherapy-in-advanced-triple-negative-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-primary-thromboprophylaxis-in-adult-ambulatory-cancer-patients-a-scholarly-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-cancer-detection-with-a-multiomic-liquid-biopsy-comparing-and-combining-blood-and-stool 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-inpatient-mortality-and-resource-utilization-with-acute-complications-among-colorecta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-proton-pump-inhibitors-on-the-pathological-complete-response-rate-in-luminal-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilizing-a-resident-led-elective-to-improve-the-understanding-of-cancer-prevention-and-survivorship 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-response-and-safety-profile-of-axatilimab-in-chronic-gvhd-pooled-analysis-of-384-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imatinib-related-toxicity-profile-in-patients-with-gastrointestinal-stromal-tumors-seen-over-a-twent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-the-nrg1her3-axis-to-overcome-therapy-resistance-in-head-and-neck-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-recognition-and-assessment-through-non-invasive-evaluation-crane-a-prospective-clinical-va 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthcare-provider-use-of-a-community-based-narrative-resource-to-support-psychosocial-care-in-aya 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conditional-cancer-specific-survival-analysis-by-hpv-status-in-oropharyngeal-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antihistamine-use-and-immune-checkpoint-inhibitor-efficacy-an-institutional-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/histopathological-distinction-between-ici-induced-psoriasis-vulgaris-and-psoriasiform-dermatitis-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-angiotensin-receptor-neprilysin-inhibitor-arni-for-prevention-of-cancer-therapy-relate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-cardio-oncologic-burden-leukemia-associated-arrhythmia-mortality-in-the-united-states-1999-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-phst001-an-anti-cd24-monoclonal-antibody-in-adult-patients-with-advanced-relaps 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-analysis-of-facility-level-survival-differences-in-elderly-splenic-marginal-zone-lymphoma-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/body-mass-index-and-the-risk-of-hematologic-adverse-events-in-hrher2-breast-cancer-patients-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thrombotic-events-in-patients-receiving-immune-checkpoint-inhibitors-incidence-risk-factors-and-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-survive-study-re-evaluating-follow-up-in-early-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/melody-a-prospective-non-interventional-multicenter-cohort-study-to-evaluate-different-imaging-guid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tropion-urothelial03-a-phase-23-study-of-datopotamab-deruxtecan-dato-dxd-platinum-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/access-to-care-and-survival-outcomes-in-older-adults-with-chronic-lymphocytic-leukemiasmall-lymphoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eortc-gucg-2238-deescalate-a-pragmatic-trial-to-revisit-intermittent-androgen-deprivation-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-open-label-multi-center-trial-of-rpt1g-in-patients-with-relapsedrefractory-acute-myeloid-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-introducing-cemiplimab-as-adjuvant-treatment-in-high-risk-cutaneous-squamous-cell-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-ibrca12i-pathogenic-variants-homologous-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-resident-learning-in-anticoagulation-management-a-single-institution-quality-improvement 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-drivers-of-early-readmission-in-cancer-patients-to-improve-care-and-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-doxorubicin-plus-trabectedin-dt-in-leiomyosarcoma-lms 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-quality-outcomes-following-implementation-of-a-comprehensive-care-program-in-community-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-clinical-presentation-and-survival-in-early-onset-triple-negative-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-features-actionable-biomarkers-and-treatment-patterns-in-early-onset-gastric-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-and-pragmatism-clinical-and-public-health-implications-of-multi-cancer-early-detection-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-iesr1i-mutation-status-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/her2-expression-in-squamous-cell-carcinoma-of-the-vulva-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-guided-microsatellite-instability-classification-in-colorectal-cancer-crc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-of-an-integrated-aging-assessment-for-cancer-patients-in-oncology-clinics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-intratumoral-oncolytic-vv1-plus-cemiplimab-simons-stage-1-results-from-head-and-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genotype-directed-targeted-therapy-combined-with-haic-and-tislelizumab-for-microsatellite-stable-col 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparable-clinical-efficacy-of-pyrotinib-in-trastuzumab-naive-and-trastuzumab-exposed-her2-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ivermectin-use-in-patients-with-cancer-over-the-past-decade-at-an-academic-cancer-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-bevacizumab-and-chemotherapy-as-second-line-therapy-in-pd-l1-positive-ras-mutant-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-influence-of-timing-a-retrospective-analysis-of-short-course-tki-induction-and-survival-outcome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-patterns-among-patient-reported-adverse-events-in-advanced-nsclc-a-post-hoc-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-31-gene-expression-profile-for-identification-of-real-world-node-negative-patients-with-stage-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-accuracy-of-urine-based-hpv-testing-for-cervical-neoplasia-and-cancer-a-landmark-systema 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-associated-left-ventricular-thrombus-in-hospitalized-oncology-patients-national-burden-and-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-and-enhancement-of-the-proacct-model-for-predicting-30-day-acute-care-events-following-ou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-the-figo-2018-cervical-cancer-staging-system-need-revision-insights-from-a-global-survey 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-sociodemographic-factors-on-molecular-testing-patterns-in-localized-and-metastatic-maligna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-us-real-world-study-of-second-line-outcomes-in-advanced-ovarian-cancer-by-first-line-parp-inhibito 2026-08-24 monthly 0.7 https://rjrindex.com/articles/timing-of-palliative-care-referral-and-overall-survival-in-patients-with-melanoma-brain-metastases-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-patterns-of-irae-onset-by-treatment-regimen-and-organ-system-in-a-pan-cancer-ici-treated-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-study-to-assess-the-safety-and-efficacy-of-sup177sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-intraperitoneal-dehydration-hyperthermia-and-chemotherapy-in-an-in-vitro-model-of-pe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glp-1-receptor-agonists-vs-5-alpha-reductase-inhibitors-for-prostate-cancer-primary-prevention-in-hi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intracranial-efficacy-of-osimertinib-in-iegfri-mutated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-prognostic-analysis-of-epidermal-growth-factor-receptor-mutated-non-sma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iesr1i-hotspot-specific-chemotherapy-resistance-patterns-in-metastatic-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/velzatinib-idrx-42-as-1l-or-2l-therapy-for-advanced-gastrointestinal-stromal-tumors-gists-by 2026-08-24 monthly 0.7 https://rjrindex.com/articles/revo-u-a-next-generation-gene-editing-free-universal-car-t-platform-to-enable-ultra-high-yield-man 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-cancer-screening-across-disease-sites-for-transgender-and-gender-diverse-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiogenomic-biomarkers-for-identifying-surgery-sparing-candidates-in-locally-advanced-gastric-or-ga 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-survival-outcomes-in-patients-with-multiple-myeloma-and-treatment-facility-volum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-adjuvant-nab-paclitaxel-plus-s-1-after-d2-resection-in-stage-iii-diffuse-gastric-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hepatic-arterial-infusion-chemotherapy-plus-lenvatinib-and-pd-1-inhibitors-as-first-line-treatment-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-biomarkers-of-sensitivity-to-bipolar-androgen-therapy-bat-in-metastatic-castration-resista 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-of-hematologic-malignancy-in-patients-with-early-stage-chronic-kidney-disease-ship-ckd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/missed-by-the-guidelines-a-meta-analysis-of-uspstf-lung-cancer-screening-ineligibility-among-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-language-barrier-a-mere-proxy-psychological-distress-among-non-english-speaking-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-feasibility-and-efficacy-of-a-tailored-exercise-program-in-patients-with-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hematologic-and-cardiovascular-outcomes-of-sglt2-inhibitors-in-patients-with-chronic-lymphocytic-leu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-acute-myeloid-leukemia-aml-patient-disease-and-molecular-characteristics-with-a-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-resection-of-cavity-shave-margins-impact-survival-in-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-an-oral-anticancer-repository-program-and-the-impact-on-access-to-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-external-validation-of-a-computational-approach-for-accelerated-read-out-of-randomiz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-incidence-and-mortality-in-lgbtq-populations-compared-with-cisgender-heterosexual-ind 2026-08-24 monthly 0.7 https://rjrindex.com/articles/her2-targeted-tyrosine-kinase-inhibitors-in-breast-cancer-real-world-analysis-of-gastrointestinal-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/falcon-lung-evolving-global-real-world-treatment-choices-and-outcomes-for-metastatic-nsclc-in-diffe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leisure-time-physical-activity-among-us-cancer-survivors-2020-2024 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-failure-if-as-a-prognostic-marker-in-adult-acute-lymphoblastic-leukemia-all 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cldn182-targeting-antibody-drug-conjugate-ba1301-in-advanced-solid-tumors-results-from-a-phase-i-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unsupervised-clustering-of-rna-seq-data-to-identify-molecular-subtypes-of-sarcomas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-of-alliance-a031902-a-phase-iii-trial-of-enzalutamide-plus-rucaparib-as-first-line-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/maintenance-treatment-with-toripalimab-and-anlotinib-after-anthracycline-based-chemotherapy-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-and-outcomes-of-minimally-invasive-resection-in-patients-with-neuroblastoma-and-wilms-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/delayed-serplulimab-combined-with-nab-paclitaxel-and-epirubicin-in-high-risk-early-hrher2-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-overall-survival-outcomes-of-lutetium-lu-sup177sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-trends-in-testicular-cancer-burden-among-adolescents-and-young-adults-15-39-years-1990-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-analysis-of-intraoperative-radiotherapy-for-soft-tissue-sarcoma-the-largest-sam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-benefit-of-doublet-versus-triplet-braf-inhibitor-based-therapy-insights-from-the-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-the-prmt5-inhibitor-azd3470-in-patients-with-relapsedrefractory-classic-hodgkin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-use-of-olaparib-in-us-veterans-with-metastatic-castration-resistant-prostate-cancer-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-by-genomic-profile-in-her2-positive-her2-metastatic-breast-cancer-mbc-a-large 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-a-tissue-free-genome-wide-methylome-enrichment-assay-for-detecting-molecular-residual 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anti-pd-1-immunotherapy-with-chemotherapy-for-poorly-chemo-responsive-thyroid-and-salivary-gland-tum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iiia-dose-finding-study-of-triplet-regimen-of-relatlimab-rela-ipilimumab-ipi-and-nivolum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-gastric-cancer-related-mortality-across-world-bank-income-groups-1980-2023-a-retrospecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-intraoperative-frozen-section-in-detection-and-surgical-decision-making-of-suspected-gallbla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/palliative-care-utilization-patterns-in-chimeric-antigen-receptor-t-cell-therapy-hospitalizations-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-burden-and-downstream-consequences-of-severe-fluoropyrimidine-associated-toxicity-in-a-sing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-cardiovascular-toxicities-with-bispecific-antibody-therapy-in-patients-with-hematolog 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-racial-and-socioeconomic-factors-on-cutaneous-b-cell-lymphoma-survival-a-seer-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-polatuzumab-vedotin-targeting-cd79b-in-the-treatment-of-non-hodgkin-lymphoma-a-syst 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-toxicity-and-quality-of-life-in-advanced-lung-cancer-the-role-of-depressive-symptoms 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-cd3cd20-bispecific-antibodies-in-richter-transformation-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-ii-study-of-pembrolizumab-plus-paclitaxel-with-or-without-bevacizumab-in-pd-l1-po 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-of-patients-managed-with-active-surveillance-versus-treatment-for-prostate-cancer-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/endocrine-stress-phenotypes-as-drivers-of-extreme-inpatient-severity-and-resource-utilization-withou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interpreting-circulating-tumor-dna-guided-risk-stratification-after-first-line-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metronomic-adjuvant-chemotherapy-mace-in-locally-advanced-oral-cavity-squamous-cell-carcinoma-post 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-the-next-generation-nectin-4-targeting-antibody-drug-conjugate-crb-701-sys6002-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-cardiotoxicity-with-her2-antibody-drug-conjugates-and-survival-after-treatment-continuati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neuropsychiatric-symptom-and-biomarker-changes-with-electroacupuncture-in-adolescent-and-young-adult 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-a-short-course-12-week-de-escalated-neoadjuvant-regimen-weekly-paclitaxel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/raisic-1-a-phase-12-clinical-trial-of-the-gpr65-inhibitor-ptt-4256-preliminary-safety-tolerabilit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chrono-a-randomized-phase-ii-trial-of-the-chronology-of-surgery-after-neoadjuvant-chemotherapy-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptomic-analyses-of-molecular-subsets-and-correlations-with-clinical-outcomes-from-the-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-ii-trial-of-mirvetuximab-soravtansine-in-folate-receptor-alpha-fra-high-recurre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-in-vivo-car-t-therapy-gt801-in-adults-with-relapsed-or-refractory-cd19-posit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-glp-1-receptor-agonist-use-on-lung-cancer-incidence-in-high-risk-patients-a-real 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-transcriptomics-guided-computational-pathology-model-to-stratify-docetaxel-benefit-in-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pyrotinib-plus-nab-paclitaxel-as-adjuvant-therapy-for-patients-with-n0n1mi-her2-positive-early-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/monitoring-blood-based-biomarkers-as-early-predictors-of-progression-free-survival-in-a-randomized-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-pembrolizumab-or-placebo-plus-chemotherapy-followed-by-adjuvant-pembrolizumab-or-placebo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-cachexia-and-symptomatic-toxicity-among-706-older-adults-with-advanced-cancer-receiving-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/midday-immune-checkpoint-inhibitor-ici-infusion-influence-on-survival-in-patients-with-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-restricted-eating-and-metformin-team-in-invasive-breast-cancer-or-dcis-a-randomized-phase-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-concomitant-medications-in-advanced-prostate-cancer-patients-receiving-apalutamide-ti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-fih-phase-i-study-of-gfs202a-a-gdf15il-6-bispecific-antibody-in-advanced-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-korea-usa-multicenter-study-of-duodenal-pancreatic-fluid-derived-exosomal-ces1-and-man2a1-as-pancr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-mogamulizumab-retreatment-in-cutaneous-t-cell-lymphoma-a-single-center-retro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-sex-based-differences-in-tumor-microenvironments-within-hematopoietic-and-reticuloendoth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immunochemotherapy-plus-thymalfasin-in-locally-advanced-gastric-cancer-a-prospective-cl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-and-toxicity-of-car-t-therapy-versus-blinatumomab-in-adult-b-cell-acute-ly 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-pegylated-liposomal-doxorubicin-plus-anlotinib-in-locally-advanced-soft-tissue-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-derived-tumor-microenvironment-features-and-recurrence-risk-in-microsatellite-stable-colon-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-phase-ii-trial-assessing-the-efficacy-and-safety-of-mcapox-plus-cetuximab-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-pd-1-inhibitor-plus-paclitaxel-pingyangmycin-and-platinum-based-chemotherapy-4p-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-machine-learning-to-predict-treatment-delivery-accuracy-in-brain-stereotactic-radiosurgery 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pan-cancer-landscape-and-real-world-management-of-braf-non-v600e-and-map2k1-alterations-analysis-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-1-evaluation-of-the-worlds-first-tri-specific-sirpa-pd-1-tgf-v-fc-fusion-prote 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-clinical-trial-failure-and-termination-in-non-small-cell-lung-cancer-immunot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-age-on-breast-cancer-outcomes-in-the-neoadjuvant-i-spy2-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detection-of-organophosphorus-pesticide-residues-in-breast-cancer-tissue-a-translational-integrated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-ilt4-on-lipid-metabolism-of-tumor-associated-macrophages-to-drive-immunosuppression-and-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-validation-of-a-comprehensive-genomic-profiling-based-approach-for-homologous-recombination 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-to-comprehensive-genomic-profiling-implementation-in-japan-and-perspectives-on-systemic-ref 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rethinking-clinical-follow-up-for-breast-cancer-survivorship-care-a-narrative-literature-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intracranial-activity-of-sacituzumab-govitecan-in-her2-negative-breast-cancer-brain-metastases-a-sy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-safety-of-elranatamab-in-patients-with-relapsedrefractory-multiple-mye 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gaps-in-patient-facing-information-on-artificial-intelligence-in-cancer-care-a-cross-sectional-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-harmonized-workflow-to-enable-efficient-tumor-normal-matched-whole-genome-sequencing-from-hmw-gdna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/atypical-radiologic-response-patterns-in-patients-treated-on-immunotherapy-clinical-trials-a-retros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/botensilimab-bot-balstilimab-bal-in-patients-pts-with-advanced-cutaneous-melanoma-cmel-ref 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-b7h3il13ra2-bispecific-armored-car-t-for-treatment-of-recurrentrefractory-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/twenty-years-of-metastatic-uveal-melanoma-management-real-world-experience-from-a-comprehensive-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-retrospective-analysis-of-outcomes-treatment-duration-dose-intensity-and-safety-of-enf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-of-patients-with-mucosal-melanoma-in-the-us-before-and-after-the-advent-of-pd-1-bas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/5-year-overall-survival-after-adjuvant-treatment-for-stage-iii-melanoma-an-english-nationwide-regis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-adjuvant-chemoendocrine-versus-endocrine-therapy-alone-in-hormone-receptor-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alternative-therapeutic-targets-in-patients-treated-with-immune-checkpoint-inhibitors-for-advanced-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cfdna-sequencing-as-a-cutting-edge-technology-to-identify-pathogenic-germline-variants-from-8353-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-versus-no-adjuvant-therapy-after-major-pathological-response-to-neoadjuvant-immunotherapy-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-use-among-women-lt-50-years-with-node-negative-early-stage-hormone-receptor-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-an-18f-labeled-glutamine-pet-radiotracer-to-detect-serine-synthesis-pathway-activit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-profile-treatment-patterns-and-survival-outcomes-of-multiple-myeloma-patients-in-the-midd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-coaching-in-enhancing-clinical-oncology-academic-performance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-inulin-on-immunotherapy-efficacy-in-extensive-stage-small-cell-lung-cancer-and-on-promotio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-and-clinical-impact-of-temozolomide-induced-hepatotoxicity-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-differentiated-sirpa-igg4-fc-fusion-protein-hcb101-in-monotherapy-and-combination-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-trial-of-adagloxad-simoleninobi-821-in-patients-with-high-risk-early-stage-triple-negativ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-ncdb-analysis-on-the-demographic-treatment-and-survival-of-small-cell-carcinoma-with-fusiform-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-survival-outcomes-of-early-onset-renal-cell-carcinoma-by-metastatic-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/light-activated-egfr-antibody-drug-conjugate-analysis-of-selectivity-and-translational-profile-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pretreatment-spatial-immune-architecture-and-1-year-clinical-benefit-to-first-line-icb-in-advanced-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-and-treatment-related-outcomes-with-folfirinox-compared-with-gemcitabinenab-paclit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-and-functional-outcomes-in-octogenarians-with-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-new-era-of-immunotherapy-comparison-of-real-world-outcomes-in-limited-stage-small-cell-lung-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cadonilimab-in-combination-with-ivonescimab-and-chemotherapy-as-first-line-1l-therapy-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-post-treatment-vaginal-structural-changes-with-psychosexual-dysfunction-in-young-cerv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cerebrospinal-fluid-biomarker-profiling-in-patients-with-non-small-cell-lung-cancer-and-leptomeninge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-information-received-and-perceived-by-patients-with-metastatic-breast-cancer-results-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-toxicity-profile-of-chimeric-antigen-receptor-t-cell-therapy-versus-bispecific-t-cell-en 2026-08-24 monthly 0.7 https://rjrindex.com/articles/practice-patterns-and-outcomes-by-genomic-risk-in-octogenarians-with-high-risk-localized-prostate-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sources-matter-learning-to-evaluate-large-language-models-for-oncology-treatment-plans-and-changes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-analysis-of-overall-survival-os-with-imetelstat-ime-in-relapsedrefractory-rr-myelofi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intravesical-recombinant-bcg-combined-with-chemo-immunotherapy-chemo-io-as-perioperative-therapy-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/timing-of-tp53-mutation-acquisition-as-a-determinant-of-outcomes-in-patients-with-myeloproliferative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-an-expedited-cancer-workup-clinic-for-uninsured-patients-at-a-metropolitan-safety 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-and-safety-of-ibi310-combined-with-sintilimab-versus-sorafenib-in-the-first-line-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequencing-in-the-post-immunotherapy-era-does-second-line-tyrosine-kinase-inhibitor-choice-impact-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-surgery-improve-breast-cancer-specific-survival-in-low-grade-dcis-a-20-year-population-based 2026-08-24 monthly 0.7 https://rjrindex.com/articles/commercial-price-variation-in-precision-oncology-testing-across-us-hospitals 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-tisle-combined-with-pofi-irinotecan-paclitaxel-oxaliplatin-and-5-fulevoleucovori 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-time-to-surgery-on-survival-outcomes-in-korean-breast-cancer-patients-a-nationwide-popula 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vessel-branching-patterns-quantified-by-artificial-intelligence-as-a-novel-prognostic-biomarker-in-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-trial-of-emavusertib-ca-4948-in-combination-with-gemcitabine-and-nab-paclitaxel-in-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-with-immune-checkpoint-inhibitors-among-patients-with-cancer-from-minoritized-raci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combined-safety-and-efficacy-results-from-three-clinical-studies-evaluating-alpha-radiotherapy-for-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-a-patient-facing-app-to-address-surgical-oncology-patients-social-determinants-of-health 2026-08-24 monthly 0.7 https://rjrindex.com/articles/synergistic-efficacy-of-intrathecal-pd-1-blockade-combined-with-whole-brain-radiotherapy-for-melanom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-progression-defined-by-longitudinal-ctdna-dynamics-for-prediction-of-outcomes-in-immune-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-treatment-delay-matter-impact-of-time-to-immunotherapy-on-survival-in-extensive-stage-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-and-site-specific-spectrum-of-second-primary-malignancies-after-adult-acute-myeloid-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-inpatient-outcomes-and-hospital-volume-disparities-after-glioma-resection-a-hcup-nis-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-with-ierbb2i-gene-amplification-and-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-accuracy-of-frozen-sections-for-intraoperative-detection-of-spread-through-air-spaces-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-high-body-mass-index-on-cancer-mortality-in-the-united-states-an-emerging-public-heal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-fibroblast-growth-factor-receptor-2-fgfr2-fusions-mutations-and-amplifications-in-intrahep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dxc006-a-first-in-class-cd56-targeting-antibody-drug-conjugate-in-advanced-solid-tumors-a-first-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-use-of-artificial-intelligence-for-automated-prognostication-and-systemic-therapeutic-dec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cross-stage-validation-of-a-multimodal-machine-learning-model-to-predict-pathological-complete-respo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/end-of-life-anti-cancer-treatment-rx-patterns-in-patients-pts-with-the-six-most-common-cancers-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/niraparib-and-dostarlimab-in-locally-advanced-head-and-neck-squamous-cell-carcinoma-la-hnscc-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-an-open-label-single-arm-phase-23-trial-spark-all-of-calaspargase-pegol-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ibii-clinical-study-of-adebrelimab-combined-with-decitabine-nab-paclitaxel-and-gemcitabine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-insights-into-survival-outcomes-and-unmet-therapeutic-needs-in-ikrasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/population-based-prediction-of-cardiovascular-mortality-in-gynecologic-cancer-survivors-using-machin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-telomere-length-and-prediction-of-cognitive-recovery-after-chemotherapy-in-patients-with-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pharmacogenetic-pgx-markers-of-cardiovascular-side-effects-cvses-in-allogeneic-hematopoietic-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/k-accelerate-a-multi-center-prospective-trial-to-evaluate-the-utility-of-a-ctdna-based-assay-for-ac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-specific-antigen-outcomes-of-darolutamide-and-androgen-deprivation-therapy-in-patient-subgr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimization-of-geospatial-oncologist-placement-a-maximum-coverage-problem-approach 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-mortality-patterns-and-treatment-disparities-of-prostate-cancer-across-g20-countries-insig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-sociodemographic-environmental-and-health-factors-with-early-onset-cancer-in-a-dive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-post-apt-trial-adoption-of-de-escalated-systemic-therapy-and-outcomes-in-small-her2-posit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gaps-in-access-to-chimeric-antigen-receptor-t-cell-car-t-therapy-post-leukapheresis-waiting-time 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analyzing-trends-in-multimorbidity-related-mortality-among-patients-with-lung-cancer-and-hypertensiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/danis-3-a-phase-ii-platform-study-of-nis793-and-anti-pd-1-combined-with-standard-of-care-soc-anti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-uveal-melanoma-genomic-landscape-and-immunogenic-profiles-of-ignaqi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deciphering-ctdna-release-influencing-factors-in-luminal-breast-cancer-via-single-cell-spatial-mappi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/endocrine-therapy-recommendation-after-breast-conserving-surgery-for-er-ductal-carcinoma-in-situ-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-plasma-and-csf-ctdna-profiling-as-used-to-define-therapeutic-landmarks-and-compartmenta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-and-survival-of-4n-and-non-4n-metastatic-neuroblastoma-across-treatment-eras-a-repo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bayonet-trial-a-multicenter-phase-ii-trial-of-staged-combination-with-encorafenib-binimetinib-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-protein-energy-malnutrition-on-outcomes-of-metastatic-triple-negative-breast-cancer-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvantadjuvant-serplulimab-vs-placebo-combined-with-chemotherapy-for-pd-l1-positive-gastric-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-axl-expression-in-upper-gastrointestinal-cancer-in-monstar-screen-2-an-interna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-cohort-studying-integrative-palliative-care-in-a-community-oncology-practice-impact 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-her2-targeted-nir-ii-fluorescent-nanoprobe-for-precision-diagnosis-and-treatment-of-her2-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-weight-of-each-node-modeling-and-quantifying-breast-cancer-lymphedema-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-between-real-world-progression-free-survival-and-time-to-next-treatment-and-death-in-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-and-facilitators-to-implementation-of-evidence-based-depression-and-distress-treatment-in-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pilot-study-of-hb-200-in-patients-with-hpv16-head-and-neck-squamous-cell-carcinoma-and-detectable-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-human-papillomavirus-hpv-vaccination-on-cervical-cancer-risk-reduction-in-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-therapy-for-stage-iv-primary-extramammary-paget-disease-a-systematic-review-of-reported-cl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-and-prognostic-factors-in-luminal-a-luma-early-breast-cancer-ebc-real-world-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-of-lymph-node-yield-and-survival-after-neoadjuvant-immunotherapy-for-head-and-neck-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/knowledge-of-breast-cancer-warning-signs-and-risk-factors-and-their-association-with-stage-at-diagno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-omic-characterization-of-high-tumor-mutational-burden-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whole-genome-hrd-phenotyping-as-a-predictor-of-parp-inhibitor-benefit-in-first-line-maintenance-high 2026-08-24 monthly 0.7 https://rjrindex.com/articles/structural-inequities-in-ovarian-cancer-care-a-national-study-of-hospital-utilization-costs-and-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-activity-of-immune-checkpoint-inhibitors-in-patients-with-advanced-sarcomas-a-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-biomarker-intended-pembrolizumab-use-in-soft-tissue-sarcomas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/scanxiety-patient-experience-of-immediate-result-release-irr-of-cancer-related-imaging 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-eligibility-and-reporting-standards-for-older-patients-with-hormone-receptor-positive-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-tumor-site-and-diagnostic-pathway-on-stage-at-diagnosis-a-population-based-study-of-5638 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-indicators-and-socioeconomic-disparities-in-teratoma-with-malignant-transformation-an-nc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-resilience-and-financial-toxicity-the-role-of-age-education-and-health-insura 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ggpp-as-a-driver-of-esophageal-squamous-cell-carcinoma-progression-via-protein-prenylation-therapeu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-cohort-study-evaluating-cetuximab-super-responders-with-recurrent-or-metastatic-squa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-an-outpatient-multidisciplinary-model-for-care-of-immune-related-adverse-events 2026-08-24 monthly 0.7 https://rjrindex.com/articles/arrhythmic-outcomes-following-immune-checkpoint-inhibitor-ici-therapy-in-patients-with-non-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diabetes-related-mortality-among-cancer-survivors-a-population-based-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-maintenance-therapy-in-unresectable-locally-advanced-esophageal-squamous-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/volumetric-analysis-of-central-nervous-system-hemangioblastomas-during-belzutifan-treatment-holiday 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chatgpt-based-conversational-ai-tool-for-training-oncologists-in-patient-communication-a-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emergency-presentation-and-inpatient-vulnerability-in-sinonasal-malignancies-national-evidence-of-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-ovarian-function-suppression-use-among-premenopausal-women-with-breast-cancer-a-longitudi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-acute-care-utilization-and-clinical-outcomes-among-patients-with-lung-cancer-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-neoadjuvant-versus-adjuvant-chemotherapy-in-stage-ii-iii-hormone-receptor-posit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-complete-response-after-neoadjuvant-chemotherapy-in-triple-negative-invasive-lobular-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-evaluation-of-the-diagnostic-value-of-micrornas-for-early-colorectal-cancer-detection-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-the-prevalence-of-antibody-drug-conjugated-induced-nausea-and-vomiting-adcinv-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/triombm-a-multicenter-phase-ii-trial-of-relatlimab-nivolumab-and-ipilimumab-in-patients-with-asy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/flt3-inhibitors-in-acute-myeloid-leukemia-a-network-meta-analysis-of-phase-iii-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-the-tcf7l2-rs7903146-t-allele-in-young-hispanic-adults-implications-for-colorectal-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-ep0062-vosilasarm-a-first-in-class-oral-selective-androgen-receptor-modulato 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-complications-in-car-t-cell-therapy-insights-from-a-national-inpatient-database 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-time-quantification-of-laryngeal-motion-in-early-glottic-cancer-using-mr-linac-cine-imaging-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ablation-success-and-long-term-recurrence-with-low-dose-versus-high-dose-radioiodine-for-remnant-thy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/developing-a-pan-cancer-foundation-model-for-digital-patient-representation-and-clinical-prediction 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-glp-1-receptor-agonist-exposure-with-mortality-infectious-and-hematologic-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clonal-hematopoiesis-and-cardiovascular-outcomes-after-hematopoietic-cell-transplantation-a-systema 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-multicenter-open-label-dose-escalation-and-expansion-study-to-evaluate-the-safety-tole 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-logic-gated-chimeric-antigen-receptor-t-cell-car-t-therapy-with-an-armored-membrane-tethered-il 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prevalence-of-osteopenia-in-adult-non-metastatic-gastrointestinal-cancer-patients-a-systematic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-non-receipt-of-fertility-counseling-during-cervical-cancer-treatment-insigh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthcare-utilization-and-health-expenditures-among-us-adults-by-cancer-and-atherosclerotic-cardi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-oxaliplatin-plus-s-1-versus-docetaxel-plus-s-1-for-stage-iii-gastric-cancer-after-d2-gastre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fruquintinib-in-combination-with-tislelizumab-vs-trifluridinetipiracil-and-bevacizumab-in-mss-mcrc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-socioeconomic-prognostic-factors-in-chronic-lymphocytic-leukemia-with-normal-fish 2026-08-24 monthly 0.7 https://rjrindex.com/articles/omaha-004-phase-3-trial-of-the-steroidogenesis-inhibitor-opevesostat-versus-androgen-receptor-pathw 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adela-a-double-blind-placebo-controlled-randomized-phase-3-trial-of-elacestrant-ela-everolimu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-and-outcomes-for-steroid-refractory-immune-related-hepatotoxicity-in-locally-advanced-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plastic-and-single-use-materials-in-breast-cancer-screening-and-diagnosis-a-multi-center-audit-of-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiac-complications-as-a-major-driver-of-icu-utilization-in-hospitalized-cancer-patients-a-nation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/highlight-1-a-randomized-placebo-controlled-double-blind-phase-3-clinical-study-to-investigate-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-ivonescimab-for-previously-treated-thymic-carcinoma-ucla-l-11 2026-08-24 monthly 0.7 https://rjrindex.com/articles/condensate-driven-transcriptional-reprogramming-to-define-core-vulnerabilities-in-esophageal-and-gas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/teliso-v-monotherapy-and-egfr-tki-combinations-in-c-met-over-expressing-nsclc-a-systematic-review-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthcare-system-gaps-in-access-to-her2-directed-chemotherapy-in-early-stage-her2-positive-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-toxicity-and-temporal-mortality-patterns-following-bispecific-t-cell-engager-therapy-a-real-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/uncoupling-of-mt1e-transcription-and-translation-in-high-cna-colorectal-cancer-a-proteostatic-adapt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-trends-in-colorectal-cancer-incidence-prevalence-and-mortality-burden-in-the-unite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metric-indicators-of-lymphedema-and-their-impact-on-symptoms-and-quality-of-life-in-breast-cancer-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-isg15-as-predictor-of-outcome-from-antiangiogenic-therapy-in-solitary-fibrous-tumor-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-between-social-capital-and-cancer-screening-rates-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/project-iota-input-optimization-for-tissue-based-assays-improving-turnaround-time-tat-of-mutati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/current-landscape-and-future-directions-of-breast-cancer-screening-and-early-detection-of-disease-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-baseline-vitamin-d-levels-with-survival-and-disease-control-in-diffuse-large-b-cell-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-non-hodgkin-lymphoma-in-south-asia-1990-2023-analysis-of-the-global-burden-of-disease-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-mycosis-fungoides-outcomes-a-multivariate-survival-and-prevalence-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genitourinary-safety-of-sglt2-inhibitors-in-patients-with-cancer-and-type-2-diabetes-a-real-world-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/profile-and-clinical-outcomes-of-patients-with-thoracic-tumors-discussed-at-a-tumor-board-in-brazil 2026-08-24 monthly 0.7 https://rjrindex.com/articles/persistent-and-divergent-cervical-cancer-burden-in-sub-saharan-africa-1990-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-demographic-determinants-of-overall-survival-in-early-onset-head-and-neck-cancers-a-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-meta-analysis-on-outcomes-of-zanidatamab-plus-chemotherapy-in-patients-with-advanced-her2-gastroes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-arv-393-a-protac-bcl6-degrader-as-monotherapy-in-patients-with-advanced-non-hodgk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/silver-supplementing-tebentafusp-with-subcutaneous-il-2-to-verifiably-eradicate-radiological-progre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-analysis-results-from-duravelo-2-zelenectide-pevedotin-zele-bt8009-in-patients-pts-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evaluation-of-a-deep-learning-based-serial-ct-imaging-biomarker-with-variable-thoracic-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/redox-status-of-endometrial-tumors-a-comparative-study-in-endometrioid-adenocarcinoma-serous-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modern-concepts-of-endometrial-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-chemoradiotherapy-versus-radiotherapy-alone-in-high-risk-endometrial-cancer-updated-meta-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/divergence-between-progression-free-and-overall-survival-treatment-effect-sizes-in-antibody-drug-con 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-1-inhibition-with-camrelizumab-in-cervical-cancer-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-risk-of-osteopenia-osteoporosis-and-pathological-fractures-in-breast-cancer-patients-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-related-immune-toxicity-and-treatment-outcomes-in-triple-negative-breast-cancer-treated-with-pem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-clinical-validation-of-a-novel-integrated-genomic-and-epigenomic-liquid-biopsy-assay-sp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-susceptibility-between-psychiatric-disorders-and-gynecologic-cancers-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-spatial-multiomics-to-identify-endosomal-trafficking-and-s100a8a9-and-fibronectin-driven-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/refusal-of-chemotherapy-surgery-and-radiation-in-non-metastatic-triple-negative-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-telehealth-experiences-medication-adherence-symptom-burden-and-financial-toxicit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antibody-drug-conjugate-adoption-in-triple-negative-breast-cancer-through-community-based-quality-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-in-non-melanoma-skin-cancer-related-hospitalizations-and-in-hospital-outcomes-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/do-mental-health-disorders-modify-cytokine-release-syndrome-risk-in-immune-effector-cell-therapy-fu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-inpatient-outcomes-and-resource-utilization-with-an-icd-10-defined-immune-related-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-safety-planning-in-nccn-cited-breast-cancer-trials-audit-and-surveillance-framework 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gender-based-differences-in-malnutrition-among-patients-with-stage-iv-lung-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/infectious-complications-in-mantle-cell-lymphoma-patients-treated-with-car-t-therapy-a-real-world-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-inpatient-treatment-delivery-for-gynecologic-cancers-a-national-analysis-using-machi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hetrombopag-in-patients-with-chemotherapy-induced-thrombocytopenia-a-global-phase-3-randomized-do 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-axicabtagene-ciloleucel-in-older-versus-younger-adults-with-diffuse-large-b-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-inpatient-ip-systemic-cancer-therapy-in-patients-pts-with-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-higher-initial-dose-and-accelerated-titration-of-ropeginterferon-alfa-2b-on-early-hematolo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pilot-study-exploring-four-meditation-practices-for-anxiety-among-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-per-patient-per-month-for-a-median-of-3-months-real-world-value-signals-of-kras 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-malnutrition-and-morbid-obesity-on-inpatient-mortality-among-patients-with-hematologic-mal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-late-phase-randomized-open-label-multi-cohort-trial-to-evaluate-immune-related-adverse-events-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-neoadjuvant-chemotherapy-reduce-axillary-lymph-node-dissection-in-postmenopausal-erher2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-to-transplant-by-sociodemographic-group-following-meld-30-implementation-in-hepatocellular-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-donafenib-plus-anti-pd-1-therapy-in-hepatocellular-carcinoma-with-high-risk-features-after 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-patterns-and-temporal-trends-of-colorectal-cancer-burden-in-older-adults-aged-70-years 2026-08-24 monthly 0.7 https://rjrindex.com/articles/maintenance-liposomal-doxorubicin-following-induction-doxorubicin-in-soft-tissue-sarcoma-a-single-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-germline-genetic-testing-rates-among-newly-diagnosed-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-for-low-income-patients-with-early-onset-colorectal-cancer-an-analysis-of-the-nat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-experience-of-home-based-oncology-care-among-privately-funded-uk-based-patients-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-febrile-neutropenia-with-colony-stimulating-factors-a-multicenter-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-correlates-of-patient-provider-communication-and-financial-toxicity-in-black-and-white-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/end-of-life-care-quality-indicators-in-advanced-cancer-patients-at-a-brazilian-tertiary-hospital 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-cutaneous-diffuse-large-b-cell-lymphoma-leg-type-a-systematic-review-of-morphological-mimi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-alternative-dosing-strategies-for-fda-approved-oncology-biologics-based-on-reanalysis-of-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comorbidities-and-concomitant-medication-use-in-patients-with-tki-naive-advanced-or-metastatic-alk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hematologic-malignancies-to-define-a-distinct-high-risk-sepsis-phenotype-among-hospitalized-cancer-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-utilization-and-inpatient-outcomes-of-minimally-invasive-colectomy-for-colorectal-cancer-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-objective-response-of-kras-g12c-inhibitors-versus-docetaxel-in-previously-treated-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elevate-empowered-social-media-coaching-for-oncologists 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-academic-multimodal-ctdna-strategy-for-minimal-residual-disease-detection-and-therapy-monitoring 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-breast-cancer-located-in-the-upper-outer-quadrant-uoq-and-axillary-lymph-node 2026-08-24 monthly 0.7 https://rjrindex.com/articles/triple-negative-oligometastatic-breast-cancer-a-retrospective-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-sequencing-after-adjuvant-treatment-failure-in-patients-with-melanoma-a-retrospective-coh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-safety-and-efficacy-of-sys6010-combined-with-enlonstobart-in-patients-with-recurrent-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-lung-cancer-and-hypertension-related-mortality-in-the-united-states-1999 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-cannabis-use-on-relapse-and-remission-rates-in-patients-with-acute-lymphoblastic-leukem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-spectrum-and-her2msi-biomarker-status-in-gastric-adenocarcinoma-a-tertiary-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rural-urban-disparities-in-chemotherapy-administration-and-quality-certifications-in-minnesota 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-trifluridine-tipiracil-with-vegf-inhibitors-and-egfr-inhibitors-in-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodal-ai-prediction-of-head-and-neck-cancer-treatment-outcomes-with-whole-slide-imaging 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-based-total-neoadjuvant-therapy-versus-neoadjuvant-chemoradiotherapy-in-locally-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-serplulimab-plus-nab-paclitaxel-and-sox-in-locally-advanced-gastric-or-gastroesophageal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/laparoscopic-versus-open-distal-gastrectomy-for-clinical-t4a-gastric-cancer-short-term-outcomes-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-checkpoint-inhibitor-pneumonitis-associated-with-anti-angiogenic-agents-in-non-small-cell-lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-germline-cancer-predisposition-pathogenic-variants-in-cancer-cohorts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/weekend-admission-and-inpatient-outcomes-in-hospitalized-patients-with-acute-promyelocytic-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-availability-and-quality-of-serious-illness-documentation-using-large-language-models 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-study-of-prolonged-administration-of-naxitamab-irinotecan-and-temozolomide-for-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-omics-approaches-to-unveil-the-mixed-molecular-characteristics-of-hepatoid-adenocarcinoma-of-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-cardiac-lymphoma-mesothelioma-and-sarcoma-a-population-based-study-of-primary-malign 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-phase-1b2-study-results-of-purinostat-mesylate-pm-in-combination-with-pomalidomide-pom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ea6232-a-phase-ii-double-blind-trial-of-sulforaphane-for-therapeutic-prevention-of-melanoma-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hiv-lymphomas-in-the-safety-net-setting-a-decade-of-experience-at-a-single-institution 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-trifluridinetipiracil-plus-oxaliplatin-in-patients-with-advanced-or-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-improvement-enhancing-family-history-documentation-for-invasive-cancer-patients-in-a-commun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/re-evaluating-pathologic-response-as-a-surrogate-endpoint-after-neoadjuvant-immune-checkpoint-inhibi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/compartment-specific-spatial-transcriptomics-to-reveal-microenvironmental-programs-driving-omental-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-grouping-of-nut-carcinoma-within-a-cancer-family-context 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-of-the-leading-cancers-in-brazil-real-world-evidence-from-a-national-data-platform 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-cancer-mortality-among-individuals-with-substance-use-disorder-in-the-unit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-toxicity-outcomes-with-adjuvant-pembrolizumab-following-nephrectomy-for-renal-cell-carcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-adjusting-for-c-kit-exon-11-mutation-status-when-comparing-prognostic-models-for-gastr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-of-cdk46-inhibitor-re-treatment-in-hrher2-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-adolescent-and-young-adult-lung-cancer-in-south-asia-19902023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-timely-immunizations-on-infection-related-outcomes-after-cll-directed-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-surufatinib-combined-with-immune-checkpoint-inhibitors-plus-chemotherapy-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cumulative-low-dose-ionizing-radiation-exposure-in-frequent-emergency-department-encounters-and-impl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-capox-combined-with-traditional-chinese-medicine-tiaopi-anchang-decoction-on-disease-fre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-first-in-human-open-label-dose-escalation-and-expansion-study-of-tak-188-a-novel-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-randomized-open-label-study-of-incb123667-versus-investigators-choice-of-chemotherapy-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-therapy-for-head-and-neck-squamous-cell-carcinoma-based-on-hyperprogression-genotyping 2026-08-24 monthly 0.7 https://rjrindex.com/articles/experiences-of-a-cancer-survivorship-elective-in-a-us-medical-school-the-first-10-years 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-plasma-based-epigenomic-profiling-from-intr-at-pid-lung-037-study-samples-to-identify-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-alkbh5-with-mefloquine-as-a-therapeutic-strategy-to-enhance-antitumor-immunity-in-osteosar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-omics-discovery-and-clinical-validation-of-col1a2-alternative-splicing-isoforms-as-liquid-biop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-the-impact-of-igtf2ii-mutations-in-thymic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beta-blockers-and-overall-survival-in-men-receiving-adt-systemic-therapy-for-metastatic-prostate-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimization-of-tumor-infiltrating-lymphocyte-til-manufacturing-in-non-small-cell-lung-cancer-nsc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemo-immunotherapy-as-a-reshaper-of-immunosuppressive-activity-and-gene-expression-of-circulating-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-circulating-mir-30a-5p-and-mir-93-5p-as-liquid-biopsy-biomarkers-for-prediction-of-prognosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-physician-characteristics-and-likelihood-of-caring-for-underserved-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-centric-insights-a-single-center-analysis-of-clinical-presentation-treatment-approaches-and-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-genetic-ancestry-on-uv-mutational-signatures-linked-to-immunotherapy-response-in-melano 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-iii-trial-adjuvant-cd40hvac-an-immunotherapy-engaging-dendritic-cells-dc-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-axis-biomarker-model-integrating-kim-1-and-madcam-1-in-metastatic-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-palliative-care-utilization-and-outcomes-among-decedent-patients-with-metastatic-cancer-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-role-of-informal-caregivers-in-metastatic-cancer-patients-treated-with-oral-anticance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-remote-therapeutic-monitoring-on-time-to-discontinuation-and-acute-care-events-among-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathology-based-machine-learning-model-for-prediction-of-pathologic-complete-response-to-neoa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-discontinuation-of-sup177sup-lu-psma-617-after 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hampe-based-msimmr-testing-with-artificial-intelligence-in-colorectal-cancer-a-blinded-evaluatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-intravenous-biosimilar-pertuzumab-and-trastuzumab-versus-subcutaneous-pertuzumabtrastuz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-decision-impact-of-18f-psma-1007-petct-for-prostate-cancer-staging-avoiding-over-and-und 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-related-adverse-events-and-patient-outcomes-in-non-small-cell-lung-cancer-a-silver-lining 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-early-cachexia-in-metastatic-nsclc-a-nationwide-veterans-health-administrat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-l1-cps-10-population-subgroup-analysis-of-keynote-412-pembrolizumab-plus-chemoradiotherapy-vers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-and-geographic-disparities-in-early-onset-pancreatic-cancer-mortality-in-the-united 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-pathway-utilization-after-endoscopic-ultrasound-in-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitor-ici-toxicity-in-a-large-prospective-cohort-of-patients-with-solid-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-educational-and-research-gaps-among-young-oncologists-in-latin-america-results-from-a-mult 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-role-of-gut-microbiota-and-their-metabolites-in-the-efficacy-of-immune-checkpoint-inhibit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serum-magnesium-level-and-survival-outcomes-in-extensive-stage-small-cell-lung-cancer-treated-with-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-peri-dose-high-sensitivity-troponin-on-clinically-significant-cardiac-events-and-il-2-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-performance-of-a-multimodal-artificial-intelligence-histopathology-based-tool-versus-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-genomic-characteristics-of-a-low-homologous-recombination-deficiency-score-subgroup-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographics-and-outcomes-of-individuals-with-young-onset-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-adherence-to-adjuvant-abemaciclib-among-patients-with-early-hormon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/amivantamab-in-hpv-unrelated-recurrentmetastatic-head-and-neck-squamous-cell-cancer-after-disease-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-ct-derived-qvt-score-as-predictor-of-bevacizumab-benefit-in-advanced-non-squamous-nsclc-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cytokine-dynamics-in-a-phase-ii-trial-of-metronomic-carboplatinpaclitaxel-combined-with-cemiplimab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-iron-supplementation-in-the-efficacy-of-immune-checkpoint-inhibitors-icis-a-real-world-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liquid-based-methylation-profiling-of-molecular-breast-cancer-subtypes-mbs-in-hormone-receptor-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-comprehensive-evaluation-of-the-effectiveness-of-the-geriatric-8-screening-tool-in-japanese-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mesenteric-approach-during-pancreaticoduodenectomy-as-modulator-of-ctc-dna-dynamics-in-pancreatic-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-from-a-pilot-feasibility-study-of-a-novel-community-health-worker-led-intervention-deliverin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-early-unfractionated-heparin-use-in-nstemi-patients-with-acute-leukemia-and-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vepdegestrant-a-proteolysis-targeting-chimera-protac-estrogen-receptor-er-degrader-plus-abemac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/yttrium-90-sirt-plus-atezolizumabbevacizumab-in-unresectable-huge-hcc-gt10-cm-a-multicenter-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-neo-epitope-based-vaccine-ose2101-with-or-without-pembrolizumab-versus-best-supportive-care-as-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-itp53i-mutated-myeloid-neoplasms 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-modal-liquid-biopsy-integrating-cfdna-fragmentomics-and-serum-biomarkers-for-the-differential 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-inflammation-and-tumor-immune-microenvironment-biomarkers-foxp3-cd68-cd163-stratified-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sintilimab-pd-1-antibody-plus-gemcitabine-and-docetaxel-gt-as-first-line-or-later-line-therapy-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/raceethnicity-stratified-survival-differences-associated-with-psychotropic-medication-use-in-pancre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rates-of-metachronous-colorectal-cancer-or-secondary-lynch-syndrome-related-cancers-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/percutaneous-cryoablation-for-the-treatment-of-extra-abdominal-desmoid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mental-health-and-malignancy-real-world-associations-between-early-onset-hormone-related-cancers-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-tocilizumab-in-resolving-chimeric-antigen-receptor-t-cell-car-t-induced-cytokine-relea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-treatment-effect-on-distant-recurrence-free-survival-from-functional-tumor-volume-change 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dual-her2-blockade-with-or-without-taxane-induction-in-hrher2-metastatic-breast-cancer-a-compara 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alrizomadlin-apg-115-alone-or-in-combination-with-lisaftoclax-apg-2575-for-the-treatment-of-pedi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-differences-in-immune-related-adverse-events-requiring-hospitalization-among-patients-with-check 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-characteristics-and-treatment-outcomes-of-adenoid-cystic-carcinoma-acc-by-differ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/de-escalation-of-neoadjuvant-chemotherapy-for-her2-positive-breast-cancer-a-systematic-review-and-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-progression-in-mgus-using-transformer-based-survival-time-series-modeling 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cyclin-amplification-in-biliary-tract-cancer-integrated-profiling-to-evaluate-immune-exclusion-dru 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-to-response-with-hmavenetoclax-as-a-predictor-of-survival-in-acute-myeloid-leukemia-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examining-the-relationship-between-social-support-and-inflammatory-markers-among-patients-with-gynec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-institutional-single-arm-phase-2-study-of-durvalumab-plus-amrubicin-in-patients-with-relap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-an-artificial-intelligence-based-deep-learning-imaging-model-for-early 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-patient-navigation-to-identify-individual-needs-and-offer-medical-and-supportive-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-retrospective-hecog-phase-iii-trial-validation-of-polaris-tme-for-the-prediction-of-tils 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rationale-315-post-hoc-analysis-of-event-free-survival-by-surgically-relevant-subgroups-treated-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-of-nutritional-risk-in-chimeric-antigen-receptor-t-cell-car-t-therapy-protein-ener 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-implications-of-context-dependent-oncogenic-ipik3cai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiotherapy-followed-by-systemic-therapy-and-tislelizumab-in-microsatellite-stable-rectal-cancer-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/harnessing-omop-cdm-for-multisite-collaborations-to-measure-cardiovascular-risk-factors-and-cardiova 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-of-iidhi-co-mutations-with-treatment-ou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cadonilimab-a-bispecific-anti-pd-1ctla-4-antibody-for-patients-with-dmmrmsi-h-metastatic-colorec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-advanced-practice-provider-led-new-consults-in-community-oncology-expanding-access-and-vo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-quality-of-life 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subsequent-therapies-and-time-to-second-progression-free-survival-events-pfs2-in-treatment-naive-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicentre-trial-of-telemonitored-circadian-rhythms-and-electronic-patient-reported-outcomes-epros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/household-costs-of-breast-cancer-and-coping-mechanisms-in-kenya-a-case-of-kenyatta-national-hospita 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aqp4-and-mog-as-definers-of-distinct-autoantibody-signatures-in-immune-checkpoint-inhibitor-induced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/measuring-keynote-522-response-from-tnbc-patient-biopsies-ex-vivo-using-the-e-slice-assay 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-access-to-effective-post-progression-therapies-on-survival-outcomes-in-first-line-randomiz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/income-inequality-and-cervical-cancer-a-comparative-analysis-of-demographics-and-healthcare-burden 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shr-a1811-plus-chemotherapy-and-bp102-as-1l-therapy-for-her2-expressing-mcrc-data-from-a-phase-ibi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-global-burden-of-thyroid-cancer-from-1990-to-2023-with-forecasts-to-2050 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-randomized-trial-to-evaluate-the-impact-of-anselamimab-on-all-cause-mortality-in-k-light-cha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-tirzepatide-versus-metformin-and-insulin-in-type-2-diabetes-patients-across 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glp-1-receptor-agonist-therapy-and-cancer-risk-and-mortality-in-patients-with-moderate-ckd-a-nation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-based-clinical-genetic-cg-prognostic-model-for-radiographic-progression-free 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-antibody-drug-conjugate-adc-eligibility-and-corresponding-prognosis-in-her2-early-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-cell-profiling-by-spectral-cytometry-to-predict-response-to-avelumab-in-advanced-bladder-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bi-1808-pembrolizumab-responses-to-a-chemotherapy-free-regimen-in-advanced-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-plasma-ctdna-genomic-biomarkers-identified-by-whole-exome-sequencing-and-a-novel-bioinfo-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ib-evaluation-of-a-recombinant-overlapping-peptide-survivin-immunotherapy-safety-immunogenic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-fruquintinib-combined-with-sintilimab-and-chidamide-in-refractory-mss-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-liquid-biopsy-training-on-real-world-testing-practices-for-advanced-nsclc-across-latin-ame 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obx-115-engineered-tumor-infiltrating-lymphocyte-til-cell-therapy-with-regulatable-membrane-bound 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-experience-with-lifleucel-tumor-selection-and-dead-in-therapy-from-a-single-institution 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-genomic-characterization-of-de-novo-prostate-cancer-presenting-with-psa-100-ngml 2026-08-24 monthly 0.7 https://rjrindex.com/articles/durvalumab-plus-platinum-etoposide-in-extensive-stage-extrapulmonary-small-cell-carcinoma-es-epscc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/continual-depletion-of-circulating-tumor-cells-using-an-automated-device-enriched-with-affinity-glas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-study-of-op-3136-a-novel-oral-selective-kat6ab-inhibitor-as-monotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-of-iegfri-and-ikras 2026-08-24 monthly 0.7 https://rjrindex.com/articles/staged-dose-escalation-of-adjuvant-abemaciclib-in-high-risk-hrher2-early-breast-cancer-first-saf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-neoadjuvant-immunochemotherapy-followed-by-surgery-in-locally-advanced-buccal-squamous-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/who-gets-access-national-discrepancies-in-clinical-trial-enrollment-among-patients-with-brain-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-implementation-of-electronic-patient-reported-outcomes-epros-for-remote-symptom-monitorin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/microbiome-associations-with-chemotherapy-induced-nausea-and-vomiting-a-metagenomic-shotgun-sequenc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-overall-survival-outcomes-of-belzutifan-treatment-in-advanced-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-baseline-quality-of-life-qol-and-early-death-in-patients-with-metastatic-renal-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-clinical-activity-and-preclinical-basis-of-panitumumab-based-egfr-blockade-in-smarcb1-de 2026-08-24 monthly 0.7 https://rjrindex.com/articles/central-nervous-system-metastases-in-hereditary-breast-cancer-according-to-germline-pathogenic-varia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-after-stereotactic-radiosurgery-versus-whole-brain-radiotherapy-for-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-circulating-tumor-dna-surveillance-as-predictor-of-progression-in-advanced-non-small-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-pathologic-response-using-a-taxane-based-gene-expression-signature-in-rna-sequencing-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sup18sup-f-f-nym124-for-safety-imaging-and-dosimet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-modeling-for-predicting-60-day-prognosis-in-newly-diagnosed-advanced-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-genomic-and-microenvironmental-profiles-of-brain-metastases-in-renal-cell-carcinoma-insigh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-ai-decision-support-in-a-rapidly-evolving-therapeutic-landscape-ie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-related-efficacy-of-antibody-drug-conjugates-in-solid-tumors-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-cancer-stem-cells-with-a-novel-virus-like-drug-conjugate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shr-1701-combined-with-fuzuloparib-and-chemotherapy-as-first-line-therapy-for-advanced-lung-squamous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-analysis-and-deep-learning-integration-to-enhance-tumour-classification-in-total-body-petct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-trial-of-til-therapy-for-metastatic-uveal-melanoma-evaluation-of-t-cell-potency-and-an-in-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-on-clinical-profile-of-immune-related-adverse-events-iraes-associated-with-immune 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-phase-iii-study-for-newly-diagnosed-maximally-resected-glioblastoma-compar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-frailty-measures-on-overall-survival-in-prostate-cancer-a-systematic-review-and-meta-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-social-isolation-with-overall-survival-in-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-neoadjuvant-chemotherapy-nac-in-older-patients-with-locally-advanced-colon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-analysis-of-a-heavily-pretreated-population-of-patients-with-bone-sarcomas-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conditional-survival-by-primary-extranodal-site-in-diffuse-large-b-cell-lymphoma-a-population-based 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serum-vegf-a-concentrations-as-a-predictive-biomarker-of-immunotherapy-response-in-refractory-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-androgen-deprivation-therapy-adt-plus-androgen-receptor-pathway-inhibitors-arpis-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-and-management-of-gastrointestinal-gi-adverse-events-aes-with-zanidatamab-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/closing-the-depression-gap-in-community-oncology-real-world-outcomes-from-collaborative-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-volunteer-integrated-palliative-home-visits-on-psychological-well-being-among-metastatic-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-and-concordance-of-a-large-language-model-chatgpt-5-as-a-clinical-decision-support-too 2026-08-24 monthly 0.7 https://rjrindex.com/articles/culmerciclib-cdk246-inhibitor-plus-fulvestrant-in-hrher2-advanced-breast-cancer-after-progres 2026-08-24 monthly 0.7 https://rjrindex.com/articles/endocrine-therapy-non-adherence-and-recurrence-risk-in-patients-with-breast-cancer-and-major-depress 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-ml-to-predict-rapid-progression-for-patients-pts-with-hrher2-metastatic-breast-cancer-mb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/organ-specific-proteomic-aging-clocks-pacs-and-mortality-in-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-trial-of-combination-gemcitabine-gem-and-nab-sirolimus-nab-s-in-advanced-leiomyosarcomas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/heart-failure-in-hospitalizations-for-hematologic-malignancies-versus-solid-tumors-national-burden 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-shared-neoantigen-peptide-library-to-promote-personalized-vaccine-strategy-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pan-cancer-prevalence-molecular-landscape-and-prognostic-impact-of-iccne1i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-individuals-with-cancer-and-pre-existing-autoimmune-disease-receiving-immune-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-mortality-and-length-of-stay-associated-with-splanchnic-vein-thrombosis-in-gastrointestina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intrathecal-ipsc-derived-natural-killer-cells-combined-with-the-stupp-regimen-for-newly-diagnosed-wh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-cadonilimab-in-patients-with-msi-hdmmr-locally-advanced-or-metastatic-gastro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/minimally-invasive-vs-open-pancreaticoduodenectomy-for-periampullary-tumors-a-systematic-review-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-safety-and-cytokine-profiling-with-addition-of-the-toll-like-receptor-tlr-78-dual-agon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-primary-malignancies-after-car-t-versus-sct-in-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-fes-pet-imaging-in-the-management-of-estrogen-receptor-positive-breast-cancer-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/discovery-of-novel-biomarkers-for-glioblastoma-using-vhh-antibodies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fusion-positive-early-stage-and-locally-advanced-lung-cancers-a-real-world-analysis-of-event-free 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequential-or-concurrent-immunotherapy-with-locoregional-radiotherapy-in-de-novo-metastatic-nasophar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-use-of-fruquintinib-in-refractory-metastatic-colorectal-cancer-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-rural-urban-disparities-in-radiotherapy-utilization-for-oral-cavity-and-pharyngeal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-predictors-and-disparities-in-second-primary-malignancy-risk-and-survival-after-index-head 2026-08-24 monthly 0.7 https://rjrindex.com/articles/delayed-time-to-treatment-initiation-among-patients-with-hpv-associated-oropharyngeal-squamous-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cd56-and-p16-expression-in-the-differential-diagnosis-of-papillary-thyroid-carcinoma-and-benign-foll 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-us-based-retrospective-observational-study-of-biomarker-testing-patterns-across-lines-of-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mechanism-driven-comparative-safety-signals-of-capivasertib-versus-cdk46-inhibitors-a-faers-pharma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-iii-study-of-en002-gel-a-first-in-class-drip-inhibitor-in-non-melanoma-skin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anatomical-and-clinical-heterogeneity-of-dmmr-colorectal-cancer-by-tumor-location 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-akt-inhibitor-ntq1062-combined-with-fulvestrant-in-patients-with-hr-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multilevel-disparities-in-hiv-associated-gastrointestinal-cancer-mortality-in-the-united-states-199 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-exposome-driven-cancer-incidence-patterns-using-multi-cancer-principal-components-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-the-investment-in-metastatic-breast-cancer-research-sufficient-and-aligned-with-patient-prioritie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-atezolizumab-versus-durvalumab-in-extensive-stage-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/timing-of-central-nervous-system-metastases-occurrence-in-patients-with-metastatic-breast-cancer-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cachexia-index-allostatic-load-and-body-composition-phenotypes-in-racially-and-ethnically-diverse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-biennial-mammography-on-stage-at-diagnosis-and-outcomes-of-breast-cancer-in-the-brazilian 2026-08-24 monthly 0.7 https://rjrindex.com/articles/features-of-gene-copy-number-variation-regulating-mitochondrial-function-in-endometrial-cancer-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pooled-analyses-of-clinical-outcomes-with-afamitresgene-autoleucel-afami-cel-in-metastatic-synovia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-sglt2-inhibitor-dapagliflozin-on-anticancer-resistance-and-alpelisib-and-fulvestrant-ind 2026-08-24 monthly 0.7 https://rjrindex.com/articles/upfront-low-dose-diet-modified-nilotinib-versus-standard-imatinib-in-indian-patients-with-newly-diag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hpv-stratified-tissue-factor-expression-and-multi-omic-correlates-of-overall-survival-after-tisotuma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-and-treatment-patterns-of-patients-with-metastatic-urothelial-cancer-in-france-results-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ibii-trial-of-first-line-trastuzumab-nivolumab-gemcitabine-and-cisplatin-in-her2-positiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/access-to-trastuzumab-deruxtecan-for-her2-low-metastatic-breast-cancer-in-brazils-unified-public-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-and-the-genomic-landscape-of-aml-in-precision-oncology-an-analysis-using-ash-hematomics-program 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tp53-mutation-adoption-of-stromal-adhesionneuronal-like-programs-as-a-driver-of-stress-adaptation-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-oncologic-outcomes-of-psma-pet-guided-salvage-radiotherapy-for-biochemical-recurrence-afte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expert-validation-of-an-artificial-intelligence-enabled-trial-matching-solution-using-real-world-dat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/greening-a-chemotherapy-day-ward 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-dll3-expression-and-tumor-subtype-on-response-to-tarlatamab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-microsatellite-instability-high-msi-hmismatch-repair-deficient-dmmr-bili 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-association-of-adjuvant-endocrine-therapy-et-after-pathologic-complete-response 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-and-sociodemographic-disparities-in-place-of-death-among-adults-with-pancreatic-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-adherence-to-interstitial-lung-disease-ildpneumonitis-toxicity-management-guidelines-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-ai-based-risk-stratification-integrating-routine-laboratory-data-with-age-on-screening-vol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-dose-tamoxifen-for-pre-cancer-and-early-disease-a-pooled-analysis-by-menopausal-status 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-radical-radiotherapy-in-de-novo-low-burden-metastatic-hormone-sensitive-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-factors-associated-with-glucagon-like-peptide-1-receptor-agonists-prescription-for-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-and-validation-of-a-methylation-signature-as-a-prognostic-marker-in-osteosarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-multivariable-prognostic-model-for-pathological-response-using-anatomical-and-patho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-tagraxofusp-hyper-cvad-and-venetoclax-for-patients-with-newly-diagnosed-or-rel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/protact-preliminary-data-from-a-first-in-human-phase-1-study-evaluating-the-safety-tolerability 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-genetic-testing-patterns-in-prostate-cancer-assessed-via-artificial-intelligence-implica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-presentation-of-brain-metastases-by-breast-cancer-subtype-and-potential-implications-for-surveil 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-ethnically-and-racially-diverse-patients-with-gynecologic-malignancies-in-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantifying-financial-toxicity-from-cancer-care-travel-in-a-geographically-isolated-us-health-syst 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overcoming-immunotherapy-resistance-in-advanced-melanoma-through-radiotherapy-a-prospective-observa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-treatment-patterns-and-outcomes-of-common-solid-tumors-in-arab-american-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-modalities-among-long-term-survivors-of-primary-pulmonary-nut-carcinoma-a-systematic-revi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantifying-time-and-financial-toxicity-of-travel-for-intravesical-chemotherapy-rationale-for-in-ho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-ad-and-neoadjuvant-nad-strategies-in-higher-risk-hormone-receptor-positive-hrher2-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-palmar-plantar-erythrodysesthesia-syndrome-ppes-hypothyroidism-and-clinical-outco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibition-for-advanced-cutaneous-squamous-cell-carcinoma-in-patients-with-concomi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-benefit-of-oral-selective-estrogen-receptor-degraders-in-iesr1i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/momentum-a-phase-2-open-label-single-arm-multicenter-study-to-evaluate-the-efficacy-of-cemsidomi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ascend-a-phase-12-dose-escalation-optimization-and-dose-expansion-study-to-evaluate-the-safety 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-oncology-research-mapping-in-morocco-patterns-quality-and-unmet-needs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-ctdna-detection-in-prostate-cancer-using-a-6-base-epigenomics-and-fragmentomics-approa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-complete-response-and-association-with-survival-benefit-in-hormone-receptor-positive-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-malignant-melanotic-nerve-sheath-tumors-mmnst-a-retrospective-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-procedure-related-mortality-among-older-us-adults-with-digestive-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/restoring-form-rethinking-function-the-dual-edged-impact-of-maxillofacial-prostheses-on-survival-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-perioperative-esketamine-on-postoperative-recovery-in-breast-cancer-patients-undergoing-mo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-outcomes-in-acute-myeloid-leukemia-a-contemporary-national-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evolving-trends-in-young-adult-ya-gastrointestinal-gi-cancer-philadelphia-in-national-context 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lymph-node-ratio-and-patterns-of-recurrence-in-oral-squamous-cell-carcinoma-treated-with-surgery-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncologists-knowledge-clinical-practices-barriers-and-facilitators-of-cardio-oncology-guideline-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-study-of-a-novel-portable-scalp-cooling-cap-for-prevention-of-chemotherapy-induced-alope 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-specific-cancer-types-and-polyarteritis-nodosa-among-hospitalized-patients-in-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progress-implementation-of-a-novel-hybrid-decentralized-clinical-trial-to-support-precision-oncolog 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-first-line-osimertinib-plus-chemotherapy-versus-amivantamab-plus-lazertinib-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shifting-patterns-in-pmbcl-and-dlbcl-care-the-role-of-community-oncology-centers-in-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-characteristics-of-a-phase-iii-randomized-controlled-trial-of-acupuncture-for-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/compassionate-release-for-incarcerated-patients-with-cancer-a-nationwide-policy-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-palliative-radiation-and-association-with-end-of-life-quality-metrics-and-healthcare-utilizat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-patients-with-head-and-neck-cancer-in-argentina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-risk-of-second-primary-malignancies-in-esophageal-cancer-survivors-insights-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-early-tacrolimus-levels-on-survival-outcomes-following-allogeneic-hematopoietic-stem-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-genetic-characteristics-of-msi-high-versus-mss-gastric-cancer-patients-a-single-instit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peri-operative-nab-paclitaxel-with-sequential-radiotherapy-in-cardiac-angiosarcoma-a-single-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/basic-palliative-care-assessments-in-the-treatment-of-urological-oncology-patients-a-prospective-cr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-based-on-voice-based-artificial-intelligence-vaaipro-a-fast-and-innovat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-breast-cancer-stage-at-diagnosis-over-two-decades-in-cote-divoire 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integration-of-individual-sev-with-single-cell-analysis-to-reveal-association-of-immune-cell-subsets 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-unstructured-oncology-ehrs-to-regulatory-grade-real-world-evidence-a-next-generation-registry 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-pretreatment-neutrophil-to-lymphocyte-ratio-in-triple-negative-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-utility-of-baseline-hypoalbuminemia-vs-peripheral-immune-biomarkers-in-a-real-world-immu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-cancer-screening-in-nigeria-findings-from-a-multi-city-community-based-psa-testing-outreac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-transarterial-therapy-combined-with-donafenib-plus-pd-1-inhibitors-for-unrese 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-outcomes-screening-rates-and-health-behaviors-by-county-level-poverty-status 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nutraceutical-therapies-for-radiation-induced-injury-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeted-sensorimotor-training-vs-general-aerobic-exercise-for-chemotherapy-induced-peripheral-neur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expression-levels-of-clock-genes-iper2i-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/construction-of-a-whole-course-psychological-nursing-model-and-its-impact-on-compliance-with-innovat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-detection-of-brca-associated-cancer-risk-and-lynch-syndrome-in-genomic-screening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-exploratory-study-of-the-potential-clinical-impact-of-ethnicity-in-patients-with-retroperitoneal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-neoadjuvant-concurrent-chemoradiotherapy-with-epirubicin-ifosfamide-in-locali 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analyzing-dual-threat-shifts-in-gastric-carcinoma-and-sepsis-mortality-in-the-united-states-from-199 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ish2b3i-in-myeloid-neoplasms-potential-pathogenic-role-of-variants-of-unce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/employment-status-and-occupational-patterns-among-working-age-us-cancer-survivors-2020-2024 2026-08-24 monthly 0.7 https://rjrindex.com/articles/actfirst-a-phase-3-trial-of-sup225sup-ac-psma-617-plus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nrg-hn006-randomized-phase-iiiii-trial-of-sentinel-lymph-node-biopsy-versus-elective-neck-dissecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-1-dose-escalation-and-expansion-study-of-pin-5018-a-ck1a-selective-molecular-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-experience-with-management-of-crs-and-icans-following-cd3xcd20-bispecific-antibody-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-glp-1-receptor-agonists-on-outcomes-in-hepatocellular-carcinoma-patients-treated-with-atez 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-olutasidenib-in-combination-with-azacitidine-followed-by-olutasidenib-maintenance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-single-arm-study-of-irinotecan-liposome-ii-combined-with-adebrelimab-gemcitabine-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/associations-between-early-on-treatment-weight-change-and-overall-survival-across-targeted-therapies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-characteristics-treatment-patterns-and-contrast-enhanced-computed-tomography-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographics-and-trends-of-acute-myeloid-leukemia-among-young-adults-in-the-united-states-and-puerto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-evaluation-of-an-ai-based-fusion-prioritization-agent-for-oncogenicity-assessment-in-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-mood-and-anxiety-disorders-in-cancer-survivors-a-systematic-review-and-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-a-cancer-oriented-geriatric-assessment-coga-clinic-to-promote-age-friendly-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characterization-of-abl-kinase-domain-mutations-associated-with-imatinib-resistance-in-chr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-survival-outcomes-of-a-large-cohort-of-patients-diagnosed-with-diffuse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-automated-quantitative-evaluation-of-lesion-response-heterogeneity-in-patients-with-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expression-of-cxcr4-in-gastric-nens 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rivaroxaban-versus-low-molecular-weight-heparin-in-cancer-associated-thrombosis-assessment-of-clini 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-outcomes-and-resource-utilization-by-complication-clustering-phenotypes-among-colorectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-characteristics-and-prognostic-predictors-in-cervical-clear-cell-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-large-language-models-to-assess-adherence-to-asco-tele-health-in-oncology-standards-in-post-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-burden-of-breast-cancer-among-women-aged-70-years-global-trends-in-dalys-and-mortality-by-soci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-peptide-decoy-dmp39-targeting-mitochondrial-metabolism-to-enhance-chemotherapy-response 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-pharmacologic-aldh2-activation-on-alcohol-driven-tumor-progression-in-aldh2-deficient-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-dnarna-co-detection-and-dna-only-ngs-for-driver-gene-identification-and-co-mutation-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-evolution-following-treatment-with-sacituzumab-govitecan-for-metastatic-breast-cancer-a-prote 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-lecture-on-knowledge-of-im-residents-in-diagnosing-and-managing-crs-and-icans 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-cytokine-and-transcriptomic-profiling-of-immune-related-adverse-events-in-early-stage-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-ki-67-with-tumor-fraction-in-metastatic-hr-positive-invasive-lobular-and-no-special-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/merkel-cell-carcinoma-incidence-trends-and-survival-rates-among-adults-from-united-states-cancer-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-characterization-of-brain-metastasis-in-colorectal-cancer-to-reveal-patterns-of-clonal-evolu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-3-study-marslight-11-evaluating-ibi363-tak-928-versus-docetaxel-in-patients-pt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/osimertinib-combined-with-bevacizumab-and-chemotherapy-as-1l-treatment-in-egfr-mutated-metastatic-no 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-pathways-of-immune-checkpoint-inhibitor-induced-hepatitis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-central-neurocytoma-in-a-multi-institutional-cohort-the-role-of-radiotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/infection-burden-with-bcma-versus-gprc5d-targeted-bispecific-antibodies-in-multiple-myeloma-a-syste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-bmi-and-bmi-and-charlson-comorbidity-index-on-mortality-in-pancreatic-cancer-a-single-ins 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-interactions-between-pharmaceutical-industry-and-oncologists-in-africa-a-secondary-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adaptive-radiotherapy-as-a-strategy-for-universal-dosimetric-accuracy-across-tumor-sizes-and-locatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-mrna-covid-19-vaccination-near-immune-checkpoint-inhibitor-initiation-with-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-basket-trial-of-precision-til-therapy-for-immunotherapy-resistant-advanced-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-imm2510-a-pd-l1-vegf-bispecific-antibody-in-participants-with-advanced-io-treate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-immunoscore-for-prognostic-stratification-in-hpv-associated-oropharyngeal-cancer-an-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathological-outcomes-of-neoadjuvant-osimertinib-based-therapies-versus-chemotherapy-in-resectable-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/canadian-cancer-trials-group-cctg-study-pr21-pludo-results-of-crossover-treatment-from-a-random 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-the-ability-of-decipher-prostate-genomic-classifier-dgc-gt085-to-identify-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-activity-and-safety-of-rnk08954-in-advanced-non-small-cell-lung-cancer-nsclc-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncologic-outcomes-following-biologic-therapy-for-immune-related-cutaneous-adverse-events 2026-08-24 monthly 0.7 https://rjrindex.com/articles/swog-s2107-randomized-phase-ii-trial-of-encorafenib-and-cetuximab-with-or-without-nivolumab-for-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-vivo-cd19-car-t-cell-therapy-str-p004-to-induce-remission-in-patients-with-autoimmune-diseases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progression-free-survival-after-next-line-of-treatment-pfs2-and-subsequent-therapies-subs-tx-in-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cd4-t-cell-reconstitution-and-cd4cd8-inversion-following-lymphodepleting-chemotherapy-for-tumor-inf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tremelimumab-t-durvalumab-d-chemotherapy-ct-vs-pembrolizumab-p-ct-in-1l-non-squamous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-pyrotinib-vs-pertuzumab-therapy-for-her2-positive-early-breast-cancer-the-helen-her-013 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1a-study-results-for-ima203cd8-a-prame-directed-t-cell-receptor-tcr-t-cell-therapy-in-ovar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-from-zzfirst-a-randomized-phase-2-trial-of-enzalutamide-ez-and-talazoparib-tala-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-results-from-the-optima-phase-iii-randomized-non-inferiority-trial-of-test-directed-chemothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-radiotherapy-versus-observation-following-curative-surgery-for-early-stage-oral-squamous-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-and-circulating-tumor-dna-ctdna-dynamics-in-patients-pts-with-microsatellite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-characteristics-management-and-outcomes-of-genomically-defined-mismatch-repair-def 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-nitrogen-metabolism-in-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-double-blind-two-arm-single-dose-parallel-study-to-compare-the-pharmacokinetics-ph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-1-study-of-tqb6411-an-egfrc-met-bispecific-antibody-drug-conjugate-adc-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/are-all-tumor-agnostic-biomarkers-equally-tissue-independent-comparative-cross-histology-efficacy-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-of-tumor-microenvironment-in-istk11i-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/engineering-and-preclinical-evaluation-of-cxcr3-expressing-egfr-targeted-car-nk-cells-for-tumor-hom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/allogeneic-cd19-targeted-car-t-therapy-brl-301-for-relapsed-or-refractory-b-cell-acute-lymphoblast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pan-cancer-computational-analysis-of-adaptive-immune-and-vascular-changes-in-primary-versus-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-tumor-genomics-and-fes-pet-in-estrogen-receptor-positive-er-breast-cancer-bc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-level-os-prediction-in-nsclc-combining-real-world-data-and-published-trial-results 2026-08-24 monthly 0.7 https://rjrindex.com/articles/definitive-bladderpelvic-radiation-after-enfortumab-vedotin-pembrolizumab-for-advanced-urothelial-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-more-always-better-outcomes-of-tip-versus-platinum-doublet-neoadjuvant-chemotherapy-in-high-ris 2026-08-24 monthly 0.7 https://rjrindex.com/articles/small-cell-prostate-cancer-risks-for-metastatic-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-ifebemtinib-in10018-combined-with-garsorasib-d-1553-in-kras 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-immune-checkpoint-inhibitors-in-patients-aged-65-74-versus-75-years-with-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamic-remodeling-of-the-extracellular-vesicle-proteome-during-systemic-therapy-in-advanced-non-sma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunologic-and-clinical-outcomes-of-perfluoroalkyl-substances-pfas-exposure-in-solid-tumors-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-safety-of-tarlatamab-in-patients-receiving-recent-or-concurrent-cns-radiation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-national-analysis-of-in-hospital-outcomes-following-cytoreductive-surgery-with-hipec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-study-on-the-efficacy-of-cd4tgf-v-bispecific-antibody-mr001-and-temozolomide-combinat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-associated-with-egfr-and-her2-alterations-in-advanced-urothelial-carcinoma-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-trial-of-io102-io103-and-nivolumab-relatlimab-in-previously-untreated-unresectable-melano 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantitative-ct-lung-fibrosis-and-immune-checkpoint-inhibitor-related-pneumonitis-in-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-alk201-a-fgfr2b-targeting-antibody-drug-conjugate-adc-for-patients-pts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-vivo-car-t-cell-engineering-in-b-cell-malignancies-a-systematic-review-of-emerging-clinical-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incremental-prognostic-value-of-an-ai-derived-histology-signature-beyond-the-21-gene-recurrence-scor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-haematological-control-long-term-renal-outcomes-of-imatinib-therapy-in-chronic-myeloid-leuka 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-market-entry-of-biosimilars-in-the-us-on-cancer-biologics-pricing-strategies-market-shar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/connectome-sparing-stereotactic-radiosurgery-results-from-the-phase-ii-cog-srs-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comeback-from-long-course-adt-with-relugolix-rel-and-darolutamide-daro-in-hormone-sensitive-pros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/forecasting-global-disparities-in-cervix-and-corpus-uteri-cancers-globocan-2022-2040-projections 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-priming-with-the-ezh2-inhibitor-tazemetostat-in-b-cell-lymphomas-receiving-car-t-cell-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-lisocabtagene-maraleucel-liso-cel-in-patients-pt-with-relapsed-or-refractory-rr-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-patient-characteristics-outcomes-and-resource-utilization-of-chimeric-antigen-receptor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-characterization-of-hif-2a-and-carbonic-anhydrase-ix-expression-and-the-genomic-landsc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precision-promise-prp-success-rates-of-paired-biopsies-and-biomarker-testing-results-for-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-epigenomic-molecular-tumor-type-prediction-for-biliary-tract-cancer-in-cup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-phosphoproteomic-signatures-in-peripheral-blood-and-prediction-of-durable-response-to-car-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-between-clinical-utility-and-coverage-real-world-impact-of-unreimbursed-ngs-testin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impact-and-molecular-profiling-of-ipteni-loss 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intratumoral-heterogeneity-of-imtapi-loss-by-immunohist 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-associations-between-patient-and-caregiver-quality-of-life-following-hematopoietic-stem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-focus-in-neoadjuvant-chemoimmunotherapy-an-analysis-of-pathologic-complete-response-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/standard-dose-ripretinib-plus-sunitinib-versus-ripretinib-dose-escalation-in-advanced-gist-after-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incretin-based-therapies-and-all-cause-mortality-and-progression-to-multiple-myeloma-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/organ-and-histology-specific-molecular-and-immune-landscape-of-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-different-metrics-for-estimating-kidney-radiation-exposure-during-treatment-for-childh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oral-selective-estrogen-receptor-degraders-in-hrher2-advanced-breast-cancer-and-impact-of-esr1-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differences-in-outcomes-for-elderly-patients-with-dlbcl-treated-at-academic-vs-community-programs-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-of-day-administration-of-immunotherapy-in-early-stage-triple-negative-breast-cancer-immune-dep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-concomitant-inpm1i-mutations-on-genomic-and-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/structural-determinants-compared-with-genetic-ancestry-and-self-reported-race-in-triple-negative-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/meaning-distress-and-desire-for-hastened-death-in-homebound-adults-with-advanced-cancer-a-cluster 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-and-socioeconomic-disparities-in-the-elderly-population-with-mycosis-fungoides-and-sezary-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cumulative-toxicity-assessed-by-area-under-the-curve-auc-in-targeted-therapy-versus-chemotherapy-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-predicted-natural-killer-cell-fitness-to-guide-daratumumab-and-transplant-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/divergent-transcriptomic-signatures-and-microenvironmental-markers-of-ikrasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-and-tumor-gene-expression-analysis-of-sacituzumab-govitecan-sg-and-trastuzuma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamic-circulating-tumor-dna-profiling-for-prediction-of-long-term-clinical-benefit-in-pmmr-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-by-lobular-lob-histology-status-at-initial-diagnosis-in-patients-pts-in-the-inavo120-ph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-of-her2-altered-nsclc-in-china-a-retrospective-multi-cen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-bone-health-outcomes-following-tamoxifen-and-aromatase-inhibitor-therapy-in-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-1l-divarasib-plus-pembrolizumab-pembro-in-advanced-or-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/all-that-glitters-is-not-gold-the-importance-of-ruling-out-other-causes-of-leptomeningeal-enhanceme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-impact-of-venous-thromboembolism-and-metastatic-disease-on-in-hospital-mortality-and-30 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-chemotherapy-with-survival-in-node-positive-penile-squamous-cell-carcinoma-stratified 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fast-tracking-precision-oncology-for-rare-cancers-a-national-decentralized-trial-offering-comprehen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-and-adjuvant-pembrolizumab-pembro-plus-standard-of-care-soc-for-resectable-locally-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-multicenter-open-label-parallel-cohort-study-to-evaluate-the-efficacy-safety-and-pharm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-subcutaneous-isa-vrd-isasocut-and-intravenous-isa-vrd-imroz-in-transplan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeted-bronchial-washing-fluid-based-sequencing-for-detection-of-actionable-genomic-alterations-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biological-subtype-discordance-after-neoadjuvant-therapy-in-early-breast-cancer-findings-from-a-15 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-class-trop2-targeted-pet-imaging-with-sup68sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/support-of-academic-non-clinical-efforts-for-cancer-investigator-faculty-at-association-of-american 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insights-through-the-renal-lens-clinical-outcomes-of-newly-diagnosed-multiple-myeloma-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-impact-of-regional-lymph-node-depletion-on-response-to-immune-checkpoint-blockade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-characteristics-and-survival-outcomes-of-typical-and-atypical-pulmonary-carcinoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-incidence-mortality-and-projections-of-early-onset-upper-gastrointestinal-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/external-validation-of-a-deep-learning-ct-biomarker-to-predict-first-line-immune-checkpoint-inhibito 2026-08-24 monthly 0.7 https://rjrindex.com/articles/off-target-hla-matches-for-prediction-of-response-in-personalised-cancer-vaccines-a-multi-trial-ret 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-trial-of-a-kras-g12vhla-a1101-restricted-tcr-engineered-t-cell-therapy-in-advanced-solid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recovery-with-residual-disparities-real-world-patterns-of-platinum-chemotherapy-use-after-the-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-dose-nivolumab-in-patients-at-high-risk-of-immune-related-adverse-events-a-retrospective-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/body-mass-index-stratified-outcomes-with-first-line-immunotherapy-in-metastatic-rcc-a-real-world-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-entpd1cd39-mediated-myeloid-t-cell-crosstalk-and-its-role-in-immunotherapy-resp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/body-mass-index-and-mortality-in-immune-checkpoint-inhibitor-treated-cancers-a-real-world-propensit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-assisted-prediction-of-radiation-failure-patterns-and-survival-after-stereotactic-radiosurgery-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-developing-braincentral-nervous-system-cns-metastases-across-multiple 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-study-to-assess-the-safety-tolerability-pharmacokinetics-and-preliminary-antitumor-acti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlative-analysis-between-external-and-internal-lymphedema-in-head-and-neck-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chromosomal-instability-and-integrated-tumor-margin-immune-ecosystem-remodeling-as-drivers-of-progre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-and-safety-results-from-rad-io-a-multi-stage-trial-of-durvalumab-with-chemoradiotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-prehabilitation-and-functional-performance-signals-in-older-adults-undergoing-hepatobiliary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-palliative-care-nurse-coordination-in-symptom-control-and-care-planning 2026-08-24 monthly 0.7 https://rjrindex.com/articles/isabela-a-phase-2-study-of-isatuximab-belantamab-mafodotin-pomalidomide-and-dexamethasone-in-rel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-early-resistance-genomic-state-ergs-as-an-identifier-of-primary-cdk46-inhibitor-failure-in-hr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/defining-a-long-term-benefit-phenotype-to-pd-1-inhibitors-in-recurrentmetastatic-head-and-neck-squa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparison-of-dara-vrd-vrd-and-dara-rd-in-transplant-ineligible-older-adults-with-newly 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hidden-advanced-physiology-in-non-metastatic-gastrointestinal-cancer-malnutritioncachexia-and-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/actionable-genomic-alterations-and-outcomes-in-lung-squamous-and-adenosquamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-from-imvigor011-a-phase-3-study-of-circulating-tumor-ctdna-guided-adjuv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-multicenter-randomized-controlled-open-label-study-efficacy-and-safety-of-m701-epcamcd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-advanced-pneumatic-compression-devices-and-usual-care-on-psychosocial-outcomes-in-head-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-olaparib-and-ceralasertib-in-patients-with-recurrent-osteosarcoma-lung-only-resec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimal-timing-of-endocrine-therapy-interruption-for-pregnancy-in-young-women-with-hormone-receptor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-a-statin-a-day-keep-prostate-cancer-pc-away-statin-use-and-disease-progression-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-global-health-to-predict-negative-health-outcomes-in-patients-with-advanced-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-treatment-of-ql1706-in-patients-with-resectable-microsatellite-instability-highmismatch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-statin-prescription-for-secondary-prevention-of-atherosclerotic-cardiovascular-diseas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-bruton-tyrosine-kinase-inhibitors-versus-venetoclax-in-chronic-lymphocytic-le 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fgfr-targeted-therapies-in-advanced-esophagogastric-cancer-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-and-randomized-clinical-trial-comparison-in-patients-with-m-iidh1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-for-comprehensive-genomic-profiling-in-myeloid-malignancies-changes-in-detectio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-hiv-hepatitis-b-and-hepatitis-c-eligibility-language-in-immune-checkpoint-inhibitor-onco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/some-features-of-the-energy-metabolism-of-primary-cell-cultures-of-sarcomas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-early-onset-colorectal-cancer-in-the-united-states-a-population-based-analysis-2000-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-national-patient-centered-ai-framework-for-equitable-oncology-clinical-trial-access-early-outcom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-trial-of-trastuzumab-deruxtecan-in-combination-with-stereotactic-radiosurgery-for-brain-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-large-language-models-to-identify-advance-care-planning-in-oncology-patients-who-present-to-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-care-in-armenia-an-assessment-of-diagnostic-and-treatment-capacity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/management-of-amivantamab-associated-scalp-toxicity-a-multicenter-retrospective-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/divergent-paths-in-the-right-colon-a-24-year-analysis-of-appendiceal-cancer-versus-cecal-cancer-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/operationalizing-yoga-as-a-quantifiable-component-of-guideline-aligned-multimodal-exercise-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/symptoms-and-life-impact-of-polycythemia-vera-pv-results-from-a-qualitative-patient-interview-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-treatment-cervical-cancer-surveillance-cytology-and-recurrence-outcomes-in-a-large-integrated-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/atrial-fibrillation-as-a-sentinel-cardiovascular-event-in-renal-cell-carcinoma-hospitalizations-nat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-disparities-in-cervical-cancer-incidence-mortality-and-disability-adjusted-life-y 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-multidisciplinary-rounds-on-time-to-treatment-for-veterans-with-lung-cancer-at-a-va-medica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-lu-psma-based-treatment-strategies-in-metastatic-hormone-sensitive-prostate-cancer-a-sy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tp53-co-mutations-and-survival-outcomes-in-patients-pts-with-nsclc-bearing-uncommon-egfr-alteratio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-arm-phase-2-study-of-neoadjuvant-mirvetuximab-soravtansine-and-carboplatin-for-fra-express 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tace-haic-combined-with-low-dose-donafenib-for-unresectable-hepatocellular-carcinoma-a-real-world-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-exploratory-trial-of-cadonilimab-ak104-plus-gemcitabine-cisplatin-gc-as-a-conversion 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-mrna-2808-in-participants-with-relapsed-or-refractory-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-double-blind-phase-3-trust-iv-study-of-adjuvant-taletrectinib-vs-placebo-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/swog-s2414-insight-a-randomized-phase-iii-trial-incorporating-pathologic-complete-response-in-par 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-multicenter-phase-ii-trial-of-radioimmunotherapy-versus-chemoimmunotherapy-followed-by-su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-induction-oxaliplatin-based-chemotherapy-followed-by-maintenance-in-isolated-peritoneal-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/benchmarking-next-generation-large-language-models-llms-evaluation-of-patient-oriented-prostate-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/venous-thromboembolism-in-gynecologic-malignancies-as-a-chronic-vascular-disease-a-systematic-revie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-metabolite-network-modeling-of-metabolic-nodes-and-oncogenic-signaling-in-gastrointestina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antidepressant-use-and-overall-survival-in-ici-treated-pan-cancer-patients-a-real-world-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/belzutifan-plus-lenvatinib-versus-cabozantinib-in-post-pd-l1-renal-cell-carcinoma-rcc-health-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circrna-signatures-associated-with-brca-mutation-status-in-ovarian-cancer-and-a-rassf8-derived-candi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liraglutide-may-be-associated-with-increased-skin-cancer-risk-a-propensity-score-matched-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-insurance-related-disparities-on-delay-in-treatment-initiation-among-colorectal-cancer-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/population-level-trends-in-breast-cancer-incidence-staging-and-mortality-in-armenia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-response-and-surgical-conversion-after-preoperative-docetaxel-cisplatin-and-oral-5-fu-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-inferior-vena-cava-filters-in-breast-cancer-patients-with-dvt-national-inpatient-sample 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-first-line-pembrolizumab-plus-chemotherapy-in-metastatic-triple-negative-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-clinical-study-of-stereotactic-radiotherapy-srt-combined-with-chemotherapy-and-tisleliz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-in-hospital-mortality-in-chemotherapy-associated-cardiomyopathy-a-national-inpatient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-related-thyroid-dysfunction-and-overall-survival-in-metastatic-colorectal-cancer-treated-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-disparities-in-pancreatic-cancer-risk-assessment-using-seer-medicare-claims-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-trends-and-burden-of-thyroid-cancer-mortality-in-south-asia-a-retrospective-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-anticancer-therapy-near-the-end-of-life-a-binational-multicenter-analysis-in-argentina-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-outcomes-and-unmet-needs-in-patients-with-acute-myeloid-leukemia-aml-who-are-ineligible 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncosphere-ai-an-agentic-ai-multidisciplinary-clinical-workflow-support-tool 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accessibility-of-mandated-coverage-insurer-and-care-team-perspectives-on-barriers-for-cancer-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-and-clinical-outcomes-of-newly-diagnosed-acute-myeloid-leukemia-with-mapk-pathway-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-the-understanding-patient-assessment-of-goals-and-treatment-in-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-outcomes-with-olutasidenib-after-venetoclax-in-idh1-mutated-aml-using-real-wo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-inpatient-outcomes-with-carcinoid-syndrome-among-malignant-neuroendocrine-tumor-hospi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-telisotuzumab-adizutecan-abbv-400-temab-a-in-patients-with-advanced-solid-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pain-on-functional-status-quality-of-life-and-cognition-in-older-adults-with-prostate-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fitness-classification-and-induction-intensity-selection-in-aml-practice-a-contemporary-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frequency-of-mutations-in-homologous-recombination-genes-in-patients-with-different-histological-typ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/facility-level-differences-and-outcomes-in-elderly-primary-cns-lymphoma-in-the-ncdb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-sepsis-related-mortality-among-adults-with-cancer-aged-25-years-in-united-states-1999-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-oxidative-stress-and-neutrophil-reprogramming-in-mediating-venous-thrombosis-in-colorectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/population-based-breast-cancer-incidence-by-age-sex-subtype-and-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-for-second-primary-malignancies-spm-in-patients-with-chronic-lymphocytic-leukemiasma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigator-initiated-phase-ii-trial-of-absk043-an-oral-pd-l1-inhibitor-in-patients-with-angiogen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-versus-petct-at-end-of-treatment-in-large-b-cell-lymphoma-a-diagnostic-accuracy-meta-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-pyrotinib-plus-trastuzumab-combined-with-chemotherapy-for-her2hr-early-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decoding-btn3a3-a-potential-biomarker-and-therapeutic-target-to-promote-glycolytic-metabolism-repro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proton-beam-therapy-versus-interventional-procedures-for-hepatocellular-carcinoma-a-systematic-revi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-testing-uptake-through-an-enhanced-oncology-nurse-led-intervention-in-patients-with-solid-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-car-t-cell-therapy-in-hematologic-malignancies-a-systematic-review-and-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-geographic-distance-from-transplant-center-on-the-risk-of-severe-graft-versus-host-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modeling-early-gastric-cancer-evolution-following-iarid1ai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-cerebrovascular-disease-related-mortality-in-patients-with-chronic-lymphoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-institutional-randomized-phase-iii-trial-comparing-anatomical-segmentectomy-and-lobectomy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-neoadjuvant-immunochemotherapy-chemoradiotherapy-and-chemothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-analysis-of-the-investigator-initiated-randomized-study-of-anti-pd-l1-durvalumab-durva-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-world-oral-solution-formulation-of-enzalutamide-bioequivalence-versus-soft-gel-capsule-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-patient-tailored-protein-marker-blood-test-for-monitoring-treatment-response-and-postoperative-rec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparison-of-enzalutamide-and-darolutamide-for-non-metastatic-castration-resistant-prost 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-bipolar-androgen-therapy-combined-with-sipuleucel-t-for-patients-with-metastatic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adapt-m-a-tool-to-predict-individualized-benefit-from-adjuvant-anti-pd-1-pd-1-in-resected-high-ri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-germline-pathogenic-variants-in-melanoma-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-nanobody-sting-agonists-on-the-tumor-microenvironment-and-adoptive-cell-therapy-for-solid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-and-cross-resistance-of-sequential-antibody-drug-conjugate-therapy-in-her2-low-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-trial-of-atr-inhibitor-berzosertib-plus-immune-checkpoint-inhibitor-avelumab-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sensitivity-of-portal-vein-ctdna-versus-peripheral-blood-in-predicting-postoperative-liver-metastasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-biological-complexity-to-clinical-precision-a-first-in-class-single-patient-level-ai-strategy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/complementary-liquid-and-tissue-ngs-testing-to-identify-actionable-therapeutic-targets-missed-by-sin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-rationally-designed-local-delivery-platform-oncoplex-for-sustained-docetaxel-release-to-overcome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-hypertension-mortality-among-patients-with-lung-cancer-a-retrospective-cd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-with-rare-cancers-treated-with-combination-immune-checkpoint-inhibitors-with-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-pelareorep-on-mutant-kras-specific-blood-til-clonal-expansion 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-durvalumab-treatment-duration-on-survival-and-healthcare-utilization-after-chemoradiation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiomics-feature-robustness-of-photon-counting-ct-and-dect-in-chest-tumor-phantom-a-dual-center-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-life-in-cancer-patients-treated-with-anchored-interleukin-12-il-12-immunotherapy-resul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-ai-in-hematology-and-oncology-fellowship-hof-training-a-multicenter-sur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/study-of-the-cytostatic-effect-of-a-new-compound-of-the-tropolon-series-on-primary-cultures-of-gliom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-de-novo-del17p-in-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-preliminary-efficacy-of-a-novel-armored-mesothelin-targeted-car-t-therapy-in-advanced-sol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-atezolizumab-durvalumab-lurbinectedin-and-tarlatamab-in-high-grade-extrapulmonary-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/individualized-recurrence-risk-prediction-as-a-challenge-to-conventional-eligibility-criteria-in-pha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-alterations-in-metastatic-renal-cell-carcinoma-mrcc-impact-on-survival-and-response-to-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-systems-level-omics-and-hallmark-based-analysis-of-pancreatic-cancer-for-the-identification-of-pot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stage-specific-survival-trends-in-small-cell-lung-cancer-in-the-united-states-a-population-based-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-objective-sarcopenia-assessment-into-geriatric-screening-as-a-predictor-of-treatment-tol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-fih-phase-iii-open-label-dose-escalation-and-expansion-study-of-ilkn421h-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-benmelstobart-combined-with-anlotinib-and-chemotherapy-as-neoadjuvant-therapy-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-decision-making-after-car-t-and-bispecific-antibody-therapy-in-relapsedrefractory-multipl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-and-mechanism-of-tertiary-lymphoid-structure-and-its-associated-b-cells-in-the-resistance-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-enfortumab-vedotin-plus-pembrolizumab-compared-with-platinum-based-chemothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-cd-19-directed-car-t-therapy-in-patients-with-primary-and-secondary-central-nervous-syst 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-and-immune-profiling-of-ibrafi-mutated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ibi363-tak-928-plus-chemotherapy-as-first-line-1l-treatment-for-advanced-non-small-cell-lung-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-socioeconomic-disparities-in-stage-at-diagnosis-and-survival-in-pancreatic-cancer-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-trends-and-burden-of-multiple-myeloma-mortality-in-south-asia-a-retrospective-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/afatinib-versus-osimertinib-for-non-small-cell-lung-cancer-with-uncommon-epidermal-growth-factor-rec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-outcomes-by-patterns-of-progression-in-patients-with-advanced-renal-cell-carcinoma-from-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-a-10-item-frailty-index-based-on-a-comprehensive-geriatric-assessment-fi-cga-10-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/are-lobectomy-and-neoadjuvant-therapy-the-missing-link-in-improving-early-stage-small-cell-lung-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-trends-and-burden-of-pancreatic-cancer-in-the-united-states-a-retrospective-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accumulation-of-cholesterol-cortisol-and-glutathione-in-mitochondria-as-a-marker-of-metabolic-adap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-hematopoietic-recovery-of-high-dose-melphalan-with-stem-cell-rescue-as-bridging-to-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/urinary-tumor-dna-guided-de-escalation-of-systemic-immunotherapy-in-extensive-very-high-risk-non-mus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recent-trends-in-utilization-of-outpatient-medical-oncology-services 2026-08-24 monthly 0.7 https://rjrindex.com/articles/career-fulfillment-and-intent-to-leave-among-oncology-physicians-a-global-survey 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expression-patterns-of-circulating-micrornas-in-classification-models-new-opportunities-in-brain-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-hlx43-anti-pd-l1-adc-in-patients-with-advanced-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-mortality-from-malignant-neoplasms-of-male-genital-organs-in-the-united-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthtree-survey-as-an-identifier-of-venous-thromboembolism-risk-mitigation-targets-in-newly-diagno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epimedin-a-to-prevent-glioblastoma-growth-and-invasion 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodal-intraoperative-diagnosis-and-grading-system-integrating-macroscopic-images-ct-imaging-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/xnw27011-a-claudin-182cldn182-targeted-antibody-drug-conjugate-adc-in-patients-with-cldn182 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ct-derived-visceral-fat-phenotypes-to-reveal-a-metabolically-defined-tofi-subgroup-in-a-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-ct-changes-pet-response-and-histopathologic-tumor-regression-in-treated-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-mortality-and-health-care-utilization-in-frail-older-patients-with-cancer-receiving-targ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhanced-financial-assistance-intervention-for-unmet-essential-needs-a-prospective-pilot-study-to-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-open-label-safety-tolerability-and-efficacy-study-of-hc-7366-in-combination-with-belz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obesity-paradox-in-gastrointestinal-cancer-patients-on-immunotherapy-a-retrospective-multi-institut 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transportation-insecurity-and-rbc-transfusion-burden-in-multiple-myeloma-and-related-plasma-cell-dis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ignite-cerala-a-phase-ii-signal-seeking-trial-of-ceralasertib-targeting-recurrent-high-grade-serous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-analysis-of-a-computational-reasoning-system-on-large-scale-tumor-genomic-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insights-from-initial-scoring-in-the-health-equity-report-card-herc-pilot-in-community-oncology-se 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-machine-learning-enhanced-analysis-of-temporal-trends-in-biomarker-based-eligibility-restrictions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-stage-ai-enabled-therapeutic-assets-an-industry-wide-analysis-of-scale-clinical-progressi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-and-gender-disparities-in-lung-cancer-mortality-in-guatemala 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-impact-of-first-immunotherapy-infusion-timing-on-outcomes-in-locally-advanced-non-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-implementation-of-an-integrated-exercise-medicine-model-within-routine-oncology-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-person-versus-telehealth-outpatient-palliative-care-visits-in-oncology-a-multicenter-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/natural-language-processing-assisted-chart-review-to-assess-documented-cannabis-use-in-electronic-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-lymph-node-dissection-extent-on-disease-free-survival-with-postoperative-nivolumab-plus-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/responses-to-trastuzumab-deruxtecan-t-dxd-in-her2-ihc-spectrum-2-versus-3-urothelial-carcinoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-psychosocial-status-of-children-who-have-a-parent-with-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/older-age-as-a-predictor-of-post-transplant-survival-in-newly-diagnosed-acute-myeloid-leukemia-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-omic-analysis-of-eocrc-divergent-methylation-and-gene-expression-signatures-in-young-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/value-of-risk-directed-thromboprophylaxis-in-ambulatory-lung-and-gastrointestinal-cancer-care-econo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/firmonertinib-combined-with-cisplatincarboplatin-plus-pemetrexed-as-neoadjuvant-therapy-in-resectab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/explainable-machine-learning-for-continuous-transcriptomic-modeling-of-metastatic-risk-in-prostate-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-cadonilimab-plus-chemotherapy-for-locally-advanced-gastricgastroesophageal-junction-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-testing-in-asian-american-and-pacific-islander-women-with-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-toxicity-of-first-line-systemic-therapy-for-hepatocellular-carcinoma-in-clinical-practice 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reduced-treatment-adherence-and-cancer-mortality-in-patients-with-depression 2026-08-24 monthly 0.7 https://rjrindex.com/articles/major-adverse-cardiovascular-events-in-androgen-receptor-signaling-inhibitor-treated-patients-with-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-overall-survival-os-and-long-term-transfusion-independence-ti-from-the-phase-3-commands 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-cadherin-17-ca17-in-blood-as-a-diagnostic-biomarker-for-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-genomic-and-clinical-factors-with-outcomes-with-front-line-chemoimmunotherapy-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-optimized-multi-biomarker-panel-for-discriminating-lung-cancer-from-ldct-positive-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-overall-survival-outcomes-of-btk-inhibitors-vs-venetoclax-based-therapy-as-second-line-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcome-comparison-of-once-versus-twice-daily-dosing-of-zanubrutinib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-a-small-extracellular-vesicle-protein-based-ovarian-cancer-score-with-o-rads-ultrasound 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-results-of-perioperative-chemoimmunotherapy-with-dcf-and-avelumab-in-locally-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bone-mineral-density-changes-in-patients-treated-with-anti-pd-1-immune-checkpoint-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nalirifox-in-combination-with-adebrelimab-for-advanced-biliary-tract-cancer-a-phase-2-niofa-01-clin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-monitoring-for-early-detection-of-disease-recurrence-in-bonesoft-tissue-sarco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-safety-and-immunogenicity-of-pertuzumab-biosimilar-versus-reference-pertuzumab-in-combina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ia-study-of-vrn101099-a-brain-penetrant-highly-selective-covalent-her2-inhibitor-in-her2-po 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-brain-metastasis-outcomes-with-t-dxd-versus-tucatinib-based-therapy-in-second-line-her2-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transient-prostate-specific-antigen-flare-induced-by-lutetium-lu-177-vipivotide-tetraxetan-in-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-treatment-failure-despite-first-line-immunotherapy-in-real-world-msi-hdmmr-gastroesophageal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sepsis-severity-and-inpatient-outcomes-in-metastatic-cancer-a-national-inpatient-sample-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-1l-trastuzumab-deruxtecan-t-dxd-based-regimens-in-advanced-her2-expressing-gastric-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-and-predictive-impact-of-baseline-gene-expression-exp-in-the-natalee-trial-of-adjuvant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-national-database-derived-nomogram-for-predicting-postoperative-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-from-a-phase-2a-study-of-atebimetinib-in-combination-with-mgnp-in-advanced-or-metastatic-pan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/image-only-and-multimodal-ai-digital-pathology-biomarkers-to-demonstrate-risk-stratification-across 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodality-neoadjuvant-downstaging-therapy-before-liver-transplantation-for-colorectal-liver-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-rna-protein-profiling-of-antibody-drug-conjugate-adc-targets-in-leiomyosarcoma-lms 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sys6010-combined-with-syh2051-in-advanced-solid-tumors-results-from-a-phase-ibii-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-a-cfdna-methylation-based-mced-test-in-patients-with-clinicoradiologic-suspicion-of-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-safety-and-efficacy-of-obinutuzumab-versus-rituximab-in-combination-with-chemotherapy-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-biomarkers-of-primary-resistance-to-anti-egfr-monoclonal-antibodies-mabs-by-comprehensive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/more-than-pain-relief-associations-between-provider-compassion-anxiety-and-burnout-in-ed-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/addressing-geographic-disparities-in-cancer-care-an-examination-of-the-contributions-of-internation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemotherapy-followed-by-transanal-endoscopic-surgery-tes-and-selective-chemoradiation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-safety-and-outcomes-of-ribociclib-versus-palbociclib-in-hormone-receptor-posi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-para-aortic-lymphadenectomy-on-prognosis-and-quality-of-life-in-preoperative-ib2-iia2-cerv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-synbindin-deficiency-on-immune-checkpoint-blocker-induced-systemic-inflammation-and-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-us-most-favored-nation-mfn-drug-pricing-on-global-oncology-access 2026-08-24 monthly 0.7 https://rjrindex.com/articles/activating-mpn-patients-through-empowering-patient-centered-education 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultra-refractory-pd-pd-pancreatic-cancer-clinical-and-molecular-insights-across-first-and-second-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/durable-treatment-free-remission-in-cml-beyond-clinical-trials-lessons-from-a-large-single-center-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/revumenib-as-maintenance-for-aml-following-allogeneic-stem-cell-transplantation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-a-telephone-genetic-screening-program-in-breast-cancer-survivorship-in-the-bronx 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transplant-associated-thrombotic-microangiopathy-after-hematopoietic-stem-cell-transplantation-in-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-esophageal-cancer-mortality-in-the-united-states-1999-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/challenges-in-identifying-her2-low-metastatic-breast-cancer-real-world-perspectives-from-a-nationwi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-features-and-survival-outcomes-of-her2-low-versus-her2-negative-ihc-0-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/line-of-therapy-and-proton-pump-inhibitor-use-as-prognostic-factors-in-advanced-soft-tissue-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preeclampsia-gene-signatures-and-pd-l1-in-endometrial-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-quality-of-life-and-mood-in-prolonged-responders-to-immune-checkpoint-inhibitors-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/translating-meta-analytic-risk-into-absolute-survival-projection-modeling-of-secondary-type-mutatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-recurrence-patterns-and-postrecurrence-outcomes-after-neoadjuvant-chemoradiothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/drivers-of-clinician-engagement-in-oncology-trial-accrual-within-an-imc-in-shanghai-a-mixed-methods 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-use-in-subgroup-analysis-versus-enrichment-trial-design-as-a-predictor-of-oncology-trial-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sleep-disorders-in-cancer-survivors-a-cross-sectional-study-from-morocco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-stage-at-diagnosis-of-hiv-associated-cancers-a-seer-analysis-2018-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-mortality-in-patients-with-hiv-and-tumor-lysis-syndrome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-features-and-survival-outcomes-of-stage-ie-pulmonary-marginal-zone-lymphoma-a-nat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-in-place-of-death-amongst-black-women-with-breast-cancer-a-retrospective-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-pembrolizumab-in-combination-with-odetiglucan-for-patients-with-metastatic-colorec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/later-line-treatment-of-pd-1-and-ctla-4-blockade-combined-with-liposomal-irinotecan-plus-leucovorin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/day-7-single-cell-rna-sequencing-of-acute-lung-responses-after-17-gy-whole-thorax-irradiation-in-mic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rainfol-04-engot-ov96gog-3134-a-phase-3-open-label-randomized-study-of-rinatabart-sesutecan-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-study-of-hpb-092-a-dual-flt3irak4-inhibitor-in-relapsed-or-refractory-acute-myeloid-leu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fusionvac22-02-a-phase-i-clinical-trial-in-progress-adjuvant-idnajb1-prkaca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-parallel-cohort-multicenter-clinical-study-of-rezvilutamide-in-combination-with-andr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-differences-in-colorectal-cancer-screening-effectiveness-in-the-plco-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-between-circulating-tumor-dna-and-radiographic-disease-status-in-soft-tissue-sarcoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stratification-of-cardiovascular-complications-with-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sleep-disorder-diagnosis-prevalence-among-adult-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-disparities-in-survival-among-patients-with-early-onset-primary-liver-cancer-a-15 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-and-factors-associated-with-first-line-chemoimmunotherapy-chemoio-or-immunotherapy-io-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/corruption-as-an-upstream-determinant-of-global-cancer-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/framing-and-availability-of-information-regarding-alternative-cancer-therapies-by-top-us-cancer-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adolescent-and-young-adult-cancer-death-burden-in-the-united-states-from-1990-to-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-quality-4d-anatomical-and-functional-mri-for-abdominal-tumor-motion-management 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-features-and-outcomes-of-eber-negative-nasopharyngeal-carcinoma-a-large-cohort-study-acros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-clinical-pathological-tool-for-rs-prediction-a-practical-alternativ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-clinical-significance-of-pathogenic-variants-in-lynch-syndrome-a-single-center-retros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-modality-and-anatomic-site-as-determinants-of-mortality-in-second-primary-cancers-after-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-aspirin-use-on-pathological-outcomes-in-locally-advanced-rectal-cancer-patients-underg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pregnancy-and-cancer-a-retrospective-case-series-of-obstetric-oncologic-and-care-compliance-outco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-post-discharge-appointment-coordination-for-hospitalized-cancer-patients-utilizing-inpatie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/raced-reduction-of-cervical-cancer-disparities-racial-literacy-as-a-strategy-to-foster-a-race-cons 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reevaluating-the-comparative-effectiveness-of-glucagon-like-peptide-1-receptor-agonists-glp-1ra-vs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/representation-of-classical-and-rare-head-and-neck-cancers-in-basket-clinical-trials-a-pooled-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-immediate-and-delayed-autologous-breast-reconstruction-methods-a-retrospective-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evolution-of-symptom-burden-across-prostate-cancer-disease-states-in-the-ehr-facilitated-cancer-symp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-bayesian-dose-finding-to-ai-enabled-decision-support-in-oncology-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-association-between-the-androgen-receptor-gene-polymorphisms-cag-repeats-and-aggressive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-and-hematologic-outcomes-in-prostate-cancer-patients-with-radiation-cystitis-receiving-hype 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-survival-and-safety-of-neoadjuvant-immune-checkpoint-inhibitors-plus-chemotherapy-in-earl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethnic-distribution-and-clinical-impact-of-serum-tumor-marker-abnormalities-in-metastatic-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-efficacy-and-complications-of-cytoreductive-surgery-with-hipec-for-colorectal-cancer-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-effects-of-acuity-circles-policy-on-waitlist-outcomes-in-hepatocellular-carcinoma-trans 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-postoperative-adjuvant-donafenib-therapy-for-patients-with-high-risk-recu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-study-of-ds5361-a-small-molecule-nonsense-mediated-mrna-decay-nmd-inhi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kandlelit-014-a-phase-2-study-of-mk-1084-as-monotherapy-and-in-combination-with-cetuximab-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-exploratory-study-of-iparomlimab-and-tuvonralimab-ql1706-combined-with-bevacizumab-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/amplify-a-phase-3-study-of-sup64sup-cu-sar-bispsma-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trident-a-phase-2-study-of-relacorilant-plus-nab-paclitaxel-and-gemcitabine-in-patients-with-previo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-among-older-adults-with-coexisting-ischemic-heart-disease-and-thoracic-malignanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rna-based-next-generation-sequencing-for-identification-of-clinically-actionable-gene-fusions-missed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interrupting-sedentary-time-to-improve-cardiometabolic-health-and-toxicity-in-patients-with-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-sms-enhanced-supportive-program-to-improve-treatment-management-and-communication-during-active-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-facility-type-with-overall-survival-in-older-adults-with-angioimmunoblastic-t-cell-ly 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-evaluation-of-romiplostim-use-for-patients-with-chemotherapy-induced-thrombocytopenia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/strengthening-supportive-care-patient-guidance-oncology-models-for-adolescents-and-young-adults-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/debriefing-initiative-on-the-oncology-firm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-an-analytics-dashboard-to-measure-infusion-treatment-initiation-timelines 2026-08-24 monthly 0.7 https://rjrindex.com/articles/drivers-of-early-readmission-and-mortality-after-metastatic-spinal-cord-compression-in-cervical-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integration-of-ai-based-risk-stratified-therapy-to-optimize-outcomes-in-localized-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-specific-drivers-of-pd-1pd-l1-inhibitor-brand-preference-in-nsclc-melanoma-and-renal-cell-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-language-barriers-on-financial-toxicity-for-spanish-speaking-patients-undergoing-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progressive-locally-advanced-or-metastatic-radioiodine-refractory-differentiated-thyroid-cancer-rai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-cause-of-death-attribution-through-real-world-data-integration-a-framework-to-improve-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-enabled-analysis-of-unstructured-ehr-data-for-identification-of-actionable-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-driven-medical-oversight-in-global-oncology-trials-standardizing-immune-related-ae-manageme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-profile-and-comparative-performance-of-limited-next-generation-sequencing-and-qpcr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-quality-of-life-outcomes-in-metastatic-breast-cancer-effects-of-palliative-home-visits-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/addition-of-18f-dcfpyl-psma-pet-to-mri-to-avoid-unnecessary-biopsy-in-men-on-active-surveillance-fi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-outcomes-in-pacritinib-treated-patients-with-mf-and-higher-platelet-count-my 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-capecitabine-and-trastuzumab-for-stage-ia-her2-positive-breast-cancer-iris-a-a-phase-ii 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-vorasidenib-vs-placebo-on-seizure-rates-and-quality-of-life-exploratory-analysis-from-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-perioperative-pembrolizumab-in-mismatch-repair-deficientmicrosatellite-unstable-localiz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imbrave251-final-analysis-of-atezolizumab-atezo-lenvatinib-lenva-or-sorafenib-sora-vs-lenva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-analysis-of-the-ropeginterferon-alfa-2b-clinical-program-in-essential-thrombocythemia-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diverging-trends-in-head-and-neck-cancer-incidence-seer-17-analysis-of-hpv-related-and-non-hpv-rela 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-tislelizumab-combined-with-chemoradiotherapy-in-high-risk-locoregionally-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-breast-cancer-attributable-to-secondhand-smoke-in-north-american-women-a-gbd-2023-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neighborhood-level-disadvantage-and-disparities-in-treatment-and-recurrence-in-tenosynovial-giant-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-clinical-trial-enrollment-rates-among-patients-with-operable-invasive-breast-cancers-an-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/associations-of-race-and-obesity-with-mortality-and-cardiotoxicity-in-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-exploratory-study-of-stratified-therapy-using-toripalimab-plus-gp-induction-followed-by-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-artificial-intelligence-ai-and-retrieval-augmented-generation-rag-to-identify-patient-repo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/see-her-screen-her-an-opportunistic-via-screening-and-hpv-vaccination-among-female-patient-attendan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rw-post-progression-outcomes-after-first-line-1l-treatment-with-ribociclib-an-aromatase-inhibi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-of-occupational-cancer-notification-in-brazil-2010-2024-a-15-year-national-database-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/historical-redlining-and-oral-squamous-cell-carcinoma-staging-at-diagnosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasminogen-activation-system-indices-in-basal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-and-sex-differences-in-the-incidence-of-hpv-positive-cancers-a-seer-database-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-national-health-insurance-ayushman-bharat-scheme-of-delivering-high-quality-cancer-surge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elderly-patients-with-extranodal-mzl-academic-vs-community-care-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-genetic-spectrum-of-59-birt-hogg-dube-patients-in-a-single-institution-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emerging-demographic-and-geographic-disparities-in-cerebrovascular-mortality-among-us-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-characterization-and-management-of-immune-checkpoint-inhibitor-induced-pruritus-a-retrospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/b-cell-enrollment-efficiency-program-beep-streamlining-accrual-to-early-phase-lymphoma-trials-at 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-liver-metastases-among-pancreatic-cancer-patients-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-study-of-mt-4561-in-patients-with-various-advanced-solid-tumors-nct06943521 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beamion-bcgc-1-four-new-phase-ibii-cohorts-to-evaluate-oral-zongertinib-with-other-agents-in-her2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-of-immunotherapy-associated-outcomes-in-patients-with-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-profile-and-treatment-outcomes-of-lymphoma-patients-a-retrospective-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-due-to-heart-failure-and-malignant-neoplasms-among-adult-patients-in-the-united 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-patients-comfort-with-artificial-intelligence-in-oncology-care-and-first-round-ai-chemo-tea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-controlled-trial-evaluating-anamorelin-hydrochloride-in-patients-with-gastric-cancer-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-current-sleep-cognition-evidence-and-translation-into-oncology-practice 2026-08-24 monthly 0.7 https://rjrindex.com/articles/do-we-really-know-how-many-veterans-have-cancer-in-the-veterans-health-administration 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circadian-immune-coherence-and-readiness-as-time-aware-early-endpoints-in-a-real-world-nsclc-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-regional-trends-in-combined-colorectal-cancer-and-cerebrovascular-disease-related-mo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/afp-response-based-model-as-a-prognostic-monitor-in-unresectable-hepatocellular-carcinoma-management 2026-08-24 monthly 0.7 https://rjrindex.com/articles/becotatug-vedotin-plus-pucotenlimab-as-first-line-therapy-in-patients-with-recurrent-or-metastatic-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-ivonescimab-in-patients-with-cutaneous-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-relationship-between-event-free-and-overall-survival-in-the-era-of-perioperative-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rediscover-2-a-phase-3-study-of-zovegalisib-zovega-rly-2608-fulvestrant-fulv-versus-capivase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/forecasting-the-durability-of-overall-survival-benefit-with-gemtuzumab-ozogamicin-in-acute-myeloid-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/application-of-bayesian-methodology-in-radiopharmaceutical-therapies-dose-optimization 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-genomic-landscape-and-outcomes-of-hrd-and-hrr-alterations-in-solid-tumors-real-world-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/llc-cell-lines-response-and-resistance-to-kras-g12c-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-tumor-grade-with-increased-cd3-t-cell-and-foxp3-regulatory-t-cell-infiltration-in-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-technology-agencies-reimbursement-decisions-for-cancer-drugs-across-four-high-income-countri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thromboembolic-events-in-patients-with-advanced-non-small-cell-lung-cancer-receiving-palliative-chem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/coping-strategies-adopted-by-caregivers-of-pediatric-oncology-patients-navigating-the-economic-burde 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-and-pain-treatment-de-escalation-of-concurrent-chemoradiotherapy-combined-with-nimotuzumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unmasking-the-clinical-impact-of-sglt-2-inhibitors-in-stage-iv-colorectal-cancer-a-real-world-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-differences-in-breast-conserving-surgery-after-neoadjuvant-chemotherapy-for-her2-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/knowledge-attitude-and-practices-of-residents-towards-venous-thromboembolism-prophylaxis-among-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-ecological-momentary-assessment-compliance-among-patients-with-cancer-pain 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-treatment-facility-type-on-survival-outcomes-in-elderly-patients-with-mantle-cell-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-plus-temozolomide-nivotem-vs-temozolomide-monotherapy-in-refractory-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-center-prospective-study-evaluating-an-ai-enabled-clinical-decision-support-tool-to-improve-bi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reducing-effort-through-informatics-driven-identification-recruitment-and-data-capture-on-a-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-shr-3821-an-adcc-enhanced-cldn1824-1bb-bispecific-antibody-in-patients-with-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-approach-for-prediction-of-immune-related-pneumonitis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-genomic-and-clinical-predictors-of-overall-survival-and-psa-response-results-from-the-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decline-in-credit-score-and-excess-mortality-risk-among-cancer-patients-evidence-from-washington-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-ai-based-pathology-classifier-to-predict-benefit-from-enzalutamide-in-metastatic-hormone-sensitiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-distribution-and-functional-heterogeneity-of-cd56bright-and-cd56dim-natural-killer-cells-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/car-t-in-the-older-adults-real-world-survival-and-toxicity-in-patients-75-years-with-relapsedref 2026-08-24 monthly 0.7 https://rjrindex.com/articles/new-imsimwg-risk-criteria-by-next-generation-sequencing-ngs-analysis-of-daratumumab-benefit-in-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-ipik3cai-amplifications-and-co-occ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemoradiotherapy-with-or-without-pd-1-blockade-in-pmmrmss-low-rectal-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/etentamig-in-patients-pts-with-relapsedrefractory-multiple-myeloma-rrmm-with-prior-exposure-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/one-vs-2-vs-3-itet2i-mutations-in-chronic-myelomonoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-neutrophil-incompetence-following-allogeneic-stem-cell-transplant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-shallow-whole-genome-sequencing-on-diagnostic-yield-and-prognostic-precision-in-myelodyspl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lipid-lowering-therapy-use-among-cancer-survivors-undergoing-lung-cancer-screening-a-cross-sectiona 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progress-of-phase-ii-study-of-mvr-t3011-an-il-12anti-pd-1-armed-oncolytic-hsv-1-in-high-risk-bcg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-transcriptome-based-risk-modeling-improve-survival-stratification-across-cytogenetic-groups-in-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-and-adjuvant-neoadj-adj-enfortumab-vedotin-ev-plus-pembrolizumab-pembro-in-partici 2026-08-24 monthly 0.7 https://rjrindex.com/articles/omitting-postoperative-radiotherapy-after-pathologic-complete-response-to-neoadjuvant-immunochemothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-shrinkage-and-depth-of-response-with-fruquintinib-in-patients-with-metastatic-colorectal-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-sosimerasib-monotherapy-in-pretreated-colorectal-cancer-with-kras-g12c-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-genomic-characterization-of-pediatric-acute-myeloid-leukemia-at-diagnosis-and-relapse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-phase-ii-trial-of-topical-betamethasone-ointment-for-preventing-severe-chem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodal-immunotherapy-for-high-risk-acute-myeloid-leukemia-and-myelodysplastic-syndrome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fine-scaled-genomic-ancestry-clusters-to-reveal-population-specific-cancer-enrichments-in-the-all-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-real-world-outcomes-of-axicabtagene-ciloleucel-axi-cel-in-relapsedrefractory-rr-larg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-digital-screening-to-increase-early-identification-of-hereditary-breast-and-ovarian-cancer-syn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-vancomycin-on-the-gut-microbiota-and-metabolic-profile-to-sensitize-microsatellite-stable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cdh6-high-gastric-cancers-as-exhibitors-of-a-reproducible-vascular-stromal-immune-excluded-tumor-mi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthcare-costs-following-osimertinib-versus-earlier-generation-tyrosine-kinase-inhibitor-initiatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-efficiency-in-precision-oncology-quantifying-time-to-treatment-initiation-for-biomarker 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-impact-of-human-papillomavirus-vaccination-on-cervical-cancer-incidence-and-prevalence-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-chemotherapy-decision-pathways-and-survival-in-early-hrher2-breast-cancer-oncotype-dx 2026-08-24 monthly 0.7 https://rjrindex.com/articles/onkobank-a-clinically-annotated-cancer-biobank-supporting-translational-and-precision-oncology-rese 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-survival-and-persistent-age-and-sex-disparities-in-uveal-melanoma-a-seer-population-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-r0-resection-after-chemotherapy-in-initially-unresectable-metastatic-colorectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/experimental-modeling-of-soft-tissue-sarcomas-with-invasion-into-bone-structures 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-barriers-to-prescribing-parp-inhibitors-including-olaparib-in-advanced-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-cemiplimab-fianlimab-following-sbrt-for-oligometastatic-clear-cell-rcc-lag-boos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sarc046-a-phase-ii-trial-of-nab-sirolimus-in-patients-with-progressing-or-symptomatic-epithelioid-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/causes-of-death-in-patients-with-lymphoplasmacytic-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rndo-564-001-a-first-in-human-phase-11b-study-of-rndo-564-a-costimulatory-bispecific-antibody-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-clonal-hematopoiesis-on-clinical-outcomes-in-patients-undergoing-car-t-cell-therapy-a-sys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gemini-breast-evaluating-minimal-residual-disease-mrd-through-longitudinal-circulating-tumor-dna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-comprehensive-molecular-profiling-in-cholangiocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/heart-failure-related-mortality-among-us-liver-and-intrahepatic-bile-duct-cancer-patients-a-25-ye 2026-08-24 monthly 0.7 https://rjrindex.com/articles/volrustomig-a-novel-bispecific-pd-1ctla-4-monoclonal-antibody-as-single-agent-first-line-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cctg-br38-consolidative-use-of-radiotherapy-to-block-curb2-oligoprogression-in-patients-with-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-association-of-post-testosterone-recovery-psa-kinetics-with-progression-and-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-dc-cik-plus-high-dose-interferon-a-versus-high-dose-interferon-a-alone-in-resected-stage-ii 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mutational-profile-of-colorectal-cancer-cells-in-patients-with-multiple-primary-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pact-chemo-improving-chemotherapy-flow-safety-and-value-through-physician-pharmacist-ehr-activati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/methylation-pipeline-to-accurately-detect-cpg-methylation-status 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pilot-study-of-allostatic-load-area-deprivation-and-race-in-endometrioid-endometrial-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-clinical-evaluation-of-st-01156-an-optimized-and-selective-degrader-of-rna-binding-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethan-a-phase-ii-study-comparing-different-endocrine-therapies-for-male-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-and-protective-factors-for-acral-mucosal-and-uveal-melanoma-in-a-multi-institutional-cohort-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-after-stereotactic-radiosurgery-for-brain-metastases-in-renal-cell-carcinoma-a-con 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-socioeconomic-and-geographic-disparities-in-survival-among-patients-with-ampullary-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/parp-inhibitor-and-immune-checkpoint-inhibitor-combination-therapy-in-pd-l1-negative-tumors-a-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-preoperative-breast-mri-on-locoregional-staging-and-management-in-early-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-statins-on-outcomes-in-renal-cell-carcinoma-patients-undergoing-immune-checkpoint-inhibito 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-tolerability-of-talimogene-laherparepvec-in-treatment-of-solid-tumors-a-systematic-rev 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-bladder-cancer-across-asia-insights-from-the-global-burden-of-disease-1999-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-integrated-population-pharmacokineticpharmacodynamic-poppkpd-model-to-select-the-linvoseltama 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-asynchronous-time-flexible-digital-multidisciplinary-care-with-overall-survival-in-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-clinical-outcomes-among-cholangiocarcinoma-patients-treated-with-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antibody-drug-conjugate-adc-after-adc-predicting-survival-in-patients-with-her2-low-metastatic-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rp2r-dose-selection-of-tal-tec-for-the-treatment-of-emd-patients-in-the-redirectt-1-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-characteristics-of-patients-with-minimal-residual-disease-in-stage-ii-iii-colon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spark-lung-a-study-of-patterns-and-outcomes-in-young-onset-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/natural-language-processing-chatbot-and-continuous-activity-monitoring-in-a-phase-ii-randomized-tria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-innovative-team-approach-to-improve-sclc-care-across-an-integrated-health-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-chemo-induced-tme-alterations-as-a-predictor-of-response-to-pd-1-blockade-in-avpc-single-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-circulating-tumor-cell-genomics-of-kras-independent-oncogenic-sub-populations-and-longit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/estimating-individual-benefit-from-adjuvant-chemotherapy-in-hormone-receptor-positive-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-corticosteroid-exposure-on-long-term-immune-checkpoint-inhibitor-responses-in-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/punch03-preliminary-results-from-a-phase-ii-study-of-disitamab-vedotin-combined-with-tislelizumab-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-overall-survival-safety-and-neurologic-function-outcomes-from-a-phase-1-trial-of-bivalent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lucicebtide-st101-plus-chemoradiation-in-newly-diagnosed-gbm-patients-efficacy-pharmacodynamics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-endovascular-embolization-in-cancer-associated-gastrointestinal-bleeding-a-nationwide-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-imaging-detected-extranodal-extension-iene-in-pathological-ene-negative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-bispecific-antibody-ivonescimab-based-regimens-in-egfr-tki-resista 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gt101-autologous-til-therapy-in-patients-with-recurrent-and-metastatic-cervical-cancer-a-phase-1-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neighborhood-social-vulnerability-and-clinical-trial-enrollment-in-colon-cancer-does-age-matter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hospital-designation-and-survival-disparities-in-young-onset-gastrointestinal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-tarlatamab-in-extensive-stage-small-cell-lung-cancer-a-single-cen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/balancing-effectiveness-and-toxicity-cabozantinib-versus-belzutifan-after-icivegf-therapy-in-older 2026-08-24 monthly 0.7 https://rjrindex.com/articles/maintenance-therapy-and-treatment-holiday-in-patients-with-unresectablelocally-advancedmetastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/folfirinox-vs-gempac-in-the-elderly-is-the-survival-benefit-worth-the-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-tiger-pac-phase-3-clinical-trial-examining-intra-arterial-gemcitabine-versus-intravenous-gemcita 2026-08-24 monthly 0.7 https://rjrindex.com/articles/synergistic-efficiency-of-methylene-blue-and-carbon-nanoparticles-for-sentinel-lymph-node-biopsy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-an-endometrial-cancer-test-from-a-vaginal-swab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-deruxtecan-in-patients-with-her2-low-recurrentmetastatic-salivary-gland-carcinoma-resu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shr-1826-a-c-met-directed-antibody-drug-conjugate-adc-in-advanced-solid-tumors-updates-from-a-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dose-escalation-results-from-a-phase-i-study-of-fz-ad004-a-trop2-directed-adc-in-patients-with-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-human-b7h3il13ra2-bispecific-armored-car-t-for-treatment-of-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emotional-health-concerns-due-to-kidney-cancer-kc-and-unmet-needs-in-patient-support-results-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stage-i-results-of-a-phase-ii-study-evaluating-thymosin-a1-combined-with-toripalimab-in-elderly-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neighborhood-disadvantage-and-correlation-with-differences-in-somatic-mutations-in-a-real-world-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-profiling-of-egfr-pacc-mutations-and-their-co-mutation-landscape-in-chinese-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-ten-year-survival-with-cell-free-dna-methylation-of-melanoma-patients-with-asymptomat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-utilization-patterns-and-adverse-events-among-patients-receiving-antibody-drug-conjugates 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overcoming-her2-directed-antibody-drug-conjugate-resistance-with-disitamab-vedotin-in-metastatic-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-of-lb1410-a-bivalent-tim-3pd-1-bispecific-antibody-in-combination-with-lb4330-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-effects-of-tgf-v-inhibition-on-immune-resistance-by-targeting-immunosuppressive-microenvir 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rural-urban-disparities-in-musculoskeletal-functional-limitation-among-cancer-patients-in-the-united 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-therapy-associated-differences-in-intracranial-disease-in-metastatic-prostate-cancer-a-rea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/taxane-based-chemotherapy-with-or-without-platinum-agents-in-metastatic-castration-resistant-prostat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inspiring-the-next-generation-of-medical-oncologists-passion-purpose-and-preventing-burnout 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-surgical-timing-on-outcomes-in-patients-with-borderline-resectable-and-locally-advanced-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reduction-in-circulating-tumor-dna-ctdna-in-relation-to-radiographic-response-and-tumor-pd-l1-expr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/construction-and-validation-of-a-prognostic-risk-model-for-lung-adenocarcinoma-based-on-pyroptosis-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/uncertainty-aware-ai-triage-for-luad-histologic-subtyping-flagging-cases-for-expert-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/are-younger-patients-considered-geographic-access-and-age-focused-design-in-advanced-pdac-trials-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-omic-profiling-to-clarify-mechanisms-of-therapy-induced-prostate-cancer-lineage-plasticity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-antibiotic-exposure-and-outcomes-of-immune-checkpoint-inhibitors-in-non-small-cell-lung-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-lifileucel-in-advanced-melanoma-a-single-institution-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-risk-factors-for-pneumonitis-in-patients-with-urothelial-carcinoma-treated-with-enfort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/etctn-10302-a-randomized-phase-ii-trial-of-radium-223-dichloride-in-combination-with-paclitaxel-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-class-dio3-inhibitor-as-a-novel-treatment-strategy-in-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examining-the-tumor-microbiology-and-microenvironment-of-patients-with-triple-negative-inflammatory 2026-08-24 monthly 0.7 https://rjrindex.com/articles/persistence-of-aggressive-biology-outcomes-of-sup177sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epigenetic-state-control-and-immune-visibility-as-prognostic-modules-in-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-accessibility-of-recruiting-clinical-trials-for-rare-and-common-gastrointestinal-malignan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-diversity-and-composition-of-sulfidogenic-gut-bacteria-in-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/closing-the-information-gap-in-oncology-a-retrieval-augmented-generation-multi-modal-ai-platform-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/latent-transitions-of-distress-risk-during-cancer-treatment-and-their-concordance-with-anxiety-depr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-severity-and-management-of-severe-adverse-events-in-first-line-1l-treatments-for-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-representation-in-clinical-trials-supporting-nccn-breast-cancer-guidelines-a-retrospective-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alkove-1-efficacy-and-safety-of-neladalkib-in-patients-with-advanced-ialki 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-aav6-neurod1-trans-differentiation-therapy-in-recurrent-malignant-glioma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-use-of-circulating-tumor-dna-to-stratify-the-risk-of-recurrence-after-surgical-debulking-in-epit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-two-year-overall-survival-and-toxicity-outcomes-of-bcma-car-t-therapy-compared-with-teclista 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-lenvatinib-plus-pembrolizumab-in-patients-pts-with-endometrial-or-ovarian-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-prophylactic-effects-for-chemotherapy-induced-neutropenia-between-same-day-versus-next 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-feasibility-of-outpatient-administration-of-targeted-alpha-therapies-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunonutrition-intervention-in-driver-gene-negative-non-small-cell-lung-cancer-patients-with-sarcop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-results-of-the-phase-2-study-of-silevertinib-bdtx-1535-in-previously-treated-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-plus-ipilimumab-combined-with-chemotherapy-as-first-line-treatment-for-her2-negative-unres 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-barriers-to-the-clinical-breast-exam-in-telangana-india-a-survey-study-of-participan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-pathologic-complete-response-following-neoadjuvant-tchp-in-her2-positive-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-results-of-neoadjuvant-therapy-with-pyrotinib-subcutaneous-trastuzumab-and-capecitabine-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/herthena-breast04-a-phase-3-randomized-open-label-study-evaluating-the-efficacy-and-safety-of-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinico-transcriptomic-risk-stratification-to-guide-abiraterone-treatment-intensification-in-high-ri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-status-and-tarlatamab-outcomes-in-a-large-multi-institution-real-world-database-of-2l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pre-progression-discontinuation-and-off-treatment-progression-free-interval-after-enfortumab-vedotin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-incidence-of-hypothyroidism-and-thyroiditis-after-car-t-cell-therapy-versus-standard-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ugt1a1-status-and-clinical-outcomes-in-pancreatic-cancer-patients-receiving-liposomal-irinotecan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-perioperative-use-of-tislelizumab-in-treating-clinically-node-positive-urothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-clonal-plasma-cell-s-phase-after-autologous-stem-cell-transplantation-and-surviv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alfa-score-as-a-predictor-of-long-term-benefit-with-frontline-brigatinib-in-ia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-accelerated-partial-breast-irradiation-simultaneous-integrated-boost-technique-rush-experienc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-pfs-in-third-line-immune-checkpoint-inhibitor-resistant-advanced-nsclc-treated-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/paired-nectin4-expression-analysis-pre-and-post-enfortumab-vedotin-and-pembrolizumab-in-urothelial-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-biomarker-analysis-of-ociperlimab-oci-plus-tislelizumab-tis-in-patients-pts-with-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/benefits-of-utilizing-experiential-learning-in-a-medical-school-cancer-survivorship-course 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-neoadjuvant-toripalimab-combined-with-temozolomide-in-resectable-stage-ii 2026-08-24 monthly 0.7 https://rjrindex.com/articles/career-destination-effects-of-receipt-of-the-american-society-of-clinical-oncology-young-investigato 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-baseline-gut-microbiome-features-between-response-subgroups-of-patients-pts-with-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-rpl37-on-the-proliferation-migration-and-invasion-of-non-small-cell-lung-cancer-cells 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-mrd-positivity-at-ultra-sensitive-ctdna-levels-using-a-wgs-based-personalized-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-ibi3017-an-innovative-bispecific-anti-trop2-and-b7h3-antibody-drug-conjugate-on-anti-tum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/urinary-rna-as-response-predictor-for-patients-with-metastatic-urothelial-carcinoma-treated-with-pem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hybrid-ai-framework-for-automated-prostate-cancer-disease-state-ascertainment-from-real-world-electr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-lymphovascular-invasion-in-breast-carcinoma-using-mri-based-radiomics-a-systematic-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-and-prognostic-performance-of-urinary-metabolomic-biomarkers-in-lung-cancer-a-systematic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-imaging-cytology-profiling-system-for-rapid-point-of-care-molecular-diagnosis-of-leptomen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/malignant-leydig-cell-tumor-a-population-level-demographic-study-using-the-national-cancer-database 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-aryl-hydrocarbon-receptor-ahr-modulation-on-survival-in-pre-clinical-head-and-neck-model 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-i-study-of-hsk41959-an-mta-cooperative-prmt5-inhibitor-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-global-phase-12a-trial-of-shr-a1904-a-cldn182-targeting-adc-in-advanced-solid-tumors-expressin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-first-line-comprehensive-genomic-profiling-on-survival-outcomes-for-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/towards-hyper-sensitive-mrd-assessment-of-enspyre-as-a-cost-effective-ctdna-detection-technique-usi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-neutrophil-to-lymphocyte-ratio-on-pathological-response-in-her2-positive-breast-cancer-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/statin-exposure-and-clinical-outcomes-in-metastatic-prostate-cancer-a-propensity-matched-trinetx-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pre-existing-autoimmune-disease-on-outcomes-of-immune-checkpoint-inhibitors-in-non-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-data-of-ibi3028-the-first-clinical-stage-bispecific-dual-payload-adc-targeting-egfrc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcome-of-apalutamide-therapy-in-mhspc-patients-depending-on-age-dose-reduction-and-ps 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-evaluation-of-ct03-a-cardiosafe-first-in-class-bifunctional-mcl1-degrader-for-the-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rituximab-pre-conditioning-in-a-phase-i-study-of-carv3-team-e-for-recurrent-glioblastoma-gbm-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cumulative-incidence-and-risk-factors-of-trastuzumab-deruxtecan-related-interstitial-lung-disease-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-and-frequency-of-iegfri-mutations-among 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-multi-omics-to-routine-precision-oncology-biologically-informed-knowledge-transfer-for-pre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-cns-lymphoma-patients-treated-with-glucarpidase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-significance-of-iegfri-amplification-in-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-assessment-of-treatment-adherence-among-vorasidenib-treated-patients-with-idh-mutant-glio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-safety-and-efficacy-of-a2b694-a-logic-gated-mesothelin-msln-targeted-tmod-chimeric-antige 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-spatial-analysis-of-the-tumor-immune-microenvironment-in-nsclc-primary-tumors-and-brain 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concomitant-radiotherapy-tremelimumab-and-durvalumab-for-advanced-nsclc-patients-progressing-on-fi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-survival-with-clinical-characteristics-and-cd68cd206-expression-in-stage-iiia-squamo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-and-evolutionary-dynamics-of-irasi-al 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-immune-checkpoint-inhibitors-with-increased-pancreatitis-risk-in-gastrointestinal-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-of-localized-pulmonary-pleomorphic-adenocarcinoma-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-propensity-score-matched-analysis-comparing-first-line-regional-systemic-and-intralesional-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-body-composition-on-cardiac-function-in-women-with-early-breast-cancer-taking-cardioto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-among-medicare-beneficiaries-treated-with-first-line-1l-bruton-tyrosine-kinase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncoseek-20-an-updated-blood-based-assay-for-multi-cancer-early-detection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-site-central-baseline-imaging-discordance-in-oncology-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vididencel-an-active-immunotherapy-in-high-grade-serous-ovarian-carcinoma-patients-analysis-of-tum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/platinum-rechallenge-versus-non-platinum-regimens-as-second-line-treatment-for-advanced-thymoma-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outpatient-administration-of-cycle-1-of-bispecific-antibody-therapy-in-hematologic-malignancies-a-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-chemotherapy-plus-disitamab-vedotin-rc48-and-toripalimab-in-her2-overexpressed-local 2026-08-24 monthly 0.7 https://rjrindex.com/articles/echo-cancer-advisor-a-modular-ai-framework-for-interpretable-patient-specific-oncology-decision-su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-tislelizumab-plus-chemoradiotherapy-for-patients-with-advanced-biliary-tract-cancer-a-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/actionable-germline-findings-in-endometrial-cancer-from-a-large-multigene-panel-tested-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-sph4336-plus-endocrine-therapy-in-hr-positiveher2-negative-metastatic-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evolution-of-immune-checkpoint-inhibitor-trials-in-oncology-from-2011-to-2025-a-cross-sectional-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-ai-based-quantitative-b7-h3-evaluation-in-the-tumor-microenvironment-with-molecular-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinico-genomic-landscape-and-prognostic-impact-of-apcctnnb1-oncogenic-alterations-in-non-small-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-baseline-severe-cytopenia-on-post-bcma-car-t-cell-therapy-outcomes-in-multiple-myeloma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-impact-and-prognostic-utility-of-circulating-tumor-dna-in-stage-i-iv-non-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-patterns-of-lung-cancer-among-psychoactive-substance-using-older-adults-in-the-united-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-disseminated-intravascular-coagulation-on-in-hospital-outcomes-in-patients-with-multiple-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-results-with-ima401-a-magea48-targeted-t-cell-receptor-based-bispecific-t-cell-enga 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-and-patient-demographics-in-endocervical-adenocarcinoma-insights-from-the-aacr-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequencing-strategy-of-immunotherapy-with-chemoradiotherapy-in-stage-iii-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/consolidated-pd-l1-inhibitors-after-chemoradiotherapy-versus-placebo-in-non-resectable-non-small-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/update-of-the-eortc-qlq-ovarian-cancer-module-eortc-qlq-ov28-phase-i-and-ii 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phasex-as-a-phase-09-translational-platform-to-de-risk-bite-immunotherapy-through-mechanistic-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-outcomes-of-sleeve-versus-standard-lobectomy-in-patients-with-non-small-cell-lung-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-sacituzumab-govitecan-in-patients-with-muscle-invasive-bladder-cancer-final-results-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/organ-specific-metastatic-progression-in-non-small-cell-lung-cancer-treated-with-pembrolizumab-versu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-and-treatment-related-determinants-of-long-term-cancer-survival-a-population-based-se 2026-08-24 monthly 0.7 https://rjrindex.com/articles/contribution-of-atezolizumab-atezo-to-the-efficacy-of-the-zanzalintinib-zanza-atezo-combinatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-early-on-treatment-coordinated-inflammatory-niche-plasma-signature-as-a-predictor-of-response-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-breast-density-reporting-on-supplemental-mri-and-ultrasound-use 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-prophylaxis-cmv-in-the-letermovir-era-incidence-risk-factors-and-outcomes-following-hct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-lisocabtagene-maraleucel-liso-cel-in-patients-pt-with-relapsed-or-refract 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-and-timing-of-palliative-care-consultation-in-patients-with-newly-diagnosed-metastatic-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-oral-and-genital-hpv-45-and-non-vaccine-targeted-hpv-35-among-us-adults 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cfdna-wgs-vs-plasma-proteomics-for-minimally-invasive-mrd-assessment-in-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-the-genomic-landscape-of-langerhans-cell-histiocytosis-using-the-aacr-project-genie-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/allele-specific-targeting-of-cd33-as-a-novel-approach-to-enhance-car-t-selectivity-in-relapsed-acute 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interrogation-of-fibrolamellar-cancer-to-provide-clinically-relevant-insights-into-therapeutic-vulne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/follow-up-of-outpatients-taking-oral-anticancer-drugs-in-the-multidisciplinary-community-hospital-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/remote-activity-monitoring-to-detect-physical-function-decline-and-unexpected-medical-events-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enterprise-wide-implementation-of-multicancer-detection-testing-across-a-large-academic-health-syste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prenatal-hormonal-imprinting-reflected-by-anogenital-distance-and-risk-of-breast-cancer-a-case-cont 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-operative-management-in-mismatch-repair-deficient-dmmr-esophagogastric-cancer-egc-following 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-of-early-onset-colorectal-cancer-in-the-who-eastern-mediterranean-region-regional-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-of-constructing-an-external-control-arm-for-early-efficacy-assessment-in-phase-1a-metho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficient-machine-learning-for-pulmonary-nodule-classification-on-computed-tomography-a-lightweight 2026-08-24 monthly 0.7 https://rjrindex.com/articles/e-pros-in-oncology-improving-treatment-adherence-to-treatment-while-reducing-emergency-care-and-cos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-gut-microbiota-and-peri-initiation-proton-pump-inhibitorantibiotic-exposure-with-out 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-features-treatment-patterns-and-outcomes-in-young-women-with-metastatic-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-risk-stratification-schema-for-patients-with-non-small-cell-lung-cancer-with-multiple-organ-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/communication-of-tumor-testing-and-molecular-results-to-patients-and-caregivers-in-glioblastoma-a-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transfusion-effectiveness-and-clinical-outcomes-in-acute-leukemia-do-poor-responders-have-worse-out 2026-08-24 monthly 0.7 https://rjrindex.com/articles/siltuximab-for-the-prevention-of-severe-immune-related-adverse-events-during-immune-checkpoint-inhib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fern-ec-01-bnt323-01-a-phase-3-trial-of-trastuzumab-pamirtecan-her2-adc-versus-investigators-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/donafenib-plus-transarterial-chemoembolization-tace-with-or-without-anti-pd-1-antibodies-for-unres 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-growth-and-accessibility-enrollment-weighted-access-to-us-lung-cancer-clinical-trials-2015 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bone-marrow-immune-cell-state-analysis-and-selective-apc-alterations-in-prolonged-cytopenia-followin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-metronomic-cyclophosphamide-with-pembrolizumab-in-checkpoint-inhibitor-refractory-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iiia-dose-escalation-dose-optimization-and-dose-expansion-study-to-evaluate-the-safety-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiology-nlp-derived-real-world-progression-endpointing-and-clinicogenomic-correlates-after-177lu-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artemide-biliary02-a-phase-3-randomized-global-study-of-rilvegostomig-or-durvalumab-with-chemothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/xalience-a-phase-3-open-label-multicenter-randomized-study-of-xaluritamig-plus-abiraterone-vs-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/indurans-a-randomized-phase-ii-trial-on-induction-immunochemotherapy-followed-by-surgery-or-chemora 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-clinical-study-of-doc1021-dubodencel-dendritic-cell-immunotherapy-for-refractory-mela 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proteogenomic-profiling-of-gallbladder-cancer-for-identification-of-distinct-biology-and-subtype-spe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adoption-and-inpatient-outcomes-of-chimeric-antigen-receptor-t-cell-therapy-in-lymphomas-and-leukemi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iia-open-label-multi-center-study-of-the-dna-polymerase-theta-inhibitor-art6043-administered 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-outcomes-of-first-generation-versus-second-and-third-generation-tyrosine-kin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-usability-of-a-clinical-trial-knowledge-platform-in-a-community-cancer-network 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combining-zanidatamab-folfox-and-pembrolizumab-as-first-line-therapy-for-her2pd-l1-positive-gastr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alpha-emitting-radionuclide-or-beta-emitting-radionuclide-combined-with-metastasis-directed-stereota 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-with-brexucabtagene-autoleucel-in-refractory-mantle-cell-lymphoma-a-systematic-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/heterogeneity-of-interim-pet-partial-metabolic-response-in-dlbcl-risk-stratification-using-dsuvmax 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-maintenance-therapy-patterns-in-ibrcai-wild 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-neoadjuvant-pembrolizumab-in-early-stage-triple-negative-breast-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-immune-therapy-based-regimens-in-sarcomatoid-lung-cancer-a-systematic-review-and-meta-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-solid-basaloid-and-classic-adenoid-cystic-carcinoma-of-the-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevention-of-paclitaxel-induced-peripheral-neuropathy-using-limb-cryotherapy-evidence-from-a-resou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-geographic-disparities-in-hodgkin-lymphoma-mortality-among-adolescents-and-young-adults-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-treatment-patterns-and-outcomes-of-patients-with-small-bowel-cancer-a-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/brain-metastases-in-her2-positive-metastatic-gastrointestinal-cancers-incidence-timing-and-impli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-a-large-language-model-generated-after-visit-summary-from-outpatient-hematologyoncolo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/three-decades-of-breast-cancer-predisposition-genetic-testing-at-a-comprehensive-cancer-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-ongoing-phase-1-2a-study-of-eo1001-an-oral-brain-penetrant-pan-erbb-inhibitor-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/envafolimab-kn035-plus-gemcitabine-and-oxaliplatin-gemox-compared-with-gemox-as-first-line-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-characteristics-treatment-patterns-and-outcomes-of-newly-diagnosed-diffuse-large-b-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-advanced-radiofrequency-ablation-electrode-systems-for-hepatocellular-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-and-disparities-in-gallbladder-cancer-mortality-a-us-population-based-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-g8-screening-and-carg-toxicity-scores-to-predict-emergency-room-er-hospital-ip-admission 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-predictors-of-survival-and-disease-progression-in-melanoma-a-real-world-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neighborhood-deprivation-and-nativity-in-breast-cancer-stage-at-diagnosis-among-us-and-latin-amer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncology-social-work-outreach-as-a-predictor-of-oncology-appointment-completion-among-cancer-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-premmplus-in-a-racially-and-ethnically-heterogenous-population-undergoing-germline-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-neighborhood-effects-and-geographic-embeddings-in-random-forest-modeling-of-mammography-scre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-factors-and-delays-in-care-for-gestational-trophoblastic-neoplasia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hospital-volume-travel-burden-and-survival-disparities-in-stage-iv-melanoma-a-us-national-cohor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gastric-cancer-outcomes-in-adolescents-and-young-adults-in-alberta-canada 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-survivor-perspectives-on-nutrition-results-of-a-comprehensive-survey 2026-08-24 monthly 0.7 https://rjrindex.com/articles/myoepithelial-carcinoma-defining-natural-history-and-therapeutic-outcomes-in-a-rare-malignancy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/malignant-hemangiopericytoma-a-national-cancer-database-study-of-demographic-and-socioeconomic-fact 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-analysis-of-cd8-t-cell-neighbors-using-multiplexed-immunofluorescence-mxif-in-esophageal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-extracolonic-cancers-in-individuals-with-lynch-syndrome-a-canadian-population-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-data-platform-backbone-of-cancer-research-office 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ocular-cancer-and-inpatient-thrombotic-phenotypes-associations-with-retinal-vascular-occlusions-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognosis-of-mediastinal-lymph-node-metastases-in-pediatric-patients-with-osteosarcoma-and-lung-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/myoepithelial-carcinoma-a-national-cancer-database-study-of-demographic-and-socioeconomic-factors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-survival-for-rural-and-urban-populations-during-the-opioid-epidemic-a-seer-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-rna-sequencing-on-diagnosis-and-therapy-early-results-from-a-tertiary-cancer-center-in-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dietary-changes-in-head-and-neck-cancer-patients-pre-and-post-chemotherapy-andor-radiation-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-perioperative-radiotherapy-on-prognosis-in-patients-with-operable-rectal-cancer-who-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bcg-at-home-a-first-in-kind-pilot-trial-of-home-based-intravesical-bacillus-calmette-guerin-deliver 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-clinical-outcomes-in-patients-with-triple-negative-breast-cancer-tnbc-and-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/knowledge-and-uptake-of-hpv-vaccination-among-hispanic-women-and-vaccine-eligible-children 2026-08-24 monthly 0.7 https://rjrindex.com/articles/failure-to-rescue-after-acute-cardiac-events-in-cancer-versus-non-cancer-hospitalizations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bone-health-and-antiresorptive-agent-use-in-asian-american-pacific-islander-aapi-women-with-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/remote-scalable-weight-loss-interventions-after-early-stage-breast-cancer-a-systematic-review-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/arterial-and-venous-thromboembolic-events-in-ialki-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-delivery-of-personalized-cancer-risk-reduction-real-world-engagement-with-acs-cancerrisk360 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-socioeconomic-vulnerability-and-treatment-delivery-in-patients-receiving-oral-antic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-hmgb1-expression-as-a-biomarker-of-immunogenic-cell-death-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-chemotherapy-in-patients-with-grade-2-or-3-appendiceal-cancer-undergoing-cytoreductive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-bidirectional-cohort-study-of-chemotherapy-targeted-alternating-therapy-on-outcomes-of-third-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/melanoma-stage-as-influenced-by-31-gep-risk-prediction 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-ncdb-analysis-on-the-demographic-treatment-and-survival-of-seromucinous-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-related-adverse-events-with-immune-checkpoint-inhibitors-insights-from-real-world-practice-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-vlponc-01-a-novel-il-12-encoding-sarna-viral-replicon-particle-alone-and-in-combi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combination-of-tulmimetostat-and-pd-1-blockade-for-patients-with-advanced-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/petosemtamab-plus-pembrolizumab-as-first-line-1l-treatment-of-pd-l1-high-metastatic-non-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrin-a-subvsub-v-sub3sub 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glp-1-therapy-and-hormone-receptor-positive-breast-cancer-risk-and-survival-a-real-world-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-interpreting-circulating-tumor-dna-guided-risk-stratification-after-first-line-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-treatment-effect-and-first-recurrence-behavior-after-curative-liver-surgery-for-hcc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ep4-antagonist-ono-4578-plus-nivolumab-and-chemotherapy-in-her2-negative-unresectable-advanced-or-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-the-chemotherapy-free-regimen-of-blinatumomab-and-ponatinib-in-patients-with-newl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-associations-between-incretin-based-therapies-and-plasma-cell-disorders-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-from-inmmycar-the-ongoing-first-in-human-phase-1-study-of-kln-1010-in-patients-pts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-recurrence-risk-in-stage-iibc-melanoma-across-time-implications-for-stratification-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-results-of-tazemetostat-in-japanese-patients-with-advanced-epithelioid-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-bat8006-in-combination-with-bat1308-in-patients-with-advanced-endometrial-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-trial-of-androgen-deprivation-therapy-interruption-in-patients-responding-exceptionally-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-a-weight-loss-intervention-wli-on-quality-of-life-qol-and-symptoms-in-women-with-breas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-treatment-of-qls31905-plus-chemotherapy-in-patients-with-pancreatic-cancer-and-gastric-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-classifier-driven-nccn-risk-reclassification-to-track-distinct-transcriptomic-signatures-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ringside-a-phase-3-randomized-placebo-controlled-trial-of-varegacestat-for-treatment-of-progressin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/swivel-a-randomized-phase-ii-trial-of-switching-medications-versus-guideline-directed-interventions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epigenetic-profiling-to-identify-aggressiveness-markers-in-non-hodgkin-lymphoma-via-a-targeted-methy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/benefit-of-adjuvant-therapy-in-high-risk-gist-a-large-scale-real-world-analysis-of-2166-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modern-hodgkin-lymphoma-treatments-to-reduce-second-cancer-risks-influence-of-risk-adapted-screenin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-accuracy-of-circulating-tumor-dna-for-post-remission-surveillance-in-diffuse-large-b-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-comparing-sequencing-of-car-t-followed-by-bite-versus-bite-followed-by-car-t-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/variants-of-uncertain-significance-and-contralateral-risk-reducing-mastectomy-in-early-stage-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-responders-to-trifluridinetipiracil-plus-bevacizumab-in-previously-treated-metastatic-col 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-and-long-term-prognostic-impact-of-trastuzumab-deruxtecan-related-interstitial-lung-dis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/belzutifan-in-docetaxel-pretreated-metastatic-castration-resistant-prostate-cancer-mcrpc-phase-1b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-and-disparities-in-prostate-cancer-with-co-occurring-cardiometabolic-disorders-amon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pulmonary-immune-related-adverse-events-post-immune-checkpoint-inhibitors-ici-real-world-experien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-cavitation-enhanced-drug-delivery-ceedd-by-sonosensitive-particles-and-foc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamic-biological-and-metabolic-response-by-ebv-dna-and-sup18sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-combination-study-of-galunisertib-and-capecitabine-in-patients-with-chemotherapy-resistan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/allostatic-load-as-a-mediator-of-exposomic-risk-pathways-to-early-onset-cancer-a-cross-cohort-valid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-localized-rectal-cancer-outcomes-with-ctdna-analysis-using-a-novel-ultrasensitive-stru 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-and-variability-in-lymphedema-therapy-for-head-and-neck-cancer-survivors-secondary-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-and-adjuvant-enfortumab-vedotin-plus-pembrolizumab-for-participants-with-muscle-invasive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ib-open-label-clinical-trial-of-jab21822-combined-with-second-line-chemotherapy-for-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reduced-oxaliplatin-exposure-in-gastrointestinal-cancers-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ischemic-heart-disease-as-a-competing-cause-of-death-among-patients-with-lung-cancer-in-the-united-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-clinical-and-molecular-characterization-of-wnt-pathway-alterations-in-metastatic-castrati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-pemetrexed-and-pembrolizumab-in-patients-pts-with-recurrent-andor-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunogenicity-profiles-in-pediatric-extra-cranial-rhabdoid-tumors-a-framework-for-future-risk-stra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/durvalumab-plus-chemotherapy-prior-to-chemoradiotherapy-and-followed-by-durvalumab-as-consolidation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-determinants-of-survival-after-biliary-tract-cancer-resection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-i-open-label-multicenter-study-of-hj-004-a-novel-egfr-protac-degrader-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-internal-medicine-residents-confidence-in-oncology-goals-of-care-conversations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sigvie-003-phase-3-trial-of-frontline-sigvotatug-vedotin-plus-pembrolizumab-vs-pembrolizumab-alone 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adaptive-phase-23-study-of-eik1001-a-tlr78-dual-agonist-in-combination-with-pembrolizumab-as-fi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-open-label-trial-of-neoadjuvant-immunotherapy-in-combination-with-capox-for-resectable-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/developing-an-integrated-survivorship-checklist-for-lmic-feasibility-and-results-from-a-tertiary-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-incidence-and-mortality-in-biliary-tract-cancers-in-the-united-states-2000-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-multi-center-clinical-trial-evaluating-the-safety-pharmacokinetics-pharmacodynamics-and-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/symbiotic-gi-03-a-randomized-double-blind-phase-3-study-of-first-line-pf-08634404-a-pd-1vegf-bi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-23-trial-of-pumitamig-pd-l1-vegf-a-bsab-plus-chemotherapy-versus-bevacizumab-plus-chemoth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rethinking-infection-prevention-after-modern-cll-and-nhl-therapy-a-real-world-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-donafenib-combined-with-hepatic-artery-infusion-chemotherapy-and-sintilimab-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kite-753-a-phase-2-study-of-an-autologous-anti-cd19cd20-car-t-cell-therapy-in-car-naive-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-ql1706-based-combination-therapy-in-recurrent-or-metastatic-endometrial-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sensory-neuropathy-and-neuropathic-pain-during-taxane-chemotherapy-in-cipn-free-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-cemiplimab-plus-cetuximab-prior-to-salvage-surgery-for-recurrent-oral-cavity-squamous-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-ubamatamab-regn4018-a-muc16cd3-bispecific-antibody-administered-alone-or-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-multicenter-randomized-non-inferiority-trial-comparing-selective-versus-modified-neck-di 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stereotactic-body-radiotherapy-sbrt-combined-with-pd-1-inhibitor-and-chemotherapy-in-early-stage-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beamion-lung-3-zongertinib-in-resectable-iher2i-mutan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/projected-burden-of-lung-cancer-and-pneumonia-among-older-adults-in-the-united-states-a-cdc-wonder 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-ctdna-based-mrd-combined-with-pet-ct-and-gastroscopy-for-treatment-efficacy-in-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/moving-the-surgical-prostate-cancer-treatment-to-value-early-results-in-patient-reported-outcomes-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-gpd1l-in-colorectal-cancer-progression-a-systematic-review-of-its-expression-molecular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-delays-in-treatment-initiation-and-interruptions-in-head-and-neck-squamous-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/foundation-models-to-bridge-the-data-scarcity-and-explainability-gap-in-pancreatic-cancer-diagnosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nationwide-oncologist-survey-on-biomarker-integration-and-evidence-based-gastricgej-cancer-care-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-predictors-of-palliative-care-utilization-across-a-mid-atlantic-healthcare-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-heart-failure-related-mortality-among-us-adults-with-leukemia-1999-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-procedural-position-of-multi-cancer-early-detection-mced-in-cancer-screening-paradigm-a-simul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-latency-interval-on-survival-in-second-primary-malignancies-after-head-and-neck 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-sacubitrilvalsartan-in-the-prevention-of-cancer-therapy-related-cardiac-dysfunction-ctr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemoimmunotherapy-before-chemoradiation-vs-chemoradiation-alone-for-stage-iib-iiic1-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regenovar-a-phase-iii-study-of-ubamatamab-plus-carboplatin-paclitaxel-and-bevacizumab-as-salvage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-amivantamab-hyaluronidase-in-imeti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-experience-with-later-line-chemotherapy-in-four-tumor-types 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-care-and-long-term-survival-in-metastasizing-ameloblastoma-an-ncdb-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cholangiocarcinoma-care-across-america-a-tale-of-two-coasts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-variation-in-thromboprophylaxis-models-of-care-and-implementation-supports-for-hospitalized-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/open-laparoscopic-versus-robotic-surgery-for-siewert-type-iiiii-adenocarcinoma-of-esophagogastric 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modified-soluble-interleukin-2-receptor-to-ferritin-ratio-for-diagnosis-of-lymphoma-associated-hemop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-and-disparities-in-gallbladder-cancer-mortality-in-the-united-states-1999-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-2-trial-of-ruxolitinib-in-combination-with-radiation-and-temozolomide-compared-to-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-cost-per-month-of-response-for-olutasidenib-olu-versus-ivosidenib-ivo-for-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fruquintinib-in-combination-with-camrelizumab-paclitaxel-liposome-and-nedaplatin-as-first-line-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-tyrosine-kinase-inhibitors-as-a-post-hematopoietic-stem-cell-transplant-maintenance-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-regimen-of-liposomal-irinotecan-plus-capecitabine-as-total-neoadjuvant-therapy-for-locally-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/penpulimab-ak105-combined-with-cetuximab-as-first-line-treatment-in-recurrentmetastatic-head-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tucatinib-subcutaneous-sc-trastuzumab-tuc-trast-sc-in-patients-pts-with-solid-tumors-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stage-dependent-metabolic-reprogramming-in-treatment-naive-lung-adenocarcinoma-from-oxidative-flexi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-epigenomic-profiling-of-plasma-for-non-invasive-detection-of-met-activation-to-uncover 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-academic-center-based-care-on-clinical-outcomes-in-light-chain-amyloidosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-1000-patients-report-of-global-practice-patterns-and-clinical-outcomes-in-the-collaborative-oc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/admission-acuity-and-inpatient-outcomes-among-hospitalizations-for-pancreatic-cancer-in-the-united-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-pathological-outcomes-of-patients-with-germ-cell-tumor-undergoing-surgical-resection-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-clinical-scale-multiscale-spatial-transcriptomics-tumor-architecture-profiling-in-scru 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-dual-immune-checkpoint-inhibitors-ici-by-the-time-of-infusion-in-advanced-non-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-surgical-resection-combined-with-intraoperative-cesium-131-brachytherapy-in-brain-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-inpatient-radiation-for-central-nervous-system-cns-tumors-timing-predictors-and-in-hospit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-proteogenomic-profiling-to-reveal-prognostic-subtypes-and-actionable-targets-in-adenoid-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/institutional-disparities-in-actionable-mutation-detection-in-pancreatic-ductal-adenocarcinoma-an-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-new-keratinocyte-cancers-during-pembrolizumab-in-resectable-cutaneous-squamous-cell-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1b-study-of-a-brain-penetrant-mek-inhibitor-pf-07799544-plus-next-generation-braf-dimer-inhi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-pd-1-versus-pd-l1-inhibitors-combined-with-chemotherapy-as-first-line-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-plus-ipilimumab-with-chemotherapy-as-first-line-therapy-for-nsclc-a-single-center-real-wo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-performance-of-novel-exosomal-liquid-rna-biopsy-assay-in-breast-cancer-segment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-experience-with-t-cell-receptor-cellular-therapy-in-advanced-solid-malignancies-a-multi-cente 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-duration-of-bone-targeting-agent-on-adverse-events-aes-and-skeletal-related-events-sre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rad-sg-adaptive-radiation-therapy-with-concurrent-sacituzumab-govitecan-for-bladder-preservation-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-sepsis-related-mortality-among-patients-with-lung-cancer-a-25-year-nation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-the-navya-earthshot-enabled-clinical-decision-support-system-on-treatment-turnaround-time 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-and-frailty-analyses-of-transplant-ineligible-tie-patients-pts-with-newly-diagnosed-multiple 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-social-vulnerability-on-end-of-life-care-in-hematologic-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/who-even-talks-to-her-anymore-misalignment-between-cervical-cancer-care-landscape-and-community-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effects-of-the-covid-19-pandemic-on-cancer-incidence-and-cancer-specific-mortality 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-nab2-stat6-distal-fusion-with-risk-level-of-metastatic-disease-and-thoracic-primary-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/operational-and-clinical-drivers-of-subcutaneous-pd-1pd-l1-inhibitor-adoption-a-mixed-methods-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-random-patterns-of-multiple-primary-malignancies-in-the-era-of-cancer-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enabling-blood-based-mass-spectrometry-mrd-detection-in-multiple-myeloma-without-archived-serum-samp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-follow-up-after-identification-of-variants-of-uncertain-significance-in-highly-penetran 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-onset-gastrointestinal-cancers-racial-disparities-in-stage-and-survival-from-large-scale-comm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-efficacy-and-immunogenicity-of-adjuvant-therapy-with-personalized-cancer-vaccine-pcv-rgl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-combined-t-cell-and-nk-cell-activity-in-immune-checkpoint-inhibitor-ici-therapy-in-end 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pseudoprogression-after-neoadjuvant-immunotherapy-for-resectable-nsclc-incidence-petct-patterns 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glp-1-receptor-agonist-utilization-and-survival-outcomes-in-a-large-us-community-oncology-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-incidence-survival-and-cause-of-death-in-kaposi-sarcoma-in-the-antiretroviral-therapy-er 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-from-a-phase-ii-study-of-adjuvant-dostarlimab-with-pelvic-radiation-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-external-validation-of-the-immotion151-molecular-subtypes-in-patients-with-advanced-renal-cell-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oral-mannitol-for-chemotherapy-induced-constipation-cic-a-randomized-multicenter-controlled-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-genomic-predictors-of-outcomes-in-patients-pts-with-advanced-urothelial-carcinoma-au 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-duration-with-avutometinibdefactinib-in-recurrent-low-grade-serous-ovarian-carcinoma-by-k 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erythrocyte-anti-pd-1-conjugates-in-patients-with-advanced-solid-tumors-resistant-to-anti-pd-1pd-l1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-il7-on-immtac-mediated-killing-by-t-cells-in-vitro-and-t-cell-fitness-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/5-aminolevulinic-acid-fluorescence-guided-surgery-vs-conventional-white-light-resection-in-glioma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/knowledge-distilled-efficientnets-for-peripheral-blood-smear-classification 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-trends-and-demographic-disparities-in-renal-cell-carcinoma-mortality-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-ctdna-reassessment-ltctdna-in-nsclc-immunotherapy-responders 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liposomal-irinotecan-plus-cisplatincarboplatin-as-second-line-therapy-for-platinum-sensitive-relaps 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-durvalumab-with-or-without-tremelimumab-in-metastatic-nsclc-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/management-of-pancreatic-metastases-from-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-with-first-line-platinum-etoposide-plus-durvalumab-versus-platinum-etoposide-alone 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-pcsk9-inhibitors-with-clinical-outcomes-in-patients-with-cancer-receiving-immune-chec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cohort-level-safety-and-efficacy-results-for-sup212sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fixed-duration-subcutaneous-sc-mosunetuzumab-mosun-in-elderlyunfit-patients-with-previously-unt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gdf-15-levels-and-clinical-correlates-in-head-and-neck-cancer-patients-developing-a-risk-model-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-serum-microrna-371a-3p-testing-for-testicular-germ-cell-tumors-in-a-pathology-depa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-baseline-demographics-on-therapy-management-in-patients-pts-with-metastatic-castration-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-impact-of-atrial-fibrillation-afib-on-cardiovascular-cv-outcomes-and-healthcare-resou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/defining-when-and-how-to-support-palliative-care-communication-international-consensus-on-timing-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thromboelastography-guided-platelet-transfusion-and-associations-with-utilization-and-outcomes-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-controlled-trial-of-a-multilingual-digital-genetic-cancer-risk-assessment-tool-in-a-div 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-the-taylor-cancer-research-center-tcrc-and-tempus-ai-time-partnership-on-clinical-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toxicity-risk-calculator-for-personalised-prediction-of-iraes-in-patients-with-solid-tumours-receivi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-invasive-characterization-of-intratumoral-cd8-t-cells-using-standard-of-care-soc-ct-and-89zr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liposomal-irinotecan-combined-with-oxaliplatin-5-fluorouracilleucovorin-with-or-without-camrelizum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-eftilagimod-alfa-an-apc-activator-via-mhc-class-ii-on-lymphocyte-activation-and-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-radiomics-based-model-for-the-prediction-of-whoisup-in-clear-cell-renal-cell-carcinoma-using-cont 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-de-escalation-in-high-risk-resectable-melanoma-with-major-pathologic-response-mpr-after-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-sex-based-disparities-in-pancreatic-cancer-clinical-trial-enrollment-a-systematic-review-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prth-101-an-investigational-treatment-for-thoracic-solid-tumors-targeting-discoidin-domain-receptor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-context-constrained-oncology-agent-for-automated-guideline-concordant-treatment-decision-support 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-sars-cov-2-vaccination-with-survival-outcomes-in-patients-with-metastatic-solid-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-value-in-the-age-of-accelerated-approval-a-pembrolizumab-case-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-analysis-of-the-tinivo-2-phase-3-trial-long-term-outcome-of-tivozanib-tivo-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-basket-study-of-telisotuzumab-adizutecan-temab-a-abbv-400-a-c-met-protein-targeting-anti-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-preoperative-pathological-risk-prediction-model-for-thymic-tumors-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/indefinite-versus-2-years-fixed-duration-of-immune-checkpoint-inhibition-in-metastatic-non-small-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-combination-of-regorafenib-avelumab-in-patients-with-hpv-associated-cancer-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-re-adoption-of-open-radical-hysterectomy-on-postoperative-outcomes-in-the-united-state 2026-08-24 monthly 0.7 https://rjrindex.com/articles/t-cell-stem-like-memory-cells-as-a-novel-biomarker-to-identify-patients-with-sustained-disease-contr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iatmi-mutations-in-pancreatic-cancer-a-real-world-analysis-of-molecular-la 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-plus-lenvatinib-for-unresectable-anaplastic-thyroid-cancer-results-of-the-phase-2-navigat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-disparities-and-future-burden-of-multiple-myeloma-a-population-based-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/when-im-translating-im-a-daughter-as-well-perspectives-of-caregivers-supporting-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-clinical-prediction-score-to-identify-symptomatic-patients-at-high-risk-for-colorectal-cancer-in-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hallmarks-of-cancer-in-stage-ii-iii-nsclc-treated-with-chemoradiotherapy-crt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-interpretable-machine-learning-model-using-routine-clinicopathological-variables-to-predict-posto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-findings-from-the-promise-registry-a-us-decentralized-prospective-prostate-cancer-genetic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-and-safety-of-first-line-pd-1-inhibitors-plus-metronomic-oral-vinorelbine-in-elderl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-novel-anti-cancer-drug-by-locking-inhibition-of-amino-acid-transporter-lat1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/t320-tissue-factor-targeted-adc-from-pre-clinical-research-to-phase-i-clinical-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-large-language-models-to-extract-diagnosis-recurrence-and-death-dates-from-breast-cancer-ele 2026-08-24 monthly 0.7 https://rjrindex.com/articles/doctor-am-i-cured-characteristics-of-long-term-survivors-with-advanced-melanoma-treated-with-immun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/two-decades-of-change-trends-and-disparities-in-breast-cancer-surgical-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/endometrial-cancer-mortality-and-persistent-disparities-in-the-united-states-1999-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-risk-stratification-in-a-us-based-database-to-identify-subgroups-of-patients-with-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-relacorilant-and-nab-paclitaxel-in-platinum-resistant-ovarian-cancer-a-grade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/discharge-trajectories-and-30-day-readmission-risk-in-hospitalized-breast-cancer-patients-with-malig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-use-of-complementary-and-alternative-medicine-in-the-middle-east-for-managing-neutropenia-in-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-cancer-with-hypertension-among-middle-aged-and-older-adults-in-united-states-1999-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-ripretinib-on-the-pharmacokinetics-pk-of-repaglinide-a-sensitive-cyp2c8-probe-substrate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-clinical-characteristics-of-patients-with-t1114-positive-multip 2026-08-24 monthly 0.7 https://rjrindex.com/articles/myxoid-leiomyosarcoma-a-population-based-ncdb-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-affecting-outcomes-in-early-onset-vs-average-onset-head-and-neck-cancers-a-multicenter-retr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-enzymatic-component-of-the-nitric-oxide-system-in-mitochondria-of-melanoma-and-skin-what-change 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-and-regional-variation-of-cervical-cancer-in-nigeria-a-systematic-review-and-meta-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-cardiovascular-mortality-among-ovarian-cancer-patients-in-the-united-states-a-22 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiotherapy-followed-by-capox-plus-tislelizumab-in-microsatellite-stable-rectal-cancer-with-synchro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/uterine-serous-and-clear-cell-carcinomas-hormonal-profile-and-expression-of-steroid-hormone-recepto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-ultrasensitive-ddpcr-and-ngs-for-circulating-tumor-hpv-dna-in-minimal-residual-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-use-of-regorafenib-for-refractory-metastatic-colorectal-cancer-survival-outcomes-and-ass 2026-08-24 monthly 0.7 https://rjrindex.com/articles/translating-real-world-data-into-actionable-insights-an-ai-powered-model-for-prostate-cancer-surviv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-observational-study-to-investigate-the-effectiveness-and-safety-of-niraparib-maintenance-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/malnutrition-as-a-hidden-driver-of-inpatient-mortality-in-gastrointestinal-cancer-a-national-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-body-fat-in-early-stage-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-clinical-and-dosimetric-study-on-the-feasibility-and-adaptability-of-mr-linac-in-the-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/are-patient-reported-outcome-measures-valid-across-diverse-cancer-populations-a-review-of-psychome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/derivation-and-external-validation-of-a-prognostic-nomogram-for-her2-negative-early-breast-cancer-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/terminal-admission-phenotypes-and-inpatient-mortality-in-gastrointestinal-malignancies-a-national-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-isocryptolepine-analogs-with-submicromolar-antiproliferative-activity-en-route-to-next-in-cla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-and-access-disparities-in-ovarian-cancer-treatment-and-outcomes-a-retrospective-cohor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/strategic-alignment-of-quality-improvement-interventions-to-address-barriers-to-adult-vaccination-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/timing-of-biomarker-testing-and-associated-clinical-outcomes-in-ovarian-cancer-patients-a-retrospec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-to-evaluate-safety-tolerability-and-pharmacokinetics-of-lnp8701-sos1-inhibitor-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perception-and-awareness-of-cancer-immunotherapy-among-healthcare-professionals-and-students-at-a-te 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sensitivity-of-ca-125-by-ovarian-cancer-histology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/upfront-ultrafast-multigene-panel-testing-for-nccn-guideline-recommended-biomarker-detection-in-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-importance-of-family-history-in-indicating-hboc-genetic-testing-in-a-resource-limited-setting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-cardiovascular-outcomes-with-gnrh-agonist-and-antagonist-therapy-in-non-metastatic-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lattice-sfrt-combined-with-systemic-therapy-for-bulky-unresectable-hepatocellular-carcinoma-a-retro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-evaluation-of-a-dark-kinase-based-transcriptional-score-in-acute-myeloid-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determinants-of-recurrence-after-curative-gastrectomy-in-young-onset-gastric-cancer-a-latin-america 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-trilaciclib-against-chemotherapy-induced-myelosuppression-an-updated-systematic-review-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-internal-validation-of-a-web-based-risk-assessment-tool-for-chemotherapy-induced-per 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-anlotinib-and-sintilimab-combined-with-gemox-in-advanced-combined-hepatocellu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-secondary-hematologic-malignancies-with-radioactive-iodine-therapy-for-differentiated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcome-of-asian-and-non-hispanic-white-patients-with-colorectal-cancer-in-a-nci-designated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eunetccc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-the-accelerator-working-an-updated-empirical-analysis-of-fda-accelerated-approvals 2026-08-24 monthly 0.7 https://rjrindex.com/articles/late-hematological-toxicity-after-chemotherapy-exome-analysis-with-long-term-follow-up-in-mexican-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-pre-existing-chronic-kidney-disease-with-in-hospital-mortality-and-resource-utilizati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prompt-engineering-and-readability-of-large-language-model-generated-patient-education-materials-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-racial-and-age-disparities-in-response-and-survival-among-acute-myeloid-leukemia-aml 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-feasibility-and-hematologic-toxicity-of-induction-chemotherapy-in-advanced-cervical-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-systemic-therapy-in-patients-with-anaplastic-thyroid-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-with-modern-first-line-systemic-therapy-in-advanced-hepatocellular-carcinoma-a-sy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differentiation-and-stage-as-independent-predictors-of-survival-in-laryngeal-neuroendocrine-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/drivers-of-non-evaluable-imaging-timepoints-in-oncology-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-application-research-of-the-intervention-program-for-medication-compliance-of-endocr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unintended-access-barriers-how-upper-payment-limit-implementation-may-risk-patient-access 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gastric-cancer-incidence-prevalence-and-mortality-burden-in-the-united-states-retrospective-epide 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-to-venetoclax-containing-regimens-in-patients-with-relapsedrefractory-rr-t-cell-acute-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-two-arm-study-of-tolododekin-alfa-ank-101-in-combination-with-an-anti-pd-1pd-l1-antib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/study-design-of-omaha-015-a-phase-2-basket-study-of-steroidogenesis-inhibitor-opevesostat-in-partic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/design-of-an-innovative-clinical-development-program-using-randomized-controlled-phase-2-trial-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tuc-toc-phase-ii-trial-nct05955170-tucatinib-in-combination-with-oral-etoposide-vp16-and-trastu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/body-mass-index-as-a-prognostic-factor-for-trastuzumab-deruxtecan-efficacy-in-advanced-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-atm-as-a-prognostic-biomarker-in-breast-cancer-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhanced-recovery-after-surgery-eras-pathways-in-gynecologic-oncology-a-systematic-review-and-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deciphering-the-intricate-crosstalk-of-the-efna1-epha3-axis-in-orchestrating-the-proangiogenic-niche 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-metabolic-response-and-circulating-tumor-biomarkers-as-early-indicators-of-therapy-outco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-outcomes-among-early-onset-breast-cancer-hospitalizations-with-metabolic-dysfunction-assoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/objective-responses-and-survival-outcomes-by-grade-3-4-neutropenia-in-refractory-metastatic-colorect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-dietary-habits-and-lifestyle-in-patients-with-bone-sarcoma-pilot-study-results-of-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-risk-of-interstitial-lung-disease-and-pneumonitis-with-trastuzumab-deruxtecan-vs-trastuzu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vitiligo-and-alopecia-areata-as-complementary-human-models-of-immune-mediated-melanoma-protection-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/county-level-residential-radon-exposure-testing-patterns-and-cancer-incidence-in-michigan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-incidence-prevalence-and-short-term-outcomes-in-young-onset-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rainfol-03-engot-en-31gog-3128-a-global-phase-3-open-label-randomized-study-of-rinatabart-ses 2026-08-24 monthly 0.7 https://rjrindex.com/articles/carbon-sustain-study-visit-sparing-low-emission-hypofractionated-radiation-therapy-in-a-traffic-de 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-iii-study-of-gemcitabine-plus-cisplatin-with-s-1-versus-gemcitabine-plus-cisplati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-surgery-and-the-type-of-immune-check-point-inhibitors-ici-in-patients-with-locally-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-prevalence-and-temporal-trends-of-colorectal-cancer-across-age-sex-race-and-ethnicity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-versus-delayed-inpatient-radiotherapy-in-head-and-neck-cancer-and-associated-in-hospital-outco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pd-l1-and-hpv-biomarkers-on-immune-checkpoint-inhibitor-efficacy-in-locally-advanced-hnscc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-role-of-oncologist-type-in-shared-decision-making-for-patients-with-metastatic-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emerging-trends-in-research-strategies-in-the-first-line-recurrent-or-metastatic-head-and-neck-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-larotrectinib-in-solid-tumors-with-tropomyosin-receptor-kinase-fusion-getne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-differences-in-cardiovascular-disease-prevention-and-treatment-amongst-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clear-cell-type-squamous-cell-carcinoma-an-ncdb-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/urban-rural-disparities-in-the-global-south-the-impact-of-urbanicity-on-obesity-comorbidities-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-artificial-intelligence-assistance-on-combined-pd-l1-scoring-on-whole-immunohistochemical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nutritional-anemia-and-risk-of-critical-illness-among-hospitalized-patients-with-head-and-neck-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-of-cytokine-release-syndrome-in-patients-treated-with-tarlatamab-for-extensive-stage-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-immunotherapy-strategies-in-pmmr-advanced-endometrial-cancer-a-network-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-systematic-review-and-meta-analysis-of-artificial-intelligence-assisted-colon-capsule-endoscopy-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/large-scale-emr-based-machine-learning-for-early-risk-stratification-of-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-cancer-mortality-among-adults-with-psychoactive-drug-use-disorders-in-unit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-insurance-based-differences-in-nutritional-anemia-among-hospitalized-patients-with-head-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transfer-of-care-after-virtual-oncology-second-opinions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/race-neighborhood-deprivation-and-mortality-in-prostate-cancer-a-real-world-analysis-from-the-med 2026-08-24 monthly 0.7 https://rjrindex.com/articles/infection-associated-transitions-to-critical-care-level-interventions-in-adult-cancer-hospitalizatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dont-smoke-the-odds-improving-lung-cancer-screening-among-current-smokers-in-east-texas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-multiplex-digital-pcr-based-iesr1i-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alternative-splicing-signatures-to-predict-response-from-hyperthermic-intra-peritoneal-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mammogram-energy-use-metering-to-map-optimization-strategies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-trends-and-burden-of-esophageal-cancer-in-the-united-states-1990-2023-a-retrospect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-large-language-models-llms-for-pharmacogenomic-pgx-guided-prescribing-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictivity-of-coagulation-markers-in-diagnosing-acute-promyelocytic-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-and-demographic-trends-in-hypertension-associated-breast-cancer-mortality-in-the-united-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/maintenance-therapy-after-induction-chemotherapy-with-anti-egfr-antibody-and-survival-in-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reassessing-neutropenic-vs-liberalized-diets-in-post-chemotherapy-and-hematopoietic-stem-cell-transp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personality-driven-roles-of-large-language-models-for-axillary-surgery-recommendation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/medicaid-expansion-and-timely-colorectal-cancer-treatment-initiation-among-young-adults-in-virginia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/automated-detection-of-tertiary-lymphoid-structures-tls-on-whole-slide-pathology-images-using-an-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oral-fluoropyrimidines-as-alternatives-to-intravenous-5-fluorouracil-in-combination-with-immune-chec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-gastrointestinal-gi-immune-related-adverse-events-iraes-real-world-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-emergent-thyroid-disorders-and-outcomes-of-first-line-pembrolizumab-plus-chemotherapy-in-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-time-to-treatment-initiation-in-mcl-a-seer-analysis-from-2000-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-and-ipilimumab-as-second-or-later-line-therapy-in-hepatocellular-carcinoma-a-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-baseline-protein-energy-malnutrition-with-mortality-and-healthcare-utilization-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-adjuvant-chemoradiotherapy-vs-tegafurgimeraciloteracil-monotherapy-vs-ob 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-screening-in-the-transgender-population-examining-the-specificities-of-cancer-risk-from-a-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-evolution-of-her2-targeted-clinical-trials-across-solid-tumors-shifts-in-tumor-representatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-recurrence-and-outcome-determinants-in-nf1-associated-malignant-peripheral-nerve-sheath-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-first-in-human-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-prelimin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pharmacokinetics-and-pharmacodynamics-evaluation-in-phase-i-trial-of-apx-343a-selective-nox-inhibit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nrg-gi008-colon-adjuvant-chemotherapy-based-on-evaluation-of-residual-disease-circulate-north-amer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-multicenter-study-of-dptx3186-to-evaluate-safety-tolerability-and-pharmacokinetics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-patterns-of-hyperlipidemia-and-cardiometabolic-toxicity-in-patients-with-alk-fusion-posi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/partial-breast-irradiation-followed-by-neoadjuvant-immunochemotherapy-in-early-tnbc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-dependent-recurrence-risk-stratification-after-neoadjuvant-chemotherapy-for-risk-adapted-survei 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-pharmacokinetics-and-neutropenia-related-pharmacodynamics-of-bal0891-in-patients-with-solid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-clinically-applicable-toolkit-for-cervical-gastric-type-adenocarcinoma-diagnostic-model-predicti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-locoregional-recurrence-lrr-in-hormone-receptor-hrher2-breast-cancer-bc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinctive-profile-of-antiproliferative-activity-and-interaction-with-doxorubicin-of-a-new-indole-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-baseline-circulating-emdscs-in-patients-with-advanced-non-small-cell-lung-cancer-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-patients-with-pi3k-pathway-alterations-by-treatment-type-the-md-anderson-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-and-clinical-characteristics-of-patients-with-non-small-cell-lung-cancer-nsclc-harboring 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-systematic-review-and-meta-analysis-on-safety-and-efficacy-of-lu-177-psma-617-and-standardized-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hrs-5041-an-androgen-receptor-degrader-in-metastatic-castration-resistant-prostate-cancer-a-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-large-scale-multi-target-deep-learning-model-for-virtual-genomic-and-molecular-risk-profiling-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/timing-of-chemotherapy-in-breast-cancer-a-meta-analytic-evaluation-of-neoadjuvant-versus-adjuvant-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-of-liquid-biopsy-and-tissue-cgp-for-identification-of-guideline-recommended-actionable-v 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radium-223-without-androgen-deprivation-therapy-adt-in-patients-pts-with-biochemically-recurrent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trended-real-world-analysis-of-drug-treated-mcrpc-assessment-of-a-diagnostic-and-co-management-gap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-hypofractionated-radiotherapy-plus-gm-csf-on-antitumor-activity-with-pd-1pd-l1-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-intrathecal-chemotherapy-in-iegfri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncologic-safety-and-patient-reported-outcomes-of-sentinel-lymph-node-biopsy-omission-in-early-breas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tissue-free-minimal-residual-disease-evaluation-and-clinical-utility-in-early-breast-cancer-a-real 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-survivorship-program-assessing-and-addressing-patients-needs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-twin-models-for-counterfactual-prediction-in-nsclc-a-validation-study-using-clinical-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-from-a-pilot-trial-of-neoadjuvant-durvalumb-in-combination-with-tremelimuab-for-cisp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicenter-clinical-study-of-sup18sup-falf-her2-bch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-and-temporal-trends-of-pediatric-central-nervous-system-tumors-in-kenya-a-15-year-analysis-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gzmk-t-cells-in-glioblastoma-and-an-activated-non-exhausted-phenotype 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metabotyping-using-early-body-weight-velocity-in-lung-cancer-patients-treated-with-pembrolizumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-atm-as-a-prognostic-biomarker-in-non-small-cell-lung-cancer-a-systematic-review-and-meta-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lung-cancer-screening-in-septuagenarians-do-survival-benefits-persist-with-advancing-age 2026-08-24 monthly 0.7 https://rjrindex.com/articles/paxg-versus-mfolfirinox-as-first-line-therapy-for-unresectable-locally-advanced-or-metastatic-panc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/depletion-of-t-regulatory-cells-by-denileukin-diftitox-cxdl-e7777-in-combination-with-pembrolizuma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-responses-to-ugn-102-across-eortc-recurrence-score-groups-in-patients-with-recurrent-low-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-preliminary-efficacy-of-oh2-combined-with-bs006-sequential-intratumoral-injection-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/paired-urine-and-plasma-ctdna-profiling-to-enable-longitudinal-molecular-monitoring-during-her2-adc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emergence-of-single-week-adjuvant-breast-radiation-therapy-for-early-stage-breast-cancer-in-the-unit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-systemic-therapy-sequencing-after-earlier-generation-egfr-tki-failure-in-nscl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-defined-outcomes-in-metastatic-clear-cell-renal-cell-carcinoma-mccrcc-receiving-first-li 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-overview-of-mortality-for-malignant-neoplasm-of-the-brain-and-cerebrovascular-diseases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-quantum-scalpel-unveiling-new-dimensions-in-cancer-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-patterns-of-overtreatment-in-low-risk-and-undertreatment-in-high-risk-prostate-cancer-and-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-transportation-insecurity-among-cancer-patients-in-urban-cancer-clinics-in-ontario-canada 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adapt-t-dxd-multi-institutional-real-world-study-of-dose-adapted-trastuzumab-deruxtecan-in-her2-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-pathology-based-triage-for-the-21-gene-recurrence-score-a-meta-analysis-and-qualitati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/weekend-admission-and-early-in-hospital-mortality-among-patients-with-hematologic-malignancies-admit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlates-of-patient-enrollment-in-a-population-based-randomized-controlled-trial-of-cascade-geneti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-signatures-of-cns-relapse-in-dlbcl-patients-profiled-with-next-generation-sequencing-ngs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-to-neoadjuvant-chemoimmunotherapy-in-egfr-or-alk-mutated-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-comparison-of-treatment-and-survival-outcomes-with-zanubrutinib-zanu-and-acalabrutini 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transdermal-drug-delivery-to-the-normal-and-the-radiated-breast-determinants-of-individual-variatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-and-subgroup-efficacy-analysis-of-ga-68-ngul-and-lu-177-dgul-pocuvotide-satetraxe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-of-glucagon-like-peptide-1-receptor-agonists-in-patients-with-breast-cancer-a-real-world-mul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-and-subsequent-treatment-utilization-following-anti-b-cell-maturation-antigen-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trabectedin-with-concomitant-radiotherapy-in-resectable-retroperitoneal-l-sarcoma-a-multicenter-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-assisted-preoperative-communication-in-prostate-cancer-a-prospective-single-blinded-randomized 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-asciminib-for-newly-diagnosed-chronic-myeloid-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-modern-systemic-and-multimodality-treatments-on-post-relapse-survival-in-retroperitoneal-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-obecabtagene-autoleucel-obe-cel-on-adult-patients-pts-with-relapsedrefractory-b-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-induction-strategies-in-acute-myeloid-leukemia-10-year-real-world-experience-with-73-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-experience-with-neoadjuvant-chemoimmunotherapy-in-resectable-nsclc-a-single-academic-ins 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-determinants-of-metastatic-burden-and-survival-in-metastatic-urothelial-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serial-ctdna-genomic-profiling-integrated-with-a-networked-molecular-tumor-board-in-first-line-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-safety-of-central-nervous-system-tumor-patients-in-phase-1-trials-a-single-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/objective-response-rates-with-ori-c101-an-armored-gpc3-directed-car-t-in-heavily-pretreated-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-peripheral-blood-immune-analysis-in-patients-receiving-immune-checkpoint-inhibitor-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/scaling-digital-patient-navigation-to-improve-access-to-multidisciplinary-melanoma-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/capivasertib-plus-fulvestrant-in-chinese-patients-with-hrher2-advanced-breast-cancer-interim-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-efficacy-and-safety-of-first-line-anlotinib-plus-carboplatinpaclitaxel-induction-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proglumide-gemcitabine-gem-and-nab-paclitaxel-nab-p-in-patients-pts-with-pancreatic-ductal-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-financial-and-credit-status-of-participants-enrolled-in-swog-s1912cd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/virtual-multiplex-immunofluorescence-characterization-of-spatial-immune-architectures-and-tertiary-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/large-cell-carcinoma-with-rhabdoid-phenotype-demographics-treatment-and-survival-in-the-ncdb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whole-genome-sequencing-based-ultra-sensitive-ctdna-molecular-residual-disease-assessment-in-resecta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-ischemic-heart-disease-mortality-among-lymphoma-patients-in-the-united-states-19 2026-08-24 monthly 0.7 https://rjrindex.com/articles/brentuximab-vedotin-plus-cyclophosphamide-doxorubicin-etoposide-and-prednisone-chepa-in-newly-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disitamab-vedotin-rc48-tislelizumab-and-s-1-as-first-line-therapy-for-her2-overexpressing-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/when-does-time-become-a-burden-evaluating-the-association-between-time-spent-on-cancer-care-and-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-on-overall-survival-after-adjusting-for-treatment-crossover-in-first-line-metastatic-nsclc-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequencing-of-fallopian-tube-p53-signature-found-concurrently-with-p53-mutant-uterine-cancers-and-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-personalized-neoantigen-vaccine-to-reprogram-the-immune-landscape-of-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-after-intravenous-iron-use-in-patients-with-cancer-and-iron-deficiency-a-propensit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-knowledge-distilled-efficientnet-to-enable-rapid-scalable-glioma-diagnosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-postsurgical-circulating-tumor-dna-ctdna-dynamics-on-eligibility-of-colorectal-cancer-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progression-free-survival-as-a-surrogate-endpoint-for-overall-survival-in-metastatic-triple-negative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/azenosertib-plus-paclitaxel-for-platinum-resistant-ovarian-cancer-results-from-a-phase-1b-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-immune-related-pathologic-response-score-as-a-predictor-of-survival-after-immune-checkpoint-inhib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-and-biomarker-landscape-of-mtap-deficiency-in-gastrointestinal-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-heat-shock-protein-90-alpha-hsp90a-as-a-biomarker-for-cancer-cachexia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-automated-ehr-integrated-intervention-system-for-patient-reported-insomnia-symptoms 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-changes-in-patient-reported-quality-of-life-qol-and-hope-among-early-phase-cancer-cli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fire-4-aio-krk-0114-efficacy-of-third-line-rechallenge-with-cetuximab-versus-investigators-choic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-primary-cardioprotection-with-perindopril-bisoprolol-and-trimetazidine-in-high-risk-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-cldn18cldn182-ihc-assays-43-14a-vs-epr19202-and-the-correlation-with-clinical-effi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-artificial-intelligence-to-evaluate-outcomes-and-disparities-in-young-onset-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-classification-of-neuroendocrine-carcinoma-of-the-bladder 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-circulating-tumor-dna-ctdna-profiling-from-patients-pts-treated-with-zanidatamab-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/refining-breast-cancer-risk-stratification-for-selection-of-women-at-intermediate-to-high-risk-for-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burnout-among-caregivers-of-hospitalized-medical-oncology-patients-a-cross-sectional-survey-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/standardized-exam-style-benchmarking-of-large-language-models-in-breast-cancer-clinical-decision-mak 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-oral-serds-including-giredestrant-on-survival-in-hr-her2-metastatic-breast-cancer-a-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reproductive-and-pregnancy-related-outcomes-among-adolescent-and-young-adult-female-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-detection-of-multiple-myeloma-and-mgus-progression-risk-using-artificial-intelligence-and-rout 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trilaciclib-for-myeloprotection-in-adjuvant-and-first-line-chemotherapy-for-advanced-gastricgastroe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phlebotomy-adherence-and-hematocrit-control-in-patients-with-polycythemia-vera-in-the-united-state 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bl0020-a-novel-tumor-microenvironment-tme-targeting-nano-mediated-polypeptide-drug-conjugate-nmp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adverse-events-and-their-management-in-patients-with-tenosynovial-giant-cell-tumor-tgct-treated-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-cytokine-dynamics-during-neoadjuvant-chemotherapy-versus-endocrine-therapy-and-cdk46-inhib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-pharmacokinetics-pk-of-lurbinectedin-lurbi-in-pediatric-patients-pts-with-relapsed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-burden-and-outcomes-colon-cancer-survival-across-the-us-safety-net-spectrum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-comparing-the-use-of-glp-1-receptor-agonists-in-patients-with-endometrial-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-whole-exome-and-whole-genome-sequencing-tumor-informed-circulating-tumor-dna-mrd-assay 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pemigatinib-for-untreated-unresectablemetastatic-cholangiocarcinoma-mcca-with-fibroblast-growth-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fecal-microbiota-transplantation-to-reverse-resistance-to-tki-plus-pd-1-inhibitors-in-unresectable-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-and-prognostic-value-of-mri-radiomics-in-patients-with-hormone-receptor-positive-her2-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidental-breast-findings-identified-on-non-breast-imaging-a-multi-facility-real-world-analysis-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-schwann-cells-with-immune-cold-tumor-microenvironment-in-triple-negative-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systematic-modeling-of-tumor-microenvironment-mediated-nk-cell-dysfunction-in-pancreatic-cancer-to-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clerad-probe-dosimetric-analysis-of-i-124-pet-guided-remnant-radioiodine-ablation-in-differentiated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-gene-detection-and-turnaround-time-between-tissue-and-guardant360-liquid-biopsy-next-ge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/informing-optimal-duration-of-adjuvant-chemotherapy-act-in-resected-stage-i-iv-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dose-dependent-effect-of-dinutuximab-ir700-photoimmunotherapy-on-gd2-expressing-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-ct-01-a-dual-molecular-glue-degrader-of-gspt1-and-nek7-as-monotherapy-and-in-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/apobec-mutational-signatures-to-predict-immune-checkpoint-inhibitor-benefit-in-tmb-low-metastatic-ns 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-expanded-multigene-panel-testing-in-hereditary-cancer-patients-from-the-baja-californ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-testing-first-line-treatment-patterns-and-survival-in-metastatic-non-small-cell-lung-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-survival-longitudinal-prognostication-in-glioblastoma-using-conditional-survival-a-populatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-neutrophil-percentage-to-albumin-ratio-with-progression-free-survival-and-overall-sur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-pros-and-health-related-quality-of-life-hrqol-with-taletrectinib-in-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/guideline-adherence-in-action-baseline-neuroimaging-rates-for-nsclc-a-northern-ireland-north-west-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obesity-associated-genomic-heterogeneity-in-breast-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-patients-with-cell-cycle-alterations-by-treatment-type-the-md-anderson-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/testosterone-suppression-safety-and-adherence-with-relugolix-in-patients-with-metastatic-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-dostarlimab-monotherapy-as-first-line-treatment-in-programmed-cell-death-liga 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-from-ocean-ii-a-phase-ii-study-of-encorafenib-binimetinib-combination-in-chinese-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/refined-temporal-to-frontal-horn-shunting-for-trapped-temporal-horn-syndrome-long-term-outcomes-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-comorbidity-burden-and-in-hospital-outcomes-in-patients-with-lung-cancer-a-retrospec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-tmb-ptmb-and-circulating-tumor-fraction-ctf-dynamics-as-biomarkers-of-benefit-from-the-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-hyperthermic-intraperitoneal-chemotherapy-hipec-with-cytoreduction-in-peritoneal-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-characteristics-homologous-recombination-repair-mutation-hrrm-testing-treatment-patte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iconic-improving-outcomes-through-collaboration-in-osteosarcoma-insights-from-a-national-prospect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-potential-of-prostest-for-predicting-outcome-in-adt-treated-black-south-african-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-dose-adjusted-etoposide-prednisone-vincristine-cyclophosphamide-and-doxorubici 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dyadic-exercise-intervention-for-lgbtq-cancer-survivors-associations-with-health-related-quality-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/same-daynext-day-cancer-care-program-an-early-access-program-for-patients-with-aggressive-malignan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/blood-derived-small-extracellular-vesicle-based-liquid-biopsy-for-repeatable-genomic-and-transcripto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-ai-augmented-analysis-of-quantitative-circulating-tumor-dna-ctdna-burden 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-characterization-of-renal-cell-carcinoma-brain-metastasis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anti-pd-1-pd-1-monotherapy-versus-combination-with-anti-ctla-4-for-metastatic-uveal-melanoma-mum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-early-on-treatment-cytokine-dynamics-following-induction-chemo-immunotherapy-with-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-translational-study-of-p38-inhibitor-pexmetinib-plus-nivolumab-following-anti-pd-1l1-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proactive-response-initiative-for-symptom-management-prism-a-multi-institutional-symptom-monitori 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-center-retrospective-analysis-of-antibody-drug-conjugate-utilization-and-associated-toxicit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-treatment-ctdna-monitoring-using-a-tumor-informed-whole-genome-sequencing-based-assay-in-homolo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-first-line-treatment-of-cllsll-with-the-all-oral-combination-of-sonrotoclax-sonro-and-z 2026-08-24 monthly 0.7 https://rjrindex.com/articles/coverage-of-subcutaneous-versus-intravenous-oncology-therapies-by-us-commercial-health-plans 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whole-genome-sequencing-based-ctdna-testing-for-post-surgical-monitoring-and-early-detection-of-recu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-molecular-profiling-in-advanced-non-small-cell-lung-cancer-nsclc-measurable-surviva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-and-adjuvant-pembrolizumab-plus-chemotherapy-for-locally-advanced-gastric-or-gastroesoph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-deep-learning-model-for-intraoperative-diagnosis-of-lung-adenocarcinoma-using-frozen-section-whole 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recurrence-patterns-and-site-level-survival-in-the-previous-phase-iii-study-of-il13-pe38qqr-implica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/knowledge-distillation-for-glioma-diagnosis-resnet-based-deep-learning-for-who-grade-stratification 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-determinants-of-radiation-necrosis-in-diffuse-glioma-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-immunotherapy-era-on-survival-in-stage-iv-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-intravenous-ipi201-in-combination-with-anti-pd-1-therapy-in-a-colorectal-cancer-mouse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-characteristics-of-nsclc-first-line-immunotherapy-super-responders-in-three-european-lung-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-to-treatment-initiation-and-clinical-toxicity-and-supportive-care-outcomes-in-multiple-myelom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-and-longitudinal-capture-of-routine-patient-reported-outcomes-in-non-small-cell-lung 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-with-glioblastoma-multiforme-gbm-with-lymphopenia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leader-member-exchange-lmx-and-workforce-outcomes-in-radiation-oncology-a-preliminary-generationa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-model-for-lung-cancer-risk-stratification-using-routine-complete-blood-count-exams 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-deoxyribonucleic-acid-dna-and-treatment-outcomes-of-gastroesophageal-cancer-a-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrative-genomic-profiling-of-indian-brain-tumors-prognostic-markers-and-actionable-therapeutic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/resnets-in-the-diagnosis-of-gliomas-knowledge-distillation-from-resnet101-to-resnet18-for-accurate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biologic-and-clinical-implications-of-hpv-genome-state-variation-in-oropharyngeal-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extended-monitoring-and-biomarker-analysis-in-metastatic-melanoma-patients-treated-with-til-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-prediction-for-progression-free-survival-pfs-and-overall-survival-os-by-genomic-instabi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-career-focused-training-program-leader-perspectives-on-professional-development-pathways 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-deruxtecan-for-the-management-of-leptomeningeal-metastases-from-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cross-platform-concordance-between-tumor-informed-and-tumor-naive-ctdna-mrd-assays-in-early-stage-ns 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-mortality-and-disability-burden-of-young-onset-non-colorectal-gastrointestinal-cancers-1990 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-profiling-of-diffuse-intrinsic-pontine-glioma-in-aacr-project-genie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-first-line-platinum-plus-two-day-etoposide-combined-with-immunotherapy-in-extensi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neurological-adverse-events-related-to-immune-checkpoint-inhibitors-in-cancer-treatment-a-systemati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-spatial-atlas-of-adc-targets-in-immunotherapy-treated-nsclc-to-link-compartment-specific 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-of-car-t-cells-engineered-with-tgf-vril-9r-domain-swapped-chimeric-receptor-and-membr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frequent-monitoring-of-nsclc-immunotherapy-using-an-mdetect-liquid-biopsy-to-identify-therapy-respon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-multi-center-pharmacodynamic-study-of-the-fatty-acid-synthase-fasn-inhibitor-tvb-2640-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/automatic-pharmacogenomic-testing-provided-on-liquid-biopsy-access-prevalence-and-integration-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neutrophil-counts-as-a-prognostic-biomarker-following-breast-cancer-surgery-insights-from-a-mayo-cl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-failure-and-outcomes-in-triple-negative-compared-to-estrogen-receptor-positive-breast-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-imtapi-copy-number-alteration-cna-in-nsc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-benefits-of-early-phase-clinical-trials-for-rare-malignancies-asian-single-center-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-triage-forward-outpatient-diagnostic-pathway-for-cancer-evaluation-early-experiences-from-a-suspi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-environmental-factors-and-social-determinants-of-health-on-molecular-alterations-in-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-safety-of-elranatamab-in-low-weight-patients-findings-from-the-summit-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinician-readiness-and-ethical-thresholds-for-agentic-ai-autonomy-in-oncology-care-a-multi-special 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-fine-tuned-small-language-models-slms-vs-large-language-models-llms-in-modeled-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rapid-ai-assisted-intraoperative-diagnosis-for-biliary-tract-adenocarcinoma-using-femtosecond-laser 2026-08-24 monthly 0.7 https://rjrindex.com/articles/building-a-real-time-cancer-data-mart-cdm-for-an-integrated-health-system-leveraging-traditional 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-convolution-vision-transformer-based-modeling-for-histopathological-classification-of-colore 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-12-month-overall-survival-from-response-rate-and-6-month-progression-free-survival-in-onc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-analysis-of-aggressive-disease-and-treatment-response-in-recurrentmetastatic-head-and-nec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-functional-tumor-profiling-lead-to-superior-care-within-standard-of-care-a-meta-analysis-of-ra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/childcare-provision-during-breast-cancer-radiation-therapy-piloting-of-the-waiting-room-watchers-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-screening-uptake-and-barriers-among-women-in-hue-vietnam-a-cross-sectional-survey 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-deviations-from-guideline-concordant-care-in-triple-negative-breast-cancer-a-patient-reported 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-evaluation-of-targeted-rna-sequencing-and-rna-exome-sequencing-for-fusion-detection-in-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-fertility-divide-disparities-across-counseling-referral-and-utilization-of-fertility 2026-08-24 monthly 0.7 https://rjrindex.com/articles/building-a-patient-driven-integrated-research-infrastructure-to-accelerate-therapeutic-advances-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analytical-characterization-of-the-next-generation-her2-cal27-immunohistochemistry-assay-a-compar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-resource-impact-and-disparities-in-low-value-care-during-terminal-hospitalizations-for-lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pre-treatment-circulating-tumour-dna-ctdna-to-predict-survival-and-aid-decision-making-in-head-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perspectives-of-oncology-professionals-on-cancer-care-for-displaced-populations-in-africa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postpartum-associated-breast-cancer-patient-outcomes-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-colorectal-carcinoma-associated-with-tobacco-use-as-a-cause-of-death-in-the-united 2026-08-24 monthly 0.7 https://rjrindex.com/articles/endometrial-cancer-risk-management-in-patients-with-lynch-syndrome-at-a-tertiary-community-cancer-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-characteristics-and-real-world-utilization-of-darolutamide-in-advanced-prostate-cancer-among 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-circulating-tumor-dna-for-recurrence-risk-assessment-and-adjuvant-therapy-decision-mak 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-process-mapping-to-improve-clinical-care-for-patients-receiving-cancer-treatment-in-resource-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-pre-diagnostic-upper-endoscopy-and-metastatic-gastric-cancer-at-diagnosis-among 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insurance-related-disparities-in-emergency-department-presentation-among-hospitalized-colorectal-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-enabled-analysis-of-prognostic-pi3k-pathway-alterations-in-african-american 2026-08-24 monthly 0.7 https://rjrindex.com/articles/histology-dependent-survival-and-treatment-benefit-in-primary-tracheal-cancer-a-population-based-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-trends-in-the-evolving-use-of-first-line-therapy-in-metastatic-castration-sensitive-prost 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-early-onset-colorectal-cancer-a-20-year-epidemiological-study-at-a-referral-center-in-nor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-with-immune-checkpoint-inhibitors-in-patients-with-pre-existing-autoimmune-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-feasibility-and-tolerability-of-pedmark-for-otoprotection-in-young-adults-receiving-cispl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-demographic-characteristics-in-ameloblastoma-patients-a-single-center-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-assessment-of-a-global-anonymized-human-in-the-loop-ai-decision-support-platform-for-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/screen-failures-among-patients-who-consented-for-early-phase-cancer-clinical-trials-epcts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tcm-based-syndrome-stratification-and-biological-profiling-of-cancer-related-fatigue-a-cross-sectio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integration-of-a-diabetes-practitioner-in-breast-cancer-care-and-its-impact-on-glucose-management 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-adjuvant-tace-versus-haic-after-curative-resection-for-high-risk-bclc-0 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-as-a-determinant-of-systemic-therapy-initiation-in-advanced-colorectal-cancer-experience-from-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-adjuvant-chemotherapy-in-patients-with-early-stage-biliary-tract-cancers-an-ncdb-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/making-telehealth-delivery-of-cancer-care-at-home-effective-and-safe-a-pragmatic-cluster-randomized 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-squalene-epoxidase-association-with-cholesterol-dependent-akt-activation-and-prognosis-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequencing-antibody-based-and-car-t-therapies-in-relapsedrefractory-follicular-lymphoma-an-anchore 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trust-ethics-and-patient-engagement-in-clinical-research-findings-from-the-lacog-1123-astral-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-analysis-of-efficacy-and-safety-of-adjuvant-donafenib-plus-transarterial-chemoembolization-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gliofocus-a-global-open-label-randomized-phase-3-study-comparing-niraparib-with-temozolomide-in-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/polaris-polymetastatic-lesion-ablative-radiotherapy-with-immunotherapy-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pre-operative-chemotherapy-versus-surgery-first-with-peri-operative-interventions-in-early-triple-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lisocabtagene-maraleucel-liso-cel-as-first-line-1l-therapy-for-transplant-ineligible-patients-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inequality-of-access-to-breast-reconstruction-in-brazil-an-ecological-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-randomized-trial-of-tislelizumab-plus-gemcitabinecapecitabine-gx-versus-tislelizumab-pl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/economic-burden-of-non-approved-alternative-therapies-among-patients-with-stage-iv-cancer-a-prospec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quintessential-2-a-phase-3-study-of-arlocabtagene-autoleucel-versus-standard-of-care-in-adult-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-non-comparative-multicenter-phase-ii-trial-of-neoadjuvant-becotatug-vedotin-alone-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/durvalumab-and-oleclumab-in-resectable-pancreatic-ductal-adenocarcinoma-a-window-of-opportunity-tri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-in-hospital-outcomes-among-patients-with-lung-cancer-receiving-immune-checkpoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/falls-among-older-adults-with-cancer-a-nationwide-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/construction-and-clinical-application-of-a-bundled-nursing-care-program-for-picc-management-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-and-disparities-in-liver-cancer-incidence-in-the-united-states-1999-2022-a-nationw 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1b2-trial-of-melphalan-percutaneous-hepatic-perfusion-php-therapy-and-nivolumabrelatlimab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-absk061-selective-fgfr23-inhibitor-combined-with-absk043-oral-pd-l1-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reducing-oncology-transportation-burden-with-decentralized-treatment-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-microplastics-on-the-colorectal-tumor-immune-microenvironment-and-immunotherapy-resistanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-angiogenic-fibrotic-and-immunosuppressive-tumor-microenvironment-with-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-toxicity-of-the-antitumor-agent-spesn38-8 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-and-disparities-in-small-intestine-neoplasms-among-us-adults-aged-65-years-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-mortality-related-to-malignant-genital-neoplasms-in-the-united-states-199 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-chemotherapy-after-parp-inhibitor-progression-in-ovarian-cancer-a-large-real-world-coho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinguishing-hemoglobin-nadir-from-clinically-significant-anemia-events-during-curative-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequencing-trastuzumab-deruxtecan-and-sacituzumab-govitecan-in-metastatic-breast-cancer-a-systemati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-levels-of-mitochondrial-gene-copy-number-and-microrna-transcripts-as-effective-minimally-inva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-real-world-safety-of-nivolumab-versus-pembrolizumab-in-malignant-melanoma-a-propensity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prior-authorization-utilization-administrative-burden-and-implications-for-timely-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-line-therapeutic-strategies-following-resistance-to-egfr-tkis-in-advanced-egfr-mutant-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-gvax-pancreas-vaccine-with-crs-207-in-pretreated-metastatic-pancreatic-adenoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-chemotherapy-in-small-cell-lung-cancer-as-a-high-risk-care-delivery-phenotype-national-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-approach-to-identify-country-specific-drivers-of-global-cancer-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-lessons-from-the-implementation-of-a-pan-african-clinico-genomic-cancer-platform-the-african 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-the-randomized-phase-2-dose-optimization-study-of-alveltamig-zg006-a-trispecif 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alcohol-related-hospitalizations-among-patients-with-cancer-in-the-united-states-trends-and-associa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/race-associated-clinicogenomic-predictors-in-non-small-cell-lung-cancer-treated-with-immune-checkpoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-teratoma-components-in-germ-cell-tumor-patients-undergoing-high-dose-chem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-skeletal-muscle-index-as-an-independent-prognostic-factor-in-locally-advanced-head-and-neck 2026-08-24 monthly 0.7 https://rjrindex.com/articles/covid-19-mrna-vaccination-and-risk-of-immune-related-adverse-events-in-ici-treated-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-pregnancy-associated-cancer-mortality-in-the-united-states-a-national-analysis-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-car-t-clinical-trial-availability-and-accessibility-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/how-long-is-long-enough-outcomes-with-finite-duration-bispecific-antibody-therapy-in-multiple-myelo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pre-transplant-mrd-negativity-and-tp53-mutation-status-determine-survival-after-car-t-therapy-bridge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-young-patients-with-non-small-cell-lung-cancer-in-latin-america-a-real-world-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/olanzapine-for-chemotherapy-related-anorexia-impact-on-body-composition 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-prior-treatment-setting-on-the-efficacy-of-rucaparib-vs-physicians-choice-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-study-of-225acac-psma-xt-a-novel-alpha-particle-emitting-radioligand-therapy-in-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-personalized-ctdna-into-clinical-surveillance-of-soft-tissue-sarcoma-performance-timin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recurrence-risk-prediction-using-a-large-multi-site-observational-dataset-of-patients-with-early-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pharmacokinetic-variability-with-pembrolizumab-dosage-switching-and-its-impact-on-immune-related-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-payload-resistant-human-ovarian-cancer-cell-lines-to-better-understand-antibody-drug 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultra-sensitive-circulating-tumor-dna-ctdna-detection-as-predictor-of-survival-outcomes-in-endomet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-facility-type-and-metastatic-burden-with-survival-in-gastric-adenocarcinoma-a-nation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancertrialsbr-an-open-access-collaborative-platform-to-improve-visibility-and-access-to-cancer-cl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/paclitaxel-plus-bevacizumab-with-or-without-atezolizumab-for-hormone-receptor-positiveher2-negative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-outcomes-of-germline-and-sporadic-nf1-associated-gastrointestinal-strom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-meilian-fuxin-liquid-for-radiation-induced-oral-mucositis-in-head-and-neck-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-multicenter-study-of-nasox-regimen-as-adjuvant-chemotherapy-for-patients-with-resected-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-analysis-of-plasma-cell-centered-inflammatory-immunosuppressive-niches-and-response-to-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precision-histopathologic-classification-of-epithelial-ovarian-cancer-subtypes-using-a-computational 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-neoadjuvant-spatially-fractionated-stereotactic-body-radiotherapy-on-antitumor-immunity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ibiia-study-of-bat8010bat1006-an-anti-her2-monoclonal-antibody-exatecan-conjugate-combine-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-features-of-south-african-colorectal-cancer-patients-by-hiv-status-in-a-retrospect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-tislelizumab-as-neoadjuvant-therapy-combined-with-mrd-monitoring-in-locally-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-and-responsiveness-of-standard-tyrosine-kinase-inhibitor-dose-versus-dose-de-escalation-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-imaging-as-a-tool-to-predict-patient-outcomes-in-advanced-her2-low-breast-cancer-on-trastu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tegavivint-a-downstream-wntv-catenin-inhibitor-dose-finding-results-from-a-phase-12-trial-in-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-anthracycline-related-cardiomyopathy-in-long-term-childhood-cancer-survivors-the-powe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/refining-clinical-trial-eligibility-for-minimal-residual-disease-in-patients-with-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multiplexed-immunohistochemistry-mihc-analysis-and-clinical-outcomes-of-nelmastobart-in-combinatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-cell-intrinsic-programs-of-metabolic-adaptation-and-immune-evasion-in-colorectal-cancer-liver 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tisagenlecleucel-tisa-cel-in-pediatric-and-young-adult-patients-with-high-risk-hr-b-cell-acute-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-overlapping-burden-of-atrial-fibrillation-and-lung-cancer-insights-from-us-mortality-data-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/doubling-cascade-testing-uptake-for-hereditary-cancer-syndromes-results-from-a-cluster-randomized-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pragmatic-hybrid-observational-study-evaluating-the-effectiveness-of-trastuzumab-deruxtecan-t-dx 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pilot-study-of-autologous-tumor-infiltrating-lymphocytes-ln-145-in-adult-patients-with-undiffere 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-adnexal-features-and-histological-response-to-intralesional-sp-002-in-nodular-basal-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-patterns-of-dose-reduction-and-early-discontinuation-of-abemaciclib-for-early-stage-horm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-sup225sup-acac-etn029-a-dll3-targe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-analysis-in-participants-with-renal-cell-carcinoma-treated-with-adjuvant-pembrolizumab-or-plac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-patterns-of-pd-l1-expression-biomarker-testing-and-immunotherapy-utilization-across-lun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-nivolumab-combined-with-brentuximab-vedotin-in-patients-with-relapsed-and-ref 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-predictors-of-delayed-hematologic-engraftment-after-autologous-stem-cell-transplantati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-syngeneic-immunocompetent-mouse-model-of-gbc-to-reveal-cxcl5-mediated-early-tumor-progressio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/failure-to-rescue-following-acute-hepatic-decompensation-in-hospitalized-patients-with-hepatocellula 2026-08-24 monthly 0.7 https://rjrindex.com/articles/donafenib-plus-sintilimab-combined-with-tace-or-haic-for-unresectable-hepatocellular-carcinoma-a-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-affordability-of-the-asco-annual-meeting-a-longitudinal-analysis-over-5-years 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-trial-of-lisocabtagene-maraleucel-for-minimal-residual-disease-in-patients-with-large-b-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncofertility-counseling-practices-in-aya-patients-diagnosed-with-stage-i-iii-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fetal-like-epithelial-niches-at-the-invasive-margin-to-inform-prognosis-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-neoadjuvant-tchp-with-primary-empegfilgrastim-e-prophylaxis-in-her2-positive-early-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trajectories-of-circulating-epithelial-tumor-cells-for-early-prostate-cancer-detection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-the-geographic-redistribution-of-mmat-3-policy-on-regional-and-socioeconomic-disparities-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/afatinib-versus-chemotherapy-in-advanced-nsclc-with-uncommon-iegfri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-first-line-combination-therapies-with-third-generation-egfr-tkis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pmh-001-a-first-in-human-phase-i-study-of-the-novel-microtubule-disruptor-cci-001-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determinants-of-trial-completion-termination-and-efficacy-in-solid-tumor-immunotherapy-mapping-io 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-the-role-of-large-language-models-in-cancer-mortality-prediction-a-real-world-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-network-meta-analysis-of-efficacy-and-safety-of-neoadjuvant-anti-her2-treatments-in-her2-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metal-exposure-and-ki67-response-to-neoadjuvant-aromatase-inhibitor-therapy-in-estrogen-receptor-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-spatial-transcriptomics-single-nucleus-rna-sequencing-and-histopathology-to-reveal-immu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-caregiver-and-patient-burden-with-alk-positive-advanced-non-small-cell-lung-cancer-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-online-cme-on-addressing-clinical-decision-making-for-immunotherapy-in-advanced-squamo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sezanne-a-phase-2-randomized-open-label-multicenter-study-to-evaluate-the-optimal-dose-safety-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoirenie-a-phase-2-randomized-trial-of-intensified-neoadjuvant-therapy-for-melanoma-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-hwk-007-a-next-generation-protein-tyrosine-kinase-7-ptk7-targeted-antibody-dr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-open-label-single-arm-dose-finding-and-expansion-phase-1b2-study-to-evaluate-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-protocol-improvemf-a-phase-1b-trial-of-imetelstat-ime-ruxolitinib-rux-in-patients-pt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-covid-19-on-short-and-long-term-outcomes-in-patients-with-diffuse-large-b-cell-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-or-adjuvant-pd-1pd-l1-blockade-with-curative-intent-multimodality-therapy-for-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-risk-assessment-using-the-mirai-breast-cancer-risk-prediction-model-a-preliminary-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-awareness-to-action-a-mixed-method-community-study-on-uptake-of-population-based-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-combined-transarterial-embolizationchemoembolization-and-hepatic-arterial-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-early-access-to-cancer-medicines-in-the-united-kingdom-following-incorporation-of-the-fd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-time-to-breast-cancer-treatment-initiation-at-an-urban-safety-net-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stage-gap-and-projected-metastatic-surge-for-young-onset-colorectal-cancer-a-decade-long-call-to-ac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-burden-of-retinoblastoma-incidence-prevalence-and-mortality-in-the-united-states-1990 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peg-timing-in-head-and-neck-cancer-is-there-a-sweet-spot-a-real-world-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-darovasertib-in-uveal-melanoma-patients-undergoing-primary-local-therapy-optimum-10-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-ngs-in-patient-stratification-for-first-line-chemotherapy-in-locally-advancedad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-factors-driving-use-of-ret-inhibitor-pralsetinib-and-associated-real-world-outcomes-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-pregnancy-outcomes-following-temporary-interruption-of-adjuvant-endocrine-therapy-in-earl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-the-covid-19-pandemic-on-early-stage-breast-cancer-post-lumpectomy-breast-radiation-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-early-nlr-normalization-in-msi-h-mcrc-a-real-world-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/social-deprivation-index-sdi-as-a-predictor-of-racial-and-ethnic-disparity-in-a-large-real-world-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inequities-in-breast-cancer-mortality-with-contributing-cardiometabolic-disorders-among-us-women-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-anal-cancer-in-the-united-states-an-analysis-of-npcr-data-and-comparison-to-seer-1998 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-line-options-in-patients-with-braf-negative-advanced-melanoma-following-progression-on-anti-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-manual-to-ai-assisted-improving-infusion-scheduling-in-a-high-volume-cancer-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-assessment-of-the-impact-of-neighborhood-vulnerabilities-on-prostate-cancer-outcomes-in-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-subtype-and-survival-in-inflammatory-breast-cancer-a-contemporary-population-based-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-depression-and-associated-factors-among-patients-with-advanced-cancer-undergoing-compr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-experience-based-assessment-of-informed-consent-forms-written-by-generative-artificial-inte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-and-in-hospital-outcomes-of-intracoronary-imaging-during-percutaneous-coronary-inter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-and-prognostic-value-of-plasma-d-dimer-levels-for-metastasis-and-survival-in-gastric-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-endoscopic-sleeve-en-bloc-resection-for-sinonasal-mucosal-melanoma-a-propensity-score-match 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-chemotherapy-in-metastatic-colorectal-cancer-with-liver-dysfunction-due-to-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-neoadjuvant-prognostic-nutritional-index-as-a-predictor-of-pathological-response-and-survival-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-pneumococcal-disease-in-patients-with-b-cell-malignancies-a-retrospective-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perceived-financial-barriers-and-delayed-hospital-care-for-breast-and-cervical-cancer-in-nigeria-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-and-caregiver-knowledge-and-understanding-of-acute-myeloid-leukemia-and-satisfaction-with-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-analysis-and-therapeutic-management-of-radiation-induced-sarcomas-of-the-head-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-from-unspecified-malignant-neoplasm-of-the-liver-among-us-adults-aged-45-year 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-adding-s-1-to-chemotherapy-regimens-in-advanced-gastric-cancer-a-meta-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/verification-of-clinical-benefit-following-fda-accelerated-approval-in-oncology-a-time-to-event-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-feasibility-study-of-tumor-infiltrating-lymphocytes-til-in-patients-with-cutaneous-squamous-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glucagon-like-peptide-1-receptor-agonist-glp-1-ra-and-hematologic-cancer-risk-among-older-adults-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lenalidomide-plus-rituximab-for-relapsedrefractory-indolent-non-hodgkin-lymphoma-5-year-follow-up 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-first-in-human-phase-i-dose-escalation-and-dose-expansion-study-of-trophoblast-cell-surfac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modular-car-t-cells-advancing-flexibility-safety-and-efficacy-in-solid-cancer-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-as-a-complement-to-gene-expression-based-site-prediction-to-guide-therapy-in-cancer-of-unknown 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-clinical-significance-of-itet2i-driven-clonal-hema 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detection-of-adaptive-immune-receptor-cdr3s-in-tumor-proteomes-and-correlations-with-survival-probab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/topoisomerase-1-and-dna-damage-pharmacodynamic-responses-and-mechanism-of-trastuzumab-deruxtecan-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcome-of-neoadjuvant-immunotherapy-for-patients-with-resectable-stage-iiiiv-cutaneous-melanoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-telpegfilgrastim-in-the-prophylaxis-of-chemotherapy-induced-neutropenia-in-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-snhg11-as-a-prognostic-and-predictive-biomarker-for-anti-egfr-benefit-in-colorectal-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-for-uncommon-iegfri-mutations-in-lung-ade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-tumor-immune-microenvironment-and-real-world-efficacy-of-first-line-immunotherap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iher2i-mutations-in-advanced-nsclc-prevalence-mutational-context-and-cli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-on-changes-in-uptake-sepsis-and-costs-with-dual-immunotherapy-for-first-line-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-gallium-68-labeled-fapi-pet-imaging-in-oncology-results-of-a-study-in-310-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-throughput-phenotypic-profiling-of-patient-derived-colon-cancer-organoids-to-reveal-a-chemoresi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-spatial-tumor-microenvironment-states-to-define-response-and-primary-resistance-to-immune-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-outcomes-in-first-line-1l-non-small-cell-lung-cancer-nsclc-with-maintenance-of-immune-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-immunotherapy-rechallenge-in-solid-tumors-after-discontinuation-of-immune-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-multi-omics-and-tcr-sequencing-to-identify-early-tumor-cavity-homing-and-phenotypic-evol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transposon-engineered-hypoxia-inducible-t-cells-for-treatment-of-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-efficacy-and-brain-uptake-of-an-insulin-mediated-nanoparticle-co-delivering-trastuzumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leptomeningeal-carcinomatosis-in-pancreatic-cancer-clinical-presentation-management-and-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-immune-related-adverse-events-iraes-with-large-language-model-llm-embeddings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-surgical-glove-compression-therapy-as-a-prevention-of-paclitaxel-induced-peripheral-neur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-from-a-phase-ii-study-of-tislelizumab-combined-with-radiotherapy-as-bladder-preserving 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-preliminary-efficacy-of-m9466-hrs-1167-in-combination-with-abiraterone-acetate-and-pred 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peptide-receptor-radionuclide-therapy-with-sup177sup-lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemotherapy-withwithout-pd-1i-in-locally-advanced-laryngealhypopharyngeal-cancer-a-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-exploratory-study-to-assess-the-safety-immunogenicity-and-preliminary-anti-tumor-activity-of-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/screening-for-intrinsic-and-acquired-resistance-mutations-to-anti-egfr-in-real-world-mss-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-seer-based-joinpoint-analysis-investigating-the-effect-of-shared-decision-making-on-prostate-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilisation-of-the-henry-score-in-malignant-bowel-obstruction-and-characterisation-of-management-app 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mitochondrial-dna-mtdna-expression-as-used-to-define-metabolic-and-immune-states-in-colorectal-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anitocabtagene-autoleucel-anito-cel-clinical-trial-manufacturing-experience-in-patients-with-relap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-endometrial-cancer-ec-survival-after-molecular-classification-mc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-talquetamab-vs-teclistamab-in-relapsed-refractory-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/grace-a-conversational-ai-platform-for-geriatric-oncology-risk-and-capability-evaluation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cxcl9spp1-ratio-macrophage-polarization-and-outcomes-with-pembrolizumab-or-enfortumab-vedotin-plus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-depth-of-response-on-long-term-clinical-outcomes-exploratory-analyses-from-multiple-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-optimized-machine-learning-model-for-overall-survival-prediction-in-brain-metastasis-patients-usi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-prospective-trial-evaluating-duration-of-pd-1-and-pd-l1-inhibitor-therapy-in-advanced-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-abemaciclib-in-pn2-3-patients-with-hrher2-early-breast-cancer-real-world-outcomes-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-adoption-and-pathological-insights-of-neoadjuvant-chemoimmunotherapy-in-resectable-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-validation-of-a-brain-cancer-liquid-biopsy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clonal-hematopoiesis-in-head-and-neck-carcinomas-receiving-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/redefining-lung-cancer-screening-eligibility-smoking-duration-vs-pack-years-in-a-national-va-cohor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-institution-retrospective-analysis-of-the-distinct-differences-between-spontaneous-malignan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hi-c-sequencing-to-identify-clinically-actionable-fusions-in-non-small-cell-lung-cancer-missed-by-ot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ib-results-from-the-phase-ibii-study-of-sup177sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hippocampus-avoidance-versus-standard-prophylactic-cranial-irradiation-for-small-cell-lung-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultrasensitive-ctdna-detection-for-relapse-and-response-prediction-in-melanoma-patients-treated-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-burden-among-adults-with-type-2-diabetes-mellitus-in-the-united-states-1999-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-oncology-board-exam-readiness-through-a-longitudinal-review-curriculum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-circulating-small-extracellular-vesicle-mirnas-for-immunochemotherapy-response-in-es-sclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ptprz1-met-fusion-and-induction-of-reprogrammed-immuno-microenvironment-via-met-ifn-v-lgals9-signali 2026-08-24 monthly 0.7 https://rjrindex.com/articles/virtual-ai-informed-immunocyte-profiling-vaip-from-hampe-as-a-predictor-of-multi-cancer-prognosi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-bl-m05d1-a-novel-claudin182-directed-antibody-drug-conjugate-adc-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breaking-the-stromal-barrier-in-bladder-tumor-with-a-urea-powered-platelet-nanomotor-for-potentiated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-hematological-parameters-and-timing-of-immunotherapy-administration-on-outcomes-in-first-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/opportunistic-plasma-ctdnatesting-in-egfr-mutant-mnsclc-using-a-hospital-validated-sequencing-platfo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-immune-checkpoint-inhibitor-related-pneumonitis-in-non-small-cell-lung-cancer-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-antibody-drug-conjugate-target-antigen-expression-in-patients-with-biliary-tract 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-stk11-keap1-and-nfe2l2-mutations-in-lung-squamous-cell-carcinoma-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-cooking-related-household-air-pollution-hap-on-never-smoker-nsclc-risk-in-women-systema 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-analysis-examining-liquid-biopsies-with-tissue-biopsies-in-patients-with-advanced-no 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-real-world-outcomes-with-talquetamab-and-teclistamab-in-relapsedrefractory-multiple-mye 2026-08-24 monthly 0.7 https://rjrindex.com/articles/central-nervous-system-metastases-in-gynecologic-cancers-real-world-outcomes-and-prognostic-factors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/once-unthinkable-population-level-changes-in-five-year-survival-for-metastatic-non-small-cell-lung 2026-08-24 monthly 0.7 https://rjrindex.com/articles/taxane-and-platinum-combination-as-a-predictor-of-pathologic-complete-response-in-i-spy2-by-gene-exp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-transposon-baff-car-t-cells-lmy-920-for-non-hodgkin-lymphoma-nhl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-larotrectinib-in-patients-with-itrki 2026-08-24 monthly 0.7 https://rjrindex.com/articles/developing-workshops-to-enhance-self-efficacy-among-patients-in-cancer-survivorship-a-collaborative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-framework-for-monoclonal-b-cell-lymphocytosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-clinical-outcomes-for-patients-with-deficient-mismatch-repair-dmm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/explainable-ai-to-enable-precision-risk-stratification-for-advanced-melanoma-in-underrepresented-mid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-impact-of-comprehensive-genomic-profiling-in-colon-cancer-evidence-from-community-oncolo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-vistatim3-heterodimerization-and-macrophage-metabolic-reprogramming-in-microsatellite-stabl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-trends-in-early-onset-uterine-cancer-and-the-rising-bmi-attributable-burden-a-population-bas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ponv-risk-score-and-gender-as-predictors-of-delayed-ambulation-in-outpatient-thyroid-and-parathyroid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stable-colorectal-cancer-burden-in-inflammatory-bowel-disease-over-a-decade-nationwide-us-trend-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/designing-a-triple-negative-breast-cancer-patient-journey-a-multi-stakeholder-initiative-to-improve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-survival-and-treatment-compliance-of-cancer-patients-enrolled-in-medication-access-progra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/doacs-versus-vitamin-k-antagonists-for-cancer-associated-vte-updated-systematic-review-and-meta-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iparomlimab-and-tuvonralimab-pd-1ctla-4-bifunctional-antibody-monotherapy-or-combination-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-and-demographic-differences-in-genomic-testing-and-outcomes-in-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-adjuvant-treatment-strategies-in-locally-advanced-gastroesophageal-and-gastric 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-associated-bradyarrhythmias-and-inpatient-deterioration-in-us-hospitalizations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-immunotherapy-on-sotorasib-toxicity-in-nsclc-a-real-world-matched-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/brca-p-can-denosumab-reduce-breast-cancer-risk-in-ibrca1i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pre-diagnostic-imaging-and-radiology-report-based-risk-modeling-for-pancreatic-ductal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/her2-discordance-in-upper-gastrointestinal-cancers-in-a-us-based-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cider-secure-high-throughput-extraction-of-clinical-variables-from-non-english-pathology-reports-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/histopathological-patterns-of-breast-cancer-at-diagnosis-among-patients-in-the-federal-capital-terri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-trends-in-leukemia-incidence-by-age-sex-and-sociodemographic-index-a-gbd-2023-joinpoint-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridges-a-phase-3-randomized-trial-of-immediate-postoperative-cesium-131-tile-based-radiation-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-adebrelimab-combined-with-chemotherapy-followed-by-response-adaptive-concurrent-chemoradio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-trial-to-evaluate-csf-ctdna-and-safety-of-plixorafenib-alone-or-with-retifanlimab-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-the-rates-of-hypersensitivity-reactions-in-patients-undergoing-first-dose-taxanes-utilizin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/venous-thromboembolism-as-a-trigger-for-acute-cardiac-decompensation-during-cancer-hospitalizations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-reliability-of-isatuximab-subcutaneous-on-body-injector-results-across-the-phase-3-irakl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-real-world-study-on-the-efficacy-and-safety-of-anlotinib-in-combination-with-immunot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validating-a-single-item-screener-for-low-digital-health-literacy-among-surgical-oncology-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-decision-support-for-icu-admission-in-febrile-oncology-patients-optimizing-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-multi-omic-signatures-that-underlie-ikrasi-var 2026-08-24 monthly 0.7 https://rjrindex.com/articles/icbfbi-mutations-as-a-predictive-biomarker-of-endocrine-therapy-benefit-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-prognostic-impact-of-recurrence-in-esophageal-carcinoma-patients-achieving-complete-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proteomic-profiling-of-circulating-tumor-cells-ctcs-in-metastatic-urothelial-cancer-muc-as-assoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-implementation-of-an-online-family-cascade-genetic-testing-platform-the-preventive-risk-ou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-utilization-of-bispecific-t-cell-engager-therapy-for-relapsedrefractory-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oxybutynin-for-vasomotor-symptoms-across-cancer-related-and-menopause-associated-settings-a-systema 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-short-term-fasting-compared-to-free-diet-in-ovarian-cancer-patients-results-from-a-two-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precision-risk-stratification-for-lung-cancer-in-copd-evidence-from-the-all-of-us-program 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-disease-incidence-in-women-with-early-onset-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-characteristics-of-clinical-trials-presented-in-asco-plenary-sessions-2011-2025 2026-08-24 monthly 0.7 https://rjrindex.com/articles/knowledge-distillation-enabled-resnet-framework-for-hepatocellular-carcinoma-diagnosis-on-multiphase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-post-traumatic-stress-disorder-and-associated-factors-among-adult-sarcoma-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-plenary-to-practice-a-large-language-model-llm-based-thematic-analysis-of-landmark-clinical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-naive-multimodal-cfdna-mrd-assay-to-predict-recurrence-in-a-prospective-cohort-of-patients-und 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapy-related-myeloid-neoplasms-after-radioligand-therapy-in-neuroendocrine-tumors-a-multicenter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-trial-of-single-dose-neoadjuvant-pd-1-blockade-with-or-without-a-cd40-agonist-in-hpv-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-adjuvant-chemotherapy-on-survival-in-node-positive-n2n3-stage-iii-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-human-immunodeficiency-virus-on-in-hospital-outcomes-among-patients-hospitalized-with-mult 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-serpentine-trial-a-phase-ii-clinical-study-decoding-immune-responses-by-scrna-seq-and-tcr-seq-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-risk-patterns-of-secondary-breast-cancer-in-medullary-versus-papillary-thyroid-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-stromal-fak-signaling-to-address-chemotherapy-and-immunotherapy-resistance-in-gastric-type 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zanubrutinib-plus-rituximab-as-front-line-treatment-for-mucosa-associated-lymphoid-tissue-malt-lym 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-real-world-overall-survival-between-atezolizumab-and-durvalumab-containing-first-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-adjusted-survival-comparison-for-tislelizumab-tis-chemotherapy-ct-versus-placebo-pbo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/jskn016-a-first-in-class-anti-trop2her3-bispecific-antibody-drug-conjugate-adc-in-patients-pts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-feasibility-of-cabozantinib-cabo-in-combination-with-cisplatin-doxorubicin-and-high-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-tumor-fraction-tf-dynamics-to-refine-progression-free-survival-and-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/propensity-score-matched-analysis-of-trifluridine-tipiracil-plus-bevacizumab-ftdtpibev-vs-anti-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-fertility-concerns-on-endocrine-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-combined-with-liposomal-doxorubicin-and-dacarbazine-as-first-line-therapy-for-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-immune-programs-and-association-with-toxicity-burden-and-antitumor-response-during-immu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-versus-adjuvant-chemotherapy-for-resectable-high-grade-soft-tissue-sarcoma-a-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hrs-4642-combined-with-adebrelimab-in-previously-treated-patients-with-metastatic-pancreatic-ductal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subgroup-analyses-by-disease-volume-and-ide-novoi-recu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-glucagon-like-peptide-1-glp-1-receptor-agonists-on-outcomes-in-metastatic-non-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-remote-emotional-support-and-symptom-self-management-intervention-remi-a-pilot-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-effectiveness-of-decitabinecedazuridine-plus-venetoclax-versus-azacitidine-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temperature-controlled-hand-foot-cooling-for-prevention-of-chemotherapy-induced-polyneuropathy-cipn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-of-head-and-neck-cancers-in-syria-an-analysis-from-the-national-oncology-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-diagnosis-to-survivorship-mapping-the-lived-experience-of-patients-with-cancer-in-the-philippi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multidisciplinary-care-in-head-and-neck-squamous-cell-carcinoma-a-retrospective-analysis-at-a-safet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-of-a-psychosocial-oncology-consult-service-pre-post-a-one-session-educational-interventi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-surrogate-endpoints-in-health-technology-assessment-a-review-of-company-submissions-for-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reinforce-a-phase-iii-randomized-trial-of-treatment-intensification-with-docetaxel-in-metastatic-ho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-lung-cancer-burden-attributable-to-environmental-and-occupational-exposures 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determinants-of-survival-in-356-patients-failing-frontline-hma-ven-for-newly-diagnosed-aml 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-experience-and-quality-of-life-in-a-decentralized-cancer-care-model-for-advanced-prostate-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-access-to-molecular-diagnostics-and-immunotherapy-for-advanced-melanoma-in-syria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamics-of-tissue-fatty-acid-profiles-and-association-with-radiotherapy-toxicity-in-locally-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-eligibility-for-perioperative-pembrolizumab-in-resectable-locally-advanced-head-and-neck 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-mortality-following-unplanned-breast-cancer-hospitalizations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-mrna-covid-19-vaccination-on-survival-in-pembrolizumab-treated-stage-iv-colon-cancer-a-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/electronic-nicotine-delivery-systems-versus-combustible-cigarettes-a-systematic-review-and-meta-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/uterine-cancer-mortality-and-demographic-disparities-in-the-united-states-in-relation-to-female-obes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-preventable-cancer-with-unequal-outcomes-cervical-cancer-disparities-in-wisconsin-2014-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-cancer-prevalence-in-ohio-rural-urban-differences-environmental-toxicity-and-correlation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-and-disparities-in-esophageal-cancer-and-respiratory-failure-mortality-among-adults 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-influence-of-immune-checkpoint-inhibitors-on-treatment-results-in-cancer-patients-real-world-ev 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-combination-versus-single-agent-immune-checkpoint-inhibition-in-locally-advanced-msi-hd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-gedatolisib-geda-pharmacokinetics-pk-drug-drug-interactions-ddi-and-exposure-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-triplet-therapy-with-hypomethylating-agent-venetoclax-and-flt3-inhibitor-ve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-a-real-time-updated-evidence-library-in-addressing-lag-in-guideline-updates-to-aide-physic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-in-imeti-ex14-nsclc-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sintilimab-in-combination-with-cetuximab-and-chemotherapy-as-first-line-treatment-for-microsatellite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-quality-improvement-initiative-to-improve-genomic-testing-rates-in-patients-with-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-among-patients-with-high-risk-and-very-high-risk-non-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-mat2a-mediated-metabolic-pathways-a-novel-strategy-for-non-small-cell-lung-cancer-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-contributing-to-non-initiation-of-planned-systemic-therapy-among-inpatients-evaluated-for-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-the-tumor-microenvironment-in-primary-versus-metastatic-lymph-node-malignanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-genomic-landscape-of-early-onset-colorectal-cancer-a-comparative-analysis-with-averag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-malignant-neoplasms-and-alzheimers-disease-related-mortality-in-the-unite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/popliteal-node-metastasis-in-infra-popliteal-melanoma-arcane-or-mundane 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-prevalence-co-occurrence-and-descriptive-analysis-of-esr1-and-pik3ca-mutations-in-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/telehealth-use-at-the-end-of-life-among-medicare-decedents-with-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-of-multidisciplinary-therapy-combining-local-ablative-therapy-with-immune-checkpoint 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tigos-ls-an-open-label-randomized-study-of-bms-986489-atigotatug-nivolumab-fixed-dose-combinati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clarity-gbm-a-phase-ii-multi-centered-open-label-single-arm-study-to-evaluate-the-safety-and-eff 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-monitoring-in-peptide-receptor-radionuclide-therapy-treated-patients-with-gast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-zeaxanthin-alone-or-in-combination-with-pembrolizumab-in-metastatic-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-in-inpatient-incidence-of-head-and-neck-cancer-and-anatomic-subsites-in-the-united-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/menopausal-hormone-therapy-use-and-counseling-patterns-among-surgically-menopausal-brca-mutation-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rates-of-inadequate-ovarian-suppression-in-premenopausal-breast-cancer-patients-receiving-ovarian-fu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gender-distribution-of-international-cancer-research-funding 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-full-dose-apixaban-vs-rivaroxaban-for-cancer-associated-venous-thromboembolis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-ai-enabled-framework-for-pre-visit-decision-support-using-patient-similarity-analysis-in-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-actionability-and-molecular-landscapes-of-fusion-driven-sarcomas-a-multi-modal-integration 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-study-of-itp53i-mutations-in-circulating-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-pharmacovigilance-analysis-of-adverse-events-associated-with-zanidatamab-versus-trastuzu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dont-ask-dont-tell-missing-ecogs-and-anticancer-treatment-neutrophil-to-lymphocyte-ratios-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geospatial-hotspot-analysis-of-breast-cancer-in-ohio-environmental-and-rural-urban-disparities-info 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-perspectives-on-artificial-intelligence-use-in-cancer-care-confidence-adoption-and-barri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-rurality-on-screening-and-prevention-strategies-for-patients-with-hereditary-breast-and-ov 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transforming-patient-care-in-oncology-nationwide-results-of-comprehensive-genomic-profiling-guided 2026-08-24 monthly 0.7 https://rjrindex.com/articles/electronic-health-record-based-gut-disruption-and-perfluoroalkyl-and-polyfluoroalkyl-substances-drin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-myelodysplastic-syndrome-and-acute-myeloid-leukemia-among-hospitalizations-with-sickle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deficiencies-in-oncology-marketing-applications-leading-to-fda-rejections-an-assessment-of-complete 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multidisciplinary-onco-critical-care-management-clinical-impact 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-of-lymphoid-and-hematopoietic-malignancies-among-us-adults-a-cdc-wonder-based-dem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-patient-priorities-for-survivorship-care-in-older-adults-with-cancer-a-collaborative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-diasurv-an-ai-based-algorithm-for-stage-ii-colon-cancer-risk-stratification 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pilot-study-of-a-personalized-cancer-vaccine-in-combination-with-immune-checkpoint-inhibitor-in-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-prostate-cancer-mortality-among-men-with-hypertension-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antibiotics-and-immune-related-toxicity-during-pembrolizumab-therapy-in-nsclc-real-world-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inhaled-delivery-of-kb707-a-novel-hsv-based-immunotherapy-in-combination-with-pembrolizumab-in-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-bma-improve-outcomes-in-mhspc-with-bone-metastases-landmark-propensity-matched-analysis-and-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-ubenimex-combined-with-pembrolizumab-nab-paclitaxel-and-carboplatin-for-previo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-pneumonitis-risk-after-chemoradiation-and-durvalumab-by-chemotherapy-regimen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-dependent-features-of-primary-non-small-cell-lung-cancer-course-in-patients-with-previous-covid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-open-label-multi-center-single-arm-study-of-atezolizumab-and-bevacizumab-in-the-treatme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-based-volumetric-vs-bidimensional-rano-20-progression-assessment-prognostic-value-for-overall-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-immune-profiling-to-identify-gpnmb-as-a-mediator-of-immune-suppression-that-limits-response 2026-08-24 monthly 0.7 https://rjrindex.com/articles/carcinomas-of-unknown-primary-treated-with-molecularly-guided-therapies-and-immune-checkpoint-inhibi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-nivolumab-compared-with-platinum-based-chemotherapy-in-bladder-cancer-a-real-world-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-of-pembrolizumab-efficacy-and-safety-in-patients-with-nsclc-with-high-pd-l1-expr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/urinary-tumor-dna-as-a-biomarker-of-pathologic-response-and-molecular-residual-disease-in-muscle-inv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-burden-reduction-after-two-doses-of-cemiplimab-in-advanced-non-melanoma-skin-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-stage-iibiic-cutaneous-melanoma-treated-with-wide-local-excision-and-adjuvant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-northstar-ctdna-assay-for-monitoring-gastrointestinal-malignancies-a-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-neoadjuvant-chemotherapy-matter-in-endocrine-sensitive-breast-cancer-insights-from-a-10-year 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-treatment-sequencing-matter-in-stage-iv-nsclc-with-brain-metastases-a-national-cancer-database 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-engineered-tcr-t-cell-therapy-afami-cel-lete-cel-in-pediatric-synovial-sar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-delayed-sodium-thiosulfate-on-cisplatin-induced-ototoxicity-in-pediatric-and-adolescent-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-basket-trial-of-brigatinib-for-ialki-fusion-po 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erythropoietin-receptor-epor-expression-to-identify-a-biologically-aggressive-tumor-phenotype-in-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-and-immune-and-cardiopulmonary-toxicities-of-durvalumab-following-concurrent-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-potentially-inappropriate-medications-on-performance-status-functional-status-and-ov 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zongertinib-combined-with-t-dxd-in-her2-positive-metastatic-gastric-gastroesophageal-junction-or-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decision-making-and-regret-after-radical-cystectomy-in-patients-with-bladder-cancer-an-internationa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/convenience-vs-complexity-adoption-of-subcutaneous-pd-l1s-in-lung-cancer-in-eu4uk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prion-like-dynamics-of-galectin-3-as-a-driver-of-colorectal-cancer-progression-a-digital-pathology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/statistical-data-and-mortality-rates-for-prostate-cancer-from-1999-to-2021-in-the-population-of-unit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-diabetes-and-glycemic-control-on-pathologic-complete-response-after-neoadjuvant-chemothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/muc5ac-driven-transcriptional-reprogramming-for-stratification-of-pancreatic-ductal-adenocarcinoma-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-prostate-cancer-screening-in-germline-pathogenic-variant-carriers-the-patrol-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-bispecific-antibodies-in-relapsedrefractory-rr-follicular-lymphoma-fl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keynote-811-6-year-median-follow-up-of-pembrolizumab-plus-trastuzumab-and-chemotherapy-for-previous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-folfirinox-ffx-combined-with-the-glycogen-synthase-kinase-3beta-gsk-3v-inhib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-integrated-multidisciplinary-analysis-of-pre-treatment-cachexia-in-locally-advanced-non-small-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-profiling-of-antibody-drug-conjugate-target-expression-in-epithelial-ovarian-cancer-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/azeliragon-a-rage-inhibitor-plus-temozolomide-and-radiotherapy-in-patients-with-newly-diagnosed-gl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enabling-hybrid-ai-radiologist-endpoints-in-clinical-trials-imaging-workflows 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ea1181-accuracy-of-pre-surgery-mri-to-predict-pathologic-complete-response-after-taxane-trastuzuma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-between-neoadjuvant-and-adjuvant-chemo-immunotherapy-in-patients-with-stage-ii-iii 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-vulnerability-among-us-cancer-survivors-differences-by-veteran-status-and-va-health-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-response-with-survival-in-patients-with-relapsedrefractory-high-risk-neuroblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-genetic-landscape-of-individuals-evaluated-in-a-chip-cardiology-clinic-a-single-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-analysis-of-aspirin-and-structured-exercise-as-adjuvant-therapy-in-localized-colo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-plus-cetuximab-and-irinotecan-in-relapsedrefractory-rasbraf-wild-type-and-microsatell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-yes-an-mhealth-intervention-for-adolescent-and-young-adults-aya-with-breast-cancer-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overcoming-resistance-to-prior-car-t-therapy-efficacy-and-safety-of-a-sequential-multi-antigen-tar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-incidence-and-predictors-of-chronic-opioid-use-in-early-survivorship-for-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-stratification-using-baseline-objective-clinical-information-in-patients-with-stage-iv-lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-caused-by-coexisting-malignant-neoplasms-and-type-2-diabetes-mellitus-in-us-adults-a-cd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fitbit-derived-activity-and-heart-rate-patterns-for-predicting-12-month-hospitalization-in-an-nih-al 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-predictors-of-treatment-response-in-the-bounce-back-mind-body-resiliency-trial-for-aya-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/format-matters-digital-vs-print-delivery-of-a-job-retention-intervention-during-breast-cancer-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expanding-access-to-tyrosine-kinase-inhibitors-for-treatment-of-philadelphia-chromosome-positive-acu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/estimation-of-the-impact-of-chemotherapy-induced-biological-age-acceleration-on-breast-cancer-surviv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodal-diffusion-on-low-rank-approximation-radiomic-phenotypes-with-deep-learning-survival-model 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-alternative-approach-to-limiting-surgical-and-radiation-stress-in-patients-with-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-neoadjuvant-chemoradiotherapy-response-and-postoperative-recurrence-in-locally-advanced-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-the-nutripal-nutritional-screening-algorithm-in-advanced-cancer-palliative-care-a-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-converge-study-a-phase-ii-single-arm-trial-of-adebelimab-combined-with-targeted-therapy-and-li 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-performance-of-an-ai-based-recurrence-score-in-early-breast-cancer-patients-treated-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-low-and-high-grade-icans-after-car-t-a-nationwide-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-diabetes-mellitus-on-inpatient-outcomes-among-hospitalized-patients-with-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/monoclonal-gammopathy-associated-autoinflammation-a-systematic-review-and-meta-analysis-of-schnitzl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-antitumor-effect-of-2-11-dimethyl-1h-benzoeindol-2-yl-567-trichloro-13-tro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/firmonertinib-combined-with-platinum-based-chemotherapy-in-patients-with-iegfr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/consideration-of-adjusted-ideal-body-weight-dosing-in-bg-c9074-b7-h4-targeting-adc-from-pharmacoki 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-pixel-to-precision-a-systematic-review-of-ct-radiomics-in-the-diagnosis-of-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-cardiovascular-and-cerebrovascular-mortality-among-us-decedents-with-malignant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-dose-escalation-of-ctx-8371-a-novel-pd-1pd-l1-bispecific-antibody-in-patients-with-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-5-year-survival-outcomes-of-short-course-radiation-followed-by-mfolfox-6-plus-avelumab-in-lo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-trastuzumab-emtansine-t-dm1-combined-with-ribociclib-in-patients-with-her2-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-treatment-recovery-patterns-among-patients-with-early-stage-cancer-who-develop-taxane-induced-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-vt-ebv-n-on-disease-free-survival-as-post-remission-therapy-in-ebv-positive-extranodal-nk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-itonsli-on-tumor-suppressor-function-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-foxm1-in-regulating-immune-memory-in-triple-negative-breast-cancer-and-targeting-foxm1-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-driven-assessment-of-immunochemotherapy-with-or-without-fruquintinib-as-first-line-treatme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/copy-number-aberration-profiling-using-shallow-whole-genome-sequencing-based-leukoprint-in-multiple 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrocabosarc-a-phase-ii-trial-combining-pembrolizumab-and-cabozantinib-in-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-impact-of-a-statewide-intervention-on-multiple-myeloma-bispecific-t-cell-engaging-ant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-2026-primary-care-oncology-toolkit-an-evolving-shared-care-framework-for-the-implementation-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-resection-versus-stereotactic-body-radiation-therapy-in-stage-iv-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-niraparib-maintenance-on-progression-free-survival-and-overall-survival-an-updated-meta-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/monalizumab-plus-durvalumab-plus-platinum-based-chemotherapy-for-first-line-treatment-of-extensive-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fluorescence-guided-surgery-with-5-aminolevulinic-acid-5-ala-in-ovarian-fallopian-tube-and-prima 2026-08-24 monthly 0.7 https://rjrindex.com/articles/listening-explaining-caring-patient-experience-in-an-oncology-primary-care-clinic-background 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impactof-imeti-amplification-amp-on-telisotuzumab-ved 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-and-patterns-of-recurrence-for-patients-pts-with-advanced-urothelial-carcinoma-auc-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-deruxtecan-t-dxd-for-pretreated-patients-in-china-with-her2-ihc-3-solid-tumors-desti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparison-of-ipilimumab-nivolumab-dosing-strategies-in-melanoma-brain-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-ialox12bi-gene-alterations-with-tmb-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shared-treatment-decision-making-between-physicians-and-their-patients-with-metastatic-urothelial-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-engage-program-for-childhood-cancer-survivors-results-from-a-multidisciplinary-distance-delive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/smoking-signature-as-used-to-define-a-genomically-distinct-subset-of-class-i-braf-mutant-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-the-immune-effects-of-enfortumab-vedotin-and-pembrolizumab-evp-on-peripheral-blood 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-patterns-of-aspirin-and-anticoagulant-prophylaxis-at-imid-associated-vte-onset-in-multipl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-utilization-and-survival-trends-of-adjuvant-immunotherapy-in-postoperative-stage-ii-iii-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-homologous-recombination-repair-deficiencies-in-prostate-cancer-in-the-russian-federat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-patterns-and-temporal-trends-of-first-line-immunotherapy-use-in-metastatic-nsclc-in-brazi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/terminal-admission-phenotype-in-acute-myeloid-leukemia-a-national-analysis-of-inpatient-care-intens 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-controlled-multicenter-phase-3-study-of-rp1-vusolimogene-oderparepvec-combined-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-outcomes-of-neoadjuvant-pembrolizumab-among-patients-with-early-stage-triple-neg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ngs-based-idpydi-diplotype-analysis-beyond-conventional 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-and-disparities-in-cancer-related-mortality-among-adults-with-diabetes-in-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-functional-precision-medicine-strategy-to-guide-patient-selection-for-oncolytic-vaccination-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-facility-type-on-outcomes-for-elderly-patients-75-years-with-burkitt-lymphoma-real-wo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-cellular-senescence-to-enhance-skeletal-muscle-recovery-in-survivors-of-breast-cancer-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-1-inhibitor-plus-vegfr-2-inhibitor-and-chemotherapy-versus-chemotherapy-alone-for-locally-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-meaning-and-purpose-among-patients-with-cancer-and-with-elevated-psychological-distres 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intrathecal-chemotherapy-and-central-nervous-system-relapse-in-acute-lymphoblastic-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-erythrocytosis-on-overall-survival-thrombotic-events-and-risk-of-transformation-to-aml-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-study-on-the-application-of-metaproteomic-and-serum-metabolomic-integration-analysis-in-tace-combi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/organ-specific-endocrine-toxicities-and-serious-outcomes-associated-with-immune-checkpoint-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-double-blind-double-dummy-randomized-controlled-phase-3-trial-of-iparomlimab-and-tuvonralimab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/yl205-a-novel-anti-napi2b-antibody-drug-conjugate-adc-in-patients-with-ovarian-cancer-prelimina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optecoptal-a-phase-2-study-to-evaluate-outpatient-op-step-up-administration-of-teclistamab-tec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/who-receives-car-t-therapy-a-national-examination-of-racial-and-ethnic-differences-in-hospitalized 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-pralsetinib-as-first-line-treatment-of-ireti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enfortumab-vedotin-plus-pembrolizumab-evp-vs-chemotherapy-for-previously-untreated-locally-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-first-line-folfirinox-versus-gemcitabine-plus-nab-paclitaxel-in-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12a-study-of-concomitant-radiotherapy-with-olaparib-and-temozolomide-in-unresectable-high-gra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/discovery-from-single-cell-rna-sequencing-profiles-of-18-cptac-glioblastoma-patients-and-validation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-comparing-the-use-of-glp-1-agonists-in-patients-with-multiple-myeloma-and-comorb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zopapogene-imadenovec-drba-a-novel-non-replicating-adenoviral-vector-based-immunotherapy-effects-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-clinical-utility-of-an-hampe-based-tumor-origin-prediction-model 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-clinical-trial-of-intravesical-yh01-for-bcg-unresponsive-high-risk-non-muscle-invasive-bl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iegfri-mutated-lung-cancer-a-comparative-analysis-of-common-and-uncommon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-phase-11b-study-of-amg-436-as-monotherapy-and-combination-therapy-in-patients-with-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-sintilimab-plus-bevacizumab-following-curative-resection-of-spontaneously-ruptured-hepatoce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-trial-evaluating-addition-of-adjuvant-chemotherapy-to-ovarian-function-suppression-end 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-dose-escalation-study-of-the-selective-egfrher2-exon-20-inhibitor-pfl-721-in-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-antitumor-activity-of-vrn110755-a-brain-penetrant-selective-egfr-inhibitor-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-clustering-of-renal-cell-carcinoma-in-west-virginia-counties-with-historical-perfluorooct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-dosimetry-of-yttrium-90-radiation-segmentectomy-for-unresectable-hepatocellular-carcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-hematology-oncology-education-through-a-structured-ai-based-board-review-series-an-asco-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/functional-assessment-of-polymerase-proofreading-variants-to-define-sensitivity-to-immune-checkpoint 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-chemoimmunotherapy-followed-by-hypofractionated-radiotherapy-and-consolidation-immunothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-anamorelin-in-patients-with-non-small-cell-lung-cancer-and-cancer-cachexia-un 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rethinking-cancer-attribution-in-oncology-vbc-models-eampm-vs-treatment-based-approach 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tobacco-use-driven-lung-cancer-mortality-in-the-united-states-a-population-based-analysis-from-2003 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bevacizumab-rechallenge-in-platinum-resistant-ovarian-cancer-evidence-from-a-propensity-score-match 2026-08-24 monthly 0.7 https://rjrindex.com/articles/explainable-ai-to-predict-molecular-classes-of-renal-cell-carcinoma-from-digital-pathology-images 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-circulating-tumor-cells-and-association-with-early-resistance-in-patients-with-metastatic-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-oncologists-a-gpt-based-model-and-a-seer-based-survival-calculator-for-cancer-prognostic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prophylactic-peptide-vaccine-targeting-resistance-mutations-in-advanced-alk-positive-lung-cancer-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/data-driven-precision-prognostic-stratification-in-breast-cancer-leptomeningeal-metastasis-the-bc-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iaib-trial-of-fap-dox-ava6000-a-fibroblast-activation-protein-fap-released-doxorubicin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-pralsetinib-in-ireti-fusion-posi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-ultra-low-6-month-psa-cutoff-for-radiographic-pfs-stratification-in-high-volume-mhspc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-circulating-tumor-dna-dynamics-as-a-prognostic-and-predictive-biomarker-in-solid-tumors-treate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combining-hc-7366-with-belzutifan-in-patients-with-renal-cell-carcinoma-to-alter-tumor-and-microenvi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/center-level-delivery-patterns-and-capacity-during-rapid-car-t-expansion-in-the-united-states-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/timing-and-prognostic-impact-of-thromboembolic-events-in-lung-cancer-patients-treated-with-immune-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-combined-with-chemotherapy-versus-chemotherapy-alone-in-advanced-pancreatic-ductal-ade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/landscape-of-actionable-genomic-alterations-in-primary-versus-metastatic-lesions-from-chinese-lung-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-update-of-truce-01-a-phase-2-study-of-preoperative-tislelizumab-combined-with-lo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-immune-checkpoint-inhibitor-infusion-timing-on-overall-survival-in-non-small-cell-lung-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-changes-in-blood-based-immune-gene-expression-as-a-predictor-of-outcomes-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-first-in-human-fih-study-evaluating-safety-and-efficacy-of-abbv-706-results-from-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/amivantamab-in-iegfri-mutated-nsclc-with-refractory-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alzheimers-biomarkers-in-oncology-the-impact-of-cancer-treatment-on-neurodegenerative-diagnostic-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mapping-the-exhausted-and-tolerized-myeloid-populations-in-the-glioblastoma-tumor-microenvironment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparison-of-anti-gprc5d-bispecific-therapy-versus-anti-bcma-treatment-in-relapsedrefra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-response-assessment-using-pet-rano-10-and-rano-20-in-vorasidenib-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitor-adoption-timing-and-survival-in-an-urban-lung-cancer-cohort-a-landmar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-multidisciplinary-therapy-combined-with-pembrolizumab-for-patients-with-synchronou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-yl201-an-anti-b7h3-antibody-drug-conjugate-adc-in-patients-with-previously-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breaking-barriers-evaluation-of-a-low-threshold-community-based-hpv-vaccination-model-for-gender-mi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-to-enhance-detection-of-high-risk-minimal-residual-disease-in-ovarian-cancer-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antigen-presentation-suppression-as-a-hallmark-of-immune-evasion-and-poor-outcomes-in-small-cell-lun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/untreated-advanced-urothelial-carcinoma-auc-in-the-modern-treatment-era-patterns-of-care-from-a-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-treatment-of-recurrent-high-grade-gliomas-with-camrelizumab-in-combination-with-apatinib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/re-sensitizing-pd-1pd-l1-relapsedrefractory-solid-tumors-phase-1a-results-of-ios-1002-a-lilrb12 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-of-tumor-repopulating-like-epithelial-cells-and-a-repair-dominant-niche-in-pathologic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keynote-b59-an-open-label-multicenter-phase-12-study-of-efdelikofusp-alfa-gi-101a-cd80-igg4-fc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cognitive-impairment-during-anti-egfr-targeted-therapy-in-metastatic-colorectal-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-loneliness-in-glioblastoma-patients-and-caregivers-using-a-nationwide-survey 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-assisted-systematic-review-and-pooled-analysis-of-anthracycline-versus-taxane-based-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-plasmablastic-lymphoma-according-to-immune-status 2026-08-24 monthly 0.7 https://rjrindex.com/articles/international-variation-in-diagnostic-and-treatment-practices-in-patients-with-her2-ebc-the-rwe-pe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-physical-activity-patterns-and-patient-reported-cognitive-function-among-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spectrum-of-germline-pathogenic-and-novel-brca1-and-brca2-gene-mutations-in-a-cohort-of-1780-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-multi-cohort-study-with-pemetrexed-plus-cisplatin-combination-in-patients-with-relapsed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-value-of-tumor-deposits-in-prognosis-evaluation-and-clinical-stage-optimization-of-colorectal-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-adherence-to-adjuvant-endocrine-therapy-across-age-groups-in-hormone-receptor-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mdx-124-a-first-in-class-annexin-a1-targeting-antibody-in-patients-with-locally-advanced-or-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-erlotinib-versus-observation-after-complete-resection-of-iegfri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zongertinib-combination-therapy-in-her2-positive-metastatic-breast-cancer-mbc-first-results-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-adapted-step-up-local-therapy-for-malignant-portal-vein-tumor-thrombus-from-hepatic-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-study-of-cdx-1140-a-cd40-agonist-in-combination-with-capecitabine-and-oxaliplatin-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erbb-family-members-as-mediators-of-acquired-resistance-to-immunotherapy-in-high-grade-serous-ovaria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-structured-oncologist-led-home-visits-on-psychological-distress-and-resilience-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-recurrence-and-risk-factors-in-resectable-early-stage-adenocarcinoma-with-uncommon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/external-validation-of-new-prostate-cancer-risk-groups-by-psma-pet-ppp3 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-low-muscle-mass-assessed-by-bioelectrical-impedance-analysis-and-clinical-outcom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comfort-survey-a-comparison-of-the-comfort-level-of-hematologic-and-solid-tumor-oncology-specialist 2026-08-24 monthly 0.7 https://rjrindex.com/articles/consumer-wearables-and-medical-care-utilization-in-gastrointestinal-cancers-a-fitbit-data-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gut-microbiome-characteristics-in-patients-with-hormone-receptor-positive-hr-her2-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-hlx07-vs-placebo-combined-with-serplulimab-and-chemotherapy-for-nasopharyngeal-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-ipatasertib-in-combination-with-pembrolizumab-for-first-line-treatment-of-recurre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elacestrant-in-combination-with-capivasertib-in-patients-with-erher2-advanced-breast-cancer-upda 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-life-in-patients-with-gastroenteropancreatic-neuroendocrine-tumors-receiving 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mapping-access-to-retinoblastoma-care-geographic-disparities-and-service-availability-across-africa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-third-line-treatments-in-metastatic-colorectal-cancer-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-safety-of-trifluridine-tipiracil-with-or-without-bevacizumab-in-metastatic-col 2026-08-24 monthly 0.7 https://rjrindex.com/articles/atrial-fibrillation-in-hematologic-malignancies-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-related-adverse-events-and-associated-clinical-outcomes-in-cancer-patients-treated-with-immun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metformin-use-and-outcomes-among-breast-cancer-patients-on-immunotherapy-insights-from-a-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-biomarker-testing-rates-targeted-therapy-use-and-clinical-outcomes-in-patients-with-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-antibody-drug-conjugates-and-targeted-therapies-in-acute-myeloid-leukem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-efficacy-of-hereditary-cancer-didactic-training-program-for-advanced-practice-provider 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accelerate-tobacco-treatment-in-cancer-care-with-evidence-based-implementation-strategies-how-to-ge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mid-treatment-circulating-tumor-hpv-dna-to-guide-early-radiotherapy-cessation-in-hpv-associated-orop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-cancer-outcomes-through-equity-interventions-tailored-for-hispanic-families 2026-08-24 monthly 0.7 https://rjrindex.com/articles/golcadomide-golca-a-potential-first-in-class-oral-celmod-rituximab-r-in-patients-pts-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/facility-level-differences-in-treatment-patterns-and-outcomes-among-patients-aged-75-years-with-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/staging-surgery-and-relapse-patterns-in-uterine-sarcomas-a-single-institution-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/winship-4468-18-phase-ii-evaluation-of-the-effect-of-2-versus-6-hour-oxaliplatin-infusions-on-neur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-and-disparities-in-liver-cancer-incidence-in-the-united-states-1999-2022-a-joinpoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiotoxicity-and-mortality-trends-in-chemotherapy-treated-breast-cancer-patients-before-and-during 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-evaluation-of-immune-checkpoint-inhibitors-in-soft-tissue-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-soft-tissue-sarcoma-of-the-heart-in-the-united-states-1975-2022-a-seer-based-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-board-based-multi-agent-llms-with-guideline-retrieval-and-consensus-deliberation-implications 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-expenditure-of-cardioprotective-drugs-in-cancer-survivors-medical-expenditure-panel-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinicopathologic-features-and-outcomes-of-gastric-esophageal-and-gastroesophageal-junc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-context-matters-knowledge-distillation-enabled-resnet-modeling-for-noninvasive-stratificatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-strategies-and-survival-outcomes-in-hepatic-epithelioid-hemangioendothelioma-a-systematic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/declined-or-refused-electronic-health-record-documentation-of-patients-who-do-not-proceed-with-rec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-demographic-reporting-in-clinical-trials-supporting-nccn-nsclc-guidelines 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transarterial-embolization-plus-hepatic-arterial-infusion-chemotherapy-combined-with-rivoceranib-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ide892-as-monotherapy-and-in-combination-with-ide397-in-patients-with-5-methylthioadenosine-phosphor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-differences-in-survival-and-prognostic-factors-among-patients-with-mycosis-fungoides-and-seza 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-fih-dose-escalation-and-dose-optimization-study-to-evaluate-the-safety 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-conversion-surgery-survival-outcomes-and-safety-of-atezolizumab-plus-bevacizumab-with-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dexrazoxane-for-anthracycline-cardiotoxicity-prevention-in-pediatric-and-aya-cancers-systematic-rev 2026-08-24 monthly 0.7 https://rjrindex.com/articles/economic-factors-and-screening-practices-in-global-lung-cancer-staging-disparities-a-systematic-rev 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhanced-recovery-after-surgery-in-major-oncologic-head-and-neck-surgery-a-systematic-review-and-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-institutional-epidemiologic-and-oncologic-profile-of-gastrointestinal-stromal-tumors-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-clinical-study-of-pd-1-inhibitor-tislelizumab-combined-with-chemotherapy-for-unresectable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-access-gap-first-line-blinatumumab-for-kmt2a-rearranged-infant-acute-lymphoblastic-leu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liposomal-irinotecan-combined-with-5-fulv-and-bevacizumab-as-second-line-therapy-for-metastatic-col 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-and-demographic-trends-in-mortality-from-multiple-myeloma-with-coexisting-mental-and-behavi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/large-genomic-rearrangements-in-germline-ibrca12i-path 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-a-droplet-digital-pcr-test-for-monitoring-esr1-ctdna-variants-in-blood 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mapping-the-treatment-journey-following-antibody-drug-conjugate-adc-initiation-sequencing-pattern 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-inherited-cancer-care-and-its-impact-in-a-rural-setting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cytisinicline-for-smoking-cessation-among-patients-with-a-history-of-cancer-a-post-hoc-analysis-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inotuzumab-ozogamicin-versus-blinatumomab-in-pediatric-relapsedrefractory-cd22-positive-b-cell-acut 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-specific-risks-of-leukemia-in-li-fraumeni-syndrome-in-children-adolescents-young-adults-and-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-germline-ibrca12i-variants-on-breas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pulmonary-hypertension-associated-mortality-among-patients-with-lung-cancer-a-cdc-wonder-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toxicity-versus-benefit-a-prospective-matched-analysis-of-sbrt-with-vs-without-adt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-patient-reported-outcomes-measurement-information-system-promis-utilization-in-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-cardiovascular-kidney-and-metabolic-disease-in-breast-and-lung-cancer-patients-in-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-systemic-delays-in-targeted-therapy-tt-access-for-advanced-nsclc-ancslc-with-actionabl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-multi-center-study-of-kivu-107-a-novel-ptk7-targeting-antibody-drug-conjugate-adc-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dedicated-multidisciplinary-oligometastatic-breast-cancer-clinic-ombcc-as-a-platform-for-standardi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-diagnostic-delay-signature-in-rare-gynecologic-cancers-assessment-of-emergency-presentation-ac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/palliative-care-utilization-in-patients-with-iegfri-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-national-mortality-patterns-in-intrahepatic-versus-extrahepatic-cholangiocarcinoma-a-popul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-atlas-study-a-first-in-human-phase-12-trial-of-ac-225rtx-2358-in-patients-with-relapsed-or-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-non-hodgkin-lymphoma-in-sarcoidosis-patients-with-salivary-gland-involvement-a-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-donafenib-combined-with-tace-and-withwithout-pd-l1-inhibitors-for-unresect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-of-typical-and-atypical-lung-neuroendocrine-tumors-in-a-rural-us-population 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-open-label-single-arm-study-of-lirafugratinib-in-patients-with-previously-treated-unres 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-app-led-intake-model-to-expedite-diagnostic-workup-for-patients-with-suspected-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lineage-specific-outcomes-and-resource-utilization-associated-with-antiphospholipid-syndrome-and-thr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hepatic-artery-infusion-chemotherapy-plus-adebrelimab-and-bevacizumab-as-first-line-treatment-for-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-open-label-dose-escalation-study-of-car001-mrna-engineered-nb-carbite-ghd-t-cells-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tidal-a-phase-ii-study-of-the-dll3-directed-t-cell-engager-tarlatamab-in-dll3-positive-metastatic-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-phase-1-study-of-dcc-2812-monotherapy-in-patients-with-advanced-genitourinary-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-use-of-piflufolastat-f-18-and-imaging-associated-treatment-patterns-in-early-stage-prosta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acceptability-of-a-narrative-video-intervention-to-promote-clinical-trial-decision-making-among-blac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inflammatory-markers-as-predictors-of-pathological-complete-response-in-patients-with-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pain-response-with-stereotactic-body-radiation-therapy-versus-conventional-external-beam-radiotherap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-related-hypomagnesemia-and-pertuzumab-discontinuation-in-her2-positive-breast-cancer-a-de 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-pd-1pd-l1-inhibitors-combined-with-chemotherapy-in-early-stage-triple-negative-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subtype-specific-melatonin-receptor-expression-on-circulating-tumor-cells-and-associated-inflammator 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-genomic-and-transcriptomic-profiling-of-a-breast-cancer-cohort-in-the-uae-compared-with-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-incidence-and-severity-of-neurotoxicity-with-six-fda-approved-chimeric-receptor-t-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iugt1a1i-gene-variants-associated-with-irinotecan-toxicity-in-patients-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/new-oral-serd-plus-cdk46-inhibitors-in-recurrent-or-metastatic-erher2-breast-cancer-a-systemati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-baveno-vii-criteria-for-endoscopy-risk-stratification-prior-to-systemic-therapy-in-unrese 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-breast-cancer-central-nervous-system-metastases-treated-with-sacituzumab-govi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/landscape-of-peripheral-immune-response-induced-by-multimodal-thermal-therapy-combined-with-chemoimm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-sglt2i-and-glp1-agonists-on-prostate-cancer-incidence-and-outcomes-a-real-world-propensit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-concurrent-tissue-tbx-and-liquid-lbx-based-comprehensive-genomic-profiling-cgp-on-bi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racialethnic-and-age-related-disparities-in-contralateral-breast-cancer-risk-among-survivors-seer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-glp-1-receptor-agonist-use-with-mortality-and-hospitalization-in-women-with-breast-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-ii-clinical-trial-on-intratumoral-autologous-cd1c-bdca-1-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-immune-checkpoint-inhibitor-administration-timing-with-toxicity-and-survival-in-uteri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-ctdna-detection-at-the-time-of-relapse-during-melanoma-surveillance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-visceral-disease-burden-and-treatment-delivery-factors-association-with-outcomes-after-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-mortality-among-patients-with-mental-and-behavioral-disorders-in-the-united-states-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-immune-checkpoint-inhibitors-in-soft-tissue-sarcoma-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-trends-and-burden-of-gastric-cancer-mortality-in-south-asia-a-retrospective-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-infectious-workup-and-antibiotic-use-during-tarlatamab-initiation-in-patients-with-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-mitochondrial-free-radical-markers-in-endometrioid-adenocarcinoma-and-an-exp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/partial-versus-radical-nephrectomy-for-renal-cell-carcinoma-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recon-a-trainee-led-needs-informed-professional-development-and-global-connectivity-model-for-youn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/t-bren-bl-m07d1-in-patients-with-recurrent-or-metastatic-rm-ovarian-cancer-results-from-two-ph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-in-malignant-thymic-neoplasms-a-comprehensive-real-world-analysis-from-a-brazili 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dna-methylation-based-liquid-biopsy-for-longitudinal-monitoring-of-treatment-response-in-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-double-blind-placebo-controlled-pilot-study-of-add-on-beta-sitosterol-supplementation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cld-401-a-next-generation-systemic-gene-therapy-for-tumor-localized-expression-of-il-15-superagonis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-kidney-sparing-approach-using-disitamab-vedotin-plus-toripalimab-for-high-risk-upper-urinary-tract 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-virtual-transcriptome-screening-to-identify-repurposable-combination-partners-for-jin-a02 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-ii-study-of-selinexor-added-to-standard-induction-and-consolidation-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-first-in-human-study-of-yttrium-90-carbon-microspheres-in-patients-with-unresectable-hep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/next-generation-multi-cancer-early-detection-mced-assay-independent-blinded-validation-of-a-locke 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effective-colorectal-cancer-screening-in-the-united-states-comparative-analyses-of-four-molecu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-fdg-pet-based-bone-marrow-assessment-on-prognostic-accuracy-compared-to-conventional-histo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/guard-01-a-randomized-open-label-trial-of-efbemalenograstim-alfa-as-primary-prophylaxis-for-neutro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toxicity-and-efficacy-characterization-of-doxorubicin-and-trabectedin-association-versus-doxorubicin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-clonal-hematopoiesis-driven-by-mosaic-chromosomal-alterations-with-epigenetic-age-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-analysis-of-teclistamab-plus-daratumumab-in-relapsed-or-refractory-multiple-myelo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-hematotoxicity-using-ct-derived-body-composition-in-rectal-cancer-patients-receiving-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-variant-topography-of-inpm1i-mutations-in-acu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tinengotinib-tt-00420-in-advancedmetastatic-fgfr2-altered-cholangiocarcinoma-following-prior-chem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-from-an-ongoing-phase-1-study-of-lb2102-a-dntgfbr2-armored-dll3-targeted-autolo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unmet-rehabilitation-needs-in-cancer-survivors-a-population-level-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-complete-response-with-neoadjuvant-chemoimmunotherapy-in-clinical-stage-ii-iii-nsclc-a-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characteristics-of-therapy-related-myeloid-neoplasms-in-parp-inhibitor-treated-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-challenges-in-the-adoption-of-emerging-therapies-for-extensive-stage-small-cell-lung-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-role-of-immune-cell-subsets-and-intestinal-flora-in-immune-related-adverse-event-of-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-and-molecular-features-of-krukenberg-tumors-from-gastric-cancer-gc-a-single-ins 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-to-neoadjuvant-chemotherapy-in-both-the-breast-and-lymph-nodes-in-patients-with-inflammator 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dce-mri-for-assessment-of-pathologic-complete-response-after-completion-of-neoadjuvant-therapy-in-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-ischemic-stroke-and-ischemic-heart-disease-related-mortality-among-patients-with-malignanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-racial-disparities-in-pulmonary-embolism-related-mortality-among-older-adults-with-neopla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-olaparib-plus-atr-inhibitor-ceralasertib-in-patients-with-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iiia-study-of-dn022150-a-novel-selective-noncovalent-small-molecule-kras-g12d-inhibitor-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-systemic-chemotherapy-combined-with-camrelizumab-cam-and-apatinib-apa-for-bclc-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/should-we-call-every-cancer-a-rare-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/what-money-cannot-buy-addressing-the-socioeconomic-status-ceiling-effect-for-black-patients-across 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diminishing-returns-among-black-patients-with-cancer-the-intersection-of-race-and-neighborhood-soci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-immune-checkpoint-blockade-in-deficient-mismatch-repairmicrosatellite-instability-high-ga 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-it-time-to-move-beyond-graft-versus-host-disease-free-relapse-free-survival-as-a-primary-end-poi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-chemoradiotherapy-in-esophageal-adenocarcinoma-matters 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-for-minimal-residual-disease-in-colon-cancer-ready-for-prime-time 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-blockade-in-deficient-mismatch-repairmicrosatellite-instability-high-gastric-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/body-size-and-bladder-cancer-risk-a-pooled-analysis-of-prospective-studies-from-the-national-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-iiiii-trial-comparing-hepatectomy-followed-by-mfolfox6-with-hepatectomy-alone-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-quality-of-chemoradiotherapy-in-esophageal-adenocarcinoma-matters 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tissue-free-circulating-tumor-dna-assay-and-patient-outcome-in-a-phase-iii-trial-of-folfox-based-adj 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-hepatic-arterial-infusion-with-oxaliplatin-after-surgery-of-four-or-more-colorectal-li 2026-08-24 monthly 0.7 https://rjrindex.com/articles/selpercatinib-and-the-crossover-conundrum-potential-impact-of-postprogression-therapies-on-overall 2026-08-24 monthly 0.7 https://rjrindex.com/articles/addition-of-metastasis-directed-therapy-to-standard-of-care-for-oligometastatic-disease-primary-agg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/balancing-risk-benefit-and-reality-navigating-early-phase-studies-in-pediatric-diffuse-midline-gl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-phase-i-trial-of-gd2cart-cells-augmented-with-constitutive-interleukin-7-receptor-for-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-pathologic-response-evaluation-and-detection-in-circulating-tumor-dna-study-ultrasensitive-circ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-prognosis-to-action-circulating-tumor-dna-and-the-next-phase-of-risk-stratification-in-triple 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-parametric-assumptions-unsupervised-methods-enhance-dna-repair-gene-discovery-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/medicaid-expansion-and-stage-at-diagnosis-timely-initiation-and-receipt-of-guideline-concordant-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/methodologic-considerations-for-subsequent-colorectal-cancer-in-survivors-of-childhood-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evolving-medicaid-policy-and-implications-for-high-quality-cancer-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-tissue-free-circulating-tumor-dna-assay-and-patient-outcome-in-a-phase-iii-trial-of-folfox 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-il15-activated-cytokine-induced-killer-cells-after-allogeneic-hct-shows-dura 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-methodologic-considerations-for-subsequent-colorectal-cancer-in-survivors-of-childhood-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-beyond-parametric-assumptions-unsupervised-methods-enhance-dna-repair-gene-discovery-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-unmutated-igg1-a-wrong-choice-for-therapeutic-antibodies-targeting-immune-checkpoints-lessons-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-treatment-of-thyroid-cancer-asco-guideline 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-mosperafenib-a-novel-paradox-breaker-b-raf-proto-oncogene-serinethreonine-kinase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ending-the-controversy-around-pretreatment-dihydropyrimidine-dehydrogenase-dpd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-from-thresholds-to-tumor-sidedness-reframing-human-epidermal-growth-factor-receptor-2-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-from-the-genetic-information-and-family-testing-study-a-cluster-randomized-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/blood-brain-barrier-heterogeneity-in-nrg-bn007-implications-for-immunotherapy-delivery 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fullerene-for-reducing-acute-radiation-dermatitis-in-patients-undergoing-radiotherapy-for-head-and-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dear-doctor-we-still-have-no-idea-of-what-dose-of-capecitabine-you-should-prescribe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/residual-absolute-volume-of-blastema-as-a-predictor-of-clinical-outcomes-in-patients-with-wilms-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/old-dog-new-tricks-oxybutynin-for-the-treatment-of-androgen-deprivation-therapy-related-vasomotor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-rezetecan-in-human-epidermal-growth-factor-receptor-2-expressing-advanced-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-efficacy-and-safety-data-from-the-phase-iii-arrow-study-of-pralsetinib-in-patients-with-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alliance-a222001-oxybutynin-versus-placebo-for-the-treatment-of-hot-flashes-in-patients-receiving-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-blood-brain-barrier-heterogeneity-in-nrg-bn007-implications-for-immunotherapy-delivery 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-thresholds-to-tumor-sidedness-reframing-human-epidermal-growth-factor-receptor-2-in-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-design-and-objectives-for-patients-with-prostate-cancer-recommendations-from-the-prostate-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/how-much-is-enough-ultra-low-doses-of-immunotherapy-to-improve-access-and-affordability 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-limitations-in-study-design-and-stratification-in-phase-ii-stereotactic-radiosurgery-tria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-and-targeted-therapy-for-advanced-gastroesophageal-cancer-asco-guideline-update 2026-08-24 monthly 0.7 https://rjrindex.com/articles/good-oncologist-doctoring-lessons-from-the-art-of-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/when-the-system-is-the-treatment-rethinking-nonpharmacologic-breakthroughs-in-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/limitations-in-study-design-and-stratification-in-phase-ii-stereotactic-radiosurgery-trial-for-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/calypso-final-results-of-savolitinib-and-durvalumab-combination-in-metastatic-papillary-renal-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/target-trial-emulation-for-regulatory-and-clinical-decision-making-in-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-what-we-can-learn-from-leap-010-in-recurrentmetastatic-head-and-neck-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiosurgery-for-small-cell-lung-cancer-brain-metastases-comparing-the-jlgk0901-and-bwhdfci-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-hardship-before-diagnosis-influence-on-late-stage-cancer-presentation-and-the-role-of-scr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-ultra-low-dose-immunotherapy-in-relapsed-refractory-solid-tumors-phase-iii-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-ipilimumab-in-patients-with-pretreated-advanced-neuroendocrine-carcinoma-the-gco-001-ni 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-with-or-without-lenvatinib-as-first-line-therapy-for-recurrent-or-metastatic-head-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/viktoria-1-trial-of-gedatolisib-plus-fulvestrant-with-or-without-palbociclib-in-hormone-receptor-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expanding-indications-for-stereotactic-radiosurgery-in-small-cell-lung-cancer-with-brain-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-mifamurtide-in-nonmetastatic-high-grade-osteosarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-classifier-for-metabolic-subtypes-of-nasopharyngeal-carcinoma-to-guide-personalized 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disruptive-analysis-of-total-neoadjuvant-therapy-in-locally-advanced-rectal-cancer-clinical-and-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-haploidentical-donor-selection-for-pediatric-hematopoietic-cell-transplant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precision-oncology-20-guiding-magic-bullets-with-expression-based-liquid-biopsy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-bcma-chimeric-antigen-receptor-t-cell-therapy-in-patients-with-newly-diagnosed-mul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-clinician-communication-asco-guideline-update 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transarterial-chemoembolization-and-immunotherapy-another-good-marriage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mifamurtide-in-nonmetastatic-high-grade-osteosarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transarterial-chemoembolization-combined-with-camrelizumab-and-rivoceranib-for-unresectable-hepatoce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-delta-like-ligand-3-expression-across-lung-neuroendocrine-subtypes-interpreting-response 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thanksgiving-still 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemotherapy-with-capox-versus-chemoradiation-for-locally-advanced-rectal-cancer-with-un 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nationwide-mammographic-screening-among-a-large-population-of-underserved-subgroups 2026-08-24 monthly 0.7 https://rjrindex.com/articles/delta-like-ligand-3-expression-across-lung-neuroendocrine-subtypes-interpreting-response-in-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pharmacokinetics-and-safety-of-selumetinib-granule-formulation-in-children-with-symptomatic-inopera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pediatric-friendly-formulations-critical-to-maximizing-benefit-of-novel-therapeutics-such-as-selume 2026-08-24 monthly 0.7 https://rjrindex.com/articles/izalontamab-brengitecan-in-locally-advanced-or-metastatic-non-small-cell-lung-cancer-with-actionable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-focal-boosting-in-localized-prostate-cancer-in-the-era-of-systemic-therapy-and-prostate-sp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gene-therapy-related-malignancy-and-the-risk-of-cancer-exceptionalism 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incremental-progress-in-the-cervical-cancer-screening-revolution 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pivekimab-sunirine-in-blastic-plasmacytoid-dendritic-cell-neoplasm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-of-multiple-myeloma-asco-ontario-health-cancer-care-ontario-living-guideline 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quiet-work-of-clarity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-with-or-without-risk-reducing-mastectomy-in-ibrca1i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-breast-cancer-after-ovarian-cancer-in-women-with-a-pathogeniclikely-pathogenic-variant-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/focal-boosting-in-localized-prostate-cancer-in-the-era-of-systemic-therapy-and-prostate-specific-mem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-prospective-cohort-study-of-cervical-cancer-screening-using-triage-of-women-who-are-human 2026-08-24 monthly 0.7 https://rjrindex.com/articles/past-present-and-future-of-dexamethasone-in-multiple-myeloma-and-al-amyloidosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pharmacodynamics-of-camizestrant-treatment-in-postmenopausal-women-with-estrogen-receptor-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/wbc-growth-factors-asco-guideline-update 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-heavy-alcohol-use-associated-with-young-onset-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-year-clinical-outcomes-with-nivolumab-plus-ipilimumab-versus-chemotherapy-as-first-line-treatme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/threshold-dose-response-association-between-alcohol-consumption-and-risk-of-young-onset-pancreatic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/windows-of-opportunity-in-breast-cancer-learning-more-from-fewer-patients-in-a-shorter-time 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-circulating-tumor-dna-and-copy-number-alterations-on-clinical-outcome-in-relapsedrefracto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-induction-nivolumab-before-chemoradiation-in-intermediatehigh-risk-human-papillom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-power-of-i-dont-know 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-can-pathologic-complete-response-serve-as-a-valid-surrogate-end-point 2026-08-24 monthly 0.7 https://rjrindex.com/articles/axitinib-and-long-acting-octreotide-in-advanced-extrapancreatic-neuroendocrine-tumors-a-randomized 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-nivolumab-before-chemoradiation-in-high-risk-human-papillomavirus-driven-oropharynx-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-it-time-to-retire-the-unified-cancer-of-unknown-primary-concept-in-the-precision-oncology-era 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-pathologic-complete-response-serve-as-a-valid-surrogate-end-point 2026-08-24 monthly 0.7 https://rjrindex.com/articles/timing-is-of-the-essence-sequencing-immune-checkpoint-blockade-and-radiotherapy-for-success-in-lung 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erdafitinib-or-erdafitinib-plus-cetrelimab-for-patients-with-metastatic-urothelial-carcinoma-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thromboembolic-events-during-perioperative-therapy-for-resectable-and-borderline-resectable-pancreat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survivorship-after-chimeric-antigen-receptor-t-cell-therapy-for-hematologic-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-efficacy-and-biomarker-study-of-bevacizumab-for-hearing-loss-resulting-from-neurofibromatos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-enhancing-representation-and-reporting-of-body-mass-index-in-cancer-randomized-clinical-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethics-of-backfilling-in-early-phase-oncology-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-br31-trial-adjuvant-durvalumab-as-the-third-contender-in-resected-non-small-cell-lung-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stellar-phase-iii-randomized-open-label-study-of-eflornithine-plus-lomustine-versus-lomustine-alo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tbcrc-048-olaparib-expanded-expansion-cohorts-phase-ii-study-of-olaparib-monotherapy-for-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-molecular-diagnosis-paving-the-way-for-therapeutic-success-in-recurrent-astrocytoma-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-rise-and-fall-of-neoadjuvant-carboplatin-for-human-epidermal-growth-factor-receptor-2-posit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-representation-and-reporting-of-body-mass-index-in-cancer-randomized-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemoradiation-atezolizumab-in-limited-stage-small-cell-lung-cancer-results-of-nrg-oncologyallia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-electronic-patient-reported-outcomes-and-palliative-care-in-pediatric-advanced-cancer-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/international-consensus-driven-recommendations-for-patient-reported-outcome-research-objectives-in-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncology-drug-development-challenges-of-increasingly-available-therapies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-clinical-study-of-adebrelimab-and-bevacizumab-combined-with-cisplatincarboplatin-in-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-clinical-results-and-associated-biomarkers-from-an-ongoing-phase-1-study-of-fx-909-a-first 2026-08-24 monthly 0.7 https://rjrindex.com/articles/swog-s1823cctg-gcc-01-secondary-use-of-data-north-american-patterns-of-care-in-clinical-stage-i-ge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-clinicopathological-features-and-prognoses-of-de-novo-metastatic-male-and-female-bladd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progression-after-first-line-chemotherapy-with-normal-serum-tumor-markers-stm-in-non-seminomatous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-kim-1-and-ctdna-as-prognostic-markers-in-oligometastatic-clear-cell-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imges-study-a-prospective-multicentre-phase-ii-trial-of-sequential-intravesical-mitomycin-c-and-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assistance-of-a-large-language-model-based-ai-agent-in-preoperative-communication-for-reduction-of-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/associations-of-dna-damage-repair-ddr-pathway-class-and-allelic-configuration-with-survival-in-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-high-grade-prostate-cancer-at-diagnosis-in-the-united-states-from-2004-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/salvage-radiotherapy-after-radical-prostatectomy-in-a-japanese-cohort-analysis-from-the-mican-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-comparing-the-use-of-glp-1-agonists-in-patients-with-bladder-cancer-and-comorbid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-rezvilutamide-in-preventing-the-flare-phenomenon-induced-by-gnrh-agonists-in-newly-diagn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-coverage-whole-genome-sequencing-of-urinary-tumor-dna-to-characterize-genomic-correlates-of-lymp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantifying-the-hidden-burden-of-metastatic-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1b2-keymaker-u03-substudy-03c-of-belzutifan-plus-zanzalintinib-or-belzutifan-monotherapy-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-monitoring-of-self-reported-symptoms-by-patients-treated-with-cabozantinib-plus-nivolumab-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-and-physician-preferences-for-treatment-in-advanced-renal-cell-carcinoma-pear-an-internat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-cabozantinib-in-relapsed-refractory-germ-cell-tumors-gct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-delivery-of-prostate-cancer-germline-testing-at-the-department-of-veterans-affairs-a-clus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/benign-persistent-elevation-of-alphafoetoprotein-afp-after-curative-treatment-for-germ-cell-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-overall-survival-os-improvements-in-metastatic-urothelial-carcinoma-muc-across-three 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-risk-localized-prostate-cancer-treated-with-neoadjuvant-lhrh-agonistantagonist-and-enzalutamid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prognostic-role-of-pd-l1-in-penile-squamous-cell-carcinoma-a-systematic-review-and-meta-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-interruption-guided-by-on-treatment-prostate-specific-membrane-antigen-psma-petct-imagi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fifteen-year-survival-analysis-from-the-ascende-rt-randomized-trial-of-external-beam-boost-versus-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-genomic-profiling-and-circulating-tumor-dna-monitoring-to-optimize-surveillance-strategi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relapsedrefractory-clinically-advanced-ca-testicular-non-seminomatous-germ-cell-tumors-nsgct-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-trial-of-darolutamide-to-enhance-prostate-specific-membrane-antigen-expression-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-3v-hsd1-on-back-conversion-and-androgen-signaling-in-crpc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enfortumab-vedotin-ev-related-cutaneous-toxicity-to-predict-metabolic-response-on-fluorodeoxygluco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-a-diet-high-in-omega-3-polyunsaturated-fatty-acids-pufas-on-inhibition-of-soluble-epoxi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-quantitative-functional-rad51-foci-and-genomic-alterations-in-predicting-parpi-respons 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-lenvatinib-plus-pembrolizumab-in-patients-with-advanced-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/network-meta-analysis-of-second-and-later-line-therapies-in-advanced-renal-cell-carcinoma-a-compar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-innovation-to-evidence-trends-in-aiml-clinical-trials-in-gu-oncology-2010-2025 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-urinary-diversion-type-influence-long-term-renal-outcomes-after-radical-cystectomy-a-multicent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pattern-of-disease-recurrence-and-outcomes-of-localized-high-risk-renal-cell-carcinoma-rcc-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-selective-renal-tumor-embolization-combined-with-axitinib-and-reduced-dose-toripalimab-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-therapeutic-efficacy-of-radical-prostatectomy-and-external-beam-radiation-therapy-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-upfront-dose-reductions-on-efficacy-of-enfortumab-vedotin-and-pembrolizumab-evp-in-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-clinical-outcomes-with-iclostridium-butyricumi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-trial-of-belzutifan-in-participants-from-china-and-japan-with-von-hippel-lindau-disease-asso 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-results-from-climate-a-prospective-cohort-study-assessing-the-clinical-utility-of-mir-371a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-as-a-real-time-biomarker-in-marker-negative-germ-cell-tumors-gct-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-randomized-double-blind-placebo-controlled-study-of-adjuvant-saruparib-azd5305-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/saruparib-androgen-receptor-pathway-inhibitor-arpi-androgen-deprivation-therapy-adt-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-diversity-and-clinical-relevance-of-germline-dna-damage-repair-gene-variants-in-3005-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-psa-decline-patterns-in-the-chinese-subgroup-of-libertas-a-phase-3-study-of-apalutami 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomised-multicentre-phase-ii-trial-of-active-surveillance-with-or-without-six-months-of-apalu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/protact-a-first-in-human-phase-1-dose-escalation-and-expansion-study-evaluating-the-safety-tolera-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamic-investigator-initiated-enterprise-divine-in-prostate-cancer-randomized-phase-ii-trial-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surveillance-after-complete-response-cr-to-first-line-chemotherapy-chemo-in-non-seminomatous-ger 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-socioeconomic-disparities-in-early-onset-vs-late-onset-bladder-cancer-a-cross-sect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-disparities-in-variant-histology-bladder-cancer-insights-from-seer-2000-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-pharmacists-into-uro-oncology-care-evaluation-of-patient-satisfaction-and-well-being 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-trial-and-practice-real-world-data-of-adjuvant-nivolumab-in-high-risk-muscle-invasive-urot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-overlooked-culprit-tumor-size-in-muscle-invasive-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-early-circulating-tumor-dna-ctdna-response-in-advanced-urothelial-carcinoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-comparison-of-ar-v7-transcripts-from-whole-blood-and-circulating-tumor-cells-in-castrati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-sup177sup-lulu-psma-617 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-relationship-between-vasculitis-and-metastasis-in-kidney-related-urogenital-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iparp1i-and-ibrca12i-expressi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-clinical-trial-of-neoadjuvant-sasanlimab-and-stereotactic-body-radiation-therapy-as-an-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-post-hifu-surveillance-diagnostic-performance-of-18f-psma-petct-and-mpmri-for-local-pros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fixed-low-dose-nab-paclitaxel-with-tislelizumab-in-non-metastatic-bladder-cancer-a-post-hoc-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-prediction-of-psa-nadir-in-metastatic-castration-sensitive-prostate-cancer-with-machine-learni 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-renal-cell-carcinoma-with-sarcomatoid-differentiation-treated-with-first-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-demographic-disparities-in-prostate-cancer-patients-undergoing-radical-prostatectomy-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-pro-from-a-dose-escalation-and-expansion-trial-of-fractionated-and-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-method-of-analysis-that-uses-standard-of-care-psa-values-to-help-guide-optimal-treatment-dec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-prostate-specific-antigen-response-and-overall-survival-in-metastatic-hormone-sensitive-prosta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-urothelial-carcinoma-with-squamous-differentiation-with-nectin-4-expression-and-outco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-deruxtecan-t-dxd-in-pretreated-patients-pts-with-her2-expressing-bladder-cancer-fin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gemcitabine-intravesical-system-plus-cetrelimab-or-cetrelimab-alone-as-neoadjuvant-therapy-in-muscle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-pembrolizumab-plus-belzutifan-versus-pembrolizumab-for-clear-cell-renal-cell-carcinoma-ccr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mri-targeted-biopsy-with-index-lesion-ipsilateral-or-bilateral-systematic-biopsy-in-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lunar-safety-and-efficacy-evaluation-of-nadofaragene-firadenovec-instilled-into-the-renal-pelvis-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/any-regression-of-tumor-art-to-discriminate-improvement-in-overall-survival-os-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-cell-detection-and-prognostic-relevance-in-patients-with-metastatic-genitourinary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-implications-of-prostate-specific-antigen-psa-flare-and-response-dynamics-in-talapro-2-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiometabolic-healths-influence-on-outcomes-in-men-with-localized-high-risk-prostate-cancer-hrpc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nezastomig-anti-psmacd28-with-or-without-cemiplimab-anti-pd-1-in-patients-with-metastatic-castr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-use-and-effectiveness-of-first-line-enfortumab-vedotin-ev-with-pembrolizumab-p-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-radium-223-in-the-frontier-study-impact-of-prior-up-front-therapy-in-mcrpc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-neoadjuvant-chemotherapy-on-perioperative-outcomes-following-nephroureterectomy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-access-to-clinical-trial-participation-among-underrepresented-kidney-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-use-of-novel-hormonal-therapies-in-european-and-north-american-patients-pts-with-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-monitoring-of-biochemically-recurrent-prostate-cancer-bcr-using-prostate-specific-memb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fgfr-altered-metastatic-urothelial-carcinoma-in-the-real-world-setting-insight-from-the-multicenter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serum-amyloid-a4-and-cognitive-functioning-in-long-term-testicular-germ-cell-tumor-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-omic-remodeling-of-urine-exposed-ileal-mucosa-after-ileocystoplasty 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-design-and-objectives-for-prostate-cancer-recommendations-from-the-prostate-cancer-clinical-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/membranous-nectin-4-expression-to-predict-enfortumab-vedotin-response-in-metastatic-urothelial-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-preoperative-glycemic-control-and-outcomes-after-radical-prostatectomy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-os-in-elderly-frail-or-high-comorbidity-veterans-receiving-androgen-receptor-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-darolutamide-safety-and-effectiveness-in-nonmetastatic-castration-resistant-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-vs-switch-maintenance-checkpoint-inhibition-in-urothelial-carcinoma-a-systematic-review-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-predictors-of-primary-retroperitoneal-lymph-node-dissection-p-rplnd-vs-primary-chemot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fruquintinib-combined-with-everolimus-in-chinese-patients-with-advancedmetastatic-clear-cell-renal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biopsy-patterns-following-high-intensity-focused-ultrasound-as-assessed-by-capra-score 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-in-the-real-world-utilization-of-177lu-psma-617-in-metastatic-castrate-resistant-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/discontinuation-rates-among-patients-with-metastatic-castration-sensitive-prostate-cancer-mcspc-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-clinico-genomic-characterization-reveal-more-aggressive-prostate-cancer-among-older-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-baseline-hot-flashes-on-sleep-metrics-during-initial-treatment-in-libertas-clinical-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-mutational-burden-to-predict-overall-survival-independent-of-tp53-status-in-tcga-bladder-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-renal-function-in-non-hydronephrotic-patients-receiving-pd-1-icis-for-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-sacituzumab-govitecan-sg-plus-pembrolizumab-pembro-followed-by-response-adapted-bla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-outcomes-with-second-line-2l-therapies-in-patients-pts-with-advanced-urot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aspire-gct-a-single-arm-phase-ii-clinical-trial-of-aspirin-to-prevent-venous-thromboembolism-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiographic-recurrence-patterns-for-prostate-cancer-with-pathologic-lymph-node-involvement-followin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-based-detection-of-treatment-emergent-metastatic-neuroendocrine-carcinoma-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ierbb3i-altered-clinically-advanced-urothelial-bladder-cancer-genomic-lan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liquid-biopsy-based-detection-of-mtap-gene-loss-in-non-muscle-invasive-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/resq133a-nmibc-a-phase-12-clinical-trial-of-intravesical-recombinant-mycobacterium-bacillus-calmet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-analysis-of-treatment-responses-to-enfortumab-vedotin-combined-with-pembrolizumab-evp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-to-guide-response-adapted-bladder-preservation-in-muscle-invasive-blad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-time-to-next-treatment-in-metastatic-urothelial-cancer-patients-enfortumab-vedotin-and-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-genomic-prognostic-and-hallmark-signatures-from-decipher-grid-to-predict-adverse-outcome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognosis-of-patients-pts-with-synchronous-vs-metachronous-metastatic-or-locally-advanced-urotheli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequencing-of-therapeutic-agents-before-and-after-metastatic-castration-resistant-prostate-cancer-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/skeletal-muscle-index-as-a-prognostic-and-predictive-biomarker-in-de-novo-hormone-sensitive-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-2-trial-of-lenvatinib-plus-pembrolizumab-with-or-without-stereotactic-body-radiot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multiomics-approach-for-patient-stratification-and-novel-target-identification-in-metastatic-clear-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-us-community-based-evaluation-of-recurrence-among-non-muscle-invasive-bladder-cancer-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genome-wide-association-to-identify-snps-associated-with-severe-adverse-events-and-clinical-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fruquintinib-plus-serplulimab-as-first-line-therapy-in-metastatic-or-unresectable-non-clear-cell-ren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rescuing-cancer-immunotherapy-with-plasma-exchange-in-bladder-cancer-1-recipe-b1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/external-validation-of-a-digital-pathology-based-multimodal-artificial-intelligence-mmai-derived-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inherited-risk-for-prostate-cancer-pca-following-the-natural-history-of-men-with-increased-geneti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-of-nivolumab-plus-cabozantinib-in-metastatic-renal-cell-carcinoma-mrcc-using-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-rules-based-ai-triage-system-to-identify-nccn-indicated-genetic-testing-in-prostate-cancer-a-perf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-cancer-causes-of-death-in-patients-with-hormone-sensitive-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatially-resolved-her2-and-ar-expression-in-prostate-cancer-and-its-implications-for-her2-as-a-dist 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-urinary-exosomal-fam153c-rpl19-in-detection-and-risk-stratification-of-prostate-cancer-a-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effects-of-sodium-glucose-cotransporter-2-inhibitor-use-on-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-management-and-multidisciplinary-care-in-highvery-high-and-intermediate-risk-localized 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-treatment-burden-of-bcg-versus-sequential-gemcitabine-and-docetaxel-for-non-muscle-invas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-pembrolizumab-in-non-clear-cell-renal-cell-carcinoma-after-nephrectomy-an-international-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sppade-symptom-burden-and-epro-based-outcome-prediction-in-patients-with-mcrpc-treated-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-transitions-and-healthcare-resource-utilization-in-patients-with-metastatic-cas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/carboplatin-in-patients-with-metastatic-castration-resistant-prostate-cancer-harboring-somatic-or-ge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/opportunities-for-precision-oncology-real-world-patterns-and-disparities-in-fgfr3-testing-among-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ideate-prostate01-a-phase-3-randomized-open-label-study-of-ifinatamab-deruxtecan-versus-docetaxel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sup177sup-lulu-psma-617-sup1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-global-gaps-expanding-gu-oncology-education-through-iecho-telementoring 2026-08-24 monthly 0.7 https://rjrindex.com/articles/four-year-outcomes-of-a-genetic-based-screening-protocol-for-prostate-cancer-unveiling-the-italian 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preoperative-muscle-quantity-to-predict-acute-kidney-injury-after-radical-cystectomy-a-multicenter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aligning-goals-of-care-at-the-time-of-treatment-planning-with-the-abc123-framework-a-pilot-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-tumor-methionine-metabolism-via-mat2a-on-cd8-t-cell-exhaustion-through-sam-chop-axis-in-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-pro-and-tolerability-of-capivasertib-capi-plus-abiraterone-abi-versu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hcrn-gu22-598-phase-2-trial-of-enfortumab-vedotin-plus-pembrolizumab-with-selective-bladder-sparing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1b2-study-of-combination-sup177sup-lu-girentuxim 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preoperative-ct-radiomics-deep-learning-signature-for-lymphovascular-invasion-in-bladder-cancer-ext 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-application-of-50-tesla-non-enhanced-mri-in-the-preoperative-assessment-of-renal-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/external-validation-of-ai-age-discrepancy-as-a-measure-of-frailty-in-kidney-tumor-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-serum-kidney-injury-molecule-1-with-treatment-response-and-survival-in-metastatic-ren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-silence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-dynamics-as-a-predictive-biomarker-of-response-and-survival-in-metastatic-urot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-dna-repair-gene-gdrg-variants-in-bcg-un-responsive-patients-a-potential-genetic-implicat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-of-androgen-deprivation-therapy-with-time-to-dementia-a-large-competing-risk-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-concordance-of-prostate-cancer-clinical-trials-and-disease-incidence-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-androgen-receptor-inhibitors-for-the-treatment-of-metastatic-castration-sensitive-prostate-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/membranous-and-cytoplasmic-nectin4-expression-and-outcomes-with-enfortumab-vedotin-plus-pembrolizuma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metaproteomics-based-subtypes-in-muscle-invasive-bladder-carcinoma-and-association-with-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-darolutamide-monotherapy-in-patients-with-castration-sensitive-prostate-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mechanistic-insights-into-bacillus-calmette-guerin-bcg-sensitivity-in-non-muscle-invasive-bladder 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-early-quality-of-life-qol-changes-on-io-based-regimens-in-the-prospective-observational 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unveiling-the-rare-p16-expression-and-real-world-management-of-penile-cancer-in-bolivia-insights-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-treatment-approaches-on-survival-in-bulky-node-positive-penile-squamous-cell-carcinoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-treatment-patterns-in-patients-with-locally-advanced-or-metastatic-urot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthcare-utilization-and-expenditure-burden-in-bladder-cancer-a-nationally-representative-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-of-enfortumab-vedotin-in-patients-with-advanced-urothelial-cancer-in-spain-the-enfa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-immune-related-adverse-events-iraes-and-treatment-discontinuation-rates-tdr-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-ii-trial-of-maintenance-oral-etoposide-versus-observation-following-high-dose-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-and-ipilimumab-maintenance-therapy-for-advanced-or-metastatic-urothelial-carcinoma-final 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigation-of-the-portos-gene-expression-signature-and-the-benefit-of-docetaxel-in-the-ecog-acrin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-docetaxel-in-combination-with-177-lutetium-psma-iampt-in-patients-with-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-outcomes-among-patients-with-localized-prostate-cancer-lpc-undergoing-radical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-comparing-the-use-of-glp-1-agonists-in-patients-with-renal-cell-carcinoma-rcc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-tislelizumab-in-combination-with-disitamab-vedotin-rc48-followed-by-distal-ureterectom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/body-composition-metrics-and-clinical-outcomes-for-patients-with-metastatic-castration-resistant-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiation-dose-tailoring-guided-by-enhanced-targeting-radtarget-a-multi-center-randomized-control 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-overall-survival-results-from-the-eortc-1333peace-3-trial-enzalutamide-with-or-without-radiu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-co-occurrence-of-targetable-key-genomic-alterations-genalt-in-metastatic-prostate-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-sup177sup-lulu-psma-617 2026-08-24 monthly 0.7 https://rjrindex.com/articles/triplet-therapy-with-adt-darolutamide-and-biweekly-docetaxel-for-high-risk-metastatic-castration-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pam50-intrinsic-subtyping-and-decipher-genomic-classifier-in-biochemically-recurrent-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-multiparametric-prostate-mri-mpmri-vs-positive-biopsy-cores-on-risk-of-adverse-path 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evaluation-of-olaparib-combined-with-novel-hormone-therapy-in-metastatic-castration-resis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-variations-in-bladder-cancer-bc-clinical-trial-availability-within-the-united-states-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastatic-lesion-location-and-avidity-on-baseline-psma-petct-as-predictor-of-duration-of-lu177-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/head-to-head-comparison-of-pembrolizumab-axitinib-versus-pembrolizumab-lenvatinib-in-metastatic-rcc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/representation-of-latin-american-oncologists-in-oral-sessions-at-the-asco-genitourinary-cancers-symp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liquid-biopsy-for-detection-of-ddr-gene-alterations-in-metastatic-prostate-cancer-mpc-diagnostic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-on-patients-characteristics-guiding-physicians-choice-of-first-line-treatment-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/polypharmacy-and-potential-drug-drug-interactions-with-novel-androgen-receptor-signaling-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metabolic-reprogramming-in-chromophobe-renal-cell-carcinoma-transcriptomic-insights-into-the-transi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-outcomes-of-bladder-cancer-racial-and-socioeconomic-disparities-in-a-nationally-represent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liquid-biopsy-guided-disitamab-vedotin-combined-with-toripalimab-and-radiotherapy-for-multimodal-org 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aspire-a-randomized-phase-iii-trial-of-androgen-deprivation-therapy-adt-plus-apalutamide-a-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-assessment-of-actinium-225-prostate-specific-membrane-antigen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-genomic-profiling-in-prostate-cancer-clinical-relevance-of-brca12-pathogenic-variant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rejoice-pantumor01-a-phase-2-signal-seeking-study-of-raludotatug-deruxtecan-r-dxd-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-cell-free-dna-methylation-as-a-predictive-biomarker-for-hormonal-therapy-response-in-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-lu-177-dgul-in-a-phase-2-study-of-patients-with-metastatic-castration-resista 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diabetic-retinopathy-as-a-marker-for-renal-cell-carcinoma-among-patients-with-type-2-diabetes-mellit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-as-modifier-of-early-proteomic-remodeling-after-androgen-deprivation-therapy-adt-in-prostate-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-genomic-classifier-scores-and-initial-management-of-localized-prostate-cancer-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-survival-outcomes-of-primary-sarcoma-of-the-kidney-psk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-neoadjuvant-chemotherapy-guided-bladder-preservation-in-muscle-invasive-bladder 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-clinical-impact-of-germline-variants-in-dna-repair-genes-in-patients-who-underwent-curative-surg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultra-hypofractionated-radiotherapy-and-concomitant-oral-relugolix-for-treatment-of-intermediate-ris 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-intravesical-gemcitabinedocetaxel-plus-systemic-pembrolizumab-in-high-risk-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bladder-full-or-empty-for-pelvic-radiation-therapy-before-a-multi-center-randomized-controlled-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-ca9-and-psma-expression-in-clear-cell-renal-cell-carcinoma-ccrcc-and-the-effect-of-pri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-her2-ihc-on-enfortumab-vedotin-ev-or-evpembrolizumab-evp-benefit-in-metastatic-urothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-from-phase-ii-enfortumab-vedotin-plus-toripalimab-compared-to-gemcitabine-cispla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncological-outcomes-and-her2-expression-of-urothelial-carcinoma-with-squamous-differentiation-a-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-a-urinary-dna-methylation-biomarker-test-in-the-diagnosis-and-surveillance-of-up 2026-08-24 monthly 0.7 https://rjrindex.com/articles/are-long-term-remissions-possible-with-hormonal-therapy-only-post-hoc-analysis-of-embark-examining 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deferred-cytoreductive-nephrectomy-in-patients-with-advanced-rcc-treated-with-first-line-nivolumab-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptomic-deep-learning-approach-for-predicting-chemotherapy-response-to-cisplatin-and-gemcitab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extra-pc-a-phase-ii-trial-of-masofaniten-epi-7386-and-enzalutamide-with-androgen-deprivation-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b2-study-of-for46-in-combination-with-enzalutamide-enza-in-patients-with-metastatic-cast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-first-in-human-study-of-avzo-103-a-bispecific-nectin4trop2-antibody-drug-conjugate-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-durvalumab-in-completely-resected-early-stage-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-subsequent-therapies-post-enfortumab-vedotinpembrolizumab-evp-in-patients-pts-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/urinary-tumor-dna-utdna-and-circulating-tumor-dna-ctdna-in-patients-pts-with-muscle-invasive-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/belzutifan-bel-plus-lenvatinib-lenva-versus-cabozantinib-cabo-for-advanced-renal-cell-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ev-prime-phase-ibii-study-of-enfortumab-vedotin-and-pembrolizumab-combined-with-radiotherapy-as-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-and-clinical-correlates-of-belzutifan-treatment-in-renal-cell-carcinoma-rcc-a-retrospecti-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-safety-efficacy-pharmacokinetics-pk-and-pharmacodynamics-pd-of-pasritamig-in-asian-pop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-study-exploring-genomic-correlates-of-clinical-outcome-in-patients-with-metastatic-cas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plant-based-dietary-indices-and-quality-of-life-in-men-with-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-quality-of-life-qol-with-novel-hormonal-therapy-nht-in-metastatic-castration-sensit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serum-igg-a-novel-biomarker-for-efficacy-and-prognosis-in-metastatic-clear-cell-renal-cell-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-renal-cell-carcinoma-mortality-associated-with-tobacco-use-in-us-adults-aged-45-years 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-social-determinants-of-definitive-surgical-management-in-bladder-cancer-a-two-decade-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-utility-of-tumor-mutational-burden-in-older-adults-75-years-with-bladder-cancer-a-tcg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-endpoints-as-surrogates-for-overall-survival-in-metastatic-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-survival-outcomes-among-lutetium-177-experienced-patients-with-metastatic-cas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dose-optimisation-and-psma-receptor-intensification-with-sup177sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-results-of-a-dose-escalation-study-evaluating-iclostridium-butyricumi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-utilization-of-tissue-free-ctdna-monitoring-in-patients-with-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-computational-histology-artificial-intelligence-chai-prognostic-bi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-characterization-of-upper-tract-urothelial-carcinoma-utuc-with-or-without-sarcomatoid-diff 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-depressive-symptoms-in-men-with-advance-prostate-cancer-pc-results-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-profile-of-darolutamide-adt-compared-to-enzalutamide-apalutamide-and-abiraterone-in-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/etctn-10483-phase-ib-trial-of-erdafitinib-e-combined-with-enfortumab-vedotin-ev-following-prior 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aggressive-variant-prostate-cancer-features-and-therapeutic-outcomes-in-patients-with-de-novo-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-the-2025-nccn-update-in-defining-very-high-risk-prostate-cancer-on-surgical-outcomes-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-molecular-evolution-of-treatment-emergent-small-cellneuroendocrine-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-among-patients-with-metastatic-hormone-sensitive-prostate-cancer-in-contemporary-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-oncological-outcomes-of-prostate-cancer-upgrading-following-robot-assisted-radical-prostat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sacituzumab-tirumotecan-sac-tmt-plus-pembrolizumab-pembro-in-participants-pts-with-advanced-ur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-abiraterone-versus-enzalutamide-on-depression-and-anxiety-in-hormone-sensitive-prostate-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-rising-psa-during-salvage-radiotherapy-post-radical-prostatectomy-on-relapse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-cancer-correlating-the-clinical-phenotype-to-the-genotype 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-safety-and-cost-effectiveness-of-reduced-vs-full-initial-dose-androgen-receptor-signalin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-quality-of-life-endpoint-planning-and-reporting-in-phase-iii-genitourinary-oncology-ra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-trial-of-pembrolizumab-p-with-response-guided-bladder-sparing-in-patients-with-muscle-inva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-frailty-and-quality-of-life-in-low-income-uninsured-men-with-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/p3bep-anzup-1302-an-international-randomized-phase-3-trial-of-accelerated-versus-standard-bep-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-delayed-cytoreductive-nephrectomy-in-patients-with-metastatic-clear-cell-renal-cell-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-efficacy-of-belzutifan-in-pre-treated-renal-cell-carcinoma-a-real-world-retrospective-coho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tanker-70-tgf-v-receptor-type-2-knockout-allogeneic-nk-cells-for-renal-cell-carcinoma-expressing-cd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ivonescimab-in-metastatic-clear-cell-renal-cell-carcinoma-mccrcc-after-immune-checkpoint-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-coexisting-amyloidosis-with-survival-outcomes-in-bladder-cancer-a-real-world-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cytoshrink-a-randomized-phase-ii-trial-of-cytoreductive-stereotactic-hypofractionated-radiotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-performance-of-sup18sup-f-flotufolastat-pet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-first-line-1l-treatment-tx-patterns-and-overall-survival-os-in-patients-pts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-genomic-dedifferentiation-signature-to-predict-clinical-outcomes-with-doublet-vs-triplet-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-in-resected-renal-cell-carcinoma-active-monitoring-vs-durvalumab-and-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-transcriptomic-characterization-of-nectin-4-expression-in-penile-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-binary-dual-stain-immunohistochemistry-classifier-to-predict-pathologic-downstaging-after-neoadjuv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-it-time-to-redefine-the-phoenix-criterion-for-biochemical-failure-in-the-era-of-psma-petct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-randomized-cross-over-trial-to-assess-patient-preference-for-goserelin-microsphere-v 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-randomised-control-clinical-trial-of-radiotherapy-with-radiosensitisation-versus-intrave 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-luxar-02-phase-ii-study-of-luxdegalutamide-in-combination-with-sup177s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-and-adjuvant-enfortumab-vedotin-ev-plus-pembrolizumab-pembro-for-participants-with-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/avelumab-ave-in-combination-with-other-anticancer-agents-as-first-line-maintenance-1lm-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fapfn1cav1-cancer-associated-fibroblast-subtype-and-its-association-with-aggressive-behavior-in-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gaps-in-brca-mutation-testing-among-mcrpc-patients-insights-from-us-cancer-practices-2018-2024 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-associations-between-serum-oxo-androgens-race-and-radiographic-progression-free-surviva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mevpro-3-phase-iii-trial-of-mevrometostat-plus-enzalutamide-versus-placebo-plus-enzalutamide-in-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-concomitant-distant-lymph-node-metastases-in-metastatic-hormone-sensitive-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-comorbidity-as-a-predictor-of-poorer-survival-and-arpi-efficacy-in-metastatic-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-psa-and-metastatic-prostate-cancer-at-presentation-in-the-united-states-from-2004-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-opinions-and-treatment-guidance-in-non-or-minimally-metastatic-testicular-cancer-is-chatgpt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-systemic-therapy-in-penile-cancer-a-single-center-experience-from-a-tertiary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-neoadjuvant-intravesical-mitomycin-c-therapy-administered-immediately-prior-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-ai-assisted-eligibility-screening-for-prostate-cancer-clinical-trial-match 2026-08-24 monthly 0.7 https://rjrindex.com/articles/new-prostate-cancer-risk-groups-by-psma-pet-ppp3 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-bolstering-outcomes-by-optimizing-immunotherapy-strategies-with-evolocumab-and-nivo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frequency-and-determinants-of-reproductive-organ-involvement-in-female-patients-undergoing-radical-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tulmistar-02-a-phase-iii-open-label-study-of-dose-escalation-and-expansion-of-tulmimetostat-in-com 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-social-environment-on-prostate-cancer-care-across-the-clinical-risk-spectrum-for-black-men 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-national-analysis-of-the-impact-of-opioid-use-disorder-on-clinical-outcomes-in-hospitalized-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncoeducate-a-pilot-study-of-generative-ai-to-support-patient-education-in-gu-cancer-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-and-outcomes-of-response-adapted-and-retreatment-sup177sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/short-term-intensified-pembrolizumab-and-tivozanib-for-high-risk-renal-cell-carcinoma-strike-alli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/heterogeneity-and-synergistic-inhibition-of-the-polyadp-ribose-polymerase-and-androgen-receptor-si 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rucaparib-vs-docetaxel-dtx-or-second-generation-androgen-receptor-pathway-inhibitor-arpi-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-programmed-cell-death-protein-ligand-1-nuclear-translocation-mediated-by-enolase-on-urothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-radiographic-and-genomic-predictors-of-response-to-neoadjuvant-chemotherapy-for-high-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antibody-drug-conjugates-in-genitourinary-malignancies-the-clinical-trial-landscape-and-emerging-ef 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantifying-the-value-of-tumor-response-and-survival-perceived-monetary-loss-in-anticancer-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-non-muscle-invasive-bladder-cancer-nmibc-genomic-score-ngs-to-predict-early-bcg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-treatment-tx-patterns-and-outcomes-in-patients-pts-with-locally-advanced-or-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-for-precision-oncology-moving-beyond-feasibility-and-safety 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keymaker-u03-substudy-03b-novel-investigative-regimens-for-previously-treated-advanced-clear-cell-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-phenotyping-and-trial-emulation-to-identify-checkpoint-inhibitor-responders-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/three-versus-6-months-of-adjuvant-oxaliplatin-fluoropyrimidine-chemotherapy-for-colorectal-cancer-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/persian-trial-nct03449719-predictive-features-of-complete-biochemical-response-within-a-randomize 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-artificial-intelligence-digital-pathology-algorithm-to-predict-outcomes-in-a-cohort-of-men-diagno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-survival-disparities-and-comorbidity-predictors-with-lu-177-psma-617-and-parp-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-sup177sup-lu-psma-617-in-chi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-a-prospective-single-center-phase-ii-study-on-modern-androgen-deprivation-therapy-follow 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-without-causality-between-bap1-loss-and-the-metastasis-associated-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethnic-disparities-and-variations-in-testicular-germ-cell-tumours-a-retrospective-real-world-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-multi-center-phase-ibii-trial-of-first-line-cadonilimab-plus-axitinib-in-advanced-n-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigation-of-the-natural-killer-nk-cell-axis-in-decoy-resistant-il18-treatment-in-bladder-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-heterogeneity-in-urothelial-carcinoma-with-trophoblastic-differentiation-real-world-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-outcomes-of-open-versus-robot-assisted-radical-nephrectomy-with-ivc-thrombectomy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-rx-patterns-and-attrition-rates-in-patients-pts-with-metastatic-castration-resistant-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-body-composition-on-the-efficacy-of-chemotherapy-in-men-with-metastatic-aggressive-vari 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-asp5541-prl-02-a-long-acting-intramuscular-depot-injection-of-abiraterone-decano 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whole-genome-based-ultrasensitive-circulating-tumor-dna-clearance-as-a-biomarker-of-exceptional-outc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-platelet-polygenic-risk-score-to-predict-renal-cell-carcinoma-survival-via-sustained-thromb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-circulating-tumor-dna-profiling-in-patients-with-metastatic-urothelial-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/turning-the-tide-in-recurrent-nsgct-retrospective-insights-into-tip-vs-non-tip-salvage-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/icon-trial-phase-iii-trial-of-inulin-gel-in-combination-with-ipilimumab-and-nivolumab-in-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-symptomatic-hypoxia-in-a-high-altitude-cohort-of-patients-with-renal-cell-carcinoma-rc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-there-an-opportunity-for-checkpoint-inhibition-in-myc-amplified-castration-resistant-prostate-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/renal-outcomes-following-sup177sup-lu-psma-617-lupsma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-hospitalizations-on-health-related-quality-of-life-and-overall-survival-in-metastatic-cast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-open-label-randomized-dose-finding-and-dose-expansion-study-of-gedatolisib-in-combina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-practice-of-active-surveillance-for-prostate-cancer-trends-variation-and-quality-within-a-lar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/establishment-and-characterization-of-a-panel-of-prostate-adenocarcinoma-xpdx-models-representing-na 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-liquid-biopsy-targeted-proteomic-assay-to-predict-outcomes-in-castration-resistant-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-ibrcai-real-world-outcomes-with-polyadp-ribos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/topline-results-from-bond-003-cohort-p-a-multi-national-single-arm-study-of-intravesical-cretostim 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-steroid-pretreatment-on-adverse-events-and-overall-survival-during-enfortumab-vedotin-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-fgfr3-alterations-on-first-line-platinum-based-chemotherapy-in-patients-with-metastatic-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-utilization-and-timing-of-initiation-of-bone-targeting-agents-btas-in-patients-with-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-microenvironmental-nrg1-activation-of-her3-as-a-driver-of-resistance-to-pi3k-pathway-inhibitio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-invasive-prostate-cancer-subtyping-using-5hmc-sequencing-of-cell-free-dna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-clinical-evidence-based-risk-estimator-for-individualizing-benefit-and-response-in-oligometastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-neoadjuvant-chemotherapy-nac-use-in-stage-ii-iii-bladder-cancer-a-california-cancer-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-composite-biomarker-approach-to-withhold-neoadjuvant-chemotherapy-in-select-muscle-invasive-bladde 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stockholm3-mri-population-based-screening-two-year-outcomes-comparing-stockholm3-and-psa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/homologous-recombination-deficiency-signature-hrdsig-in-adenocarcinoma-of-the-bladder-acb-impli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-transcriptomic-investigation-of-the-cell-of-origin-and-oncogenic-pathways-across-variant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mir-371a-3p-as-a-potential-biomarker-for-monitoring-disease-activity-and-therapeutic-response-in-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrative-genomic-landscape-of-germline-exome-alterations-in-renal-cell-carcinoma-unclassified-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/structured-step-based-prehabilitation-before-radical-cystectomy-and-its-impact-on-postoperative-reco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-disparities-in-the-availability-of-renal-cell-carcinoma-rcc-clinical-trials-in-the-unit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-computational-histology-artificial-intelligence-chai-powered-prognos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-prostate-specific-antigen-psa-doubling-time-dt-and-prostate-specific-membrane-ant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metformin-effects-on-renal-function-in-mcrpc-during-psma-radiopharmaceutical-therapy-rpt-a-retros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/availability-of-clinical-trials-investigating-prostate-cancer-pc-in-the-united-states-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/skeletal-related-event-impact-on-prostate-cancer-mortality-in-the-older-population-in-the-us-a-24-y 2026-08-24 monthly 0.7 https://rjrindex.com/articles/consensus-guidance-on-early-identification-and-management-of-peripheral-neuropathy-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-outcomes-of-enfortumab-vedotin-plus-pembrolizumab-versus-platinum-based-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-burden-of-recurrence-among-older-adults-with-muscle-invasive-bladder-cancer-undergoing-tri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-metastatic-bladder-cancer-patients-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-ctdna-guided-adjuvant-atezolizumab-atezo-in-muscle-invasive-bladder-cancer-mi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthy-donor-fecal-microbiota-transplantation-combined-with-immunotherapy-in-metastatic-renal-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/succinate-dehydrogenase-b-deficient-renal-cell-carcinoma-rcc-a-genomic-landscape-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enfortumab-vedotin-and-pembrolizumab-evp-outcomes-in-patients-pts-with-advanced-urothelial-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/switch-androgen-receptor-pathway-inhibitor-strategies-in-metastatic-castration-resistant-prostate-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bleeding-risk-with-concurrent-anticoagulation-and-vegf-tki-therapy-in-mrcc-a-real-world-trinetx-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-analysis-of-androgen-production-uptake-and-conversion-apuc-genes-to-highlight-srd5 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-real-world-survival-and-prescription-patterns-of-darolutamide-versus-apalutamide-in-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-life-adherence-and-adverse-events-among-patients-with-advanced-prostate-cancer-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-feasibility-trial-investigating-inductive-apalutamide-therapy-combined-with-radical-prostatectomy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-spatial-analysis-of-the-tumor-immune-interface-in-localized-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/durable-outcomes-in-aggressive-variant-prostate-cancer-treated-with-first-line-carboplatin-docetaxel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-significance-of-baseline-serum-igg-in-metastatic-renal-cell-carcinoma-patients-undergoing-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/homologous-recombination-repair-hrr-mutation-in-de-novo-metastatic-hormone-sensitive-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-neoadjuvant-adt-duration-prior-to-radiotherapy-in-high-risk-prostate-cancer-rationale-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-performance-in-primary-retroperitoneal-lymph-node-dissection-a-stage-based-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-patients-pts-responding-to-enfortumab-vedotin-plus-pembrolizumab-evp-explo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pre-visit-educational-videos-on-clinic-efficiency-for-prostate-cancer-radiation-oncology-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-to-primary-chemoablation-with-ugn-102-in-different-eotrc-risk-groups 2026-08-24 monthly 0.7 https://rjrindex.com/articles/three-year-median-follow-up-update-of-bgb-a317-2002-iit-a-phase-2-study-of-neoadjuvant-tislelizumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathological-outcomes-and-disease-free-survival-dfs-in-keynote-905-neoadjuvant-and-adjuvant-neoa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-and-clinical-outcomes-of-renal-tumor-upstaging-from-ct1-to-pt3a-disease-in-patients-who-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inhibiting-a26-sialylation-and-its-association-with-nectin-4-stability-and-macropinocytic-uptake-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-quality-of-life-measures-for-use-in-shared-decision-making-in-advanced-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-in-men-with-metastatic-castration-resistant-prostate-cancer-treated-with-olaparib-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-neutrophil-to-eosinophil-ratio-ner-in-patients-with-metastatic-renal-cell-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-trial-of-urinary-tumor-dna-utdna-testing-guided-repeat-transurethral-resection-re-turb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodal-integration-of-vi-rads-radiomics-and-deep-learning-features-for-prediction-of-pathology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inferring-optimal-mtap-homozygous-loss-homozygous-deletion-detection-in-urothelial-cancer-prevale 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-prior-immune-checkpoint-inhibitor-ici-and-interval-from-ici-exposure-on-outcomes-with-en 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-adverse-events-aes-and-clinical-outcomes-in-first-line-enfortumab-vedotin-pembroliz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-and-predictors-of-inpatient-palliative-care-utilization-in-metastatic-prostate-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/omaha-003-phase-3-trial-of-cyp11a1-inhibitor-opevesostat-versus-androgen-receptor-pathway-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-dose-escalation-and-expansion-of-ab001-in-patients-with-metastatic-castration-resistant-pros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/guarding-the-kidneys-in-the-immunotherapy-era-pooled-incidence-and-severity-of-immune-related-nephr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-risk-classifier-performance-in-pet-guided-post-prostatectomy-patients-secondary-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ct-vs-15t-mr-guidance-in-salvage-radiotherapy-of-locally-recurrent-prostate-cancer-after-radical-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicohort-phase-2-trial-of-androgen-deprivation-therapy-adt-docetaxel-doce-and-nivolumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proliferation-and-immune-informed-fusion-of-multiscale-image-features-for-bladder-cancer-prognosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cast-ai-cystectomy-after-systemic-therapy-with-adc-and-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/design-and-implementation-of-a-patient-centric-expanded-access-program-with-cretostimogene-grenadeno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-enfortumab-vedotin-plus-pembrolizumab-followed-by-maintenance-pembrolizumab-in-first-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-clear-cell-renal-cell-carcinoma-ccrcc-patients-treated-with-belzutifan-stra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/front-line-1l-treatment-and-recurrence-patterns-among-patients-with-high-risk-non-muscle-invasive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-gemcitabine-plus-carboplatin-as-second-line-therapy-after-prior-enfortumab-vedoti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acute-and-chronic-gugi-toxicity-after-conventional-versus-hypofractionated-radiotherapy-hfrt-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/her2-and-nectin-4-ihc-expression-and-clinical-outcomes-with-enfortumab-vedotin-plus-pembrolizumab-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/duplex-seq-derived-urinary-cell-free-dna-of-lynch-syndrome-patients-with-upper-tract-urothelial-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-molecular-mechanism-of-lymph-node-metastasis-driven-by-b-lymphocyte-foxo1-palmitoylation-induced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-ipilimumab-plus-nivolumab-followed-by-consolidating-chemoradiotherapy-as-bladder-sparing-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-nature-of-progression-on-active-surveillance-for-grade-group-2-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-lutetium-lu-177-vipivotide-tetraxetan-on-prostate-cancer-outcomes-by-race 2026-08-24 monthly 0.7 https://rjrindex.com/articles/3-weekly-docetaxel-75-mgm-sup2sup-vs-2-weekly-docetaxe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemotherapy-of-node-positive-m0-urothelial-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-risk-of-medication-related-osteonecrosis-of-the-jaw-and-survival-outcomes-with-rankl-inh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-and-treatment-outcomes-in-metastatic-prostate-cancer-with-brain-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hypervigilance-a-phase-ib-clinical-trial-to-optimize-risk-benefit-of-nezastomig-psmaxcd28-costimul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-disitamab-vedotin-combined-with-intravesical-electromotive-mitomycin-c-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-outcomes-of-contemporary-immune-check-point-inhibitors-combinations-in-black-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sasan-sparing-a-phase-2-trial-of-sasanlimab-maintenance-as-bladder-sparing-option-after-neoadjuvant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-active-surveillance-in-young-men-with-low-risk-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-a-pathomics-signature-in-ide-novoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obesity-associated-epigenetic-remodeling-under-androgen-deprivation-therapy-implications-for-cardio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-subsequent-therapy-in-patients-with-metastatic-renal-cell-carcinoma-of-intermediate-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/opening-the-black-box-biologic-pathways-underlying-multimodal-digital-pathology-artificial-intellig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-analysis-in-participants-pts-with-advanced-clear-cell-renal-cell-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-chemotherapy-retroperitoneal-lymph-node-dissection-for-patients-with-metastatic-pure-seminoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-a-post-prostatectomy-digital-pathology-based-multimodal-artificial-intelligence-mmai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adding-metformin-to-androgen-deprivation-therapy-adt-in-metastatic-hormone-sensitive-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intismeran-autogene-v940mrna-4157-plus-bacillus-calmette-guerin-bcg-versus-bcg-alone-for-high-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-effectiveness-of-first-line-1l-cabozantinib-c-versus-cabozantinib-with-ni 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cadonilimab-plus-lenvatinib-in-advanced-renal-cell-carcinoma-interim-analysis-of-a-prospective-mul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-in-patients-with-locally-advanced-or-metastatic-urothelial-cancer-lamuc-in-fran 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concurrent-use-of-angiotensin-converting-enzyme-inhibitors-acei-or-angiotensin-receptor-blockers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aggressive-variants-and-clinical-patterns-of-progression-in-real-world-metastatic-hormone-sensitive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-and-genomic-implications-of-her2-expression-in-metastatic-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shifting-177lu-psma-617-upstream-in-mcrpc-a-meta-analysis-of-randomized-trials-stratified-by-taxane 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-randomized-trial-of-eribulin-e-with-gemcitabine-vs-standard-of-care-soc-for-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/swog-2427-single-arm-phase-ii-study-of-bladder-preservation-with-immunoradiotherapy-after-a-clinica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-response-adapted-treatment-de-escalation-in-metastatic-urothelial-carcinoma-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-and-disparities-in-bladder-cancer-mortality-associated-with-tobacco-use-between-1999 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-cancer-screening-uptake-and-predictors-of-elevated-prostate-specific-antigen-levels-in-sout 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-kinetics-as-a-biomarker-of-response-to-enfortumab-pembrolizumab-in-advanced-ur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-and-trial-design-factors-influencing-participation-in-prospective-bladder-and-kidney-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/db-1311bnt324-a-novel-b7h3-adc-in-patients-with-heavily-pretreated-mcrpc-from-a-phase-12-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-enriched-iyes1i-tumor-expression-at-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-clear-cell-subtype-for-kidney-tumors-from-cross-sectional-imaging-using-artificial-intell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-and-clinical-correlates-of-early-onset-clear-cell-renal-cell-carcinoma-eorcc-a-real-wor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kidney-injury-molecule1-kim-1-in-localized-and-metastatic-renal-cell-carcinoma-rcc-a-meta-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/educational-representation-of-genitourinary-malignancies-in-medical-student-curricula-a-cross-secti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cross-institutional-comparison-of-the-mir-371a-3p-assay-in-pre-surgical-germ-cell-tumor-gct-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/contemporary-patterns-of-treatment-and-outcomes-in-germ-cell-tumors-across-a-provincial-cancer-syste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/remodeling-of-the-periprostatic-adipose-microenvironment-in-aggressive-prostate-cancer-insights-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artemis-003-a-phase-2-study-of-hs-20093-gsk5764227-in-patients-with-metastatic-castration-resista 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-prostate-cancer-and-mental-health-a-comparison-across-cancer-types-using-the-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/structural-classification-of-foxa1-alterations-and-their-association-with-clinical-outcomes-in-prost 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-large-language-models-llm-to-guide-adjuvant-treatment-recommendations-for-renal-cell-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ecog-acrin-ea8192-cohort-c-a-phase-ii-trial-of-neoadjuvant-gemcitabinedurvalumab-in-patients-pts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-ancestry-and-stage-specific-differences-in-prostate-cancer-genomic-alterations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-lutetium-177-dotatate-in-metastatic-prostate-cancer-with-neuroendocrine-differen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-large-language-models-for-grading-ctcae-toxicity-after-radiation-therapy-for-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-impact-of-the-medicare-prescription-payment-plan-for-medicare-part-d-beneficiaries-with-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-ai-as-a-practical-decision-support-tool-for-oncologists-genitourinary-gu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imaging-meets-genomics-in-treatment-naive-prostate-cancer-suvmax-on-prostate-specific-membrane-anti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-quality-adjusted-time-without-symptoms-or-toxicity-q-twist-in-patients-with-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-remote-exercise-on-fatigue-and-quality-of-life-qol-across-genitourinary-gu-cancer-type 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-performance-of-sup18sup-f-flotufolastat-pet-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-dyadic-exercise-approach-to-prevent-declines-in-physical-and-mental-health-in-couples-during-radia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-intra-patient-contemporaneous-comparison-of-sup18sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-tolerability-of-ipilimumabnivolumab-in-older-70-years-versus-younger-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extracellular-vesicles-evs-and-circulating-tumor-dna-ctdna-as-potential-biomarkers-of-response-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fostering-inclusive-language-for-genitourinary-cancer-research-a-multi-stakeholder-co-creation-effo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keymaker-u04-substudy-04b-first-line-1l-enfortumab-vedotin-ev-plus-pembrolizumab-pembro-based 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pilot-phase-i-trial-of-an-implantable-microdevice-for-in-vivo-evaluation-of-drug-response-in-renal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/drug-releasing-intravesical-floating-technology-drift-for-administration-of-sequential-gemcitabine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-in-the-diagnosis-and-prognosis-of-upper-tract-urothelial-carcinoma-a-compre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survivorship-outcomes-of-stage-i-testis-cancer-management 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-a-computational-histology-artificial-intelligence-chai-prognostic-biomarker-in-muscl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/synergistic-efficacy-of-gedatolisib-and-darolutamide-in-prostate-cancer-to-overcome-resistance-to-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-life-assessment-during-prostate-cancer-radionuclide-therapy-updated-fact-rnt-psychometri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rndo-564-001-a-first-in-human-phase-11b-study-of-rndo-564-a-bispecific-antibody-for-the-treatmen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-neoadjuvant-chemotherapy-on-outcomes-of-bladder-preserving-chemoradiotherapy-in-muscle-inv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/end-of-life-care-preferences-in-penile-cancer-patients-shifting-patterns-and-disparities-over-two-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-platinum-based-neoadjuvant-chemotherapy-with-gemcitabine-at-800-mgm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/izabright-bladder01-a-randomized-open-label-phase-23-trial-of-izalontamab-brengitecan-iza-bren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigation-of-profile-related-evidence-determining-individualized-cancer-therapy-i-predict-n-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-parallel-group-phase-ii-study-neoteric-of-atezolizumab-with-or-without-tiragolumab-afte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disitamab-vedotin-plus-pd-1-inhibitors-as-neoadjuvant-therapy-for-cisplatin-ineligible-muscle-invasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-evaluation-of-treatment-patterns-following-cabozantinib-treatment-for-advanced-renal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-major-adverse-cardiac-events-in-men-with-prostate-cancer-receiving-androgen-deprivatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pelvic-lymph-node-risk-stratification-in-prostate-cancer-a-machine-learning-approach-toward-a-predi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/poster-evaluating-the-impact-of-virtual-peer-led-support-groups-on-prostate-cancer-survivorship-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/noninvasive-fragmentomic-profiling-of-plasma-cell-free-dna-cfdna-in-metastatic-prostate-cancer-mp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/discrepancies-in-the-administration-of-sequential-therapies-for-metastatic-renal-cell-carcinoma-rea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-genomic-analysis-of-chemerin-in-prostate-cancer-pca-and-correlation-with-markers-of-imm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-glp1-receptor-agonists-on-severity-of-prostate-cancer-at-diagnosis-a-propensity-score-wei 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-onset-prostate-cancer-a-time-series-analysis-of-age-stratified-trends 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-evaluation-of-sexual-function-over-5-years-in-patients-with-localized-prostate-cancer-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-her2-expression-in-prostate-cancer-compared-with-other-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-cabazitaxel-following-177lu-psma-617-lupsma-in-patients-with-metastatic-castration-res 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-results-from-core-008-cohort-a-phase-2-study-of-intravesical-cretostimogene-grenadenorepvec-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-outcomes-of-advanced-prostate-cancer-among-black-compared-to-white-men-in-the-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptomic-characterization-of-prostate-cancer-in-patients-with-hiv-infection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determinants-of-treatment-intensification-in-metastatic-hormone-sensitive-prostate-cancer-instituti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatially-mapping-the-prostate-cancer-tumor-microenvironment-to-reveal-immune-cell-drivers-of-aggres 2026-08-24 monthly 0.7 https://rjrindex.com/articles/homologous-recombination-repair-gene-alterations-and-outcomes-with-enfortumab-vedotin-plus-pembroliz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multidimensional-profiling-of-clinical-trial-cohorts-and-the-characterization-of-radiotherapyimmuno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-clinical-outcomes-and-genomic-predictors-of-psma-petct-guided-cytoreductive-progression-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dissecting-the-tumor-microenvironment-of-advanced-urothelial-carcinoma-pre-and-post-enfortumab-vedot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imtapi-loss-in-penile-squamous-cell-carcinoma-penscc-a-genomic-landscape 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-response-after-neoadjuvant-therapy-in-renal-cell-carcinoma-using-irrvt-criteria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-pre-operative-circulating-tumor-dna-ctdna-status-with-clinicopathologic-characteris 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncological-outcomes-of-primary-retroperitoneal-lymph-node-dissection-in-patients-with-clinical-stag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-time-to-recurrence-after-radical-cystectomy-for-bladder-cancer-impact-subsequent-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-epidural-analgesia-vs-combined-intravenous-patient-controlled-analgesia-and-transversus-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-derived-primary-prostate-cancer-epithelial-cultures-for-studying-prostate-cancer-cell-evolut 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-intraoperative-frozen-section-analysis-neurosafe-on-oncologic-and-functional-outcomes-af 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-neoadj-gemcitabine-intravesical-system-gem-idrs-plus-cetrelimab-cet-or-cet-alone-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rethinking-germline-testing-in-localized-prostate-cancer-prevalence-of-germline-variants-and-associ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examination-of-decipher-prostate-genomic-classifier-in-patients-with-de-novo-metastatic-disease-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-tivozanib-in-metastatic-renal-cell-carcinoma-in-a-diverse-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/urologist-level-variation-in-androgen-deprivation-therapy-intensification-in-patients-with-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-safety-of-first-line-1l-systemic-regimens-for-locally-advanced-or-metastatic-uroth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-age-on-outcomes-in-metastatic-non-clear-cell-renal-cell-carcinoma-mnccrcc-a-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-blinded-validation-of-a-urinary-cfdna-methylation-assay-in-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detecting-imtapi-loss-in-liquid-biopsies-from-patients-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-mutated-ib2mi-an-immune-related-gene 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-bleomycin-shortage-on-real-world-outcomes-in-germ-cell-tumors-a-multicenter-retrospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-arpi-utilization-patterns-and-outcomes-in-metastatic-castration-sensitive-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-of-systemic-therapies-after-sup177sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-rankl-inhibitors-versus-bisphosphonates-in-metastatic-prostate-cancer-with-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-loss-of-kdm6a-mediated-genomic-instability-and-metabolic-reprogramming-on-response-to-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-and-molecular-determinants-of-response-in-penile-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pharmacokinetics-and-dosimetry-of-lutetium-lu-177-zadavotide-guraxetan-in-patients-with-metastatic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-cancer-organ-tropism-in-mcrpc-patients-using-triple-tracer-pet-imaging-radiomics-clusteri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-2-study-of-enhanced-ar-blockade-with-enzalutamide-in-high-risk-patients-with-bioc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gemcitabine-intravesical-system-gem-idrs-in-combination-with-cetrelimab-cet-versus-chemoradiothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/palliative-care-utilization-and-hospitalization-outcomes-among-patients-with-renal-cell-carcinoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-mortality-from-bladder-cancer-with-chronic-kidney-disease-in-the-united-states-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/divergent-biology-and-outcomes-of-somatic-transformations-sm-in-germ-cell-tumors-gct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/addressing-barriers-to-adopting-first-line-standards-of-care-in-lamuc-a-community-practice-informe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-safety-and-tolerability-of-tara-002-in-patients-with-bcg-naive-and-unresponsive-high-grade-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/arto-trial-nct03449719-long-term-overall-survival-analysis-from-a-randomized-phase-ii-trial-testi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-of-bone-modifying-agents-in-metastatic-hormone-resistant-prostate-cancer-a-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integration-of-genomic-classification-and-clinical-characteristics-as-a-predictor-of-survival-in-de 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-empower-trial-evaluating-a-home-based-physical-activity-program-pap-with-the-exerciserx-digit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-ancillary-multiparametric-mri-features-in-pi-rads-3-prostate-lesions-and-their-associa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-cabozantinib-formulation-with-reduced-pharmacokinetic-variability-and-the-potential-to-impro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-ultra-sensitive-whole-genome-circulating-tumor-dna-detection-to-predict-early-recurrence-in-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-metabolic-syndrome-and-treatment-outcomes-in-metastatic-prostate-cancer-a-retro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-omaha-u01-substudy-01a-oral-cyp11a1-inhibitor-opevesostat-alone-or-in-combination-with-ot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/contemporary-survival-and-treatment-outcomes-in-malignant-spermatic-cord-tumors-a-two-decade-popula 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conventional-dose-chemotherapy-as-first-salvage-in-germ-cell-tumors-outcomes-from-an-ibero-american 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-prostate-cancer-mortality-after-the-2012-uspstf-psa-guideline-comparisons-with-kidney-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-institution-analysis-of-outcomes-with-first-line-ipilimumab-and-nivolumab-for-514-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-genomic-characteristics-of-advanced-urothelial-carcinoma-uc-patients-pts-who-fail-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-analysis-from-the-prospective-pt0-study-of-systematic-endoscopic-evaluation-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-blind-spots-in-rezilient-1-does-post-platinum-zipalertinib-address-needs-in-epidermal-gro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-analysis-from-the-phase-2-litespark-013-study-of-2-different-belzutifan-bel-doses-in-par 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kim-1-levels-in-papillary-renal-cell-carcinoma-from-the-calypso-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-in-intermediate-risk-biochemically-recurrent-prostate-cancer-bcr-the-national-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-nivolumab-ipilimumab-and-cabozantinib-in-patients-with-brain-metastases-from-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-with-radium-223-in-metastatic-castration-resistant-prostate-cancer-us-patient-su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-patients-pts-with-metastatic-castration-resistant-prostate-cancer-mcrpc-rec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimas-a-phase-ii-randomized-decentralized-de-escalation-trial-in-patients-pts-with-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-outcomes-from-a-randomized-controlled-trial-comparing-mri-guided-transurethral-ultraso 2026-08-24 monthly 0.7 https://rjrindex.com/articles/angelica-herbal-supplement-agn-cogniq-acute-dose-safety-and-pharmacokinetics-pk-dose-response-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/estimated-net-benefit-of-talazoparib-tala-enzalutamide-enza-for-patients-pts-with-mcrpc-usin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toripalimab-in-patients-with-previously-treated-advanced-upper-tract-urothelial-carcinoma-a-subgrou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/carpet-trial-a-phase-ii-trial-evaluating-trastuzumab-deruxtecan-in-metastatic-castration-resistant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-efficacy-and-patient-experience-with-neoadjuvant-cabozantinib-for-locally-advanced-renal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-phase-ii-study-of-first-line-modified-folfirinox-in-patients-with-advanced-urachal-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/promoter-methylation-of-aquaporin-1-as-a-prognostic-biomarker-in-clear-cell-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-analysis-of-new-perioperative-treatment-regimens-for-muscle-invasive-bladder-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/twenty-five-years-of-bladder-cancer-mortality-in-the-us-1999-2024 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-digital-ki67-based-risk-modeling-on-prognostic-precision-in-non-muscle-invasive-bladder-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hormone-therapy-use-and-duration-with-post-operative-radiotherapy-for-recurrent-prostate-cancer-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/swog-s1602-a-phase-iii-randomized-trial-to-evaluate-bcg-strain-differences-and-priming-with-intrade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-utility-of-lactate-dehydrogenase-in-patients-with-metastatic-seminoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vertebral-surgery-in-the-management-of-complex-postchemotherapeutic-retroperitoneal-lymph-node-disse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-a-one-time-sensitive-screening-intervention-on-prostate-cancer-mortality-the-sthlm3-rando 2026-08-24 monthly 0.7 https://rjrindex.com/articles/androgen-deprivation-therapy-and-radiotherapy-with-or-without-cabazitaxel-in-very-high-risk-localize 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-assessment-of-patient-reported-quality-of-life-and-mental-health-during-active-surveill 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-adolescent-and-young-adult-renal-cell-carcinoma-in-the-modern-era 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-in-participants-pts-with-bacillus-calmette-guerin-bcg-unresponsive-high-risk-non-muscle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-and-outcomes-among-patients-with-metastatic-castrate-resistant-prostate-cancer-with-an-ar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trimodal-therapy-versus-radical-cystectomy-in-muscle-invasive-bladder-cancer-the-overlooked-influen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/forager-2-a-randomized-phase-3-study-evaluating-the-efficacy-and-safety-of-vepugratinib-combined-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bladder-cancer-bc-screening-in-un-affected-caucasian-ancestry-family-members-of-patients-who-teste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-retroperitoneal-lymph-node-dissection-in-patients-with-ct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-radiomic-skeletal-muscle-features-on-prostate-t1-weighted-mri-with-major-adverse-card 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-risk-evaluation-in-men-with-prostate-cancer-study-care-pc-pilot-study-to-assess-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultra-sensitive-molecular-residual-disease-detection-via-tumor-informed-whole-genome-sequencing-base 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-urethral-squamous-cell-carcinoma-insights-and-outcomes-from-a-27-year-institutional-experie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-tryptophan-serotonin-kynurenine-pathways-on-immune-landscape-and-survival-in-clear-cell-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-models-combining-sup68sup-ga-psma-pet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-obesity-on-biphasic-immune-remodeling-of-cd45-circulating-cells-during-androgen-deprivat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-urinary-detection-of-fgfr-alterations-to-guide-fgfr-inhibitor-therapy-in-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/parallel-liquid-biopsy-analysis-of-mir-371a-3p-and-cell-free-dna-in-testicular-germ-cell-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-an-anti-pd-l1il-15-variant-fusion-protein-sim0237-in-bcg-unresponsive-high-ris 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-prior-5-a-reductase-inhibitor-exposure-with-ici-benefit-in-metastatic-rcc-multicentr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-evidence-based-first-line-therapy-for-metastatic-urothelial-carcinoma-a-quality-improv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-maximal-transurethral-resection-before-neoadjuvant-chemotherapy-on-pathological-response-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rna-based-liquid-biopsy-testing-of-urine-to-predict-pathological-complete-response-to-radiomolecular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-gain-trial-gemcitabine-alternating-with-intravesical-bcg-randomized-against-bcg-alone-for-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inclusion-of-patients-from-latin-america-in-pivotal-trials-in-genitourinary-gu-and-cutaneous-malig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-characteristics-of-long-term-survivors-with-metastatic-castration-resistant-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precision-diagnostics-in-prostate-cancer-treatment-predict-a-phase-2-multi-arm-biomarker-based-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-utilization-in-metastatic-renal-cell-carcinoma-mrcc-following-implementation-of-a-nation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-affecting-racial-impact-in-testicular-cancer-outcomes-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/solace-a-phase-1-pharmacokinetic-dosimetry-safety-and-dose-optimization-study-for-a-single-dose 2026-08-24 monthly 0.7 https://rjrindex.com/articles/consolidate-a-phase-iii-study-of-radiotherapy-combined-with-enfortumab-vedotin-ev-for-locally-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/activity-and-biomarker-analyses-with-casdatifan-cas-a-next-generation-hif-2a-inhibitor-in-refrac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-depth-and-durability-of-response-in-patients-pts-with-previously-untreated-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-the-dll3-t-cell-engager-gocatamig-in-participants-pts-with-neuroendocrine-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-positive-ureteral-margin-on-upper-tract-recurrence-after-radical-cystectomy-for-bladder-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-radiotherapy-and-interventional-therapy-for-adrenal-oligometastases-a-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ferroptosis-suppression-and-its-association-with-chemoradiotherapy-resistance-in-muscle-invasive-bla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-outcomes-associated-with-enzalutamide-enza-vs-apalutamide-apa-in-metastatic-cast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-monitoring-of-fgfr3-altered-metastatic-urothelial-cancer-treated-with-dabogratinib-formerly-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-peripheral-blood-neutrophillymphocyte-ratio-nlr-dynamics-to-predict-primary-refractory-dise 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultra-sensitive-whole-genome-sequencing-based-molecular-residual-disease-detection-in-resectable-ren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ivhli-wild-type-clinically-advanced-clear-cell-renal-cell-carcinoma-ccrcc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunological-clustering-from-peripheral-blood-to-define-prognosis-and-t-cell-exhaustion-profiles-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surveillance-of-patients-with-complete-response-following-first-line-chemotherapy-for-germ-cell-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-non-luminal-subtype-with-overall-survival-in-high-risk-non-muscle-invasive-bladder-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-zanzalintinib-for-patients-with-advanced-urothelial-carcinoma-following-prior-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequential-flotufolastat-f18-psma-pet-scans-to-enhance-detection-of-prostate-cancer-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-genomic-predictors-of-sipuleucel-t-sip-t-outcomes-in-men-with-metastatic-castration-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-rx-patterns-and-survival-outcomes-in-patients-with-metastatic-chromophobe-renal-cell-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/profiling-bcraness-phenotype-in-public-prostate-cancer-datasets-without-homologous-repair-gene-mutat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-open-label-phase-ii-study-of-adaptive-combination-immunotherapy-with-vegfr-tki-for-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-and-trends-in-the-in-hospital-mortality-for-malignant-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimal-duration-of-immune-checkpoint-inhibitor-therapy-in-genitourinary-cancers-a-systematic-revie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapy-resistant-subclones-as-drivers-of-progression-in-aggressive-variant-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-the-dll3cd3-t-cell-engager-obrixtamig-in-patients-with-genitourinary-extrapu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/end-of-life-treatment-patterns-in-patients-with-advanced-urothelial-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-impact-of-rdi-on-outcomes-in-patients-treated-with-enfortumab-vedotin-pembrolizumab-combin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/physician-perspectives-on-the-implementability-of-a-cardiovascular-risk-score-for-prostate-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-rx-patterns-and-outcomes-with-second-line-2l-therapy-in-patients-pts-with-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/partial-nephrectomy-pn-versus-ablative-therapies-at-for-t1a-clear-cell-renal-cell-carcinoma-ccr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intratumoral-mature-tlss-to-predict-response-to-ici-rechallenge-in-non-clear-cell-renal-cell-carcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/androgen-receptor-pathway-inhibitors-triplet-therapy-araat-real-world-outcomes-in-metastatic-horm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-and-predictors-of-online-cancer-information-seeking-among-urological-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-spatial-transcriptomics-to-analyze-the-molecular-landscape-of-tuberous-sclerosis-complex-asso 2026-08-24 monthly 0.7 https://rjrindex.com/articles/marking-techniques-for-target-lymph-nodes-in-node-positive-breast-cancer-treated-with-neoadjuvant-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/selective-bladder-preservation-after-neoadjuvant-zanidatamab-combined-with-tislelizumab-and-chemothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-the-risk-of-prostate-cancer-metastasis-at-diagnosis-in-the-va-health-care-system-from-ha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/harnessing-caregiver-support-to-improve-shared-decision-making-in-metastatic-prostate-cancer-treatme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-radium-223-therapy-in-combination-with-enzalutamide-for-metastatic-castration-resistant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-baseline-serum-igg-in-metastatic-clear-cell-renal-cell-carcinoma-treated-with-fi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-comprehensive-population-wide-genomic-testing-in-metastatic-prostate-cancer-mpca-a-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-provocative-analysis-of-first-line-strategies-in-advanced-urothelial-carcinoma-reconstructed-indi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-circulating-tumor-dna-ctdna-and-itp53i-al 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-treatment-acquired-homozygous-losses-homozygous-deletions-of-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-care-qoc-measures-among-patients-with-recurrent-papillary-only-bacillus-calmette-gueri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extended-multi-centre-review-of-adjuvant-pembrolizumab-for-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-survival-outcomes-with-single-agent-erdafitinib-erda-in-patients-pts-with-advanced-ur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/histopathologic-and-spatial-transcriptomic-analyses-of-en-bloc-resections-of-de-novo-and-recurrent-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expansion-and-characterization-of-tumor-infiltrating-lymphocytes-from-primary-and-metastatic-immune 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-socioeconomic-disadvantage-using-ai-analysis-of-ct-imaging-in-kidney-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-multicenter-development-and-external-validation-of-a-narrow-band-imaging-based-predictio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-belzutifan-in-patients-with-metastatic-clear-cell-renal-cell-carcinoma-mccrc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-overall-survival-with-evolving-systemic-therapies-for-metastatic-non-clear-cell-rcc-an-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subclinical-hepatic-injury-and-risk-of-nonalcoholic-steatohepatitis-after-adjuvant-systemic-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-the-preoperative-de-ritis-ratio-and-its-association-with-sarcopenia-in-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapy-for-stage-iv-non-small-cell-lung-cancer-without-driver-alterations-asco-living-guideline-2-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-retroperitoneal-lymph-node-dissection-for-clinical-stage-iiab-metastatic-seminoma-a-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/blood-and-urine-based-ctdna-profiling-and-monitoring-in-bladder-carcinoma-in-situ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/micro-ultrasound-compared-with-mri-targeted-biopsy-in-detecting-clinically-significant-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hemoglobin-albumin-lymphocyte-and-platelet-halp-score-as-a-prognostic-indicator-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-her2-and-nectin4-expression-with-clinical-outcomes-in-patients-pts-with-advanced-ur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-findings-and-clinical-outcomes-after-immune-checkpoint-blockade-in-renal-cell-carcinoma-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/family-awareness-of-genetic-risk-in-affected-caucasian-ancestry-members-with-bladder-cancer-bc-ass 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-utilization-among-patients-pts-with-metastatic-hormone-sensitive-prostate-cancer-mhspc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-early-achievement-of-ultra-low-psa-levels-with-radiologic-progression-free-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-operative-pelvic-lymph-node-radiation-therapy-in-lymph-node-positive-prostate-cancer-and-mortal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-omics-profiling-of-residual-cancer-burden-after-neoadjuvant-hormonal-therapy-guides-subtype-di 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-luxdegalutamide-in-combination-with-abiraterone-in-adult-patients-with-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-dose-escalation-study-of-ktx-2001-an-nsd2-inhibitor-alone-and-in-combination-with-darolut 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-monitoring-of-derived-neutrophil-to-lymphocyte-ratio-dnlr-as-a-predictive-biomarker-of-benef 2026-08-24 monthly 0.7 https://rjrindex.com/articles/population-level-trends-in-radiation-treatment-of-low-risk-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-frailty-and-its-drivers-in-bladder-cancer-using-machine-learning-derived-vulnerabilit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/next-generation-sequencing-of-bladder-and-upper-tract-micropapillary-variant-urothelial-carcinoma-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toward-noninvasive-genomic-profiling-in-muscle-invasive-bladder-cancer-using-quantitative-ct-texture 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-validity-of-foundationone-cdx-assay-to-identify-ihrri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-bladder-to-upper-urinary-tract-unveiling-the-epidemiological-dynamics-of-urothelial-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-effectiveness-and-safety-of-avelumab-first-line-maintenance-1lm-in-locally-advanced-or-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sup225sup-acac-aky-1189-a-nectin-4-targeted-radioph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/changes-in-ctcae-v6-effect-on-dose-escalation-and-dose-limiting-toxicity-with-repeat-analysis-of-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-patients-with-grade-group-1-prostate-cancer-with-extraprostatic-extension-resu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prolaris-test-on-diagnostic-biopsy-for-localized-prostate-cancer-prognosis-across-risk-groups-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-risk-with-androgen-receptor-pathway-inhibitors-real-world-evidence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-2-trial-of-nivolumab-relatlimab-plus-ipilimumab-vs-nivolumab-plus-ipilimumab-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-toxicity-profiles-of-next-generation-androgen-receptor-pathway-inhibitors-in-the-geria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/blind-spots-in-rezilient-1-does-post-platinum-zipalertinib-address-needs-in-epidermal-growth-factor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-pembrolizumab-and-enfortumab-vedotin-in-variant-histology-urothelial-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cyto-kik-a-phase-ii-trial-of-cytoreductive-surgery-in-kidney-cancer-plus-immunotherapy-nivolumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-pasritamig-pas-docetaxel-doce-in-participants-with-metastatic-castratio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psma-pet-versus-conventional-imaging-in-metastatic-prostate-cancer-evaluation-of-disease-volume-cla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/end-of-life-treatment-patterns-in-patients-pts-with-metastatic-renal-cell-carcinoma-mrcc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-outcomes-of-patients-pts-with-small-cell-or-neuroendocrine-carcinoma-scne-of-the-pros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-sup177sup-lu-psma-617-in-neuroendocrine-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intermittent-fasting-in-prostate-cancer-patients-receiving-androgen-deprivation-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-cfchip-seq-to-predict-cell-surface-target-expression-in-neuroendocrine-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ccl21-as-a-treatment-linked-prognostic-biomarker-in-metastatic-castration-resistant-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pan-cancer-assessment-of-deletions-in-coq-biosynthesis-pathway-genes-associated-with-poor-prognosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/histologic-predictors-of-clinically-significant-biochemical-recurrence-and-psa-kinetics-after-radica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardio-kidney-metabolic-syndrome-and-prostate-cancer-prognostic-significance-of-higher-stages-for-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-and-racial-patterns-in-prostate-cancer-stage-migration-following-uspstf-psa-screening-polic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-immune-checkpoint-inhibitor-combination-therapies-by-metastatic-site-in-meta-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-pt-preferences-for-treatment-tx-of-non-metastatic-hormone-sensitive-prostate-cancer-nmh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-safety-of-first-line-1l-avelumab-axitinib-ave-axi-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sasanlimab-plus-bacillus-calmette-guerin-in-bcg-naive-high-risk-non-muscle-invasive-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-data-from-uplift-phase-iii-study-of-cdk46-inhibition-with-abemaciclib-to-upregulate-psma-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-from-the-phase-2-trial-of-abiraterone-olaparib-or-abiraterone-olaparib-in-first 2026-08-24 monthly 0.7 https://rjrindex.com/articles/empower01-a-phase-ii-study-of-zanidatamab-combined-with-bacillus-calmette-guerin-bcg-in-her2-posi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/autoantibody-aab-profiling-in-metastatic-cisplatin-ineligible-metastatic-urothelial-carcinoma-muc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-circulating-tumor-dna-ctdna-in-the-detection-of-residual-disease-and-recurrence-for-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-alterations-and-pathologic-responses-to-neoadjuvant-androgen-receptor-pathway-inhibitor-arp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthcare-resource-utilization-hcru-and-costs-among-us-patients-pts-with-locally-advanced-or-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-cancer-screening-in-a-geriatric-population 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relevance-of-fresh-frozen-sections-ffs-for-carcinoma-in-situ-cis-detection-in-radical-cystectomy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/addressing-common-medications-that-influence-immunotherapy-response-in-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determining-individual-preferences-for-gynecomastia-avoidance-among-men-with-prostate-cancer-a-qual 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-treatment-with-disitamab-vedotin-plus-perioperative-toripalimab-in-patients-with-her2-ex 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peripheral-blood-correlates-of-outcomes-with-adjuvant-tremelimumab-plus-durvalumab-for-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-genomic-correlates-of-brain-metastases-in-small-cell-carcinoma-of-the-bladder 2026-08-24 monthly 0.7 https://rjrindex.com/articles/protact-a-first-in-human-phase-1-study-evaluating-the-safety-tolerability-and-anti-tumor-activit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-hit-ipik3cai-mutations-in-clinically-advanced-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-of-recurrent-non-muscle-invasive-bladder-cancer-with-ugn-301-zalifrelimab-alone-and-in-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitor-combinations-in-sarcomatoid-metastatic-clear-cell-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-serum-ldh-on-clinical-outcomes-in-patients-with-good-risk-metastatic-non-seminomatous-germ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interaction-between-obesity-and-vitamin-d-and-testosterone-and-vitamin-d-in-prostate-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-ctdna-status-with-upstaging-pathologic-outcomes-and-genomic-alterations-in-high-ris 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-cancer-in-patients-with-hiv-a-multisite-retrospective-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cystectomy-free-survival-following-cretostimogene-grenadenorepvec-in-high-risk-bcg-unresponsive-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-of-metastatic-urothelial-cancer-in-a-multicenter-argentine-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-censorship-in-the-interpretation-of-outcomes-of-the-enfortumab-vedotin-plus-pembrolizumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-capability-of-combining-exodx-epi-and-pre-biopsy-prostate-mri-in-detecting-clinically-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-dose-escalationexpansion-study-of-regn10597-anti-pd-1-il2ra-il2-in-patients-with-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detection-of-bone-metastases-in-men-with-low-psa-biochemical-recurrence-of-prostate-cancer-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/egfr-her2-alterations-in-advanced-urothelial-carcinoma-auc-a-retrospective-analysis-on-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-cardiovascular-disease-risk-factors-in-patients-with-prostate-cancer-initiating-novel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/microplastics-and-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ascending-dose-escalation-of-belzutifan-plus-palbociclib-for-previously-treated-advanced-clear-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-enfortumab-vedotin-plus-pembrolizumab-versus-neoadjuvant-pembrolizumab-in-cisplatin-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-line-therapy-after-ipilimumab-and-nivolumab-in-advanced-renal-cell-carcinoma-a-multicenter-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/description-and-management-strategies-of-prespecified-treatment-emergent-adverse-events-teaes-amon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-disitamab-vedotin-plus-immunotherapy-in-locally-advanced-or-metastatic-ur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-trial-of-urinary-tumor-dna-utdna-testing-guided-cystoscopy-in-high-riskvery-high-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-evaluating-the-efficacy-and-safety-of-perioperative-enfortumab-vedotin-plus-toripal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-and-clinical-impact-of-actionable-genomic-alterations-in-non-clear-cell-renal-cell-carcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/blood-and-urine-liquid-biopsy-for-molecular-monitoring-in-her2-positive-muscle-invasive-bladder-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-multi-layered-omics-analysis-of-the-ubc-landscape-for-precision-medicine-and-its-clini 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-and-predicting-non-cancer-mortality-risk-in-mhspc-following-doublet-therapy-in-the-stamp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparison-of-prostate-specific-antigen-psa-response-in-metastatic-castration-sensitive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-safety-and-efficacy-of-daily-oral-iangelica-gigasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-study-of-sup68sup-ga-psma-11-pet-combined-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chromophobe-renal-cell-carcinoma-long-term-survival-and-treatment-patterns-from-a-real-world-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-metastatic-urothelial-carcinoma-patients-discontinuing-enfortumab-vedotin-due-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-analysis-of-neoadjuvant-atezolizumab-in-upper-tract-urothelial-carcinoma-results-from-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-utility-of-neutrophillymphocyte-ratio-nlr-in-patients-receiving-177lu-psma-617-lupsma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/v-set-immunoregulatory-receptor-as-a-novel-molecular-target-for-genitourinary-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-patient-reported-outcomes-as-nonmuscle-invasive-bladder-cancer-clinical-trial-endp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-and-clinical-utility-of-a-six-gene-signature-for-aggressive-prostate-cancer-among-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-patient-characteristics-and-treatment-patterns-among-patients-with-metastatic-castration 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-transforming-total-neoadjuvant-therapy-neoteric-signals-a-step-forward-in-the-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-toxicity-with-androgen-receptor-pathway-inhibitors-in-metastatic-prostate-cancer-a-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/contemporary-analysis-of-the-prognostic-significance-of-intraductal-carcinoma-of-the-prostate-idc-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/severe-acute-kidney-injury-after-abiraterone-vs-enzalutamide-in-advanced-prostate-cancer-a-seer-med 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radium-223-without-androgen-deprivation-therapy-adt-in-patients-pts-with-biochemically-recurrent-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/her2-expression-and-genomic-alterations-in-plasmacytoid-urothelial-carcinoma-results-from-a-large-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-biochemical-and-clinical-predictors-of-castration-resistance-and-survival-in-metastatic-hor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-androgen-receptor-pathway-inhibitor-arpi-dose-reduction-on-overall-survival-of-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-study-of-gsk5458514-administered-alone-or-in-combination-with-other-anticancer-agents-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-enzalutamide-and-bipolar-androgen-therapy-on-clonal-hematopoiesis-and-clinical-outcomes-am 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epigenomic-alterations-associated-with-androgen-receptor-pathway-inhibitor-response-in-metastatic-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-therapy-combined-with-radiotherapy-versus-systemic-therapy-alone-for-oligometastatic-kidney 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-italic-rcc-study-a-randomized-study-of-clinical-and-humoral-impact-of-primary-tumor-ablation-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/internet-based-lifestyle-intervention-to-eradicate-obese-frailty-in-prostate-cancer-survivors-the-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-analysis-of-vorolanib-combined-with-cadonilimab-in-previously-untreated-patients-with-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trim28-mediated-sumoylation-of-erg-at-k389-and-its-association-with-cell-proliferation-parp-inhibit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-to-assess-peptidomimetic-carbonic-anhydrase-ix-imaging-and-therapy-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/direct-comparative-and-network-meta-analysis-of-parp-inhibitor-and-androgen-receptor-targeted-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sarcomatoid-versus-rhabdoid-dedifferentiation-and-histologic-grade-specific-outcomes-in-metastatic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/homologous-recombination-deficiency-signature-hrdsig-status-in-ibrca12i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-large-language-model-framework-for-automated-extraction-of-pathology-data-in-radical-cystect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-and-longitudinal-body-composition-profile-association-with-immune-checkpoint-inhibitor-ici 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-docetaxel-triplet-therapy-with-androgen-receptor-pathway-inhibitor-arpi-doublet-in-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapy-for-stage-iv-non-small-cell-lung-cancer-with-driver-alterations-asco-living-guideline-2026-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-pilot-trial-of-pre-visit-patient-education-as-preparation-for-decision-making-in-newly-di 2026-08-24 monthly 0.7 https://rjrindex.com/articles/save-a-multicenter-randomized-phase-2-trial-of-salvage-radiotherapy-srt-with-androgen-deprivation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-determinants-of-testosterone-recovery-following-androgen-deprivation-therapy-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serial-proteomic-characterization-of-plasma-extracellular-vesicles-ev-to-identify-changes-that-pre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-of-venous-tumor-thrombi-in-renal-cell-carcinoma-to-immune-checkpoint-inhibitor-therapy-a-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emotional-concerns-due-to-kidney-cancer-kc-and-disparities-in-patient-support-across-north-america 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-avelumab-axitinib-vs-sunitinib-in-patients-pts-with-very-favorable-risk-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/end-of-life-treatment-patterns-in-patients-pts-with-metastatic-castration-resistant-prostate-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combining-psma-pet-metrics-and-circulating-tumor-cell-rna-sequencing-to-predict-lupsma-response 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-impact-of-cardiovascular-disease-and-adt-on-survival-disparities-in-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spectra-study-a-phase-ii-trial-of-supraphysiological-androgen-to-enhance-treatment-activity-with-dn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-with-immune-checkpoint-inhibitor-andor-enfortumab-vedotin-in-patients-with-mtap-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-piflufolastat-f18-imaging-on-disease-management-for-prostate-cancer-patients-observations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acute-kidney-injury-to-predict-cardiovascular-outcomes-following-radical-cystectomy-a-multicenter-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-plasma-metabolomic-profiling-of-metastatic-urothelial-carcinoma-muc-pre-and-post-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examining-the-impact-of-tgf-ss-activity-on-fibroblast-infiltration-and-immune-exclusion-in-mibc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-setd2-mutation-with-prognostic-features-and-susceptibility-to-acute-kidney-injury-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unveiling-sex-based-disparities-in-advanced-renal-cell-carcinoma-insights-from-the-real-world-meet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-surveillance-in-non-clear-cell-renal-cancer-is-current-practice-best-practice 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-non-luminal-molecular-subtypes-and-complete-response-rates-after-neoadjuvant-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-her2-expression-and-ierbb2i-alterations-on-cl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-bleomycin-dose-omissions-on-clinical-outcomes-in-non-seminomatous-germ-cell-tumors-a-syst 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-performance-of-immune-combinations-ici-ici-vs-ici-tki-in-metastatic-renal-cell-carcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-gleason-pattern-4-length-on-adverse-surgical-pathology-and-oncologic-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-nephrectomy-in-patients-with-pathologic-complete-response-to-immune-checkpoint-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-safety-of-enfortumab-vedotin-plus-pembrolizumab-versus-gemcitabine-plat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obrixtamig-bi-764532-in-patients-pts-with-relapsedrefractory-delta-like-ligand-3-dll3-high-ex 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adc-target-signatures-in-urothelial-carcinoma-a-transcriptomic-framework-for-precision-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tp53-mutations-tp53mut-as-a-predictive-biomarker-for-lutetium-177-psma-lu-psma-vs-docetaxel-ben 2026-08-24 monthly 0.7 https://rjrindex.com/articles/contemporary-outcomes-of-nephrectomy-with-ivc-thrombectomy-analysis-from-a-large-multi-institutiona 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-attrition-and-survival-outcomes-in-patients-with-metastatic-unclassified-renal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adiposity-and-response-to-adt-ar-pathway-inhibitors-arpi-in-men-with-metastatic-hormone-sensitiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/br31-trial-adjuvant-durvalumab-as-the-third-contender-in-resected-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-advanced-stage-prostate-cancer-over-the-last-decade-analysis-from-the-national-cancer-dat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-mrt-2359-a-highly-selective-oral-gspt1-molecular-glue-degrader-mgd-in-combi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-safety-analysis-of-a-randomized-phase-ii-trial-comparing-pembrolizumab-with-radiation-versus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-microsatellite-instabilitymismatch-repair-deficiency-phenotype-in-upper-tract-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-senescence-and-antigen-presentation-defects-in-bcg-unresponsive-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-cabozantinib-and-nivolumab-in-metastatic-castration-resistant-prostate-cancer-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/features-of-early-and-late-recurrence-versus-de-novo-metastatic-ccrcc-findings-from-javelin-renal-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimal-hour-of-immune-checkpoint-inhibitors-icis-administration-in-metastatic-renal-cell-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-long-term-outcomes-of-extreme-responders-to-first-line-treatment-of-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pragmatic-phase-2-trial-of-locally-ablative-therapy-in-oligo-progressive-genitourinary-gu-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastasis-directed-therapy-with-or-without-pembrolizumab-for-oligometastatic-clear-cell-renal-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-imutyhi-mutations-with-clinical-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/county-level-educational-attainment-and-long-term-outcomes-in-older-men-with-prostate-cancer-a-seer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advanced-2-interim-efficacy-and-safety-data-in-bcg-unresponsive-participants-with-high-grade-non-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gut-microbiome-gmb-biomarkers-in-patients-pts-with-metastatic-castration-resistant-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tobacco-use-and-survival-among-veterans-with-metastatic-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intravesical-t3011-an-il-12anti-pd-1-armed-oncolytic-hsv-1-in-bcg-naive-high-risk-nmibc-a-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-kidney-injury-marker-1-kim-1-in-metastatic-renal-cell-carcinoma-with-divergent-histolo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bladder-cancer-innervation-does-it-affect-prognosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-analyses-of-bilateral-testicular-germ-cell-cancers-bitcoin-study-from-the-italian-germ-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/redefining-multimodal-treatment-in-high-volume-metastatic-hormone-sensitive-prostate-cancer-prospec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b2-study-to-evaluate-the-safety-and-efficacy-of-igermetostat-xnw5004-in-combination-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rc48g001-a-phase-2-study-of-disitamab-vedotin-in-her2-expressing-previously-treated-advanced-uc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-and-predictive-impact-of-her-2-expression-in-metastatic-urothelial-carcinoma-results-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/core-008-cohort-b-evaluating-intravesical-cretostimogene-grenadenorepvec-in-patients-with-high-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-quality-of-life-pain-and-symptomatic-skeletal-events-in-the-phase-3-psmaddition-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-darolutamide-and-adt-in-patient-subgroups-by-baseline-comorbidities-and-conco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-multicenter-open-label-study-evaluating-the-efficacy-and-safety-of-dabogratinib-tyra-300 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-with-lutetium-177-psma-617-in-metastatic-castration-resistant-prostate-cancer-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-circulating-tumor-dna-in-patients-with-renal-cell-carcinoma-at-increased-risk-of-recurren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-early-termination-in-phase-2-3-genitourinary-oncology-trials-a-two-decade-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-relative-dose-intensity-to-predict-survival-outcomes-in-patients-treated-with-enfortumab-vedot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/omaha-004-phase-3-trial-of-cyp11a1-inhibitor-opevesostat-versus-androgen-receptor-pathway-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-survival-outcomes-in-veterans-receiving-radium-223-for-metastatic-castr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-role-of-peripheral-blood-erythroblasts-for-treatment-intensification-in-metastatic-hormon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-effectiveness-of-novel-doublet-therapies-for-metastatic-hormone-sensitive-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-expansion-study-of-sup212sup-pb-advc001-in-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-clinical-trial-of-autologous-gamma-delta-t-cells-genetically-engineered-with-a-chimeric-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-radiosensitivity-biomarker-for-radiation-induced-gu-toxicity-following-radiation-therapy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detecting-ifgfr3i-genomicalterations-in-liquid-biopsies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imtapi-loss-in-sarcomatoid-renal-cell-carcinoma-srcrcc-a-genomic-landsca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-neoadjuvant-therapy-utilization-and-outcomes-in-patients-with-muscle-invasive-bladder-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-docetaxel-bladder-penetration-following-gemcitabine-pretreatment-an-analysis-of-concentr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-angiogenic-myeloid-cytokine-axis-to-predict-benefit-from-first-line-immune-checkpoint-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insulin-pathway-changes-in-localized-prostate-cancer-a-multi-institutional-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-dynamics-in-bone-dominant-metastatic-castration-resistant-prostate-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-tumor-mutational-burden-on-clinical-outcomes-in-muscle-invasive-bladder-cancer-patients-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-phase-1-dose-escalation-results-of-vir-5500-amx-500-a-dual-masked-pro-xten-t-cell-eng 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastatic-progression-and-toxicity-in-high-risk-clear-cell-renal-cell-carcinoma-patients-treated-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-nccn-based-risk-groups-to-the-proteus-definition-of-high-risk-localized-prostate-cancer-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tropion-urothelial03-a-phase-23-study-of-datopotamab-deruxtecan-dato-dxd-platinum-chemotherapy-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-trial-of-neoadjuvant-leuprorelin-darolutamide-or-both-prior-to-radical-prostatectomy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-results-from-the-phase-1-study-of-gotistobart-bnt316onc-392-in-combination-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/maintenance-zanzalintinib-with-oral-etoposide-following-high-dose-chemotherapy-in-patients-with-rela 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-putative-liquid-biopsy-gene-panel-for-predicting-liver-metastasis-in-castration-res 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-chemoradiotherapy-regimens-in-muscle-invasive-bladder-cancer-a-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-the-molecular-assessment-of-mri-targeted-prostate-biopsies-utilizing-near-real-time-stimul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-between-clinical-genomic-and-ai-based-risk-stratification-in-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bone-fractures-with-androgen-pathway-inhibitors-arpi-in-patients-pts-with-prostate-cancer-pca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-prostate-specific-antigen-kinetics-between-androgen-receptor-signaling-inhibitor-doubl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tulmistar-01-a-phase-iii-dose-optimization-study-of-tulmimetostat-in-combination-with-luxdegalutam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-circulating-tumor-dna-as-a-biomarker-in-testicular-seminoma-and-non-seminomatous-germ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-profiling-in-circulating-tumor-dna-from-a-multicenter-prospective-study-of-radium-223-in-bon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-age-number-of-cycles-of-chemotherapy-and-presence-of-visceral-metastases-on-psa-response 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ideate-prostate02-a-phase-12-open-label-umbrella-substudy-of-ifinatamab-deruxtecan-based-treatmen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-eight-first-line-regimens-in-metastatic-hormone-sensitive-prostate-cancer-mhs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-cost-impact-of-cabazitaxel-versus-lutetium-177-vipivotide-tetraxetan-lu-psma-for-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-improvement-initiative-to-increase-osteoporosis-screening-in-patients-with-prostate-cancer-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-outcomes-of-abiraterone-vs-enzalutamide-in-metastatic-castration-sensitive-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-biomarker-characteristics-of-treatment-emergent-neuroendocrine-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-neoadjuvant-chemotherapy-relative-dose-intensity-on-pathological-complete-response-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-combined-chemotherapy-and-immunotherapy-for-upper-tract-urothelial-carcinoma-final-resu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-adjuvant-hyperthermic-intraperitoneal-chemotherapy-in-patients-with-locally-advanced-colon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nci9673-part-b-etctn-randomized-phase-ii-study-of-nivolumab-with-or-without-ipilimumab-in-refract 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bruin-313-and-314-trials-open-the-door-for-noncovalent-bruton-tyrosine-kinase-inhibition-as-initial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/three-year-follow-up-of-nivolumab-avd-versus-brentuximab-vedotin-avd-in-adolescents-with-advanced-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pirtobrutinib-versus-ibrutinib-in-treatment-naive-and-relapsedrefractory-chronic-lymphocytic-leukem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/north-star 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extended-endocrine-therapy-following-5-years-of-adjuvant-luteinizing-hormone-releasing-hormone-agoni 2026-08-24 monthly 0.7 https://rjrindex.com/articles/methodologic-and-reporting-gaps-in-the-surf-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-revisiting-methodologic-paradigms-in-local-therapies-for-hepatocellular-carcinoma-insigh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-pirtobrutinib-for-treatment-naive-chronic-lymphatic-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-therapy-in-patients-with-metastatic-castration-resistant-prostate-cancer-asco-living-guide-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hepatic-arterial-infusion-pump-chemotherapy-in-patients-with-unresectable-intrahepatic-cholangiocarc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapeutic-considerations-in-early-stage-estrogen-receptor-positive-ibrca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bruin-cll-313-randomized-phase-iii-trial-of-pirtobrutinib-versus-bendamustine-plus-rituximab-in-unt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/revisiting-methodologic-paradigms-in-local-therapies-for-hepatocellular-carcinoma-insights-from-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/all-things-excellent-are-as-difficult-as-they-are-rare 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-computational-histology-artificial-intelligence-powered-predictive-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-benefit-of-chemoradiotherapy-versus-chemotherapy-after-induction-therapy-for-conversion-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-simultaneous-durvalumab-and-platinum-based-chemoradiotherapy-in-unresectable-stage-iii-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/upfront-modified-folfoxiri-plus-panitumumab-for-irasbrafi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-benefit-of-specialist-palliative-care-in-oncology-rethinking-clinical-trial-design 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-major-pathologic-response-the-best-surrogate-end-point-for-neoadjuvant-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-neoadaura-can-we-afford-to-overlook-objective-response-rates-and-is-major-pathologic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/music-therapy-versus-cognitive-behavioral-therapy-via-telehealth-for-anxiety-in-survivors-of-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sustained-benefit-of-blinatumomab-in-infants-with-ikmt2ai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mothers-grief 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phased-variant-supported-circulating-tumor-dna-as-a-prognostic-biomarker-after-first-line-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-validation-of-circulating-tumor-dna-measurable-residual-disease-after-first-line-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/automated-lymph-node-and-extranodal-extension-assessment-improves-risk-stratification-in-oropharynge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-efficacy-in-mismatch-repair-proficient-colorectal-cancer-patients-with-and-without-liv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-successful-outcomes-of-newly-diagnosed-t-lymphoblastic-lymphoma-results-from-childrens-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadaura-can-we-afford-to-overlook-objective-response-rates 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-key-considerations-for-the-lenvatinib-pembrolizumab-chemotherapy-regimen-in-advanced-gastr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-atezolizumab-in-early-stage-non-small-cell-lung-cancer-signals-silences-and-the-need-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/twelve-month-results-from-the-cisto-study-comparing-radical-cystectomy-versus-bladder-sparing-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/key-considerations-for-the-lenvatinib-pembrolizumab-chemotherapy-regimen-in-advanced-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-noninferiority-trial-of-a-liberalized-diet-versus-the-neutropenic-diet-in-hematopoietic-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomically-smoldering-multiple-myeloma-is-not-a-distinct-entity-but-a-collection-of-monoclonal-gamm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/new-validated-staging-system-for-light-chain-al-amyloidosis-with-stage-iiic-defining-ultra-poor-ri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-chance-to-heal-with-cold-hard-steel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ifinatamab-deruxtecan-in-patients-with-extensive-stage-small-cell-lung-cancer-primary-analysis-of-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/benefits-harms-and-burden-of-colorectal-cancer-screening-among-childhood-cancer-survivors-previous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-improving-the-reporting-of-long-term-effects-in-the-impower010-trial-and-adjuvant-atezo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/b7-h3-as-a-universal-target-for-solid-tumor-therapy-clinical-promise-and-biological-complexity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-the-reporting-of-long-term-effects-in-the-impower010-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-epirubicin-plus-cyclophosphamide-followed-by-taxanes-with-or-without-carboplatin-in-early-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/management-of-cancer-during-pregnancy-asco-guideline 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-optimizing-control-arms-in-chronic-lymphocytic-leukemia-clinical-trials-the-bruin-cll-321 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumultuous-development-of-venetoclax-in-t1114-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/smell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/noncomparative-comparisons-the-paradox-of-randomized-noncomparative-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-refining-myeloma-precursors-and-their-risk-of-progression-through-genomics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-ribociclib-plus-letrozole-in-women-with-recurrent-low-grade-serous-carcinoma-of-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomics-define-malignant-transformation-in-myeloma-precursor-conditions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-control-arms-in-chronic-lymphocytic-leukemia-clinical-trials-the-bruin-cll-321-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/venetoclax-dexamethasone-versus-pomalidomide-dexamethasone-in-t1114-positive-relapsedrefractory 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dinutuximab-beta-added-to-temozolomide-based-chemotherapy-for-children-with-relapsed-and-refractory 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-noncomparative-comparisons-the-paradox-of-randomized-noncomparative-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-omics-characterization-of-response-to-tyrosine-kinase-inhibitor-plus-immunotherapy-in-msspmmr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-toxicity-outcomes-of-total-neoadjuvant-flot-versus-perioperative-flot-in-resectable-gas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mode-of-presentation-and-symptoms-of-colorectal-cancer-crc-by-primary-tumor-and-molecular-subgroup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/repertoire-real-world-treatment-tx-patterns-and-outcomes-in-us-patients-pts-with-her2-negative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/donafenib-and-sintilimab-plus-transcatheter-arterial-chemoembolization-for-unresectable-hepatocellul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-cell-intrinsic-c5ar1-in-colorectal-cancer-survival-and-chemoresistance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-art-123-in-combination-with-folfox-bevacizumab-for-patients-with-metastatic-color 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-claudin182-expression-in-gastric-cancer-a-large-single-center-cohort-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combining-low-dose-regorafenib-with-pembrolizumab-for-patients-with-msi-h-colorectal-cancer-regpem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/how-about-the-impact-of-tumor-regression-grade-on-pancreatic-adenocarcinoma-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-brca2-braf-apc-and-pten-expression-on-the-prognostic-significance-of-surgical-margin-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastatic-patterns-and-outcomes-among-early-onset-versus-average-onset-gastroenteropancreatic-neuro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-a-novel-polymeric-fdump-cf10-versus-5-fu-in-efficacy-and-tolerability-in-preclinica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-metastatic-sites-and-lauren-subtype-on-survival-outcomes-of-first-line-pd-1-inhibitors-com 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-data-of-oxaliplatin-retreatment-in-patients-with-metastatic-colorectal-cancer-in-a-real-wor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-chimeric-antigen-receptor-t-cell-therapy-in-diffuse-large-b-cell-lymphoma-long-te 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-rare-histologic-variants-of-esophageal-cancer-a-national-cancer-database-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-analysis-of-her2-status-based-on-central-and-local-testing-results-from-the-destiny-gast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cracking-the-code-clinical-predictors-of-brain-metastases-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-biliary-drainage-strategy-and-in-hospital-outcomes-in-malignant-biliary-obstruction-a-natio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intra-arterial-gemcitabine-versus-intravenous-gemcitabine-pharmacokinetic-and-pharmacodynamic-sub-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-docetaxel-oxaliplatin-and-s-1-therapy-for-patients-with-large-type-3-or-type-4-gastric 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acupuncture-and-acupressure-to-mitigate-chemotherapy-induced-peripheral-neuropathy-for-gi-cancer-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lanreotide-octreotide-switch-in-advanced-gastrointestinal-neuroendocrine-tumors-ginets 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-multicenter-retrospective-analysis-of-systemic-treatments-in-well-differentiated-grade-3-g3 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-caused-by-gall-bladder-carcinoma-in-the-united-states-population-from-1999-2024 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-atezolizumab-plus-bevacizumab-in-patients-with-unresectable-hepatocellular-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-disitamab-vedotin-rc48-in-combination-with-sintilimab-and-xelox-for-periope 2026-08-24 monthly 0.7 https://rjrindex.com/articles/myeloid-stromal-il1rap-as-a-therapeutic-vulnerability-in-pancreatic-cancer-rationale-for-a-neoadjuv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-treatment-strategy-for-locally-advanced-pancreatic-cancer-using-carbon-ion-radiothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-adjuvant-chemotherapy-benefit-in-younger-and-older-molecular-residual-disease-positive-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-of-immunotherapy-versus-standard-of-care-in-microsatellite-stable-metastatic-colore 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-routine-collection-of-electronic-patient-reported-outcome-measures-eproms-coupled-with-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peptide-receptor-radionuclide-therapy-lu-177-prrt-in-neuroendocrine-tumors-net-over-16-years-si 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gata6-expression-with-ca19-9-levels-as-biomarkers-in-resectable-pancreatic-adenocarcinoma-treated-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-ii-trial-of-medical-cannabis-to-reduce-symptom-burden-in-patients-with-newly-diag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inappropriate-use-of-tumor-markers-for-gi-cancer-screening-in-asymptomatic-patients-a-systematic-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-clinical-outcomes-of-metastatic-gastric-cancer-real-world-evidence-from-retr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-revumenib-in-patients-pts-with-advanced-colorectal-cancer-crc-and-other-sol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keystep-008-pembrolizumab-pembro-based-combinations-for-microsatellite-instability-high-msi-hm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-and-treatment-trends-in-brca-mutated-metastatic-pancreatic-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/continuous-maintenance-or-intermittent-first-line-1l-therapy-for-advanced-pancreatic-cancer-apc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glp-1-receptor-agonists-and-pancreatic-cancer-risk-a-meta-analysis-of-real-world-and-trial-evidence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subgroup-analyses-from-the-phase-3-panova-3-trial-of-tumor-treating-fields-ttfields-with-gemcitabi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-pancreatic-versus-duodenal-adenocarcinoma-a-national-cancer-database-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-trial-of-cbx-12-for-metastatic-chemotherapy-refractory-microsatellite-stable-colorectal-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-assisted-automated-abstraction-for-enhanced-patient-insights-in-gastrointestinal-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-barriers-to-cancer-care-in-a-war-zone-a-study-of-challenges-facing-patients-with-gi-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/amigo-a-phase-2-trial-of-amivantamab-in-iegfri-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-prognostic-impact-of-idh-mutations-in-intrahepatic-cholangiocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-and-immune-landscape-of-early-onset-versus-average-onset-well-differentiated-enteropancrea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-efficacy-and-safety-of-immunotherapy-combinations-as-first-line-treatment-for-hepatoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-immune-checkpoint-inhibitors-in-colorectal-cancer-a-network-meta-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-survival-and-responses-to-her2-directed-treatment-in-gastrointestinal-cancers-based-on-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/short-course-radiotherapy-scrt-followed-by-immunochemotherapy-plus-fruquintinib-as-the-total-neoad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-related-adverse-events-iraes-in-lynch-vs-non-lynch-microsatellite-instability-high-msi-hig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-lbl-007-anti-lag-3-plus-tislelizumab-anti-pd-1-and-chemotherapy-as-first-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-hoc-central-radiological-review-of-the-altair-study-in-patients-with-molecular-residual-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-ii-trial-of-medical-cannabis-to-reduce-symptom-burden-in-patients-with-newly-diag-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intratumoral-immune-landscape-changes-after-neoadjuvant-chemoradiation-in-esophageal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bxq-350-efficacy-and-safety-evaluation-in-first-line-mcrc-patients-a-phase-1b2-study-of-bxq-350-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-practice-patterns-of-radiotherapy-utilization-in-pancreatic-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/no-operation-after-short-course-radiotherapy-followed-by-consolidation-chemotherapy-in-locally-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-profiling-of-epithelial-neoplasms-of-the-appendix-insights-across-histological-subtypes-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bold-100-001-a-randomized-phase-2-study-of-bold-100-plus-folfox-vs-folfox-in-patients-with-refracto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-new-standard-for-coeliac-plexus-radiotherapy-contouring 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-circulating-exosomal-microrna-signature-for-the-detection-of-minimal-residual-disease-after-curati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/foxtrot-predictive-effects-of-ierbb2i-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inferring-liver-cancer-stage-from-medicare-claims-data-a-machine-learning-approach-to-broaden-outco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b2-study-on-the-efficacy-and-safety-of-bxq-350-a-first-in-class-sphingolipid-metabolism-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/minimal-residual-disease-mrd-trials-in-colorectal-cancer-crc-an-overview-of-a-heterogeneous-fie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamic-regulation-of-cldn182-expression-during-immunotherapy-implications-for-biomarker-driven-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/consensus-molecular-subtypes-and-divergent-genomic-landscapes-with-clinical-implications-in-biliary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-uncommon-idpydi-polymorphisms-with-sever 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-perioperative-tumor-treating-fields-novottf-200tp-combined-with-gemcitabine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-trends-and-misclassification-patterns-of-hepatocholangiocarcinoma-a-seer-database-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-head-to-head-comparison-of-gpt-based-prognostic-predictions-and-oncologists-in-gastrointestinal-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-update-on-the-impact-of-covid-19-on-colorectal-cancer-screening-using-medicare-claims-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-to-timely-diagnosis-of-early-onset-colorectal-cancer-a-systematic-review-and-qualitative-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liquid-biopsy-to-reveal-colorectal-cancer-molecular-subtype-information-from-ctdna-epigenetics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/how-collaboration-between-surgeons-and-medical-oncologists-affects-outcomes-for-patients-with-pancre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/secondary-primary-malignancy-spm-in-localized-gastrointestinal-gi-cancer-a-national-database-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-microwave-ablation-versus-open-surgical-resection-in-colorectal-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tolerability-and-outcomes-after-neoadjuvant-and-definitive-radiation-of-elderly-patients-with-locali 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anastomotic-leak-and-oncologic-outcomes-after-colorectal-cancer-resection-a-real-world-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cruk-phase-ii-trial-of-ginisortamab-with-1-1st-line-gemcitabine-nab-paclitaxel-ag-or-2-mek 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-in-combination-with-chemotherapy-as-conversion-therapy-for-esophageal-squamous-cell-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-brachytherapy-use-and-survival-outcomes-in-rectal-adenocarcinoma-insights-from-the-nation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-analysis-of-activity-in-esophageal-cancer-during-phase-1-dose-escalation-of-iks014-a-her2-tar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/river-mpdac-a-phase-2b3-study-of-ponsegromab-for-the-treatment-of-cachexia-in-patients-with-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zanidatamab-chemotherapy-ct-tislelizumab-for-first-line-1l-her2-positive-her2-locally-adv-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-performance-of-an-improved-colorectal-cancer-crc-screening-blood-test 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-botensilimab-and-agen1423-an-anti-cd73-tgfv-trap-bifunctional-antibody-in-subje 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-advanced-hepatocellular-carcinoma-ahcc-patients-treated-with-atezolizumab-pl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-and-safety-outcomes-of-first-line-immune-checkpoint-inhibitor-combinations-versus-tyrosine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-nutritional-index-as-a-predictor-of-survival-in-metastatic-gastroesophageal-cancer-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-outcomes-among-metastatic-colorectal-cancer-mcrc-patients-with-liver-metastase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-systemic-therapy-in-patients-with-hepatocellular-carcinoma-and-decompensated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-for-incurable-anal-cancer-according-to-hiv-status 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-framework-for-contextual-mass-categorization-leveraging-explainable-ai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cadonilimab-plus-chemotherapy-versus-pd-1-inhibitor-plus-chemotherapy-as-first-line-1l-treatment-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-total-neoadjuvant-therapy-tnt-on-overall-complete-response-cr-for-locally-advanced-rec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-hepatic-artery-infusion-chemotherapy-haic-or-lenvatinib-combined-with-sinti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/discovery-of-a-functional-biomarker-for-sensitivity-to-poly-adp-ribose-polymerase-inhibitors-parpi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-relapse-and-lack-of-benefit-from-adjuvant-chemotherapy-following-surgical-resection-of-early 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-randomized-double-blind-placebo-controlled-study-to-evaluate-ly3537021-for-the-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemotherapy-for-colorectal-cancer-with-synchronous-and-exclusive-peritoneal-metastasis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reproducibility-and-clinical-concordance-of-a-tumor-informed-mrd-assay-in-patients-with-resected-col 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-from-the-randomized-phase-2-study-1801-part-3b-of-elraglusib-plus-gemcitabinenab-paclitax 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-significance-of-a-false-positive-stool-multi-target-dna-test 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rethinking-dogma-association-between-radiation-dose-and-pathologic-outcomes-or-survival-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/onc201-for-chemoprevention-of-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-mao-b-a-novel-gut-brain-axis-link-in-colorectal-cancer-progression 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sarcopenia-measured-radiographically-as-a-prognostic-and-predictive-factor-of-response-to-perioperat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-enfortumab-vedotin-in-patients-with-advanced-or-metastatic-colorectal-cancer-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociocultural-and-educational-determinants-of-delayed-diagnosis-in-anal-cancer-insights-from-a-5-ye 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-utilization-of-tissue-free-ctdna-monitoring-in-patients-with-cholangiocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/innovative-carbon-ion-radiotherapy-for-unresectable-pancreatic-cancer-using-sib-and-let-optimization 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zolbetuximab-pembrolizumab-and-chemotherapy-as-first-line-treatment-for-patients-with-cldn182-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-between-nivolumab-plus-ipilimumab-folfox-and-nivolumab-plus-folfox-therapy-as-first-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-ii-trial-of-perioperative-chemotherapy-plus-atezolizumab-and-tiragolumab-in-localized-esopha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obesity-as-a-modifiable-risk-factor-in-familial-adenomatous-polyposis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/too-late-to-help-disparities-in-palliative-and-hospice-care-among-veterans-with-pancreatic-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-epidermal-growth-factor-receptor-inhibitors-in-locally-advanced-and-metastatic-anal-squa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1b2-study-of-arfolitixorin-in-combination-with-5-fluorouracil-5fu-oxaliplatin-and-bevaciz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-significance-of-c-met-expression-in-patients-with-advanced-gastroesophageal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-in-advanced-radiation-technique-use-and-survival-for-pancreatic-ductal-adenocarcinoma-and-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-tumor-intrinsic-pathways-to-identify-novel-targets-in-immune-cold-esophagogastric-adenocarcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-long-term-survival-from-metastatic-colorectal-cancer-a-single-centre-irish-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ibii-study-of-asp-1929-photoimmunotherapy-pit-for-esophageal-cancer-ineligible-for-curative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-outcomes-of-patients-diagnosed-with-metastatic-pancreatic-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-in-hospital-mortality-among-pancreatic-cancer-patients-using-modified-cancer-frailty-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-a-phase-2-study-of-a-novel-dll4-vegf-a-bispecific-antibody-tovecimig-ctx-009-as-a-mo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-of-gemcitabine-plus-cisplatin-with-immune-checkpoint-inhibitor-and-with-s-1-in-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pancreatic-acinar-cell-carcinoma-pacc-a-comparative-genomic-landscape-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-personalized-evidence-based-care-for-veterans-with-hepatocellular-carcinoma-hcc-insigh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-phase-1b2-trial-of-gemcitabine-cisplatin-nab-paclitaxel-and-tislelizumab-gentis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-factors-related-to-survival-in-advanced-pancreatic-cancer-in-elderly-patients-at 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-irasbrafi-mutations-and-clinical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-localized-pancreatic-cancer-treated-with-neoadjuvant-chemotherapy-nac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ibii-dose-escalation-and-dose-expansion-study-of-valemetostat-tosylate-ds-3201b-with-ate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neuroendocrine-carcinoma-of-the-esophagus-a-genomic-landscape-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-hepatic-arterial-infusion-pump-haip-therapy-on-disease-control-and-survival-outcome-in-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-randomized-multicenter-phase-3-study-of-trastuzumab-deruxtecan-t-dxd-chemothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-management-of-perioperative-flot-for-resectable-gastric-gastroesophageal-junction-or-esop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-arv-806-a-protac-kras-g12d-degrader-in-ikrasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-rock2-signaling-on-resistance-to-kras-inhibitors-in-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-ponsegromab-in-patients-with-colorectal-cancer-and-cachexia-a-subgroup-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-time-toxicity-of-metastatic-pancreatic-cancer-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-trial-of-the-oncolytic-virus-svv-001-in-combination-with-nivolumab-and-ipilimumab-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/5hmc-as-a-novel-liquid-biopsy-biomarker-for-colorectal-cancer-to-enable-detection-and-unveil-tumor-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/apixaban-versus-rivaroxaban-for-venous-thromboembolism-in-gastric-cancer-insights-from-a-propensity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-between-the-timing-of-recurrence-and-circulating-tumor-dna-ctdna-doubling-time-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-assisted-endoscopic-diagnosis-of-upper-gastrointestinal-neoplasia-a-systema 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-gastric-cancer-mortality-by-subsite-cardia-vs-non-cardia-and-racial-disparities-from-19 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sox-tegafur-plus-oxaliplatin-plus-anti-pd-1-antibody-with-or-without-car-like-t-cell-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-performance-of-liquid-rna-l-rna-biopsy-in-a-gastrointestinal-cancer-segment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-disease-stabilization-and-toxicity-outcomes-of-immune-checkpoint-inhibitors-in-gastroente 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sorbitol-supplemented-diet-combined-with-neoadjuvant-chemoimmunotherapy-in-locally-advanced-gastric 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-role-of-pik3ca-and-co-alterations-in-advanced-biliary-tract-cancer-a-multicenter-retrosp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bxq-350-in-combination-with-folfox7-and-bevacizumab-evaluation-of-effect-on-oxaliplatin-induced-cip-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/helicobacter-pylori-and-risk-of-esophageal-cancer-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/total-gastrectomy-tg-versus-distal-gastrectomy-dg-for-distal-diffuse-gastric-cancer-gc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-demographic-reporting-in-clinical-trials-supporting-nccn-gastric-cancer-guidelines 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nutritional-status-cachexia-and-sarcopenia-as-predictors-of-mortality-in-colorectal-cancer-a-nati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/profiling-tumor-characteristics-and-outcomes-in-colorectal-cancers-crc-from-carriers-of-the-recess 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-analysis-to-predict-the-clinical-benefit-of-everolimus-in-gastro-entero-pancreatic-neuroen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diffusion-weighted-magnetic-resonance-imaging-versus-surgical-staging-in-patients-with-colorectal-pe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cell-free-dna-predictive-epigenetic-signatures-psig-for-risk-stratification-of-pancreatic-ductal-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-1l-trastuzumab-deruxtecan-t-dxd-with-volrustomig-and-fluoropyrimidine-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breakwater-phase-3-post-hoc-subgroup-analyses-by-age-in-patients-pts-with-braf-v600e-mutant-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/access-to-fertility-preservation-services-among-commercially-insured-adults-with-early-onset-colorec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/flipi24-a-modern-prognostic-model-and-clinical-trial-enrichment-tool-for-newly-diagnosed-follicular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-response-to-gemcitabine-based-neoadjuvant-therapy-on-the-outcomes-of-gemcitabine-plus-nab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-variations-in-gastrointestinal-cancer-mortality-a-comprehensive-analysis-of-us-regiona 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-and-predictors-of-90-day-all-cause-readmission-in-hepatocellular-carcinoma-a-real-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-peripheral-angptl3-on-the-efficacy-of-anti-pd1-therapy-for-advanced-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-the-modified-glasgow-prognostic-score-in-patients-with-metastatic-pancreatic-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/curative-therapy-after-atezolizumab-and-bevacizumab-treatment-for-unresectable-hepatocellular-carcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stability-of-immune-microenvironment-changes-associated-with-progression-risk-in-barretts-esophagus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-cf33-hnis-oncolytic-virus-on-m2-macrophages-and-tumor-microenvironment-in-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-surgical-procedures-and-short-and-mid-term-outcomes-for-transverse-colon-cancer-a-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-potentially-actionable-genomic-alterations-in-early-onset-versus-later-onset 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-whole-genome-analysis-of-colorectal-cancer-conductor-study-integrating-rasbraf-ms 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-two-year-survival-in-patients-receiving-chemotherapy-for-metastatic-pancreatic-ductal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-biomarker-analysis-and-clinical-outcomes-of-the-pd-1tgfvr2-bispecific-antibody-inca33890-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-hepatic-arterial-infusion-pump-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/small-cell-carcinoma-of-the-esophagus-a-seer-based-analysis-of-stage-stratified-radiotherapy-outcom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-barriers-and-missed-opportunities-for-early-diagnosis-in-young-onset-biliary-tract-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/associations-between-ecog-performance-status-ps-and-patient-reported-outcomes-pros-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regorafenib-dose-escalation-versus-fixed-dosing-in-refractory-metastatic-colorectal-cancer-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-cancer-metastatic-dmmr-immunotherapy-commit-study-a-randomized-phase-iii-study-of-atez 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zanzalintinib-versus-everolimus-in-patients-with-previously-treated-advanced-neuroendocrine-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-oxaliplatin-with-s-1-sox-versus-s-1-in-patients-with-stage-ii-iii-gastric-or-gastro-oesop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trop-2-expression-and-the-tumor-microenvironment-in-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-vilanterol-in-combination-with-a-cldn182-bispecific-antibody-in-patients-with-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-metastatic-distribution-in-microsatellite-stable-metastatic-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proteogenomic-interrogation-of-gastrointestinal-neuroendocrine-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/skeletal-muscle-loss-during-neoadjuvant-chemotherapy-as-a-predictor-of-major-postoperative-complicat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pain-mitigation-in-pancreatic-adenocarcinoma-a-long-term-analysis-of-denervation-via-transvascular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unmasking-the-lethality-national-mortality-patterns-of-pancreatic-cancer-in-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alliance-a022104nrg-gi010-a-randomized-phase-iiiii-trial-testing-the-efficacy-of-triplet-versus-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/majority-of-people-minority-of-places-the-people-place-gap-in-us-biliary-tract-cancer-trial-access 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathological-complete-response-after-systemic-conversion-therapy-and-curative-resection-in-initially 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antibiotic-therapy-and-outcomes-with-gemcitabine-cisplatin-and-durvalumab-in-advanced-cholangiocarc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-predictors-of-local-recurrence-after-crt-and-surgery-in-locally-advanced-rectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-nalirifox-nanoliposomal-irinotecan-oxaliplatin-with-fluorouracil-and-folinic-ac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptomic-profiling-and-demographic-analysis-of-appalachian-and-non-appalachian-patients-with-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erbb2her2-status-in-biliary-tract-cancer-patients-in-the-spanish-retud-registry 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-nanoliposomal-irinotecan-with-tas102-and-bevacizumab-for-patients-with-refractor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/descriptive-analysis-of-outcomes-in-participants-with-combined-hepatocellular-cholangiocarcinoma-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-11b-study-of-the-theranostic-pair-ryz811-diagnostic-and-ryz801-therapeutic-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-patients-pts-with-child-pugh-class-b-cp-b-liver-function-at-progression-aft 2026-08-24 monthly 0.7 https://rjrindex.com/articles/claudin-182-and-trop-2-as-emerging-biomarkers-in-biliary-tract-cancers-expression-analysis-and-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-analysis-results-of-a-phase-ii-trial-of-laparoscopicrobotic-total-gastrectomy-with-spleen-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ikf-035abc-hcc-a-phase-iiib-randomized-multicenter-open-label-trial-of-atezolizumab-plus-bevaci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-pd-1-antibody-toripalimab-combined-with-chemotherapy-versus-chemotherapy-alone-in-loca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-comparing-the-use-of-glp-1-agonists-in-patients-with-colon-cancer-and-comorbid-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pattern-of-progression-in-advanced-hepatocellular-carcinoma-treated-with-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immune-checkpoint-inhibitors-icis-for-localized-dmmrmsi-h-gastroesophageal-cancers-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neo-adjuvant-radiotherapy-prior-to-endoscopic-submucosal-dissection-for-superficial-esophageal-squam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-and-sociodemographic-trends-of-hepatocellular-carcinoma-in-nevada-a-decade-long-statew 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinico-genomic-characterization-of-itp53i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-trastuzumab-deruxtecan-versus-real-world-treatment-in-her2-amplified-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-for-early-onset-colorectal-cancer-in-the-united-states-an-epidemiologic-investigation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnical-disparities-in-treatment-outcomes-in-patients-with-advanced-hcc-who-received-fir 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-learning-based-cfdna-fragment-level-analysis-a-genome-scanning-approach-for-detection-of-color 2026-08-24 monthly 0.7 https://rjrindex.com/articles/italian-prospective-observational-realflot-study-four-year-update 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-first-line-anti-egfr-antibody-versus-anti-vegf-therapy-stratified-by-dna-methyl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mtap-loss-in-anal-melanoma-a-genomic-landscape-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-anlotinib-combined-with-penpulimab-and-nab-paclitaxel-as-first-line-treatment-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunohistochemical-genetic-and-transcriptomic-profiles-of-jejunoileal-adenocarcinoma-compared-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-analysis-of-systemic-therapies-for-advanced-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accru-gi-1810-trifluridinetipiracil-ftd-tpi-or-paclitaxel-pac-in-combination-with-ramucirumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-hepatocellular-carcinoma-hcc-incidence-and-impact-of-hepatitis-c-antiviral-therapy-a-po 2026-08-24 monthly 0.7 https://rjrindex.com/articles/levity-as-a-tool-for-difficult-conversations-healthcare-provider-experiences-with-the-butts-amp-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-and-potential-therapeutic-implications-of-molecular-testing-utilizing-a-large-da 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pilot-study-of-cannabidiol-cbd-to-prevent-neuropathy-cipn-in-colorectal-cancer-crc-chemotherap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lap-net1-phase-1b-study-investigating-the-association-of-np137-with-mfolfirinox-in-locally-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lean-individuals-with-metabolic-dysfunction-associated-steatotic-liver-disease-and-gastrointestinal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-study-to-evaluate-the-safety-tolerability-and-preliminary-efficacy-of-a-heterologous-pri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-benmelstobart-ben-combined-with-concurrent-chemoradiotherapy-ccrt-versus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-ai-as-a-decision-support-tool-for-practicing-oncologists-gastrointestinal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-recurrence-in-a-diverse-population-based-sample-of-adults-with-early-onset-colorectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-folfirinox-and-sbrt-for-borderlinelocally-advanced-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trifluridinetipiracil-and-pembrolizumab-combination-as-later-line-treatment-in-patients-with-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intraperitoneal-therapies-ip-for-pancreatic-ductal-adenocarcinoma-pdac-a-systematic-synthesis-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-evaluation-of-immunotherapy-combination-approaches-versus-tyrosine-kinase-inhibitor-mo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determinants-of-biomarker-testing-and-treatment-selection-by-oncologists-caring-for-patients-pts-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-smoking-on-immunotherapy-outcomes-in-gastric-gastro-esophageal-junction-and-esophageal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-sarcopenia-on-short-and-long-term-outcomes-after-multimodal-therapy-for-esophageal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rural-urban-disparities-in-pancreatic-cancer-mortality-hotspots-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-and-prognostic-role-of-protease-activated-receptors-pars-in-colorectal-cancer-crc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-and-physician-preferences-for-third-line-or-later-3l-treatments-of-metastatic-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emergency-department-diagnosis-and-guideline-concordant-care-in-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-flot-in-gastric-cancer-effect-on-survival-among-east-asian-patients-in-a-canadian-pop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/race-and-income-related-disparities-in-survival-outcomes-in-patients-with-pancreatic-neuroendocrine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colonoscopy-choices-in-a-changing-world-do-gender-preferences-still-exist-for-colonoscopy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-efficacy-and-use-of-immunotherapy-in-treatment-of-microsatellite-instability-low 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-intraperitoneal-cf33-hnis-combined-with-pd-l1-blockade-on-gastric-cancer-peritoneal-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-sting-agonist-adu-s100-combined-with-a-cldn182-bispecific-antibody-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-open-label-single-arm-multi-center-study-of-trans-arterial-tirapazamine-embolization-ta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-and-30-day-readmissions-among-hepatocellular-carcinoma-patients-hospitalized-for-portal-ve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-presurgical-circulating-tumor-dna-ctdna-levels-and-other-clinical-factors-in-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-variation-and-regulation-of-mica-alters-natural-killer-cell-mediated-immunosurveillance-in-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frequency-of-peritoneal-metastasis-pm-as-exclusion-criteria-in-clinical-trials-of-gastrointestinal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-alter-pa-001-trial-a-multicenter-open-label-randomized-phase-ii-trial-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inflammatory-and-immune-marker-dynamics-following-intratumoral-alpha-dart-for-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-detection-of-hepatocellular-carcinoma-using-red-blood-cell-dna-signatures 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cytoreductive-surgery-crs-with-hyperthermic-intraperitoneal-chemotherapy-hipec-in-malignant-peri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/indian-hedgehog-expression-and-association-with-cetuximab-benefit-in-metastatic-colorectal-cancer-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oxaliplatin-induced-portal-hypertension-in-colorectal-cancer-a-systematic-review-of-incidence-mech 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-randomized-controlled-trial-to-confirm-efficacy-of-surgery-plus-postoperative-dose-modifie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-disparities-in-the-place-of-death-in-patients-with-colorectal-cancer-analysis-of-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/associations-of-9p21-deletions-on-chemotherapy-outcomes-in-pancreatic-ductal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dose-dependent-antitumor-activity-of-hcb101-plus-ramucirumab-and-paclitaxel-in-previously-treated-ga 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-extended-neoadjuvant-flot-for-resectable-gastroesophageal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conversion-chemotherapy-for-locally-advanced-pancreatic-carcinoma-folfirinox-or-gemcitabine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-minimal-residual-disease-detection-using-tumor-informed-circulating-tumor-dna-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/continued-zenocutuzumab-treatment-beyond-progression-in-patients-with-inrg1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-mfolfoxfiri-after-curative-intent-resection-of-oligometastatic-colorectal-cancer-phase-ii 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glp-1-receptor-agonist-vs-aspirin-for-primary-prevention-of-colorectal-cancer-evidence-from-a-real 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-open-label-study-of-oral-s241656-bdtx-4933-as-monotherapy-and-in-combination-with-oth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-ctdna-in-patients-with-colorectal-cancer-and-liver-metastases-associations-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-sbrt-to-liver-and-portal-vein-tumor-thrombus-followed-by-immunotherapy-or-lenvatinib-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-time-of-day-administration-of-neoadjuvant-chemoradiotherapy-on-pathologic-complete-respons 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-5-fluorouracil-leucovorin-oxaliplatin-and-docetaxel-flot-administration-in-matterho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-dose-escalation-and-expansion-study-of-ryz401-a-novel-radiopharmaceutica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conditional-survival-after-surgical-resection-of-well-differentiated-pancreatic-neuroendocrine-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-for-pembrolizumab-in-msi-high-msi-h-advanced-colorectal-cancer-crc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-determinants-of-ctdna-shedding-in-colorectal-cancer-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-sexual-health-and-post-treatment-issues-among-female-survivors-of-anal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/test-your-biomarkers-real-world-perspectives-and-patient-reported-outcomes-on-biomarker-testing-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toripalimab-plus-hepatic-artery-infusion-chemotherapy-in-hepatocellular-carcinoma-patients-of-barcel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-meta-analysis-of-immunotherapy-combinations-for-first-line-treatment-in-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sintilimab-combined-with-lenvatinib-versus-hepatic-artery-infusion-chemotherapy-haic-for-neoadjuva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/total-neoadjuvant-therapy-vs-standard-therapy-in-locally-advanced-rectal-cancer-a-single-center-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-the-clinical-presentation-of-early-onset-colorectal-cancer-constipation-as-a-novel-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-adjuvant-mfolfox6-on-imaging-diagnosis-after-hepatectomy-for-colorectal-liver-metastasis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-and-clinical-correlates-of-alk-fusions-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-hospital-outcomes-of-splanchnic-vein-thrombosis-in-patients-with-gastrointestinal-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-the-prevalence-of-germline-pathogenic-variants-gpv-in-neuroendocrine-neoplasms-nens 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-cancer-readmissions-identifying-high-risk-patients-and-drivers-of-cost 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-folfirinox-for-locally-advanced-pancreatic-cancer-the-need-for-individualized-strategies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pyroptosis-and-gasdermin-expression-in-metastatic-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-utility-of-geriatric-assessment-and-management-in-older-adults-with-cancer-from-evidence-to-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-proton-pump-inhibitors-and-antibiotics-on-survival-in-immunotherapy-treated-gastrointestin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combining-the-albumin-bilirubin-albi-score-and-ecog-performance-status-for-enhanced-prognosticatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-adjuvant-chemotherapy-on-prognosis-in-patients-with-familial-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-piwi-rna-signatures-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/data-driven-subtyping-and-differential-glufosfamide-benefit-in-pancreatic-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-regional-lymph-node-ratio-lnr-in-locally-advanced-gastric-cancer-a-single-cen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/procedure-specific-mortality-risk-in-octogenarians-undergoing-curative-gi-cancer-resection-a-contem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proximal-gastrectomy-versus-total-gastrectomy-in-locally-advanced-upper-gastric-cancer-after-neoadju 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-first-line-immune-checkpoint-inhibitors-plus-chemotherapy-versus-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-unsupervised-visual-representation-learning-on-whole-slide-images-of-bile-duct-stricture 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-combination-therapy-with-anti-egfr-antibody-as-first-line-treatment-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-of-a-phase-ii-study-of-fruquintinib-plus-sintilimab-as-a-second-line-therapy-for-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-cdc-based-analysis-of-anal-cancer-mortality-disparities-in-us-adults-aged-65-years 2026-08-24 monthly 0.7 https://rjrindex.com/articles/changing-landscape-of-multidisciplinary-management-in-locally-advanced-rectal-cancer-2015-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-trials-on-the-menu-a-patient-and-clinician-validated-plain-language-platform-for-pancreat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/s2408-a-randomized-phase-iii-blinded-trial-of-lanreotide-for-the-prevention-of-postoperative-pancre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clarity-gastric-01-a-randomized-phase-3-study-of-sonesitatug-vedotin-sone-ve-a-claudin182-cldn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artemide-hcc01-a-phase-3-randomized-open-label-sponsor-blinded-multicentre-global-study-of-ril 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-year-analysis-of-the-juliet-trial-of-tisagenlecleucel-in-patients-with-relapsedrefractory-larg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-meta-analysis-of-cohort-studies-assessing-flot-regimen-in-the-treatment-of-esophageal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/three-year-outcomes-and-multi-omics-biomarker-discovery-of-locally-advanced-esophageal-squamous-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fruquintinib-and-pirfenidone-in-combination-with-anti-pd-1-antibody-in-pmmrmss-metastatic-colorecta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pancreastatin-as-a-predictive-biomarker-for-outcomes-with-peptide-receptor-radionuclide-therapy-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/idpydi-genotype-guided-dose-personalization-for-fluoropyrimidine-prescribin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-oxaliplatin-or-irinotecan-rechallenge-vs-standard-third-line-therapies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-self-controlled-electroacupuncture-helmet-for-chemotherapy-induced-cognitive-impairment-res 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-chemotherapy-versus-preoperative-chemoradiation-therapy-in-gastroesophageal-adenocarci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-rate-of-msi-highdmmr-upper-and-lower-gi-cancers-to-neoadjuvant-immunotherapy-a-systematic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-feasibility-analysis-to-align-fit-for-purpose-real-world-rw-data-to-emulate-the-azur-1-single-ar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-trial-of-tas-102-with-or-without-celecoxib-in-ctdna-defined-minimal-residual-disease-mrd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-heterozygous-ugt1a128-genotype-on-toxicity-dose-intensity-and-treatment-compliance-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncologic-outcomes-in-patients-undergoing-robotic-esophagectomy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-agent-system-for-automated-identification-of-competitive-clinical-trials-in-colorectal-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diffuse-idiopathic-skeletal-hyperostosis-dish-and-gastrointestinal-system-cancer-a-mayo-clinic-pl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fit-as-a-cornerstone-of-crc-screening-optimization-for-advanced-neoplasia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-serial-ctdna-dynamics-to-predict-clinical-outcomes-in-metastatic-and-locally-advanced-pdac-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-associated-mutation-patterns-and-a-potential-therapeutic-opportunity-in-early-onset-colorectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-understaging-in-early-gastric-cancer-a-common-and-significant-problem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-adapted-neoadjuvant-therapy-in-gastric-cancer-rant-gc-a-phase-ib-feasibility-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-adjuvant-toripalimab-in-stage-iib-iic-or-iii-colon-cancer-with-mismatch-repair-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modeling-analysis-of-rationale-305-impact-of-peritoneal-metastasis-pm-representation-on-clinical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-institutional-experience-on-patterns-of-ivermectin-and-fenbendazole-use-among-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-from-the-safety-lead-in-for-a-phase-1b2-study-of-ivosidenib-plus-durvalumab-and-gemcitabine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-institutional-retrospective-study-of-idh2-mutated-cholangiocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequential-transarterial-chemoembolization-and-stereotactic-body-radiotherapy-followed-by-immunother 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-large-language-models-llm-to-guide-adjuvant-chemotherapy-ac-recommendations-in-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-initial-corticosteroid-doses-and-second-line-immunosuppressants-on-overall-duration-of-cor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-randomized-study-comparing-telisotuzumab-adizutecan-monotherapy-with-standard-of-care-in-p-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/significance-of-atypical-peritoneal-cytology-in-patients-with-locally-advanced-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-yield-of-germline-genetic-testing-for-early-onset-colorectal-cancer-in-a-safety-net-healt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/us-gastrointestinal-malignancies-mortality-trends-among-asian-and-pacific-islander-populations-1999 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-ierbb2i-her2-amplification-rna-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-exercise-and-nutritional-prehabilitation-on-preoperative-lean-body-mass-in-elderly-gastric 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-obesity-molecular-subtype-and-immunotherapy-outcomes-in-intrahepatic-cholangio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-utility-of-histotype-px-colorectal-as-a-prognostic-and-potentially-predictive-biomarker 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-liquid-biomarkers-to-track-fibrotic-changes-in-pancreatic-cancer-patients-treated-with-combin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-liver-cancer-and-frailty-in-elderly-life-study-longitudinal-functional-status-analysis-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-liquid-biopsy-molecular-profiling-among-native-american-patients-with-pancreatic-ductal-adeno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-tis-chemotherapy-ct-vs-placebo-pbo-ct-as-first-line-treatment-for-locally-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-chemoimmunotherapy-on-survival-in-stage-ii-iv-gastric-adenocarcinoma-an-ncdb-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-trifluridinetipiracil-bevacizumab-in-refractory-metastatic-colorectal-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exposure-response-analyses-from-a-randomized-dose-optimization-study-of-telisotuzumab-adizutecan-te 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-trial-of-efficacy-and-safety-of-imc002-a-vhh-based-anti-cldn182-car-t-therapy-for-gastroe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/magnetic-and-indocyanine-green-icg-sentinel-lymph-node-mapping-in-colorectal-cancer-a-feasibility 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-the-nectin2-tigit-axis-on-resistance-to-pd-l1-blockade-combined-with-chemoradiotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-plus-chemoradiotherapy-crt-versus-crt-or-chemotherapy-ct-as-the-neoadjuvant-treatme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-and-assessing-the-clinical-effectiveness-of-deep-inspiration-breath-hold-compared-to-free 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-readmission-and-readmission-related-mortality-in-older-adults-with-pancreatic-adenocar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-biomarkers-of-systemic-treatment-in-pancreatic-ductal-adenocarcinoma-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adebrelimab-with-or-without-induction-chemotherapy-followed-by-concurrent-chemoradiotherapy-for-unre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pancreatic-cancer-and-coexisting-diabetes-survival-outcomes-from-a-provincial-canadian-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regorafenib-combined-with-trifluridinetipiracil-versus-regorafenib-monotherapy-in-refractory-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-trends-in-gi-cancer-demographic-and-socioeconomic-influences 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-of-elderly-patients-with-advanced-pancreatic-ductal-adenocarcinoma-utilizing-a-metronomic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-risk-factors-of-non-neutropenic-enterocolitis-with-adjuvant-capecitabine-and-oxaliplat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-configurations-and-liver-niche-drive-tumor-intrinsic-state-plasticity-in-metastatic-mss-crc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/matching-adjusted-indirect-comparison-of-fruquintinib-versus-ramucirumab-in-advanced-gastric-or-gast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiofrequency-ablation-versus-stereotactic-body-radiation-therapy-for-early-stage-hepatocellular-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-stratified-iraes-with-immune-checkpoint-inhibitors-in-patients-with-metastatic-gastric-and-color 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-ferric-carboxymaltose-on-anemia-in-patients-with-gastrointestinal-cancer-a-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decoding-molecular-clinico-pathological-and-outcome-differences-between-early-onset-eo-lt50-ye 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-and-transcriptomic-predictors-of-early-vs-late-recurrence-after-curative-intent-surgery-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-distal-gastrectomy-be-considered-a-treatment-option-for-localized-type-4-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-pancreatic-parenchymal-fibrosis-on-long-term-outcomes-in-pancreatic-cancer-patients-measur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-adjuvant-and-perioperative-systemic-therapies-in-gastric-and-gastroesophageal-junction 2026-08-24 monthly 0.7 https://rjrindex.com/articles/closing-the-documentation-gap-cdi-physician-advisor-education-and-its-effect-on-quality-metrics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-safety-of-futibatinib-vs-pemigatinib-in-metastatic-cholangiocarcinoma-faers-based-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tmac-trial-a-randomized-single-blinded-sham-controlled-study-evaluating-effectiveness-of-repetiti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advanced-pancreatic-adenocarcinoma-outcomes-in-patients-with-ddr-deficiencies-outside-of-brca12-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-morphomics-and-metabolomics-as-metastatic-pancreatic-cancer-prognosticators 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-multicenter-study-of-zw251-a-novel-glypican-3-gpc3-targeted-antibody-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preoperative-chemotherapy-with-docetaxel-oxaliplatin-and-s-1-for-gastric-cancer-with-extensive-lym 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distribution-of-driver-and-allele-specific-kras-mutations-across-racial-and-ethnic-groups-in-pancrea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-modified-gemcitabinenab-paclitaxel-schedules-in-first-line-therapy-for-advanced-pancr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-randomized-global-trial-to-investigate-efficacy-and-safety-of-epcam-4-1bb-bsab-bnt3 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-hrd-status-and-arid1a-expression-in-individual-gastrointestinal-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-circulating-tumor-dna-ctdna-to-monitor-patients-undergoing-total-neoadjuvant-treatment-tnt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inferring-optimal-detection-of-imtapi-homozygous-loss 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-plus-ipilimumab-vs-lenvatinib-or-sorafenib-as-first-line-treatment-for-unresectable-hepato 2026-08-24 monthly 0.7 https://rjrindex.com/articles/idpydi-testing-in-gi-cancers-a-real-world-analysis-of-costs-and-quality-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-preliminary-efficacy-results-of-sup212sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-journey-for-participants-pts-in-the-matterhorn-trial-a-global-randomized-phase-3-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-retifanlimab-in-gastrointestinal-malignancies-a-systematic-review-of-clinica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/5-fu-freedom-patient-perspectives-from-colontown-on-the-practice-of-pump-self-disconnect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-liver-function-on-survival-outcomes-in-patients-pts-treated-with-first-line-atezolizumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthful-plant-based-diet-index-hpdi-and-risk-of-upper-gastrointestinal-cancer-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-multidisciplinary-management-of-hcc-with-cirrhosis-in-community-based-settings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-residual-disease-detection-using-whole-genome-sequencing-based-ctdna-assay-for-resectable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/which-patients-with-colorectal-cancer-develop-brain-metastases-a-multicenter-analysis-of-clinical-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-combination-immunotherapy-in-patients-with-child-pugh-class-b-hepatocellular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-on-the-impact-of-glp-1-receptor-agonists-on-survival-and-metastatic-risk-in-colo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mutational-analysis-and-identification-of-potential-biomarkers-in-patients-with-metastatic-pancreati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/redefining-the-use-of-a-first-line-folfirinox-like-regimen-in-older-patients-with-metastatic-pancrea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiotherapy-versus-local-ablation-therapy-for-the-treatment-of-hepatocellular-carcinoma-a-systemat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-first-line-chemotherapy-in-elderly-patients-with-advanced-biliary-tract-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-penpulimab-a-pd-1-inhibitor-anlotinib-an-antiangiogenic-targeted-drug-nab-paclitaxe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-ctdna-in-early-switch-of-first-line-mfolfirinox-in-metastatic-pancreatic-ductal-adenocarc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-characterization-of-biliary-tract-cancer-patients-from-the-spanish-retud-registry 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-significance-of-serum-tumor-marker-dynamics-during-preoperative-chemotherapy-and-hepatectom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-center-phase-1b2-clinical-trial-of-concurrent-administration-of-fruquintinib-and-ftdtpi-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantification-of-circulating-tumor-dna-ctdna-using-a-methylation-based-tissue-free-colorectal-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-readmission-drivers-in-right-versus-left-sided-colorectal-cancer-insights 2026-08-24 monthly 0.7 https://rjrindex.com/articles/source-matters-performance-of-guideline-anchored-rag-versus-broad-evidence-llms-in-gi-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-enhanced-biomarker-analysis-of-wnt-tgf-v-and-pi3k-pathway-alterations-in-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-robot-assisted-surgery-on-postoperative-sexual-function-in-younger-male-rectal-cancer-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-multiomics-on-tumor-microenvironment-remodeling-in-locally-advanced-rectal-cancer-follo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/activity-of-dem301-a-novel-anti-dem-txx-antibody-drug-conjugate-for-the-treatment-of-gastrointestin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bmi-at-diagnosis-and-pre-diagnosis-weight-loss-as-predictors-of-stage-and-survival-in-hepatocellular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conversion-surgery-for-stage-iv-gastric-cancer-real-world-insights-with-a-focus-on-elderly-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conditional-recurrence-free-survival-after-curative-resection-of-esophageal-cancer-integrated-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploration-of-her2-expression-in-advanced-hepatocellular-carcinoma-using-tumor-biopsy-samples 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-robotic-vs-laparoscopic-liver-resection-for-bclc-stage-0-i-hepatocellular-carcinoma-a-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pancreatic-metastases-from-small-cell-lung-cancer-systematic-review-of-clinical-presentation-diagn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-institutional-analysis-of-missed-opportunities-in-lynch-syndrome-diagnosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progression-free-survival-with-the-ice-regimen-in-refractory-rasbraf-wild-type-and-mss-mcrc-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-controlled-phase-ii-trial-comparing-nivolumab-ipilimumab-plus-radiotherapy-versus-nivolu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-of-consensus-molecular-subtype-classification-of-colorectal-cancer-using-preoperative-bi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-regimen-selection-systemic-therapy-completion-and-host-determinants-as-predictors-in-localiz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-a-blood-biomarker-test-for-early-detection-of-pancreatic-ductal-adenocarcinoma-pdac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precemtabart-tocentecan-precem-tct-m9140-in-patients-with-mcrc-efficacy-and-safety-data-at-the-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-a-computational-histology-artificial-intelligence-powered-predictive-biomarker-for-chemothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-pembrolizumab-for-participants-with-hepatocellular-carcinoma-and-complete-radiologic-respon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-perioperative-and-neoadjuvant-therapies-including-immunotherapy-in-resectable-gastroesop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-codon-level-kras-mutations-on-response-to-tas-102-tas-102bevacizumab-or-regorafenib-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-short-course-radiotherapy-combined-with-capox-and-pd-1-inhibitor-for-msspmmr-high-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-ikrasi-exon-3-exon-4-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-efficacy-and-biomarker-analysis-of-cldn182-targeted-adc-combined-with-the-net-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/jaguar-jaccro-pm-01-a-prospective-study-to-evaluate-the-clinical-utility-of-serial-comprehensive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-potential-new-biomarker-for-enhanced-molecular-imaging-of-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-enabled-precision-oncology-in-early-onset-colorectal-cancer-molecular-chara 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biliary-tract-carcinoma-real-world-evidence-in-a-developing-country 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retreatment-patterns-and-outcomes-in-patients-pts-with-gastroenteropancreatic-neuroendocrine-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-and-treatment-patterns-by-specific-metastatic-sites-in-stage-iv-colon-cancer-a-na 2026-08-24 monthly 0.7 https://rjrindex.com/articles/durable-responses-to-immunotherapy-in-dmmrmsi-h-metastatic-colorectal-cancer-patients-with-poor-per 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptomic-analysis-of-patients-with-colorectal-cancer-in-ireland 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-arm-phase-2-study-of-the-fgfr-inhibitor-futibatinib-futi-in-combination-with-pembrolizumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-based-outcomes-and-patterns-of-care-of-patients-with-metastatic-pancreatic-cancer-an-updated-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-sintilimab-plus-capecitabine-in-resected-extrahepatic-cholangiocarcinoma-interim-report-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-tolerability-of-all-trans-retinoic-acid-bevacizumab-and-atezolizumab-in-refractory-micr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-first-in-human-open-label-multicenter-study-of-bi3706674-kras-multi-inhibitor-monother 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-evaluation-of-asp3082-a-first-in-class-selective-protein-degrader-in-patients-pts-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-palliative-care-and-clinical-outcomes-in-gastric-cancer-with-sepsis-a-population-based-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/readability-and-quality-of-information-of-ai-generated-patient-education-materials-on-familial-adeno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-transcriptomic-analysis-of-early-and-late-onset-colorectal-cancer-across-tcga-geo-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-the-sequencing-and-timing-of-transarterial-chemoembolization-and-systemic-therapy-in-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tas-102-plus-bevacizumab-in-refractory-metastatic-colorectal-cancer-a-systematic-review-and-meta-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-analysis-of-immunomodulatory-low-dose-radiotherapy-plus-chemoimmunotherapy-as-conversion-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-dietitian-follow-up-after-pancreatectomy-and-post-operative-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-dcf-plus-nivolumab-versus-induction-dcf-for-unresectable-locally-advanced-esophageal-squam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-claudin-1-cldn1-expression-on-molecular-correlates-and-clinical-outcomes-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-dpyd-variants-across-ancestries-in-a-large-real-world-cohort-of-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/isocitrate-dehydrogenase-1-mutations-in-biliary-tract-cancer-patients-in-spanish-retud-registry 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disco-diagnostic-performance-of-sup64sup-cu-sartate-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tp53-y220c-mutation-in-esophageal-adenocarcinoma-a-genomic-landscape-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequencing-fruquintinib-and-trifluridinetipiracil-to-improve-outcomes-in-the-real-world-management 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-correlation-between-clonal-hematopoiesis-and-response-to-regorafenib-and-nivolumab-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-therapeutic-targeting-of-xct-on-usp15smad-driven-gemcitabine-resistance-in-kras-mutant-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detecting-imtapi-loss-in-liquid-biopsies-from-patients-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemo-immunotherapy-sequential-with-radiotherapy-and-immunotherapy-consolidation-in-patients-with-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemoradiotherapy-versus-chemotherapy-alone-for-locally-advanced-esophageal-adenocarcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/generalized-applicability-of-da-vinci-sp-for-gastrectomy-considering-from-short-term-outcomes-learn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-ppv-of-sup18sup-ffapi-74-pet-to-identify-fap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/atezolizumab-with-bevacizumab-and-nonplatinum-chemotherapy-for-recurrent-ovarian-cancer-final-resul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-care-and-access-to-resources-in-neuroendocrine-tumors-nets-a-cross-sectional-survey-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-hepatocellular-carcinoma-outcomes-by-distance-insurance-and-treatment-access-a-10 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultrasensitive-structural-variant-based-ctdna-detection-of-mrd-in-colorectal-cancer-the-citcca-stud 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gallbladder-and-bile-duct-cancer-a-us-mortality-overview 2026-08-24 monthly 0.7 https://rjrindex.com/articles/number-needed-to-treatharm-nntnnh-a-benefitrisk-analysis-of-fruquintinib-vs-other-treatments-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-first-line-immune-checkpoint-inhibitor-combinations-in-advanced-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-liver-directed-therapy-on-survival-in-patients-with-colon-cancer-and-isolated-hepatic-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-neurotoxicity-patterns-across-neuroendocrine-tumor-grades-a-real-world-analysis-of-12 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-patient-attrition-across-the-colorectal-cancer-screening-pathway-insights-from-a-lar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-age-stage-and-social-vulnerability-index-with-colon-cancer-diagnosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-to-guide-rechallenge-with-cetuximab-plus-irinotecan-in-chinese-rasbraf-wild-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-trifluridinetipiracil-plus-ramucirumab-in-advanced-gastric-cancer-as-third-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-of-homologous-recombination-deficiency-signature-in-esophageal-and-gastric-adenoca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spliceosome-driven-transcriptomic-profiling-to-reveal-prognostic-subtypes-and-risk-stratification-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pathological-complete-response-after-dcf-neoadjuvant-chemotherapy-followed-by-surgery-on-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glucagon-like-peptide-1-receptor-agonists-and-the-risk-of-developing-malignancies-of-the-liver 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-run-in-results-from-c-solve-jaccro-gc-12-a-randomized-non-comparative-phase-ii-trial-of-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emerging-radiation-paradigms-utilization-and-survival-outcomes-of-brachytherapy-vs-ebrt-in-pancreat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-fulvestrant-in-combination-with-sup177sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kandlelit-012-phase-3-study-of-mk-1084-a-ikras-g12ci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cadonilimab-combined-with-folfirinox-and-bevacizumab-as-first-line-treatment-for-microsatellite-stab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-claims-based-machine-learning-to-assign-pancreatic-cancer-stage-for-enhanced-outcomes-researc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fecal-microbiota-transplantation-fmt-combined-with-first-line-gemcitabine-and-nab-paclitaxel-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-the-idylla-cdx-msi-test-in-identifying-msi-h-mcrc-patients-eligible-for-nivoluma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gastrointestinal-malignancies-in-syria-an-epidemiological-analysis-from-the-countrys-main-cancer-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glp-1-receptor-agonist-use-and-pancreatic-cancer-risk-in-patients-with-chronic-pancreatitis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-open-label-study-of-rp2-oncolytic-immunotherapy-expressing-anti-ctla-4-in-combination 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-biomarker-testing-in-patients-with-metastatic-colorectal-cancer-through-patient-education 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-outcomes-of-folfox-vs-folfiri-as-second-line-therapy-in-metastatic-biliary-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-free-rna-cfrna-as-a-predictive-tool-for-immunotherapy-benefit-in-mismatch-repair-defic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-capecitabine-and-temozolomide-captem-in-patients-with-gastrointestinal-neuroendocrine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantitative-radiomics-based-biomarker-discovery-for-prognostic-stratification-in-gastroesophageal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-characterization-of-resectable-pancreatic-ductal-adenocarcinoma-r-pdac-on-the-neopancone-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-tumor-informed-minimal-residual-disease-detection-in-pancreatic-cancer-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-postoperative-ctdna-dynamics-on-eligibility-for-the-altair-randomized-trial-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-clinical-and-molecular-comparative-analysis-of-kras-exon-2-and-kras-non-exon-2-mutated-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-outcomes-of-durvalumab-plus-gemcitabine-and-cisplatin-d-gemcis-or-gemcis-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-nutrition-in-patients-with-pancreatic-cancer-nuance-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-for-phase-ii-study-of-durvalumab-d-and-tremelimumab-t-plus-pet-directed-chemor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-pancreatic-cancer-screening-and-detection-in-patients-with-pathogenic-germline-variants 2026-08-24 monthly 0.7 https://rjrindex.com/articles/do-glucagon-like-peptide-1-receptor-agonists-offer-protective-effect-on-colon-cancer-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-organ-preservation-in-lynch-syndrome-a-tailored-conservative-surgical-approach 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicenter-retrospective-study-on-treatment-outcomes-of-gastric-cancer-with-positive-peritoneal-cyt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/once-daily-oral-paltusotine-in-the-treatment-of-patients-with-carcinoid-syndrome-biomarker-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-open-label-study-evaluating-the-safety-tolerability-pharmacokinetics-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-23-randomized-study-of-bms-986504-with-nab-paclitaxel-nab-p-and-gemcitabine-gem-in-firs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-utility-of-geriatric-assessment-and-management-in-older-adults-with-cancer-model-based-economi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-safety-and-efficacy-of-endoscopic-ultrasound-guided-alpha-radiotherapy-for-advanced-pan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-chemoresistance-a-phase-ii-study-of-iadademstat-iada-with-paclitaxel-p-in-extrapulmon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-disparities-in-hepatocellular-carcinoma-and-their-effect-on-patterns-of-systemic-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-gastric-cancer-recurrence-after-endoscopic-submucosal-dissection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alternating-neoadjuvant-gemcitabine-nab-paclitaxel-gnp-and-nal-irinotecan-5-fluorouracil-and-foli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examining-the-link-between-tobacco-use-and-gastric-cancer-mortality-a-us-population-based-perspec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemotherapy-in-resectable-gastric-cancer-an-international-propensity-matched-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/locoregional-therapy-for-hepatocellular-carcinoma-before-transplant-impact-on-tumor-necrosis-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-to-investigate-the-efficacy-and-safety-of-acoustic-cluster-therapy-with-modified-fol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/design-of-a-hybrid-site-and-decentralized-clinical-research-study-of-an-early-detection-blood-test-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antibody-mediated-blockade-of-gremlin-1-in-combination-with-gemcitabine-or-mek-inhibition-in-a-genet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/physical-activity-and-molecular-residual-disease-mrd-in-stage-iii-colon-cancer-findings-from-calg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-a-vaginal-dilator-during-chemoradiation-for-anal-cancer-to-mitigate-toxicity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-benefit-of-nutritional-support-in-advanced-gastric-cancer-patients-receiving-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-chemotherapy-in-metastatic-colorectal-cancer-comparative-outcomes-from-a-resource-limite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/t-core2401-trial-a-randomized-phase-ii-trial-of-mfolfox6-plus-cetuximab-versus-mfolfox6-plus-bevaci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pooled-analysis-of-individual-patient-data-ipd-from-clinical-trials-of-trifluridinetipiracil-ftd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-comparison-of-overall-survival-os-in-deficient-mismatch-repairmicrosatellite-instabi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proposal-of-a-novel-pnd-based-staging-system-for-locoregional-gastric-neuroendocrine-carcinoma-a-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-accuracy-of-circulating-tumor-dna-for-early-detection-of-colorectal-cancer-a-systematic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-driven-and-evidence-based-therapy-for-metastatic-colorectal-cancer-beat-crc-a-system-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-an-implantable-microdevice-for-personalized-drug-testing-in-colorectal-liver 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-plus-chemotherapy-in-her2-negative-metastatic-gastric-gej-and-esophageal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-expanding-utility-of-diagnostic-laparoscopy-in-pancreatic-ductal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/legal-guidance-and-advocacy-for-caregivers-legacy-care-a-pilot-clinical-trial-for-patients-with-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/wnt-pathway-alterations-in-bevacizumab-treated-early-onset-colorectal-cancer-an-artificial-intellig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artemide-gastric01-a-phase-3-randomized-study-of-rilvegostomig-with-fluoropyrimidine-and-trastuzuma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-for-locally-advanced-pancreatic-cancer-the-dilemma-of-david-versus-goliath-after-neopa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ierbb3i-driver-genomic-alterations-in-intrahepatic-cholangiocarcinoma-a-ge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inferring-optimal-detection-of-imtapi-homozygous-loss-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-liquid-biopsy-in-diagnosis-prognosis-and-monitoring-of-hepatocellular-carcinoma-a-systema 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-cancatch-surf-assay-for-tissue-agnostic-detection-of-minimal-residual-disease-in-color 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-locally-advanced-mismatch-repair-deficient-colorectal-tumours-treated-with-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-approach-to-estimating-trial-feasibility-with-oncollm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantifying-mlh1-promoter-methylation-via-liquid-biopsy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-center-prospective-study-to-evaluate-effectiveness-of-68ga-fapi-petct-in-the-initial-evalu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-study-of-claudin-182-cldn182-association-with-molecular-subtypes-mutationsbiomark 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-predictors-and-evolutionary-correlates-of-chemotherapy-response-in-pancreatic-ductal-adenoca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicenter-nonrandomized-clinical-trial-to-evaluate-the-efficacy-and-toxicity-of-a-combination-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimising-outcomes-in-young-onset-metastatic-colorectal-cancer-from-a-multidisciplinary-model-of-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-recurrence-patterns-in-rectal-cancer-after-neoadjuvant-therapy-insights-from-25-years-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-the-impact-of-proton-pump-inhibitor-ppi-exposure-on-survival-outcomes-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-immunotherapy-based-combination-in-first-line-management-of-hepatocellular-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-circulating-tumor-dna-in-patients-with-resectable-pancreatic-cancer-using-a-patient-speci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-economic-outcomes-of-robotic-vs-open-gastrectomy-a-propensity-score-matched-analysis-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-phase-2-study-evaluating-the-efficacy-and-safety-of-hlx43-an-anti-pd-l1-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multiomic-profiling-to-identify-pharmacodynamic-and-response-biomarkers-for-casdozokitug-with-pd-l1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-in-metastatic-squamous-cell-carcinoma-of-the-anal-canal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-features-and-overall-survival-of-patients-with-early-onset-colorectal-cancer-in-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-pembrolizumab-plus-chemotherapy-with-short-course-radiotherapy-as-induction-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-characteristics-clinical-profiling-and-outcomes-of-advanced-pancreatic-ductal-adenocarcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-clinical-validation-of-the-northstar-response-using-methylated-ctdna-as-a-dynamic-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relative-survival-at-1-3-5-and-10-years-by-raceethnicity-in-colorectal-cancer-a-seer-based-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-primary-results-of-a-randomized-phase-ii-trial-of-trifluridinetipiracil-ftdtpi-plus-ramuciru 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proactif-final-results-from-the-largest-prospective-real-world-study-of-1196-primary-liver-cancer-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-prospective-comparison-of-sorafenib-and-lenvatinib-as-first-line-therapy-for-unresectable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-carcinoid-syndrome-in-small-versus-large-intestinal-neuroendocrine-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/key-lessons-from-phase-i-trials-in-gastroesophageal-cancer-treated-in-gustave-roussy-cancer-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-determinants-of-survival-and-a-predictive-immune-biomarker-for-immunotherapy-in-fibrolamell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-pralsetinib-in-ireti-fusion-posi-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-peritoneal-immune-landscape-in-gastrointestinal-peritoneal-metastasis-patients-and-the-impact-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trifluridine-tipiracil-versus-radioembolization-for-patients-with-refractory-colorectal-liver-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clonal-hematopoiesis-of-indeterminate-potential-a-potential-risk-factor-for-gi-malignancies-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-and-prognostic-factors-for-immune-checkpoint-inhibitors-in-dmmrmsi-h-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/international-and-contrasting-perspectives-on-early-onset-colorectal-cancer-awareness-testing-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/open-versus-minimally-invasive-surgery-for-large-type-3-and-type-4-gastric-cancer-a-multicenter-ret 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-squamous-cell-carcinoma-of-the-small-intestine-a-population-based-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-phase-ii-trial-of-ramucirumab-plus-irinotecan-in-patients-with-early-relapsed-gastric 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-universal-germline-sequencing-in-white-vs-minority-populations-with-primary-gastroint 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-randomized-study-of-atezolizumab-plus-multikinase-inhibitor-mki-versus-mki-alone-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sglt2-inhibitors-and-outcomes-in-pancreatic-cancer-a-large-scale-propensity-matched-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-immune-contexture-in-smarca4-deficient-gastric-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-informed-ctdna-monitoring-during-surveillance-for-early-detection-of-recurrence-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-tinengotinib-in-advanced-cholangiocarcinoma-analysis-of-molecular-response-and-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-distribution-and-equity-in-access-to-gastrointestinal-cancer-clinical-trials-in-the-unite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-liposomal-irinotecan-in-patients-with-advanced-pancreatic-cancer-a-prospecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-the-phase-12-study-of-tsn1611-a-highly-selective-kras-g12d-inhibitor-in-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preoperative-nalirifox-versus-upfront-surgery-in-high-risk-resectable-pancreatic-cancer-a-randomize 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-surufatinib-in-advanced-neuroendocrine-neoplasm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-trial-of-high-dose-sbrt-combined-with-atezolizumab-and-bevacizumab-in-advanced-hepatocellula 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-stereotactic-body-radiotherapy-and-focal-adhesion-kinase-inhibitor-in-advanced-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-chemotherapy-and-immune-checkpoint-inhibitor-treatment-in-high-risk-stage-ii-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gut-microbiota-perturbations-in-response-to-sars-cov-2-and-survival-outcomes-in-patients-with-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-simple-abc-score-for-prognosis-stratification-and-treatment-selection-in-advanced-hepatocellular-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/external-validation-of-magic-d-in-taiwanese-patients-with-advanced-biliary-tract-cancer-receiving-du 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-randomized-double-blind-placebo-controlled-study-of-lecithinized-superoxide-dismutase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunomodulatory-effects-of-lenvatinib-targeting-immunosuppressive-macrophages-in-combination-with-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-relationship-between-the-diagnostic-interval-length-and-survival-in-colon-cancer-the-role-of-di 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-combined-therapy-folfox-with-dabrafenib-and-cetuximabpanitumumab-as-first-line-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gemini-perioperative-periop-gastric-a-phase-2-study-of-novel-agent-based-combinations-as-periop-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-pancreatic-cancer-burden-across-states-sex-and-risk-factors-a-gbd-2021-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pilot-study-of-atrovastatin-aspirin-asa-chemoprevention-in-patients-pts-with-lynch-syndrom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-in-advanced-gastric-cancer-gc-across-racial-and-ethnic-groups-in-the-immunother 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-anti-egfr-therapy-in-elderly-mcrc-patients-a-monocentric-analysis-stratified-by-comorbid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidental-gastric-micro-gists-in-sleeve-gastrectomy-incidence-and-intraoperative-management-in-a-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-prevalence-in-us-patients-with-gastricgastroesophageal-junction-adenocarcinoma-gea-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-and-mutational-factors-related-to-survival-in-patients-with-gastrointestinal-str 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-gpc3-and-its-association-with-tumor-gpc3-expression-and-clinical-outcomes-in-advanced-hepatoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-sarcomatoid-hepatocellular-carcinoma-patients-treated-with-immunotherapy-a-multi-instit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-glucagon-like-peptide-1-receptor-agonists-on-clinical-outcomes-in-pancreatic-cancer-a-lar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-outcomes-with-tremelimumab-t-rechallenge-in-the-phase-3-himalaya-study-of-t-plus-durvalumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-outcomes-of-patients-with-m-iidh1i-cholangioc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-phase-1-results-of-incb161734-a-novel-oral-kirsten-rat-sarcoma-kras-g12d-inhibitor-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-triweekly-cetuximab-in-combination-with-capecitabine-as-first-line-maintenanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-soy-food-consumption-in-preventing-hepatocellular-carcinoma-a-systematic-review-and-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/triunite-02-a-phase-2-open-label-randomized-study-of-neoadjuvant-capeox-plus-tislelizumab-and-chi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-differences-in-pancreatic-cancer-survival-and-treatment-at-a-high-volume-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/online-patient-and-caregiver-conversations-focused-on-neuroendocrine-neoplasms-nens-a-global-them 2026-08-24 monthly 0.7 https://rjrindex.com/articles/narmafotinib-amp945-in-combination-with-gemcitabine-and-nab-paclitaxel-as-first-line-treatment-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/arb1002-a-potential-first-in-class-cdh17-specific-adc-for-treatment-of-pancreatic-and-other-gastro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-and-toxicity-of-stereotactic-mr-guided-adaptive-radiation-therapy-smart-in-local 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-chemotherapy-plus-pd-1-inhibitor-with-chemoradiotherapy-for-metastatic-escc-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-durvalumab-plus-gemcitabinecisplatin-in-combined-hepatocellular-cholangiocar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/estimating-the-clinical-and-economic-impact-of-delaying-recurrence-in-resectable-gastric-and-gastroe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicenter-prospective-validation-of-panclaudinai-an-ai-for-predicting-claudin-182-from-ct-in-pan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-genomic-profiles-of-ierbb2her2i-mutant-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-palliative-care-and-acute-care-use-at-the-end-of-life-in-young-adults-with-gi-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/small-cell-carcinoma-and-large-cell-neuroendocrine-carcinoma-of-colon-and-rectum-incidence-surviva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iib-study-of-inavolisib-inavo-bevacizumab-bev-or-cetuximab-cetux-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-efficacy-of-immunotherapy-in-hepatocellular-carcinoma-hcc-based-on-etiology-a-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-evolving-vs-conventional-regimens-in-braf-v600e-mutated-metastatic-colorecta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adebrelimab-combined-with-albumin-paclitaxel-and-nedaplatin-as-neoadjuvant-therapy-for-locally-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-vs-late-onset-primary-colon-adenocarcinoma-gene-expression-dependent-overall-survival-in-chem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-complications-and-overall-survival-in-elderly-patients-with-gastric-cancer-a-retrospe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b2-multicenter-open-label-study-to-evaluate-the-efficacy-and-safety-of-gsk5764227-gsk2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reducing-the-resection-range-after-neoadjuvant-therapy-for-locally-advanced-upper-rectal-and-rectosi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-epacadostat-incb024360-combined-with-short-course-radiotherapy-in-patients-with-locall 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-early-line-anti-egfr-therapy-to-facilitate-retreatment-for-select-patients-with-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-cldn182-supsup-cd8 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-resected-gastrointestinal-stromal-tumors-treated-with-3-years-of-adjuvant-imati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-durvalumab-plus-olaparib-in-patients-with-metastatic-pancreatic-cancer-and-dna-dam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemotherapy-and-serplulimab-in-msspmmr-locally-advanced-rectal-cancer-firm-a-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-evaluation-of-zinc-clobetasol-and-combination-prophylaxis-for-regorafenib-induced-hand 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-factors-associated-with-advanced-colorectal-neoplasia-in-average-risk-asymptomatic-individ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/meteorite-a-phase-ii-study-of-y-90-capecitabine-and-atezolizumab-in-oligometastatic-crc-bruog430 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shared-genetic-susceptibility-between-autoimmune-diseases-and-pancreatic-ductal-adenocarcinoma-a-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-safety-of-apixaban-versus-rivaroxaban-in-pancreatic-cancer-associated-v 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-of-immunotherapy-as-a-neoadjuvant-treatment-in-liver-transplant-recipients-with-hepatobi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-pathological-and-molecular-characteristics-of-advanced-colorectal-cancer-in-younger-vs-ol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-differences-in-the-impact-of-pre-existing-mental-health-diagnosis-on-colorectal-cancer-surviv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-ctdna-monitoring-in-patients-with-resectable-pancreatic-ductal-adenocarcinoma-du 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-and-clinical-profile-of-inflammatory-bowel-disease-patients-with-small-bowel-cancer-a-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/btn1a1-expression-as-a-biomarker-for-patient-selection-phase-1b-ihc-analysis-and-clinical-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-longitudinal-comprehensive-distress-screening-on-cancer-related-distress-and-overall-survi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-ca19-9-reduction-on-resectability-and-survival-in-pancreatic-cancer-patients-following-neo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-characteristics-first-line-treatments-and-overall-survival-among-locally-advanced-unresec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stereotactic-body-radiotherapy-for-resectable-pancreatic-ductal-adenocarcinoma-in-patients-unfit-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-of-programmed-death-ligand-1-pd-l1-status-in-primary-esophageal-squamous-cell-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-liver-cancer-and-frailty-in-elderly-life-study-understanding-longitudinal-functional-status-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-symptom-patterns-among-young-medicaid-insured-individuals-with-colorectal-cancer-a-population 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-third-line-regorafenib-versus-fruquintinib-in-the-treatment-of-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ib-trial-on-the-safety-and-feasibility-of-low-dose-radiotherapy-combined-with-immunochemothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-molecular-profile-and-treatment-patterns-in-advanced-gastroesophageal-adenocarcinoma-a-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-quizartinib-for-newly-diagnosed-iflt3i-intern 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-ilustro-trial-of-1l-zolbetuximab-plus-mfolfox6-and-nivolumab-in-patients-with-cldn182-loca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breakwater-primary-analysis-of-first-line-1l-encorafenib-cetuximab-ec-folfiri-in-braf-v600e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-outcomes-of-the-plato-act5-randomised-trial-personalizing-anal-cancer-radiotherapy-dose 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-asp3082-monotherapy-or-in-combination-with-mfolfirinox-in-patients-pts-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-clinical-and-molecular-characteristics-of-patients-with-pik3ca-mutation-with-and-witho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-cabozantinib-cabo-combined-with-ipilimumab-ipinivolumab-nivo-and-transarteri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-randomized-study-of-telisotuzumab-adizutecan-abbv-400-temab-a-in-combination-with-stand 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-detection-of-multiple-cancers-using-5-hydroxymethylcytosine-at-cancer-mutatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-efficacy-of-celiac-plexus-radiosurgery-for-pancreatic-cancer-pain-an-international-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bevacizumab-atezolizumab-b-a-durvalumab-tremelimumab-d-t-and-lenvatinib-l-in-advanced-hepatoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-infusion-timing-it-on-survival-outcomes-across-gastrointestinal-gi-malignancies-a-mul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examining-the-role-of-circulating-tumor-dna-in-gastroesophageal-cancers-treated-with-curative-intent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-safety-profiles-of-atezolizumab-bevacizumab-vs-tyrosine-kinase-inhibitors-in-advanced-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-dpyd-alterations-and-treatment-related-toxicity-in-a-chilean-cohort-of-cancer-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-early-onset-adverse-events-aes-to-inform-treatment-strategies-in-pan-gastrointestinal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/type-2-diabetes-and-the-risk-of-gastrointestinal-cancers-in-individuals-with-metabolic-dysfunction-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/three-year-and-five-year-outcomes-of-a-phase-ii-study-of-perioperative-capeox-therapy-for-advanced-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-novel-tyrosine-kinase-inhibitors-in-rare-gist-subtypes-a-clinico-genomic-analysis-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-cohort-study-of-concurrent-chemoradiotherapy-combined-with-or-without-immune-checkpoint-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/everolimus-or-lanreotide-who-is-the-true-winner-for-gi-nets 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hepatocellular-carcinoma-second-line-systemic-therapies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-interplay-of-hla-diversity-and-copy-loss-t-cell-profiles-and-immunotherapy-efficacy-in-colorec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/altopanc-local-ablative-therapies-in-oligometastatic-pancreatic-adenocarcinoma-a-bi-national-french 2026-08-24 monthly 0.7 https://rjrindex.com/articles/critics-ii-a-multicenter-randomized-phase-ii-trial-of-neo-adjuvant-chemotherapy-followed-by-surgery 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-tisle-combined-with-pofi-irinotecan-paclitaxel-oxaliplatin-and-5-fulevoleucovori-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liposomal-irinotecan-carboplatin-or-oxaliplatin-lyricx-with-or-without-nivolumab-in-the-first-lin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-durvalumab-or-pembrolizumab-plus-gemcitabine-and-cisplatin-gemcis-in-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-zolbetuximab-plus-chemotherapy-for-cldn182-positive-gastric-cancer-a-single 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-comparative-analysis-of-colorectal-cancer-in-high-income-north-america-vs-asian-subregions-tempor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mapping-preventable-risks-obesity-alcohol-and-hepatocellular-carcinoma-in-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-survival-outcomes-in-klatskin-tumors-a-real-world-analysis-of-the-trinetx-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-rationale-for-fgfr1-blockade-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-transcriptomic-signatures-of-irad51i-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-surgeon-specialty-and-health-system-characteristics-on-outcomes-after-pancreatic-adenocarc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-invasive-early-detection-of-gastric-cancer-using-red-blood-cell-dna-genomic-signature-a-multi-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-avapritinib-for-unresectable-or-metastatic-gastrointestinal-stromal-tumors-with-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mtap-deficient-pancreatic-adenocarcinoma-clinical-and-molecular-features 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-affecting-overall-survival-in-early-onset-gastroenteropancreatic-neuroendocrine-tumours-gep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-gaps-in-colorectal-cancer-care-real-world-impact-of-a-national-clinical-navigation-program 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-hepatic-arterial-infusion-chemotherapy-with-folfox-or-folfiri-plus-drug-eluti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reevaluating-complete-response-assessing-whether-imaging-alone-is-sufficient-to-predict-survival-af 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-cost-of-care-how-insurance-status-and-socioeconomic-factors-affect-colorectal-cancer-outcomes-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-following-stereotactic-mr-guided-adaptive-radiation-therapy-smart-in-medically-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liver-transplantation-for-unresectable-colorectal-liver-metastases-pooled-real-world-data-from-all 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-trial-of-emavusertib-ca-4948-in-combination-with-folfoxpd-1-inhibitor-trastuzumab-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-neoadjuvant-short-course-radiotherapy-followed-by-ivonescimab-with-or-without-chem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/amivantamab-plus-folfox-or-folfiri-in-irasbrafi-wild-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-lat1-related-gene-expression-and-its-impact-on-prognostic-tumor-mutations-and-ga 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-profiling-and-its-association-with-clinical-outcomes-in-metastatic-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-patient-reported-outcomes-in-stage-iiiii-rectal-cancer-in-the-netherlands 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-single-arm-phase-ii-study-of-trilaciclib-combined-with-immunotherapy-and-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decreasing-hypoxia-with-mitochondrial-inhibition-in-locally-advanced-rectal-cancer-phase-1-trial-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-and-sociodemographic-characterization-of-gastrointestinal-cancers-in-rural-patients-particip 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-durvalumab-and-pembrolizumab-combined-with-chemotherapy-in-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-plus-ipilimumab-ni-in-patients-pts-with-colorectal-cancer-crc-with-brca12-alterati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pilot-study-of-stomach-cancer-early-detection-and-prevention-with-endoscopy-pilot-screen-acceptab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adverse-events-with-pd-1-inhibitors-in-gastric-cancer-a-real-world-comparative-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ibii-study-of-zanzalintinib-xl092-in-second-line-and-beyond-for-the-treatment-of-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-re-introduction-of-gemcitabine-plus-cisplatin-in-combination-with-durvalumab-aft 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-and-clinical-outcomes-of-mdm2-amplifications-in-biliary-tract-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emb-01-a-tetravalent-anti-egfrcmet-bispecific-antibody-in-the-left-sided-rasbraf-wild-type-lat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-significance-of-oligometastatic-esophageal-squamous-cell-carcinoma-a-retrospective-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-quantitative-pathologic-analysis-to-identify-microsatellite-stability-in-digitized-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-chemotherapy-induced-peripheral-neuropathy-using-metadata-with-machine-learning-models 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-phase-2-study-of-total-neoadjuvant-therapy-tnt-consisting-of-flot-with-pembrolizumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transarterial-chemoembolization-tace-combined-with-sintilimab-and-bevacizumab-versus-tace-alone-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-dose-escalation-and-expansion-study-of-trop2-car-engineered-il-15-transduced-cord-blood-deri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-outcomes-in-patients-diagnosed-with-metastatic-pancreatic-ductal-adenocarcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-early-c-reactive-protein-kinetics-as-an-early-response-marker-in-biliary-tract-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-lb1908-an-autologous-claudin-182-targeted-car-t-cell-product-in-subjects-with-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-lirafugratinib-in-ifgfrii-naive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-of-pleiotropic-genetic-risk-variants-for-pancreatic-cancer-and-diabetes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/definitive-sbrt-in-unresectable-pancreatic-cancer-long-term-outcomes-with-moderate-vs-high-dose-app 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-framework-to-grade-the-quality-of-surrogate-endpoints-at-the-trial-level-an-analysis-of-sur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/care-delivery-among-patients-with-early-onset-versus-average-onset-cholangiocarcinoma-a-nationwide 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obesity-associated-colorectal-cancer-and-the-association-with-chemokine-signaling-and-tumor-remodeli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/young-onset-colorectal-cancer-yocrc-in-the-nationwide-precision-oncology-trial-impress-norway 2026-08-24 monthly 0.7 https://rjrindex.com/articles/coupling-tumor-genomics-whole-transcriptome-sequencing-and-patient-outcomes-to-define-the-tumor-mi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-trastuzumab-deruxtecan-in-her2-positive-advanced-gastric-and-gastroesophageal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-benefit-and-toxicity-of-combining-immunotherapy-with-gemcitabine-cisplatin-versus-standard 2026-08-24 monthly 0.7 https://rjrindex.com/articles/managing-the-primary-tumor-in-patients-with-rectal-cancer-and-synchronous-liver-metastases-the-role 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-for-rapid-progression-in-metastatic-pancreatic-adenocarcinoma-clinical-histopat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hepatocellular-carcinoma-in-nevada-impact-of-hbvhcv-metabolic-syndrome-and-alcohol-use-disorder 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-features-treatment-patterns-and-outcomes-of-microsatellite-instability-high-msi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characterization-of-resected-non-metastatic-pancreatic-cancer-pc-based-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multiomic-analysis-and-oncologic-outcomes-in-pancreatic-cancer-by-pin1-expression 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-association-of-inflammatory-markers-with-clinical-outcomes-of-patients-with-kras-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-immunotherapy-plus-gemcitabine-cisplatin-versus-chemotherapy-alone-in-advanced-cholangioc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-neoadjuvant-chemotherapy-with-fluorouracil-leucovorin-oxaliplatin-and-docetaxel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improvement-of-survival-in-advanced-gastric-cancer-over-15-years-real-world-analysis-by-5-year-peri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-anti-pd-l1-therapy-in-advanced-hepatocellular-carcinoma-with-or-without-metabolic-synd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-locoregional-colorectal-cancer-incidence-by-race-and-ethnicity-in-us-adults-aged-45-49-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-prognostic-nomogram-to-guide-clinical-decision-making-in-metastatic-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/brain-metastases-in-gastro-esophageal-cancers-survival-and-prognostic-insights-from-an-asian-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-line-irinotecan-followed-by-third-line-cetuximab-plus-irinotecan-versus-second-line-cetuximab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-stage-iii-iv-squamous-cell-anal-carcinoma-scac-real-world-treatment-patterns-outc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-biomarker-testing-landscape-of-locally-advanced-gastricgastroesop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-open-label-study-of-enfortumab-vedotin-in-patients-with-previously-treated-locally-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/monthly-alternating-nalirifox-and-gnp-for-metastatic-pancreatic-ductal-adenocarcinoma-altcap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neuroligin-family-genes-expression-associated-with-first-line-treatment-outcomes-in-patients-pts-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-gastric-cancer-genome-explorer-a-spatial-and-single-cellular-registry-for-identifying-novel-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-neoadjuvant-her-2-targeted-therapy-in-resectable-her-2-positive-gastric-and-esophagogast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hospital-frailty-risk-score-and-in-hospital-mortality-after-pancreatectomy-in-adults-65-a-national 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emerging-landscape-of-car-t-cell-therapy-in-gastrointestinal-malignancies-a-systematic-review-of-cl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncologists-perceptions-of-evidence-and-standardization-in-appendiceal-cancer-management-a-nationa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-sequencing-to-reveal-immune-features-of-treatment-response-to-neoadjuvant-chemoradiother 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ibii-study-of-fruquintinib-combined-with-sox-and-toripalimab-in-advanced-metastatic-gastricg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/atezolizumab-plus-tiragolumab-in-combination-with-chemoradiotherapy-in-localized-squamous-cell-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cldn182-ihc-cutoff-and-efficacy-of-anti-cldn182-therapy-in-gastric-and-gastroesophageal-junction-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clonal-hematopoiesis-in-gi-cancer-frequent-but-not-a-predictor-of-oxaliplatin-neuropathy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-adebrelimab-plus-sox-and-nab-paclitaxel-in-resectable-locally-advanced-gastric-and-gastr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/total-neoadjuvant-treatment-in-locally-advanced-rectal-cancer-a-retrospective-multicentre-cohort-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-significance-of-serum-ca125-kinetics-as-an-early-predictor-of-tumor-progression-in-pancreat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pilot-study-of-mobile-application-based-exercise-and-nutrition-interventions-for-gastrointestinal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/opportunities-for-harmonization-of-us-food-and-drug-administration-regulatory-decisions-exemplified 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-study-on-the-influence-of-physical-activity-in-managing-cancer-related-fatigue-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aspirin-use-and-pi3k-mutations-in-metastatic-colorectal-cancer-mcrc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/folfirinox-for-locally-advanced-pancreatic-cancer-the-need-for-individualized-strategies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-clonal-hematopoiesis-of-indeterminate-potential-across-different-systemic-cancer-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-ii-trial-evaluating-the-efficacy-of-zolbetuximab-in-the-second-line-for-claudin182 2026-08-24 monthly 0.7 https://rjrindex.com/articles/landmark-analysis-of-overall-survival-os-by-objective-response-in-patients-pts-with-previously-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/short-term-outcomes-of-induction-flot-plus-nivolumab-for-unresectable-locally-advanced-esophageal-sq 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-dose-radiotherapy-followed-by-chemoimmunotherapy-in-neoadjuvant-treatment-of-locally-advanced-es 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-comparing-the-use-of-glp-1-agonists-in-patients-with-hepatocellular-cancer-hcc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-apixaban-and-rivaroxaban-in-colon-cancer-patients-with-venous-thromboembolis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-in-advanced-gastric-cancer-among-elderly-patients-80-years-old-treated-with-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-indicators-in-lynch-syndrome-associated-stage-iv-colorectal-cancer-treated-with-pembroliz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-double-blinded-international-phase-iii-trial-comparing-hlx22-in-combination-with-tras 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-regorafenib-in-patients-with-advanced-biliary-tract-cancer-an-updated-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extracellular-vesicle-tissue-factor-and-venous-thromboembolism-outcomes-in-pancreatic-cancer-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-decades-of-esophageal-cancer-mortality-in-the-united-states-shifting-patterns-by-sex-race-ag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glucagon-like-peptide-1-receptor-agonists-more-than-just-weight-loss-medications 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sylt-030-efficacy-and-safety-of-tislelizumab-plus-mfolfox6-versus-tislelizumab-plus-pof-paclitaxel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-economic-implications-of-venous-thromboembolism-in-pancreatic-cancer-patients-evidence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-metabolic-and-lifestyle-risk-factors-on-hepatocellular-carcinoma-incidence-and-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-efficacy-of-neoadjuvant-mono-immunotherapy-for-t-sub4sub 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-medicaid-expansion-on-time-to-treatment-and-survival-in-metastatic-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/supporting-utility-and-representation-in-genomics-based-clinical-trial-enrollment-surge-interim-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-spevatamig-pt886-in-combination-with-gemcitabine-plus-nab-paclitaxel-gnp-in-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-systemic-therapy-plus-intraperitoneal-ip-paclitaxel-ptx-in-gastricgej-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/late-nonrelapse-mortality-a-hidden-risk-in-triplet-therapy-for-iidhi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-neoadjuvant-tqb2102-in-locally-advanced-or-early-human-epidermal-growth-facto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-late-nonrelapse-mortality-a-hidden-risk-in-triplet-therapy-for-iidh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/individual-patient-data-meta-analysis-of-consensus-molecular-subtypes-as-biomarkers-of-first-line-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/are-you-bereaved 2026-08-24 monthly 0.7 https://rjrindex.com/articles/carboplatin-for-premenopausal-triple-negative-breast-cancer-time-to-rethink-the-neoadjuvant-standar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/amivantamab-plus-lazertinib-in-atypical-iegfri-mutated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quizartinib-for-newly-diagnosed-iflt3i-internal-tandem-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/addition-of-carboplatin-to-sequential-taxane-anthracycline-neoadjuvant-chemotherapy-in-triple-negati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-five-year-outcomes-of-the-polarix-study-comparing-pola-r-chp-and-r-chop-in-patients-with-di 2026-08-24 monthly 0.7 https://rjrindex.com/articles/if-exercise-were-a-pill-wed-all-prescribe-it-to-patients-with-cancer-but-its-not 2026-08-24 monthly 0.7 https://rjrindex.com/articles/challenges-remaining-for-yttrium-90-radioembolization-the-case-for-standardized-dosimetry-and-compa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sun-sets-on-rituximabgemcitabineoxaliplatin-as-bispecific-antibodies-rise-the-sunmo-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sup177sup-lu-prostate-specific-membrane-antigen-neoadjuvant-to-stereotactic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-practical-assessment-and-management-of-vulnerabilities-in-older-patients-receiving-systemic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-glofitamab-plus-polatuzumab-vedotin-in-relapsedrefractory-large-b-cell-lymph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pulmonary-tumor-burden-in-favorable-histology-wilms-tumor-outcomes-a-report-from-the-chil 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antibody-drug-conjugates-and-bispecific-antibodies-for-lymphoma-partners-of-convenience-or-a-perfec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mosunetuzumab-plus-polatuzumab-vedotin-in-transplant-ineligible-refractoryrelapsed-large-b-cell-lym 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-man-at-the-bow 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigation-of-dna-damage-response-genes-validates-the-role-of-dna-repair-in-pediatric-cancer-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-decoding-the-end-points-of-poly-adp-ribose-polymerase-inhibitor-trials-in-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decoding-the-end-points-of-poly-adp-ribose-polymerase-inhibitor-trials-in-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-defense-of-adjuvant-cdk46-inhibitors-in-early-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-overall-survival-analysis-from-the-phase-ii-pharos-study-of-encorafenib-plus-binimetinib-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characterization-informs-prognosis-in-patients-with-localized-ewing-sarcoma-a-report-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-revisiting-radium-223-in-oligometastatic-castration-sensitive-prostate-cancer-ravens-tria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reflection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-iii-dose-escalation-and-expansion-study-of-zelenectide-pevedotin-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/us-food-and-drug-administration-approval-summary-imetelstat-for-selected-patients-with-low-to-inte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reducing-daunorubicin-in-induction-therapy-in-children-with-b-lineage-all-with-favorable-prognosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-year-outcomes-of-the-polarix-study-comparing-pola-r-chp-and-r-chop-in-patients-with-diffuse-lar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/revisiting-radium-223-in-oligometastatic-castration-sensitive-prostate-cancer-ravens-trial-insights 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-impact-of-lean-body-mass-based-oxaliplatin-dose-calculation-on-neurotoxicity-in-adjuvant-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trybeca-1-a-randomized-phase-iii-study-of-eryaspase-combined-with-chemotherapy-versus-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-cancer-institutes-working-group-on-biochemically-recurrent-prostate-cancer-clinical-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-oxaliplatin-dosing-and-toxicity-a-cautionary-perspective-on-efficacy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comment-on-human-epidermal-growth-factor-receptor-2-low-metastatic-breast-cancer-treatment-costs-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-the-trials-real-world-considerations-for-sentinel-lymph-node-biopsy-omission-in-early-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/remission-assessment-by-circulating-tumor-dna-in-large-b-cell-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-comment-on-human-epidermal-growth-factor-receptor-2-low-metastatic-breast-cancer-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-long-term-continuous-nirogacestat-treatment-in-adults-with-desmoid-tumors-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oxaliplatin-dosing-and-toxicity-a-cautionary-perspective-on-efficacy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metformin-active-surveillance-trial-in-low-risk-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-remission-in-diffuse-large-b-cell-lymphoma-will-minimal-residual-disease-add-value-to-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ruxolitinib-versus-best-available-therapy-in-patients-with-steroid-refractory-acute-graft-versus-hos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-fighter-bigger-than-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/simultaneous-durvalumab-and-platinum-based-chemoradiotherapy-in-unresectable-stage-iii-non-small-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fusing-oncolytic-virotherapy-with-cancer-immunotherapy-to-treat-therapy-resistant-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tar-200-for-bacillus-calmette-guerin-unresponsive-high-risk-non-muscle-invasive-bladder-cancer-resu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-year-follow-up-analysis-of-zuma-5-axicabtagene-ciloleucel-in-relapsedrefractory-indolent-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/next-generation-oncolytic-viruses-to-overcome-resistance-to-anti-pd-1-therapy-in-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rp1-combined-with-nivolumab-in-advanced-anti-pd-1-failed-melanoma-ignyte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-inotch1i-a-potential-new-biomarker-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-arm-pivotal-studies-in-bacillus-calmette-guerin-unresponsive-non-muscle-invasive-bladder-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-incorporating-lifileucel-into-management-of-advanced-pd-1-blockade-resistant-melan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inotch1i-a-potential-new-biomarker-in-the-era-of-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-efficacy-and-safety-of-lifileucel-tumor-infiltrating-lymphocyte-cell-therapy-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/caution-in-interpreting-inotch1i-mutation-as-a-predicti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sirolimus-and-cyclosporine-with-post-transplant-cyclophosphamide-or-mycophenolate-mofetil-as-graft-v 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lymphedema-treatment-act-a-critical-step-for-cancer-survivors-but-unresolved-equity-gaps-persist 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-response-to-neoadjuvant-chemotherapy-and-breast-cancer-subtypes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-efficacy-and-safety-of-avutometinib-defactinib-in-recurrent-low-grade-serous-ovarian-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-learning-model-for-breast-shear-wave-elastography-to-improve-breast-cancer-diagnosis-inspired 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recurrence-patterns-of-esophageal-adenocarcinoma-in-the-phase-iii-esopec-trial-comparing-perioperati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/end-points-for-the-next-generation-bladder-sparing-perioperative-trials-for-patients-with-muscle-inv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-bl-b01d1-in-patients-with-locally-advanced-or-metastatic-urothelial-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inotuzumab-ozogamicin-then-blinatumomab-for-older-adults-with-newly-diagnosed-b-cell-all-alliance-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precision-oncology-and-modernizing-evidence-standards-a-critical-commentary-on-the-cochrane-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bringing-trustworthy-artificial-intelligence-to-the-clinical-forefront-at-ijco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-an-artificial-intelligence-digital-pathology-biomarker-to-predict-bene 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-the-evolving-landscape-of-cns-management-in-small-cell-lung-cancer-prophylactic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/foundation-model-for-predicting-prognosis-and-adjuvant-therapy-benefit-from-digital-pathology-in-gi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-to-neoadjuvant-chemotherapy-and-breast-cancer-subtypes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/apples-oranges-and-esopec-recurrence-patterns 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-identifying-patients-with-low-relapse-rate-despite-high-risk-estrogen-receptor-positivehum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hippocampal-avoidance-during-prophylactic-cranial-irradiation-for-patients-with-small-cell-lung-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-ctla-4pd-l1-blockade-versus-surgery-chemotherapy-in-deficient-mismatch-repairmic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-results-from-blood-and-marrow-transplant-clinical-trials-network-1702-clinical-transplant-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-beyond-1-month-a-broader-look-at-the-robomet-trial-results-and-robomet-revisited-is-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-machine-learning-predicts-oxaliplatin-benefit-in-early-colon-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/looking-for-the-best-allogeneic-donor-and-the-bmt-ctn-1702-study-noli-tempus-perdere 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-the-guided-missile-paradigm-embracing-the-complexity-of-antibody-drug-conjugates 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-systemic-anticancer-therapy-administration-near-the-end-of-life-with-health-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ziftomenib-in-relapsed-or-refractory-inpm1i-mutated-am 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pass-01-randomized-phase-ii-trial-of-modified-folfirinox-versus-gemcitabinenab-paclitaxel-and-mole 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-specific-radiation-dose-and-chemotherapy-risk-for-subsequent-colorectal-malignancies-in-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-phase-ii-study-of-sup177sup-lu-dotatate-for-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-early-chemotherapy-intensification-with-escalated-beacopp-in-patients-with-advanced-stage-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/robomet-revisited-is-stereotactic-body-radiotherapy-truly-effective-for-painful-bone-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-molecular-profiling-to-guide-treatment-selection-in-metastatic-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalizing-chemotherapy-in-metastatic-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-1-month-a-broader-look-at-the-robomet-trial-results 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modified-fluorouracil-leucovorin-irinotecan-and-oxaliplatin-or-s-1-irinotecan-and-oxaliplatin-v 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-pass-01-randomized-phase-ii-trial-of-modified-folfirinox-versus-gemcitabinenab-paclitaxel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-racial-and-ethnic-disparities-along-the-care-cascade-for-older-adults-newly-diagnosed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/us-food-and-drug-administration-approval-summary-ribociclib-with-an-aromatase-inhibitor-in-the-adju 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acknowledgment-of-reviewers-2025 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treat-the-tumor-spare-the-esophagus-the-case-for-organ-preservation-in-locally-advanced-esophageal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-systemic-anticancer-treatments-and-health-services-use-at-the-end-of-life-among-adults-with-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postmastectomy-radiation-therapy-an-astro-asco-sso-clinical-practice-guideline 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-rethinking-treatment-priorities-in-estrogen-receptor-low-breast-cancer-and-cdk46-inhib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/benefit-of-chemoradiotherapy-versus-chemotherapy-after-induction-therapy-for-conversion-of-unresecta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rethinking-treatment-priorities-in-estrogen-receptor-low-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/why-adjuvant-treatment-with-a-cdk46-inhibitor-should-be-recommended-for-women-with-high-risk-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-agent-divarasib-in-patients-with-ikras-g12ci-po 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-disparities-along-the-treatment-cascade-among-medicare-fee-for-service-beneficiari 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cdk46-inhibitors-in-estrogen-receptor-low-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recalibrating-digital-predictions-uncovering-the-limits-of-the-mmai-prostate-lt-adt-predictive-mode 2026-08-24 monthly 0.7 https://rjrindex.com/articles/arsenic-trioxide-and-all-trans-retinoic-acid-combination-therapy-for-the-treatment-of-high-risk-acut 2026-08-24 monthly 0.7 https://rjrindex.com/articles/apollo-optimizing-the-treatment-of-high-risk-acute-promyelocytic-leukemia-with-all-trans-retinoic-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/taletrectinib-in-ros1-fusion-positive-non-small-cell-lung-cancer-promising-yet-premature 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-mitochondrial-activator-of-caspases-mimetics-accelerate-progression-of-locally-advanced-head 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-plus-chemotherapy-versus-chemotherapy-as-perioperative-therapy-in-locally-advanced-gas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-ii-trial-of-pazopanib-versus-placebo-in-patients-with-advanced-extrapancreatic-neur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-tar-200-for-bacillus-calmette-guerin-unresponsive-high-risk-non-muscle-invasive-bladder-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-human-epidermal-growth-factor-receptor-2-in-patients-with-metastatic-colorectal-cancer-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-brain-metastasis-imbalance-in-trust-implications-for-interpreting-intracranial-efficacy-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/brain-imaging-surveillance-for-patients-with-metastatic-breast-cancer-a-randomized-clinical-trial-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keynote-585-fails-while-matterhorn-succeeds-in-gastric-cancer-what-lessons-can-we-learn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-baseline-brain-metastasis-imbalance-in-trust-implications-for-interpreting-intracranial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-dose-randomized-study-of-sunvozertinib-in-platinum-pretreated-non-small-cell-lung-cancer-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/xevinapant-or-placebo-plus-platinum-based-chemoradiotherapy-in-unresected-locally-advanced-squamous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-recalibrating-digital-predictions-uncovering-the-limits-of-the-mmai-prostate-lt-adt-predi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-and-ipilimumab-for-metastatic-castration-resistant-prostate-cancer-with-an-immunogenic-sig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-patients-with-low-relapse-rate-despite-high-risk-estrogen-receptor-positivehuman-epider 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-prospective-study-of-supplemental-screening-with-contrast-enhanced-mammography-in-women-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-pediatric-and-adolescent-considerations-for-the-revised-asco-guidelines 2026-08-24 monthly 0.7 https://rjrindex.com/articles/brown-paper-bags 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precision-and-combination-strategies-for-immune-checkpoint-inhibitors-in-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-sup177sup-lu-dotatate-for-progressive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/us-food-and-drug-administration-approval-summary-inavolisib-with-palbociclib-and-fulvestrant-for-en 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-there-a-role-for-mifamurtide-in-nonmetastatic-high-grade-osteosarcoma-results-from-the-italian-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-ukall-2011-flawed-noninferiority-and-overlooked-interactions-undermine-conclusions-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/focal-boost-to-the-intraprostatic-tumor-in-external-beam-radiotherapy-for-patients-with-localized-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-the-potential-importance-of-pharmacokinetic-variability-in-the-setting-of-all 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pediatric-and-adolescent-considerations-for-the-revised-asco-guidelines 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-of-mediastinal-lymph-node-dissection-for-ground-glass-opacity-dominant-lung-adenocar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mediastinal-nodal-evaluation-may-be-safely-omitted-in-select-patients-with-ground-glass-dominant-lun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ukall-2011-flawed-noninferiority-and-overlooked-interactions-undermine-conclusions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/afatinib-dose-reduction-and-pseudo-acute-kidney-injury 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-isatuximab-subcutaneous-by-on-body-injector-versus-isatuximab-intravenous-plus-pomalidomide 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modern-targeted-radiation-in-patients-with-brain-metastases-from-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reading-the-room-a-joint-perspective-from-a-scientist-and-patient-partnered-working-group-on-the-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-afatinib-dose-reduction-and-pseudo-acute-kidney-injury 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antibody-based-therapies-for-the-treatment-of-hodgkin-lymphoma-in-older-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stereotactic-radiosurgery-in-patients-with-small-cell-lung-cancer-and-1-10-brain-metastases-a-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/muscle-invasive-bladder-cancer-a-watershed-moment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/positron-emission-tomography-guided-brentuximab-vedotin-etoposide-cyclophosphamide-doxorubicin-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-avd-versus-brentuximab-vedotin-avd-in-older-patients-with-advanced-stage-classic-hodgkin-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-pathogeniclikely-pathogenic-mutations-and-subsequent-neoplasms-among-childhood-cancer-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dual-immune-check-point-blockade-in-imgmti-unmethylate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-outcomes-beyond-age-50-years-in-survivors-of-childhood-cancer-a-report-from-the-childhood-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-dose-escalation-results-for-the-delta-like-ligand-3cd3-igg-like-t-cell-engager-obrixtamig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/why-is-earlier-detection-the-key-to-reducing-pancreatic-cancer-so-challenging-despite-technologica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/caution-needed-before-adopting-reduced-dose-elective-neck-irradiation-in-head-and-neck-cancer-a-res 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inconsistent-and-inaccurate-cancer-clinical-trial-reporting-of-venous-and-arterial-thrombotic-events 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-and-biomarker-analysis-evaluating-neoadjuvant-plus-adjuvant-relatlimab-anti-lag3 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-analysis-of-epik-oengot-ov61-alpelisib-plus-olaparib-versus-chemotherapy-in-platinum-resis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adagio-a-phase-iib-open-label-single-arm-multicenter-study-assessing-the-efficacy-and-safety-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diabetes-and-colorectal-cancer-risk-and-survival-according-to-tumor-immunity-status 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-osimertinib-a-step-ahead-or-just-a-step 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-caution-needed-before-adopting-reduced-dose-elective-neck-irradiation-in-head-and-neck-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-cell-free-dna-fragmentomics-based-model-for-early-detection-of-pancr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-osimertinib-for-resectable-iegfri-mutated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-adapted-surgical-and-radiotherapy-de-escalation-in-resectable-cutaneous-squamous-cell-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/us-food-and-drug-administration-approval-summary-trastuzumab-deruxtecan-for-the-treatment-of-adult 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-bo-112-plus-pembrolizumab-for-patients-with-anti-pd-1-resistant-advanced-melanoma-phase-ii 2026-08-24 monthly 0.7 https://rjrindex.com/articles/random-assignment-but-without-comparison-a-missed-opportunity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-randomized-phase-ii-study-of-nab-paclitaxel-and-gemcitabine-with-or-without-tocilizumab-as 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-avutometinib-defactinib-in-recurrent-low-grade-serous-ovarian-cancer-prima 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-allogeneic-chimeric-antigen-receptor-t-cell-persistence-in-relapsedrefractory-large-b-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-of-real-world-adjuvant-anti-pd-1-checkpoint-inhibition-and-targeted-therapy-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patritumab-deruxtecan-her3-dxd-mk-1022-in-non-small-cell-lung-cancer-after-platinum-based-chemoth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-5-year-remission-and-survival-after-treatment-with-ciltacabtagene-autoleucel-in-cartitu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-transplant-cyclophosphamide-based-graft-versus-host-disease-prophylaxis-after-mismatched-unrela 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bo-112-plus-pembrolizumab-for-patients-with-anti-pd-1-resistant-advanced-melanoma-phase-ii-clinical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-phase-iii-trial-of-pirtobrutinib-versus-idelalisibrituximab-or-bendamustinerituximab-in-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/guidance-for-ijcoi-authors-on-subgroup-representation-and-reporting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-random-assignment-but-without-comparison-a-missed-opportunity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-optimizing-allogeneic-chimeric-antigen-receptor-t-cell-persistence-in-relapsedrefractory 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-cure-a-cure-my-kingdom-for-a-cure 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retraction-disability-adjusted-life-years-from-human-papillomavirus-related-oral-cavity-and-pharynx 2026-08-24 monthly 0.7 https://rjrindex.com/articles/totality-of-the-evidence-optimizing-dosage-selection-strategies-in-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapy-for-stage-iv-non-small-cell-lung-cancer-without-driver-alterations-asco-living-guideline-v 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rewriting-risk-a-data-driven-look-at-myeloma-genetics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-de-novo-oligometastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/international-myeloma-societyinternational-myeloma-working-group-consensus-recommendations-on-the-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-inappropriate-conclusions-on-surrogate-end-points-in-early-breast-cancer-trials-and-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/co-occurrence-of-cytogenetic-abnormalities-and-high-risk-disease-in-newly-diagnosed-and-relapsedref 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inappropriate-conclusions-on-surrogate-end-points-in-early-breast-cancer-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breastfeeding-after-hormone-receptor-positive-breast-cancer-results-from-the-positive-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-sharper-focus-greater-comfort-lessons-from-the-robomet-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-art-of-the-art-of-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lisocabtagene-maraleucel-versus-standard-of-care-for-second-line-relapsedrefractory-large-b-cell-ly 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-frontline-triplet-regimens-with-a-hypomethylating-agent-venetoclax-and-isocitrate-dehy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/microbiome-modulation-for-the-treatment-of-solid-neoplasms 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapy-for-stage-iv-non-small-cell-lung-cancer-with-driver-alterations-asco-living-guideline-vers-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-hematopoietic-stem-cell-transplantation-outcomes-for-high-risk-aml-a-report-from-the-child 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multisite-randomized-trial-of-inpatient-palliative-care-intervention-for-patients-undergoing-hematop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/methodologic-considerations-in-assessing-invasive-disease-free-survival-as-a-surrogate-end-point-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-surveillance-in-the-united-states-in-jeopardy-leveraging-21st-century-technology-to-enhance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-plus-famitinib-versus-camrelizumab-alone-and-investigators-choice-of-chemotherapy-in-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-ii-study-of-concurrent-versus-sequential-pembrolizumab-in-combination-with-chemorad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-lean-body-mass-based-oxaliplatin-dose-calculation-on-neurotoxicity-in-adjuvant-treatment-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-of-e3311-an-ecog-acrin-cancer-research-group-phase-ii-trial-of-transoral-surger 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-outcomes-after-transoral-robotic-surgery-for-oropharyngeal-carcinoma-reflections-on-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgery-versus-ablation-for-hepatocellular-carcinoma-a-randomized-controlled-trial-surf-rct-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ruxolitinib-in-patients-with-corticosteroid-refractory-or-corticosteroid-dependent-chronic-graft-ver 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-intrinsic-and-microenvironmental-determinants-of-impaired-antitumor-immunity-in-chromophobe-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/should-we-screen-for-malignancies-in-people-with-ataxia-telangiectasia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-benefit-and-safety-of-reduced-elective-dose-in-definitive-radiotherapy-for-head-and-neck-sq 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-mid-treatment-positron-emission-tomography-adaptive-radiotherapy-in-stage-iii-non-small-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-randomized-open-label-phase-iii-study-of-tilsotolimod-in-combination-with-ipilimumab-vers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/azacitidine-venetoclax-and-revumenib-for-newly-diagnosed-inpm1i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-optimizing-outcomes-after-transoral-robotic-surgery-for-oropharyngeal-carcinoma-reflectio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glofitamab-combined-with-pola-r-chp-or-r-chop-as-first-therapy-in-younger-patients-with-high-risk-la 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-international-myeloma-societyinternational-myeloma-working-group-consensus-recommendations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-neoadjuvant-therapy-for-locally-advanced-rectal-cancer-omission-of-radiotherapy-or-not 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-sup131sup-i-metaiodobenzylguanidine-with-dinutuximab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/isatuximab-subcutaneous-by-on-body-injector-versus-isatuximab-intravenous-plus-pomalidomide-and-dexa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-after-allogeneic-transplantation-in-advanced-cutaneous-t-cell-lymphomas-cutallo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lenvatinib-plus-pembrolizumab-and-chemotherapy-versus-chemotherapy-in-advanced-metastatic-gastroesop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dendrimer-nanoparticle-dep-delivery-of-topoisomerase-i-inhibitor-sn38-dep-sn38-safety-tolerab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-dynamic-financial-impacts-among-adolescents-and-young-adults-with-cancer-a-longitudinal-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-fertility-preservation-in-people-with-cancer-asco-guideline-update 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-therapy-for-locally-advanced-rectal-cancer-omission-of-radiotherapy-or-not 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-trial-of-pirtobrutinib-versus-idelalisibrituximab-or-bendamustinerituximab-in-covalent-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pasritamig-a-first-in-class-bispecific-t-cell-engager-targeting-human-kallikrein-2-in-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adoptive-cell-transfer-of-tumor-infiltrating-lymphocytes-for-metastatic-acral-lentiginous-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enduring-economic-effects-of-a-cancer-diagnosis-in-adolescence-and-young-adulthood 2026-08-24 monthly 0.7 https://rjrindex.com/articles/why-we-do-not-recommend-that-women-with-breast-cancer-receive-adjuvant-treatment-with-a-cdk46-inhib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zipalertinib-in-patients-with-epidermal-growth-factor-receptor-exon-20-insertion-positive-non-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-alliance-a091802-randomized-trial-of-avelumab-plus-cetuximab-versus-avelumab-alone-in-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-treating-fields-open-the-door-to-progress-for-patients-with-locally-advanced-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-comment-on-the-study-of-nrg258-limitations-and-future-directions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-benefit-of-palliative-oophorectomy-for-patients-with-ovarian-metastasis-from-baseline-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-from-first-in-human-phase-i-study-of-a-novel-cd19-1xx-chimeric-antigen-receptor-with-calibra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zanubrutinib-and-venetoclax-for-patients-with-treatment-naive-chronic-lymphocytic-leukemiasmall-lym 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comment-on-the-study-of-nrg258-limitations-and-future-directions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mindfulness-and-tai-chi-for-cancer-health-match-study-primary-outcomes-of-a-preference-based-mult 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-treating-fields-with-gemcitabine-and-nab-paclitaxel-for-locally-advanced-pancreatic-adenocarci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nephrotoxicity-surveillance-for-childhood-and-young-adult-survivors-of-cancer-recommendations-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/calibrating-chimeric-antigen-receptor-car-signaling-to-improve-car-t-cell-therapies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-year-survival-outcomes-with-atezolizumab-after-chemotherapy-in-resected-stage-ib-iiia-non-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-of-adaptive-manufactured-lentiviral-anti-cd20anti-cd19-chimeric-antigen-receptor-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-low-value-cancer-treatments-in-medicare-advantage-versus-traditional-medicare 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-whipple-of-choice 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-chimeric-antigen-receptor-t-cell-therapy-for-mantle-cell-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-therapy-in-patients-with-metastatic-castration-resistant-prostate-cancer-asco-guideline-up 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bmt-care-app-a-randomized-controlled-trial-of-a-psychosocial-digital-application-for-caregivers-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-overall-survival-and-long-term-safety-with-ripretinib-versus-sunitinib-in-patients-with-gi-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prodige-29-ucgi-26-neopan-a-phase-iii-randomized-trial-comparing-chemotherapy-with-folfirinox-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mantle-cell-lymphoma-optimal-treatment-with-bruton-tyrosine-kinase-targeted-approaches 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retraction-phase-1-clinical-trial-of-epcam-car-t-cell-therapy-in-patients-with-gastrointestinal-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acalabrutinib-plus-bendamustine-rituximab-in-untreated-mantle-cell-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-toxicity-in-cancer-clinical-trials-an-issue-in-need-of-clarity-and-solutions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-no-limit-wjog13320g-of-first-line-nivolumab-plus-low-dose-ipilimumab-for-microsate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-and-cost-effectiveness-of-treating-human-epidermal-growth-factor-receptor-2-low-metastatic-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-analysis-of-the-phase-iii-codebreak-300-study-of-sotorasib-plus-panitumumab-versus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-novel-prediction-model-for-hearing-loss-from-cisplatin-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-iii-trial-of-ramucirumab-beyond-progression-plus-irinotecan-in-patients-with-ramuci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-treatment-options-and-modalities-in-pancreatic-adenocarcinoma-insights-from-espac4 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-ib-clinical-trial-of-db-020-intratympanic-injections-to-reduce-high-dose-cisplatin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-adjuvant-treatment-options-and-modalities-in-pancreatic-adenocarcinoma-insights-from-espa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sharper-focus-greater-comfort-lessons-from-the-robomet-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-and-the-evolving-benefit-risk-assessment-for-poly-adp-ribose-polymerase-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dose-escalated-stereotactic-versus-conventional-radiotherapy-for-painful-bone-metastases-robomet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-phase-trials-in-ijournal-of-clinical-oncologyi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcription-phone-call-2018 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapy-for-diffuse-astrocytic-and-oligodendroglial-tumors-in-adults-asco-sno-guideline-rapid-recom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/practical-guidelines-for-the-treatment-of-gestational-trophoblastic-disease-collaboration-of-the-eu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rationale-for-investigation-of-neoadjuvant-chemoimmunotherapy-before-chemoradiation-in-unresectable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hypofractionated-dose-escalated-radiation-versus-conventionally-fractionated-radiation-for-localize 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-assessing-clinical-utility-of-datopotamab-deruxtecan-versus-chemotherapy-for-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-clinical-utility-of-datopotamab-deruxtecan-versus-chemotherapy-for-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/every-patient-is-unique-and-deserves-the-best-the-present-and-future-treatment-landscape-of-uncommo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-line-endocrine-therapy-with-or-without-palbociclib-rechallenge-in-patients-with-hormone-recep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pragmatic-randomized-study-of-afatinib-versus-chemotherapy-for-patients-with-non-small-cell-lung-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-of-patients-and-prognostic-factors-across-treatment-lines-in-metastatic-colorectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-and-clinical-implications-of-p53-dysfunction-in-patients-with-myelodysplastic-syndr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-ii-study-of-nab-paclitaxel-and-gemcitabine-with-or-without-tocilizumab-as-first-lin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-radium-223-and-stereotactic-ablative-radiotherapy-versus-stereotactic-ablative-radiother 2026-08-24 monthly 0.7 https://rjrindex.com/articles/becotatug-vedotin-vs-chemotherapy-in-pre-heavily-treated-advanced-nasopharyngeal-carcinoma-a-rando 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sacituzumab-govitecan-sg-pembrolizumab-pembro-vs-chemotherapy-chemo-pembro-in-previously-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trust-trial-of-radical-upfront-surgical-therapy-in-advanced-ovarian-cancer-engot-ov33agoovar-op7 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-genetic-information-and-family-testing-gift-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-reduced-port-laparoscopic-surgery-for-patients-with-colon-and-upper-rectal-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/promoting-reasonable-career-expectations-and-maximizing-professional-fulfillment-for-academic-oncolo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toxicity-within-6-months-of-heterogeneous-fluorodeoxyglucose-guided-radiotherapy-dose-escalation-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anlotinib-versus-bevacizumab-added-to-standard-first-line-chemotherapy-among-patients-with-rasbraf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-postneoadjuvant-prognostic-breast-cancer-staging-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camizestrant-cdk46-inhibitor-cdk46i-for-the-treatment-of-emergent-iesr1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-international-multicenter-prospective-randomized-trial-of-adjuvant-chemotherapy-for-stage-ia-ii 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-care-beyond-walls-ccbw-a-randomized-pragmatic-trial-of-home-based-versus-in-clinic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aspirin-as-secondary-prevention-for-colorectal-cancer-liver-metastases-asac-a-multicenter-random 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequential-infusion-of-mesenchymal-stem-cell-for-graft-versus-host-disease-prevention-in-haploidenti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-nivolumab-nivo-vs-placebo-pbo-in-patients-pts-with-resectable-nsclc-updated-sur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pro-active-results-of-a-pragmatic-phase-iv-randomized-trial-comparing-the-effectiveness-of-prophyla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hematopoietic-stem-cell-transplantation-outcomes-for-high-risk-aml-a-report-from-the-childrens-onc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-analysis-of-the-eortc-2139-mgcolumbus-ad-trial-a-randomized-trial-of-adjuvant-encorafenib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/event-free-survival-efs-in-matterhorn-a-randomized-phase-3-study-of-durvalumab-plus-5-fluorourac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disitamab-vedotin-dv-plus-toripalimab-tor-and-chemotherapy-ctrastuzumab-tra-as-first-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-iii-trial-of-the-impact-of-a-structured-exercise-program-on-disease-free-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/jmt101-in-combination-with-irinotecan-and-sg001-versus-regorafenib-in-patients-with-metastatic-color 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-ii-trial-investigating-whether-atezolizumab-after-chemoradiotherapy-crt-prolongs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sup18sup-f-labeled-fluorodeoxyglucose-positron-emiss 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-trial-of-standard-chemotherapy-alone-or-combined-with-atezolizumab-as-adjuvant-therapy-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/r-alps-a-randomized-double-blind-placebo-controlled-multicenter-phase-iii-clinical-trial-of-tqb2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-with-chemoradiotherapy-in-patients-with-high-risk-locally-advanced-cervical-cancer-fi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-anti-b-cell-maturation-antigen-chimeric-antigen-receptor-t-cell-for-the-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-phase-ii-nibit-ml1-study-of-nivolumab-plus-ipilimumab-and-astx727-or-nivolumab-plus-ipilimumab-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/de-escalated-neoadjuvant-taxane-plus-trastuzumab-and-pertuzumab-with-or-without-carboplatin-in-her2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-from-verify-a-phase-3-double-blind-placebo-pbo-controlled-study-of-rusfertide-for-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivopostop-gortec-2018-01-a-phase-iii-randomized-trial-of-adjuvant-nivolumab-added-to-radio-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-ii-study-of-neoadjuvant-neoadj-anti-pd-1-dostarlimab-d-vs-d-anti-tim-3-cobol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-stupp-regimen-with-or-without-anlotinib-for-newly-diagnosed-glioblastoma-res 2026-08-24 monthly 0.7 https://rjrindex.com/articles/academic-medical-centers-and-asco-recommendations-starting-a-difficult-discussion 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enlighted-phase-3-study-interim-results-of-efficacy-and-safety-of-padeliporfin-vascular-targeted-ph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-importance-of-defining-recurrence-in-hepatocellular-carcinoma-local-or-both-local-and-oth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rosella-a-phase-3-study-of-relacorilant-in-combination-with-nab-paclitaxel-versus-nab-paclitaxel-mo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-2-trial-of-encorafenib-binimetinib-nivolumab-vs-ipilimumab-nivolumab-in-bra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-deruxtecan-t-dxd-vs-ramucirumab-ram-paclitaxel-ptx-in-second-line-treatment-of-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/panitumumab-retreatment-followed-by-regorafenib-versus-the-reverse-sequence-in-chemorefractory-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-double-blind-placebo-controlled-randomized-phase-iii-trial-of-fulvestrant-and-ipatasertib-as-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/napoli-3-a-phase-3-study-of-nalirifox-in-patients-with-metastatic-pancreatic-ductal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/importance-of-defining-recurrence-in-hepatocellular-carcinoma-local-or-both-local-and-other-intrahe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-1-blockade-with-toripalimab-incorporated-into-induction-chemotherapy-and-radiotherapy-with-or-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-plus-relatlimab-vs-nivolumab-alone-for-the-adjuvant-treatment-of-completely-resected-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tarlatamab-versus-chemotherapy-ctx-as-second-line-2l-treatment-for-small-cell-lung-cancer-sclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-reproducibility-of-clinically-meaningful-change-in-physical-capacity-tested-by-online-6-mi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/firstengot-ov44-a-phase-3-clinical-trial-of-dostarlimab-dost-and-niraparib-nira-in-first-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pragmatica-lung-swog-s2302-a-prospective-randomized-study-of-ramucirumab-plus-pembrolizumab-vers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lower-dose-versus-standard-dose-abiraterone-in-patients-with-metastatic-castration-resistant-prostat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-every-patient-is-unique-and-deserves-the-best-the-present-and-future-treatment-landscape-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/writing-a-medical-memoir-lessons-from-a-long-steep-road 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sentinel-lymph-node-biopsy-versus-pelvic-lymphadenectomy-in-cervical-cancer-the-phenix-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-1-year-versus-minimum-2-years-of-anti-pd1-based-immunotherapy-as-first-line-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-deruxtecan-t-dxd-pertuzumab-p-vs-taxane-trastuzumab-pertuzumab-thp-for-first 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vepdegestrant-a-protac-estrogen-receptor-er-degrader-vs-fulvestrant-in-er-positivehuman-epiderm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reproducibility-of-clinically-meaningful-change-in-physical-capacity-tested-by-online-6-minute-walk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-empirical-dietary-inflammatory-pattern-edip-and-survival-in-patients-with-stag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-folfirinox-chemotherapy-for-resectable-pancreatic-adenocarcinoma-a-multicenter-random 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-with-neoadjuvant-nivolumab-nivo-chemotherapy-chemo-in-patients-with-resectabl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-randomized-non-inferiority-trial-comparing-adjuvant-platinum-plus-paclitaxel-to-platin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/campass-benmelstobart-in-combination-with-anlotinib-vs-pembrolizumab-in-the-first-line-treatment-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/savolitinib-savo-combined-with-osimertinib-osi-versus-chemotherapy-chemo-in-egfr-mutant-egfrm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-randomized-study-of-neoadjuvant-pembrolizumab-p-alone-or-in-combination-with-vidutolimo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/panova-3-phase-3-study-of-tumor-treating-fields-ttfields-with-gemcitabine-and-nab-paclitaxel-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-a-randomized-phase-iii-trial-of-pre-operative-chemotherapy-with-mfolfirinox-or-paxg-regim 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nrg-br003-a-randomized-phase-iii-trial-comparing-doxorubicin-plus-cyclophosphamide-followed-by-week 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-encorafenib-cetuximab-mfolfox6-in-braf-v600e-mutant-metastatic-colorectal-cancer-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anesthesia-type-during-surgery-for-treatment-of-biologically-aggressive-cancers-results-of-the-ga-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mitomycin-plus-bcg-as-adjuvant-intravesical-therapy-for-high-risk-non-muscle-invasive-bladder-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-amplitude-trial-niraparib-nira-and-abiraterone-acetate-plus-prednisone-aap-for-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-a-phase-i-clinical-trial-of-cetuximab-biosimilar-rph-002 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eosinophilia-and-basophilia-in-essential-thrombocythemia-and-polycythemia-vera-clinical-genetic-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decoding-nampt-and-tigar-a-molecular-blueprint-for-reprogramming-tumor-metabolism-and-immunity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nimotuzumab-plus-chemotherapy-in-the-posterior-line-treatment-for-lung-adenocarcinoma-with-third-gen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/complementary-value-of-a-digital-pathology-biomarker-to-post-surgery-circulating-tumor-dna-in-risk-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-frequency-of-driver-mutations-in-non-small-cell-lung-cancer-patients-the-turkish-nation-wide-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frailty-index-as-a-predictor-of-postoperative-outcomes-in-oral-carcinoma-patients-undergoing-surgery 2026-08-24 monthly 0.7 https://rjrindex.com/articles/economic-burden-of-cytokine-release-syndrome-in-older-adults-and-underserved-populations-a-nationwi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/estrogen-receptor-er-expression-on-circulating-tumor-cells-ctcs-and-cell-free-dna-cfdna-mutati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-neoadjuvant-immunotherapy-in-head-and-neck-squamous-carcinoma-hnscc-a-systematic-revi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-influencing-surgical-treatment-of-adenoid-cystic-carcinoma-of-the-head-and-neck-a-national 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-management-of-cervical-lymph-node-metastases-in-differentiated-thyroid-carcinoma-experie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-role-of-estrogen-receptor-er-expression-in-breast-cancer-bc-metastases-and-its-dynami 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-and-prognostic-convergence-of-hrher2-metastatic-breast-cancer-mbc-to-a-tnbc-like-prof 2026-08-24 monthly 0.7 https://rjrindex.com/articles/m6a-methylated-lncrnas-to-facilitate-keratinocyte-pyroptosis-and-to-spark-cutaneous-toxicities-assoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-thyroid-cancer-mortality-in-the-united-states-a-24-year-retrospective-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mfolfox6-bevacizumab-pd-1-monoclonal-antibody-vs-mfolfox6-in-locally-advanced-pmmrmss-crc-a-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-risk-factors-for-venous-thromboembolism-after-car-t-cell-therapy-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perturbational-single-cell-rna-sequencing-of-patient-tumors-in-merkel-cell-and-small-cell-lung-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-tsn222-a-novel-dual-action-tumor-immune-agonist-datia-in-patients-with-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relationship-between-immune-mediated-adverse-events-and-clinical-outcomes-in-patients-with-metastati-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-in-patients-with-neuroendocrine-tumors-and-concomitant-protein-energy-malnutrition 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-therapies-for-advanced-melanoma-after-immunotherapy-failure-efficacy-and-safety-insights 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preoperative-treatment-for-potentially-resectable-esophageal-cancer-insights-from-a-nationwide-real 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precision-medicine-research-on-chemo-immunotherapy-combination-treatment-for-locally-advanced-or-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-practices-and-outcomes-of-metastatic-merkel-cell-carcinoma-a-retrospective-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-targeted-therapy-healthcare-costs-and-survival-with-large-panel-testing-narrow-testing-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/monitoring-pd-l1-expression-in-cancer-associated-macrophage-like-cells-as-predictor-of-clinical-outc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-hlx07-plus-serplulimab-with-or-without-chemotherapy-versus-serplulimab-plus-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-non-randomized-clinical-study-to-evaluate-the-efficacy-of-intraperitoneal-pd-1-monoclo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/microbial-metabolic-pathways-to-abrogate-immunotherapy-toxicity-and-promote-anti-tumor-response-in-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extracellular-vesicle-digital-scoring-assay-for-assessment-of-treatment-responses-in-hepatocellular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hyponatremia-as-a-predictor-of-in-hospital-mortality-in-cirrhotic-and-non-cirrhotic-hepatocellular-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-of-door-to-door-hpv-dna-screening-using-self-collected-vaginal-swabs-for-early-detection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nimotuzumab-with-chemoradiotherapy-for-newly-diagnosed-high-risk-locally-advanced-squamous-cervica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-tumors-blood-and-ascites-to-establish-correlations-with-treatment-benefit-in-platinu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-and-clinicopathological-factors-affecting-survival-in-young-women-real-world-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-rucaparib-on-circadian-rhythms-and-adverse-events-in-ovarian-cancer-insights-from-the-mam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/applying-learning-science-principles-lsp-through-a-simulation-session-sim-for-oncology-trainees 2026-08-24 monthly 0.7 https://rjrindex.com/articles/struma-ovarii-an-ncdb-retrospective-study-of-demographic-and-socioeconomic-factors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-disparities-in-access-to-and-outcomes-of-liver-transplantation-lt-for-hepatocellular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hif-family-transcription-factor-expression-in-a-cohort-of-4362-patients-with-renal-cell-carcinoma-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-role-of-pre-treatment-eosinophilia-in-nsclc-patients-undergoing-immune-checkpoint-inhibit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-and-outcome-of-breast-cancers-diagnosed-in-patients-with-germline-atm-mutations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-and-clinical-characteristics-of-large-cell-medulloblastoma-a-comprehensive-ncdb-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-feasibility-of-csf-and-plasma-ctdna-in-braf-altered-glioma-during-treatment-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-2021-united-states-cancer-screening-guideline-changes-on-racial-and-ethnic-differences-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-quality-of-life-qol-for-patients-pts-with-metastatic-renal-cell-carcinoma-mrcc-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-non-hodgkin-lymphoma-and-sepsis-related-mortality-among-older-adults-1999-2020-a-cdc-won 2026-08-24 monthly 0.7 https://rjrindex.com/articles/design-of-a-first-in-human-multicenter-open-label-study-of-zw171-a-mesothelin-x-cd3-targeting-bispe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-fog-001-a-first-in-class-direct-v-catenin-tcf-inhibitor-in-patients-with-col 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunonet-a-multicenter-open-label-proof-of-concept-phase-ii-trial-evaluating-np137-as-add-on-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lurbinectedin-with-immunotherapy-in-extensive-stage-small-cell-lung-cancer-current-insights-and-fut 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-and-safety-of-zurlectrectinib-in-adult-patients-pts-with-locally-advanced-or-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-insights-into-advanced-combined-small-cell-lung-cancer-clinical-characteristics-and-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-krt3-on-colorectal-cancer-growth-through-regulation-glycolysis-via-the-cebpd-lrrc8a-akt-si 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relationship-between-folr1-expression-and-pan-cancer-subgroup-of-tumors-with-specific-transcriptomic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-efficacy-and-safety-of-front-line-cdk46-inhibitor-therapy-in-hrher2-advanced-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-prediction-of-prognosis-in-advanced-solid-tumor-patients-using-tumor-growth-rates-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-new-option-for-post-cdk46is-resistance-era-multicenter-real-world-study-of-anlotinib-based-combi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-glp-1-receptor-agonist-prescriptions-among-breast-cancer-survivors-with-type-2-diabet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-frailty-modulate-the-predictive-value-of-performance-status-in-older-adults-with-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-acute-toxicity-questionnaire-adherence-of-nonmetastatic-patients-treated-in-an-infusio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-stages-ii-iv-gastric-cancer-a-13-year-single-center-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitors-for-ovarian-cancer-a-retrospective-analysis-of-efficacy-and-tolerabili 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-pathogenic-germline-variants-in-hereditary-breastovarian-cancer-patients-at-the-natio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/meta-analysis-of-55-studies-examining-the-association-between-bmi-and-lung-cancer-risk-in-non-smoker 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sars-cov-2-infection-risk-and-covid-19-prevalence-in-cancer-patients-during-the-first-wave-of-covid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-phase-iii-study-for-recurrent-glioblastoma-comparing-bevacizumab-alone-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/knowledge-practice-and-attitude-on-human-papillomavirus-and-cervical-cancer-among-medical-students 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vault-proteins-as-prognostic-biomarkers-and-therapeutic-targets-in-lower-grade-gliomas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-response-and-safety-of-neoadjuvant-pembrolizumab-with-or-without-entinostat-in-muscle-inv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-genetic-mutation-profile-and-cns-pharmacokinetics-in-relapsedrefractory-primary-cns-lym 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-occupational-carcinogens-in-laryngeal-cancer-a-global-trend-analysis-1990-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-with-and-without-radiotherapy-following-the-diagnosis-of-bone-metastasis-for-stage-4-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncologists-happiness-at-work-and-integrative-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breaking-down-the-505b2-drug-price-paradox 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapeutic-decisions-and-outcome-of-patients-with-stage-i-testicular-germ-cell-tumor-single-centre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-between-recreational-physical-activity-and-health-related-quality-of-life-among-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/economic-evaluation-of-work-productivity-gains-associated-with-ribociclib-rib-in-hormone-receptor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/video-based-genetic-counseling-to-reduce-physician-workload-and-enhance-consulter-understanding-a-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examining-factors-affecting-clinical-trial-enrolment-in-the-clinical-trials-navigator-program 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-between-germline-mutations-in-homologous-recombination-repair-related-genes-and-clinical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stereotactic-body-radiation-therapy-sbrt-for-prostate-specific-membrane-antigen-positron-emission 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-ai-to-enhance-symptom-capture-and-reduced-hospitalizations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-paradoxical-impact-of-depression-on-mortality-length-of-stay-and-hospitalization-charges-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acute-myeloid-leukemia-aml-post-high-dose-cytarabine-hidac-outcomes-academic-versus-collaborati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-treatment-strategies-for-synchronous-malignancies-integrating-overlapping-regimens-for-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-profiles-patient-expectations-and-outcomes-from-an-integrative-oncology-clinic-in-india-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pioneering-cancer-survivorship-care-in-latin-america-early-results-from-the-oc-sobre-viver-program 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-hierarchical-clustering-approach-to-dissect-behavioral-symptoms-in-early-stage-breast-cancer-bc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pembrolizumab-on-geriatric-syndromes-in-older-patients-with-nsclc-a-propensity-matched-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-results-from-a-phase-i-study-of-the-shp2-inhibitor-gh21-as-monotherapy-in-patients-with-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fear-of-cancer-recurrence-in-long-term-colorectal-cancer-survivors-a-randomized-controlled-trial-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-augmentation-of-multiplex-chromogenic-assays-for-use-with-colocalized-multi-specific-targets 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-the-gastric-risk-immuno-progression-score-grips-in-advanced-gastric 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-efficacy-and-safety-results-of-tislelizumab-t-and-axitinib-a-combined-with-stereotac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unveiling-inequities-racial-disparities-in-macce-outcomes-among-esophageal-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-donafenib-combined-with-interventional-therapy-and-withwithout-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-use-of-carboplatin-containing-chemotherapy-in-early-triple-negative-breast-cancer-tnbc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-platform-to-identify-patients-for-cancer-vaccine-trials-the-nhs-england-cancer-vaccine-launch-pad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-stratified-mortality-and-disability-adjusted-life-years-dalys-due-to-gastric-cancer-among-olde 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-the-combination-of-3-t-whole-body-mri-and-18f-fdg-petct-in-the-management-of-multiple-myelo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarkers-of-neoadjuvant-dalpiciclib-in-patients-with-operable-her2-negative-luminal-b-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-environmental-genetic-and-genomic-profile-of-patients-with-rapid-progression-to-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-among-patients-with-metastatic-castration-resistant-prostate-cancer-mcrpc-rece 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparable-efficacy-of-venetoclax-50mg-with-posaconazole-versus-venetoclax-400mg-in-newly-diagnosed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-disparities-in-time-to-treatment-a-comprehensive-multidisciplinary-clinic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-for-survival-in-advanced-epithelial-ovarian-cancer-a-retrospective-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-chatbot-utilization-on-genetic-testing-uptake-in-diverse-clinic-settings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-outcomes-of-breast-cancer-hospitalizations-in-the-northeastern-vs-western-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-obesity-on-immune-related-adverse-events-in-patients-with-diagnosis-of-triple-negative-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hbv-tcr-t-cell-therapy-preclinical-and-clinical-insights-into-specificity-safety-and-efficacy-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-and-clinicopathological-features-of-young-women-with-breast-cancer-an-observational-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-predictors-and-outcomes-of-venous-thromboembolism-in-patients-hospitalized-with-thyroid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-diagnostic-imaging-for-superficial-soft-tissue-masses-on-a-community-level 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outpatient-palliative-care-consultation-and-end-of-life-outcomes-among-a-retrospective-cohort-of-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-kras-g12c-inhibitors-in-metastatic-colorectal-cancer-a-systematic-review-and-meta-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-trial-of-dual-egfr-inhibition-with-cetuximab-and-afatinib-in-patients-with-recurrentmetasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/facilitating-meaningful-patient-involvement-in-the-design-and-conduct-of-cancer-research-the-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tarlatamab-induced-immune-related-adverse-events-retrospective-real-world-pharmacovigilance-study-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clonal-hematopoiesis-ch-in-participants-with-metastatic-castration-resistant-prostate-cancer-mcrp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-results-of-oncobax-ak-in-combination-with-ipilimumabnivolumab-in-advanced-clear-cell-renal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-or502-an-antibody-targeting-leukocyte-immunoglobulin-like-receptor-b2-lilrb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/upfront-modified-folfoxiri-plus-panitumumab-pan-versus-folfoxpan-for-unresectable-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ways-to-accelerate-the-local-implementation-and-adoption-of-the-homologous-recombination-deficiency 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-anti-vegf-amp-anti-egfrs-in-microsatellite-instable-msi-h-metastatic-colorectal-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-approaches-to-early-detection-of-colon-adenocarcinoma-evaluating-conventional-and-biomarke 2026-08-24 monthly 0.7 https://rjrindex.com/articles/scrum-japan-monstar-screen-3-comprehensive-tumor-microenvironment-analysis-via-multi-omics-in-a-lar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detection-of-kmt2a-partial-tandem-duplication-ptd-in-aml-by-whole-genome-sequencing-wgs-address 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-survival-outcomes-of-patients-with-de-novo-stage-iv-melanoma-a-13-year-single-center-exp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-the-tolerability-and-safety-of-hedgehog-inhibitors-in-real-life-a-cohort-of-330-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiologic-factors-and-survival-outcomes-of-patients-with-metastatic-malignant-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-evaluation-of-a-reflex-blood-based-methylated-ctdna-multi-cancer-early-detection-test-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-early-palliative-care-in-advanced-sarcoma-patients-for-enhanced-quality-of-life-the-sar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultrasensitive-circulating-tumor-dna-ctdna-detection-for-prognostication-in-triple-negative-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-response-to-neoadjuvant-sequenced-lymphatic-sparing-sbrt-plus-pembrolizumab-in-hpv-negat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/explaining-the-relationships-between-age-endocrine-therapy-persistence-and-risk-of-recurrence-in-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-multicenter-study-of-frontline-maintenance-therapy-with-lifileucel-plus-pembrolizumab-in-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hepatotoxic-adverse-events-with-immune-checkpoint-inhibitors-real-world-pharmacovigilance-study-usi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/jskn003-a-biparatopic-her2-targeting-adc-in-heavily-pretreated-her2-positive-breast-cancer-a-pool 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-first-line-1l-nivolumab-plus-relatlimab-nivo-rela-versus-nivo-plus-ipil 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hypothesis-generative-head-to-head-study-comparing-efficacy-of-afatinib-and-osimertinib-based-on-imm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-and-characteristics-of-kras-g12d-mutations-in-patients-with-solid-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-khorana-score-in-advanced-egfr-mutated-nsclc-patients-receiving-first-line-osimertini 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-complementary-value-of-ctdna-and-tissue-ngs-in-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-of-treatment-free-remission-in-chronic-myeloid-leukemia-after-discontinuation-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-bti615-on-malignant-cells-expansion-and-bone-marrow-fibrosis-in-a-myelofibrosis-mice-mod 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prognostic-impact-of-tp53-mutation-on-survival-outcomes-in-alk-fusion-positive-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cadence-of-circulating-tumor-dna-ctdna-testing-for-molecular-surveillance-in-early-stage-breast-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-longitudinal-image-derived-ai-prognostication-as-a-predictor-of-overall-survival-os 2026-08-24 monthly 0.7 https://rjrindex.com/articles/electronic-patient-reported-outcomes-with-vital-sign-monitoring-versus-usual-care-during-trastuzumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/timing-is-everything-how-gen-ai-driven-digital-platforms-influence-the-way-real-world-cancer-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-implementation-of-a-home-bortezomib-injection-program-in-the-us-ann-arbor-va-close 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-chemotherapy-decisions-in-low-resource-settings-with-deep-learning-a-novel-approach-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-two-electroacupuncture-regimens-on-symptoms-and-brain-structures-in-breast-cancer-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-a-deep-learning-network-on-imaging-quality-of-low-ibi-valu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validating-navya-earthshot-an-ai-enabled-point-of-care-solution-for-guideline-adherent-treatment-pl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socio-economic-and-geographic-survival-disparities-among-children-with-lymphoma-in-the-usa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bc3195-a-novel-adc-targeting-cadherin-3-cdh3-updated-results-of-a-first-in-human-phase-i-study-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-therapy-after-neoadjuvant-immunotherapy-combined-with-chemotherapy-in-locally-advanced-rese 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-body-mass-index-on-the-pathological-complete-response-among-women-with-non-metastatic-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glutamine-synthetase-expression-levels-as-a-prognostic-biomarker-in-fibrolamellar-hepatocellular-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographical-disparities-and-temporal-trends-in-the-prevalence-of-hospitalized-esophageal-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/wilms-tumor-in-morocco-epidemiology-challenges-in-management-and-the-promise-of-micrornas-as-diag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recurrence-free-survival-dynamics-following-adjuvant-chemotherapy-for-resected-non-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-cdc2-licensing-by-ccl5-supsup-th1-cells-following-bcl9bcl9l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adverse-effects-of-immune-checkpoint-inhibitors-in-advanced-endometrial-cancer-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-protein-biomarkers-for-early-detection-of-cervical-cancer-and-squamous-intraepithelial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-global-trends-of-cervical-cancer-1990-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-plasma-proteomics-based-model-for-predicting-response-to-neoadjuvant-chemotherapy-in-ovarian-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multifactorial-analysis-of-first-author-retention-in-asco-accepted-works 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kelim-index-as-predictor-of-treatment-outcome-in-ovarian-cancer-surgery 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-treatment-and-survival-outcomes-in-small-cell-ovarian-cancer-a-populatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-bereavement-education-and-emotional-preparedness-a-global-survey-of-oncology-residency-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/increased-racial-and-ethnic-groups-representation-in-clinical-trials-in-a-demographically-diverse-po 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-insurance-coverage-on-diagnosis-and-surgical-treatment-of-gastric-malignancies-in-urban-po 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-project-optimus-dose-escalation-of-sn-38-pro-drug-pcs11t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-radiometabolic-correlatives-of-ddpcr-liquid-biopsy-for-braf-v600-mutated-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/key-predictors-of-peritonitis-in-ovarian-cancer-hospitalizations-insights-for-early-intervention 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proportion-of-positive-lymph-nodes-in-relation-to-survival-of-patients-with-epithelial-ovarian-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/augmenting-clinician-workflow-to-enable-delivery-of-guideline-concordant-cancer-care-with-an-llm-bas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geospatial-disparities-in-access-to-clinical-trials-for-aids-defining-malignancies-in-the-continenta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reproducibility-of-the-correlation-between-race-and-outcomes-associated-with-treatment-of-her2-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racialethnic-disparities-in-neoplasm-mortality-and-the-role-of-healthcare-access-in-the-united-stat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-digital-patient-monitoring-on-health-outcomes-and-healthcare-resource-utilization-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-cancer-incidence-in-singapore-over-the-last-two-decades 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-virus-specific-t-cells-to-enhance-the-activity-of-bispecific-antibodies-in-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mainstreaming-the-diagnosis-of-lynch-syndrome-ls-in-colorectal-cancer-crc-patients-the-italynch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-additional-bcg-versus-sequential-gemcitabine-docetaxel-in-bcg-exposed-high-risk-non-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-chimeric-antigen-receptor-car-t-cell-therapy-brg01-targeting-the-epstein 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-early-integrated-neuropsychological-care-in-patients-with-brain-metastases-a-phase-2-rand 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-current-cigarette-smoking-and-relationships-with-demographic-and-psychosocial-factors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-and-demographic-disparities-in-lung-cancer-prevalence-among-young-adults-a-seer-based-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-versus-targeted-therapy-in-high-and-low-nrf2-lung-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concurrent-chemoradiotherapy-in-locally-advanced-lung-cancer-with-cisplatin-etoposide-or-carboplatin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keap1-mutated-renal-cell-carcinoma-rcc-characterization-of-an-emerging-molecularly-defined-rcc-su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiometabolic-health-in-men-with-prostate-cancer-under-active-surveillance-following-a-home-based 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-activation-of-mapk-signaling-as-a-potential-mechanism-of-acquired-resistance-to-lorlatini 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-anti-vegf-therapy-duration-on-krasnras-wt-mcrc-survival-after-anti-egfr-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-anal-cancer-characteristics-between-asian-american-and-pacific-islander-subgroups 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-and-prognostic-impacts-of-sclc-comprehensive-index-sci-in-extensive-stage-small-cell-lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-cancer-and-sepsis-mortality-among-the-elderly-analysis-from-1999-to-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/significance-of-changes-in-serum-ldh-and-hbdh-in-predicting-the-efficacy-of-first-line-chemoimmunoth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kras-mutant-oncolytic-virus-vaccine-therapy-for-metastatic-colorectal-cancer-a-preclinical-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunorare-sup5sup-a-national-platform-of-5-academic-phase-ii-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-of-fruquintinib-in-young-and-late-elderly-chinese-patients-with-colorectal-cancer-in-real-wor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-characteristics-of-inflammatory-bowel-disease-patients-in-saudi-arabia-and-their-relatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-observational-study-of-application-of-multi-target-fecal-fit-dna-testing-in-postoperativ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-on-the-effectiveness-and-toxicity-of-cdk-46-inhibitors-combined-with-hormonal-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparision-of-operative-outcomes-based-on-exposure-to-neoadjuvant-chemotherapy-in-minimally-invasiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/msi-h-colon-cancer-can-we-utilize-a-watch-and-wait-approach 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-trends-in-race-and-gender-disparities-in-the-incidence-of-pheochromocytoma-from-2000-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunological-phenotype-as-a-predictor-for-response-after-isolated-limb-perfusion-for-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/introducing-a-capacity-building-model-to-improve-cancer-research-in-mena 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-relationship-between-prr11-expression-and-prognosis-in-early-erher2-low-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-of-malignant-neoplasms-of-bone-and-articular-cartilage-across-three-decades 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-prognostic-factors-for-survival-in-metastatic-osteosarcoma-a-2004-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-therapeutic-approaches-for-targeting-kras-in-cancer-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-trial-of-binimetinib-plus-hydroxychloroquine-inpatients-with-previously-treated-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-frailty-on-outcomes-in-elderly-pancreatic-cancer-patients-undergoing-chemotherapy-a-natio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/endotrophin-analysis-of-a-fibroinflammatory-biomarker-during-breast-cancer-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-metabolomic-signatures-for-predicting-pancreatic-ductal-adenocarcinoma-survival-the-clinical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-racial-and-gender-diversity-among-adult-hemato-oncology-trainees-over-last-decade-and-impa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-molecular-features-of-early-onset-metastatic-pancreatic-cancer-and-their-impact-on-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-molecule-matched-treatment-on-hyperprogressive-disease-after-immunotherapy-a-retros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recent-trends-in-us-real-world-first-line-1l-treatment-patterns-for-patients-with-locally-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-of-angiotensin-converting-enzyme-inhibitors-aceis-and-angiotensin-receptor-blockers-arbs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/virtual-personalized-exercise-program-for-subjects-with-lung-cancer-a-feasibility-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/raceethnicity-socioeconomic-status-and-health-system-factors-related-to-stage-of-presentation-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-flare-reactions-secondary-to-t-cell-engaging-immunotherapies-a-study-from-the-french-reisamic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-rurality-on-patients-with-synchronous-colorectal-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-polycythemia-vera-treatments-with-reduced-mortality-rates-among-us-veterans 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-a-daily-scrum-at-the-gastrointestinal-oncology-ward-on-length-of-stay-a-tertiary-center-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/measuring-the-success-of-genentechs-air-site-alliance-in-enrolling-diverse-patients-a-framework 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-dose-chemotherapy-and-pembrolizumab-combined-with-radiotherapy-in-the-first-line-treatment-of-ct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-safety-and-efficacy-of-sintilimab-combined-with-chemotherapy-as-neoadjuvant-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-plus-short-course-chemo-radiotherapy-for-conversion-therapy-of-unresectable-escc-late 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-iii-trial-investigating-platinum-and-taxane-chemotherapy-in-metastatic-castration-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-patient-understanding-of-pathology-reports-insights-from-a-large-database-of-patient-inqu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-targeted-therapy-in-patients-with-advanced-non-small-cell-lung-cancer-in-response-to-broad-ge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-correlates-of-response-in-patients-with-metastatic-castration-resistant-prostate-cancer-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/promis-scores-of-cancer-survivors-in-the-comprehensive-outcomes-for-after-cancer-health-coach-stud 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-county-level-medical-debt-and-timely-treatment-initiation-among-individuals-newly-dia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combined-impact-of-patients-and-disease-characteristics-on-survival-outcome-in-early-hormone-recepto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/knowledge-and-practice-of-geriatric-oncology-among-cancer-care-providers-in-africa-a-cross-sectiona 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-features-and-survival-outcomes-of-small-node-negative-breast-cancer-a-multicenter-retros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trent-002-a-prospective-multicenter-randomized-controlled-phase-ii-study-to-evaluate-the-efficacy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-center-retrospective-outcomes-analysis-of-patients-with-localized-synovial-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-parp-inhibitors-in-brca-mutated-her2-negative-breast-cancer-a-systematic-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-metaplastic-breast-carcinoma-a-rare-tumor-with-unique-clinicopathological-features-and-limite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-assessment-and-development-of-a-machine-learning-based-prediction-model-for-survival-in-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-landscape-in-lung-cancer-lymphocyte-subsets-as-potential-predictors-of-treatment-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-sapylin-versus-dexamethasone-atomized-inhalation-for-ccrt-induced-oral-mucosi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-leukemia-inhibitory-factor-and-its-receptor-in-lung-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-patient-frailty-on-the-choice-of-induction-treatment-for-transplant-ineligible-tie-newly 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intraintertumoral-heterogeneity-assessed-by-blood-based-next-generation-sequencing-ngs-to-predict 2026-08-24 monthly 0.7 https://rjrindex.com/articles/open-label-phase-ibii-study-of-cetuximab-cet-plus-ly3214996-with-or-without-abemaciclib-in-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-itp53i-mutation-status-on-cancer-specific-survival-after-firs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-sbrt-followed-by-evorpacept-and-pembrolizumab-in-hpv-mediated-head-and-neck-squamous-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-characterization-of-anal-canal-squamous-cell-carcinoma-ascc-and-outcomes-on-matched-target 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-to-determine-the-clinical-and-pathological-path-response-to-neoadjuvant-nivolumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immunotherapy-for-patients-with-resectable-stage-iiiiv-cutaneous-melanoma-a-swedish-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-clinical-trial-of-jin-a02-a-4th-generation-egfr-tki-in-egfr-mutated-advancedmetastatic-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-word-research-on-the-effect-and-safety-of-gemcitabine-combined-with-pd-1-inhibitors-and-recombi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-hospitalized-metastatic-cancers-of-the-lip-oral-cavity-and-pharynx-with-burden-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-impact-of-race-and-sex-on-oral-squamous-cell-carcinoma-clinical-presentation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-features-and-survival-outcomes-in-patients-with-high-microsatellite-instability 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gender-and-racial-disparities-in-survival-from-head-and-neck-cancer-a-competing-events-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cd5-deleted-chimeric-antigen-receptor-cells-senza5-cart5-to-enhance-immunotherapy-against-t-cell-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-anlotinib-combined-with-131i-therapy-in-the-treatment-of-distant-metastatic-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decoding-her2-dynamics-exploring-her2-expression-across-a-real-world-breast-cancer-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-trends-in-older-adults-with-anaplastic-thyroid-cancer-atc-a-seer-database-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-inequities-in-sarcoma-clinical-trials-a-comprehensive-analysis-over-the-last-decade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epigenetic-and-phenotypic-signatures-of-t-cell-response-to-blinatumomab-in-pediatric-relapsed-and-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalized-tumor-informed-circulating-tumor-dna-as-predictor-of-progression-risk-after-long-term-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-induction-targeted-therapy-tt-with-immune-checkpoint-inhibitor-ici-therapy-switch-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiotherapy-plus-nimotuzumab-versus-cisplatin-in-low-risk-locoregionally-advanced-nasopharyngeal-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dissecting-survival-disparities-in-philadelphia-chromosome-positive-vs-negative-b-cell-acute-lympho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/equivalence-of-ina-an-ai-based-nutrition-platform-to-human-dietitians-for-counseling-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-sociodemographic-factors-and-medicaid-expansion-on-postoperative-outcomes-for-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-global-equity-in-cancer-care-comparative-environmental-impacts-of-radiotherapy-in-brazil 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-performance-status-on-outcomes-for-solid-tumor-patients-receiving-inpatient-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-uchl1-on-tolerogenic-dc-maturation-and-promotion-of-mregdc-treg-crosstalk-to-nullify-anti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-raceethnicity-on-clinical-outcomes-for-metastatic-colorectal-cancer-mcrc-patients-in-ph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-efficacy-of-lbl-024-a-novel-and-uniquely-designed-bispecific-antibody-against-pd-l1-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vedolizumab-or-infliximab-treatment-option-in-immune-checkpoint-inhibitor-induced-colitis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/belantamab-mafodotin-plus-lenalidomidedexamethasone-in-newly-diagnosed-intermediate-fit-amp-frail 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-of-the-phase-2-elm-2-study-odronextamab-for-patients-pts-with-relapsedrefrac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-co-administration-of-a-vaccine-with-immune-checkpoint-inhibitors-with-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relativity-020-intracranial-ic-activity-of-nivolumab-relatlimab-nivo-rela-in-patients-pts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantification-of-tumor-subregions-in-glioblastoma-multiforme-a-volumetric-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-post-treatment-toxicities-using-the-pre-treatment-oral-microbiome-in-the-context-of-de 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-low-dose-nivolumab-in-advanced-cancers-a-retrospective-analysis-from-medical-oncology-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/income-and-location-divide-in-myeloma-outcomes-a-call-for-equitable-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-cadonilimab-combined-with-chemotherapy-followed-by-chemoradiotherapy-for-locally-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-patients-views-on-clinical-research-in-brazil-concerns-knowledge-and-misconceptions-a-nat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ibii-study-of-fluzoparib-in-combination-with-dalpiciclib-in-patients-with-locally-advanced-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hepatitis-b-virus-reactivation-in-hepatocellular-carcinoma-patients-undergoing-immune-checkpoint-inh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-performance-of-mtap-homozygous-deletion-detection-based-on-next-generation-sequencing-technology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alliance-a092104-a-randomized-phase-23-study-of-olaparib-plus-temozolomide-versus-investigators-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-development-of-gntbm-38-a-novel-class-i-histone-deacetylase-inhibitor-while-combined-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-of-oral-paclitaxel-dhp107-vs-intravenous-paclitaxel-in-her2-negative-recurrent-or-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-thromboembolism-in-savedimpede-risk-stratified-newly-diagnosed-multiple-myel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-and-validation-of-arsenic-associated-genes-and-risk-model-for-predicting-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-risks-associated-with-aromatase-inhibitors-versus-tamoxifen-in-breast-cancer-a-syste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/maintenance-therapy-with-azacitidine-and-valproic-acid-after-allogeneic-stem-cell-transplant-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-nivo-plus-ipilimumab-ipi-vs-chemotherapy-chemo-or-nivo-monotherapy-for-microsatellit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-of-rituximab-plus-chemotherapy-in-pediatric-burkitt-lymphoma-a-systematic-review-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-derived-exosomes-tdes-as-communicators-for-cancer-development-and-metastasis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sustained-mrd-negativity-in-patients-with-newly-diagnosed-multiple-myeloma-treated-with-carfilzomib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-of-cancer-associated-achalasia-caa-a-25-year-review-from-a-cancer-hospit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-parp-inhibitor-niraparib-plus-hsp90-inhibitor-pimitespib-in-solid-tumors-dos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-report-of-ror2-directed-therapy-with-a-conditionally-active-antibody-drug-conjugate-in-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-between-emotional-distress-prior-to-receiving-immune-checkpoint-inhibitors-and-overa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-tyrosine-kinase-inhibitors-and-low-dose-immunotherapy-in-metastatic-renal-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-time-to-relapse-ttr-and-metastasectomy-mts-on-survival-in-leiomyosarcoma-lms-a-cans 2026-08-24 monthly 0.7 https://rjrindex.com/articles/denosumab-monotherapy-versus-bisphosphonate-switching-in-breast-cancer-bone-metastases-a-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-olaparib-in-idh1-and-idh2-mutant-advanced-chondrosarcomas-and-other-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pooled-analysis-of-jskn003-a-biparatopic-anti-her2-antibody-conjugate-adc-in-patients-with-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-abbv-706-a-seizure-related-homolog-protein-6-sez6-targeting-antibody-drug 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-and-readmission-rates-post-car-t-cell-therapy-in-relapsedrefractory-multiple-myeloma-rea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-study-of-amt-676-an-anti-cdh17-antibody-drug-conjugate-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-non-coding-rna-lncrna-snhg11-as-a-prognostic-and-predictive-biomarker-in-metastatic-colorecta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-role-of-exercise-in-modulating-immunity-and-immunotherapy-outcomes-in-cancer-a-syste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-disparities-with-racial-age-and-sex-differences-in-myelodysplastic-syndromes-a-surveilla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pan-tumor-application-of-trastuzumab-deruxtecan-t-dxd-monotherapy-in-her2-3-advanced-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/invoke-a-phase-1-study-of-okn4395-a-first-in-class-ep2ep4dp1-triple-prostanoid-receptor-antagoni 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-significance-of-the-cgrp-pathway-gene-expression-in-advanced-solid-tumors-a-sub-analysis-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-definitive-radiotherapy-with-concurrent-and-adjuvant-immune-checkpoint-inhibitors-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ib-study-of-the-combination-of-regorafenib-with-conventional-chemotherapy-in-patients-with-new 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anti-trop2-adc-esg401-in-a-master-protocol-clinical-trial-for-salivary-gland-cancer-based-on-molecul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trop2-expression-in-the-gastroenteropancreatic-neuroendocrine-tumors-an-analysis-of-179-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improved-survival-and-prognostication-in-melanoma-patients-with-brain-metastases-an-update-of-the-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leap-002-long-term-follow-up-lenvatinib-plus-pembrolizumab-versus-lenvatinib-plus-placebo-for-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-to-quality-of-life-qol-improvement-or-deterioration-in-patients-pts-with-primary-advanced-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systematic-review-of-immunotherapy-associated-cardiotoxicities 2026-08-24 monthly 0.7 https://rjrindex.com/articles/application-of-an-epigenomic-based-classifier-to-identify-cancer-signal-of-origin-on-liquid-biopsy-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-spectrum-of-cutaneous-carcinoma-a-single-center-retrospective-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elranatamab-in-combination-with-daratumumab-and-lenalidomide-edr-in-patients-with-newly-diagnosed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/telisotuzumab-adizutecan-abbv-400-temab-a-monotherapy-vs-trifluridinetipiracil-plus-bevacizumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-based-differences-in-clinical-outcomes-for-solid-tumours-a-pooled-ipd-meta-analysis-of-contempo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-adg126-an-anti-ctla-4-masking-antibody-in-combination-with-pembrolizumab-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-based-minimal-residual-disease-mrd-measured-by-guardant-reveal-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-dynamics-as-a-predictor-of-treatment-response-in-metastatic-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-hospital-systems-on-surgical-outcomes-in-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-large-validation-study-of-ai-powered-pd-l1-analyzer-compared-to-pathologists-assessment-of-pd-l1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/duration-of-response-dor-following-treatment-with-ugn-102-in-patients-with-recurrent-low-grade-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disitamab-vedotin-rc48-tislelizumab-and-s-1-as-first-line-therapy-for-her2-overexpressing-advanc-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-smartwatch-based-electrocardiogram-ecg-abnormality-detection-among-childhood-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-results-from-ichoice-02-a-phase-2-trial-of-induction-chemoimmunotherapy-followed-by-respons 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-observational-study-on-health-resource-utilization-and-patterns-of-care-for-skeletal-rel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-acr-368-and-low-dose-gemcitabine-combination-therapy-in-patients-with-recurrent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-surgical-delay-beyond-8-weeks-on-tumor-progression-and-lymph-node-involvement-in-early-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/physical-rehabilitation-program-for-cardiorespiratory-health-and-quality-of-life-among-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-survival-predictors-of-older-cancer-patients-in-bangladesh-a-multicenter-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-racial-and-regional-disparities-in-breast-cancer-mortality-among-the-female-population-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-and-quality-of-life-superiority-in-modern-phase-iii-oncology-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-efficacy-and-tumor-immune-microenvironment-changes-with-neoadjuvant-chemotherapy-and-cemipl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-institution-retrospective-study-of-multicentric-gliomas-stratified-by-iidhi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-analyses-from-a-global-meta-analysis-in-metastatic-uveal-melanoma-mum-to-determine-progres 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cellular-proliferation-and-tumor-suppression-pathways-as-potential-targets-in-clinically-aggressive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/irinotecan-liposome-in-chinese-patients-with-advanced-pancreatic-cancer-a-prospective-multicenter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/career-transitions-and-practice-patterns-among-international-medical-graduates-in-oncology-workforce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burnout-and-other-causes-of-physician-attrition-a-qualitative-study-of-physicians-leaving-direct-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/virtual-reality-for-pain-and-anxiety-management-during-bone-marrow-biopsy-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/experience-of-25-patients-treated-with-echoendoscopically-implanted-sup32sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tqb2868-combined-with-anlotinib-and-nab-paclitaxel-plus-gemcitabine-as-first-line-treatment-for-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-readmission-rates-length-of-stay-and-mortality-among-bone-marrow-transplant-and-car-t-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-stereotactic-body-radiotherapy-vs-conventional-radiotherapy-for-early-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-in-stage-iii-alk-nsclc-patients-in-china-a-multicenter-retrospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-determinants-of-survival-of-hepatoid-adenocarcinoma-of-the-lungs-analysis-of-a-po 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-atezolizumab-combined-with-cisplatin-and-vinorelbine-as-adjuvant-therapy-for-com 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-liquid-biopsy-with-qpcr-validation-a-machine-learning-based-model-for-lung-cancer-detecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-egfr-mutated-non-small-cell-lung-cancer-treated-with-surgery-exerpos-02-gfpc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/atrial-fibrillation-epidemiology-and-impact-on-clinical-outcomes-in-non-hodgkin-lymphoma-patients-ho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determinants-in-trimodality-therapy-for-bladder-cancer-overcoming-chemoradiotherapy-resistance-via 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-htmc0435-combination-with-temozolomide-in-relapsed-extensive-stage-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-immunotherapy-on-small-cell-lung-cancer-survival-a-focus-on-treatment-setting-race-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-to-evaluate-the-safety-and-tolerability-of-bxq-350-a-novel-sphingolipid-metabolism 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-decision-support-system-based-on-artificial-intelligence-and-the-patients-subjective-inten 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-to-evaluate-the-safety-and-efficacy-of-switchable-car-t-cell-therapy-with-fy001-and-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-clinical-validation-of-a-cell-free-dna-methylation-sequencing-test-for-multi-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-genetic-testing-among-patients-with-pancreatic-cancer-pc-a-pancreatic-cancer-action-netw 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-biological-subtypes-of-follicular-lymphoma-revealed-by-tumor-and-immune-cell-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-bladder-cancer-mortality-the-influence-of-tobacco-use-and-sociodemographic-factors-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preventative-intervention-uptake-among-women-with-breast-cancer-and-pathogenic-germline-variants 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-hospital-based-cancer-registry-in-planning-the-cancer-control-program-in-semiurban-setting-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toxicity-profile-of-fruquintinib-fruq-versus-regorafenib-rego-in-refractory-metastatic-colorecta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-outcomes-of-pseudoadjuvant-chemotherapy-for-resectable-metastatic-colon-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-between-the-number-of-circulating-epithelial-tumor-cells-cetcsctcs-and-circulating-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-lung-cancer-development-using-chest-x-ray-with-microrna-samples-in-health-screening-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-outcomes-of-patients-with-metastatic-colorectal-cancer-mcrc-treated-with-trifl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-neutrophil-to-lymphocyte-ratio-in-small-cell-lung-cancer-in-the-era-of-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-dalpiciclib-plus-toremifene-in-advanced-hr-positive-her2-negative-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-disparities-in-risk-of-second-primary-lung-cancer-among-initial-lung-cancer-surviv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-analysis-of-pyrotinib-in-her2-positive-metastatic-breast-cancer-a-multicenter-real-world-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-institution-review-of-early-onset-colorectal-cancer-10-year-retrospective-clinical-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pressure-related-injury-on-hospitalized-patients-with-colorectal-cancer-a-united-states-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-pan-cancer-universal-germline-testing-in-an-ethnically-diverse-and-rural-community 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-center-single-arm-prospective-clinical-study-initiated-by-a-researcher-on-the-efficacy-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-predictors-of-lymphatic-leak-after-nephrectomy-using-american-college-of-surgeons-nation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-clinical-risk-scoring-system-for-the-prediction-of-early-infection-after-car-t-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-trial-of-mk2-inhibitor-in-combination-with-mfolfirinox-for-untreated-metastatic-pancreatic-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-perioperative-intraperitoneal-paclitaxel-in-patients-with-gastric-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-life-and-lifestyle-changes-during-and-after-therapy-in-women-with-endometrial-cancer-a-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-sacituzumab-govitecan-for-advanced-esophageal-squamous-cell-carcinoma-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-characteristics-and-outcomes-of-t-cell-prolymphocytic-leukemia-a-population-based-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unveiling-inequities-in-retinoblastoma-treatment-a-seer-based-analysis-of-race-ethnicity-geograph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/representation-in-clinical-trials-evaluating-lifestyle-interventions-targeting-energy-balance-in-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-imaging-of-the-immunotherapy-and-radioimmunotherapy-response-by-immunopet-via-a-new-targe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-global-regional-and-national-burden-of-soft-tissue-sarcomas-and-other-extraosseous-sarcomas-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1a1b-trial-in-relapsedrefractory-t-cell-non-hodgkin-lymphoma-to-determine-the-safety-profi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pilot-study-of-the-apricitycare-program-for-early-detection-and-management-of-treatment-related-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-sup68sup-ga-fapi-petct-and-sup18sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-third-line-and-later-3l-therapies-post-poly-adp-ribose-polymerase-inhibitor-parpi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-the-performance-of-ovarian-cancer-score-for-diagnosing-ovarian-cancer-in-a-multicenter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-clinical-study-of-the-efficacy-and-safety-of-adebrelimab-in-combination-with-lenvatinib-as-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-ai-powered-evaluation-of-protein-drug-targetability-through-subcellular-le 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-camrelizumab-plus-apatinib-and-gemcitabine-oxaliplatin-in-patients-with-borderline-res 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ib-clinical-study-to-evaluate-the-safety-tolerability-pharmacokinetic-profile-and-prelimin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-situational-analysis-of-pediatric-cancer-diagnostic-and-research-capacity-at-two-childhood-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-patient-reported-outcomes-pros-in-men-with-metastatic-castration-resistant-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-incidence-and-mortality-among-aya-patients-with-lung-adenocarcinoma-and-squamo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-determinants-of-survival-of-hepatoid-adenocarcinoma-of-the-stomach-analysis-of-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-circulating-immune-and-metabolic-markers-with-clinical-outcomes-in-the-enzamet-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/wildfire-smoke-risk-mitigation-behaviors-and-cancer-risk-a-community-based-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-time-to-treatment-on-overall-survival-for-patients-with-oropharyngeal-squamous-cell-carcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/electronic-patient-reported-outcomes-in-breast-cancer-patients-receiving-adjuvant-chemotherapy-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psychosocial-digital-application-for-caregivers-of-patients-undergoing-hematopoietic-stem-cell-trans 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pretreatment-serum-sodium-as-a-prognostic-factor-for-patients-with-advanced-esophageal-cancer-receiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-chemoradiation-followed-by-surgery-on-outcomes-compared-to-definitive-chemoradiation-in-lo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploration-of-the-benefits-and-resistance-mechanisms-of-immunotherapy-based-on-pd-l1-expression-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-on-bispecific-antibodies-bsabs-administration-in-community-oncology-settings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stop-cancelling-surgery-for-esophageal-cancer-an-analysis-of-treatment-related-mortality-in-60000 2026-08-24 monthly 0.7 https://rjrindex.com/articles/omission-of-sentinel-node-biopsy-in-early-invasive-breast-cancer-does-age-matter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-phase-ii-trial-assessing-the-efficacy-and-safety-of-mcapox-plus-cetuximab-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psychologic-distress-amongst-adolescent-and-young-adult-cancer-survivors-and-parents 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accelerated-aging-among-long-term-survivors-of-childhood-cancer-a-report-from-the-childhood-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-smarca4-deficiency-and-stk11-co-mutations-on-non-small-cell-lung-cancer-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunoembolization-in-liver-predominant-metastatic-uveal-melanoma-a-single-center-retrospective-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-associations-between-chronic-health-condition-burden-and-financial-hardship-among-adult 2026-08-24 monthly 0.7 https://rjrindex.com/articles/depth-of-response-and-progression-free-survival-in-patients-with-advanced-ialki 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-adverse-events-associated-with-kimmtrak-in-metastatic-uveal-melanoma-using-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-genomic-alterations-identification-and-potential-shared-neoantigens-for-non-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-cisplatin-regimens-for-locoregionally-advanced-head-and-neck-squamous-cell-carcinoma-a-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/revisiting-the-relevance-of-sidedness-in-colonic-tumor-molecular-profiling 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-real-world-survival-of-first-line-atezolizumab-nivolumab-and-pembrolizumab-in-older-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-pucotenlimab-combined-with-standard-chemotherapy-regimens-in-the-neoadjuvant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-differences-in-chemotherapy-completion-and-adverse-events-among-patients-with-colon-cancer-calg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-onset-colorectal-cancer-in-pakistan-frequency-and-association-with-stage-and-grade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-laryngeal-carcinoma-related-mortality-among-adults-in-the-united-states-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combined-soliq-molecular-profiling-using-whole-exome-sequencing-in-advanced-hnscc-at-baseline-les 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-validation-of-dynamic-circulating-tumor-dna-ctdna-based-mrd-for-predicting-progression 2026-08-24 monthly 0.7 https://rjrindex.com/articles/virtual-yoga-vyocas-intervention-for-psychological-distress-a-decentralized-digital-randomized-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-and-shared-genomic-drivers-in-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cross-sectional-study-on-the-impact-of-receiving-potentially-sensitive-test-results-online-on-the-em 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-gender-demographics-and-equity-among-hematologists 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-clinical-outcomes-of-sweet-syndrome-in-hospitalized-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-the-impact-of-delays-to-radiotherapy-on-prostate-cancer-mortality-in-localized-prostat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/remote-physiologic-and-behavioral-monitoring-to-predict-early-treatment-response-in-metastatic-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neuropsychiatric-disorders-among-patients-with-breast-cancer-during-the-covid-19-pandemic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-2-trial-of-flexible-and-extended-dosing-of-sup177sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mvp-can-model-accelerating-cancer-diagnosis-for-underserved-inpatients-to-bridge-health-gaps 2026-08-24 monthly 0.7 https://rjrindex.com/articles/facs-based-whole-genome-crispri-screen-to-uncover-steap1-regulators-in-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/door-to-door-oral-cancer-screening-for-22278-individuals-february-2020-april-2024-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-benefits-of-using-a-different-donor-for-transplantation-consolidation-after-donor-derived 2026-08-24 monthly 0.7 https://rjrindex.com/articles/knowledge-attitudes-and-practices-of-breast-cancer-screening-among-women-in-rural-communities-in-fc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-predictive-biomarkers-of-anti-egfr-resistance-in-egfr-mutated-non-small-cell-lung-cancer-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/abiraterone-with-discontinuation-of-gonadotropin-releasing-hormone-gnrh-analogues-in-patients-pts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imaging-and-biomarker-factors-for-predicting-durable-responses-to-177lu-psma-therapy-in-metastatic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-based-predictive-tool-for-identifying-druggable-mutations-in-lung-cancer-using-nationwide-compreh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-ai-based-spatial-assessment-of-tumor-infiltrating-lymphocytes-til-and-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/innovative-data-visualization-tool-for-tracking-system-failures-in-colorectal-cancer-screening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-machine-learning-approach-to-breast-cancer-screening-using-non-invasive-mrna-collection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-patient-preferences-for-supplemental-methods-of-communication-of-new-drug-approvals-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tackling-the-high-economic-impact-of-recurrence-in-resected-medicare-patients-with-early-stage-tripl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pan-cancer-gene-set-discovery-via-scrna-seq-for-optimal-deep-learning-based-downstream-tasks-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-co-occurring-tp53-and-intracellular-proliferation-pathway-mutations-on-disease-recurrence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-life-use-of-g-csf-in-patients-with-small-cell-lung-cancer-sclc-secondary-data-analysis-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/linking-gene-expression-to-tumor-microenvironment-using-hampe-features-in-stomach-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-g-csf-primary-prophylaxis-on-prevention-of-severe-neutropenia-in-folfirinox-therapy-a-sys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targetable-mutations-in-cutaneous-skin-cancers-a-comparative-study-across-melanoma-squamous-cell-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-quality-of-life-improvements-in-radiation-cystitis-and-head-and-neck-cancer-patients-foll 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamic-prediction-of-cancer-associated-thrombosis-to-guide-prophylactic-anticoagulation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unresectable-advanced-cutaneous-squamous-cell-carcinoma-patient-characteristics-and-outcomes-follow 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neurocognitive-outcomes-following-306-gy-whole-ventricular-radiotherapy-with-54-gy-total-dose-focal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequential-versus-concurrent-strategy-of-immunotherapy-and-radiotherapy-in-advanced-non-small-cell-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-non-bcma-car-t-cell-therapy-for-multiple-myeloma-a-systematic-review-and-meta-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-learning-powered-hampe-whole-slide-image-analysis-of-endothelial-cells-to-characterize-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-niraparib-induced-changes-in-glucose-levels-during-three-month-therapy-in-normoglycemic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-neoadjuvant-chemotherapy-andor-osimertinib-in-patients-with-iegfr-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidermal-growth-factor-receptor-egfr-inhibitor-induced-dermal-toxicity-treated-with-topical-appli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-dose-escalation-trial-of-talazoparib-in-combination-with-belinostat-in-select-advanced-solid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalized-targeted-glioblastoma-therapies-by-iex-vivoi-drug-screenin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-12a-study-of-pbp1510-anti-pauf-mab-in-advancedmetastatic-pancreatic-adenoca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/external-validation-of-a-pathology-based-multimodal-artificial-intelligence-biomarker-for-predicting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-for-brain-metastasis-in-adolescent-and-young-adult-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-from-the-randomized-phase-2-study-1801-part-3b-of-elraglusib-in-combination-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characteristics-treatment-patterns-and-survival-outcomes-in-biliary-tract-cancers-a-ret 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-efficacy-and-safety-of-hyperthermic-intraperitoneal-chemotherapy-hipec-as-an-adjunc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-analyses-of-homologous-recombination-repair-alterations-hrrm-by-gene-subgroup-and-pote 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-barriers-and-effective-strategies-to-improve-biomarker-testing-rates-in-non-small-cell-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-impact-of-non-exonuclease-ipolei-and-ipold1i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/network-pharmacology-analysis-of-phytochemicals-in-targeting-cancer-a-systems-biology-approach 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cryoablation-combined-with-camrelizumab-and-apatinib-in-advanced-hepatocellular-carcinoma-a-prospec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-implications-of-glycemia-in-non-diabetic-patients-with-metastatic-melanoma-undergoing-imm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-bg-c9074-a-b7-h4-targeting-adc-in-patients-with-advanced-solid-tumors-prel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-progression-free-survival-and-overall-survival-in-relapsedrefractory-diffuse-la 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-os-and-duration-of-response-for-transfusion-independence-ti-in-erythropoiesis-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-homologous-recombination-deficiency-and-brca-status-in-ovarian-cancer-analytical-perf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unveiling-drivers-of-mhc-repression-and-therapeutic-strategies-to-counter-immune-evasion-in-small-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-in-patients-with-brain-metastases-secondary-to-melanoma-treated-with-nivolumabr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-dietary-patterns-on-inflammation-and-colon-cancer-risk-a-retrospective-study-of-796-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-circulating-tumor-dna-ctdna-dynamics-with-clinical-response-in-muscle-invasive-blad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-tarlatamab-in-patients-with-relapsed-extensive-stage-small-cell-lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-incidence-and-survival-of-uveal-melanoma-a-seer-based-retrospective-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-ctc-and-ev-based-detection-of-psma-protein-and-efficacy-of-sup177sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-salmonella-il2-in-combination-with-folfirinox-on-overall-and-progression-free-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-first-in-human-phase-12-study-of-tsn1611-a-highly-selective-kras-g12d-inhibitor-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-insights-into-the-impact-of-an-ambient-ai-scribe-solution-on-clinical-documentation-to-reduce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intermittent-parp-inhibitor-regimen-in-ovarian-cancer-ipiroc-a-proof-of-concept-exploratory-pragm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-characterization-of-baseline-and-post-progression-tumors-in-immotion010-a-randomized-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accelerating-treatment-decisions-with-liquid-biopsy-ngs-in-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-development-of-the-cost-of-cancer-in-31-european-countries 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1a-dose-escalation-study-of-rs-0139-a-novel-tumor-targeted-nanomedicine-for-advanced-solid-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-blood-based-multi-cancer-detection-in-circulating-tumor-dna-ctdna-5-ye 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-randomized-clinical-trial-evaluating-perioperative-therapy-neoadjuvant-chemotherapy-ver 2026-08-24 monthly 0.7 https://rjrindex.com/articles/origami-3-a-randomized-phase-3-study-of-amivantamab-plus-folfiri-vs-cetuximab-or-bevacizumab-plus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reduced-dose-ptcy-in-patients-with-acute-myeloid-leukemia-receiving-matched-unrelated-donor-allogene 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-value-of-observerships-abroad-lessons-from-ua-med-supporting-ukrainian-cancer-care-during-the-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-time-to-treatment-failure-ttf-as-a-surrogate-endpoint-for-overall-survival-os-to-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-efficacy-and-safety-of-etentamig-a-b-cell-maturation-antigen-bcma-bispecific-antibody-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-in-patients-with-multiple-myeloma-and-renal-failure-in-the-united-states-1999-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intersectional-disparities-in-mortality-of-laryngeal-cancer-a-retrospective-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subsequent-treatments-and-outcomes-in-bacillus-calmette-guerin-unresponsive-patients-with-high-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-phase-iii-clinical-trial-of-novel-biosimilar-of-pembrolizumab-rph-075 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-on-incidence-and-survival-in-kaposi-sarcoma-during-the-post-retroviral-era-a-sur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peri-transplant-supportive-and-palliative-care-andor-comorbidity-management-for-older-medically-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nationwide-trends-and-disparities-in-end-of-life-care-for-acute-myeloid-leukemia-a-2019-2021-nis-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-prognostic-risk-score-for-hepatocellular-carcinoma-recurrence-post-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-pancreas-tissue-bank-pcrftb-global-facilitation-of-pancreatic-research 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-molecular-outcomes-of-gastrointestinal-malignancies-treated-with-early-phase-studies-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/board-certification-and-billing-practices-of-international-medical-graduate-hematologists-and-oncolo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-place-of-death-in-patients-with-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-efficacy-of-tyrosine-kinase-inhibitors-and-other-targeted-therapies-in-imatinib-resis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/choosing-oncology-a-cross-sectional-study-of-caribbean-medical-students-fourth-year-elective-rotat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-prospective-validation-of-a-novel-cfdna-based-diagnostic-model-for-the-early-detecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-of-ultrafine-gold-nanoparticles-aunps-as-radio-contrast-agent-for-early-cancer-detection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/higher-school-of-oncology-a-decade-of-advancing-oncology-training-in-resource-limited-settings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-debulking-versus-non-surgical-management-for-the-control-of-carcinoid-syndrome-in-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-nivolumab-and-ipilimumab-combined-with-gemcitabine-nab-paclitaxel-and-adaptive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastatic-pancreatic-cancer-molecular-characterization-therapeutic-implications-and-survival-out 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-recurrence-detection-in-stage-iii-colorectal-cancer-patients-through-molecular-residual-di 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-molecularly-targeted-trials-of-tyrosine-kinase-inhibitors-tki-for-the-periop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-and-patterns-of-recurrence-in-a-cohort-treated-with-pacific-protocol-a-single-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-zavatar-test-guided-chemotherapy-vs-standard-of-care-in-relapsed-ovarian-cancer-and-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-molecular-search-engine-paired-with-rna-sequencing-analysis-to-develop-potent-and-selective-vegfr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-biomarker-rct-in-women-at-high-risk-for-breast-cancer-low-dose-tamoxifen-and-lifestyle-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-multimodal-multidisciplinary-care-on-clinical-outcomes-in-patients-with-breast-cancer-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mammography-results-in-male-ibrcai-carriers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/positron-emission-tomography-utility-for-progression-free-survival-prediction-in-her2-positive-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-beyond-progression-and-rechallenge-with-pyrotinib-in-her2-positive-metastatic-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-and-trend-of-breast-cancer-attributable-to-high-red-meat-consumption-in-the-united-states-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-precise-car-t-bridging-therapy-for-diffuse-large-b-cell-lymphoma-a-multicenter-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nrg-br007-a-phase-iii-trial-evaluating-de-escalation-of-breast-radiation-debra-following-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-hdac-iiib-selective-inhibitor-purinostat-mesylate-in-relapsed-and-refractory-diffuse-large-b-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-allostatic-load-and-breast-radiomic-features-among-diverse-women-undergoing-scre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-trimodal-therapy-on-survival-outcomes-in-non-urothelial-muscle-invasive-bladder-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-stimulated-raman-histology-based-cellularity-for-random-forest-prediction-of-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/paired-dnarna-genetic-testing-to-uncover-cryptic-pathogenic-variants-pv-associated-with-pten-hama 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thromboembolic-disease-in-breast-cancer-analysis-of-risk-factors-and-outcomes-from-the-2022-nationa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-neoadjuvant-chemotherapy-nac-anti-her2-antibodies-mabs-on-gut-microbiome-composi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-from-targeted-axillary-lymph-node-dissection-after-neoadjuvant-chemotherapy-for-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-disparities-in-asian-americans-with-epithelial-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-tazemetostat-in-patients-with-refractoryrelapsed-follicular-lymphoma-or-diff 2026-08-24 monthly 0.7 https://rjrindex.com/articles/international-metastatic-renal-cell-carcinoma-database-consortium-imdc-classification-and-regressi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-raceethnicity-on-outcomes-in-patients-with-follicular-lymphoma-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-clinical-characteristics-with-the-use-of-proteomic-testing-for-lung-nodule-malignancy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-immune-cell-subsets-and-cytokine-profiles-with-immune-related-hyperinflammatory-state 2026-08-24 monthly 0.7 https://rjrindex.com/articles/znf74-as-a-novel-therapeutic-target-in-melanoma-unveiling-mechanisms-and-developing-precision-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-peripheral-cancer-associated-tcr-signals-for-the-early-detection-of-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-predictive-model-for-survival-outcome-of-patients-with-early-stage-medullary-breast-carcinoma-a-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-non-small-cell-lung-cancer-real-world-analysis-of-immunotherapy-era-vs-pre-imm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/drivers-of-homologous-recombination-deficiency-hrd-in-metastatic-colorectal-cancer-mcrc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-binimetinib-plus-imatinib-in-patients-with-unresectable-kit-mutant-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-for-head-and-neck-squamous-cell-carcinoma-treated-with-versus-without-neoadjuvant-systemic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-for-aspiration-pneumonia-related-to-postoperative-chemoradiotherapy-for-high-risk-head 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elcin-elacestrant-in-women-and-men-with-cdk46-inhibitor-cdk46i-naive-estrogen-receptor-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unveiling-demographic-and-socioeconomic-patterns-in-hidradenocarcinoma-a-retrospective-national-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-features-and-clinical-panthological-factors-of-acral-malignant-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-oral-nepa-versus-fosaprepitant-combined-with-palonosetron-for-preventing-high 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-fixed-dose-regimens-of-serplulimab-an-anti-pd-1-antibody-in-patients-with-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-treatment-outcomes-of-colorectal-cancer-in-a-resource-restricted-countr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dose-expansion-data-from-iintune-1-a-phase-12-study-of-the-sting-agonist-dazostinag-plus-pembroliz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-iii-study-of-bys10-in-patients-pts-with-locally-advanced-or-metastatic-ret-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-real-world-validation-of-a-multi-modal-machine-learning-model-to-predict-response-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/changes-in-demographics-and-patterns-of-colon-cancer-in-the-united-states-a-comprehensive-seer-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disease-outcomes-in-immune-checkpoint-inhibitor-colitis-a-study-comparing-initial-endoscopic-and-hi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-nk-1-receptor-antagonist-based-therapy-for-prevention-and-treatment-of-chemot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-and-clinical-insights-of-trastuzumab-deruxtecan-efficacy-in-advanced-breast-cancer-abc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-cervical-cancer-in-uzbekistan-trends-in-incidence-and-mortality 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-immune-checkpoint-inhibitors-combined-with-tkis-for-recurrent-or-metastatic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-of-circulating-tumor-dna-and-tissue-genomic-profiling-in-ovarian-cancer-influencing-fac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-controlled-trial-of-high-fidelity-simulation-versus-mentoring-training-for-residents-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-single-arm-phase-2-trial-exploring-the-use-of-pamiparib-combined-with-surufatinib-as 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gynecologic-oncology-referral-rates-of-adnexal-masses-suspicious-for-ovarian-cancer-in-an-academic-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quadrant-of-co-occurrence-of-circulating-tumor-dna-and-pd-l1-expression-on-circulating-tumor-cells-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinguishing-tumor-vs-clonal-hematopoiesis-ch-derived-itp53i-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-racial-demographic-reporting-in-clinical-studies-supporting-nccn-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-time-to-completion-of-multi-target-stool-dna-testing-a-retrospective-study-across-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-and-patient-engagement-with-a-novel-digital-platform-for-cancer-care-navigation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-time-to-treatment-initiation-on-overall-survival-for-patients-with-osteosarcoma-a-seer-da 2026-08-24 monthly 0.7 https://rjrindex.com/articles/screening-for-social-needs-and-providing-enhanced-support-preliminary-findings-from-a-multi-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alcohol-abuse-among-adults-with-esophageal-cancer-and-impact-on-outcomes-of-esophagectomy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-claudin-182-cld182-in-gastric-cancers-and-clinical-correlation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-frailty-and-clinical-outcomes-in-older-adults-with-early-breast-cancer-results 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-pharmacovigilance-study-of-myelotoxicity-with-parp-inhibitors-in-breast-and-ovarian-malig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-sarcopenia-diagnosis-defined-by-low-muscle-mass-measured-by-bioelectrical-impedance-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perception-of-postoperative-functional-status-in-gastrointestinal-and-hepatobiliary-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-socioeconomic-and-geographic-disparities-on-early-mortality-and-treatment-related-complica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-data-to-dollars-evaluating-the-predictive-power-of-enhancing-oncology-model-risk-adjusters 2026-08-24 monthly 0.7 https://rjrindex.com/articles/variations-in-psma-pet-utilization-psa-testing-and-urologist-involvement-in-advanced-castrate-resi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancement-of-30-day-acute-care-event-prediction-model-following-outpatient-chemotherapy-using-vita 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-for-evidence-based-treatment-recommendation-in-oncology-a-blinded-evaluation-of-large-language-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-specific-antigen-psa-screening-from-fingerstick-blood-initial-validation-of-a-point-of-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detection-of-circulating-tumor-cells-and-pten-loss-in-localized-prostate-cancer-before-and-after-rad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-older-matched-sibling-donors-compared-to-younger-matched-unrelated-donors-in-allogeneic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-cancer-mortality-trends-in-the-us-1999-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-biological-patterns-of-breast-cancer-recurrence-in-young-women-a-us-population-based-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparate-recovery-of-cancer-screenings-by-demographic-in-traditional-medicare-post-pandemic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-biomarker-testing-and-targeted-therapy-integration-in-early-stage-nsclc-a-quality-improv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-collaborative-care-in-oncology-improving-quality-of-life-and-mental-health-for-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evolving-beyond-the-unknown-primary-investigating-histopathology-after-diagnostic-transoral-robot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-transcriptomic-profiling-of-the-tumor-microenvironment-in-egfr-and-kras-mutant-non-small-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-prognostic-score-for-stage-iv-nsclc-using-advance-machine-learning-algorithms-an-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-cbdca-pem-pembrolizumab-in-elderly-75-yrs-patients-with-advanced-non-sq-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-high-risk-group-according-to-oncotype-dx-recurrence-score-using-dynamic-contrast-enhanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-the-collection-of-patient-reported-outcomes-key-factors-influencing-completion-and-drop-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frailty-and-days-at-home-in-the-year-after-surgery-for-ovarian-cancer-a-patient-centered-outcome-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-induced-vasomotor-symptoms-in-patients-with-hr-breast-cancer-receiving-adjuvant-endocrine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographics-and-outcomes-of-cancer-patients-on-medicaid-versus-private-insurance-admitted-to-the-ho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hot-flashes-and-night-sweats-in-women-with-breast-cancer-prevalence-and-severity-of-symptoms 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-venous-thromboembolism-vte-events-in-patients-with-egfr-mutant-non-small-cell-lung-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tropion-lung02-datopotamab-deruxtecan-dato-dxd-plus-pembrolizumab-pembro-with-or-without-platin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imaging-with-sup89sup-zrzr-dfo-sc1656-anti-dll3-antibody-in-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-economic-value-of-comprehensive-genomic-profiling-in-patients-with-advanced-solid-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-potent-and-selective-fourth-generation-inhibitors-targeting-egfr-for-nsclc-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-observational-study-to-evaluate-efficacy-and-safety-of-immunotherapy-io-in-elderly-el 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chylopericardium-and-chylous-effusions-during-treatment-with-selective-ret-inhibitors-selpercatinib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/us-population-level-costs-and-cost-savings-associated-with-long-term-follow-up-ltfu-screening-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-safety-and-efficacy-of-gt201-a-first-in-class-autologous-tumor-infiltrating-lymphocyt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anlotinib-in-combination-with-epirubicin-followed-by-maintenance-anlotinib-versus-placebo-plus-epiru 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-contribution-of-metabolic-risk-factors-to-uterine-cancer-related-deaths-and-prediction 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emerald-y90-a-phase-2-study-to-evaluate-transarterial-radioembolization-tare-followed-by-durvalum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/short-course-radiotherapy-followed-by-sintilimab-and-capox-as-total-neoadjuvant-treatment-in-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pilot-single-arm-pragmatic-trial-in-progress-of-in-home-versus-in-clinic-subcutaneous-nivolumab-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/human-vs-ai-a-comparative-effectiveness-study-of-large-language-models-for-automated-biomarker-ext 2026-08-24 monthly 0.7 https://rjrindex.com/articles/telehealth-and-cancer-care-delivery-an-updated-real-world-analysis-of-the-impact-of-telehealth-on-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prognostic-classification-system-for-extent-of-resection-in-idh-mutant-grade-2-glioma-a-report-by 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-state-of-the-oncologist-workforce-in-america-in-areas-prone-to-natural-disasters 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-ihelicobacter-pylorii-infection-on-molecular-alterations-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liposomal-irinotecan-plus-bevacizumab-in-irinotecan-refractory-metastatic-colorectal-cancer-a-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-omics-investigation-for-the-tumor-immune-microenvironment-and-spatial-heterogeneity-in-hepatoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-study-of-either-ivosidenib-monotherapy-or-azacitidine-monotherapy-in-patients-with-idh1-muta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ca209-8ty-trial-a-randomized-phase-2-trial-of-nivolumab-and-ipilimumab-with-or-without-stereotactic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pilot-study-of-an-enhanced-telehealth-program-for-patients-with-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/depression-in-patients-with-advanced-prostate-cancer-in-swog-advanced-cancer-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chitinase-3-like-1-ichi3l1i-a-potential-prognostic-biomarker-for-imm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-clinical-predictors-of-cranial-nerve-palsies-cnps-post-ciltacabtagene-autoleucel-ci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-stereotactic-radiotherapy-and-enfortumab-vedotin-a-phase-iii-study-for-localized-cisp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-clinical-outcomes-with-platinum-based-chemotherapy-after-enfortumab-vedotin-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-of-neoantigen-specific-immune-responses-by-vb10neo-in-combination-with-atezolizumab-in-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-irinotecan-liposome-combined-with-5-fulv-bevacizumab-as-first-line-therapy-in-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modernizing-clinical-trial-accessibility-integrating-the-ai-powered-lookuptrials-app-into-the-ctn-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-eik1003-a-selective-parp1-inhibitor-as-monotherapy-in-participants-with-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-i-study-of-tqb2103-a-claudin182-cldn182-targeted-antibody-drug-conjugate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-a-phase-1-study-of-lb1908-an-autologous-claudin-182-targeted-chimeric-antig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/teclistamab-in-relapsedrefractory-systemic-al-amyloidosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-serplulimab-combined-with-gemcitabine-plus-nab-paclitaxel-gnp-and-sbrt-for-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-bruton-tyrosine-kinase-inhibitor-btki-use-and-clinical-outcomes-among-patients-with-chr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-factors-affecting-aesthetic-outcomes-and-safety-in-breast-conserving-surgery-a-multicen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-anti-pd-1-monoclonal-antibody-and-folfoxiri-combined-with-long-course-radiotherapy-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/propan-bayesian-dose-finding-of-propranolol-combined-with-metronomic-fixed-dose-cyclophosphamide-ba 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bms-986504-in-patients-pts-with-advanced-solid-tumors-with-homozygous-imtap-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-as-monotherapy-or-in-sequential-combination-with-lenvatinib-for-neoadjuvant-treatment-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-hypertension-in-patients-newly-diagnosed-with-chronic-lymphocytic-leukemiasmall-lymphocytic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-diversity-in-oncology-trials-key-strategies-from-the-acori-community-oncology-inclusive-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-type-of-brca12-pathogeniclikely-pathogenic-variants-and-outcome-in-young-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ropeginterferon-alfa-2b-versus-anagrelide-for-the-treatment-of-essential-thrombocythemia-topline-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-testing-of-lung-cancer-in-north-america-versus-globally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-less-frequent-dosing-with-elranatamab-elra-in-patients-with-relapsed-or-ref 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-dietary-factors-on-esophageal-cancer-over-three-decades-a-global-epidemiological-over 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sox30-mediated-activation-of-cxcl2-as-promotor-of-pmn-mdsc-recruitment-and-immunosuppressive-microen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/palbociclib-plus-endocrine-therapy-or-gnrh-analogs-versus-capecitabine-or-placebo-for-hrher2-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemoradiotherapy-plus-pd-1-inhibitor-tislelizumab-for-high-risk-and-mrf-low-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-and-morbidity-outcomes-in-patients-with-inflammatory-bowel-disease-with-colon-cancer-a-na 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-trastuzumab-deruxtecan-for-metastatic-her2-and-her2-low-breast-cancer-a-sys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-colorectal-cancer-and-iron-deficiency-anemia-related-mortality-in-the-united-states-a-nat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-expression-of-human-endogenous-retrovirus-env-gene-product-as-a-hallmark-of-sidedness-in-operabl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/operetta-a-phase-ii-study-evaluating-neoadjuvant-and-adjuvant-olaparib-plus-pembrolizumab-following 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-treatment-outcomes-of-hepatosplenic-t-cell-lymphoma-mayo-clinic-experi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-a-program-addressing-multi-level-barriers-to-completion-of-hereditary-cancer-genetic-test 2026-08-24 monthly 0.7 https://rjrindex.com/articles/forecasting-incidence-and-mortality-rates-of-bladder-cancer-in-older-adults-using-autoregressive-int 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-based-disparities-in-hpv-related-cancer-outcomes-insights-into-social-determinants-of-health 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-obesity-in-postoperative-outcomes-of-robot-assisted-radical-cystectomy-for-bladder-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-concurrent-pathogenic-variants-in-ibrca1i-breast-cancer-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/growing-burden-of-cancer-and-high-body-mass-index-in-the-united-states-from-1990-2021-a-benchmarkin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-single-institution-application-of-a-deep-learning-based-radiomic-score-in-metastatic-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/microrna-based-biomarkers-of-outcome-in-soft-tissue-sarcoma-treated-with-hypofractionated-preoperati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impacts-on-prognosis-of-the-relationship-between-decline-in-renal-function-associated-with-pemet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-a-combined-artificial-intelligent-system-for-lung-cancer-stage-prediction-and-classification 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-margin-mutation-dissemination-patterns-in-iegfri-l858r-mutated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-rituximab-maintenance-on-outcomes-in-follicular-lymphoma-an-indian-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-and-adjuvant-iruplinalkib-in-resectable-ialki-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-of-fruquintinib-monotherapy-and-combination-therapy-in-chinese-patients-with-colorectal-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-and-survival-analysis-across-different-age-groups-in-elderly-patients-with-es-sel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-estrogen-receptor-er-and-progesterone-receptor-pr-expression-levels-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-sr-8541a-in-combination-with-botensilimab-and-balstilimab-in-subjects-with-refrac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-risk-stratification-in-breast-cancer-a-10-year-follow-up-of-a-single-institution-prospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reported-side-effects-from-treatment-in-a-prospective-phase-ii-randomised-trial-evaluating-local-con 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-early-detection-of-lung-cancer-methylation-anchor-probe-for-low-signal-enrichment-maple 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-caprine-herpes-virus-1-cphv-1-on-cell-viability-and-chemosensitivity-in-breast-cancer-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-bintrafusp-alfa-m7824-in-patients-with-gastrointestinal-tumors-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-access-to-pediatric-oncology-clinical-trials-identifying-modifiable-enrollment-barriers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evidence-in-real-world-settings-for-multiple-primary-malignancies-in-prostate-cancer-comparison-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-peripheral-treg-expansion-after-sbrt-combined-with-low-dose-radiotherapy-to-predict-subsequent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integration-of-advanced-practice-nurses-and-telemonitoring-in-the-management-of-immune-mediated-adve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-autoimmune-disease-on-toxicity-and-outcomes-after-idecabtagene-vicleucel-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/are-patients-with-early-stage-non-small-cell-lung-cancer-receiving-timely-testing-for-the-alk-rearra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-timeliness-of-first-appointment-with-medical-oncology-a-quality-improvement-initiative-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-diagnostic-workup-location-on-time-to-treatment-for-patients-with-non-small-cell-lung-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-for-high-grade-prostate-cancer-in-an-inner-city-population-analysis-of-commonly-dispen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-profiles-and-treatment-outcomes-in-young-adults-with-stage-iv-non-small-cell-lung-cancer-ns 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-ikrasi-ipg12ci-inhibitors-in-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-prior-treatment-tx-on-the-clinical-activity-of-imetelstat-ime-in-transfusion-dependent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-static-and-dynamic-risk-assessment-in-hma-treated-mds-patients-undergoing-stem-cell-transp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-meta-analysis-analyzing-the-efficacy-and-safety-of-datopotamab-deruxtecan-dato-dxd-in-previously 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-evaluating-the-effectiveness-of-blue-button-a-tool-for-institution-agnostic-ehr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-chemotherapy-on-financial-toxicity-in-african-american-breast-cancer-patients-early-findi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-disparities-in-pancreatic-cancer-treatment-the-role-of-pre-diagnosis-healthcare-utili 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unveiling-the-role-of-sodium-glucose-cotransporter-2-inhibitors-in-hepatocellular-carcinoma-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-radiotherapy-planning-skills-through-structured-deliberate-practice-and-artificial-intelli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lactylation-mediated-igf2bpsrmrp-axis-and-effects-on-bladder-cancer-progression-through-the-regulat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-evaluation-of-the-nilotinib-paclitaxel-combination-in-patients-with-rare-solid-tumors-rapid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relevance-and-specificity-of-the-french-cian-lung-cohort-for-clinical-research-analyses-in-lung-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/international-phase-ii-randomized-placebo-controlled-study-investigating-the-combination-of-yiv-906 2026-08-24 monthly 0.7 https://rjrindex.com/articles/midpoint-mri-as-an-early-predictor-of-responses-to-neoadjuvant-chemotherapy-in-patients-with-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-durvalumab-combined-with-various-chemotherapy-regimens-in-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapeutic-response-score-to-predict-prognosis-for-unresectable-hepatocellular-carcinoma-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-variant-interpretation-in-hereditary-cancer-testing-with-rna-analysis-from-residual-blood 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unraveling-survival-disparities-in-primary-central-nervous-system-cns-lymphoma-an-analysis-of-rac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-preventive-breast-cancer-screening-findings-from-a-national-dataset 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-between-circulating-tumor-dna-ctdna-and-disease-status-in-soft-tissue-sarcoma-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-early-recognition-and-treatment-of-immune-related-myositis-and-myasthenia-gravis-reduce-mortali 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-chinese-medicine-compound-fufang-ejiao-syrupfor-symptom-burden-of-cancer-related-fatigu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-making-inroads-into-advanced-endometrial-cancer-management-a-single-center-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-for-medicaid-recipients-with-early-onset-breast-cancer-an-analysis-of-the-nationa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lobaplatin-based-chemotherapy-with-immunotherapy-as-first-line-treatment-in-patients-with-advanced-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-healthtree-cure-hub-registry-a-patient-centered-multicenter-approach-to-advancing-multiple-mye 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-cancer-medications-shortage-on-the-survival-of-patients-with-lung-cancer-a-multicenter-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-impact-of-immunotherapy-in-metastatic-uveal-melanoma-a-retrospective-single-center-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adela-a-double-blind-placebo-controlled-randomized-phase-3-trial-of-elacestrant-ela-everolimu-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-pd-1pd-l1-inhibitors-in-non-small-cell-lung-cancer-in-elderly-patients-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/minimal-residual-disease-mrd-test-utilization-in-the-first-6-months-after-initiating-mrd-testing-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-gaps-in-colorectal-cancer-screening-research-in-the-arab-world-a-16-year-bibliometric-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-of-adjuvant-dc-cik-following-high-dose-ifn-versus-high-dose-ifn-or-anti-pd1-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-plasma-ctdna-mutational-profile-and-heterogeneity-in-renal-cell-carcinoma-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/new-diagnostic-technology-for-the-isolation-and-analysis-of-live-myeloma-cells-from-the-blood-of-mul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-a-novel-rna-m6a-regulatory-gene-expression-signature-with-proliferation-and-disease-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rare-immune-related-adverse-events-a-retrospective-analysis-from-a-single-center-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-pembrolizumab-carboplatin-paclitaxel-and-radiation-for-the-treatment-of-early 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eribulin-plus-pyrotinib-in-trastuzumab-resistant-her2-positive-advanced-breast-cancer-a-single-arm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/azur-4-a-phase-2-open-label-randomized-study-of-neoadjuvant-dostarlimab-plus-capecitabine-plus-ox 2026-08-24 monthly 0.7 https://rjrindex.com/articles/osimertinib-plus-anlotinib-in-patients-with-untreated-egfr-mutated-advanced-non-small-cell-lung-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-ifn-alpha-2b-as-adjuvant-treatment-for-acral-melanoma-a-retrospective-analysis-of-113-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-digital-platforms-accelerate-education-and-adoption-of-newly-implemented-treatment-guideli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/open-source-modular-ai-coupled-with-agentic-ai-for-comprehensive-breast-cancer-note-generation-and-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-tepotinib-and-immune-checkpoint-inhibitor-therapy-for-met-exon-14-skipping-nscl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/human-compared-to-ai-a-single-blind-evaluation-of-spanish-language-translation-quality 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pediatric-patients-with-tenosynovial-giant-cell-tumor-real-world-results-from-an-observational-regi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-larotrectinib-in-patients-with-trk-fusion-thyroid-carcinoma-an-updated-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantum-mechanics-based-multi-tensor-aiml-discovery-and-validation-of-actionable-and-mechanisticall 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-combined-with-2-cycles-of-chemotherapy-as-first-line-treatment-for-advanced-non-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-decreased-treatment-intensity-in-patients-with-metastatic-colon-cancer-a-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-the-international-consensus-classification-icc-for-systemic-mastocytosis-and-the-may 2026-08-24 monthly 0.7 https://rjrindex.com/articles/luspatercept-in-patients-with-lower-risk-myelodysplastic-syndromes-mds-a-systematic-review-and-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hospice-utilization-in-veterans-with-newly-diagnosed-metastatic-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-pain-and-emergency-department-utilization-in-patients-with-newly-diagnosed-ovarian 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapeutic-impact-of-bet-inhibition-on-immune-cell-death-checkpoints-in-mpn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-transit-and-radiotherapy-cost-effectiveness-approach-to-environmental-health-savings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-prevalence-of-homologous-recombination-repair-alterations-hrra-and-poly-adp-ribose-po 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ceramides-and-response-to-dual-secondary-hormonal-therapy-in-metastatic-castration-resistant-prostat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bilateral-germ-cell-tumor-of-the-testis-tgct-implications-for-a-stem-cell-versus-genetic-origin-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-chatgpt-perform-as-well-as-pharmacists-in-identifying-potentially-inappropriate-medications-pim 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-medicare-reimbursement-for-urological-cancer-surgeries-in-male-genitourinary-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-citation-impact-and-social-media-engagement-in-cancer-pain-research 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-between-profitability-clinical-benefit-and-physicians-selection-of-cancer-drugs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-frontline-folfirinox-with-fluorouracil-based-and-gemcitabine-basedchemotherapies-in-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-heart-failure-hospitalizations-among-patients-with-malignant-carcinoid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-case-control-study-of-thermosensitive-embolic-agents-tempsle-and-microspheres-in-tace-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-anatomical-concept-and-standardized-technique-for-single-port-laparoscopic-para-aortic-lymphad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-to-treatment-initiation-tti-in-patients-with-colorectal-cancer-and-liver-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-with-trifluridinetipiracil-monotherapy-or-in-combination 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-chemotherapy-with-or-without-toripalimab-followed-by-concurrent-chemoradiotherapy-for-loco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-a-multidisciplinary-intervention-based-on-a-supervised-training-program-on-cardiovascular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-trends-and-regional-disparities-in-young-onset-breast-cancer-age-specific-patterns-from-1990 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-health-disparities-in-prostate-cancer-patients-with-and-without-venous-throm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multiomic-approach-for-detecting-clinically-significant-prostate-cancer-in-seminal-fluid-results 2026-08-24 monthly 0.7 https://rjrindex.com/articles/isopsa-in-prostate-cancer-a-systematic-review-of-diagnostic-prognostic-and-economic-implications 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-between-gleason-grade-group-psa-levels-and-prostatectomy-outcomes-for-the-optimize 2026-08-24 monthly 0.7 https://rjrindex.com/articles/persistent-racial-disparities-in-aml-survival-in-the-flt3-inhibitor-era 2026-08-24 monthly 0.7 https://rjrindex.com/articles/automated-clinical-data-extraction-from-oncology-trials-using-large-language-models 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-changes-in-credit-status-for-newly-diagnosed-metastatic-colorectal-cancer-patients-swo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequential-chemo-immunotherapy-as-a-novel-bridging-strategy-for-non-complete-responders-after-neoadj 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-in-patients-with-stage-23-hrher2-negative-breast-cancer-bc-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ib-study-of-a-plasmid-dna-based-immunotherapy-encoding-the-htert-psma-and-wt1-ino-5401 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-safety-and-efficacy-of-tarlatamab-in-patients-with-small-cell-lung-cancer-or-extrapulmona 2026-08-24 monthly 0.7 https://rjrindex.com/articles/palbociclib-in-patients-pts-with-ovarian-cancer-oc-with-cdkn2a-alterations-results-from-the-tar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ind241-a-canadian-cancer-trials-group-liquid-biopsy-informed-platform-trial-to-evaluate-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-impact-of-physical-activity-on-survival-outcomes-in-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/carcinoid-heart-disease-and-urinary-5-hiaa-in-patients-with-pancreatic-neuroendocrine-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-immunotherapy-of-high-risk-neuroblastoma-patients-with-long-term-infusion-of-dinutuxi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-of-vaginal-tampon-versus-swab-in-the-collection-of-vaginal-fluid-for-endometrial-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-body-mass-index-diabetes-and-tumor-mutational-burden-in-ovarian-fallopian-tube-and-pri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-analysis-guiding-adjuvant-therapy-in-patients-pts-with-colorectal-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-preliminary-efficacy-and-safety-results-of-neoadjuvant-phase-ii-study-of-anlotinib-plus-tisleliz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-analysis-between-tumor-tissue-her2-status-by-immunohistochemistry-ihc-and-in-situ-hybr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/heterogeneity-in-the-expression-of-gprc5d-between-patients-with-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/creation-of-the-ideal-health-care-pathway-for-integrating-ctdna-testing-into-clinical-practice-throu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-small-cell-lung-cancer-sclc-pre-and-post-2018-a-seer-based-analysis-of-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodal-thermal-therapy-to-promote-the-expansion-of-tumor-reactive-like-cx3cr1-sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-to-predict-immune-related-adverse-events-in-cancer-patients-treated-with-icis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sasanlimab-as-bladder-sparing-maintenance-treatment-after-neoadjuvant-chemotherapy-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-culturally-tailored-educational-tool-designed-to-increase-access-to-somatic-testing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-controlled-open-label-phase-2-study-of-the-pd-1il-2-supa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-cost-of-convenience-evaluating-economic-differences-in-sq-and-iv-biotherapeutic-formulations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-pathological-response-in-unresectable-hepatocellular-carcinoma-treated-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psa-as-a-predictor-of-small-cell-transformation-in-prostatic-adenocarcinoma-a-seer-2000-2021-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-genomic-and-immune-microenvironment-differences-in-chinese-populations-revealing-potent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-large-language-models-to-extract-cancer-diagnosis-histology-grade-and-staging-from-unstruc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imneo-high-accuracy-neoantigen-prediction-through-ai-based-integrated-analysis-of-multiple-immunoge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liposomal-curcumin-and-standard-radiation-and-temozolomide-for-newly-diagnosed-high-grade-gliomas-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1b2-keynote-365-cohort-i-pembrolizumab-pembro-plus-carboplatin-and-etoposide-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oral-microbiome-diversity-and-oral-human-papillomavirus-associated-differences-in-black-vs-white-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequoia-5-year-follow-up-in-arm-c-frontline-zanubrutinib-monotherapy-in-patients-with-del17p-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progression-free-survival-as-a-surrogate-outcome-for-overall-survival-in-ovarian-cancer-maintenance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-learning-based-contouring-of-couinaud-segments-on-ct-utility-for-volumetric-analysis-of-future 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-anti-pd-1-combined-with-thymosin-and-sox-in-neoadjuvant-treatment-of-cstage-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-clinical-trial-screening-with-a-comprehensive-large-language-model-platform 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validating-a-semantic-similarity-approach-for-automated-data-extraction-in-phase-ii-oncology-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-antitumor-activity-of-sup177sup-lu-catelase-a-preliminary-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-ovarian-function-suppression-with-adjuvant-endocrine-therapy-on-survival-outcomes-in-y 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-adagrasib-ada-with-pembrolizumab-pembro-in-patients-pts-with-advancedmetastatic-kr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-decade-of-progress-trends-in-5-year-survival-across-17-cancer-types 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-circulating-tumor-cell-distribution-with-pd-l1-expression-in-baseline-and-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elegant-elacestrant-versus-standard-endocrine-therapy-et-in-women-and-men-with-node-positive-est-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-clinical-outcome-assessments-in-patients-with-tenosynovial-giant-cell-tumor-treated-with-v 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-of-low-grade-intermediate-risk-non-muscle-invasive-bladder-cancer-with-ugn-102-results-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insight-into-the-global-mortality-trends-due-to-prostate-cancer-among-the-under-55-population-an-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/15-year-survivorship-in-patients-with-metastatic-gastrointestinal-stromal-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dauntless-1-a-phase-2-clinical-trial-to-evaluate-pmd-026-a-first-in-class-pan-rsk-inhibitor-combi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-sociodemographic-and-facility-related-determinants-of-immunotherapy-use-in-metastatic-tri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-idecabtagene-vicleucel-and-ciltacabtagene-autoleucel-in-relapsedrefractory 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-insights-into-cardiometabolic-comorbidities-and-their-role-in-triple-negative-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-outcomes-of-head-and-neck-cancer-in-sub-saharan-africa-insights-from-a-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-combined-with-cetuximab-and-chemotherapy-in-recurrent-or-metastatic-head-and-neck-squam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-induction-chemoimmunotherapy-versus-induction-chemotherapy-in-patients-with-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-immune-checkpoint-inhibitors-on-unplanned-emergency-department-consultations-in-mnsclc-mo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-steroid-sparing-agents-ssas-for-immune-related-adverse-events-iraes-in-patients-pts-dis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relative-lymphocyte-percentage-as-a-predictive-biomarker-for-immune-checkpoint-inhibitor-in-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-treatment-resistance-on-cspg4-expression-in-metastatic-melanoma-across-multiple-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinico-genomic-characteristics-of-clinical-trial-participation-and-its-impact-on-clinical-outcome-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-mk-3475a-in-relapsed-or-refractory-classic-hodgkin-lymphoma-or-primary-mediastinal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-baseline-clinical-factors-with-outcomes-in-patients-with-localized-ewing-sarcoma-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-chemotherapy-induced-cardiotoxicity-among-african-american-women-with-breast-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-histology-dependent-immunobiological-differences-in-metastatic-nsclc-implicatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-prediabetes-as-a-potential-risk-factor-for-breast-cancer-a-systematic-review-and-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-safety-and-biomarker-analysis-of-a-phase-2-study-of-lbl-007-alcestobart-an-anti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-immune-checkpoint-inhibitors-ici-in-biliary-tract-cancer-btc-real-world-outcomes-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-mastocytosis-a-study-of-trends-survival-and-second-primary-malignancies-among-adults-in-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/self-reported-adherence-to-cancer-therapy-development-and-validation-of-a-cancer-specific-dose-nona 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-first-second-and-third-generation-tyrosine-kinase-inhibitors-in-chron 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-after-stem-cell-boost-for-poor-engraftment-following-allogeneic-hematopoietic-stem-cell-tra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-from-flex-utility-of-mammaprint-in-guiding-treatment-planning-for-patients-aged 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-hormone-therapy-usage-with-adverse-cardiovascular-events-in-prostate-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-clinical-trial-site-efficiency-and-unlocking-patient-access-to-clinical-trials-using-techn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-court-documented-major-adverse-financial-events-before-cancer-diagnosis-and-mortality 2026-08-24 monthly 0.7 https://rjrindex.com/articles/uptake-of-targeted-therapy-in-a-large-cohort-of-patients-with-advanced-prostate-cancer-and-germline 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-number-of-lymph-node-dissections-related-to-survival-of-patients-with-locally-advanced-esophagea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-chemotherapy-utilization-among-urban-upper-gi-malignancy-cancer-patients-at-a-safety 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-protein-energy-malnutrition-on-mortality-length-of-stay-and-hospitalization-costs-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-dose-anti-pd-l1-inhibitor-strategies-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fes-and-fdg-pet-imaging-performance-comparison-for-potential-use-in-biology-guided-radiotherapy-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-sup177sup-lu-jh020002-in-patients-with-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-1-dose-escalation-and-expansion-clinical-trial-to-evaluate-the-safety-pharmaco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-nivolumab-vs-docetaxel-as-second-line-treatment-in-advanced-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-data-from-phase-1b2-epcore-nhl-4-epcoritamab-epcor-in-chinese-patients-pts-with-relapsed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-the-tgfv-signaling-pathway-to-mitigate-tumor-metastasis-in-9p21-loss-urothelial-bladder-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-the-incidence-of-hodgkins-lymphoma-in-the-middle-east-and-north-africa-over-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mapping-biological-networks-in-lung-adenocarcinoma-using-transcriptomic-analysis-to-identify-prognos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-dose-escalation-and-dose-expansion-study-for-lncb74-a-b7-h4-targeted-antibody-drug-conjug 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anlotinib-plus-everolimus-as-first-line-treatment-for-advanced-non-clear-cell-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-irradiation-on-the-killing-effect-of-nk-cells-in-colon-cancer-through-mybtim3-axis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-postoperative-acute-kidney-injury-in-robotic-assisted-pulmonary-lobectomy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-inflammatory-biomarkers-as-predictors-of-outcomes-and-immune-related-adverse-events-irae 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-life-comparison-between-immunotherapy-and-conventional-chemotherapy-in-patients-with-advanced-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitors-ici-in-thymic-epithelial-tumors-tet-a-real-world-assessment-of-eff 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-biomarkers-for-colorectal-cancer-in-a-nigerian-population 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-profiling-of-colorectal-liver-metastasis-and-insight-into-their-prognostic-value 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-nuclear-cd276-on-cd36-mediated-lipid-metabolism-reprogramming-on-tki-resistance-in-hepato 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-regorafenib-following-first-line-immune-checkpoint-inhibitor-failure-in-patients-with-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-pemetrexed-plus-oxaliplatin-as-2-supndsup-line-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-palliative-care-utilization-in-advanced-head-and-neck-cancer-hospitalizati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/out-of-touch-understanding-the-frequency-and-trajectory-of-chemotherapy-induced-neuropathy-peripher 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-readmission-to-index-vs-non-index-hospitals-after-major-cancer-surgery-doe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-characteristics-and-survival-outcomes-in-adolescent-and-young-adults-with-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/considering-the-caregiver-in-early-phase-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-a-large-language-model-llm-for-pan-cancer-automated-detection-of-anti-cancer-therapy-toxici 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-profiling-of-immune-and-stromal-alterations-in-colorectal-cancer-with-diabetes-mellitu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detection-of-esr1-and-pik3ca-actionable-mutations-in-breast-cancer-using-liquid-biopsy-a-step-towar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inclusion-of-people-living-with-hiv-in-food-and-drug-administration-fda-oncology-pivotal-registrat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumour-microbiome-and-immune-dysregulation-in-early-onset-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-ai-predictive-models-to-develop-thymic-tumor-specific-peptides-mimicking-col17a1-alterati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eter901-a-randomized-open-label-phase-iii-trial-of-anlotinib-in-combination-with-anti-pd-l1-antib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-kite-363-anti-cd19cd20-chimeric-antigen-receptor-car-t-cell-therapy-in-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-molecular-determinants-of-survival-in-pancreatic-neuroendocrine-tumors-a-comprehensive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-validation-of-different-hrd-assays-in-high-grade-serous-ovarian-cancer-in-greek-population 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-role-of-preoperative-plasma-insulin-like-growth-factor-1-igf-1-as-a-predictor-of-su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whole-genome-bisulfite-sequencing-of-cell-free-dna-to-investigate-molecular-contributors-to-racial-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-peptide-receptor-radionuclide-therapy-in-combination-with-capecitabine-and-temozolomide 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sintilimab-combined-with-lenvatinib-versus-hepatic-artery-infusion-chemotherapy-haic-for-neoadjuva-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-strategies-and-outcomes-of-inflammatory-myofibroblastic-sarcoma-insights-from-a-retrospec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pain-attribution-and-management-in-non-aggressive-bone-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reliable-detection-of-merkel-cell-polyomavirus-in-merkel-cell-carcinoma-by-whole-exome-next-generati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-receipt-of-palliative-treatments-among-disaggregated-hispanic-populations-with-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-palliative-care-on-the-management-and-outcomes-of-elderly-pancreatic-cancer-patients-follo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-prevention-of-cardiotoxicity-in-cancer-patients-treated-with-fluoropyrimidines-a-randomized 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-discordance-between-immunochemistry-of-mismatch-repair-proteins-and-next-generation-sequ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/changing-oncology-training-in-latin-america-a-mentorship-program-design-and-implementation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-nimotuzumab-plus-ag-regimen-as-conversion-therapy-for-locally-advanced-pancre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-tobacco-use-and-sociodemographic-factors-on-mortality-in-pancreatic-cancer-in-the-united-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-clonal-competition-model-of-pdac-liver-metastasis-on-a-pan-carcinoma-gene-signature-of-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinico-radiographic-predictors-of-overall-survival-in-stage-ii-iii-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-pembrolizumab-and-epacadostat-combination-therapy-in-metastatic-epithelial-de 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-choosing-hematologyoncology-as-a-career-path 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-nationwide-survey-of-gaps-in-oncology-residency-education-in-armenia-and-the-potential-role-of-jou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinician-perspectives-on-digital-and-computational-pathology-in-oncology-opportunities-and-challen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-regorafenib-combination-with-pd-1-inhibitors-vs-regorafenib-monotherapy-in-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-the-relationship-between-the-number-of-hematoporphyrin-intravesical-perfusion-photodynam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-informed-liquid-biopsy-in-predicting-recurrence-in-patients-with-operable-gastroesophageal-ade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-tumor-genomics-and-clinical-outcomes-in-in-adolescent-and-young-adult-aya-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/application-of-artificial-intelligence-in-the-development-of-patient-oriented-oncology-information 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-difference-of-clinical-and-molecular-characteristics-between-hr-positiveher2-positive-and-hr-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-an-early-sepsis-treatment-decision-algorithm-in-children-and-adolescents-with-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-utilization-of-active-surveillance-treatment-and-survival-in-prostate-cancer-insights-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-and-therapy-response-in-irasi-mutated-myeloid-malign 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-mobile-mammography-versus-urban-hospital-based-breast-cancer-screening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/receipt-of-guideline-concordant-oncologic-care-between-older-hiv-positive-and-older-hiv-negative-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/desensitization-protocols-for-platinum-based-chemotherapy-in-metastatic-cervical-cancer-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diffuse-large-b-cell-lymphoma-patients-with-early-post-diagnosis-mortality-at-a-quaternary-care-cent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genital-cancer-mortality-in-comorbid-vs-non-comorbid-populations-a-nationwide-trend-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-cerebrovascular-disease-related-mortality-in-older-adults-with-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-in-nsclc-uncovering-disparities-and-advancing-health-equity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-in-disability-adjusted-life-years-dalys-of-pancreatic-cancer-among-individuals-age 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-of-maintenance-therapy-with-metformin-and-temozolomide-for-newly-diagnosed-glioblas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-neuroradiologists-input-on-peer-review-meetings-for-cns-radiotherapy-treatment-planning 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-inequalities-in-mortality-due-to-hepatocellular-cancer-in-male-patients-with-alcoholic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-the-colorectal-cancer-alliances-digital-screening-quiz-in-advancing-crc-screening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-scoping-review-of-uptake-and-interventions-in-specialty-and-non-primary-care-clinical-settings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/addressing-lung-cancer-screening-gaps-in-refugee-populations-insights-from-a-retrospective-cohort-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-trends-in-brain-and-cns-cancer-across-high-income-countries-a-benchmarking-study-1990 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-utilization-of-palliative-care-services-by-patients-with-glioblastoma-a-cross-sectional-study-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-center-case-control-study-on-osteoporosis-risk-in-cancer-patients-receiving-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-nivolumab-plus-chemotherapy-versus-chemotherapy-alone-for-the-treatment-of-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-after-osimertinib-dose-reduction-discontinuation-in-1l-iegfri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-of-plasma-cell-leukemia-in-the-us-incidence-mortality-and-survival-predictors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-analysis-of-a-multicenter-open-label-phase-2-study-evaluating-the-efficacy-and-safety-of-tis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regulation-of-tumor-associated-fibroblasts-by-tacstd2-in-esophageal-squamous-cell-carcinoma-and-its 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-triple-oral-metronomic-chemotherapy-in-patients-with-advanced-esophageal-squa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-trial-of-apx-343a-nox-inhibitor-targeting-caf-mediated-immunosuppression-as-monotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-combination-of-pd-1-inhibitor-with-chemotherapy-salvage-chemoradiotherapy-for-local-primary-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/carfilzomib-or-bortezomib-with-lenalidomide-and-dexamethasone-vrd-for-initial-therapy-of-newly-di 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-clinical-study-using-ai-based-imaging-analysis-technology-to-continuously-monitor-sarcopenia-and-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alcohol-use-and-liver-cancer-mortality-in-the-us-1999-2020-a-cdc-wonder-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inconsistent-housing-support-for-oncologic-patients-at-nci-designated-cancer-centers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-and-increasing-awareness-of-social-determinants-of-health-of-patients-with-cancer-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-oncology-fellows-insights-to-enhance-cancer-care-a-quality-improvement-initiative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-zanubrutinib-treatment-patterns-in-mantle-cell-lymphoma-mcl-among-us-community-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vitamin-d-deficiency-in-prostate-cancer-prevalence-in-a-sun-rich-climate-and-the-influence-of-andro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-interest-and-satisfaction-with-integrative-oncology-approaches-among-hospitalized-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-on-genomic-features-of-prostate-cancer-patients-with-and-without-treatment-emer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-brca-alterations-on-androgen-receptor-pathway-inhibition-treatment-outcome-in-advanced-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-access-to-breast-cancer-clinical-trials-with-breastcancertrialsorg-and-a-dedicated-clinic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-therapy-related-aml-t-aml-with-venetoclax-based-therapies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-hepatocellular-carcinoma-admissions-comorbidities-and-outcomes-a-nationwide 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-hbv-related-vs-hcv-related-hepatocellular-carcinoma-under-targeted-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/language-matters-impact-of-medical-interpretation-on-lung-cancer-screening-adherence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accuracy-and-inclusiveness-of-health-insurance-information-in-generative-artificial-intelligence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-digital-literacy-gap-empowering-patients-and-care-partners-through-the-digital-sherpa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/operational-feasibility-and-impact-of-a-digital-platform-for-symptom-management-in-oncology-a-real 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-cancer-study-enrollments-between-urban-rural-frontier-and-remote-participants 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-fih-study-of-novel-oral-serd-fwd1802-in-patients-with-erher2-unresectable-locally-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-prognosis-of-pulmonary-lymphoepithelioma-like-carcinoma-a-multicentre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-pik3ca-mutations-for-response-to-cdk46-inhibitors-in-hormone-receptor-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-iegfri-assessment-in-plasma-and-tissue-samples-in-early-no 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modified-four-quadrant-enhanced-coloanal-anastomosis-fqecaa-for-patients-receiving-intersphincteri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-therapy-with-mfolfoxiri-combined-with-camrelizumab-and-bevacizumab-for-microsatellite-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/taps-chemistry-a-novel-ultrasensitive-pan-cns-cancer-liquid-biopsy-assay 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-invasive-fungal-infections-in-patients-with-chronic-lymphocytic-leukemia-treated-with-bruton 2026-08-24 monthly 0.7 https://rjrindex.com/articles/setting-a-precedent-development-of-a-core-outcome-set-for-locoregional-treatment-outcome-reporting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-assessment-using-urinary-tumor-dna-utdna-to-identify-potential-candidates-for-repeat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-dose-furmonertinib-combined-with-bevacizumab-and-pemetrexed-in-non-small-cell-lung-cancer-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-first-line-prolgolimab-and-nurulimab-versus-nivolumab-and-ipilimumab-in-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-baseline-and-dynamic-circulating-tumor-cell-monitoring-in-advanced-lung-cancer-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-reflectance-confocal-microscopy-for-noninvasive-diagnosis-and-accurate-surgical-margin-ass 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-l1-expression-on-circulating-tumor-cells-and-ctc-clusters-as-a-minimal-cellular-disease-in-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-insights-neoadjuvant-keynote-522-regimen-in-triple-negative-breast-cancer-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/triplet-versus-doublet-therapy-in-older-patients-with-metastatic-hormone-sensitive-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-use-of-circulating-tumor-dna-ctdna-to-evaluate-need-for-additional-targeted-therapies-in-her2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plp-driven-exosomal-breakthroughs-advancing-immune-solutions-for-complex-tumor-microenvironments 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-imaml2i-fusions-as-oncogenic-drivers-in-human-malignancy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-outcomes-of-metastatic-germ-cell-tumors-with-highly-elevated-human-chor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combination-ipilimumabnivolumab-for-refractory-merkel-cell-carcinoma-a-single-institution-experien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-the-anti-tumor-activity-and-mechanism-of-action-of-tara-002-and-bcg-in-bladd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-assessment-in-patients-with-early-stage-classical-hodgkin-lymphoma-treated-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-based-differences-in-complications-in-patients-with-diffuse-large-b-cell-lymphoma-receiving-axic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-workers-and-womens-perspectives-on-barriers-to-cervical-cancer-screening-and-treatment-upta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prophylactic-dexamethasone-dex-with-outpatient-step-up-dosing-sud-of-bispecific-antibodies-bsab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-impact-of-financial-toxicity-among-cancer-patients-on-immunotherapy-and-targeted-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-i-trial-of-adjuvant-personalized-cancer-vaccine-tg4050-in-resected-locally-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transforming-oncology-clinical-trial-matching-through-multi-agent-ai-and-an-oncology-specific-knowle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-results-of-an-open-label-single-arm-phase-ii-trial-investigating-the-efficacy-and-safety-of-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-safety-and-efficacy-of-pdl1v-pf-08046054-a-vedotin-based-adc-targeting-pd-l1-in-combinat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-nivolumab-in-resected-esophageal-or-gastroesophageal-junction-cancer-ecgejc-following-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-disitamab-vedotin-rc48-in-combination-with-tislelizumab-and-bevacizumab-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-complete-response-to-neoadjuvant-chemotherapy-in-early-stage-male-breast-cancer-across-mo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-a-fellow-led-tumor-board-to-enhance-learning-and-support-in-fellow-continuity-clin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-donafenib-combined-with-anti-pd-1-antibody-plus-transarterial-chemoemboli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-dynamics-during-anti-pd-1-based-therapy-to-predict-clinical-outcomes-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-omic-analysis-and-overall-survival-update-of-phase-ii-trident-study-durvalumab-plus-olaparib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalized-survival-prediction-in-primary-urinary-tract-melanoma-pmut-using-a-nomogram 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shr-a1811-in-patients-pts-with-her2-expressing-advanced-gynecological-cancers-gynecol-c-a-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/isatuximab-bortezomib-lenalidomide-and-dexamethasone-isa-vrd-in-newly-diagnosed-multiple-myelom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inb-200-phase-1-study-of-gene-modified-autologous-gamma-delta-ghd-t-cells-in-newly-diagnosed-gliob 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nimotuzumab-combined-with-chemotherapy-in-the-first-line-treatment-for-patients-with-stage-ivb-recu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantum-wild-a-phase-3-randomized-double-blind-placebo-controlled-trial-of-quizartinib-in-combin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-results-of-the-randomized-phase-3-keynote-412-trial-of-pembrolizumab-pembro-or-placebo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-the-ezh12-inhibitor-valemetostat-tosylate-ds-3201b-in-pediatric-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sacituzumab-tirumotecan-sac-tmt-as-first-line-treatment-for-unresectable-locally-advancedmetastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subcutaneous-daratumumab-dara-bortezomiblenalidomidedexamethasone-vrd-with-dara-lenalidomi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/huntingtons-disease-as-a-protective-factor-for-non-melanoma-skin-cancer-a-retrospective-cohort-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ibi354-anti-her2-antibody-drug-conjugate-adc-in-patients-pts-with-her2-positive-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retracted-phase-1-clinical-trial-of-epcam-car-t-cell-therapy-in-patients-with-gastrointestinal-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/brazilian-society-of-surgical-oncology-realities-and-challenges-of-surgical-oncologists-in-palliati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-trade-study-a-phase-2-trial-to-assess-the-tolerability-of-abemaciclib-dose-escalation-in-early 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-trastuzumab-deruxtecan-t-dxd-in-her2-positive-and-low-metastatic-breas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-association-of-pik3ca-in-hpv-driven-head-and-neck-squamous-cell-carcinoma-hnscc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-responses-to-sync-t-therapy-in-situ-personalized-cancer-vaccination-with-intratumoral-immu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-prospective-study-on-compassionate-and-off-label-novel-anticancer-therapies-in-children 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-line-outcomes-in-metastatic-renal-cell-carcinoma-the-role-of-international-metastatic-renal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-radiomic-features-with-disease-free-survival-following-neoadjuvant-chemoimmunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-marital-status-on-survival-in-patients-with-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perceptions-attitudes-and-concerns-about-artificial-intelligence-applications-in-patients-with-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-toxicity-of-intravesical-sequential-gemcitabine-and-docetaxel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-bevacizumab-in-combination-with-radiotherapy-and-temozolomide-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-envafolimab-in-combination-with-recombinant-human-endostatin-and-chemotherapy-for-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-study-of-ib-t101-an-outlast-car-t-product-for-the-treatment-of-cd70-posit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/melanoma-mortality-in-brazil-insights-from-over-25-years-of-data-and-the-impact-of-limited-immunoth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-influencing-clinical-trial-enrollment-in-glioblastoma-patients-a-retrospective-study-at-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-analysis-and-racial-and-gender-disparities-in-adult-t-cell-leukemialymphoma-a-population 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adherence-to-cervical-cancer-screening-among-sexual-and-racialethnic-minorities-during-the-covid-19 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-open-label-safety-tolerability-and-efficacy-study-of-hc-7366-in-combination-with-belz-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-31-gene-expression-profile-as-a-guide-to-better-risk-aligned-care-decisions-for-patients-with-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accelerator-based-boron-neutron-capture-therapy-a-randomized-controlled-trial-for-refractory-recurr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-burden-and-trend-of-tracheal-bronchus-and-lung-cancer-attributable-to-residential-radon-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ipelife-phase-iii-double-blind-trial-of-icannabis-sativai-extract-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-tracheal-bronchus-and-lung-cancer-in-high-income-north-america-trends-from-1990-to-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-study-of-neoadjuvant-regn7075-cemiplimab-chemotherapy-chemo-vs-cemiplimab-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unraveling-clonal-hematopoiesis-of-indeterminate-potential-chip-in-cancer-prevalence-clonal-dyna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-dose-escalation-study-of-a-first-in-class-hif1-and-hif2-dual-inhibitor-r01-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-evaluation-of-sup64sup-cu-labeled-cetuximab-in-immuno-pet-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-extracellular-vesicle-based-assay-for-early-detection-of-pancreatic-ductal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-of-the-automated-heart-health-assessment-ah-ha-tool-on-cardiovascular-health-improve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-a-multisite-randomized-trial-of-bright-ideas-young-adults-efficacy-of-problem-solving-sk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proteomic-evaluation-of-her-2-expression-and-activation-in-tumors-that-are-rna-overexpressed-but-no 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-incorporating-symptom-burden-with-mortality-as-a-composite-outcome-on-accuracy-and-bias-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-folfirinox-versus-gemcitabine-based-regimens-for-treatment-of-metastatic-panc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/food-insecurity-dietary-quality-and-cardiovascular-risk-in-early-childhood-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/slamf8-as-a-potential-therapeutic-target-for-modulating-tumor-associated-macrophages-in-colorectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-features-of-complement-activation-signatures-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adaptive-designed-eniluracil-capecitabine-phase-2-trial-in-advanced-or-metastatic-breast-cancer-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/durvalumab-and-tremelimumab-combination-therapy-versus-durvalumab-monotherapy-in-metastatic-lung-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-safety-and-effectiveness-of-cemiplimab-in-combination-with-platinum-doublet-chemother 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-for-immune-checkpoint-inhibitor-related-adverse-events-in-the-geriatric-lung-cancer-pop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-health-co-morbidities-on-outcomes-in-patients-with-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-outcomes-in-merkel-cell-carcinoma-a-nationwide-analysis-of-sociodemographic-characterist 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profile-and-disparity-of-care-in-metastatic-non-small-cell-lung-cancer-in-a-low-middle-inc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-relationship-between-tumor-mutational-burden-tmb-and-microsatellite-instability-msi-in-bilia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-enrollment-in-a-clinical-trial-on-treatment-outcomes-of-patients-with-pancreas-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-disparities-in-survival-outcomes-among-adolescent-and-young-adult-patients-with-pan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-and-prognostic-applications-of-blood-cadherin-17-ca17-and-ca199-on-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nanoparticle-polymeric-micellar-paclitaxel-combined-with-gemcitabine-in-first-line-treatment-of-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-analysis-comparison-of-radical-antegrade-modular-pancreatectomy-ramps-and-stand 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-differential-expression-of-genes-with-survival-and-relapse-in-patients-treated-on-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-case-based-learning-program-in-medical-oncology-a-trainee-led-feasibility-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-and-predictive-impact-of-next-generation-sequencing-in-metastatic-pancreatic-ductal-adeno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-postoperative-circulating-tumor-dna-and-tumor-markers-in-resected-pancreatic-ade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tagraxofusp-and-low-intensity-chemotherapy-for-the-treatment-of-cd123-positive-relapsed-or-refractor-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-primary-tumor-resection-on-survival-outcomes-in-de-novo-metastatic-urothelial-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-propensity-matched-analysis-of-second-line-2l-folfiri-ram-versus-ram-pac-in-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pediatric-cancer-registry-in-turkey-2002-2024-tpog-and-tphd-the-data-from-the-last-23-years 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-twins-as-simulations-of-individual-cancer-pathophysiology-through-extensive-tumor-profiling 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-results-of-a-multi-center-phase-i-study-of-utidelone-capsule-a-novel-oral-micro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mri-concentric-partial-response-pattern-as-a-predictor-of-pathological-complete-response-in-early-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-combined-with-concurrent-chemoradiotherapy-for-locally-recurrent-esophageal-cancer-a-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decoding-immunotherapy-responders-in-hepatocellular-carcinoma-patients-with-stable-disease-multi-om 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-homologous-recombination-deficiency-in-korean-patients-with-epithelial-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-lipidomics-analysis-of-early-and-late-stage-ovarian-cancer-serum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-a-prospective-multicenter-study-evaluating-a-combined-circulating-tumor-dna-ct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-burden-of-liver-malignancies-due-to-nash-an-analysis-of-gbd-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-clinical-trial-communication-skills-training-for-oncology-fellows 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lighting-up-pnet-creating-murine-models-with-a-novel-bioluminescent-cell-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-homologous-recombination-deficiency-in-different-molecular-subgroups-of-endometrial-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-circulating-tumor-cells-identified-in-the-peripheral-blood-of-patients-with-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognosis-of-isolated-groin-recurrence-following-sentinel-lymph-node-biopsy-in-primary-node-negative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-itp53i-somatic-mutations-on-prognosis-in-endometrial-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-burden-of-chimeric-antigen-receptor-t-cell-therapy-a-national-inpatient-sample-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-and-sitravatinib-as-adjuvant-therapy-for-hepatocellular-carcinoma-patients-at-high-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dna-damage-measurements-as-a-potential-biomarker-for-immunotherapy-response-in-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-different-formulations-of-goserelin-on-testosterone-suppression-in-patients-with-prost 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ipdsim-an-interpretable-model-to-assess-individual-clinical-antagonism-in-combination-therapies-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/external-beam-radiation-therapy-for-salvage-after-focal-therapy-as-primary-treatment-in-prostate-ade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-extracapsular-extension-and-seminal-vesicle-invasion-in-prostate-cancer-using-preopera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-post-operative-opioid-fills-after-cancer-directed-surgery-among-medicare-beneficiaries-by-race 2026-08-24 monthly 0.7 https://rjrindex.com/articles/active-cancer-in-the-era-of-covid-19-a-multivariable-meta-analysis-vs-non-cancer-controls-with-vari 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-unmet-needs-in-radiation-induced-nausea-and-vomiting-after-moderately-emetogenic-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-adherence-and-tolerability-of-flt3-inhibitors-as-post-allogeneic-transplant-maintenance-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-allostatic-load-al-and-residential-segregation-with-breast-biopsy-outcomes-after-sc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-variables-associated-with-prolonged-survival-in-aml-with-tp53-aberration 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncology-primary-care-clinics-for-comprehensive-care-of-high-risk-adolescent-and-young-adult-aya-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomised-clinical-trial-to-improve-healthy-lifestyle-adherence-in-prostate-cancer-patients-under 2026-08-24 monthly 0.7 https://rjrindex.com/articles/how-do-health-concerns-present-in-cancer-survivors-who-require-interpreters-database-analysis-of-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insights-into-the-mortality-trends-due-to-gastric-cancer-across-204-regions-worldwide-1990-to-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-a-first-in-human-fih-phase-i-study-of-ptx-912-in-patients-with-locally-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-disparities-in-gastric-cancer-trends-a-retrospective-analysis-of-tumor-location-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-in-incidence-of-gastric-cancer-among-older-adults-70-from-1990-to-2021-across-204 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-cancer-care-outcomes-and-social-determinants-of-health-in-the-rio-grande-valley-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/publication-and-data-sharing-of-completed-nci-cooperative-group-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-zanubrutinib-treatment-patterns-in-chronic-lymphocytic-leukemiasmall-lymphocytic-lymphom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-a-breast-cancer-survivorship-needs-assessment-tool-an-asco-quality-training-progr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-homologous-recombination-repair-gene-mutations-on-survival-in-metastatic-castration-sensit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-and-safety-of-the-amivantamab-to-lazertinib-versus-lazertinib-alone-in-egfr-mutant-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/computational-pathology-informed-immune-biomarker-for-trastuzumab-benefit-in-her2-breast-cancer-va 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-significance-of-relative-dose-intensity-of-capox-therapy-in-epidemiological-evaluation-of-gastri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-free-dna-derived-from-active-chromatin-as-a-predictive-biomarker-for-clinical-benefit-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-gender-based-differences-in-the-molecular-profile-of-myeloid-neoplasms-insights-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-survival-after-de-escalated-neoadjuvant-therapy-in-her2-early-breast-cancer-a-pooled 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-fairness-assessment-of-machine-learning-models-for-predicting-30-day-readmission-aft 2026-08-24 monthly 0.7 https://rjrindex.com/articles/generative-artificial-intelligence-ai-for-predictive-analysis-can-ai-estimate-the-likelihood-of-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-phase-1-clinical-trial-of-ini-4001-a-novel-tlr78-agonist-in-patients-with-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-prognostic-model-to-optimize-the-timing-of-docetaxel-doc-following-an-androgen-receptor-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-patients-with-mnsgcts-with-and-without-teratoma-in-the-primary-tumor-an-intern 2026-08-24 monthly 0.7 https://rjrindex.com/articles/family-mental-illness-and-physical-abuse-for-predicting-cannabis-use-among-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ibii-study-to-evaluate-safety-and-preliminary-efficacy-of-the-wee1-inhibitor-debio-0123-in-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-analysis-explores-gjb2-mediated-interactions-in-cancer-associated-pericyte-subgroups-tha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combined-raf-and-mek-inhibition-in-solid-cancers-with-kinase-impaired-braf-mutations-soratram-phas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-trametinib-in-patients-with-advanced-solid-tumors-harboring-genomic-alterations-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bevacizumab-tas-102-and-irinotecan-in-oxaliplatin-and-fluoropyrimidine-pre-treated-metastatic-colo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-fruquintinib-in-combination-with-folfiri-as-second-line-treatment-for-ras-mut 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-sample-characteristics-on-rna-based-next-generation-sequencing-ngs-for-fusion-gene-detec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-the-q61h-mutational-subtype-on-the-response-to-standard-first-line-treatment-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-minimization-analysis-of-treatment-with-intravenous-or-subcutaneous-trastuzumab-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regorafenib-versus-local-standard-of-care-in-patients-with-grade-2-3-meningioma-no-longer-eligible-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/environmental-pfas-exposure-as-an-understudied-social-determinant-of-health-for-endometrial-cancer-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-muscle-invasive-bladder-cancer-burden-the-impact-of-bcg-shortage-and-its-interaction-with-epide 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-clinical-trial-of-adjuvant-ado-trastuzumab-emtansine-t-dm1-for-patients-with-her2-positi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-different-induction-therapy-for-locally-advanced-marginal-resectable-and-unresectable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-study-of-a-pooled-synthetic-long-peptide-mutant-kras-vaccine-in-patients-with-pancreatic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-and-refinement-of-society-of-immunotherapy-of-cancer-sitc-definitions-for-pd-l1-resis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-toripalimab-plus-chemotherapy-and-radiotherapy-for-treatment-naive-advanced-es 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-racialethnic-inequities-in-uptake-of-psma-pet-imaging-among-patients-with-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/skewed-offspring-distribution-of-itp53i-pathogenic-variants-in-israeli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-proportion-and-survival-of-stage-iv-breast-cancer-between-2010-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-mutational-profiles-and-their-correlation-with-organ-specific-metastases-in-mss-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-disparities-in-palliative-care-utilization-among-children-with-late-stage-bone-and-sof 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gastric-juice-pir-1245-a-promising-prognostic-biomarker-for-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socio-behavioral-needs-and-prostate-and-breast-cancer-mortality-rates-in-african-americans-hispanic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-oncology-clinician-and-staff-experiences-with-substance-use-disorders-among-cancer-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-care-of-patients-with-hrher2-early-breast-cancer-at-high-risk-of-recurrence-through-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/social-factors-and-severity-of-phenotypic-frailty-in-the-elevate-longitudinal-cohort-of-older-adults 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-4-1bbl-ox40l-fusion-protein-on-the-anti-tumor-activity-of-car-t-cells-in-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dysphagia-in-cancers-of-the-lip-oral-cavity-and-pharynx-patients-impact-on-cachexia-hospitalizat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thymidine-kinase-activity-tka-as-independent-predictor-of-outcome-in-metastatic-breast-cancer-mbc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glycosylation-patterns-of-tumor-derived-small-extracellular-vesicles-and-hypoxia-signatures-in-head 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-value-of-pet-ct-for-early-detection-of-mronj-in-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iiia-study-to-evaluate-the-tolerability-safety-pharmacokinetics-and-efficacy-of-ecirucicl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decoding-anterior-tongue-carcinoma-beyond-tnm-indian-multi-centric-real-world-data-on-molecular-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-safety-of-ondansetron-oral-soluble-film-for-the-prevention-of-chemother 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-body-weight-and-body-composition-on-survival-and-toxicities-in-patients-receiving-cdk46-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perilipin-5-as-mediator-of-high-fat-diet-induced-hepatocellular-carcinoma-immune-escape-by-stabiliza 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-differences-in-biomarker-testing-for-targetable-alterations-among-patients-with-hr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-race-and-ethnicity-in-high-impact-lung-cancer-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-bxq-350-a-novel-sphingolipid-metabolism-modulator-on-neuronal-environments-through-modul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-a-study-design-that-promotes-diversity-in-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-causal-modeling-to-uncover-cell-cell-communication-dynamics-in-the-tumor-microenvironment-dur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epigenetic-and-transcriptional-consequences-of-mtap-loss-in-lung-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-landscape-of-liver-metastases-in-advanced-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gbc-11004-an-ai-driven-novel-kinase-target-with-potential-to-overcome-osimertinib-resistance-in-nsc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-toxicity-in-the-curative-setting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-heart-cross-talk-cytokine-release-pattern-from-anthracycline-treated-cancer-cell-lines-and-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-from-a-phase-i-study-of-kl590586-in-patients-with-advanced-ret-mutant-medullary-thyroid-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-neoadjuvant-imaging-for-prediction-of-pathologic-complete-response-to-keynote-522-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transoral-robotic-surgery-tors-and-de-escalated-adjuvant-therapy-for-human-papillomavirus-related 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-in-waldenstrom-macroglobulinemia-wm-patients-who-discontinue-bruton-tyrosine-ki 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-mediating-role-of-inflammation-in-the-association-between-platinum-based-chemotherapy-and-cardio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transarterial-chemoembolization-combined-with-atezolizumab-plus-bevacizumab-versus-transarterial-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-trends-in-telehealth-utilization-by-medical-oncology-practices-at-stanford-medicine-and-ma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-telemedicine-on-access-to-care-in-surgical-oncology-clinics-distance-and-time-to-visit-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-diagnosis-management-and-outcomes-in-transgender-nonbinary-and-gender-diverse-indi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/omission-of-elective-neck-irradiation-in-pt3-t4-oral-squamous-cell-carcinoma-with-a-pn0-neck-impact 2026-08-24 monthly 0.7 https://rjrindex.com/articles/minimal-residual-disease-mrd-negativity-neg-in-patients-pts-with-relapsed-or-refractory-multip 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ribbon-um-treatment-individualisation-by-ebv-stratification-in-nasopharyngeal-carcinoma-npc-a-ph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-implication-of-mdm2-amplification-in-advanced-biliary-tract-cancer-btc-a-propensity-scor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rc48-adc-combined-with-radiotherapy-and-immunotherapy-as-salvage-therapy-for-advanced-solid-tumors-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-results-of-terbium-161-sup161sup-tbtb-psma-iampt-rad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-epitope-mrna-vaccine-for-effective-immunotherapy-in-esophageal-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/her2-adc-trastuzumab-rezetecan-shr-a1811-in-her2-positive-breast-cancer-with-brain-metastases-upd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/commission-on-cancer-lung-cancer-surgery-quality-metric-and-overall-survival-in-a-population-based-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-and-biomarker-results-of-nure-combo-a-phase-2-study-of-neoadjuvant-nivolumab-nivo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-circulating-tumor-dna-ctdna-variant-allelic-frequency-vaf-with-outcomes-on-matche 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unlocking-the-potential-of-zolbetuximab-in-cldn182-positive-gastric-cancer-a-comprehensive-systema 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-marking-techniques-for-target-lymph-nodes-in-2596-patients-with-node-positive-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-monotherapy-efficacy-of-novel-immune-checkpoint-blockade-gv20-0251-anti-igsf8-in-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-study-of-combined-treatment-with-dupilumab-anti-il-4ra-and-cemiplimab-anti-pd-1-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/folate-receptor-alpha-fra-folr1-expression-and-persistence-in-ovarian-cancer-in-clinical-trial-sa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/promising-early-results-of-mhb088c-b7-h3-adc-in-patients-pts-with-metastatic-castration-resistan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-study-of-ctim-76-a-claudin-6-cldn6-directed-bispecific-antibody-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-gynecologic-melanomas-a-population-based-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-epigenomic-profiling-to-reveal-molecular-correlates-of-response-and-resistance-to-177lu-psma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicenter-trial-of-microbubble-enhanced-transcranial-focused-ultrasound-mb-fus-with-monthly-adju 2026-08-24 monthly 0.7 https://rjrindex.com/articles/meta-analysis-of-car-t-and-bispecific-antibodies-in-follicular-lymphoma-a-comparative-efficacy-asse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-pd-1-inhibitor-combined-with-nab-paclitaxel-and-cisplatin-in-resectable-locally-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-first-in-human-clinical-trial-of-ag01-a-recombinant-monoclonal-antibody-to-progranulinglyc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-induction-chemo-immunotherapy-on-the-chance-for-re-irradiation-in-high-risk-recurrent-naso 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tub-030-a-novel-adc-targeting-5t4-a-phase-iiia-multi-center-first-in-human-clinical-trial-5-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-human-ai-teams-on-oncology-prescreening-final-analysis-of-a-randomized-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-in-vivoengineered-car-macrophages-on-physical-barriers-tumor-regression-and-immune-memory 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lrrc15-radioimmunotheranostics-targeting-tgfv-driven-resistance-in-immune-excluded-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shr-a1811-in-her2-expressing-salivary-gland-cancers-preliminary-efficacy-and-safety-results 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-polatuzumab-vedotin-plus-rituximab-cyclophosphamide-doxorubicin-and-prednis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-neoadjuvant-lenvatinib-plus-pembrolizumab-in-merkel-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/famitinib-for-familial-adenomatous-polyposis-associated-aggressive-desmoid-tumors-32-month-follow-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-nivolumab-and-ipilimumab-in-treating-metastatic-colorectal-cancer-mcrc-a-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/project-optimus-principles-challenges-and-a-paradigm-shift-in-dose-optimization-for-cancer-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-basket-trial-of-ado-trastuzumab-emtansine-for-patients-with-iher2i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-early-versus-late-palliative-care-referral-pcr-on-healthcare-utilization-in-pancreat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/supervised-home-based-exercise-in-patients-with-advanced-non-small-cell-lung-cancer-nsclc-on-maint 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-cardiac-evaluation-in-patients-with-advanced-lung-cancer-who-received-immune-checkpoint-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-and-management-experience-summary-of-immune-related-adverse-events-in-136-gynecologic-malig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enlonstobart-in-patients-with-pd-l1-positive-recurrentmetastatic-cervical-cancer-updated-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serum-muc5ac-as-a-dynamic-biomarker-for-tumor-response-prognosis-and-risk-stratification-in-resect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/linking-comfort-levels-and-knowledge-gaps-in-hematologyoncology-ho-fellowship-education-insights 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysing-the-impact-of-size-of-ngs-panel-in-defining-first-line-therapeutic-strategies-in-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-nimotuzumab-addition-to-neoadjuvant-chemotherapy-in-pancreatic-carcinoma-a-retrospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mapping-the-burden-of-uterine-cancer-in-the-eu-from-1990-2021-global-and-national-disparities-age 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-comparative-efficacies-of-camrelizumab-as-a-single-or-combination-therapy-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mutational-spectrum-of-cell-proliferation-genes-as-early-predictive-markers-for-aggressive-disease-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hyperthermic-intraperitoneal-chemotherapy-in-recurrent-ovarian-cancer-an-updated-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-clinical-trial-interpretability-and-efficiency-a-bayesian-re-analysis-of-individual-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/successful-implementation-of-virtual-oncology-and-hematology-services-in-a-rural-health-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-plasma-metabolomic-profile-to-predict-breast-cancer-survival-risk-stratification-based-on-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/solid-tumor-specific-patterns-of-immune-related-adverse-events-due-to-immune-checkpoint-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-role-of-ccnd1-in-neoadjuvant-therapy-efficacy-in-esophageal-squamous-cell-carcinoma-and-it 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-angiotensin-converting-enzyme-inhibitors-aceis-or-angiotensin-ii-receptor-blockers-arbs-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/endoscopic-submucosal-dissection-with-adjuvant-chemotherapy-for-early-gastric-cancer-unnecessary-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-combined-with-paclitaxel-and-nedaplatin-as-neoadjuvant-therapy-for-locally-advanced-eso 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unpacking-the-relationship-between-cancer-survival-and-political-environment-in-the-united-states-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-clinical-benefits-of-genomic-profiling-for-advanced-solid-tumors-in-portugal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-study-of-the-nalirifox-regimen-in-perioperative-treatment-of-borderline-resectable-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/current-patterns-of-care-referral-to-palliative-care-for-patients-with-metastatic-gynecologic-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-palliative-care-on-mortality-length-of-stay-and-hospital-charges-in-common-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-utilization-of-patient-derived-organoids-as-a-platform-for-predicting-the-efficacy-of-anti-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ampullary-adenocarcinoma-what-is-the-best-approach-insights-from-a-large-retrospective-series 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mechanisms-of-efficacy-of-endonuclease-inhibition-in-neuroblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-features-and-outcomes-in-hispaniclatino-hl-with-metastatic-renal-cell-carcinoma-mrcc-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-oral-contraceptive-use-and-pancreatic-cancer-risk-an-updated-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hypertension-and-vegf-a-level-correlation-in-cancer-patients-starting-vegf-inhibitors-a-prospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-immune-inflammation-index-as-a-survival-predictor-in-advanced-urothelial-carcinoma-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-for-stage-ii-and-iii-medullary-renal-cancer-patients-treated-with-perioperative-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glucagon-like-peptide-1-receptor-agonists-and-the-risk-of-chemotherapy-induced-peripheral-neuropathy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-and-survival-outcomes-in-secondary-acute-myeloid-leukemia-a-seer-based-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-disparities-in-patients-with-acute-lymphoblastic-leukemia-a-focus-on-young-adult-and-adole 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-stampede2-trial-a-site-survey-of-current-patterns-of-care-access-to-imaging-and-treatment-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multiple-myeloma-as-a-predictor-of-in-hospital-outcomes-in-esrd-patients-a-nationwide-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-macrophage-checkpoint-clever-1-inhibition-with-bexmarilimab-plus-azacitidine-in-myelodys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-advanced-practice-providers-in-a-clinical-research-program-to-provide-trial-prescreening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-access-to-novel-high-cost-therapies-across-canada-a-survey-of-pediatric-oncology-prov 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-of-precision-medicine-in-the-management-of-metastatic-prostate-cancer-a-retrospecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-10-day-astx727-decitabinecedazuridine-in-combination-with-venetoclax-for-relaps 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-molecular-features-of-concomitant-egfr-and-smarca4-mutations-in-an-east-asian-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-using-ngs-in-lung-cancer-patients-revolutionizing-targeted-therapy-and-personal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-local-estrogen-therapy-among-breast-cancer-patients-in-seer-mhos-database 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-baseline-characteristics-and-diagnostic-path-of-polish-patients-with-alk-positive-nsclc-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-her2-expression-in-prostate-cancer-among-mexican-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-hospitalization-outcomes-among-adult-patients-with-prostate-cancer-using-the-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disco-app-a-patient-intervention-to-reduce-the-financial-burden-of-cancer-in-a-diverse-patient-popu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-deep-learning-model-artificial-intelligence-and-radiologists-in-breast-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-large-language-model-to-predict-loss-to-follow-up-for-oncology-patients-discharged-to-skill 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recent-advances-in-feature-selection-methods-for-breast-cancer-recurrence-prediction-a-systematic-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cox-models-vs-machine-learning-for-survival-prediction-do-traditional-approaches-still-hold-their 2026-08-24 monthly 0.7 https://rjrindex.com/articles/practice-patterns-related-to-ovarian-function-suppression-in-the-swog-s2010-clinical-trial-of-young 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-quality-of-life-inclusion-in-phase-iii-clinical-trials-for-advanced-gastrointestinal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-navigation-bronchoscopy-vs-shape-sensing-robotic-assisted-bronchoscopy-in-terms-of-mal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-of-a-phase-ii-study-of-cabozantinib-in-patients-with-imeti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breaking-barriers-for-patients-with-stage-iv-non-small-cell-lung-cancer-with-brain-metastases-insig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-mri-biomarkers-on-survival-in-tnbc-patients-a-retrospective-multi-center-cohort-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-imeti-genomic-alterations-ga-identified-in-colorectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-and-safety-of-entrectinib-in-children-with-extracranial-solid-or-primary-central-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-risk-factor-control-and-risk-of-future-cardiovascular-events-in-survivors-of-childhoo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-intratumoural-bacteria-in-resistance-to-lag-3-targeting-therapeutics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicogenomic-features-of-non-small-cell-lung-cancer-patients-with-ibrafi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-patients-with-multiple-myeloma-treated-with-t-cell-engagers-compared-to-those 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-dose-escalation-study-to-assess-the-oncolytic-virus-vcn-01-safety-and-efficacy-in-refracto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-as-a-prognostic-biomarker-for-long-term-survival-in-de-novo-oligometastatic-no 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-demographic-and-socioeconomic-factors-in-eccrine-adenocarcinoma-a-national-cancer-databas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analyses-of-first-line-immune-checkpoint-inhibitors-in-unresectable-merkel-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimal-maintenance-therapy-strategy-for-metastatic-nasopharyngeal-carcinoma-insights-from-a-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-early-ebv-dna-clearance-to-select-optimal-induction-chemotherapy-cycles-for-locoregional-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-adverse-events-in-multiple-myeloma-patients-a-comparative-study-analysis-of-daratumu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-biomarker-directed-multi-center-phase-iiiii-study-of-ctdna-molecular-response-adaptive-immuno-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-infection-risk-factors-and-related-complications-in-newly-diagnosed-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-hla-matching-on-clinical-outcomes-in-a-phase-2-trial-of-bria-imt-plus-anti-pd1-in-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-neurological-disorders-and-negative-outcomes-in-head-and-neck-cancer-patients-du 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-clinical-outcomes-and-dna-co-alterations-of-erbb2-amplified-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pilot-randomized-controlled-trial-of-photobiomodulation-therapy-in-head-and-neck-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-aspirin-for-chemoprevention-in-lynch-syndrome-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilizing-the-eortc-item-library-to-develop-a-tailored-patient-reported-outcome-measure-prom-cscc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/strengthening-multidisciplinary-collaboration-to-enhance-early-stage-melanoma-outcomes-a-quality-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-tissue-analysis-and-correlation-of-microenvironmental-changes-with-combined-immunothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncolytic-virus-vg161-in-combination-with-camrelizumab-as-second-line-therapy-in-patients-with-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determaio-kit-decentralizing-classification-of-the-tumor-microenvironment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combining-low-dose-regorafenib-with-pembrolizumab-as-a-front-line-therapy-for-patients-with-msi-h-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-markers-associated-with-survival-in-pd-l1-high-non-small-cell-lung-cancer-treated-with-fi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-sociodemographic-factors-on-thyroid-cancer-trends-in-the-united-states-a-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/myopathic-syndromes-and-immune-checkpoint-inhibitors-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-skin-integrated-melanoma-organoids-to-study-the-tumor-microenvironment-mediated-mecha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/universal-solid-tumor-therapy-with-cd5-deleted-dsg2-directed-car-t-cells 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-evidence-based-nsclc-testing-and-treatment-across-academic-and-community-based-settings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-cutaneous-toxicity-from-doxorubicin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-clinical-outcomes-and-healthcare-resource-utilization-in-non-hodgkins-lymphoma-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-urothelial-cancer-screening-outcomes-among-patients-with-lynch-syndrome-at-rural-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-with-definitive-surgery-or-radiotherapy-after-neoadjuvant-immunochemotherapy-in-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disitamab-vedotin-combined-with-fruquintinib-in-patients-with-her2-expressing-or-her2-mutationampli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-efficacy-and-safety-of-anlotinib-in-postoperative-non-pcr-non-small-cell-lung-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/promoting-sun-safety-and-melanoma-prevention-in-the-community-through-a-multi-component-community-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/total-transvaginal-natural-orifice-endoscopic-surgery-v-notes-for-colon-cancer-a-prospective-coho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-institution-experience-using-bevacizumab-for-iidh12i-mutant-gl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-pivotal-trial-of-microbubble-enhanced-transcranial-focused-ultrasound-mb-fus-for-pl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/delayed-or-upfront-brain-radiotherapy-in-treatment-naive-lung-cancer-patients-with-asymptomatic-or-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-outcomes-for-patients-pts-with-rr-chronic-lymphocytic-leukemia-cllsmall-lymphocy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-of-somatic-whole-exome-sequencing-and-germline-genotyping-of-dpyd-to-screen-for-dpd-defi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequential-ehr-interventions-to-increase-genetic-testing-for-breast-and-ovarian-cancer-predispositio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-related-germline-landscape-of-endometrial-cancer-focus-on-early-onset-cases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-and-prognostic-factors-in-breast-cancer-patients-with-leptomeningeal-metastasis-insights-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-and-clinical-trends-in-common-hematological-malignancies-in-arkansas-arkansas-centr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-analysis-of-safety-and-efficacy-of-palbociclib-in-hr-positive-her-2-negative-mbc-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-differences-in-toxicities-among-patients-receiving-regorafenib-or-trifluridinetipiracil-for-ref 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-dose-escalation-study-of-lnp7457-prmt5-inhibitor-in-patients-with-advanced-or-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-of-lurbinectedin-in-extensive-stage-small-cell-lung-cancer-es-sclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adrb2-driven-immunosuppression-as-a-novel-prognostic-indicator-and-therapeutic-avenue-following-neoa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acolbifene-vs-tamoxifen-for-breast-cancer-prevention-in-premenopausal-women-at-high-risk-for-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-transcription-factor-sox30-in-triple-negative-breast-cancer-metastasis-and-tumor-immune-micr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-and-immunophenotypic-landscape-of-early-stage-pulmonary-carcinoid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ngs-technologies-and-metastatic-colorectal-cancer-experience-and-future-in-uzbekistan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-genetic-variants-and-immunotherapy-combined-modality-with-neoadjuvant-therapy-outcome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-chemotherapy-with-or-without-intravesical-bcg-in-nmibc-patients-a-bayesian-net 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-evaluating-olutasidenib-and-azacitidine-in-patients-with-iidh1i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/splicing-factor-3b-subunit-1a-sf3b1-mutations-in-lymphoid-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-performance-of-artificial-intelligence-in-predicting-recurrence-after-surgical-resection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-trends-in-gallbladder-cancer-incidence-mortality-and-survival-disparities-the-impact-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/open-label-single-arm-single-center-phase-1b2-clinical-study-of-fruquintinib-combined-with-trastu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-veterans-diagnosed-with-chronic-myeloid-leukemia-in-the-tyrosine-kinase-inhibitor-era 2026-08-24 monthly 0.7 https://rjrindex.com/articles/employer-sponsored-insurance-paid-sick-leave-and-financial-toxicity-among-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-circulating-tumor-dna-the-best-surveillance-tool-for-detecting-post-adjuvant-relapse-in-stage-i-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-ctdna-testing-in-breast-cancer-and-its-connection-to-stress-and-anxiety 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-fianlimab-anti-lag-3-plus-cemiplimab-anti-pd-1-versus-cemiplimab-plus-placebo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gender-disparities-in-major-adverse-cardiovascular-and-cerebrovascular-events-among-gastric-cancer-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-and-mortality-risk-among-esophageal-cancer-patients-with-varied-hiv-status-seeking-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-of-pap-derived-ctdna-for-detection-of-sporadic-and-lynch-associated-endometrial-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultrasensitive-detection-and-tracking-of-circulating-tumor-dna-ctdna-and-association-with-relapse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-using-talimogene-laherparepvec-nivolumab-and-trabectedin-for-advanced-leiomyosarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proteogenomic-characterization-of-antibody-drug-conjugate-target-expression-profiles-in-transcriptio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-adverse-event-profiles-for-car-t-cell-therapies-and-bispecific-antibodies-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-hidden-risk-the-prevalence-of-humoral-immunodeficiency-in-patients-with-lymphoproliferati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-antibody-drug-conjugate-adc-sequential-use-in-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intravesical-disitamab-vedotin-rc48-for-patients-with-her2-expressing-high-risk-non-muscle-invasiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-interim-analysis-of-cabonen-an-international-multicenter-phase-ii-trial-investigating-caboz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12a-multicenter-first-in-human-open-label-clinical-trial-evaluating-mdx2001-a-tetraspec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-income-and-rurality-in-us-cancer-mortality-a-seer-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-open-label-phase-2b-study-of-the-bet-bromodomain-inhibitor-beti-zen-3694-plus-enzal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-study-of-asciminib-in-combination-with-dasatinib-prednisone-and-blinatumomab-for-ph-posi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-efficacy-and-safety-study-of-hb0025-a-pd-l1vegf-bispecific-antibody-in-combination-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-controlled-open-label-trial-to-determine-the-optimal-duration-of-steroid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-and-statistical-prediction-of-overall-survival-os-from-pre-dose-plasma-biomarkers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/osteoradionecrosis-as-a-complication-following-intensity-modulated-radiation-therapy-or-proton-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perception-and-concerns-of-the-hematology-and-oncology-hemonc-workforce-about-artificial-intellige 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ongoing-phase-12-trial-of-the-hematopoietic-progenitor-kinase-1-hpk1-inhibitor-ndi-101150-as-mono 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-ii-trial-evaluating-the-combination-of-tg4001-an-hpv16-therapeutic-vaccine-and-av 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-molecular-landscape-of-immunotherapy-treatment-and-advanced-disease-in-head-and-neck-squamous-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-analyses-of-immune-reconstitution-biomarkers-from-a-ph1b-study-of-an-investigational-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-biosimilar-entry-in-the-market-for-biologic-cancer-drugs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combined-anti-angiogenic-chemoradiotherapy-with-pd-1-monoclonal-antibody-for-chinese-patients-with-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-selumetinib-in-adults-with-neurofibromatosis-type-1-nf1-and-symptomatic-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-socioeconomic-disparities-in-cancer-outcomes-insights-from-a-federally-qualified-health 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-ivosidenib-and-vorasidenib-on-2-hydroxyglutarate-levels-in-low-grade-glioma-an-in-vivo-mr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-adjuvant-treatment-for-intrahepatic-cholangiocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-observationaltranslational-study-to-conduct-real-world-evidence-and-develop-biomarkers-of-fruqui 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-features-and-survival-outcomes-in-women-with-endometrial-neuroendocrine-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-center-open-label-single-arm-phase-i-study-with-dose-expansion-cohort-of-sacituzumab-gov 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tagitanlimab-versus-placebo-in-combination-with-gemcitabine-and-cisplatin-as-first-line-treatment-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-pathologic-response-after-neoadjuvant-therapy-and-survival-first-results-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-novel-mdm2-inhibitor-alrizomadlin-apg-115-with-or-without-toripalimab-in-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-3-study-of-ivonescimab-plus-chemotherapy-versus-pembrolizumab-plus-chemotherapy-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/update-on-gbm-agile-a-global-phase-23-adaptive-platform-trial-to-evaluate-multiple-regimens-in-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/atezolizumab-plus-bevacizumab-in-combination-with-platinum-based-chemotherapy-for-ovarian-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-performance-of-signatera-genome-assay-in-a-cohort-of-patients-pts-with-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-from-the-phase-12-monumental-1-study-of-talquetamab-a-gprc5dcd3-bispecific-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-study-of-ivosidenib-vs-placebo-in-locally-advanced-or-metastatic-idh1-mutant-conventional-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glofitamab-plus-gemcitabine-and-oxaliplatin-glofit-gemox-in-patients-pts-with-relapsedrefractor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-perioperative-chemotherapy-versus-neoadjuvant-chemoradiation-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-multi-center-study-of-carfilzomib-lenalidomide-and-dexamethasone-krd-with-or-without 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-enlight-an-ai-predictor-of-immune-checkpoint-blockade-icb-response-and-resistance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-analysis-of-adjuvant-atezolizumab-in-non-small-cell-lung-cancer-patients-in-chin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determining-the-recommended-phase-2-dose-rp2d-of-dose-intense-irinotecan-combined-with-iva-chemoth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/able-22-safety-and-efficacy-evaluation-of-nadofaragene-firadenovec-alone-or-in-combination-with-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/e7386-study-102-global-dose-expansion-cohort-of-e7386-lenvatinib-len-in-patients-pts-with-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/il-15rafc-superagonist-shr-1501-with-or-without-bacille-calmette-guerin-bcg-for-high-risk-non-musc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fire-4-aio-krk-0114-randomized-study-evaluating-the-efficacy-of-cetuximab-re-challenge-in-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-wildfire-dominated-pm-sub25sub-exposure-and-non-sm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cd123-expression-and-its-correlation-with-mutation-profile-in-acute-myeloid-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/activate-a-pilot-randomized-activity-coaching-trial-to-increase-vitality-and-energy-during-post-ope 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-socioeconomic-disparities-in-early-onset-squamous-cell-carcinoma-of-the-cervix-a-na 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-onset-cancer-in-chile-27-year-mortality-rate-trends-from-a-nationwide-database-with-focus-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-data-claims-based-review-of-car-t-procedures-time-to-adverse-events-patient-character 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-pilot-study-of-neoadjuvant-chemotherapy-combined-with-immunotherapy-in-the-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-versus-radiologist-interpretation-in-predicting-treatment-response-in-lung-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/community-oncologists-and-patients-perspectives-on-the-post-car-t-care-transition-a-convergent-mi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-social-determinants-of-health-on-mortality-in-diffuse-large-b-cell-lymphoma-dlbcl-using 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-and-outcomes-of-disseminated-intravascular-coagulation-in-pancreatic-cancer-patients-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-neoadjuvant-and-surgical-treatment-for-locally-advanced-cervical-cancer-a-network-meta-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-ethnic-sex-and-subspecialty-demographic-composition-of-initial-fellow-of-the-fellow-of-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-torc12-inhibitor-onatasertib-combined-with-toripalimab-in-patients-with-advanced-cervical-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/harnessing-social-media-for-cancer-prevention-and-early-detection-challenges-opportunities-and-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-for-ovarian-cancer-patients-in-the-post-poly-adp-ribose-polymerase-inhibitor-parp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-lymph-node-dissection-on-the-prognosis-of-patients-with-intrahepatic-cholangiocarcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-related-pathologic-response-irpr-features-and-immunotherapeuticresponse-score-itrs-to-pre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-location-of-death-among-adolescents-and-young-adults-with-solid-and-liquid-tumors-in-the-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-regorafenib-combined-with-immune-checkpoint-inhibitors-in-advanced-hepatocell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-determinants-in-nodular-sclerosis-hodgkins-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-in-vitro-fertilization-on-malignant-transformation-of-endometriotic-cysts-a-retrospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adaptive-organoid-based-precision-therapy-study-in-pancreatic-cancer-adopt-a-phase-ii-single-arm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transarterial-chemoembolization-plus-donafenib-with-or-without-anti-pd-1-antibodies-for-unresectable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-death-thrombotic-and-hemorrhagic-events-in-anticoagulated-patients-with-atrial-fibrillatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-tace-combined-with-lenvatinib-and-pd-1-inhibitor-in-intermediate-stage-hcc-ex 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-alcohol-use-and-liver-cell-carcinoma-related-mortality-in-the-us-a-24-yea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathognomonic-genetic-signatures-of-gallbladder-cancer-results-of-ongoing-prospective-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-single-cell-sequencing-to-identify-endothelial-expression-of-immune-checkpoint-ligands-in-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-post-ovarian-cancer-in-germline-non-brca-homologous-recombination-hr-gene-pathogenic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accuracy-of-mri-in-the-detection-of-pathological-complete-response-post-neoadjuvant-therapy-in-local 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-racial-and-ethnic-disparities-in-early-onset-versus-average-onset-gastrointestinal-cancers-a-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-and-safety-of-disitamab-vedotin-rc48-in-pretreated-her2-positive-advanced-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sintilimab-anti-pd-1-antibody-combined-with-chidamide-an-oral-subtype-selective-hdaci-followed-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/escalating-burden-and-trend-of-cancer-attributable-to-smoking-in-southeast-asia-east-asia-and-ocean 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-comprehensive-analysis-of-primary-malignant-brain-tumors-radiotherapy-in-a-low-resourced-country 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decoding-spatial-transcriptomics-based-heterogeneity-of-tme-in-early-stage-invasive-pulmonary-adenoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-with-technically-resectable-stage-iii-non-small-cell-lung-cancer-treated-with-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-on-atezolizumab-versus-placebo-in-adjuvant-therapy-of-pleural-mesothelioma-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-and-appalachian-comparison-of-axicabtagene-ciloleucel-and-lisocabtagene-maraleucel-in-rel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-year-survival-outcomes-from-cres-sup3sup-t-s-1-plus-cisplatin-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-autonomic-dysfunction-on-function-toxicity-and-survival-in-patients-with-lymphoma-treate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/better-together-synergy-of-germline-and-somatic-testing-in-hrr-pathway-driven-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/memantine-in-radiation-induced-cognitive-dysfunction-in-brain-metastases-a-double-blinded-randomiz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-polycythemia-vera-related-mortality-in-the-united-states-from-1999-to-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-of-liver-malignancies-in-jordan-a-mena-region-insight 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-cancer-burden-in-pakistan-a-30-year-analysis-from-the-global-burden-of-disease-study-199 2026-08-24 monthly 0.7 https://rjrindex.com/articles/engaging-community-to-co-design-multilevel-intervention-to-reduce-lung-cancer-disparities-in-persist 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-evaluation-of-mismatch-repair-mmr-genes-in-breast-cancer-patients-missing-lynch-syndrome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/application-of-a-novel-multiplex-imaging-based-immunotherapy-panel-and-ai-powered-analysis-solution 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiomic-analysis-on-pretreatment-mri-to-predict-response-to-atezolizumab-plus-bevacizumab-in-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-end-of-life-care-among-patients-with-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-to-palliative-care-access-in-patients-with-brain-metastases-a-comprehensive-national-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/itx-0121-a-therapeutic-strategy-for-transcription-coupled-repair-deficient-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-cell-free-dna-cfdna-as-a-biomarker-in-pancreatico-biliary-malignancies-a-longitudin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pbmc-and-machine-learning-based-biomarker-signature-to-predict-second-line-chemotherapy-success-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/importance-of-recist-11-training-program-for-improving-performance-of-contract-research-organizatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemo-praidict-ebc-a-deep-learning-solution-for-predicting-pathological-complete-response-on-biopsi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-in-incidence-of-pancreatic-cancer-among-adults-aged-70-and-older-across-204-nations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/parenting-challenges-of-international-medical-graduate-hematologists-oncologists-in-the-united-state 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncologists-attitudes-and-beliefs-toward-crying-with-patients-and-its-correlation-with-burnout 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-patterns-in-renal-cancer-mortality-a-20-year-analysis-of-us-mexico-border-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-the-results-of-intravesical-perfusion-therapy-combined-with-immediate-or-non-immediate-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodal-evaluation-of-metabolic-dysfunction-associated-steatotic-liver-disease-masld-related-bi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-reflections-on-the-horse-trial-hyperthermic-intraperitoneal-chemotherapy-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-randomised-study-to-evaluate-the-antitumour-activity-of-roginolisib-a-novel-non-atp-comp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/opioid-use-disorder-among-females-with-breast-cancer-a-comprehensive-analysis-of-prevalence-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-and-validation-of-hypoxia-and-energy-metabolism-related-gene-signatures-in-lung-adeno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-bcma-in-relapsed-and-refractory-multiple-myeloma-a-systematic-review-and-meta-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/omission-of-concurrent-chemotherapy-in-and-out-of-a-phase-iii-randomized-controlled-trial-for-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognosis-and-survival-evaluation-in-treating-high-risk-braf-v600-mutation-stage-iii-or-iv-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-open-label-dose-expansion-cohort-of-the-tolerability-of-tolododekin-alfa-ank-101-in-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-rc48-adc-in-triple-negative-breast-cancer-subtypes-fuscc-tnbc-umbrella-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-a-targeted-enzymatic-methylation-based-early-detection-test-by-different-colorectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-autoimmune-reactivity-in-neurotoxicities-n-tox-in-melanoma-patients-treated-with-immune-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dual-immune-checkpoint-inhibition-in-advanced-incurable-radioidine-refractory-differentiated-thyroid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oral-fixed-dose-cyclophosphamide-and-capecitabine-combination-a-novel-therapeutic-approach-in-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-for-disease-detection-and-monitoring-in-head-and-neck-cancer-a-real-world-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-of-toxicity-profile-with-cellular-immunotherapy-from-india-cellular-insights-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-expressional-deregulations-of-micro-rnas-and-their-potential-role-as-molecular-biomark 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-results-of-tqb2930-a-her2-targeted-bispecific-antibody-combined-with-chemothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/limited-changes-in-the-cns-immune-microenvironment-in-patients-with-breast-cancer-metastasis-and-cap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-life-use-of-g-csf-in-non-small-cell-lung-cancer-nsclc-secondary-data-analysis-from-the-frenc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-decision-support-tool-dst-in-breast-cancer-automated-national-comprehensive-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-dynamic-analysis-of-serial-ctdna-testing-to-enhance-diagnostic-and-prognostic-assessment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-zilovertamab-vedotin-in-pediatric-and-young-adult-hematologic-malignancies-or-sol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/self-assembled-patient-derived-tumor-like-cell-clusters-for-personalized-drug-testing-in-diverse-sar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/new-pediatric-formulation-of-asciminib-in-children-with-chronic-myeloid-leukemia-in-chronic-phase-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-malnutrition-on-cardiovascular-outcomes-in-malignant-melanoma-patients-treated-with-pembr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/selective-aso-based-jak2-inhibitor-for-the-treatment-of-hematological-malignancies-with-jak2-v617f-m-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vitamin-d-serum-level-as-a-predictor-of-response-to-immunotherapy-for-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-derived-extracellular-vesicles-a-potential-novel-liquid-biomarker-for-pancreatic-ductal-adeno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-with-programmed-cell-death-1programmed-cell-death-ligand-1-inhibitors-for-kaposi-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/avidity-engineered-multifunctional-antibodies-for-stimulation-and-orchestration-of-innate-and-adapti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dihydropyrimidine-dehydrogenase-dpd-deficiency-related-variants-among-mexican-patients-with-gastro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-hospital-outcomes-of-radiation-pneumonitis-and-drug-induced-pneumonitis-in-patients-with-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-a-remote-patient-monitoring-system-by-electronic-patient-reported-outcomes-epros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-tumor-immune-microenvironment-in-gastric-cancer-patients-with-peritoneal-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-testing-and-targeted-therapy-use-in-lung-cancer-across-state-medicaid-programs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effective-cancer-care-the-role-of-oncology-biosimilars-in-generating-cost-savings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-flot-vs-eox-regimen-and-non-metastatic-gastric-carcinoma-survival-outcomes-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/esophageal-squamous-cell-carcinoma-mortality-to-incidence-ratio-mir-and-survival-trends 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-disability-adjusted-life-years-dalys-and-mortality-rates-in-gastric-cancer-among-elderly 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-outcomes-of-immune-checkpoint-inhibitor-ici-rechallenge-after-ici-pneumonitis-a-sin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/why-the-duration-of-cancer-treatment-requires-a-closer-look-an-empirical-analysis-of-recent-fda-app 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-study-on-first-line-immunochemotherapy-in-advanced-gastricgastroesophageal-junction-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-patients-with-or-without-dna-repair-pathway-alterations-by-treatment-type-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/addressing-domestic-abuse-in-cancer-care-developing-and-piloting-a-specialized-intervention-for-hea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-comparative-study-of-hypertension-htn-and-time-to-treatment-failure-ttf-with-acalab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-capecitabine-plus-oxaliplatin-capox-vs-paclitaxel-plus-carboplatin-pc-as-chemother 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-between-a-multidisciplinary-tumor-board-and-chatgpt-40-in-the-management-of-genitourina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metanova-a-phase-ii-trial-of-metastasis-directed-radiotherapy-for-de-novo-oligometastatic-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-among-patients-with-advanced-nsclc-treated-with-amivantam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-early-and-late-recurrence-across-breast-cancer-subtypes-in-the-cctgma32-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transforming-care-direct-pathologist-patient-interactions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/virtual-oncology-collaborative-tumor-board-using-multiple-artificial-intelligence-agents 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-non-dre-voided-urine-genomic-assay-to-diagnose-prostate-cancer-and-to-assess-its-aggressiveness 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-model-to-forecast-patient-availability-for-oncology-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-efficacy-of-sup68sup-ga-psma-petct-scan-as-a-single-staging 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disaggregating-asian-american-and-pacific-islander-subgroups-to-evaluate-disparities-in-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-antiresorptive-bone-agents-in-hormone-sensitive-metastatic-prostate-cancer-mhspc-a-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rates-of-early-mortality-in-acute-promyelocytic-leukemia-patients-a-seer-based-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-flt3-inhibitors-on-the-outcomes-of-flt3-itd-positive-acute-myeloid-leukemia-following-allo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-nivolumab-and-docetaxel-combination-therapy-versus-nivolumab-monotherapy-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-immunotherapy-use-in-dmmrmsi-h-metastatic-crc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-treatment-adherence-and-unmet-needs-of-older-breast-cancer-survival-in-nigeria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shifts-in-medicare-spending-for-patients-with-cancer-undergoing-chemotherapy-following-implementatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-recurrence-patterns-in-hispanic-vs-non-hispanic-patients-with-leiomyos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-optimal-choice-and-combination-strategy-of-vascular-targeting-therapy-for-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-double-blind-three-arm-parallel-group-phase-1-study-to-assess-the-pharmacokinetics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-methylation-based-tissue-free-test-for-the-detection-of-molecular-residual-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pricing-availability-and-affordability-of-cancer-medicines-in-5-middle-income-countries-in-south-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/economic-modelling-to-inform-pricing-for-lmics-of-immune-checkpoint-inhibitors-in-advanced-pd-l1-hig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-trends-and-clinicopathological-characteristics-for-patients-with-gastric-cancer-in-a-refere 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mytx-011-a-cmet-targeting-antibody-drug-conjugate-adc-in-patients-with-previously-treated-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-an-electronic-patient-reported-outcomes-epro-based-symptom-management-program-esym 2026-08-24 monthly 0.7 https://rjrindex.com/articles/v-rules-real-world-effectiveness-and-safety-of-cpx-351-in-patients-with-secondary-acute-myeloid-leu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-black-versus-non-hispanic-white-women-with-stage-iv-breast-cancer-treated-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decoding-oncology-terminology-using-large-language-models-for-patient-education 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-trial-of-personalized-ai-identified-tcr-transduced-t-cell-therapy-in-advanced-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unraveling-relatlimab-rela-specific-biology-biomarker-analyses-in-patients-pts-with-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rational-use-of-adjuvant-anti-pd-1-multi-omics-model-of-recurrence-in-stage-iii-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-living-systematic-literature-review-l-slr-for-non-small-cell-lung-nsclc-prostate-pc-and-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-cv-event-risk-in-patients-pts-with-metastatic-castration-resistant-prostate-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/care-ai-cancer-assessment-risk-estimation-using-artificial-intelligence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-analysis-from-neoavax-a-neoadjuvant-trial-of-avelumabaxitinib-in-patients-pts-with-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-results-from-a-first-in-human-phase-1-study-of-ly4170156-an-adc-targeting-folate-receptor-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-from-a-phase-12-study-of-7mw3711-a-novel-b7-h3-antibody-drug-conjugate-adc-incorporating 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastatic-site-pattern-as-predictor-of-outcome-of-first-line-alternating-oxaliplatin-based-chemothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-clinical-disparities-in-rectal-cancer-survival-a-retrospective-cohort-analysis-usin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-for-adults-with-kmt2a-r-acute-myeloid-leukemia-treated-with-venetoclax-plus-azacitidine-ve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/design-of-the-phase-3-dreamm-10-study-belantamab-mafodotin-plus-lenalidomide-and-dexamethasone-brd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multiregional-randomized-controlled-open-label-phase-3-study-of-the-anti-claudin182-cldn182 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-cancer-leptomeningeal-metastasis-with-allogeneic-chimeric-antigen-receptor-ghd-t-cell-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bispecific-antibody-therapy-in-central-nervous-system-cns-multiple-myeloma-mm-multicenter-retro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-and-addressing-barriers-to-germline-testing-in-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-circulating-tumor-rna-ctrna-in-a-combined-circulating-tumor-dna-ctdna-and-ct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/her2-expression-dynamics-and-prognostic-significance-in-the-treatment-of-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tocilizumab-prophylaxis-for-outpatient-administration-of-teclistamab-in-relapsedrefractory-multiple 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dose-optimization-of-pf-07248144-a-first-in-class-kat6-inhibitor-in-patients-pts-with-erher2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/9mw2821-a-novel-nectin-4-antibody-drug-conjugate-adc-combined-with-toripalimab-in-treatment-naiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-the-diet-study-a-randomized-controlled-phase-2-trial-of-a-high-fiber-diet-inte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-study-of-the-ezh2-inhibitor-tr115-in-patients-with-relapsedrefractory-non-hodgkins-lymph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-transhepatic-arterial-infusion-chemotherapy-haic-with-folfox-regime-plus-cadonilimab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-durvalumab-d-chemotherapy-ct-novel-anticancer-agents-and-adjuvant-d-novel-agen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-characteristics-of-stages-ii-iii-nsclc-patients-pts-who-initiate-neoadjuvant-chemo-immu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-outcome-of-pulmonary-hypertension-in-myelofibrosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-adherence-to-cancer-care-for-socioeconomically-disadvantaged-patients-with-central-nervous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/membrane-specific-her2-expression-by-artificial-intelligence-based-quantitative-scoring-for-predicti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-clinical-study-to-evaluate-the-safety-tolerability-and-pharmacokinetic-characteristics-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bat8008-a-trop-2-antibody-drug-conjugate-adc-in-patients-with-advanced-solid-tumor-results-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glucagon-like-peptide-1-receptor-agonists-and-incidence-of-obesity-related-cancer-in-adults-with-dia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pediatric-cancer-in-the-united-states-a-comparison-of-three-data-sources 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-patterns-of-oncotype-dx-o-dx-testing-and-chemotherapy-ct-use-among-patients-with-earl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-hmpl-306-an-inhibitor-of-mutant-idh1idh2-midh12-in-western-patients-pts-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-study-of-dysgeusia-related-factors-in-head-and-neck-cancer-patients-undergoing-radiothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-potent-and-selective-inhibitors-targeting-flt3-for-aml-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pegylated-liposomal-doxorubicin-in-advanced-anthracycline-pre-treated-liposarcoma-patients-report 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-genetic-susceptibility-for-severe-cardiac-events-in-testicular-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trajectories-of-multidimensional-worry-in-survivors-of-early-breast-cancer-bc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adherence-of-published-randomized-phase-3-cancer-trials-to-principles-proposed-by-common-sense-oncol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gender-gap-in-cancer-care-at-a-resident-led-federally-qualified-health-center-retrospe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/complex-interplay-between-housing-insecurity-and-forgone-care-among-us-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bilateral-mastectomy-and-breast-cancer-mortality-for-invasive-lobular-carcinoma-a-seer-based-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-h3k18-lactylation-in-cancer-associated-fibroblasts-on-malignant-pleural-effusion-progressi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-low-dose-nivolumab-combined-with-chemotherapy-as-neoadjuvant-treatment-for-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-lung-cancer-mortality-among-older-adults-with-chronic-lower-respiratory-di 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-nivolumab-for-patients-with-meningiomas-refractory-to-surgery-and-radiotherapy-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-surveillance-circulating-tumor-dna-and-merkel-polyomavirus-antibody-titer-for-detectio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pretreatment-insights-into-primary-sarcoma-tissues-using-a-novel-approach-of-ex-vivo-functional-prof 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-histone-demethylation-to-knock-down-ihoxa-as2i-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-and-predictors-of-survival-in-non-surgical-management-of-malignant-bowel-obstruction-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-trends-of-mucinous-small-bowel-adenocarcinoma-an-ncdb-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-for-patients-with-advanced-and-metastatic-pancreatic-cancer-treated-with-sacituz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gender-specific-trends-in-incidence-and-prevalence-of-pancreatic-cancer-a-global-burden-of-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/actionable-insights-liquid-ngs-in-community-oncology-practice 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-palliative-care-needs-of-early-phase-clinical-trial-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-with-anlotinib-and-chemotherapy-for-second-line-treatment-of-pancreatic-ductal-adenocar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concurrent-mutations-in-dna-damage-repair-genes-ibrca1i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-and-early-stage-clinical-study-on-the-regulation-of-tumor-associated-inflammatory-factor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-clinical-utility-and-microsatellite-instability-detection-on-the-marsden360-ctdna-sequ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-treatment-ctdna-dynamics-to-predict-response-to-chemotherapy-in-patients-with-metastatic-pancr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-results-of-a-multi-center-phase-ii-study-of-utidelone-injection-in-combination-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-metastatic-burden-in-shaping-mortality-trends-in-patients-with-kidney-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunological-signatures-and-clinical-outcomes-in-patients-with-thymic-epithelial-tumors-and-good-sy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-trilaciclib-versus-granulocyte-colony-stimulating-factor-regarding-chemotherapy-associ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/economic-and-clinical-impact-of-influenza-virus-infection-in-hospitalized-lung-cancer-patients-a-na 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-18f16a-fluoro-17v-fluoroestradiol-fes-pet-in-predicting-response-to-endocrine-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-based-complete-blood-count-model-for-colorectal-cancer-detection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-pathological-differences-in-colorectal-cancer-rectum-left-colon-and-microsatellite-insta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetics-and-family-history-in-a-diverse-cohort-of-females-with-early-onset-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-lost-evidence-a-phase-iii-multicenter-randomized-controlled-trial-of-neoadjuvant-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-top-10-italian-priorities-in-renal-cell-carcinoma-rcc-a-people-centered-approach-to-cancer-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pde5-inhibitor-use-on-survival-outcomes-in-male-predominant-cancers-a-propensity-score-ma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploration-of-neoadjuvant-therapy-regimens-and-prediction-of-immune-effects-for-her2-positive-local 2026-08-24 monthly 0.7 https://rjrindex.com/articles/microrna-mediated-resistance-mechanisms-in-nat-treated-her2-positive-breast-cancer-bc-a-single-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-a-1021-gene-ngs-panel-for-hrd-detection-in-clinical-samples 2026-08-24 monthly 0.7 https://rjrindex.com/articles/descriptive-epidemiology-of-gallbladder-cancer-gbc-real-world-clinical-characteristics-and-outcom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-selfie-study-cervical-precancer-detection-using-novel-human-papillomavirus-biomarkers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recent-trends-in-cancer-distribution-and-survival-outcomes-among-adolescent-and-young-adult-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-pathogenic-variants-in-ibrca1-i-ibrca2-i-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-a-polygenic-risk-score-for-breast-cancer-in-chinese-women-a-three-stage-case-control 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-cytomegalovirus-infection-among-patients-receiving-chimeric-antigen-receptor-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-analysis-of-population-based-screening-for-6-gene-panel-testing-for-hereditary-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-survival-of-central-nervous-system-tumors-in-a-population-based-cancer-regis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-for-cancer-risk-stratification-a-bi-directional-approach-to-screening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-declining-renal-function-on-bladder-cancer-bc-mortality-in-the-us-1999-2023-a-regre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-systemic-therapy-in-breast-cancer-with-cns-metastases-real-world-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-rates-of-liver-and-intrahepatic-bile-duct-cancers-in-young-hispanic-populations-an-explor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-transcriptomics-analysis-to-predict-response-to-immune-checkpoint-blockade-icb-in-recurren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-genomic-characteristics-and-outcomes-among-patients-with-metastatic-lobular-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcome-treatment-modalities-and-overall-survival-in-microsatellite-stable-and-unstable-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-mitoxantrone-hydrochloride-liposome-in-relapsed-and-refractory-pediatric-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pulmonary-embolism-outcomes-across-five-cancer-types-a-nationwide-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-patterns-of-cell-surface-marker-expression-in-clinically-relevant-subgroups-of-non-smal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-deruxtecan-t-dxd-in-patients-pts-with-hr-negative-her2-low-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-serplulimab-with-dp-induction-chemotherapy-followed-by-nimotuzumab-and-imrt-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-chemotherapy-using-gemcitabine-and-cisplatin-followed-by-hypofractionated-radiotherapy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-early-colorectal-cancer-screening-programme-based-on-bisulfite-free-sequencing-of-methylated-circ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-mesenchymal-stem-cell-therapy-in-radiation-induced-xerostomia-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-active-cancer-on-mortality-and-complications-after-tavr-a-systematic-review-and-meta-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnosis-and-follow-up-of-immune-related-hypophysitis-with-mri-of-pituitary-gland 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-durvalumab-plus-chemotherapy-with-or-without-oleclumab-for-locally-advanced-or-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/macroscale-genomic-alterations-in-histomolecular-invasive-lobular-carcinoma-compared-to-other-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recurrence-risk-prediction-model-in-her2-positive-early-breast-cancer-after-her2-targeted-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psychological-interventions-for-anxiety-in-older-patients-with-lung-cancer-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-clinical-trials-landscape-in-follicular-lymphoma-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-from-hepatocellular-carcinoma-associated-with-non-alcoholic-fatty-liver-disease-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-stereotactic-body-radiotherapy-for-cervical-cancer-score-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-design-of-novel-parp-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/re-volve-phase-ii-clinical-trial-in-women-with-ovarian-cancer-progressing-post-parp-inhibitor-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-effectiveness-in-unresectable-hepatocellular-carcinoma-patients-treated-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-the-safety-and-efficacy-of-small-versus-medium-size-particles-in-drug-eluting-bead-chemoem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-patient-characteristics-and-treatment-patterns-among-cholangiocarcinoma-patients-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/developing-a-culturally-appropriate-non-opioid-pain-coping-skills-training-intervention-for-spanish 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-co-occurring-kras-and-gain-of-function-tp53-mutations-with-aggressive-metastasis-thro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-tumor-microenvironment-in-cholangiocarcinoma-impact-of-natural-killer-cells-on-overall-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-burden-and-financial-toxicity-in-cancer-patients-a-sub-analysis-from-a-brazilian-prospect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-donafenib-versus-bevacizumab-in-combination-with-immune-checkpoin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-acceptance-of-scalp-cooling-in-patients-receiving-chemotherapy-for-primary-gynecologic-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outpatient-infusion-sepsis-protocol-and-outcomes-for-patients-with-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-for-black-patients-with-early-onset-breast-cancer-an-analysis-of-the-national-inp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-a-clinical-trial-navigation-program-for-cancer-patients-barriers-and-facilitators 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sexuality-and-age-functioning-and-quality-of-life-qol-in-prostate-cancer-pc-patients-after-surg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mesenchymal-stromal-cells-for-the-prophylaxis-of-graft-versus-host-disease-after-hematopoietic-stem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shared-decision-making-in-follow-up-care-for-lung-cancer-screening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pulmonary-embolism-in-cancer-patients-clinical-insights-and-outcomes-from-a-community-hospital 2026-08-24 monthly 0.7 https://rjrindex.com/articles/google-search-analysis-what-do-people-want-to-know-about-prostate-cancer-and-where-do-they-find-ans 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-toxicity-in-cancer-patients-in-senegal-a-cross-sectional-study-in-two-care-facilities 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-disparities-in-trends-of-medicare-reimbursements-and-service-volumes-for-stereotactic-radio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dalpiciclib-combined-with-chidamide-and-letrozole-as-neoadjuvant-therapy-for-hr-positive-her2-negat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frequency-of-ras-family-gene-mutations-in-metastatic-solid-tumors-in-venezuela-experience-at-a-larg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-photon-and-proton-radiotherapy-populations-in-pediatric-patients-a-single-institutional-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilizing-tp53-mutation-status-and-initial-disease-burden-at-presentation-to-risk-stratify-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-overall-survival-with-abiraterone-acetate-compared-to-enzalutamide-in-patients-with-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-and-clinical-predictors-of-30-day-readmissions-in-aml-patients-undergoing-allogeneic-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-on-treatment-on-rx-tumor-volume-reduction-tvr-to-predict-response-to-the-keynote-522-kn-5 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-a-collaborative-care-based-symptom-intervention-model-on-chemotherapy-adherence-in-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-usefulness-of-an-immune-related-adverse-events-interview-application 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-natural-language-processing-nlp-approach-for-optical-character-recognition-ocr-resilient-extra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-efficiency-and-quality-of-clinical-summaries-produced-by-a-large-language-model-llm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunorare-sup5sup-a-national-platform-of-5-academic-phase-ii-trials-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/target-therapy-adoption-for-myelodysplastic-syndromes-mds-and-acute-myeloid-leukemia-aml-a-five 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-associated-with-distress-thermometer-dt-screening-among-patients-with-cancer-a-retrospec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-current-programmed-death-ligand-1-pd-l1-testing-practices-for-metastatic-non-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kaleido-registry-a-multi-center-registry-platform-with-site-staff-and-automation-to-enable-accelera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-trends-in-disability-adjusted-life-years-dalys-and-mortality-rates-in-gastric-cancer-among 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-cells-as-prognostic-biomarkers-in-advanced-gastric-cancer-treated-with-cdc25b-phos-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-radiation-therapy-contribute-to-breast-cancer-related-lymphedema-after-axillary-node-dissection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-breast-cancer-hub-initiative-conducting-door-to-door-cervical-cancer-awareness-symptom-identific 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-psma-heterogeneity-and-alternative-targets-expression-in-psma-negative-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-outcomes-in-patients-with-myelofibrosis-and-platelets-50-x10-sup9sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-imetelstat-in-myelofibrosis-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sepsis-related-outcomes-and-the-healthcare-burden-in-esophageal-cancer-patients-with-atrial-fibrilla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-myeloproliferative-neoplasms-related-mortality-in-the-united-states-over-the-last 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-metastatic-breast-cancer-mbc-diagnosis-in-structured-electronic-health-record-ehr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptional-profiling-to-identify-a-program-of-enzalutamide-extreme-non-response-in-lethal-prost 2026-08-24 monthly 0.7 https://rjrindex.com/articles/underreporting-of-health-related-quality-of-life-in-trials-of-matched-targeted-therapies-for-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapy-related-myeloid-neoplasms-a-seer-database-analysis-of-residential-distribution-on-overall-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/op-35-does-a-tool-designed-to-measure-potentially-preventable-chemotherapy-toxicities-do-so-effecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-stromal-targeting-antitumor-car-t-cells-in-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-exploratory-study-to-predict-the-efficacy-and-prognosis-of-immunotherapy-for-extensive-stage-smal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hospitalization-patterns-in-metastatic-melanoma-patients-with-and-without-sepsis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-association-between-breast-cancer-and-coronary-artery-disease-insights-from-a-nat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-nemtabrutinib-in-relapsed-or-refractory-chronic-lymphocytic-leukemiasmall-ly 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-derived-xenografts-pdx-versus-patient-derived-organoids-pdo-as-predictors-of-clinical-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intermittent-fasting-if-during-pd-1-checkpoint-blockade-a-pilot-safety-and-feasibility-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-dose-escalation-study-of-av-380-anti-gdf15-monoclonal-antibody-in-combination-with-stan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concurrent-trastuzumab-deruxtecan-and-radiation-therapy-in-her2-positive-and-her2-low-metastatic-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-glp-1-receptor-agonists-on-outcomes-in-metastatic-renal-cell-carcinoma-patients-underg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-extrachromosomal-dna-ecdna-on-imycni-amplified-neuroblastom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-impact-of-adjuvant-treatment-in-resected-stage-iii-cutaneous-melanoma-patients-results-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-development-and-validation-of-a-simulation-model-based-calculation-engine-to-support-individuali 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-distamab-vedotin-combined-with-carboplatin-and-bevacizumab-for-her2-expressin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-icotinib-of-12-months-versus-observation-as-adjuvant-therapy-for-completely-resected-egfr-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/computational-pathology-to-predict-docetaxel-benefit-for-high-risk-localized-prostate-cancer-in-nrg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-clinical-study-of-neoadjuvant-penpulimab-combined-with-chemotherapy-for-patients-with-loc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-treatment-with-surufatinib-camrelizumab-nab-paclitaxel-and-s-1-in-locally-advanced-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/malignant-giant-cell-tumor-of-bone-a-case-series-in-the-denosumab-era 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-trial-of-the-fact-inhibitor-cbl0137-in-pediatric-patients-with-relapsed-or-refractory-soli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sensitivity-of-circulating-tumor-dna-ctdna-for-disease-recurrence-or-relapse-in-melanoma-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-and-treatment-outcomes-in-stage-iv-endometrial-carcinoma-a-13-year-single-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stereotactic-radiotherapy-plus-immunotherapy-and-influence-on-prognosis-in-driver-gene-negative-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cytokine-release-syndrome-among-acute-lymphocytic-leukemia-adults-undergoing-treatment-with-blinatum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-burden-and-trend-of-colorectal-cancer-and-its-attributable-risk-factors-in-latin-america-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metscreen-decision-support-tool-for-metastatic-colorectal-cancer-patients-based-on-organoid-drug-sc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ensartinib-as-postoperative-adjuvant-therapy-in-patients-with-alk-positive-non-small-cell-lung-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geriatric-assessment-and-management-with-a-question-prompt-list-using-a-web-based-application-to-red 2026-08-24 monthly 0.7 https://rjrindex.com/articles/what-i-wish-i-had-known-a-pediatric-oncologists-transition-to-survivorship-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multiomic-evaluation-of-tev-56278-a-pd-1-targeted-attenuated-il-2-molecule-in-a-human-ex-vivo-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-safety-and-antitumor-activity-data-from-a-phase-1-study-of-incb123667-a-selective-cdk2-inhi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-oncolytic-adenovirus-biottt001-in-patients-with-peritoneal-carcinomatosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-the-anti-trop2-antibody-drug-conjugate-adc-ibi130-in-patients-pts-with-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-time-trial-phase-ii-randomized-controlled-trial-of-time-of-day-specified-immunotherapy-for-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-cadonilimab-anti-pd-1ctla-4-bispecific-antibody-plus-chemotherapy-in-early-or-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-first-in-human-study-of-isb-2001-a-bcmaxcd38xcd3-targeting-trispecific-antibody-for-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrative-clinical-genomic-and-transcriptomic-characterization-of-circulating-kim-1-in-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-asciminib-asc-in-patients-pts-with-chronic-phase-chronic-myeloid-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/how-low-do-you-need-to-go-association-between-various-prostate-specific-antigen-psa-response-meas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-clinical-and-molecular-analysis-of-the-eortc-randomized-phase-iii-intergroup-catnon-trial-on-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-differences-in-lung-cancer-mortality-trends-across-the-united-states-us-rural-urb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-of-a-phase-1-study-of-ep0031-a-next-generation-selective-ret-inhibitor-sri-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/seizure-related-homolog-6-sez6-expression-and-ctdna-methylation-profiles-in-patients-with-high-gra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-socioeconomic-status-on-access-to-next-generation-sequencing-in-patients-with-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-standard-vs-reduced-dosing-of-sotorasib-on-efficacy-and-toxicity-in-kras-g12c-mutated-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sacituzumab-tirumotecan-sac-tmt-in-patients-pts-with-previously-treated-locally-advanced-or-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pivotal-studies-of-pharmacotherapies-approved-by-the-united-states-food-and-drug-administration-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-and-safety-results-from-the-phase-2-study-of-timdarpacept-in-combination-with-tisle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-detected-tumor-infiltrating-lymphocytes-and-response-to-pd-1-based-treatment-in-advanced-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biologics-in-the-treatment-of-immune-related-adverse-events-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultra-sensitive-pan-cancer-molecular-residual-disease-assessment-using-whole-genome-sequencing-based 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-accuracy-and-concordance-of-pathologists-and-the-utility-of-ai-assistance-software-for-di 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vebreltinib-plus-plb1004-in-egfr-mutated-nsclc-with-acquired-met-amplification-or-overexpression-aft 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-quality-of-life-hrqol-in-the-phase-3-trial-of-cabozantinib-vs-placebo-for-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/5-fu-naliri-gemcitabine-plus-nab-paclitaxel-or-both-regimens-given-sequentially-for-first-line-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transforming-liver-tumor-segmentation-a-comprehensive-meta-analysis-of-deep-learning-approaches 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-zanubrutinib-zanu-versus-fixed-duration-acalabrutinib-plus-venetoclax-av 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-safety-outcomes-of-an-outpatient-lymphoma-bispecific-antibody-program-a-single-center-ex 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-quality-of-life-and-symptoms-in-children-treated-with-chimeric-antigen-receptor-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-for-medicare-recipients-with-early-onset-breast-cancer-an-analysis-of-the-nationa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-combined-therapy-with-pemetrexed-and-carboplatin-in-progressive-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-bacterial-glycosyltransferases-on-resistance-to-lewis-y-targeting-antibody-drug-conjugates 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-for-patients-with-platinum-sensitive-recurrent-ovarian-cancer-treated-with-prolonged-parp-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-hipec-response-in-ovarian-cancer-with-pi3krasnotch-gene-signatures-a-whole-transcr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-patient-reported-outcomes-in-hospitalized-patients-with-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-gip-and-glp-1-receptor-agonists-in-prostate-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/histologic-comparison-of-the-area-of-tumor-bed-after-vacuum-assisted-biopsy-vab-or-standard-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-of-medical-mistrust-mm-to-medical-decision-making-mdm-preferences-in-cancer-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-l-and-randomized-phase-ll-trial-of-radium-223-dichloride-peposertib-and-avelumab-in-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pharmacist-led-medication-reconciliation-televisit-mrt-for-phase-1-oncology-clinical-trials-a-tel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/suboptimal-suppression-of-serum-androgen-levels-among-men-treated-with-apalutamide-and-abiraterone-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-virtual-reality-supportive-care-intervention-bmt-vr-for-patients-undergoing-hematopoietic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-colorectal-cancer-screening-rates-in-veterans-a-quality-improvement-initiative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-implications-of-using-truncated-medicare-definitions-of-avoidable-hospital-visits 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-clinical-trial-of-preoperative-pembrolizumab-and-chemotherapy-followed-by-adjuvant-pembrol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-the-science-of-cancer-in-latinos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-zero-passage-ex-vivosingle-cell-mass-response-assay-to-predict-tumor-response-an-observational-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/head-and-neck-cancers-in-southeast-asia-2022-incidence-and-mortality-estimates-for-2022-and-project 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-stage-ii-iva-esophageal-and-esophagogastric-cancers-treated-with-multimodal-therapy-a-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-care-of-older-adults-with-cancer-a-randomized-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/training-an-alternate-oncology-workforce-attendee-feedback 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unexplored-targets-in-myeloid-neoplasms-investigating-potential-areas-of-clinical-actionability-usi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-ibrcai-mutations-in-breast-cancer-shedding-light-on-radiation-out 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-prolonged-hospital-length-of-stay-following-craniotomy-for-brain-tumor-resection-a-sy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/carfilzomib-iberdomide-and-dexamethasone-kid-in-patients-with-transplant-eligible-newly-diagnose 2026-08-24 monthly 0.7 https://rjrindex.com/articles/case-study-is-there-any-impact-of-insurance-type-on-disposition-outcomes-in-cancer-patients-on-comf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-on-the-treatment-of-patients-with-ros1-positive-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lorlatinib-in-tki-naive-patients-with-advanced-alk-positive-non-small-cell-lung-cancer-nsclc-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-biomarker-analysis-for-progression-during-adaptive-androgen-deprivation-therapy-for-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peripheral-blood-cell-free-dna-testing-as-a-predictor-for-relapse-post-allogeneic-stem-cell-transpla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-medication-adherence-and-testosterone-suppression-in-patients-with-prostate-cancer-treate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/raced-reduction-of-cervical-cancer-disparities-the-impact-of-navigators-and-racial-literacy-train 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-simplified-scoring-system-to-predict-in-hospital-mortality-of-leukapheresis-in-patients-with-leuke 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-correlation-of-two-snps-in-the-drachmotif-with-gefitinib-induced-hepatotoxicity-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-monotherapy-for-melanoma-or-non-small-cell-lung-cancer-in-india-results-of-the-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-clinicopathologic-analysis-and-management-approaches-for-metaplastic-breast-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-1-inhibitors-versus-pd-l1-inhibitors-in-pd-l1-negative-advanced-non-small-cell-lung-cancer-a-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-clinical-trial-imaging-workflow-with-ai-integration 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-an-early-identification-model-for-oncology-case-management 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-analysis-of-characteristics-and-risk-of-recurrence-ror-in-black-patients-pts-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-racial-and-socioeconomic-disparities-on-radiation-therapy-delays-in-breast-cancer-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-female-breast-cancer-among-adolescent-and-young-adults-in-southeast-asia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-factors-associated-with-urinary-morbidity-in-men-undergoing-combination-prostate-radiation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-in-hematopoietic-stem-cell-transplant-patients-with-hematologic-malignancies-accou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-incorporating-apps-on-enrollment-and-engagement-in-nci-trials-at-an-ncorp-site 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-a-two-protein-panel-pms2msh6-for-detecting-mismatch-repair-deficiency-in-endo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/magnetismm-30-a-phase-1b-open-label-study-of-elranatamab-in-combination-with-iberdomide-in-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analytic-and-clinical-validation-of-a-negative-prediction-algorithm-for-actionable-mutations-utilizi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concurrent-chemoradiotherapy-with-or-without-nimotuzumab-in-induction-chemotherapy-resistant-locoreg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-real-world-study-of-first-line-pd-l1-inhibitor-use-in-patients-with-metastatic-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unraveling-the-complex-code-of-tumor-microenvironment-and-heterogeneity-by-comparing-multiple-primar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pattern-of-granulocyte-colony-stimulating-growth-factors-g-csgf-usage-in-patients-treated-with-sac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mechanisms-of-resistance-to-anti-pd1-treatment-in-recurrent-andor-metastatic-squamous-cell-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-safety-and-pharmacokinetics-pk-of-zurletrectinib-a-next-generation-pan-trk-inhibitor-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/b-cell-maturation-antigen-bcma-immunohistochemistry-ihc-staining-in-multiple-myeloma-mm-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/yap1-and-downstream-gene-alterations-in-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-continuing-neoadjuvant-intent-immunotherapy-for-advanced-resectable-cutaneous-squamous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-patients-with-de-novo-stage-metastatic-head-and-neck-cancer-a-single-center-ex 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-causes-of-failures-in-oral-leukoplakia-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-targeted-therapies-tt-and-immunotherapy-io-on-outcomes-in-patients-pts-with-anaplast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analyzing-aberrantly-methylated-collagen-genes-in-colorectal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sim0270-in-combination-with-palbociclib-in-patients-with-er-her2-advanced-breast-cancer-the-phas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultrasensitive-ctdna-monitoring-during-cdk46-inhibitor-therapy-for-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-impact-of-covid-19-on-septicemias-healthcare-associated-complications-and-mortal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-intricacies-of-illiteracy-an-indigenous-language-and-religious-beliefs-on-oncology-and-palliat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-of-patients-diagnosed-with-stage-iv-cancer-in-2020-based-on-covid-19-status 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-trends-and-survival-outcomes-in-clinical-stage-iii-melanoma-a-real-world-analysis-of-ncdb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/daily-low-dose-oral-temozolomide-as-maintenance-therapy-following-doxorubicin-plus-dacarbazine-in-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-and-temporal-trends-of-prostate-cancer-among-patients-with-acute-cardiovascular-diseases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-al-based-models-integrating-serum-proteomics-and-clinicopathologic-features-to-predict-surviv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-malignant-neoplasm-risk-after-mediastinal-radiotherapy-for-pediatric-hodgkin-lymphoma-on-chil 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lipid-metabolic-gene-expression-and-association-with-decreased-overall-survival-and-immunogenicity-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-year-survival-outcomes-in-nsclc-patients-with-concurrent-gerd-on-proton-pump-inhibitors-receivi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-burkitt-lymphoma-related-mortality-in-the-united-states-over-the-last-three-decad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-geographic-hotspots-due-to-lymphoma-related-mortality-a-21-year-retrospective-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-radio-chemoimmunotherapy-versus-neoadjuvant-chemoimmunotherapy-for-resectable-non-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-beyond-blood-harnessing-pleural-effusion-circulating-tumor-dna-for-precision-lung-cancer-diag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-and-regional-mortality-trends-due-to-pulmonary-embolism-in-patients-with-hematolymphoid-mal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gender-and-racial-disparities-in-acute-in-hospital-outcomes-of-hairy-cell-leukemia-across-the-us-20 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-and-toxicity-with-belzutifan-in-the-treatment-of-von-hippel-lindau-disease-a-si 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-oral-tazemetostat-an-ezh2-inhibitor-in-relapsed-or-refractory-b-cell-non-ho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/profiling-treatment-associated-evolutionary-dynamics-in-advanced-urothelial-cancer-via-deep-whole-ex 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-bisphosphonates-and-other-bone-modifying-agents-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serious-infections-in-patients-with-cllsll-treated-with-combination-venetoclax-and-obinutuzumab-com 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarkertesting-in-metastatic-colorectal-cancer-mcrc-2015-2024-trends-in-the-united-states-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterisation-of-ductal-carcinoma-in-situ-dcis-using-mass-spectrometry-imaging-towards-near-rea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-pneumonitis-in-asian-patients-with-small-cell-lung-cancer-a-systematic-literature-revi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/picking-needles-in-a-haystack-exploring-rare-variants-of-a-pan-cancer-target-in-the-ret-landscape-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-study-to-assess-safety-and-preliminary-evidence-of-a-therapeutic-effect-of-azeliragon-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-and-predictors-of-mortality-among-patients-with-virus-associated-cancers-in-a-high-hiv-prev 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-oncological-implications-of-hormone-replacement-therapy-in-women-with-kallmann-syndrome-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sasanlimab-in-combination-with-bacillus-calmette-guerin-bcg-in-bcg-naive-in-bcg-naive-high-risk-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-reliability-accuracy-and-utility-of-clinical-abstraction-methods-from-unstructured-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-experience-with-immune-checkpoint-inhibitors-ici-in-hepatocellular-carcinoma-hcc-5-y 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-tace-in-combination-with-sorafenib-versus-sorafenib-or-tace-alone-for-advanced-hepatocel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-randomized-control-trial-of-concurrent-paclitaxel-and-carboplatin-along-with-radiothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-prior-neoadjuvantadjuvant-chemotherapy-nactact-on-fruquintinib-plus-sintilimab-out 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-radiotherapy-combined-with-anlotinib-in-locally-advanced-non-small-cell-lung 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-colorectal-cancer-in-the-republic-of-ireland-trends-and-challenges 2026-08-24 monthly 0.7 https://rjrindex.com/articles/brain-metastasis-incidence-with-bireociclib-in-hrher2-advanced-breast-cancer-pooled-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examining-age-specific-trends-in-the-incidence-of-anorectal-cancer-associated-with-human-papillomavi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-egfr-and-vegf-inhibitors-in-stage-ii-iv-colon-cancer-a-retrospective-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-impact-of-long-term-glucocorticoid-use-on-cancer-risk-in-patients-with-rheumatologic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-due-to-cns-neoplasms-in-the-us-from-1999-to-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dietary-polyphenols-and-the-risk-of-prostate-cancer-in-the-prospective-southern-community-cohort-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-and-survival-outcome-of-brain-metastases-in-breast-cancer-patients-a-retrospecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-obesityoverweight-and-its-relationship-with-incidence-of-pancreatic-cancer-in-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-clinical-factors-associated-with-sleep-disturbance-in-breast-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/qingre-huoxue-formula-and-its-key-active-components-as-associated-with-multi-targeted-effects-on-hum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-eniluracil-capecitabine-6422-cap-in-phase-1b-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-cluster-analysis-of-clinician-distress-trajectories-when-caring-for-seriously-ill-hospitalized-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pancreatic-adenosquamous-carcinoma-pasc-a-comparative-genomic-landscape-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-potential-of-disitamab-vedotin-in-bladder-preservation-during-neoadjuvant-therapy-for-bladder-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-a-molecular-tumor-board-on-treatment-decisions-for-advanced-solid-tumors-experience-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fruquintinib-in-combination-with-camrelizumab-and-paclitaxel-liposome-and-nedaplatin-as-first-line-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-confirmatory-germline-testing-in-patients-with-somatic-brca12-pathogenic-variants-acros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-immune-checkpoint-inhibitors-in-child-pugh-b-and-c-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/donafenib-plus-hepatic-arterial-infusion-chemotherapy-and-anti-pd-1-antibody-therapies-for-unresecta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eliciting-the-patient-perspective-using-design-thinking-methodology-to-assess-the-utility-of-incorp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-communication-and-satisfaction-in-breast-cancer-does-doctor-patient-identity-conco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-pain-management-knowledge-among-hospice-family-caregivers-a-randomized-controlled-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-using-metronomic-gemcitabine-doxorubicin-and-docetaxel-plus-nivolumab-in-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elucidating-the-epigenetic-landscape-of-non-muscle-invasive-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-adjuvant-therapy-with-donafenib-in-hepatocellular-carcinoma-with-high-risk-recurrence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-lipid-laden-kupffer-cells-in-immunosuppression-and-immunotherapy-response-in-masld-relat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-3d-telomeres-profiling-for-myeloma-mrd-and-evaluation-of-concordance-between 2026-08-24 monthly 0.7 https://rjrindex.com/articles/it-io-intrathecal-administration-of-nivolumab-and-ipilimumab-in-combination-with-systemic-combinati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ficerafusp-alfa-with-pembrolizumab-in-patients-with-recurrent-or-metastatic-head-and-neck-squamous-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extranodal-malt-lymphoma-a-retrospective-survival-analysis-study-from-seer-database 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gut-microbiome-and-serum-cytokines-as-biomarkers-for-pathological-complete-response-pcr-and-recurr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-based-differences-in-outcomes-following-minimally-invasive-gastrectomy-for-gastric-cancer-a-nat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-combined-with-rivoceranib-and-tace-in-the-perioperative-treatment-of-hepatocellular-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serial-circulating-tumor-dna-ctdna-monitoring-in-early-stage-hrher2-invasive-lobular-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-and-clinical-outcomes-of-imatinib-personalized-dosing-in-gastrointestinal-stromal-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hrd-status-prediction-in-patients-with-advanced-breast-prostate-ovarian-and-pancreatic-cancers-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-autologous-chimeric-engulfment-receptor-t-cell-cer-1236-targeting-tim-4-l-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rc108-in-combination-with-furmonertinib-in-patients-with-locally-advanced-or-metastatic-egfr-mutated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-tolerability-and-preliminary-efficacy-results-of-a-phase-1-study-of-lb2102-a-dntgfvrii-arm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-ifupinostat-bebt-908-in-combination-with-rituximab-for-relapsedrefractory 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilizing-targeted-intra-tumoral-hyperthermia-as-an-immunotherapy-in-immunogenically-cold-tumor-mo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-tumor-infiltrating-lymphocytes-til-monotherapy-on-persistent-clinical-and-immunologic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mri-radiomics-to-predict-outcome-of-neoadjuvant-chemotherapy-in-patients-with-muscle-invasive-bladde 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-first-in-human-study-of-adi-270-an-armored-allogeneic-anti-cd70-chimeric-antigen-recept 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-basket-trial-of-tarlatamab-in-patients-with-advanced-dll3-expressing-tumors-university-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-educated-platelets-as-a-source-of-potential-biomarkers-for-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combination-of-tim-3-blockade-tqb2618-with-penpulimab-and-chemotherapy-in-the-first-line-treatment-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/waveline-003-phase-23-trial-of-zilovertamab-vedotin-plus-standard-of-care-in-relapsedrefractory-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1b2-study-of-lisaftoclax-apg-2575-combined-with-azacitidine-aza-in-patients-pts-with-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/variation-in-communication-of-cancer-risk-in-prostate-cancer-treatment-consultations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemokines-as-predictive-biomarkers-for-immune-checkpoint-inhibitor-ici-efficacy-in-triple-negativ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-zggs15-a-dual-specific-antibody-targeting-lag-3-and-tigit-as-monotherapy-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-combination-of-naxitamab-with-or-without-sintilimab-anti-pd-1-for-the-treatment-of-refractory 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiac-adverse-events-with-parp-inhibitors-real-world-pharmacovigilance-study-using-faers-database 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-guideline-concordant-treatment-receipt-for-localized-prostate-cancer-pca-a-seer-ba 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemo4metpanc-combination-chemotherapy-gemcitabine-and-nab-paclitaxel-chemokine-c-x-c-motif-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-immune-checkpoint-inhibitors-ici-in-patients-pts-with-central-nervous-system-cns-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-complications-of-patients-receiving-car-t-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1b-dose-extension-study-of-a-next-generation-anti-cd47-monoclonal-antibody-imc-002-combined-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-from-a-first-in-human-phase-iii-study-of-vls-1488-an-oral-kif18a-inhibitor-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/myocarditis-in-patients-with-non-small-cell-lung-cancer-treated-with-immune-checkpoint-inhibitors-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-influence-of-mri-scan-position-using-a-novel-head-and-neck-immobilization-device-on-radical-radi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-the-ctdna-mutational-landscape-in-her2-positive-metastatic-breast-cancer-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-outcomes-and-clinicopathologic-determinants-of-response-for-patients-with-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-car-t-cell-therapy-versus-standard-of-care-for-relapsedrefractor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-gene-panel-blood-test-for-the-detection-of-colorectal-adenomas-and-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sexual-behavior-characteristics-in-breast-cancer-patients-nhanes-study-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postmarketing-safety-of-loratinib-an-analysis-of-the-fda-adverse-event-reporting-system-faers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gastrointestinal-adverse-event-in-patients-with-and-without-pre-existing-inflammatory-bowel-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dual-omic-analysis-to-reveal-gene-regulatory-network-of-immune-landscape-in-childhood-solid-tumors-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-safety-and-efficacy-of-almb-0168-a-novel-monoclonal-antibody-activating-cx43-hemi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-integrated-proactive-supportive-care-pathways-in-oncology-results-from-the-proact-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ccdi-cog-molecular-characterization-initiative-the-expanding-data-on-childhood-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-change-in-cardiac-function-after-doxorubicin-and-dexrazoxane-a-report-from-cog-alte11c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-infusion-therapy-management-in-metastatic-breast-cancer-real-world-pilot-study-of-a-new-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-the-abo-gene-have-prognostic-value-for-immunotherapy-efficacy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-anlotinib-in-neoadjuvant-treatment-of-locally-advanced-differentiated-thyroid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-profile-of-spinal-laser-interstitial-thermal-therapy-for-metastatic-spinal-cord 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-cabazitaxel-c-vs-lutetium-lu-177-vipivotide-tetraxetan-lu-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tace-with-or-without-lenvatinib-as-adjuvant-therapy-for-hcc-with-microvascular-invasion-mvi-or-por 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigation-of-the-quality-of-life-of-cervical-cancer-patients-and-analysis-of-clinical-data-based 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-instability-score-gis-and-benefit-from-olaparib-ola-and-bevacizumab-bev-maintenance-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-transcriptomics-for-profiling-the-microenvironment-of-cervical-precancer-progression-from-ro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-and-prognostic-characteristics-of-gastric-type-endocervical-adenocarcinoma-a-si 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-a-novel-method-for-rapid-collection-of-microgram-amounts-of-cell-free-dna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-an-adapted-tool-to-measure-health-related-social-needs-for-the-prostat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-intensification-in-veterans-with-metastatic-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-trends-in-prevalence-and-incidence-of-pancreatic-cancer-among-adults-aged-70-and-older-a-com 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-hemoglobin-levels-and-cancer-risk-an-analysis-using-nhanes-2017-2020-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-mammogram-rates-across-texas-in-2022-a-statewide-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-25-year-perspective-on-tongue-cancer-related-mortality-nationwide-trends-and-disparities-in-the-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-of-lower-respiratory-tract-neoplasms-among-older-adults-with-history-of-tobacco-use 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-sacituzumab-govitecan-for-the-treatment-of-patients-with-diffuse-pleural-mesothel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-ddr-mutations-mt-in-idh-mutant-high-grade-gliomas-hgg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-indian-cancer-genome-landscape-pathogenic-alterations-and-emerging-therapeutic-targets 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-trends-in-soft-tissue-and-extraosseous-sarcomas-1980-2021-regional-and-economic-disparitie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transarterial-chemoembolization-plus-donafenib-and-immune-checkpoint-inhibitors-for-intermediate-hep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-transcriptomic-architecture-for-deciphering-the-complexity-of-tumor-microenvironment-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-akt-inhibitors-on-radiation-sensitivity-oxidative-stress-emt-reversal-and-immune-micro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-treatments-for-resectable-rpc-and-borderline-resectable-pancreatic-adenocarcinoma-brp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ripretinib-versus-sunitinib-in-imatinib-resistant-gastro-intestinal-stromal-tumor-with-kit-exon-11-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-os-with-nalirifox-nfx-compared-to-folfirinox-ffx-in-patients-not-previously-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-survival-in-advanced-stage-high-grade-primary-peritoneal-serous-cystadenocarcinoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/population-adjusted-indirect-comparison-paic-of-avelumab-ave-and-retifanlimab-reti-in-the-firs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pct1co-stim-tcr-t-cells-to-overcome-the-hostile-tumor-micro-environment-and-target-triple-negative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-and-addressing-unmet-needs-in-colorectal-cancer-findings-from-the-colorectal-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-spatial-profiling-mapping-tumor-responses-to-radiotherapy-in-rectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-factors-enabling-to-predict-and-management-of-hypocalcemia-following-total-thyroidectomy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-neoadjuvant-combination-immune-checkpoint-inhibitor-therapy-in-patients-with-resectable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-between-blinded-independent-central-review-committee-and-physician-assessed-responses-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-oral-mucositis-on-nutrition-among-patients-with-head-and-neck-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-associated-with-de-novo-metastatic-colorectal-cancer-in-early-onset-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-outcomes-of-multiple-myeloma-in-asian-indian-and-pakistani-americans-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-survival-outcomes-of-transoral-surgery-with-or-without-adjuvant-chemoradiotherapy-vs-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-pathologic-complete-response-in-colorectal-cancer-patients-after-immunotherapy-based-on-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-adverse-events-of-ciltacabtagene-autoleucel-a-b-cell-maturation-antigen-directed-chimeri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-adjusted-time-without-symptoms-of-disease-or-toxicity-q-twist-analysis-of-pembrolizumab-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-powered-real-time-model-for-predicting-recurrence-and-survival-in-head-and-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-based-tumor-microenvironment-and-pd-l1-analysis-using-digital-pathology-to-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-renal-failure-and-multiple-myeloma-related-mortality-among-adults-aged-55 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-incision-laparoscopic-surgery-vs-conventional-laparoscopic-surgery-for-colorectal-cancer-sho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/natural-killer-cell-transcriptomic-expression-and-prediction-of-survival-after-immune-checkpoint-blo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/representation-and-outcomes-for-older-patients-in-phase-3-clinical-trials-for-metastatic-and-unresec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-feasibility-of-a-peer-support-group-for-patients-with-cancer-presently 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-oncology-clinical-trials-by-absolute-neutrophil-count-eligibility-criteria-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-of-previous-cancer-history-with-the-incidence-of-prostate-cancer-harboring-germline 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sexual-health-communication-and-young-onset-cancer-yoc-healthcare-practitioners-attitudes-and-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-and-racial-disparities-of-chromosome-8q-gains-in-prostate-cancer-insights-from-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantifying-financial-toxicity-in-oncology-a-comprehensive-analysis-of-prescription-cost-disparitie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overuse-of-diagnostic-therapeutic-and-consultative-services-among-hospitalized-patients-approachin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-impact-of-high-body-mass-index-on-acute-lymphoblastic-leukemia-a-30-year-global-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-burnout-on-oncologists-and-hematologists-inunc-agendum-esti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/usp22-as-promoter-of-treg-cell-infiltration-and-modulator-of-immunotherapy-efficacy-through-the-pias 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lymphovascular-invasion-as-a-prognostic-factor-in-pt2-urothelial-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lapnet1-phase-1b-study-investigating-the-association-of-np137-with-mfolfirinox-in-locally-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/constructing-genetic-immune-prognostic-subtypes-of-primary-duodenal-adenocarcinoma-through-whole-exo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-differential-effect-of-stromal-genes-on-gemcitabinenab-paclitaxel-gn-and-gncisplatin-gcn-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-analysis-for-improved-treatment-response-assessment-and-prediction-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-angiotensin-converting-enzyme-inhibitors-and-angiotensin-receptor-blockers-on-immunotherap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keymaker-u06-substudy-06e-a-phase-12-open-label-umbrella-platform-study-of-ifinatamab-deruxtecan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/costs-of-ovarian-cancer-care-since-the-introduction-of-poly-adp-ribose-polymerase-inhibitors-parp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gastric-cancer-incidence-in-mongolia-a-clinical-and-molecular-pathological-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-iron-deficiency-anemia-on-long-term-cardiovascular-outcomes-in-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-standardized-documentation-for-goals-of-care-among-advanced-stage-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/building-a-community-academic-partnership-to-improve-clinical-trial-access-in-southern-alabama 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-and-acceptability-of-remote-activity-and-patient-reported-outcome-monitoring-in-men-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-node-recurrence-after-sentinel-lymph-node-biopsy-for-ycn0-patients-treated-with-primary-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-olutasidenib-in-relapsedrefractory-acute-myeloid-leukemia-outcomes-by-number-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-in-patients-pts-younger-than-50-years-old-yo-with-treatment-naive-blastic-plasmacytoid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-irak4-long-isoform-as-widely-upregulated-in-non-splicesome-mutated-acute-myeloid-leukemia-and-as 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-novel-androgen-receptor-inhibitors-in-nonmetastatic-castration-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-darolutamide-efficacy-and-safety-in-treating-non-metastatic-and-metastatic-ho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-frailty-in-vulnerable-hematopoietic-cell-transplantation-candidates 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-trial-of-sup177sup-lu-nym032-for-progressive-metastatic-cast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-acute-care-events-designing-prognostic-models-for-real-world-use 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-deep-learning-model-to-predict-residual-tumor-in-advanced-epithelial-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/increasing-lung-cancer-screening-education-among-minoritized-populations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overcoming-barriers-to-colorectal-cancer-screening-and-research-enrollment-by-minoritized-and-underi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evaluation-of-the-reduction-in-complexity-of-ordering-dna-sequencing-tests-through-the-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/flubu2-and-flumel-with-and-without-ptcy-comparative-effectiveness-and-safety-in-allogeneic-stem-tra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-trial-access-in-patients-with-pancreatic-cancer-pc-a-pancreatic-cancer-action-network-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/workforce-economic-and-infrastructural-barriers-to-global-oncology-clinical-trial-participation-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multidisciplinary-integrative-medicine-as-tailored-treatment-for-cancer-patients-a-multicentre-ret 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-genomic-profiling-of-black-and-non-hispanic-white-nhw-men-with-prostate-cancer-pca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/upgrade-rates-and-treatment-recommendations-for-patients-with-pleomorphic-and-florid-lobular-carcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-patient-reported-wellness-outcomes-in-head-and-neck-cancer-patients-treated-with-proton-vs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-genomic-landscape-of-early-mortality-in-patients-with-stage-iv-non-small-cell-lung-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-clinical-and-genomic-landscape-analysis-of-gi-stromal-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thromboembolic-events-in-immunomodulatory-drug-imid-sparing-regimens-for-patients-with-newly-diagn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-site-specific-immune-related-adverse-events-of-pd-l1-blockade-in-advanced-non-small-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-hlx22-plus-trastuzumab-and-xelox-for-first-line-treatment-of-human-epidermal-grow 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-lymphoma-and-covid-19-among-hospitalized-cancer-patients-a-population-based-cohort-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-second-line-2l-treatment-with-tivozanib-tivo-as-monotherapy-or-with-nivolumab-nivo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-multicentric-observational-real-world-evidence-rwe-study-on-cost-impact-effica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-of-patients-with-anal-small-cell-carcinoma-a-perspective-from-the-united-states-national-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-for-patients-with-extensive-stage-small-cell-lung-cancer-es-sclc-treated-with-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/over-a-decade-of-insights-into-genomic-profiling-in-metastatic-colorectal-cancer-from-a-phase-i-sett 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-tt-00973-ms-a-highly-selective-and-potent-axl-inhibitor-in-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-cdk46-inhibitors-post-chemotherapy-in-hr-her2-metastatic-breast-cancer-patients-real 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-panel-of-four-protein-tumor-markers-for-effective-and-affordable-lung-cancer-early-detection-by-ar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-aptamer-based-non-invasive-test-for-lung-cancer-a-proof-of-concept 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-features-of-breast-cancer-metastatic-to-gynecologic-sites 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-and-prognostic-factors-in-cancer-specific-survival-for-patients-with-metastatic-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-short-course-radiotherapy-followed-by-sintilimab-anlotinib-combined-with-capox 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-molecular-features-of-resected-breast-cancer-brain-metastases-a-retrospective-cohort-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decoding-tumour-bacterial-ecosystems-topological-data-analysis-of-bacterial-association-with-immuno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-survive-heroes-study-targeting-molecular-relapse-in-breast-cancer-a-secondary-adjuvant-interven 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nationwide-analysis-and-trend-of-liver-cancer-mortality-attributable-to-drug-use-in-united-states-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-epstein-barr-virus-positive-diffuse-large-b-cell-lymphoma-not-otherwise-specif 2026-08-24 monthly 0.7 https://rjrindex.com/articles/menopausal-hormone-therapy-after-a-diagnosis-of-breast-cancer-in-women-with-a-ibrcai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/economic-outcomes-of-palliative-care-in-colorectal-cancer-hospitalizations-a-propensity-matched-ret 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-germline-sequencing-and-mlpa-analysis-in-breast-cancer-patients-4-years-of-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/black-patients-with-cutaneous-t-cell-lymphoma-ctcl-and-their-likelihood-to-receive-novel-agents-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-and-sociodemographic-disparities-in-moderate-or-excessive-polypharmacy-among-ol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-prospective-non-interventional-study-to-investigate-the-treatment-patterns-of-nerati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/off-label-use-of-fam-trastuzumab-deruxtecan-in-desmoplastic-small-round-cell-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/blended-survivorship-and-palliative-care-for-patients-with-advanced-lung-cancer-receiving-targeted-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-profile-and-risk-factors-associated-with-incadronate-disodium-treatment-in-breast-cancer-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shr-a1811-as-neoadjuvant-therapy-for-hr-positive-her2-low-breast-cancer-a-single-arm-phase-ii-cli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-bowhead-health-patient-navigator-for-breast-cancer-treatment-in-india-a-pilot-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-basket-trial-evaluating-the-efficacy-of-tasurgratinib-e7090-in-patients-with-advanced-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-ctdna-monitoring-for-post-surgical-molecular-residual-disease-in-patients-with-stage-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combination-of-nivolumab-plus-ipilimumab-in-microsatellite-instability-high-metastatic-colorectal-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/copec-trial-early-determination-of-pathological-tumor-response-to-neoadjuvant-chemotherapy-in-lowi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-non-viral-apd1-msln-jl-lightning-car-t-in-advanced-malignant-mesothelioma-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-pivekimab-sunirine-pvek-in-patients-pts-with-blastic-plasmacytoid-dendrit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/amivantamab-treatment-and-intra-tumoral-gene-expression-and-immune-cell-changes-in-refractory-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-mfolfoxiri-chemotherapy-with-or-without-cadonilimab-versus-mfolfox6-alone-in-locally-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intensified-hormonal-blockade-with-sbrt-in-psma-pet-detected-oligometastatic-prostate-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/etctn-10563-a-phase-i-study-of-peposertib-and-liposomal-doxorubicin-for-advanced-or-metastatic-leio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-results-of-pdl1v-pf-08046054-a-vedotin-based-adc-targeting-pd-l1-in-patients-with-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-study-of-shr-2017-a-ranklngf-targeted-antibody-in-patients-pts-with-breast-cancer-bo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-lung-cancer-clinical-characteristics-and-tumor-subtypes-using-cell-free-dna-fragmentomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-taxane-platinum-doublet-chemotherapy-with-triple-oral-metronomic-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nut-carcinoma-survival-outcomes-and-epidemiology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-overall-survival-analysis-for-a-phase-3-randomized-trial-comparing-afatinib-to-chemotherapy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-immune-checkpoint-inhibitors-icis-in-advanced-large-cell-neuroendocrine-carcinoma-lcn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-analysis-of-modified-topaz-1-a-biweekly-regimen-of-gemcitabine-and-cisplatin-pl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctc-landscape-during-hcc-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/docetaxel-with-androgen-deprivation-therapy-adt-and-radiotherapy-rt-for-high-risk-localized-pros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-pembrolizumab-pembro-plus-chemotherapy-chemo-for-locally-advanced-gastric-or-gastr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patritumab-deruxtecan-her3-dxd-in-active-brain-metastases-bm-from-metastatic-breast-mbc-and-no 2026-08-24 monthly 0.7 https://rjrindex.com/articles/forte-a-phase-2-master-protocol-assessing-plixorafenib-for-braf-altered-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/navigating-third-line-therapies-a-comprehensive-review-of-regorafenib-versus-fruquintinib-with-plac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-outcomes-in-stage-iii-melanoma-patients-treated-with-adjuvant-immunotherapy-vs-targ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combination-of-bispecific-innate-cell-engager-ice-afm24-with-atezolizumab-in-patients-with-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/smet12-and-toripalimab-combined-chemotherapy-in-patients-with-advanced-non-small-cell-lung-cancer-wh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-pro-evaluating-physical-functioning-and-symptoms-in-patients-with-pretre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trend-of-iclostridium-difficilei-colitis-infection-and-ileus-among-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-ct-declination-among-patients-with-early-stage-hormone-receptor-positive-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-proportion-score-tps-and-response-to-first-line-1l-anti-pd-1pd-l1-plus-chemotherapy-for-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/avutometinibdefactinib-and-gemcitabinenab-paclitaxel-combination-in-first-line-metastatic-pancreat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-survival-rates-of-patients-with-primary-malignant-cardiac-tumors-a-seer-based-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-xgboost-in-predicting-outcomes-among-car-t-therapy-patients-the-impact-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-from-a-first-in-human-phase-1-dose-escalation-trial-of-adrx-0706-a-next-generat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-a-tumor-agnostic-circulating-tumor-dna-assay-for-uveal-melanoma-surveillance-and-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigation-of-clonal-hematopoiesis-frequency-following-parp-inhibitor-treatment-and-its-associati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-survival-outcomes-and-biomarker-results-of-sure-01-neoadjuvant-sacituzumab-govitecan-sg-mon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trop-2-expression-in-germ-cell-tumors-gct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-broad-spectrum-kit-inhibitor-nb003-and-activity-in-advanced-gastrointestinal-stromal-tumors-gis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trade-off-preferences-in-older-adults-with-newly-diagnosed-acute-myeloid-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-preferences-between-survival-and-quality-of-life-and-their-association-with-clinical-outco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/social-vulnerability-by-neighborhood-of-association-correlates-with-car-t-referrals 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-a-phase-ii-trial-of-olaparib-in-combination-with-ceralasertib-in-patients-with-recurrent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-iii-trial-of-catequentinib-hydrochloride-al3818-versus-placebo-in-subjects-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oligometastatic-gastrointestinal-stromal-tumor-association-between-treatment-type-metastatic-patte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptome-classification-of-pten-inactivation-to-predict-survival-benefit-from-docetaxel-at-star 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-a-large-language-model-based-system-versus-manual-review-in-clinical-data-abstraction-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-trial-of-the-therapeutic-cancer-vaccine-ose2101-versus-docetaxel-in-patients-with-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-phase-2-investigator-initiated-etctn-trial-of-olaparib-radium-223-vs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b2-open-label-study-of-selective-axl-mer-and-csf1r-inhibitor-adrixetinib-q702-in-combi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/taletrectinib-in-iros1i-non-small-cell-lung-cancer-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/swognrg-s1914-randomized-phase-iii-trial-of-inductionconsolidation-atezolizumab-sbrt-versus-sbr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-two-decades-of-cancer-trends-in-adolescents-and-young-adults-insights-from-a-resource-res 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-serplulimab-based-therapy-in-her2-negative-advanced-gastric-cancer-a-real-wo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-controlled-trial-comparing-pragmatic-interventions-to-improve-mammogram-uptake-in-a-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-center-single-arm-phase-ii-study-of-pemigatinib-combined-with-immune-checkpoint-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-venous-thromboembolism-on-survival-in-multiple-myeloma-patients-receiving-bispecific-antib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-and-facilitators-of-adoption-and-implementation-of-a-financial-navigation-program-in-nigeri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/generative-ai-to-augment-the-fairness-of-foundation-models-in-cancer-pathology-diagnosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-preoperative-chemoradiotherapy-versus-chemotherapy-for-resectable-gastric-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-treatment-patterns-and-adverse-reactions-of-bevacizumab-in-the-chinese-population-in-the-real-wo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-and-validation-of-the-clavien-dindo-classification-for-oncologic-surgeries-in-a-high-volume-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/choose-breath-not-death-improving-lung-cancer-screening-in-the-christus-good-shepherd-internal-med 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-bite-therapy-in-rural-wisconsin-a-single-center-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/apalutamide-in-patients-with-metastatic-hormone-sensitive-prostate-cancer-real-world-experience-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-weekly-docetaxel-regimens-in-prostate-cancer-a-systematic-review-and-network-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-to-germline-genetic-testing-in-advanced-prostate-cancer-survey-results-from-the-germline-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-low-dose-carboplatin-and-docetaxel-in-combination-with-toripalimab-for-early-or-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-prognostic-and-predictive-value-of-il-1v-trop2-and-b7-h3-in-egfr-mutated-egfrm-nsc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-a-pre-screening-platform-for-clinical-trials-in-patients-with-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-race-predict-adherence-to-relugolix-among-patients-with-prostate-cancer-a-veterans-health-admi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-in-male-and-female-breast-cancer-care-a-comparative-analysis-of-stage-at-presentation-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breath-based-voc-analysis-leveraging-canine-olfaction-for-multi-cancer-detection-insights-from-a-10 2026-08-24 monthly 0.7 https://rjrindex.com/articles/venous-thromboembolism-among-cancer-patients-receiving-chimeric-antigen-receptor-t-cell-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-cytopenic-myelofibrosis-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-ipss-m-in-predicting-survival-and-relapse-after-allogeneic-hsct-for-mds-a-single-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/navigator-assisted-hypofractionation-navah-phase-i-clinical-trial-of-breast-cancer-patients-impli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-invasively-collected-buccal-cell-mrna-and-potential-for-a-novel-breast-cancer-signal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunohistochemical-and-gene-expression-profiles-as-predictors-of-survival-in-recurrent-high-grade-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-liver-cancer-mortality-in-the-united-states-2010-2021-a-call-for-focused-public-health 2026-08-24 monthly 0.7 https://rjrindex.com/articles/electronic-health-records-ehr-based-machine-learning-ml-approach-to-predict-risk-of-progression 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-of-novel-electrophysiologic-biomarkers-of-cognition-in-glioma-infiltrated-cortex 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparison-of-survival-with-nivolumab-nivo-relatlimab-rela-vs-nivo-ipilimumab-ip 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-immunosuppressed-patients-with-merkel-cell-carcinoma-treated-with-immune-chec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinico-molecular-characteristics-and-enhanced-efficacy-of-immune-checkpoint-inhibitors-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-genomic-analysis-of-tumor-tissue-and-surgical-margin-distances-in-esophageal-squamous-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-alcohol-use-disorder-on-outcomes-in-gastrointestinal-cancer-patients-a-national-inpatient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-randomized-placebo-controlled-trial-on-repurposing-olanzapine-for-prevention-of-radiothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-immunotherapy-in-advanced-osteosarcoma-patients-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitor-ici-reuse-after-failure-of-first-line-ici-in-patients-with-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-meta-analysis-of-safety-and-efficacy-of-datopotamab-deruxtecan-and-sacituzumab-govitecan-for-secon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/area-deprivation-index-and-egfr-mutated-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ehealth-disease-educational-intervention-vs-outpatient-palliative-care-as-usual-among-incurable-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-outcome-of-transarterial-chemoembolization-combined-with-immune-checkpoint-inhibitors-plu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prevalence-and-outcomes-of-ascites-in-patients-hospitalized-with-pancreatic-cancer-insights-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-infectious-sarcoid-like-inflammatory-granulomatous-conditions-nsigc-associated-with-immune-che 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-characteristics-affecting-cholangiocarcinoma-patients-with-and-without-hepatitis-ba 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pancreatic-cancer-mortality-trends-2018-2023-exposing-racial-inequities-in-michigans-cancer-burd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-safety-analysis-of-an-open-label-single-arm-phase-ii-trial-investigating-the-efficacy-safety 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hepatic-arterial-infusion-chemotherapy-plus-lenvatinib-and-pd-1-inhibitors-as-first-line-treatment-f-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-hematology-amp-oncology-ho-knowledge-for-internal-medicine-residents-a-dell-med-guid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-educational-and-practice-needs-of-oncology-pharmacists-in-west-africa-a-case-stud 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-neighborhood-level-factors-with-access-to-genetic-testing-in-patients-with-resectable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hypertension-and-renal-cancer-related-mortality-patterns-in-the-united-states-from-1999-to-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-changes-in-advanced-clear-cell-renal-cell-carcinoma-ccrcc-pre-and-post-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-oncolytic-bacteria-product-sgn1-and-its-impact-on-pd-l1-expression-cd8-t-cell-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-evidence-based-treatment-selection-and-patient-centered-care-in-upper-gi-cancers-a-projec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-randomized-multicenter-study-of-adjuvant-adebrelimab-plus-capecitabine-in-resected-chola 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-covid-19-infection-on-car-t-therapy-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-supervised-prehabilitation-program-for-patients-with-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ovarian-cancer-in-adolescents-and-young-adults-compared-with-older-women-prognostic-factors-demogr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-failure-and-treatment-for-hepatocellular-carcinoma-after-immune-checkpoint-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-graft-versus-host-disease-on-mortality-length-of-stay-and-hospitalization-costs-in-bone 2026-08-24 monthly 0.7 https://rjrindex.com/articles/secondary-outcomes-by-prior-definitive-treatment-tx-in-patients-pts-with-high-risk-biochemically 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-landscape-ecology-of-dcis-microenvironmental-drivers-of-recurrence-and-progression-to-breast-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/volume-and-acuity-trends-in-geriatric-patients-with-cancer-insights-from-a-comprehensive-cancer-cen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-the-asco-pga-in-a-remote-australian-setting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-lung-cancer-risk-in-breast-cancer-survivors-a-40-year-comprehensive-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-health-experiences-among-us-immigrant-patients-with-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expanding-access-to-care-through-sustainable-replicable-model-of-care-delivery 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-comparative-analysis-of-outcomes-following-autologous-hematopoietic-cell-transplantation-in-multip 2026-08-24 monthly 0.7 https://rjrindex.com/articles/verification-of-a-novel-plasma-eight-protein-signature-predicting-long-term-efficacy-of-first-line-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-omics-evaluation-of-relapsed-pediatric-cancers-what-information-do-these-sequential-analyses 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-a-study-of-bria-ots-cellular-immunotherapy-in-metastatic-recurrent-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-disparities-in-survival-outcomes-among-children-with-non-metastatic-ewing-sarcoma-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-outcomes-in-african-american-patients-with-multiple-myeloma-the-role-of-amyloidosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-implications-of-immune-related-adverse-events-after-exposure-to-vegf-inhibitors-on-outcom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-and-clinical-determinants-of-survival-in-metastatic-breast-cancer-a-population-bas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-therapeutic-strategies-for-metastatic-triple-negative-breast-cancer-with-homologous-recom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-the-anti-immunoglobulin-like-transcript-3-ilt3-monoclonal-antibody-mab-mk-0482 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-parp-1-in-er-positive-endocrine-resistant-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-and-disparities-affecting-pharyngeal-cancer-in-the-us-a-21-year-retrospective-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-biomarker-prediction-in-oncology-enhancing-pathological-image-analysis-with-exaonepath 2026-08-24 monthly 0.7 https://rjrindex.com/articles/testicular-function-after-immune-checkpoint-inhibitors-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/population-based-assessment-of-leiomyosarcoma-lms-and-cancers-in-the-li-fraumeni-syndrome-lfs-sp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analytical-validation-of-a-1021-gene-ngs-panel-for-comprehensive-tumor-profiling-in-ffpe-and-liquid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-preferred-place-of-death-for-metastatic-melanoma-patients-in-the-united-states-from-2015-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-an-optimized-tissue-agnostic-genome-wide-methylome-enrichment-assay-to-predict-clinica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-of-patterns-of-melanoma-early-and-late-recurrence-after-adjuvant-anti-pd1-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-chemotherapy-treatment-on-immunotherapy-efficacy-in-colorectal-cancer-crc-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-powered-real-time-model-for-predicting-survival-in-advanced-ie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/5-year-survival-outcomes-after-perioperative-pembrolizumab-pembro-in-patients-with-human-papilloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-efficacy-and-safety-results-of-bat1308-a-pd-1-inhibitor-chemotherapy-bevacizumab-in-ph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-tumor-microenvironment-composition-to-favor-pd-1-inhibition-via-pretreatment-with-low-dose 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-pretreatment-emotional-distress-and-survival-outcomes-in-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/should-radiotherapy-be-considered-for-the-initial-treatment-of-ovarian-cancer-brain-metastases-find 2026-08-24 monthly 0.7 https://rjrindex.com/articles/individual-participant-data-meta-analysis-comparing-neoadjuvant-to-perioperative-chemoimmunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peripheral-and-cutaneous-t-cell-lymphomas-in-the-united-states-a-21-year-mortality-analysis-1999-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-car-t-cell-therapy-product-in-the-clinical-outcome-of-patients-with-relapsedrefractory-di 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-histological-subtypes-in-non-muscle-invasive-utuc-propensity-matched-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-1pd-l1-inhibitors-as-neoadjuvant-therapies-in-resectable-non-small-cell-lung-cancer-including-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-identification-of-a-metabolic-gene-prognostic-signature-malmps-model-to-inv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-cohort-real-world-study-of-treatment-for-metastatic-colorectal-cancer-mcrc-overall-effica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-immunotherapy-in-thymoma-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-driving-distance-to-clinic-with-treatment-route-and-dosing-for-metastatic-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fhinch-study-fertility-and-sexual-health-effects-of-cancer-therapy-in-young-women-with-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differences-in-tumor-somatic-mutations-by-race-in-va-patients-with-colon-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dalpiciclib-plus-chidamide-in-hrher2-advanced-breast-cancer-following-cdk46-inhibitor-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-systematic-review-and-critical-appraisal-of-current-recommendations-for-lung-cancer-screening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recruitment-strategies-and-enrollment-for-a-virtually-supervised-exercise-intervention-for-hispanic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-of-nsclc-with-no-targetable-driver-mutation-among-different-races-an-exploratory 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-lung-cancer-epidemiology-and-mortality-over-12-years-socioeconomic-and-demographic-dispar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-in-her2-positive-metastatic-breast-cancer-patients-with-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-pertuzumab-combined-with-taxanes-or-eribulin-in-her2-positive-breast-cancer-a-single-ar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-predictors-of-exceptional-response-exres-in-patients-pts-initiating-first-line-1l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-total-neoadjuvant-therapy-sequencing-with-surgical-intervention-and-overall-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-the-treatment-of-stage-iibc-and-iiia-colorectal-cancer-a-national-cancer-database-ncdb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilizing-cancer-community-outreach-and-engagement-to-explain-impact-of-age-income-residence-know 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dual-targeting-of-vegf-and-pd-1-a-phase-iii-trial-of-ivonescimab-a-novel-bispecific-antibody-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-landscape-of-distinct-follicular-lymphoma-histologic-grades-insights-from-genomic-and-tra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/astrocytoma-survival-patterns-and-key-prognostic-factors-a-population-based-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-metformin-exposure-on-colorectal-cancer-incidence-according-to-tumor-sidedness 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-combined-with-paclitaxel-and-nedaplatin-as-conversion-therapy-for-locally-advancedadva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-related-adverse-events-to-predict-outcomes-in-recurrentmetastatic-cervical-cancer-treated-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-of-body-fluid-cfdna-advancing-diagnostics-and-therapeutic-decisions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/board-certification-practices-of-us-hematologists-and-oncologists 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-results-from-the-kgog3056nirvana-r-trial-maintenance-niraparib-plus-bevacizumab-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-clinically-actionable-biomarker-detection-in-advanced-cancers-by-next-generation-sequenci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cervical-cancer-treatment-trajectories-in-a-sample-of-cervical-cancer-patients-in-the-democratic-rep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-sup68sup-gaga-psma-11-pet-biodistribution-with-immuno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-single-arm-clinical-study-of-icaritin-in-combination-with-gemcitabine-and-nab-pacitax 2026-08-24 monthly 0.7 https://rjrindex.com/articles/broadening-the-gates-analysis-of-potentially-modifiable-screen-failures-in-pancreatic-and-biliary-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/medical-racism-and-physician-trust-impressions-of-african-american-breast-cancer-patients-enrolled-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examination-of-post-radiation-survey-data-from-the-navigator-assisted-hypofractionation-navah-phas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ten-year-patterns-of-women-participating-in-treatment-clinical-trials-for-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-and-predictors-of-late-second-primary-malignancies-in-long-term-breast-prostate-colon-and-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-experience-with-an-immunotherapy-telehealth-platform 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recent-trends-in-reporting-and-methodological-rigor-of-non-inferiority-trials-in-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sorafenib-plus-hepatic-arterial-infusion-chemotherapy-versus-sorafenib-plus-transarterial-chemoembol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/access-to-cancer-care-for-undocumented-immigrants-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-ctdna-somatic-homologous-recombination-deficiency-hrd-in-triple-negative-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-safety-and-effectiveness-of-trastuzumab-deruxtecan-t-dxd-in-her2-overexpressing-maligna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-generative-model-for-the-design-of-novel-inhibitors-targeting-the-pd-1pd-l1-pathway 2026-08-24 monthly 0.7 https://rjrindex.com/articles/her2dx-prognostic-value-in-older-patients-with-her2-positive-early-breast-cancer-a-correlative-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-supportive-and-nutrition-care-program-for-older-adults-with-advanced-pancreatic-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stereotactic-body-radiotherapy-combined-with-pd-1-antibody-in-unresectable-colorectal-liver-metastas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/teledermatology-dermoscopy-expanding-access-to-skin-cancer-screening-to-reduce-healthcare-dispariti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-according-to-time-of-day-of-combined-immuno-chemotherapy-for-advanced-non-small-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-survival-data-analysis-in-egfr-mutated-nsclc-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-safety-and-preliminary-efficacy-of-amulirafusp-alfa-imm0306-in-combination-with-lenalidom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sarc044-a-phase-ii-trial-of-bezuclastinib-in-combination-with-sunitinib-in-patients-with-gist-who-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-pralsetinib-in-patients-with-advanced-ireti-fus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-trial-of-shr-a2102-a-nectin-4-directed-antibody-drug-conjugate-adc-in-advanced-solid-tum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-colorectal-cancer-precision-medicine-through-multi-omics-and-clinical-data-integration-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-dose-finding-phase-ib-study-to-assess-the-safety-tolerability-of-nesuparib-jpi-547 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-toripalimab-plus-capeox-in-patients-with-locally-advanced-ebv-positive-gastric-or-esopha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eaton-a-phase-i-trial-of-nazartinib-egf816-and-trametinib-in-egfr-mutant-egfrmut-non-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-outcomes-in-gyneco-oncology-in-late-and-last-line-setting-real-world-data-from-the-molecu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inhibition-of-transcriptional-cyclin-dependent-kinases-cdk1213-as-a-treatment-for-colorectal-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-imtapi-deletion-on-immunotherapy-outcomes-in-patients-with-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-post-discharge-symptom-monitoring-on-hospital-readmissions-a-randomized-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cadonilimab-plus-platinum-based-chemotherapy-bevacizumab-for-persistent-recurrent-or-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-of-survival-and-recurrence-after-liver-transplantation-for-unresectable-colorecta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-trial-of-adjuvant-cemiplimab-cemi-versus-placebo-pbo-for-high-risk-cutaneous-squamous-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iib-study-of-concurrent-intravenous-iv-and-intrathecal-it-nivolumab-n-and-relatlimab-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-survival-following-relapse-of-high-risk-neuroblastoma-a-study-from-the-inte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trofuse-020gog-3101engot-cx20-a-phase-3-randomized-active-controlled-open-label-multicenter-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-prognostic-precision-in-bladder-cancer-ai-driven-tumor-microenvironment-analysis-from-ha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-23-clinical-trial-investigating-rp2-plus-nivolumab-vs-ipilimumab-plus-nivolumab-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-tolerance-and-preliminary-efficacy-of-autologous-tumor-infiltrating-lymphocytes-tils-lm10 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-study-of-abemaciclib-a-cdk46-inhibitor-in-participants-with-hiv-associated-and-hiv-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-disitamab-vedotin-rc48-combined-with-camrelizumab-and-s-1-for-neoadjuvant-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-a-retrieval-augmented-generation-based-large-language-model-to-guide-oncologists-in-sea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pelvic-ultrasound-a-missed-opportunity-for-earlier-detection-of-cervical-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/autologous-tumor-infiltrating-lymphocytes-hs-it101-with-low-dose-lymphodepletion-and-il-2-infusion 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-a-plasma-cell-free-dna-methylation-based-multi-cancer-detection-test 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-immune-related-adverse-events-with-survival-and-treatment-outcomes-in-thymic-tumors-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-rag-01-a-novel-small-activating-rna-therapeutic-in-bcg-failure-non-muscle-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-data-from-nexicart-2-the-first-us-trial-of-car-t-in-rr-light-chain-al-amyloi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-single-arm-phase-ii-trial-of-adebrelimab-plus-nab-paclitaxel-and-carboplatin-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-after-luveltamab-tazevibulin-a-novel-folate-receptor-a-fra-targeting-antibody 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-to-timely-mental-health-care-in-cancer-patients-a-national-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-trial-of-the-androgen-receptor-ligand-directed-degrader-bms-986365-versus-investigators 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-trial-of-hcb101-a-novel-fc-based-anti-sirpa-cd47-fusion-protein-in-subjects-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-on-treatment-ctdna-dynamics-and-response-by-imaging-in-patients-with-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-activity-of-novel-targeting-of-s100a9-with-tasquinimod-for-relapsed-and-refractory-multiple 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-year-follow-up-results-from-the-phase-3-keynote-564-study-of-adjuvant-pembrolizumab-pembro-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-psagt02-after-6-12-months-treatment-for-metastatic-hormone-sensitive-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cobolimab-and-dostarlimab-in-the-first-line-treatment-of-unresectable-hepatoma-a-multi-center-sing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-mrna-car-therapy-correlative-biomarker-analysis-from-the-mt-302-phase-1-study-target 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dm005-an-anti-egfrc-met-bispecific-antibody-drug-conjugate-for-advanced-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-to-predict-outcome-after-177lulu-psma-for-metastatic-castration-resistant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-year-end-holidays-on-delayed-cancer-diagnoses-and-survival-implications-a-population-base 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hemoglobin-level-and-neutrophil-to-lymphocyte-ratio-as-prognostic-peripheral-blood-markers-of-surviv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-trends-in-disability-adjusted-life-years-dalys-and-mortality-of-pancreatic-cancer-among-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-cells-and-clusters-exhibiting-expression-of-pd-l1-in-colorectal-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aren1721-a-randomized-phase-2-trial-of-axitinibnivolumab-combination-therapy-vs-single-agent-nivo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-provider-experiences-with-telehealth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-gamma-ray-precision-effect-of-convolutional-neural-networks-on-chemotherapy-side-effects 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-disparities-in-us-neuroendocrine-tumor-clinical-trial-enrollment-over-the-past-qua 2026-08-24 monthly 0.7 https://rjrindex.com/articles/communication-in-aya-survivorship-clinical-settings-best-practices-and-challenges 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-analysis-of-a-randomized-phase-ii-study-of-front-line-chemo-immunotherapy-with-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disease-course-of-dmmr-endometrial-cancer-in-real-world-clinical-practice 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-host-genetic-variants-determining-bifidobacterium-abundance-in-the-lactose-metab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-immunotherapy-versus-chemotherapy-on-mortality-and-adverse-events-in-cancer-patients-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/associations-of-age-frailty-status-and-comorbidity-status-with-post-operative-outcomes-following-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sintilimab-plus-oxaliplatin-and-capecitabine-versus-sintilimab-plus-albumin-bound-paclitaxel-and-cap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-mortality-of-endometrial-cancer-in-appalachian-eastern-kentucky 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-data-driven-physician-engagement-and-effects-on-patient-recruitment-for-clinical-trial-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-adjuvant-nivolumab-in-resected-esophageal-or-gastroesophageal-junction-cancers-a-si 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-outcomes-of-intravenous-immunoglobulin-ivig-in-treatment-of-steroid-refractory-immune-check 2026-08-24 monthly 0.7 https://rjrindex.com/articles/venetoclax-as-cytoreductive-therapy-in-high-risk-acute-promyelocytic-leukemia-a-potential-alternati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-neoadjuvant-endocrine-therapy-naet-versus-neoadjuvant-chemotherapy-nac-in-stage-ii-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cupid-sup64sup-cu-tlx592-phase-i-pk-biodistribution-and-dosimetry 2026-08-24 monthly 0.7 https://rjrindex.com/articles/allogeneic-stem-cell-transplantation-in-chronic-myelomonocytic-leukemia-analysis-of-post-transplant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alter-pa001-a-multicenter-randomized-study-of-anlotinib-and-benmelstobart-in-combination-with-ag-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-diagnostic-accuracy-and-tumor-uptake-of-68ga-fapi-petct-versus-18f-fdg-petct-for-detec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-and-regional-mortality-trends-due-to-pulmonary-embolism-in-female-patients-with-genital-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decoding-tumor-evolution-in-advanced-ovarian-cancer-proteogenomic-insights-before-and-after-neoadju 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-immunotherapy-treatments-in-non-small-cell-lung-cancer-nsclc-using-novel-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthcare-disparities-in-merkel-cell-carcinoma-mcc-in-immune-checkpoint-inhibitor-ici-era-a-se 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-study-of-unresectable-stage-iii-or-stage-iv-melanoma-refractory-to-immune-checkpoint-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/update-on-phase-iii-pivotal-trial-of-bria-imt-cpi-vs-physicians-choice-in-advanced-metastatic-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gene-set-enrichment-analysis-of-oral-cavity-carcinoma-to-identify-pathways-associated-with-lymph-nod 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-neurocognitive-impairment-and-financial-hardship-in-adult-survivors-of-childhood-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-telomere-targeting-agent-thio-sequenced-with-cemiplimab-in-third-line-immune-checkp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evidence-of-a-role-for-oropharyngeal-cancer-cells-with-low-hpv-gene-expression-in-treatment-failure 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-decision-impact-study-of-the-breast-cancer-index-results-from-the-bci-registry-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/applications-of-artificial-intelligence-in-oncology-patient-education-a-scoping-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-equity-and-collaboration-in-a-dedicated-young-onset-cancer-clinic-a-prospective-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examining-the-link-between-p16-an-aging-biomarker-and-a-clinically-meaningful-functional-outcome-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-and-predictors-of-chronic-graft-vs-host-disease-in-bone-marrow-transplant-recipients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concurrent-acute-myeloid-leukemia-and-chronic-lymphocytic-leukemia-a-review-and-clinical-insights 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-antecedent-myelodysplastic-syndrome-treatment-on-outcomes-and-treatment-response-in-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-proton-pump-inhibitor-ppi-pharmacogenomics-pgx-on-toxicities-associated-with-immune-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/venetoclaxazacitidine-vs-intensive-chemotherapy-as-a-bridge-to-allogeneic-hsct-in-aml-experience-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-car-t-cell-therapy-versus-allogeneic-stem-cell-transplantation-in-relapsedrefractory-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/public-health-policy-and-cancer-prevention-impact-of-hpv-vaccine-laws-on-oropharyngeal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/drug-sensitivity-patterns-across-fab-subtypes-and-molecular-mutations-in-aml 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-gender-disparities-in-the-prevalence-of-severe-ards-among-lung-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-characteristics-and-outcomes-of-systemic-mastocytosis-sm-patients-pts-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-real-world-data-sources-for-clinical-oncology-research-a-review-of-studies-published-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-body-mass-index-and-overall-survival-in-veterans-receiving-immune-checkpoint-inh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elevated-risk-of-multiple-primary-malignancies-in-esophageal-cancer-survivors-incidence-patterns 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-and-facilitators-to-implementing-the-clinical-trial-navigator-program-a-qualitative-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-outpatient-rehabilitation-services-on-physical-function-and-potential-risk-of-unplanne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitor-use-and-health-care-utilization-in-an-academic-center-a-retrospective-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pharmacoeconomic-analysis-of-perioperative-chemo-immunotherapy-in-resectable-stage-iii-non-small-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toward-sequencing-every-core-needle-biopsy-by-addressing-one-gap-at-a-time 2026-08-24 monthly 0.7 https://rjrindex.com/articles/electronic-patient-reported-outcome-based-weight-management-versus-usual-care-during-induction-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fecal-microbiota-transplantation-combined-with-sintilimab-and-sox-as-first-line-treatment-for-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perception-of-women-with-breast-cancer-regarding-patient-navigation-services-served-at-the-western-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-and-facilitators-to-seeking-care-for-the-initial-diagnosis-of-melanoma-in-an-urban-safety-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-randomized-trial-of-nano-crystalline-megestrol-acetate-for-nutritional-improvement-in-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metronomic-therapy-as-a-favorable-independent-factor-for-survival-in-high-risk-oral-cavity-squamous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-plus-chemotherapy-or-apatinib-in-the-first-line-treatment-of-recurrent-or-metastatic-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-time-to-treatment-discontinuation-among-advanced-alk-positive-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-trends-and-disparities-in-laryngeal-cancer-mortality-from-1999-to-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-l1-expression-level-in-a-large-cohort-from-an-indian-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differences-in-genomic-profiles-targeted-treatment-use-and-overall-survival-in-patients-with-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-early-palliative-care-integration-on-healthcare-utilization-in-patients-with-newly-diagnos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-the-immune-microenvironment-and-spatial-phenotypes-across-her2-subtypes-in-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-language-gap-in-palliative-oncology-a-translation-and-validation-of-the-urdu-version-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-immunopathological-evaluation-and-its-comparison-with-consensus-molecular-subtypes-of-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-relevance-of-starting-alectinib-at-a-reduced-dose-in-patients-with-alk-positive-non-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/harnessing-transcriptome-signatures-and-cd103cd8-immune-infiltration-for-prognosis-and-treatment-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progressive-nk-cell-dysfunction-and-ilc-imbalance-as-drivers-of-immune-evasion-in-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-obesity-and-lifestyle-associated-risk-factors-on-outcomes-of-early-onset-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-profiling-of-cell-free-dnas-to-identify-molecular-characteristics-related-to-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-open-label-multicenter-blank-controlled-phase-iv-clinical-trial-of-biyan-qingdu-gra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-alterations-gas-associated-with-durability-of-benefit-from-trastuzumab-deruxtecan-t-dxd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/image-harmonization-for-pd-l1-immune-checkpoint-inhibitor-response-prediction-using-radiomic-featu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-and-circulating-tumor-dna-landscape-in-young-onset-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-features-and-outcomes-of-follicular-dendritic-cell-sarcoma-with-or-without-castlem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthcare-provider-experiences-in-managing-antibody-drug-conjugate-dosing-adjustments-due-to-nausea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dabrafenib-and-trametinib-in-the-treatment-of-braf-mutated-anaplastic-thyroid-cancers-atc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-cellular-interactions-in-the-tnbc-tumor-microenvironment-in-association-with-pd-l1-expressi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/benefit-of-adding-cureety-remote-patient-monitoring-rpm-to-usual-care-during-injectable-anticancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-sepsis-related-mortality-among-patients-with-malignancies-a-25-year-natio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-generative-ai-models-performance-on-patient-education-quizzes-hormone-related-sympto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-sociodemographic-and-clinical-factors-on-time-to-treatment-initiation-in-adult-soft-tissue 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intrathecal-deferoxamine-in-patients-with-leptomeningeal-metastases-phase-1a-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cross-state-variations-and-temporal-trends-in-tracheal-bronchus-and-lung-cancer-burden-in-india-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anxiety-depression-fear-of-cancer-recurrence-fcr-and-health-related-quality-of-life-hrql-in-pe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-low-dose-5-mg-versus-8-mg-dexamethasone-with-nepa-for-the-168-h-prevention-of-highly-or-moder 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-cell-proliferation-pathway-on-accessibility-to-targeted-therapeutics-in-the-spectrum-of-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-progression-decision-score-to-improve-subsequent-treatment-regimen-selection-after-init 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profile-of-hepatocellular-carcinoma-hcc-in-older-oa-versus-younger-adults-ya-receivi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iiia-clinical-study-of-4th-generation-btk-inhibitor-hbw-3220-capsules-in-patients-with-b-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-cfdna-based-protein-informed-epigenetic-signature-pep-sig-to-enable-biomarker-bas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unraveling-the-oncogenic-potential-of-p53-amyloids-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-year-outcomes-of-perioperative-or-only-adjuvant-gemcitabine-plus-nab-paclitaxel-for-resectable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-resident-education-in-ambulatory-oncology-a-targeted-needs-assessment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulated-t-cell-exhausted-subtypes-to-predict-response-in-pdac-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-plus-albumin-bound-paclitaxel-and-s-1-as-first-line-treatment-of-her-2-negative-unresec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-carboplatintaxane-cbt-with-or-without-doxorubicincyclophosphamide-ac-in-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-evaluating-olutasidenib-in-patients-with-iidh1i-mutated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-and-spatial-expression-of-cldn182-in-gastric-cancer-and-gastroesophageal-junction-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-postoperative-adjuvant-therapy-and-surgery-alone-in-pathological-n1-2-esophageal-squam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-transarterial-chemoembolization-followed-by-sintilimab-anti-pd-1-oxaliplatin-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-pt-characteristics-treatment-patterns-and-outcomes-in-unresectable-hepatocellular-carcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/methodology-for-estimation-of-progression-free-survival-in-patients-with-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-survival-outcomes-in-us-veterans-aged-80-with-newly-diagnosed-diffuse-large 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-quality-of-life-qol-in-patients-pts-with-metastatic-renal-cell-carcinoma-mrcc-on-ac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-induction-chemoimmunotherapy-with-surgery-and-concurrent-chemoradiation-followed-by-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-genomic-landscape-of-lynch-syndrome-associated-urothelial-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-cohort-study-of-real-world-clinical-outcomes-in-patients-with-cllsll-previously-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-lycat-in-egfr-tki-resistance-nsclc-progression-and-smoking-induced-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-high-dose-vitamin-c-as-adjunct-treatment-in-gastric-and-colorectal-cancers-a-systematic-rev 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-landscape-in-patients-with-squamous-cell-carcinoma-of-the-anal-canal-scac-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-scoring-systems-in-first-line-chemotherapy-combined-with-immunotherapy-unique-predictive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-recombinant-newcastle-disease-virus-expressing-trail-to-overcome-resistance-and-enhance-apopt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/penelope-a-randomized-phase-ii-trial-of-first-line-carboplatin-and-paclitaxel-in-combination-with-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-venous-thromboembolism-risk-in-hrher2-breast-cancer-patients-receiving-cdk46-inhibitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-proliferation-related-genes-as-predictive-factors-for-adjuvant-therapy-in-colon-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rectal-arterial-infusion-chemotherapy-combined-with-anti-pd1-antibody-for-microsatellite-stable-loca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/propensity-matched-analysis-of-immunotherapy-alone-vs-chemotherapy-alone-in-stage-ii-iv-colon-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-line-treatment-patterns-and-outcomes-of-advanced-gastrointestinal-stromal-tumor-a-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whos-on-the-podium-geographic-and-career-diversity-of-asco-annual-meeting-presenters 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ramucirumab-in-pediatric-and-young-adult-patients-pts-with-relapsedrefractory-rr-desmoplastic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shr-8068-plus-adebrelimab-and-bevacizumab-for-advanced-hepatocellular-carcinoma-ahcc-a-phase-1b2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/value-of-tumor-mutational-burden-as-a-prognostic-factor-in-patients-with-non-small-cell-lung-carcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rhea-1-first-in-human-fih-study-of-azd9793-a-first-in-class-cd8-guided-t-cell-engager-tce-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-biomarker-analysis-of-trastuzumab-deruxtecan-t-dxd-vs-physicians-choice-of-chemothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-first-in-human-study-of-pfl-721stx-721-in-participants-with-locally-advanced-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/parpi-effectiveness-after-cdk46i-in-ibrca1i-and-ibrca2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/octreotide-scintigraphy-versus-dotatoc-pet-concordance-of-krenning-scores-and-implications-on-prrt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-pathogenic-variants-in-cancer-predisposition-genes-and-overall-survival-of-women-with-breas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ev-302-long-term-subgroup-analysis-from-the-phase-3-global-study-of-enfortumab-vedotin-in-combinati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-of-trifluridinetipiracil-and-bevacizumab-combination-according-to-baseline-prog 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lung-cancer-diagnosis-rates-lcdr-in-lung-cancer-screening-lcs-and-incidental-pulmonary-nodule-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-exercise-referral-practices-and-barriers-among-oncologists-in-public-and-private-inst 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neopancone-gata6-expression-as-a-predictor-of-benefit-to-peri-operative-modified-folfirinox-in-rese 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-1l-datopotamab-deruxtecan-dato-dxd-rilvegostomig-in-advanced-or-metastatic-non-smal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adverse-events-and-tolerability-of-immune-checkpoint-inhibitors-ici-for-the-treatment-of-early-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/co-designing-a-smartphone-based-navigation-system-for-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-helicobacter-pylori-eradication-on-prognosis-after-gastrectomy-for-gastric-cancer-a-syste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-racial-socioeconomic-disparities-and-outcomes-of-t-cell-prolymphocytic-leukemia-a-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-physician-perspectives-of-facilitators-and-barriers-in-clinical-trial-accrual-to-inform 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-a-first-in-human-phase-1b-acceler8-001-study-of-s-531011-a-humanized-anti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-ibi363-monotherapy-or-in-combination-with-bevacizumab-in-patients-with-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-of-pod1um-201-a-phase-2-study-of-retifanlimab-a-humanized-anti-pd-1-antibody-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-and-prognostic-value-of-baseline-psma-pet-total-tumor-volume-and-suv-mean-within-enza-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utidelone-in-combination-with-etoposide-and-bevacizumab-in-her2-negative-breast-cancer-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/technical-performance-of-the-l3-skeletal-muscle-index-in-ct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequencing-guided-chemotherapy-optimization-using-real-time-evaluation-in-newly-diagnosed-dlbcl-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/claudin-182-expression-in-gastro-oesophageal-adenocarcinoma-in-a-western-population-overlap-with-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethnic-differences-in-nonalcoholic-fatty-liver-disease-nafld-among-women-with-early-stage-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-biomarkers-for-patients-with-head-and-neck-squamous-cell-carcinoma-hnscc-treated-with-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-study-evaluating-safety-pharmacokinetics-and-efficacy-of-abbv-291-a-cd79 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-global-phase-23-randomized-open-label-trial-of-bnt327pm8002-in-combination-with-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-brain-metastases-in-lung-cancer-patients-with-high-pd-l1-expression-gt50-compared 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glp-1-receptor-agonists-and-breast-cancer-risk-in-type-2-diabetes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/landscape-of-functional-dll3-expression-in-gastroenteropancreatic-neuroendocrine-neoplasms-gep-nens 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-2-peri-operative-neoadjuvant-plus-adjuvant-study-of-fianlimab-anti-lag-3-plus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-oral-prostate-cancer-riptactherapeutic-in-phase-1-for-metastatic-castrate-resistant-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-immune-landscape-in-early-onset-colorectal-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-18f-dopa-pet-and-advanced-mri-on-treatment-response-assessment-in-idh12-mutant-gliomas-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-mfge8-expression-and-regional-localization-in-glioblastoma-tumor-samples-at-diagnosis-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/two-cycles-of-neoadjuvant-therapy-with-low-dose-radiotherapy-pd-1-inhibitor-tislelizumab-albumin-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-as-an-early-response-indicator-in-anal-squamous-cell-carcinoma-treated-with-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/allogeneic-hematopoietic-stem-cell-transplantation-in-elderly-patients-age-over-70-years-with-high 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-incidence-among-indigenous-adults-in-brazil-a-19-year-analysis-of-hospital-cancer-registry-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-global-phase-iii-double-blind-randomized-trial-of-bnt327pm8002-plus-chemotherapy-chemo-compar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-outcomes-of-lymphoma-directed-car-t-cell-therapy-in-patients-with-and-without-hiv-a-retro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-olomorasib-immunotherapy-in-first-line-treatment-of-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-palliative-care-intensity-of-end-of-life-care-and-their-impact-on-overall-survival-in-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disruptive-advances-in-exosome-lyophilization-unlocking-new-frontiers-in-precision-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-sotorasib-response-duration-and-identification-of-clinically-actionable-resistance-mec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-review-of-additional-primary-cancers-in-breast-cancer-patients-from-a-tumor-registry-of-a-large-te 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-and-determinants-of-palliative-care-utilization-among-hospitalized-patients-with-acu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-accounting-of-comprehensive-radiotherapy-life-cycle-assessment-components-in-africa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/one-size-doesnt-fit-all-early-outcomes-of-implementing-the-asco-pga-in-an-australian-public-hospit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-initial-abemaciclib-dosing-with-duration-of-medication-use-in-patients-with-stage-ii 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-outcomes-of-rejection-in-solid-organ-transplant-recipients-treated-with-immune-checkpo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-landscape-of-sarcoma-patients-treated-with-an-autologous-dendritic-cell-vaccine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-related-kidney-toxicity-management-and-outcomes-in-ici-treated-patients-with-advanced-or-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-profiling-of-circulating-tumor-dna-and-microbial-landscapes-in-nasopharyngeal-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-acute-and-chronic-toxicities-from-adjuvant-therapies-post-resection-of-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/central-neck-lymphadenectomy-at-surgical-treatment-of-papillary-thyroid-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-ai-informed-biomarkers-of-spatial-organization-of-tumor-infiltrating-lymphocytes-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-chemotherapy-followed-by-chemoradiotherapy-with-cisplatin-or-cetuximab-for-unresectable-lo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/establishment-and-validation-of-a-dynamic-prognostic-model-using-serial-circulating-tumor-dna-ctdna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-ehrs-and-a-phenome-wide-association-study-to-identify-pre-diagnostic-clinical-markers-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnosis-treatment-and-outcomes-of-multiple-myeloma-in-armenia-a-real-world-experience-from-a-de 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-amyloidosis-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-ctdna-monitoring-in-patients-with-metastatic-uveal-melanoma-undergoing-isolated-hepatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fc-engineered-anti-cd9-antibodies-with-reducing-platelet-toxicity-and-efficacy-against-acute-lymphob 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proteinuria-with-preserved-renal-function-pprf-a-retrospective-cohort-study-in-newly-diagnosed-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determinants-of-oral-cavity-cancer-recurrence-in-pakistan-findings-from-a-cross-sectional-study-usi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-webcam-based-tool-to-assess-tongue-motility-and-its-correlation-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advance-care-planning-documentation-prior-to-end-of-life-systemic-therapy-a-single-institution-retr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-radioactive-iodine-refractory-rair-differentiated-thyroid-cancer-dtc-with-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicentric-evaluation-of-an-artificial-intelligence-model-to-stratify-stage-ii-colon-cancer-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-cetuximab-plus-tislelizumab-combined-with-chemotherapy-in-pmmr-rasbraf-wild-type-wt-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/landscape-analysis-of-proteins-in-the-development-of-breast-cancer-brain-metastasis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dissecting-primary-endocrine-resistance-through-ctdna-profiling-of-a-hybrid-real-world-and-clinical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/heterogeneity-in-epithelioid-hemangioendothelioma-ehe-insights-into-common-and-organ-specific-tum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-molecular-analysis-of-phase-ibii-trial-of-durvalumab-plus-doxorubicin-combination-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-discontinuation-in-desmoid-tumors-factors-associated-with-better-outcomes-after-sorafenib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/engineering-ipsc-derived-mesenchymal-stem-cells-i-mscs-to-secrete-il-7il-15-for-modulation-of-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-analysis-of-lung-adenocarcinomas-from-the-safir02-lung-trial-explores-metastasis-associate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-opioid-prescription-fills-following-cancer-directed-surgery 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tackling-healthcare-provider-bias-in-care-and-research-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-efficacy-of-voice-a-decision-support-tool-for-older-adults-with-advanced-cancer-a-pilo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-single-center-investigator-initiated-exploratory-clinical-study-in-patients-with-refra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethnic-disparities-in-clinical-trials-for-fda-approved-drugs-in-lung-cancer-a-post-covid-era-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progression-free-survival-in-control-arms-of-clinical-trials-analysis-of-fda-cancer-drug-approvals 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-analysis-on-reactive-cutaneous-capillary-endothelial-proliferation-following-camrelizu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phasex-patient-tumor-avatars-for-evaluating-anticancer-therapeutics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/achieving-equity-in-genomic-testing-for-breast-cancer-through-partner-led-strategies-and-policies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immunochemotherapy-for-locally-advanced-esophageal-squamous-cell-carcinoma-pooled-resul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/how-cancer-impacts-adolescents-and-young-adults-ayas-scholastic-experiences-insight-on-supporti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cervical-cancer-mortality-trends-and-disparities-in-women-of-the-united-states-a-two-decade-retrosp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-disease-progression-on-health-related-quality-of-life-hrqol-updated-results-from-the-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-analysis-of-scores-a-phase-iii-randomized-double-blinded-placebo-controlled-study-of-suvemc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tace-combined-with-the-intra-arterial-infusion-of-bevacizumab-for-bclc-stage-b-hepatocellular-carcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-and-demographic-trends-in-mortality-from-breast-cancer-and-cerebrovascular-diseases-in-unit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-disparities-among-patients-referred-externally-for-clinical-trials-in-a-large-commu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/equity-analysis-of-clinical-oncology-treatment-pathways-usage-in-an-integrated-health-care-delivery 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gentian-violet-compared-with-methylene-blue-for-sentinel-lymph-node-biopsy-in-breast-cancer-a-retro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-and-insurance-based-inequities-in-oncotype-dx-testing-and-score-guided-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-efficacy-and-safety-of-ponatinib-in-acute-lymphoblastic-leukemia-a-systematic-rev 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-disparities-between-patients-with-breast-cancer-with-and-without-hiv-at-jaramogi-oginga-odi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-regional-trends-and-disparities-in-leukemia-mortality-in-the-united-states-1999-202 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-metastatic-cancer-curable-a-survey-of-medical-oncologists 2026-08-24 monthly 0.7 https://rjrindex.com/articles/are-we-still-choosing-wisely-predictors-of-unnecessary-staging-imaging-in-us-veteran-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-implications-and-prevalence-of-benign-ethnic-neutropenia-ben-in-breast-cancer-patients-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-the-prostest-a-novel-blood-based-molecular-assay-versus-psa-for-prostate-cancer-stratif 2026-08-24 monthly 0.7 https://rjrindex.com/articles/access-to-initial-and-subsequent-indications-of-new-oncology-drugs-a-us-canada-comparison 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-characteristics-and-clinical-outcomes-of-driver-mutant-oligometastatic-non-small-cell-lung-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/co-mutations-in-non-small-cell-lung-cancer-real-world-data-and-clinical-insights-from-a-tertiary-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-outcomes-in-mcrpc-the-impact-of-androgen-receptor-inhibitor-sequencing-before-177lu-psma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mhc-class-i-expression-and-outcomes-in-breast-cancer-in-the-real-world-clinico-genomic-data-and-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-study-on-first-line-1l-treatment-for-46-advanced-lung-adenocarcinoma-patients-harbour 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mitoxantrone-hydrochloride-liposome-combined-with-cytarabine-ma-for-patients-with-newly-diagnosed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gene-expression-signatures-ges-derived-from-digital-histology-to-predict-pathologic-complete-respo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-germline-ibrcai-status-on-clinical-outcomes-of-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mathematical-modeling-applied-to-the-growth-and-invasion-of-gliomas-a-narrative-review-of-methods-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-barriers-facilitators-and-best-practices-for-optimal-provider-to-provider-communication-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elevated-hernia-risk-in-renal-cell-carcinoma-rcc-patients-treated-with-tyrosine-kinase-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-glioblastoma-therapy-with-a-recombinant-newcastle-disease-virus-harboring-the-pten-gene 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-proteomics-based-approach-for-detection-of-esr1-mutant-peptides-in-hormone-receptor-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preoperative-and-postoperative-risk-prediction-models-based-on-perirenal-fat-and-immune-infiltration 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-agnostic-therapies-in-a-high-volume-brazilian-center-real-world-challenges-and-opportunities 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-analysis-of-pathological-prognostic-factors-related-to-lymphovascular-invasion-lvi-and-perineu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemoimmunotherapy-in-advanced-biliary-tract-cancers-a-meta-analysis-of-clinical-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/donafenib-plus-tace-with-or-without-pd-l1-inhibitors-for-the-treatment-of-unresectable-hepatocellu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-public-and-private-ovarian-cancer-register-in-chile-potential-effect-of-national-formulary-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/envafolimab-and-chidamide-in-combination-with-gemox-as-first-line-treatment-for-advanced-and-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-local-therapy-in-chinese-patients-with-bclc-stage-c-hepatocellular-carcinoma-hcc-a-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-appropriate-therapeutic-sequence-with-angiogenesis-inhibitor-and-chemotherapy-in-patients-with-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-glioblastoma-care-insights-from-a-nationwide-survey 2026-08-24 monthly 0.7 https://rjrindex.com/articles/addressing-disparities-by-implementing-a-supportive-care-program-in-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-testing-in-newly-diagnosed-patients-with-metastatic-non-small-cell-lung-cancer-nsclc-a-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-fairness-and-mitigating-bias-in-models-predicting-financial-toxicity-among-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-locally-advanced-inoperable-nsclc-patients-converted-to-resectable-disease-by-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evaluation-of-treatment-patterns-and-clinical-outcomes-among-patients-with-primary-medias 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-and-proteomic-predictors-of-sites-of-metastases-in-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-performance-of-ishox2i-and-irassf1ai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-characteristics-and-outcomes-of-diffuse-large-b-cell-lymphoma-in-adolescents-and-young-adu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-adoption-of-adjuvant-molecularly-targeted-therapy-and-immunotherapy-for-resected-stage-ib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-odronextamab-in-non-hodgkin-lymphoma-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-carotuximab-env105-mediated-cd105-blockade-on-osimertinib-sensitivity-in-egfr-mutant-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cataloging-genomic-and-transcriptomic-features-of-relapsed-sclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-cancer-specific-survival-for-early-onset-gastric-cancer-insights-from-a-21-year 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-morbidity-and-role-of-mammographic-screening-program-in-uzbekistan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-the-pygl-with-chicoric-acid-to-normalize-glucose-metabolism-to-inhibit-progress-in-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-a-systemically-administered-innate-immune-modulator-on-anti-tumor-activity-against-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-trends-in-incidence-and-prevalence-of-gastric-cancer-among-older-adults-70-from-1990-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigation-of-pharmacodynamic-and-prognostic-potential-of-fap-activity-assessed-through-fap-media 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-personalized-prognosis-in-appendiceal-ac-and-cecal-adenocarcinoma-ca-with-machine-lear 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recognizing-international-medical-graduates-awards-and-committee-membership-in-asco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interpretable-artificial-intelligence-driven-selection-of-doublet-chemotherapy-regimens-as-second-li 2026-08-24 monthly 0.7 https://rjrindex.com/articles/residents-understanding-of-cancer-prognosis-does-the-level-of-training-or-oncology-rotation-experi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overview-of-endocrine-malignancies-in-jordan-insights-from-the-mena-region 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peripheral-eosinophilia-as-a-potential-biomarker-of-response-and-immune-related-adverse-events-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-on-effectiveness-of-palbociclib-in-indian-patients-with-breast-cancer-a-single 2026-08-24 monthly 0.7 https://rjrindex.com/articles/variation-in-mortality-from-digestive-system-cancers-in-peru-during-the-period-2001-2020-and-its-pre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-dietary-cholesterol-serum-lipids-and-cancer-specific-mortality-in-us-adults 2026-08-24 monthly 0.7 https://rjrindex.com/articles/landscape-of-homologous-recombination-repair-pathway-germline-ngs-gene-variants-in-a-tnbc-rich-cohor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-on-recurrence-risk-from-clinicopathologic-features-in-hrher2-early-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-of-first-line-chemo-immunotherapy-and-chemotherapy-on-es-sclc-a-propensity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/substudy-g-of-the-canadian-cancer-trials-group-cctg-ind234-pc-bets-v-a-circulating-tumor-dna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-ai-for-validating-the-association-between-minimal-residual-disease-mrd-and-survival-out 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-tigos-trial-a-randomized-double-blind-phase-3-trial-of-atigotatug-nivolumab-fixed-dose-combi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/isatuximab-carfilzomib-lenalidomide-and-dexamethasone-isa-krd-for-high-risk-hr-newly-diagnose 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-subcutaneous-versus-intravenous-administration-of-pd-l1-inhibitors-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-predictive-role-of-tumor-sidedness-in-irasi-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-machine-learning-risk-prediction-models-for-detection-of-early-onset-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-neoadjuvant-tqb2102-in-women-with-locally-advanced-or-early-her2-positive-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-an-ai-model-for-predicting-germline-brca12-mutations-from-hrher2-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hematological-malignancies-in-the-united-states-what-do-mortality-trends-reveal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pod1um-303interaact2-subgroup-analyses-and-impact-of-delayed-retifanlimab-treatment-on-outcomes-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/delayed-immune-related-adverse-events-associated-with-immune-checkpoint-inhibitors-a-pharmacovigila 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-the-numbers-dissecting-racial-and-gender-disparities-in-myeloma-mortality 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-sup18sup-ffluoroestradiol-fes-petct-to-guide 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodal-artificial-intelligence-mmai-model-to-identify-benefit-from-2nd-generation-androgen-rec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-surgical-and-treatment-patterns-after-neoadjuvant-checkpoint-inhibition-in-us-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarkers-of-response-to-immunotherapy-in-pancreatic-ductal-adenocarcinoma-pdac-with-homologous-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-in-metastatic-egfr-mutation-positive-nsclc-patients-a-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-predictive-impact-of-pd-l1-expression-on-immunotherapy-outcomes-and-immunophenotype-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-pembrolizumab-in-combination-with-cisplatin-or-carboplatin-and-pemetrexed-as-induc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-somaticgermline-homologous-recombination-repair-hrr-alterations-on-metastatic-hormone-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/matching-adjusted-indirect-comparison-maic-of-lisocabtagene-maraleucel-liso-cel-versus-axicabtag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/s1900e-a-phase-ii-study-examining-impact-of-co-mutations-on-sotorasib-for-previously-treated-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-utract-registry-a-single-arm-multicenter-prospective-and-retrospective-registry-study-to-eva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-clinical-outcomes-with-nivolumabipilimumab-with-or-without-iclostri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-a-small-molecule-c-myc-degrader-wbc100-in-solid-tumors-a-first-in-human-pha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/medical-oncologist-reported-challenges-of-treating-metastatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-from-the-open-label-phase-2-trial-of-palbociclib-in-patients-with-advanced-well-dif 2026-08-24 monthly 0.7 https://rjrindex.com/articles/claudin182-specific-car-t-cells-satri-cel-versus-treatment-of-physicians-choice-tpc-for-previo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hematologic-response-in-patients-with-myelofibrosis-treated-with-pacritinib-in-real-word-clinical-se 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-open-label-randomized-study-of-rinatabart-sesutecan-rina-s-vs-investigators-choice-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-differences-in-survival-of-anal-melanoma-an-analysis-of-the-united-states-national-cancer-datab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-features-and-clinical-panthological-factors-of-mucosal-malignant-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-germline-vs-somatic-brca-mutation-status-on-the-efficacy-of-rucaparib-vs-physicians-choic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lutetium-177-psma-617-in-oligo-metastatic-hormone-sensitive-prostate-cancer-bullseye-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/race-sex-and-survival-disparities-in-mycosis-fungoides-and-sezary-syndrome-a-seer8-database-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-vs-pivotal-trial-outcomes-of-imatinib-in-newly-diagnosed-chronic-myeloid-leukemia-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-lenvatinib-plus-pembrolizumab-for-resectable-clear-cell-renal-cell-carcinoma-pelur-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combining-sbrt-with-gm-csf-and-peg-ifna-to-induce-abscopal-effects-in-previously-treated-patients-wi-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/change-in-t2-weighted-signal-intensity-change-in-tumor-volume-and-exposure-response-analysis-in-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-comparison-of-palbociclib-ribociclib-and-abemaciclib-in-patients-with-hrher2-abc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-socioeconomic-status-with-secondary-primary-malignancy-risk-and-mortality 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-larotrectinib-in-patients-with-trk-fusion-lung-cancer-an-updated-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-of-dose-reduced-capmatinib-and-tepotinib-for-advanced-met-exon-14-skipping-nscl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/jskn003-a-biparatopic-anti-her2-antibody-drug-conjugate-adc-in-the-treatment-of-platinum-resista 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sacituzumab-tirumotecan-sac-tmt-in-patients-pts-with-previously-treated-advanced-egfr-mutated-no 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nsclc-in-the-immunotherapy-era-trends-in-survival-and-disparities-across-demographic-and-socioecono 2026-08-24 monthly 0.7 https://rjrindex.com/articles/starlite-1-phase-1b2-study-of-combination-sup177sup-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/soho-01-safety-and-efficacy-of-bay-2927088-in-patients-with-advanced-iher2i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/10-year-follow-up-of-a-phase-2-clinical-trial-of-pembrolizumab-pembro-in-microsatellite-instabilit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analyzing-fatigue-as-a-common-adverse-effect-in-patients-treated-with-immune-checkpoint-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-the-dll3cd3-t-cell-engager-obrixtamig-in-patients-with-extrapulmonary-neuroe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/able-41-a-real-world-evidence-study-for-bladder-cancer-patients-treated-with-nadofaragene-firadenov 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-post-chimeric-antigen-receptor-car-t-cell-monitoring-evidence-across-lisocabtagene-mar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hydroxyurea-vs-hypomethylating-vs-other-agents-in-chronic-myelomonocytic-leukemia-a-retrospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/meeting-enrollment-targets-in-imbrave152skyscraper-14-a-global-phase-3-study-in-patients-with-unre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glutaminase-isoform-expression-in-cancer-implications-for-metabolic-adaptation-and-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-pk-analysis-of-antibody-conjugated-liposome-encapsulating-doxorubicin-hf-k1-in-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/valor-study-a-phase-ii-trial-of-vorinostat-to-augment-response-to-177lutetium-psma-617-in-the-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-neoadjuvant-chemotherapy-nac-docetaxel-cisplatin-alone-dc-or-with-anti-human-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-trastuzumab-deruxtecan-in-her2-and-her2-low-metastatic-breast-cancer-real-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-normal-plasma-cell-biomarkers-after-arlocabtagene-autoleucel-arlo-cel-treatment-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-safety-and-efficacy-of-cadonilimab-mono-or-combination-therapy-in-recurrentpersistentme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-experience-of-fruquintinib-in-patients-with-metastatic-colorectal-cancer-a-single-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/autologus-dendritic-cell-vaccine-in-gbm-does-geography-matter-retrospective-analysis-from-a-single 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-informed-navigation-of-patients-in-persistent-poverty-zip-codes-to-improve-colorect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-plasma-biomarkers-with-recurrence-in-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-trial-of-intravesical-bh011-a-novel-docetaxel-formulation-in-patients-with-high-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-evidence-based-patient-centered-care-in-bladder-cancer-in-community-based-settings-a-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/polygenic-risk-score-for-breast-cancer-in-the-thai-population-addressing-genetic-disparities-in-und 2026-08-24 monthly 0.7 https://rjrindex.com/articles/revision-of-staging-system-for-natural-killer-t-cell-lymphoma-a-multicenter-study-from-the-chinese 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-determinants-of-primary-refractory-metastatic-renal-cell-carcinoma-mrc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-validation-of-northstar-response-for-monitoring-mono-and-combination-immunotherapy-efficac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-of-patients-pts-with-microsatellite-stablemismatch-repair-proficient-msspmmr-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-transcriptomic-regulation-of-the-tissue-associated-microbiome-in-oncogenic-progression-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-weighted-ctdna-dynamics-for-precision-monitoring-of-relapse-risk-in-colon-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bites-vs-icis-in-lymphoma-leukemia-and-myeloma-which-immunotherapy-reigns-supreme-a-systematic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ib-study-of-inavolisib-inavo-weekly-paclitaxel-wp-in-patients-pts-with-locally-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-role-of-c-reactive-protein-and-procalcitonin-in-risk-stratification-and-outcomes-of-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/steroid-receptor-expression-and-overall-survival-in-breast-cancer-patients-with-er-bone-metastasis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-and-prognostic-factors-of-patients-with-ewing-sarcoma-at-first-recurrence-following-modern 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-influencing-withdrawal-without-a-defined-reason-in-oncology-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-induced-changes-in-blood-indices-among-chronic-dialysis-patients-a-nationwide-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progression-patterns-and-clinical-outcomes-after-anti-pd-1-therapy-failure-in-patients-with-cutaneou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-gut-microbiome-in-pediatric-diffuse-midline-gliomas-correlative-study-results-from-the-pnoc022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-early-phase-study-enrollment-for-pediatric-oncology-patients-have-an-impact-on-symptom-burden-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapeutic-responses-in-555-advanced-nsclc-patients-enrolled-in-phase-i-studies-at-md-anderson-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/amivantamab-for-recurrentmetastatic-adenoid-cystic-carcinoma-a-multicenter-single-arm-phase-2-cl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-role-of-lrp1b-in-chemo-resistance-in-advanced-triple-negative-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-pembrolizumab-pembro-plus-plinabulin-plin-and-docetaxel-doc-for-patients-pts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-experiences-of-diagnosis-and-treatment-of-invasive-lobular-carcinoma-a-qualitative-study-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-mettl3-inhibition-in-pre-clinical-models-of-mds-and-aml 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toripalimab-plus-docetaxel-oxaliplatin-and-capecitabine-for-untreated-metastatic-gastric-and-esoph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-pareto-principle-in-oncology-how-a-minority-of-countries-account-for-the-major-share-of-latin-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fruquintinib-plus-sintilimab-and-sox-as-conversion-therapy-for-initially-unresectable-gastricgastro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-technology-enabled-clinical-trial-programs-impact-on-patient-screening-and-trial-enrollment-in-20 2026-08-24 monthly 0.7 https://rjrindex.com/articles/remote-clinical-pharmacist-impact-on-reducing-total-cost-of-care-in-enhancing-oncology-model-enrolle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-of-breast-cancer-and-problems-of-screening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-gift-that-keeps-giving-you-gifts-you-dont-want-mixed-methods-analysis-of-financial-toxicity-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sexual-function-outcomes-in-female-patients-with-pelvic-cancers-treated-with-definitive-chemoradioth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-global-scoping-review-of-barriers-and-strategies-to-implementation-of-geriatric-assessment-in-olde 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reduction-of-postoperative-radiotherapy-in-head-and-neck-squamous-cell-carcinoma-a-single-arm-phas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-therapeutic-response-in-stomach-adenocarcinoma-by-integrating-hampe-and-rna-seq-using-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-environmental-burden-and-cancer-incidence-rates-across-population-subgroups-in-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-risk-factor-severity-and-adverse-cardiovascular-events-a-report-from-the-childhood-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pancreax-artificial-intelligence-driven-diagnosis-of-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accuracy-of-early-detection-of-pancreatic-cancer-using-cfdna-methylation-marker-izfp30 2026-08-24 monthly 0.7 https://rjrindex.com/articles/screening-of-trop2-nectin-4-and-her2-in-osteosarcomas-in-pursuit-of-a-target 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conversion-therapy-for-initially-unresectable-intrahepatic-cholangiocarcinoma-a-multicenter-real-wo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-genetic-and-oncobiome-profiles-of-patients-with-nmibc-a-transcriptomic-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-nanoliposomal-irinotecan-in-metastatic-pancreatic-ductal-adenocarcinoma-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-contemporary-trends-in-diagnosis-stage-and-treatment-outcomes-for-upper-tract-urothelial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tyrosine-kinase-inhibitors-in-children-and-adolescents-with-recurrentrefractory-sarcomas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-cancer-fusionome-and-overexpressed-druggable-oncogenic-signals-in-ik-rasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-phase-ii-study-of-trastuzumab-biosimilar-ct-p6-and-chemotherapy-sox-or-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-detection-and-neoadjuvant-efficacy-prediction-for-esophageal-cancer-using-cfdna-methylation-ba 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-complete-response-and-breast-cancer-survival-post-neoadjuvant-chemotherapy-a-systematic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-dose-escalation-and-expansion-study-of-prame-t-cell-receptor-tcr-engineered-il15-transduce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-impact-of-neo-irasi-wild-type-metastatic-colorectal-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progressive-locally-advanced-or-metastatic-radioiodine-refractory-differentiated-thyroid-cancer-rai-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/durable-responses-in-ici-refractory-or-acquired-resistance-phase-2-study-of-np-g2-044-combined-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-innovative-evidence-based-laboratory-medicine-eblm-test-to-help-doctors-in-the-basic-assessment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-vascular-microenvironment-on-prognosis-in-hepatocellular-carcinoma-a-quantitative-feature 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-omics-approach-using-lipids-and-proteins-for-early-detection-in-individuals-with-signs-and-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combined-hepatocellular-cholangiocarcinoma-a-population-based-retrospective-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-center-investigation-of-an-early-detection-model-utilizing-cfdna-fragmentomics-for-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-efficacy-and-safety-of-cadonilimab-in-the-treatment-of-advanced-gynecological-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/folfox-haictace-combined-with-lenvatinib-plus-tislelizumab-as-a-conversion-therapy-in-initial-unres 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-efficacy-of-pr115002-a-novel-sortilin-targeting-peptide-drug-conjugate-in-platinum-res 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-fragmentomic-tumor-score-algorithm-for-enhanced-minimal-residual-disease-detection-and-prognostic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/folfirinox-the-best-adjuvant-treatment-for-ampullary-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeted-therapies-for-metastatic-pheochromocytoma-and-paraganglioma-a-systematic-review-and-meta-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-informed-management-of-metastatic-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-adebrelimab-with-chidamide-gemcitabine-and-s-1-in-locally-advanced-or-metastatic-pancr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-from-a-multicenter-single-arm-phase-ii-study-of-surufatinib-plus-sintilimab-and-ibi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-in-metabolic-syndrome-and-colorectal-endometrial-and-breast-cancers-in-the-us-19 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hospice-discharges-for-2022-among-patients-admitted-for-the-most-common-malignancies-an-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-and-impact-of-a-digital-care-platform-on-cancer-patients-in-india 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-prostate-cancer-local-recurrence-detection-an-analysis-of-optimal-imaging-modalities 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-social-determinants-of-health-and-immunotherapy-utilization-in-patients-with-stage-iii-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-initial-chemotherapy-dosing-on-subsequent-dosing-patterns-and-treatment-completion-in-earl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adequacy-of-immune-checkpoint-inhibitor-associated-thyroid-function-monitoring-following-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trust-and-communication-among-sexual-and-gender-minority-sgm-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-optimal-care-timeframes-for-culturally-and-linguistically-diverse-populations-and-firs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-busulfan-fludarabine-versus-busulfan-cyclophosphamide-as-a-conditioning-regim 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-west-african-ancestry-reproductive-factors-and-deprivation-with-incidence-of-triple 2026-08-24 monthly 0.7 https://rjrindex.com/articles/symptom-burden-quality-of-life-qol-social-and-behavioral-characteristics-in-young-patients-lt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-liver-to-life-the-overlooked-impact-of-masld-on-digestive-cancer-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/return-to-intended-oncologic-therapy-in-patients-with-metastatic-non-small-cell-lung-cancer-discharg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-metastatic-esophageal-and-gastroesophageal-junction-cancers-a-13-year-single-center-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-itp53i-mutations-and-variant-allelic-frequency-on-survival-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-outcomes-following-reduced-intensity-conditioning-haploidentical-hematopoiet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-for-patients-with-spop-mutated-castration-resistant-prostate-cancer-crpc-treated-with-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-emerin-dysregulation-on-the-very-small-nuclear-phenotype-and-lineage-plasticity-associated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obesity-chemotherapy-dosing-and-toxicity-results-from-the-optimal-breast-cancer-chemotherapy-dosi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-ai-in-oncology-a-performance-comparison-of-chatgpt-4o-and-chatgpt-o1-in-neuroendocrine-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-of-cancer-history-with-markers-of-cognitive-decline-in-a-large-us-national-survey-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-diagnostic-accuracy-of-deep-learning-and-hand-crafted-radiomics-models-for-detecting-lym 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-halp-score-as-a-prognostic-biomarker-in-non-small-cell-lung-cancer-a-comprehensive-meta-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-effusion-lymphoma-in-human-immunodeficiency-virus-hiv-negative-population-a-systematic-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-hospital-outcomes-of-sepsis-in-patients-with-diffuse-large-b-cell-lymphoma-insights-from-nationa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-key-prognostic-indicators-in-wilms-tumor-using-machine-learning-techniques 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lymphoma-in-sub-saharan-africa-report-from-an-oncology-centre-in-nigeria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunodriver-1-driver-alterations-dalts-and-their-immunological-implications-in-early-and-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-exploratory-study-of-clostridium-butyricum-combined-with-neoadjuvant-chemoimmunotherapy-in-urothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-venetoclax-and-ibrutinib-in-relapsedrefractory-chronic-lymphocytic-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-dose-escalation-and-cohort-expansion-phase-iiia-study-of-acr246-an-innovative-5t4-antibody-drug 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-targeted-therapy-versus-immunotherapy-in-metastatic-colorectal-cancer-a-systematic-revi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-based-on-sequencing-of-fruquintinib-regorafenib-and-tas-102-with-or-without-bevac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/observation-or-adjuvant-therapy-the-optimal-regime-for-patients-undergoing-neoadjuvant-chemoradioth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-of-lung-cancer-in-india-insights-from-a-precision-oncology-perspective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-cdk46-inhibitor-in-metastatic-hormone-receptor-positive-breast-cancer-insights-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-of-neoadjuvant-immunochemotherapy-and-identification-of-residual-cancer-cells-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-plasma-biomarkers-with-diagnostic-molecular-markers-for-potential-diagnosis-and-progn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-idh-mutation-and-1p19q-codeletion-on-immune-checkpoint-inhibitor-efficacy-in-recurren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-outcomes-between-open-and-minimally-invasive-hepatic-resections-for-hepatocellular-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-sglt2i-dapagliflozin-in-primary-prevention-of-cardiotoxicity-induced-by-short-term-anthra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/herthena-breast03-a-phase-2-randomized-open-label-study-evaluating-neoadjuvant-patritumab-deruxte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/textbook-outcomes-after-esophagectomy-a-five-year-of-experience-at-a-specialized-centre-in-a-develo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-survival-trends-for-primary-carcinomas-of-the-liver-in-the-pediatric-and-younger-adult 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-monocentric-real-word-experience-of-ct-io-combination-in-advanced-btc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-and-socioeconomic-disparities-in-barretts-esophagus-and-esophageal-cancer-mortality-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-lymph-node-dissection-on-prognosis-in-esophageal-squamous-cell-carcinoma-patients-undergoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retinoblastoma-patient-outcomes-in-the-contemporary-era-the-riverboat-consortium 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-bai3-as-a-potential-biomarker-for-lung-cancer-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-phase-i-trial-of-the-sirpa-monoclonal-antibody-bi-770371-alone-and-in-combination-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-demographics-clinical-features-and-outcomes-of-early-onset-colon-cancer-in-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/care-needs-and-considerations-for-implementing-a-community-based-palliative-care-program-for-women-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-and-safety-of-multimodal-analgesic-management-based-on-the-eras-concept-in-the-periope 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-inhaled-corticosteroids-on-immune-checkpoint-inhibitor-pneumonitis-and-mortality-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-lu177-fapi-09-therapy-in-combination-with-chemotherapy-or-immunotherapy-for-chemo-resistant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-declining-renal-function-on-multiple-myeloma-mm-mortality-in-the-us-1999-2023-a-reg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-glioblastoma-survival-a-seer-based-study-of-demographics-and-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biologically-interpretable-pathomics-driven-transformer-model-with-self-supervised-training-for-outc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/competencies-for-practicing-medical-oncology-with-common-sense-a-global-curricula-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-lymphopenia-rescue-and-ca19-9-levels-with-overall-survival-following-il-15-superagoni 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-monitoring-in-patients-pts-with-advanced-urothelial-carcinoma-auc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/practical-geriatric-assessment-pga-implementation-strategies-and-correlative-evaluations-pace-70 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hepatic-arterial-infusion-chemotherapy-combined-with-donafenib-and-tislelizumab-versus-transcatheter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/administration-of-tarlatamab-in-an-outpatient-setting-utilizing-remote-patient-monitoring-mayo-clin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modification-of-the-novel-rano-clinical-risk-score-for-low-and-middle-income-countries-without-acce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-ono-4578-an-ep4-antagonist-in-combination-with-nivolumab-after-chemoradiation-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-multicenter-clinical-trial-to-evaluate-the-safety-and-efficacy-of-abenacianine-for-injection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-alcohol-intake-and-health-related-quality-of-life-in-breast-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-two-decade-analysis-of-gastric-cancer-mortality-in-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incident-reporting-and-outcomes-of-gastrointestinal-adverse-events-with-immune-checkpoint-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-from-ovarian-cancer-in-women-of-the-united-states-a-21-year-analysis-of-trends-and-dispar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/avelumab-sacituzumab-govitecan-sg-vs-avelumab-monotherapy-as-first-line-1l-maintenance-treatme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-phase-1ab-dose-escalationexpansion-study-of-bg-68501-a-selective-cdk2-inhibito 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ibrutinib-venetoclax-plus-cd20-monoclonal-ab-initial-results-of-oasis-ii-a-prospective-randomized 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concurrent-glp1r-agonist-use-with-chemoimmunotherapy-for-early-stage-triple-negative-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/krascendo-2-a-phase-iii-study-of-divarasib-and-pembrolizumab-vs-pembrolizumab-and-chemotherapy-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-metabolic-syndrome-on-survival-among-patients-with-breast-or-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-propensity-matched-controlled-trial-evaluating-metformin-as-an-adjunct-to-neo-adjuvant-con 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-specific-factors-as-predictors-of-chemotherapy-induced-nausea-and-vomiting-insights-from-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicenter-study-of-the-impact-of-trial-eligibility-criteria-on-enrollment-to-kras-g12c-inhibitor-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-study-of-mt-303-an-innovative-in-vivo-mrna-chimeric-antigen-receptor-car-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liquid-biopsy-for-early-detection-and-monitoring-of-lung-cancer-a-systematic-review-and-meta-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-bisphosphonates-therapy-for-patients-diagnosed-with-multiple-myeloma-a-compr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/melphalanhds-treatment-for-patients-with-hepatic-dominant-metastatic-uveal-melanoma-results-from-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-medically-tailored-meal-mtm-delivery-program-to-reduce-nutritional-decline-and-improve-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-utility-of-a-personalized-ctdna-minimal-residual-disease-test-in-patients-undergoing-cura 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efbemalenograstim-alfa-for-the-primarysecondary-prophylaxis-of-intermediate-risk-febrile-neutropeni 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-the-prevalence-and-prognostic-significance-of-mtap-loss-in-endemic-nasopharyngeal-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neosent-neoadjuvant-anti-pd-1-therapy-for-patients-with-high-risk-clinical-stage-ii-melanoma-with-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decision-analysis-of-pd-1-inhibitor-combined-with-chemotherapy-in-neoadjuvant-therapy-of-resectable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-clinical-benefit-from-immune-checkpoints-and-baseline-radiomic-signature-in-inoperabl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-gene-signatures-to-guide-hrher2-mbc-therapy-in-a-diverse-cohort-insight 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hai-score-an-objective-her2-artificial-intelligence-method-for-accurate-h-score-estimation-from-ihc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mri-lesion-burden-as-a-predictor-of-progression-and-survival-in-smoldering-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-wide-rna-splicing-aberrations-and-their-potential-as-therapeutic-neoantigen-targets 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gene-set-enrichment-analysis-of-melanoma-primary-tumor-transcriptome-to-identify-pathways-associated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-plus-nab-paclitaxel-and-platinum-as-first-line-treatment-in-patients-with-recurrent-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-utilization-of-comprehensive-genomic-profiling-cgp-in-head-and-neck-squamous-cell-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitor-ici-efficacy-in-triple-negative-breast-cancer-tnbc-patients-with-liv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-study-to-assess-the-safety-of-adjuvant-natural-killer-cell-injection-in-combination-with-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-phase-i-study-of-non-viral-cd19cd22bcma-tri-targeting-jl-lightning-car-t-in-relapsedrefract 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expanding-role-of-indocyanine-green-icg-in-head-and-neck-cancer-surgeries-and-reconstructive-proce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-cardiotoxicity-in-breast-cancer-patients-treated-with-doxorubicintrastuzumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-study-on-potential-cross-reactivity-between-hypersensitivity-reactions-to-taxanes-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-in-adolescents-and-young-adults-role-of-schools-in-raising-awareness 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-observational-study-to-evaluate-pattern-of-usage-of-immune-checkpoint-inhibitors-in-the-1st-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alliance-a022101nrg-gi009-a-pragmatic-randomized-phase-iii-trial-evaluating-total-ablative-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-tumor-immune-microenvironment-in-hispanic-and-african-american-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-metformin-on-the-efficacy-of-immune-checkpoint-inhibitors-in-metastatic-melanoma-a-large 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-transposable-element-derived-neoantigens-in-atrx-mutated-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-spatial-profiling-for-identification-of-prognostic-genes-and-molecular-subgroups-in-pleural 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-pembro-with-chemoradiotherapy-crt-as-treatment-for-muscle-invasive-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unveiling-prostaglandin-d2-signaling-axis-in-the-tumor-microenvironment-for-immune-modulation-and-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-prognostic-utility-of-cell-free-cfdna-tumor-fraction-tf-in-metastatic-castration 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-safety-of-radium-223-ra-223-in-metastatic-castration-resistant-prostate-cancer-mcrpc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/qualitative-findings-from-providers-and-patients-for-planning-implementation-of-screening-clinical-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-screening-mammography-among-transgender-and-gender-diverse-tgd-individuals-a-nation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-fibronectinp21-cdkn1a-functional-axis-in-breast-cancer-as-a-marker-of-an-aggressive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/towards-a-shared-understanding-of-the-concept-of-cure-in-early-stage-treatment-of-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-immunotherapy-for-patients-with-advanced-or-metastatic-esophageal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/brain-metastasis-in-patients-with-primary-gastrointestinal-malignancy-on-anti-her2-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-and-racial-disparities-in-esophageal-cancer-admissions-comorbidities-and-outcomes-a-nationwid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-onset-gastric-cancer-a-comparison-of-metastatic-and-locoregional-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serum-and-tumor-immune-cell-distribution-as-predictor-of-response-to-immune-checkpoint-blockade-in-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/likelihood-of-unplanned-readmission-among-oncology-patients-with-a-completed-post-discharge-follow-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-and-demographic-disparities-in-multiple-myeloma-and-cardiovascular-disease-mortality-1999 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-three-month-survival-benefit-of-inpatient-chemotherapy-in-a-safety-net-hospital 2026-08-24 monthly 0.7 https://rjrindex.com/articles/positron-emission-tomography-with-computed-tomography-petct-and-minimal-residual-disease-mrd-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-increase-in-cme-consumption-associated-with-practice-change-in-the-real-world-an-empirical-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-neoadjuvant-disitamab-vedotin-in-combination-with-pertuzumab-with-or-without 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-learning-based-prediction-of-neoadjuvant-therapy-response-in-her2-positive-breast-cancer-throug 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-breast-cancer-awareness-through-artificial-intelligence-bridging-the-gap-for-low-literacy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decoding-immune-dysregulation-in-aml-insights-from-integrated-genomic-and-transcriptomic-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-cladribine-low-dose-cytarabine-and-venetoclax-alternating-with-azacitidine-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-transportation-services-on-completion-of-radiation-therapy-for-gynecologic-malignancie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/corticosteroid-cs-use-and-risk-of-adverse-events-aes-in-patients-pts-treated-for-metastatic-ho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liquid-biopsy-at-an-nci-comprehensive-cancer-center-patterns-of-utilization-performance-and-outco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-prognostic-factors-associated-with-progression-free-survival-in-pts-with-metastatic-egfr-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-penpulimab-combined-with-taxanes-and-carboplatin-in-triple-negative-breast-cancer-a-sin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pattern-of-resistance-on-first-line-egfr-directed-therapy-in-egfr-positive-metastatic-non-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fragmentation-landscape-of-cell-free-dna-in-patients-with-metastatic-castration-resistant-prostate-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-outcomes-with-sipuleucel-t-sip-t-among-black-men-with-metastatic-castrate-resista 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-clinical-trial-treatment-and-area-deprivation-index-in-the-outcomes-of-adolescent-and-youn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prescientai-an-ai-based-digital-histopathological-image-signature-for-risk-of-late-distant-recurren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-use-of-accelerated-approval-oncology-drugs-subsequently-withdrawn-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-quality-initiative-focused-on-biomarker-testing-in-stage-ib-iiia-resected-and-stage-iv-non-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/organ-agnostic-automated-recist-measurements-across-time-points-with-foundation-models 2026-08-24 monthly 0.7 https://rjrindex.com/articles/empowering-minority-patients-a-tailored-education-initiative-for-clinical-trial-awareness-in-thorac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-survivorship-and-caregiver-burden-in-multiple-myeloma-mm-using-machine-learning-ml-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/telemedicine-enabled-synchronous-medical-oncology-and-home-hospice-visits 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systematic-screening-of-perception-of-curability-among-patients-with-advanced-cancer-a-longitudinal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-study-of-antimicrobial-prophylaxis-and-infections-in-patients-with-acute-myeloid-leuke 2026-08-24 monthly 0.7 https://rjrindex.com/articles/physician-patient-communication-and-shared-decision-making-approaches-in-myeloproliferative-neoplasm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precision-calibrated-lightgbm-machine-learning-model-to-predict-serious-adverse-events-in-oncology-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-therapeutic-effect-of-interstitial-brachytherapy-on-locally-inoperable-giant-osteosarcoma-masses 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-addition-of-anti-angiogenic-agents-to-chemotherapy-and-effects-on-progression-free-survival-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/institutional-experience-with-pancreatic-head-versus-bodytail-cancer-a-comparison-of-treatment-out 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-bebt-209-a-primary-cdk4-inhibitor-in-combination-with-gemcitabine-and-carbo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gender-specific-trends-in-disability-adjusted-life-years-dalys-and-mortality-rates-of-pancreatic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-hidden-toll-defining-impacts-of-home-call-on-oncology-fellows 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-a-novel-compound-that-covalently-binds-to-the-hpv16-e6-protein-on-proliferation-of-hpv-ass 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-predictors-of-adverse-clinical-outcomes-in-pancreatic-cancer-using-a-machine-learning-fra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-open-label-study-of-olutasidenib-post-transplant-maintenance-therapy-for-patients-with-id 2026-08-24 monthly 0.7 https://rjrindex.com/articles/secondary-primary-malignancies-spms-with-car-t-cell-therapy-in-rr-dlbcl-from-real-world-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/magnetic-resonance-imaging-based-deep-learning-for-predicting-egfr-mutations-in-metastatic-non-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-cancer-screening-and-preventive-care-access-among-lgbtq-populations-a-cross-section 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-clinical-and-genomic-characterization-of-advanced-urachal-and-non-urachal-adenocarcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-inflammatory-markers-in-glioblastoma-a-meta-analysis-of-nlr-and-plr-stratified 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-ifitm3-with-the-efficacy-of-anti-pd1pd-l1-therapy-and-regulation-of-immunosensitivit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prevalence-and-outcomes-of-syndrome-of-inappropriate-antidiuretic-hormone-secretion-siadh-amon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-trial-of-capecitabine-with-cemiplimab-in-patients-with-hormone-receptor-positive-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-multicenter-open-label-study-of-hsk42360-a-brain-penetrant-braf-inhibitor-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-impacting-treatment-with-a-cdk46i-in-first-line-metastatic-hrher2-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-potential-biomarkers-for-folfiri-plus-aflibercept-as-second-line-treatment-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-study-evaluating-optimal-dose-efficacy-and-safety-of-e7386-lenvatinib-versus-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-homologous-recombination-deficiency-in-advanced-breast-cancer-treated-with-tras 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-cdk46-inhibitors-in-her2-positive-breast-cancer-a-systematic-review-and-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamic-longitudinal-patient-cohorts-using-hospital-electronic-medical-record-emr-data-via-secure 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sinusoidal-obstruction-syndrome-and-other-outcomes-in-pediatric-patients-with-acute-lymphoblastic-le 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-accuracy-of-cell-free-dna-blood-based-tests-in-the-detection-of-gastric-cancer-an-exploratory-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospero-a-phase-3-randomized-placebo-pbo-controlled-study-of-amezalpat-tpst-1120-a-peroxisom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-report-on-the-characterization-of-public-and-private-patients-with-ovarian-cancer-in-chile 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-a-52-gene-ngs-panel-combined-with-shallow-wgs-for-accurate-hrd-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-pathological-insights-from-164-patients-with-ovarian-granulosa-cell-tumors-an-18-year 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-first-line-therapies-for-unresectable-hepatocellular-carcinoma-in-the-united 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-decision-patterns-post-enfortumab-vedotin-plus-pembrolizumab-in-metastatic-urothelial-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicenter-phase-iii-study-of-abemaciclib-and-ramucirumab-in-metastatic-gastroesophageal-adenocarc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-obesity-on-survival-in-non-small-cell-lung-cancer-patients-receiving-immune-checkpoint 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unraveling-gut-gram-negative-antibiotic-resistant-colonization-dynamics-in-hematologic-cancers-insi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-patient-withdrawal-in-cancer-clinical-trials-a-systematic-evaluation-of-reasons-and-trans 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-biomarker-of-pd-l1-expression-phenotypes-in-tumor-and-immune-cells-for-combined-pd-1-and-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-ai-powered-complete-blood-count-panel-for-high-grade-cervical-lesion-identification-a-multicentr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-and-its-correlation-with-survival-in-hormone-receptor-positive-her2-negative-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-influence-of-neutropenia-severity-on-mortality-and-adverse-outcomes-in-chemotherapy-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-landscape-and-therapeutic-vulnerability-of-rras-and-rras2-mutant-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-evolving-landscape-of-academic-and-industry-partnerships-in-gynecologic-oncology-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-nci-designated-cancer-centers-medical-student-education-and-training-initiatives 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-of-maintenance-treatment-in-homologous-recombination-hr-proficient-hgsoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cell-characterization-of-uterine-carcinosarcoma-and-analysis-of-transcriptomic-shifts-in-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-patient-reported-outcome-measure-prom-to-capture-patients-experiences-with-immuno-oncology-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethnic-disparities-in-clinical-trials-for-fda-approved-drugs-in-breast-cancer-a-post-covid-era-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-transportation-barriers-on-rural-cancer-patients-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/delineating-the-role-of-the-microbiome-and-tumor-microenvironment-interactions-driving-mucosal-melan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-of-patients-at-high-risk-for-relapse-by-merlin-assay-cp-gep-in-an-independent-cohor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keymaker-u01e-a-phase-2-umbrella-study-with-rolling-arms-of-investigational-agents-with-or-without 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-inpatient-palliative-care-utilization-among-adolescents-and-young-adults-with-metastatic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-survivorship-care-coordination-between-primary-care-providers-and-cancer-care-clinicians 2026-08-24 monthly 0.7 https://rjrindex.com/articles/medicare-plan-switching-hospice-enrollment-and-place-of-hospice-services-at-the-end-of-life-among 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-gaps-evaluating-the-impact-of-urban-lung-cancer-screening-on-diverse-populations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-of-immunotherapy-early-treatment-failure-in-non-small-cell-lung-cancer-nsclc-using 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-the-bleeding-risk-in-hepatocellular-carcinoma-patients-treated-with-atezolizumabbevacizum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-second-line-cabozantinib-atezolizumab-for-patients-with-advanced-renal-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/belantamab-treatment-of-multiple-myeloma-results-from-part-1-of-the-first-in-human-phase-12-dreamm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-open-label-multi-center-study-of-the-safety-tolerability-and-efficacy-of-iph4502-as-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/earlier-brain-tumor-detection-assessing-the-impact-on-survival-recurrence-inpatient-length-of-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multigene-ngs-assay-for-biomarker-identification-in-621-colorectal-cancer-cases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prophylactic-infusion-of-allogeneic-double-negative-t-cells-as-immune-modulators-to-prevent-relapse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-prospective-open-label-multi-center-single-arm-study-of-sasanlimab-plus-sacituzumab-go 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biologic-correlates-of-circulating-tumor-dna-ctdna-shedding-in-the-intercept-colorectal-cancer-cr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-immediate-elevation-of-inflammatory-cytokines-after-platinum-pemetrexed-and-pembrolizum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ibii-trial-of-radiotherapy-combined-with-doxorubicin-and-pd-1-antibody-for-localized-high-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pre-treatment-counseling-on-uptake-of-hormone-replacement-therapy-in-patients-undergoing-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multimodal-analysis-of-ct-radiomics-and-clinical-variables-in-predicting-immunotherapy-response-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ib-study-to-assess-the-safety-and-efficacy-of-autologous-tumor-infiltrating-lymphocytes-lif 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neutralizing-antibodies-and-lymphocyte-count-as-biomarkers-in-patients-receiving-oncolytic-adenoviru 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-survival-by-race-among-men-with-metastatic-castration-resistant-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-difference-in-the-odds-of-development-of-bleomycin-pulmonary-toxicity-in-patients-with-germ-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quintessential-a-multicenter-phase-2-study-evaluating-the-efficacy-and-safety-of-arlocabtagene-auto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemoimmunotherapy-with-afatinib-for-locally-advanced-head-and-neck-squamous-cell-carcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/estrogen-receptor-expression-in-residual-breast-cancer-following-neoadjuvant-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-and-caregiver-treatment-preferences-for-alk-non-small-cell-lung-cancer-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-of-response-based-clinical-trial-and-machine-learning-generated-real-world-end-points 2026-08-24 monthly 0.7 https://rjrindex.com/articles/attention-driven-multi-scale-analysis-for-accurate-tumor-classification-in-digital-pathology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gut-microbiome-changes-in-pediatric-aml-and-association-with-event-free-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-artificial-intelligence-to-identify-high-risk-profiles-in-early-stage-melanoma-patients-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-in-advanced-intrahepatic-cholangiocarcinoma-using-pembrolizumab-combined-with-le 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-omics-analysis-of-pd-1-inhibitor-combination-in-neoadjuvant-treatment-of-pmmrmss-rectal-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-depatuxizumab-mafodotin-abt-414-in-egfr-amplified-glioblastoma-a-systemati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-hla-g-targeted-car-t-cells-ivs-3001-in-patients-with-advanced-hla-g-positiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serum-thymidine-kinase-activity-tka-as-a-potential-biomarker-in-the-sequential-immunotherapy-and-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-induced-dka-are-sugars-on-the-rise 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prophylactic-interventions-for-oral-toxicities-with-the-gprc5dcd3-bispecific-antibody-talquetamab-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-study-of-benmelstobart-in-combination-with-chemotherapy-followed-by-sequential-combination-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pansoho-phase-ii-trial-of-bay-2927088-in-patients-with-unresectable-or-metastatic-solid-tumors-othe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sosimerasib-monotherapy-in-patients-with-previously-treated-kras-g12c-mutated-non-small-cell-lung-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-following-melanoma-metastasectomy-categorized-by-response-to-immune-checkpoint-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-ribociclib-rib-nonsteroidal-aromatase-inhibitor-nsai-in-natalee-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-bmi-on-car-t-cell-therapy-outcomes-real-world-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-immunotherapy-response-in-advanced-solid-tumors-using-quantitative-imaging-features-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/drug-shortages-demand-action-policy-changes-to-protect-patient-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-year-cardiomyopathy-risk-prediction-in-survivors-of-childhood-cancer-using-electrocardiogram 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combined-genomic-profiling-of-cell-free-dna-cfdna-and-circulating-tumor-cell-dna-ctcdna-in-s1802 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-awt020-a-bifunctional-anti-pd-1il-2-fusion-protein-in-patients-with-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrin-a-subvsub-v-sub3sub-targeted-ima 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-determinants-of-immunotherapy-response-in-the-primary-tumor-of-clear-cell-renal-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiation-omission-in-patients-with-clinically-node-negative-breast-cancer-undergoing-lumpectomy-ro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ziftomenib-in-relapsedrefractory-rr-inpm1i-mutant-acute-myeloid-le 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-camrelizumab-plus-apatinib-and-temozolomide-for-resectable-stage-iiiii-acral-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-kras-g12c-inhibitors-in-metastatic-pancreatic-cancer-a-systematic-review-and-meta-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-letrozole-abemaciclib-and-metformin-in-estrogen-receptor-er-positive-recurrent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/do-obstructive-lung-diseases-affect-outcomes-in-lung-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tirabrutinib-for-the-treatment-of-relapsed-or-refractory-primary-central-nervous-system-lymphoma-ef 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psma-delay-castration-dc-an-open-label-multicenter-randomized-phase-3-study-of-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-metronomic-oral-vinorelbine-combined-with-pd-1-inhibitors-as-first-line-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clear-and-non-clear-cell-renal-cell-carcinomas-and-the-ability-to-engage-in-oxidative-phosphorylatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analytical-validation-and-clinical-performance-of-a-plasma-based-cgp-assay-neo-pantracer-lbx 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-watch-and-wait-strategy-or-surgery-after-neoadjuvant-immunotherapy-for-locally-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-duravelo-1-study-preliminary-results-of-nectin-4-targeting-zelenectide-pevedotin-bt8009 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathomics-based-prediction-of-thymic-epithelial-tumor-subtypes-within-the-french-rythmic-network 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-response-guided-neoadjuvant-sacituzumab-govitecan-and-pembrolizumab-sgp-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarkers-of-emergent-resistance-to-sotorasib-plus-panitumumab-in-ikrasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-to-evaluate-the-safety-and-efficacy-of-ssgj-707-a-bispecific-antibody-targeting-pd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-in-liver-transplant-recipients-with-and-without-obesity-a-propensity-matched-analysis-usin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/computational-pathology-to-predict-docetaxel-benefit-in-patients-with-metastatic-hormone-sensitive-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/moving-beyond-the-traditional-two-step-approach-for-prognosis-prediction-the-bayesarc-model 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-inaticabtagene-autoleucel-in-chinese-patients-with-b-all 2026-08-24 monthly 0.7 https://rjrindex.com/articles/versatile-003-a-phase-3-randomized-open-label-trial-of-pds0101-and-pembrolizumab-compared-with-pe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunoembolization-for-patients-with-uveal-melanoma-hepatic-metastasis-a-single-institution-real-wo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/structural-classification-of-ifoxa1i-alterations-and-their-association 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-data-of-efficacy-and-safety-of-luvometinib-fcn-159-in-pediatric-participants-with-neurofib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trend-of-non-small-cell-lung-cancer-in-young-people 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mri-based-machine-learning-model-for-predicting-early-relapse-in-osteosarcoma-following-neoadjuvant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cisplatin-plus-high-dose-infusional-5-fluorouracil-and-leucovorin-for-breast-cancer-bc-patients-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-testing-and-patient-demographic-disparities-among-breast-cancer-patients-across-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-merkel-cell-carcinoma-a-10-year-population-based-study-in-queensland-australia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-liquid-biopsy-on-health-related-quality-of-life-in-cancer-treatment-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-adjuvant-toripalimab-for-locally-advanced-head-and-neck-squamous-cell-carcinoma-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-alcohol-and-drug-dependence-among-hospitalized-patients-with-cancers-of-the-lip-oral-cavi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-study-of-characteristics-and-outcome-of-immune-checkpoint-inhibitor-renal-toxicities 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-subtype-prevalence-and-the-impact-of-her2-directed-therapy-on-emergency-department-ed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-bmi-on-cdk46-inhibitors-efficacy-and-safety-in-advanced-breast-cancer-results-from-a-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-psychological-intervention-on-perceived-distress-of-cancer-patients-results-from-a-longit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/social-determinants-of-health-sdoh-and-late-mortality-among-survivors-of-childhood-cancer-a-repor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-cognitive-factors-with-lung-cancer-risk-in-the-uk-biobank-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-cellular-immunotherapy-using-vaccine-generated-neoantigen-specific-effector-t-cells 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-resting-mast-cell-infiltration-in-the-sarcoma-microenvironment-with-overall-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-benefit-risk-balance-of-second-line-therapies-for-hrher2-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-b440-an-oral-ibifidobacteriumi-engineered-wt1-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/t-cell-exhaustion-and-pre-existing-t-cell-immunity-in-circulation-as-predictive-biomarkers-for-immun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unmasking-a-rare-complication-immune-checkpoint-inhibitors-icis-and-vogt-koyanagi-harada-vkh-sy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-adapt-001-on-checkpoint-inhibitor-resistance-in-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-testing-practice-patterns-for-lung-cancer-based-on-gender-insights-into-disparities-and-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-small-cell-lung-cancer-in-women-experience-of-the-national-institute-of-oncology-of-rabat-moro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-type-prediction-via-tissue-and-liquid-based-comprehensive-genomic-profiling-high-specificity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/challenges-in-knowledge-graph-generation-for-breast-cancer-using-open-source-llms-and-the-role-of-mc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-genetic-counseling-uptake-for-breast-pancreatic-and-prostate-cancers-at-a-safety-net-hos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-electronic-patient-reported-outcomes-epro-directed-virtual-model-for-addressing-oncology-suppor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-disparities-in-patient-education-for-radiation-therapy-a-cross-sectional-survey-of-practices 2026-08-24 monthly 0.7 https://rjrindex.com/articles/melanoma-burden-in-the-us-1999-2023-rising-incidence-declining-mortality-and-regional-inequities 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-pediatric-oncology-financial-toxicity-outcome-measure-with-content-and-face-validit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iib-study-of-inavolisib-inavo-alone-and-in-combination-with-endocrine-therapy-palbociclib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-a-promising-autologous-therapeutic-cancer-nanovaccine-on-tumor-associated-macrophages-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gastroesophageal-reflux-disease-and-upper-aerodigestive-tract-cancer-risk-a-meta-analysis-of-site-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhanced-efficacy-of-inavolisib-combined-with-anti-pd-1-or-anti-her2-antibody-in-treating-brain-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hematopoietic-stem-cell-transplant-in-multiple-myeloma-an-analysis-of-mortality-costs-and-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-cyclin-e-overexpression-on-anti-tumor-immune-responses-via-activation-of-the-cgassting-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nvl-330-a-selective-her2-tyrosine-kinase-inhibitor-in-patients-with-advanced-or-metastatic-her2-al 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prognostic-and-predictive-value-of-the-immunological-gene-signatures-interferon-gamma-and-tide-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-evolving-therapeutic-landscape-of-stage-iv-lung-squamous-cell-carcinoma-a-13-year-sin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mantle-cell-lymphoma-updated-seer-analysis-from-2000-to-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reflections-on-the-horse-trial-hyperthermic-intraperitoneal-chemotherapy-ibrcai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-trial-of-a-clinical-nurse-specialist-led-enhanced-survivorship-and-early-palliative-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-tumor-shed-markers-ai-driven-tumor-educated-polymorphonuclear-granulocytes-monitoring-for-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/protein-bound-paclitaxelcarboplatin-compared-to-solvent-based-paclitaxelcarboplatin-in-treatment-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-stereotactic-ablative-radiotherapy-sabr-on-detection-of-ctdna-in-patients-with-early-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-disparities-in-cervical-cancer-patients-with-and-without-hiv-at-jaramogi-oginga-odinga-teac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neocircle-investigating-circulating-tumor-dna-dynamics-as-a-predictor-of-survival-in-primary-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-study-on-the-assessment-of-first-line-drug-efficacy-in-advanced-gastric-cancer-by-monitorin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-adjuvant-donafenib-combined-with-pd-1-checkpoint-inhibitor-for-patients-at-high-risk-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-and-supportive-care-practice-patterns-among-older-adults-with-metastatic-pancreatic-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-of-5methylthioadenosine-phosphorylase-imtapi-dele 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-race-ethnicity-and-nativity-on-distribution-and-outcomes-among-women-with-choriocarci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-mortality-and-length-of-hospital-stay-following-palliative-transarterial-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-values-of-sarcopenia-for-unresectable-hepatocellular-carcinoma-treated-with-transarterial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-socioeconomic-deprivation-with-clinical-outcomes-among-hospitalized-patients-with-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-genomic-profiling-in-aya-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-risk-factors-for-the-development-of-pulmonary-hypertension-in-patients-with-myeloprolifera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncofertility-practice-patterns-in-nccn-cancer-centers-after-the-overturn-of-iroe-v-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-de-novo-oligometastatic-oligorecurrent-and-oligoprogressive-prostate-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-patient-outcomes-by-assessing-unmet-social-needs-a-preliminary-study-in-a-urologic-oncolo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-pharmacokinetics-of-mevrometostat-m-in-combination-with-enzalutamide-e-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgery-over-radiation-a-clear-path-for-malignant-phyllodes-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-and-execution-of-nationwide-molecular-tumor-boards-mtbs-in-resource-limited-setting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-study-on-epidemiology-biomarker-test-results-clinical-characteristics-and-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-mortality-from-hematological-malignancies-with-pulmonary-embolism-insights-from-us-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intraoperative-radiation-therapy-versus-partial-breast-irradiation-for-early-stage-breast-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-tiragolumab-and-atezolizumab-in-patients-with-relapsed-or-refractory-smarcb1-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/envafolimab-combined-with-albumin-bound-paclitaxel-and-cisplatin-in-the-neoadjuvant-therapy-for-loca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-effectiveness-of-immersive-virtual-reality-in-reducing-distress-in-patients-with-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adverse-events-profile-of-novel-agents-targeting-immune-checkpoints-beyond-pd-1pd-l1-and-ctla-4-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-sarcopenia-and-surgical-timing-in-locally-advanced-esophageal-squamous-cell-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-chemotherapy-allergy-to-tolerance-desensitization-as-a-safe-alternative-in-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-an-automated-dashboard-to-monitor-unplanned-reoperations-in-a-public-cancer-hospit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/payers-perspectives-on-biosimilars-in-the-us-past-present-and-future 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-abemaciclib-and-niraparib-as-neoadjuvant-therapy-in-hormone-receptor-positive-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-access-barriers-for-patients-with-uterine-malignancies-results-from-a-single-center-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-in-a-latin-american-setting-with-first-line-osimertinib-in-egfr-mutated-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/study-protocol-phase-2-trial-of-re-treatment-with-177lu-psma-617-molecular-radiotherapy-for-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/open-pilot-of-a-culturally-responsive-cognitive-behavioral-intervention-prowess-for-black-and-lat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-artificial-intelligence-ai-powered-spatial-analysis-to-predict-pathologic-complete-response 2026-08-24 monthly 0.7 https://rjrindex.com/articles/drug-eluting-transarterial-chemoembolization-combined-with-anlotinib-for-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-priorities-care-for-older-breast-cancer-survivors-a-patient-centered-approach-to-improve-qu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamic-changes-in-circulating-tumor-dna-among-taiwanese-early-breast-cancer-patients-undergoing-upf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/best-practices-and-key-barriers-for-light-chain-al-amyloidosis-patient-care-at-us-specialized-amyl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-ovarian-function-suppression-ofs-containing-adjuvant-endocrine-therapy-in-premenopau 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-and-resource-utilisation-for-liquid-biopsy-vs-tissue-biopsy-genotyping-in-advanced-nsclc-a-mic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-lungflag-lean-machine-learning-model-to-identify-individuals-with-lung-cancer-using-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-endocrine-therapy-omission-on-survival-in-er-negative-pr-low-1-10-early-stage-breas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tolerability-and-outcomes-with-serial-cycles-of-28-days-of-venetoclax-in-newly-diagnosed-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/food-insecurity-and-disparities-in-mental-health-symptoms-and-severity-among-breast-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-health-literacy-in-cancer-outpatients-receiving-oral-anticancer-drugs-and-followed-by-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/empowering-single-cell-genomics-with-scgpt-precision-clustering-and-genetic-insights-into-acute-lym 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-a-vertically-integrated-health-system-on-the-disparity-of-socioeconomic-status-seen-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-geographical-and-socioeconomic-disparities-in-patients-with-rare-tumors-seer-database-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-delivering-early-palliative-care-via-video-versus-in-person-on-end-of-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/secondary-outcomes-by-prior-definitive-treatment-tx-in-patients-pts-with-high-risk-biochemically-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/research-productivity-of-international-medical-graduate-img-hematology-and-oncology-fellows-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-germline-genetic-testing-in-pancreatic-cancer-a-quality-improvement-project 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-radiotherapy-combined-with-tyrosine-kinase-inhibitors-in-the-treatment-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-targeting-chlorin-e6-heptamethine-cyanine-conjugates-theranostic-agent-for-cancer-imaging-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-a-pilot-oncology-summer-internship-on-early-medical-students-understanding-of-oncolog 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-tis-bgb-a317-plus-chemotherapy-ctchemoradiotherapy-crt-as-positron-emission-tom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tace-halc-combined-with-donafenib-and-immune-checkpoint-inhibitors-for-bclc-stage-c-hcc-patients-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-and-biomarker-analyses-utilizing-circulating-tumor-dna-in-advanced-esophageal-squa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-cldn18-expression-in-a-western-biliary-tract-cancer-population 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-molecular-insights-into-pediatric-acute-myeloid-leukemia-in-resource-constrained-settin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-platinum-free-interval-in-advanced-endometrial-cancer-treatment-a-real-world-study-of-8 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-center-experience-of-male-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-spatial-transcriptomics-and-potential-mechanisms-of-intrinsic-resistance-to-her2-directed-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-features-of-biliary-tract-cancers-in-paired-tissues-and-ctdna-and-an-integrated-molecular-cl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spotlight-on-pre-chemotherapy-alpha-fetoprotein-and-survival-in-ovarian-yolk-sac-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ana-trial-development-of-a-diagnostic-test-and-dynamic-evaluation-of-ctdna-to-optimize-follow-up-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surufatinib-combined-with-gemcitabine-and-cisplatin-and-immune-checkpoint-inhibitor-ici-for-unrese 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peri-operative-blood-transfusion-and-ovarian-cancer-survival-rates-a-systematic-review-and-meta-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-and-allele-specific-analysis-of-germline-iatmi-altera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-a-blood-based-screening-test-for-the-early-detection-of-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-survival-outcomes-in-infused-versus-not-infused-patients-with-aggressive-b-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eliminating-breast-surgery-for-triple-negative-or-hr-her2-breast-cancer-patients-with-clinical-com 2026-08-24 monthly 0.7 https://rjrindex.com/articles/melody-a-prospective-non-interventional-multicenter-cohort-study-to-evaluate-different-imaging-guid-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/contemporary-trends-and-survival-outcomes-in-young-onset-vs-average-onset-metastatic-colorectal-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/malignant-neoplasms-of-central-nervous-system-demographic-and-geographical-disparities-in-the-unite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-of-parent-of-origin-predictions-for-hereditary-cancer-variants-using-proband-only-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-characteristics-of-mismatch-repair-mmr-protein-deficient-colorectal-cancer-crc-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-an-ancestry-specific-variant-near-the-iesr1i-gene-with-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-versus-18f-fdg-pet-ct-in-predicting-long-term-disease-control-in-patients-with-advanced-melano 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-prediction-of-post-transplant-survival-and-stratification-of-hcc-recurrence-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-practice-patterns-in-bone-marrow-biopsies-for-cutaneous-t-cell-lymphoma-a-multicenter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-tumor-burden-or-focality-in-recurrent-low-grade-intermediate-risk-non-muscle-invasive-blad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-utilization-patterns-discontinuation-and-healthcare-resource-utilization-of-fi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-the-future-socio-economic-trends-in-hodgkin-versus-non-hodgkin-lymphoma-survival-outcome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-survival-outcomes-and-adverse-events-with-adjuvant-osimertinib-in-resected-egfr-mutation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-and-prediction-of-long-term-survival-in-es-sclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-role-of-posthumous-organ-donation-attitudes-a-comparative-study-of-egyptian-cancer-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-of-patients-with-anal-adenocarcinoma-in-comparison-to-rectal-adenocarcinoma-a-perspective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tratuzumab-deruxtecan-a-real-world-study-in-the-treatment-of-metastatic-breast-cancer-in-china 2026-08-24 monthly 0.7 https://rjrindex.com/articles/opinions-of-real-world-clinicians-on-endocrine-resistance-in-hrher2-mbc-results-from-the-retract 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molgen-detecting-new-dpyd-variants-for-the-safer-delivery-of-5fu-and-capecitabine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-nivolumab-maintenance-after-autologous-hematopoietic-stem-cell-transplantation-in-rela 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitors-as-a-neoadjuvant-therapy-pre-liver-transplantation-for-hepatobiliary-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-transcriptomics-and-functional-mapping-of-the-suppressive-tme-in-primary-breast-tumor-and-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-patients-surviving-beyond-2-years-post-allogeneic-stem-cell-transplantation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-effectiveness-of-first-line-bruton-tyrosine-kinase-inhibitors-btkis-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/variable-response-rates-across-chemotherapy-regimens-for-severe-idiopathic-multicentric-castleman-di 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-overall-survival-of-head-and-neck-squamous-cell-carcinoma-in-the-us-seer-17-2018-202 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-dose-of-neoadjuvant-ipilimumab-and-nivolumab-in-resectable-melanoma-with-cd8-cell-imaging-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-effects-of-thc-on-migration-proliferation-and-tumor-growth-in-hpv-negative-hnscc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-iza-bren-bl-b01d1-an-egfr-x-her3-bispecific-antibody-drug-conjugate-adc-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inavo120-phase-iii-trial-final-overall-survival-os-analysis-of-first-line-inavolisib-inavoplac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-immune-checkpoint-inhibitors-in-solid-organ-transplant-recipients-a-systemat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-glp1-ra-with-pcsk9i-as-chemosensitizing-method-and-therapy-of-anthracycline-induced-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/changes-in-the-degree-of-satisfaction-and-quality-of-life-in-breast-cancer-patients-who-are-candidat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-steroid-prophylaxis-to-mitigate-crs-enhancing-access-to-bispecific-antibodies-in-rrmm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-serplulimab-and-bevacizumab-combined-with-nab-paclitaxelgemcitabine-followed-by-mfolfox 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-randomized-phase-ii-trial-to-assess-the-efficacy-and-safety-of-neo-adjuvant-olaparibcar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-vanguard-study-an-nci-cancer-screening-research-network-multi-cancer-detection-feasibility-stud 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-for-early-onset-colorectal-cancer-a-retrospective-analysis-of-3369-cases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/international-medical-graduates-imgs-in-leadership-roles-within-academic-oncology-in-the-united-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-lenvatinib-plus-pembrolizumab-versus-placebo-plus-pembrolizumab-in-chinese-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shap-analysis-of-predictive-factors-for-pathologic-complete-response-in-breast-cancer-patients-under 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-randomized-placebo-controlled-clinical-trial-of-can-2409prodrug-in-combination-with-stand 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-and-adjuvant-pembrolizumab-plus-standard-of-care-soc-in-resectable-locally-advanced-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-the-ox40-agonist-bgb-a445-in-combination-with-docetaxel-or-bgb-15025-an-hpk1-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gene-specific-outcomes-in-patients-with-lynch-syndrome-treated-by-immune-checkpoint-blockade-for-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-disitamab-vedotin-rc48-combined-with-toripalimab-as-adjuvant-therapy-after 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjubil-a-phase-ii-study-of-immunotherapy-with-durvalumab-and-tremelimumab-in-combination-with-cape 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-persistent-disparities-in-incidence-mortality-and-survival-of-pancreatic-cancer-a-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-pulmonary-toxicities-in-patients-with-egfr-mutant-non-small-cell-lung-cancer-nsclc-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accuracy-of-large-language-models-for-matching-cancer-patients-to-biomarker-driven-clinical-trials-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-safety-tolerability-and-efficacy-of-bry812-in-patients-with-advanced-solid-tumors-preliminary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-cns-results-from-a-randomized-subset-of-the-phase-2-savannah-study-comparing-savolitini 2026-08-24 monthly 0.7 https://rjrindex.com/articles/secn-15-a-novel-treatment-option-for-patients-with-checkpoint-inhibitor-resistant-tumors-by-targeti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-clinical-factors-associated-with-young-onset-rectal-cancer-is-the-latinx-population 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-hospital-mortality-and-incidence-trends-for-tumor-lysis-syndrome-in-the-united-states-from-2016-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-efficacy-results-from-an-ongoing-phase-iii-trial-of-cts2190-a-prmt1-inhibitor-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dareontm-9-a-phase-ib-study-of-obrixtamig-plus-topotecan-in-patients-pts-with-advanced-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-iza-bren-bl-b01d1-an-egfr-x-her3-bispecific-antibody-drug-conjugate-adc-in-pa-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-pros-in-patients-with-er-her2-advanced-breast-cancer-abc-treated-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-dose-evaluation-of-nivolumab-relatlimab-nivo-rela-in-patients-pts-with-advanced-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathways-to-advance-targeted-and-helpful-serious-illness-conversations-path-sic-a-randomized-clin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/on-shift-resident-education-about-hematologic-and-oncologic-emergencies-a-needs-based-assessment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-prophylactic-corticosteroids-on-toxicities-and-outcomes-in-car-t-cell-therapy-a-cohort-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-we-determine-the-mechanism-behind-cancer-risk-reduction-with-glucagon-like-peptide-1-receptor-ag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/desmoplastic-nodular-medulloblastoma-a-national-cancer-database-analysis-of-patient-demographics-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/short-term-pre-operative-durvalumab-medi-4736-in-early-small-triple-negative-breast-cancer-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lorlatinib-therapy-in-relapsedrefractory-alk-lymphomas-previously-treated-with-tyrosine-kinase-inh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-analysis-of-3-y-results-from-the-pivotal-epcore-nhl-1-study-outcomes-in-patients-pts-with-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-and-patterns-of-care-in-ovarian-carcinoma-patients-with-brain-metastases-a-real-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frailty-assessment-in-patients-with-advancedmetastatic-renal-cell-carcinoma-using-routine-data-coll 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-car-t-cell-therapy-and-bite-therapy-in-relapsedrefractory-diffuse-larg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-disparities-in-receipt-of-guideline-concordant-treatment-for-early-stage-non-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/daily-a-prospective-single-arm-study-evaluating-the-impact-of-vitamin-d-aspirin-exercise-and-die 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-value-of-carbon-nanoparticle-staining-in-identifying-metastatic-lymph-nodes-in-colorectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/body-composition-modulations-during-cyclic-fasting-mimicking-diet-in-patients-with-advanced-solid-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-cytotoxic-effects-of-bioactive-compounds-from-ialcea-roseai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-clinical-and-molecular-characteristics-of-braf-mutated-mss-crc-and-impact-of-inflammat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-dalpiciclib-plus-fulvestrant-and-pyrotinib-in-hr-her2-low-advanced-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-pathologist-directed-comprehensive-comparative-molecular-profiling-for-the-class 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mrd-to-identify-no-evidence-of-disease-status-in-advanced-breast-cancer-with-cr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-magnetic-bead-based-cfdna-extraction-method-for-advanced-ctdna-marker-discovery-and-methylat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cervical-cancer-screening-updates-across-paraguay-evaluation-of-the-national-cancer-control-program 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-a-surgery-based-comprehensive-treatment-on-prognosis-of-stage-iiic-cervical-squamous-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-modeling-based-on-radiomics-and-hematological-parameters-for-recurrence-free-survival-aft 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-in-vitro-and-in-vivo-evaluation-of-novel-anxv-chemo-protein-drug-conjugate-against-human 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-for-obese-patients-with-early-onset-breast-cancer-an-analysis-of-the-national-inp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gender-disparities-in-major-adverse-cardiovascular-and-cerebrovascular-events-among-liver-cancer-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combination-of-zg005-with-etoposide-and-cisplatin-ep-vs-ep-as-the-first-line-therapy-for-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-zg005-a-bispecific-antibody-targeting-pd-1-and-tigit-in-combination-with-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radio-genomics-analysis-of-contrast-enhanced-mri-for-predicting-therapeutic-response-to-lenvatinib-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-immunohistochemistry-for-mismatch-repair-testing-on-endometrial-intraepithelia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-non-canonical-role-of-homologous-recombination-deficiency-in-the-development-of-immune-cold-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-ncdb-study-examining-disparities-in-the-administration-of-immunotherapy-among-advanced-cervical-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultrasensitive-ctdna-monitoring-to-reveal-early-predictors-of-immunotherapy-success-in-advanced-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-hardship-and-non-adherence-to-lifestyle-and-surveillance-recommendations-in-adult-survivor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systematic-review-of-bcma-targeted-therapies-in-relapsedrefractory-rr-multiple-myeloma-mm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicenter-randomized-double-blinded-placebo-controlled-trial-of-ifx-hu20-ifx-as-adjunctive-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hrd-status-and-genomic-characteristics-of-chinese-nsclc-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-access-to-triple-negative-breast-cancer-tnbc-clinical-trials-are-trials-located-near-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-immunogenomic-profile-of-anal-hpv-driven-disease-for-novel-therapeutic-discovery 2026-08-24 monthly 0.7 https://rjrindex.com/articles/observational-study-of-prevalence-management-and-outcomes-of-synchronous-oligometastatic-non-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-fine-particulate-matter-exposure-and-colorectal-cancer-mortality-by-age-at-diagn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-dynamics-in-liver-limited-metastatic-colorectal-cancer-mcrc-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-plasma-proteomic-analysis-a-monitoring-strategy-for-nsclc-patients-treated-with-immuno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-features-and-clinical-panthological-factors-of-cutaneous-malignant-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adherence-to-vaccination-recommendations-in-the-adult-cancer-population 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-place-of-death-among-breast-cancer-patients-in-the-united-states-1999-2023-a-25-year-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/snf-climedin-a-hecog-prospective-randomized-trial-of-digital-support-and-intervention-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/protocol-quality-for-patient-reported-outcomes-in-multiple-myeloma-randomized-controlled-trials-acco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-care-quality-perception-among-cancer-survivors-impact-of-provider-time-spent-and-shared-deci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barbados-first-next-generation-sequencing-of-a-prostate-cancer-sample 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bep-in-intermediate-and-poor-risk-advanced-non-seminomatous-germ-cell-tumor-nsgct-standing-the-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-a-patient-registry-and-novel-follow-up-protocol-to-impact-identification-treatment-and-adher 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-analysis-of-tissue-genomic-sequencing-and-high-purity-circulating-tumor-cell-rna-sequenci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/right-care-right-place-improving-urgent-care-for-breast-cancer-patients-on-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subgroup-analysis-of-efficacy-and-safety-of-fruquintinib-plus-paclitaxel-versus-paclitaxel-in-gastro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-real-world-impact-of-atezolizumab-and-bevacizumab-combination-in-unresectable-hepatoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dna-methylation-signatures-as-predictive-biomarkers-for-chemotherapy-ct-resistance-and-survival-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hematology-oncology-education-in-postgraduate-internal-medicine-programs-in-nepal-current-status-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-hpv-test-with-urine-cytology-in-bladder-cancer-screening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-diversity-in-neuroendocrine-tumors-a-house-divided 2026-08-24 monthly 0.7 https://rjrindex.com/articles/moments-of-connection-between-clinicians-and-patients-in-oncology-a-mixed-methods-exploratory-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/navigating-healthcare-costs-and-family-support-coping-strategies-adopted-by-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-homologous-recombination-related-gene-mutations-in-survival-outcomes-of-first-li 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transforming-data-management-in-clinical-trials-uncovering-crc-pain-points-through-user-research 2026-08-24 monthly 0.7 https://rjrindex.com/articles/homologous-recombination-deficiency-hrd-profiling-in-chinese-pancreatic-ductal-adenocarcinoma-imp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neo-adjuvant-chemo-immunotherapy-in-pancreatic-cancer-results-of-the-australasian-gastrointestinal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-immune-checkpoint-inhibitors-versus-chemotherapy-in-metastatic-urothelial-carcinoma-a-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparison-of-neoadjuvant-chemoimmunotherapy-with-chemotherapy-in-muscle-invasive-bladder 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-venadaparib-plus-irinotecan-in-homologous-recombination-deficiency-hrd-gene-mutations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-dose-albumin-bound-paclitaxel-and-enhancement-of-anti-pd-1-therapy-in-bladder-cancer-by-shaping 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-in-patients-with-mismatch-repair-deficient-colorectal-cancer-a-retrospective-real 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gene-expression-profiling-of-the-tumor-microenvironment-in-asian-american-and-native-hawaiianpacifi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b2-trial-of-onvansertib-in-combination-with-nalirifox-for-first-line-treatment-of-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-clinical-trial-of-s-1-and-paclitaxel-in-combination-followed-by-5-fluorouracilepirubicinc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/receiving-a-cancer-diagnosis-during-hospitalization-and-associations-with-care-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-neoadjuvant-chemotherapy-combined-with-anti-angiogenesis-therapy-and-immunothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-prophylactic-thrombopoietin-combined-with-magnetic-resonance-guided-hematopoieti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-the-alter-e00-study-efficacy-and-safety-of-anlotinib-combined-with-radiotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-by-type-of-insurance-in-the-journey-of-cervical-cancer-care-within-the-context-of-univer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/loss-of-anpep-expression-may-promote-the-development-of-aggressive-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elucidating-contributions-to-burden-of-disease-in-cns-progression-for-egfr-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mytrialist-reach-and-utilization-a-novel-digital-cancer-clinical-trial-finder-and-education-platfor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-hematological-parameters-and-outcomes-in-patients-with-prostate-cancer-treated-with-lu-177 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implications-for-sentinel-lymph-node-biopsy-slnb-omission-in-patients-with-early-stage-node-negati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-utility-of-genomic-profiling-in-prostate-cancer-insights-from-a-phase-i-setting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-exploratory-analysis-of-myelofibrosis-mf-patient-subgroups-by-baseline-hemoglobin-levels-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-of-parpi-related-mdsaml-risk-in-breast-cancer-patients-an-international-collab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-prostate-radiation-therapy-and-survival-among-patients-with-metastatic-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unmet-need-in-adults-and-adolescents-and-young-adults-ayas-with-b-cell-acute-lymphoblastic-leukemi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-healthcare-system-distrust-in-shaping-patients-attitudes-and-beliefs-of-artificial-inte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-receipt-of-surveillance-breast-mri-among-raciallyethnically-diverse-women-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/achieving-global-breast-cancer-initiative-key-performance-indices-for-breast-cancer-patients-in-bots 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-food-and-drug-administration-based-eligibility-criteria-on-demographic-representation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-circadian-rhythms-and-chemotherapy-safety-in-remote-patients-with-pancreatic-ductal-adenoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/common-criticisms-of-the-accelerated-approvals-program-a-context-and-data-driven-assessment-of-over 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-social-and-time-toxicity-in-early-phase-cancer-clinical-trials-the-pearler-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-socio-economic-deprivation-and-cancer-trial-participation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/magnetismm-32-a-phase-3-randomized-study-of-elranatamab-vs-epd-pvd-or-kd-in-patients-with-relapse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-the-incidence-of-non-hodgkin-lymphoma-in-the-middle-east-and-north-africa-over-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploration-on-perioperative-treatment-strategies-of-driver-gene-positive-resectable-non-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-and-prognostic-factors-in-marginal-zone-lymphoma-a-single-center-experience-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-non-ibrca12i-mutations-and-clinico-radio-pathologic-features 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-association-between-dietary-zinc-intake-and-cancer-risk-insights-from-nhanes-2021-20 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sogug-neowin-a-phase-2-open-label-multicenter-multinational-interventional-trial-evaluating-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-to-evaluate-clinical-efficacy-pharmacodynamics-and-exploratory-analysis-of-pemetre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-biomarker-analyses-of-first-line-nivolumab-and-relatlimab-nivo-rela-in-advanced-or-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neotrace-a-multicenter-phase-ii-study-of-neoadjuvant-sacituzumab-govitecan-plus-zimberelimab-follow 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-on-the-management-of-potentially-resectable-stage-ib-iiia-non-small-cell-lung-cancer 2026-08-24 monthly 0.7